Corpus bibliográfico
LITERATURA DE REFERENCIA
Bibliografía consolidada de los 266 capítulos y diez apéndices, deduplicada por DOI, PMID o cita normalizada.
Los ficheros de intercambio están disponibles en JSON, CSV y RIS.
Referencias
Sección titulada «Referencias»-
Zuber ME, Gestri G, Viczian AS, Barsacchi G, Harris WA. Specification of the vertebrate eye by a network of eye field transcription factors. Development. 2003;130(21):5155-67.
-
Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, Okuda S, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature. 2011;472(7341):51-6.
-
Hever AM, Williamson KA, van Heyningen V. Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2. Clin Genet. 2006;69(6):459-70.
-
Williamson KA, FitzPatrick DR. The genetic architecture of microphthalmia, anophthalmia and coloboma. Eur J Med Genet. 2014;57(8):369-80.
-
Zagozewski JL, Zhang Q, Eisenstat DD. Genetic regulation of vertebrate eye development. Clin Genet. 2014;86(5):453-60.
-
Casey MA, Lusk S, Kwan KM. Build me up optic cup: Intrinsic and extrinsic mechanisms of vertebrate eye morphogenesis. Dev Biol. 2021;476:128-136.
-
Esteve P, Bovolenta P. Secreted inducers in vertebrate eye development: more functions for old morphogens. Curr Opin Neurobiol. 2006;16(1):13-9.
-
Graw J. Eye development. Curr Top Dev Biol. 2010;90:343-86.
-
Kwan KM. Coming into focus: the role of extracellular matrix in vertebrate optic cup morphogenesis. Dev Dyn. 2014;243(10):1242-8.
-
Bryan CD, Casey MA, Pfeiffer RL, Jones BW, Kwan KM. Optic cup morphogenesis requires neural crest-mediated basement membrane assembly. Development. 2020;147(4).
- Cardozo MJ, Sánchez-Bustamante E, Bovolenta P. Optic cup morphogenesis across species and related inborn human eye defects. Development. 2023;150(2).
- Owen LJ, Rainger J, Bengani H, Kilanowski F, FitzPatrick DR, Papanastasiou AS. Characterization of an eye field-like state during optic vesicle organoid development. Development. 2023;150(15).
- Hanson IM. PAX6 and congenital eye malformations. Pediatr Res. 2003;54(6):791-6.
- Cvekl A, Callaerts P. PAX6: 25th anniversary and more to learn. Exp Eye Res. 2017;156:10-21.
- Chan BHC, Moosajee M, Rainger J. Closing the Gap: Mechanisms of Epithelial Fusion During Optic Fissure Closure. Front Cell Dev Biol. 2020;8:620774.
- Patel A, Sowden JC. Genes and pathways in optic fissure closure. Semin Cell Dev Biol. 2019;91:55-65.
- Hardy H, Prendergast JG, Patel A, Dutta S, Trejo-Reveles V, Kroeger H, et al. Detailed analysis of chick optic fissure closure reveals Netrin-1 as an essential mediator of epithelial fusion. Elife. 2019;8.
- Patel A, Anderson G, Galea GL, Balys M, Sowden JC. A molecular and cellular analysis of human embryonic optic fissure closure related to the eye malformation coloboma. Development. 2020;147(24).
- Verma AS, Fitzpatrick DR. Anophthalmia and microphthalmia. Orphanet J Rare Dis. 2007;2:47.
- ALSomiry AS, Gregory-Evans CY, Gregory-Evans K. An update on the genetics of ocular coloboma. Hum Genet. 2019;138(8-9):865-880.
- Slavotinek A. Genetics of anophthalmia and microphthalmia. Part 2: Syndromes associated with anophthalmia-microphthalmia. Hum Genet. 2019;138(8-9):831-846.
- George A, Cogliati T, Brooks BP. Genetics of syndromic ocular coloboma: CHARGE and COACH syndromes. Exp Eye Res. 2020;193:107940.
- Yoon KH, Fox SC, Dicipulo R, Lehmann OJ, Waskiewicz AJ. Ocular coloboma: Genetic variants reveal a dynamic model of eye development. Am J Med Genet C Semin Med Genet. 2020;184(3):590-610.
- Onwochei BC, Simon JW, Bateman JB, Couture KC, Mir E. Ocular colobomata. Surv Ophthalmol. 2000;45(3):175-94.
- Williams SE, Mason CA, Herrera E. The optic chiasm as a midline choice point. Curr Opin Neurobiol. 2004;14(1):51-60.
- Sretavan DW, Reichardt LF. Time-lapse video analysis of retinal ganglion cell axon pathfinding at the mammalian optic chiasm: growth cone guidance using intrinsic chiasm cues. Neuron. 1993;10(4):761-77.
- Erskine L, Williams SE, Brose K, Kidd T, Rachel RA, Goodman CS, et al. Retinal ganglion cell axon guidance in the mouse optic chiasm: expression and function of robos and slits. J Neurosci. 2000;20(13):4975-82.
- Kuwajima T, Yoshida Y, Takegahara N, Petros TJ, Kumanogoh A, Jessell TM, et al. Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing. Neuron. 2012;74(4):676-90.
- Inatani M. Molecular mechanisms of optic axon guidance. Naturwissenschaften. 2005;92(12):549-61.
- Murcia-Belmonte V, Erskine L. Wiring the Binocular Visual Pathways. Int J Mol Sci. 2019;20(13).
- Prieur DS, Rebsam A. Retinal axon guidance at the midline: Chiasmatic misrouting and consequences. Dev Neurobiol. 2017;77(7):844-860.
- Rachel RA, Murdoch JN, Beermann F, Copp AJ, Mason CA. Retinal axon misrouting at the optic chiasm in mice with neural tube closure defects. Genesis. 2000;27(1):32-47.
- Morcos Y, Chan-Ling T. Concentration of astrocytic filaments at the retinal optic nerve junction is coincident with the absence of intra-retinal myelination: comparative and developmental evidence. J Neurocytol. 2000;29(9):665-78.
- Gupta T, Kapoor K, Sahni D, Singh B. Mapping the Time Line of Development in Each Layer of Human Foetal Retina. J Clin Diagn Res. 2016;10(3):AC04-7.
- Tsuneishi S, Casaer P. Effects of preterm extrauterine visual experience on the development of the human visual system: a flash VEP study. Dev Med Child Neurol. 2000;42(10):663-8.
- Xin W, Kaneko M, Roth RH, Zhang A, Nocera S, Ding JB, et al. Oligodendrocytes and myelin limit neuronal plasticity in visual cortex. Nature. 2024;633(8031):856-863.
- Fritzsch B, Nichols DH, Echelard Y, McMahon AP. Development of midbrain and anterior hindbrain ocular motoneurons in normal and Wnt-1 knockout mice. J Neurobiol. 1995;27(4):457-69.
- Fritzsch B. Evolution and development of extraocular motor neurons, nerves and muscles in vertebrates. Ann Anat. 2024;253:152225.
- Zacharias AL, Lewandoski M, Rudnicki MA, Gage PJ. Pitx2 is an upstream activator of extraocular myogenesis and survival. Dev Biol. 2011;349(2):395-405.
- Diehl AG, Zareparsi S, Qian M, Khanna R, Angeles R, Gage PJ. Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. Invest Ophthalmol Vis Sci. 2006;47(5):1785-93.
- Kuriki M, Korb A, Comai G, Tajbakhsh S. Interplay between Pitx2 and Pax7 temporally governs specification of extraocular muscle stem cells. PLoS Genet. 2024;20(6):e1010935.
- Whitman MC, Engle EC. Ocular congenital cranial dysinnervation disorders (CCDDs): insights into axon growth and guidance. Hum Mol Genet. 2017;26(R1):R37-R44.
- Angelini C, Trimouille A, Arveiler B, Espil-Taris C, Ichinose N, Lasseaux E, et al. CHN1 and duane retraction syndrome: Expanding the phenotype to cranial nerves development disease. Eur J Med Genet. 2021;64(4):104188.
- Aufderheide K, Whitman MC. Update on Congenital Cranial Dysinnervation Disorders (CCDDs). Int Ophthalmol Clin. 2026;66(2):180-186.
- Williams AL, Bohnsack BL. Neural crest derivatives in ocular development: discerning the eye of the storm. Birth Defects Res C Embryo Today. 2015;105(2):87-95.
- Creuzet S, Vincent C, Couly G. Neural crest derivatives in ocular and periocular structures. Int J Dev Biol. 2005;49(2-3):161-71.
- Gage PJ, Rhoades W, Prucka SK, Hjalt T. Fate maps of neural crest and mesoderm in the mammalian eye. Invest Ophthalmol Vis Sci. 2005;46(11):4200-8.
- Williams AL, Bohnsack BL. The Ocular Neural Crest: Specification, Migration, and Then What?. Front Cell Dev Biol. 2020;8:595896.
- Dryer SE. Functional development of the parasympathetic neurons of the avian ciliary ganglion: a classic model system for the study of neuronal differentiation and development. Prog Neurobiol. 1994;43(3):281-322.
- Müller F, Rohrer H. Molecular control of ciliary neuron development: BMPs and downstream transcriptional control in the parasympathetic lineage. Development. 2002;129(24):5707-17.
- Teär Fahnehjelm K, Dahl S, Martin L, Ek U. Optic nerve hypoplasia in children and adolescents; prevalence, ocular characteristics and behavioural problems. Acta Ophthalmol. 2014;92(6):563-70.
- Borchert M, Garcia-Filion P. The syndrome of optic nerve hypoplasia. Curr Neurol Neurosci Rep. 2008;8(5):395-403.
- Kelberman D, Dattani MT. Genetics of septo-optic dysplasia. Pituitary. 2007;10(4):393-407.
- McCabe MJ, Alatzoglou KS, Dattani MT. Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract Res Clin Endocrinol Metab. 2011;25(1):115-24.
- Pasca L, Politano D, Morelli F, Garau J, Signorini S, Valente EM, et al. Biological pathways leading to septo-optic dysplasia: a review. Orphanet J Rare Dis. 2025;20(1):157.
- Sataite I, Cudlip S, Jayamohan J, Ganau M. Septo-optic dysplasia. Handb Clin Neurol. 2021;181:51-64.
- Ryabets-Lienhard A, Stewart C, Borchert M, Geffner ME. The Optic Nerve Hypoplasia Spectrum: Review of the Literature and Clinical Guidelines. Adv Pediatr. 2016;63(1):127-46.
- Murray A, Schwartz T, Hornung L, Lawson S. Pituitary deficiencies related to optic nerve hypoplasia and visual acuity. Clin Endocrinol (Oxf). 2024;101(5):507-515.
- Hensch TK. Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 2005;6(11):877-88.
- Levelt CN, Hübener M. Critical-period plasticity in the visual cortex. Annu Rev Neurosci. 2012;35:309-30.
- Lieber S, Fernandez-Miranda JC. Anatomy of the Orbit. J Neurol Surg B Skull Base. 2020;81(4):319-332.
- Cunnane ME. Orbital Anatomy. Radiol Clin North Am. 2026;64(4):641-648.
- Deniz MA, Tekinhatun M. Evaluation of lamina papyracea dehiscence with paranasal computed tomography. Eur Arch Otorhinolaryngol. 2024;281(7):3649-3654.
- Açar G, Büyükmumcu M, Güler İ. Computed tomography based analysis of the lamina papyracea variations and morphology of the orbit concerning endoscopic surgical approaches. Braz J Otorhinolaryngol. 2019;85(5):551-559.
- Herzallah IR, Marglani OA, Shaikh AM. Variations of lamina papyracea position from the endoscopic view: a retrospective computed tomography analysis. Int Forum Allergy Rhinol. 2015;5(3):263-70.
- Aladeyelu OS, Burge PM, Atiba PM, Madaree A, Lazarus L. Paranasal sinus mucoceles and its distortion of craniofacial-orbital anatomy: a narrative synthesis. Eur Arch Otorhinolaryngol. 2025;282(6):2799-2810.
- Sowerby LJ, Harris MS, Joshi R, Johnson M, Jenkyn T, Moore CC. Does endoscopic sinus surgery alter the biomechanics of the orbit?. J Otolaryngol Head Neck Surg. 2020;49(1):44.
- Mills RP, Kartush JM. Orbital wall thickness and the spread of infection from the paranasal sinuses. Clin Otolaryngol Allied Sci. 1985;10(4):209-16.
- Tuysuz O, Tekin S, Dablan A, Mutlu SZ, Karagulle M. Anatomical variations of lamina papyracea, internal carotid artery, and optic canal dehiscence and protrusion: a computed tomography retrospective cohort study. BMC Med Imaging. 2026;26(1).
- Pirinc B, Fazliogullari Z, Koplay M, Unver Dogan N, Karabulut AK. Morphometric and morphological evaluation of the optic canal in three different parts in MDCT images. Int Ophthalmol. 2023;43(8):2703-2720.
- Adanir SS, Bakşi YE, Beger O, Bahşi I, Kervancioğlu P, Yalçin ED, et al. Evaluation of the Cranial Aperture of the Optic Canal on Cone-Beam Computed Tomography Images and its Clinical Implications for the Transcranial Approaches. J Craniofac Surg. 2022;33(6):1909-1913.
- Ten B, Beger O, Esen K, Adanır SS, Hamzaoğlu EC, Çiçek F, et al. Anatomic features of the cranial aperture of the optic canal in children: a radiologic study. Surg Radiol Anat. 2021;43(2):187-199.
- Treviño-Gonzalez JL, Santos-Santillana KM, Maldonado-Chapa F, Morales-Del Angel JA, Becerra-Jimenez JA. Anatomical configurations of the optic canal in the sphenoid sinus in a Hispanic population: computed tomography based study. J Laryngol Otol. 2023;137(3):279-284.
- Açar G, Gökşan AS, Aydoğdu D. Computed tomography based evaluation of the association between sphenoid sinus pneumatization patterns and variations of adjacent bony structures in relation to age and gender. Neurosurg Rev. 2024;47(1):349.
- Ozturan O, Yenigun A, Degirmenci N, Aksoy F, Veyseller B. Co-existence of the Onodi cell with the variation of perisphenoidal structures. Eur Arch Otorhinolaryngol. 2013;270(7):2057-63.
- Kutia SA, Yagyaeva SS, Vovk VV, Yarovaya OY. [Applied anatomy of the optic nerve]. Vestn Oftalmol. 2026;142(3):79-85.
- Lacey H, Oliphant H, Smith C, Koenig M, Rajak S. Topographical anatomy of the annulus of Zinn. Sci Rep. 2022;12(1):1064.
- Ma C, Zhu X, Chu X, Xu L, Zhang W, Xu S, et al. Formation and Fixation of the Annulus of Zinn and Relation With Extraocular Muscles: A Plastinated Histologic Study and Its Clinical Significance. Invest Ophthalmol Vis Sci. 2022;63(12):16.
- Kanehira C, Yamamoto M, Hirouchi H, Ishizuka S, Sakiyama K, Higa K, et al. Tendinous annulus of Zinn for a common origin of the extraocular rectus muscles: a histological study of the orbital apex from donated elderly cadavers. Anat Sci Int. 2022;97(4):369-379.
- Naito T, Cho KH, Yamamoto M, Hirouchi H, Murakami G, Hayashi S, et al. Examination of the Topographical Anatomy and Fetal Development of the Tendinous Annulus of Zinn for a Common Origin of the Extraocular Recti. Invest Ophthalmol Vis Sci. 2019;60(14):4564-4573.
- Huang Y, Wang X, Tian ZF, Cai L, Wang XM, Tang D, et al. Microsurgical Anatomy of the Common Tendinous Ring and Its Surgical Implications. Oper Neurosurg. 2025;28(6):862-871.
- Zampieri F, Marrone D, Zanatta A. Should the annular tendon of the eye be named ‘annulus of Zinn’ or ‘of Valsalva’?. Acta Ophthalmol. 2015;93(1):97-9.
- Erbek E, Çiçekcibaşı AE, Açar G, Digilli Ayaş B, Aydoğdu D. Morphometric evaluation of the anatomical relationships between the superior orbital fissure and the orbital structures based on computed tomography images with clinical implications. Int Ophthalmol. 2024;44(1):267.
- Bernardo A, Evins AI, Barbagli G, Kim MG, Kim N, Xia JJ, et al. Tailored Surgical Access to the Cavernous Sinus and Parasellar Region: Assessment of Cavernous Sinus Entry Corridors and the Periclinoid and Pericavernous Surgical Maneuvers. World Neurosurg. 2023;171:e253-e275.
- Badakere A, Patil-Chhablani P. Orbital Apex Syndrome: A Review. Eye Brain. 2019;11:63-72.
- Yeh S, Foroozan R. Orbital apex syndrome. Curr Opin Ophthalmol. 2004;15(6):490-8.
- Saini L, Chakrabarty B, Kumar A, Gulati S. Orbital Apex Syndrome: A Clinico-anatomical Diagnosis. J Pediatr Neurosci. 2020;15(3):336-337.
- Li JXL, Tong JY, Tumuluri K. Orbital apex syndrome in herpes zoster ophthalmicus clinical features, treatment and outcomes: a case series and literature review. Orbit. 2024;43(6):784-789.
- Karatag O, Guclu O, Ozer S, Oztoprak B, Resorlu M, Oztoprak I. Computed tomography analysis of the infraorbital canal and adjacent anatomical structures. J Anat. 2025;246(5):657-665.
- Orellana-Donoso M, Romero-Zucchino D, Fuentes-Abarca A, Aravena-Ríos P, Sanchis-Gimeno J, Konschake M, et al. Infraorbital canal variants and its clinical and surgical implications. A systematic review. Surg Radiol Anat. 2024;46(7):1027-1046.
- Açar G, Özen KE, Güler İ, Büyükmumcu M. Computed tomography evaluation of the morphometry and variations of the infraorbital canal relating to endoscopic surgery. Braz J Otorhinolaryngol. 2018;84(6):713-721.
- Serindere G, Serindere M. Cone beam computed tomographic evaluation of infraorbital canal protrusion into the maxillary sinus and its importance for endoscopic surgery. Braz J Otorhinolaryngol. 2022;88 Suppl 5(Suppl 5):S140-S147.
- Singh J, Rahman RA, Rajion ZA, Abdullah J, Mohamad I. Orbital Morphometry: A Computed Tomography Analysis. J Craniofac Surg. 2017;28(1):e64-e70.
- Fitzhugh A, Naveed H, Davagnanam I, Messiha A. Proposed three-dimensional model of the orbit and relevance to orbital fracture repair. Surg Radiol Anat. 2016;38(5):557-61.
- Ugradar S, Lambros V. Orbital Volume Increases With Age: A Computed Tomography-Based Volumetric Study. Ann Plast Surg. 2019;83(6):693-696.
- Diaconu SC, Dreizin D, Uluer M, Mossop C, Grant MP, Nam AJ. The validity and reliability of computed tomography orbital volume measurements. J Craniomaxillofac Surg. 2017;45(9):1552-1557.
- Sentucq C, Schlund M, Bouet B, Garms M, Ferri J, Jacques T, et al. Overview of tools for the measurement of the orbital volume and their applications to orbital surgery. J Plast Reconstr Aesthet Surg. 2021;74(3):581-591.
- Wagner ME, Gellrich NC, Friese KI, Becker M, Wolter FE, Lichtenstein JT, et al. Model-based segmentation in orbital volume measurement with cone beam computed tomography and evaluation against current concepts. Int J Comput Assist Radiol Surg. 2016;11(1):1-9.
- Piot N, Barry F, Schlund M, Ferri J, Demondion X, Nicot R. 3D printing for orbital volume anatomical measurement. Surg Radiol Anat. 2022;44(7):991-998.
- Peraza LR, Fearington FW, Hernandez-Herrerra GA, Awadallah AS, Wagner LH, Tooley AA, et al. Orbital Decompression for Thyroid Eye Disease: Outcomes by Preoperative Severity and Technique. Am J Rhinol Allergy. 2025;39(4):284-292.
- Leong SC, White PS. Outcomes following surgical decompression for dysthyroid orbitopathy (Graves’ disease). Curr Opin Otolaryngol Head Neck Surg. 2010;18(1):37-43.
- Borumandi F, Hammer B, Kamer L, von Arx G. How predictable is exophthalmos reduction in Graves’ orbitopathy? A review of the literature. Br J Ophthalmol. 2011;95(12):1625-30.
- Grusha YO, Kolodina AS, Kochetkov PA, Chetkarev KV, Sviridenko NY. [Outcomes of modified lateral orbital wall decompression using ultrasonic bone removal]. Vestn Oftalmol. 2025;141(4):21-28.
- Waterhouse N, Lyne J, Urdang M, Garey L. An investigation into the mechanism of orbital blowout fractures. Br J Plast Surg. 1999;52(8):607-12.
- Lozada KN, Cleveland PW, Smith JE. Orbital Trauma. Semin Plast Surg. 2019;33(2):106-113.
- Kim YH, Park Y, Chung KJ. Considerations for the Management of Medial Orbital Wall Blowout Fracture. Arch Plast Surg. 2016;43(3):229-36.
- Lentskevich MA, Nguyen A, Choudhary A, Obaid O, Purnell CA. What Computed Tomography Findings Are Predictive of Posttraumatic Enophthalmos in Orbital Fractures?. Plast Reconstr Surg. 2025;155(2):402e-413e.
- Kansakar P, Sundar G. Vision loss associated with orbital surgery - a major review. Orbit. 2020;39(3):197-208.
- Robinson D, Wilcsek G, Sacks R. Orbit and orbital apex. Otolaryngol Clin North Am. 2011;44(4):903-22, viii.
- Cannon PS, Rutherford SA, Richardson PL, King A, Leatherbarrow B. The surgical management and outcomes for spheno-orbital meningiomas: a 7-year review of multi-disciplinary practice. Orbit. 2009;28(6):371-6.
- Sansa-Perna A, Gras-Cabrerizo JR, Montserrat-Gili JR, Rodríguez-Álvarez F, Massegur-Solench H, Casasayas-Plass M. Our experience in the management of orbital complications in acute rhinosinusitis. Acta Otorrinolaringol Esp (Engl Ed). 2020;71(5):296-302.
- Nghiem AZ, Sanz-Magallon Duque de Estrada B, Farwana R, Osborne SF. Pediatric preseptal and orbital cellulitis - a 6 year experience from a London tertiary centre. Orbit. 2024;43(3):301-306.
- Johnston JL. Parasellar syndromes. Curr Neurol Neurosci Rep. 2002;2(5):423-31.
- Bhatti MT. Orbital syndromes. Semin Neurol. 2007;27(3):269-87.
- Kirsch CFE. Imaging of Sella and Parasellar Region. Neuroimaging Clin N Am. 2021;31(4):541-552.
- Go JL, Rajamohan AG. Imaging of the Sella and Parasellar Region. Radiol Clin North Am. 2017;55(1):83-101.
- Reddy RK, Reddy RK, Jyung RW, Eloy JA, Liu JK. Gruber, Gradenigo, Dorello, and Vail: key personalities in the historical evolution and modern-day understanding of Dorello’s canal. J Neurosurg. 2016;124(1):224-33.
- Sage MR, Blumbergs PC, Mulligan BP, Fowler GW. The diaphragma sellae: its relationship to the configuration of the pituitary gland. Radiology. 1982;145(3):703-8.
- Ferreri AJ, Garrido SA, Markarian MG, Yañez A. Relationship between the development of diaphragma sellae and the morphology of the sella turcica and its content. Surg Radiol Anat. 1992;14(3):233-9.
- Campero A, Martins C, Yasuda A, Rhoton AL Jr. Microsurgical anatomy of the diaphragma sellae and its role in directing the pattern of growth of pituitary adenomas. Neurosurgery. 2008;62(3):717-23; discussion 717-23.
- Cabuk B, Anik I, Kokturk S, Ceylan S, Ceylan S. Anatomic and histologic features of diaphragma sellae that effects the suprasellar extension. J Clin Neurosci. 2020;71:234-244.
- Guinto Balanzar G, Abdo M, Mercado M, Guinto P, Nishimura E, Arechiga N. Diaphragma sellae: a surgical reference for transsphenoidal resection of pituitary macroadenomas. World Neurosurg. 2011;75(2):286-93.
- Lenz AM, Root AW. Empty sella syndrome. Pediatr Endocrinol Rev. 2012;9(4):710-5.
- Kinjo T, al-Mefty O, Ciric I. Diaphragma sellae meningiomas. Neurosurgery. 1995;36(6):1082-92.
- Xu Y, Abhinav K, Rychen J, Arifianto MR, Lee CK, Vigo V, et al. Pituitary transposition techniques: surgical anatomy and technical nuances. J Neurosurg. 2025;143(5):1350-1363.
- Kawase T, van Loveren H, Keller JT, Tew JM. Meningeal architecture of the cavernous sinus: clinical and surgical implications. Neurosurgery. 1996;39(3):527-34; discussion 534-6.
- Kong YX, Wright G, Pesudovs K, O’Day J, Wainer Z, Weisinger HS. Horner syndrome. Clin Exp Optom. 2007;90(5):336-44.
- Zhang J, Stringer MD. Ophthalmic and facial veins are not valveless. Clin Exp Ophthalmol. 2010;38(5):502-10.
- Caranfa JT, Yoon MK. Septic cavernous sinus thrombosis: A review. Surv Ophthalmol. 2021;66(6):1021-1030.
- Reis CV, Gonzalez FL, Zabramski JM, Hassan A, Deshmukh P, Albuquerque FC, et al. Anatomy of the superior ophthalmic vein approach for direct endovascular access to vascular lesions of the orbit and cavernous sinus. Neurosurgery. 2009;64(5 Suppl 2):318-23; discussion 323.
- Najera E, Ibrahim B, Muhsen BA, Ali A, Sanchez C, Obrzut M, et al. Blood Supply of Cranial Nerves Passing Through the Cavernous Sinus: An Anatomical Study and Its Implications for Microsurgical and Endoscopic Cavernous Sinus Surgery. Front Oncol. 2021;11:702574.
- d’Avella E, Tschabitscher M, Santoro A, Delfini R. Blood supply to the intracavernous cranial nerves: comparison of the endoscopic and microsurgical perspectives. Neurosurgery. 2008;62(5 Suppl 2):ONS305-10; discussion ONS310-1.
- Conti M, Prevedello DM, Madhok R, Faure A, Ricci UM, Schwarz A, et al. The antero-medial triangle: the risk for cranial nerves ischemia at the cavernous sinus lateral wall. Anatomic cadaveric study. Clin Neurol Neurosurg. 2008;110(7):682-6.
- Corvino S, Villanueva-Solórzano PL, Offi M, Armocida D, Nonaka M, Iaconetta G, et al. A New Perspective on the Cavernous Sinus as Seen through Multiple Surgical Corridors: Anatomical Study Comparing the Transorbital, Endonasal, and Transcranial Routes and the Relative Coterminous Spatial Regions. Brain Sci. 2023;13(8).
- Martins C, Yasuda A, Campero A, Rhoton AL Jr. Microsurgical anatomy of the oculomotor cistern. Neurosurgery. 2006;58(4 Suppl 2):ONS-220-7; discussion ONS-227-8.
- van Overbeeke JJ, Jansen JJ, Tulleken CA. The cavernous sinus syndrome. An anatomical and clinical study. Clin Neurol Neurosurg. 1988;90(4):311-9.
- Bosley TM, Schatz NJ. Clinical diagnosis of cavernous sinus syndromes. Neurol Clin. 1983;1(4):929-53.
- Mahalingam HV, Mani SE, Patel B, Prabhu K, Alexander M, Fatterpekar GM, et al. Imaging Spectrum of Cavernous Sinus Lesions with Histopathologic Correlation. Radiographics. 2019;39(3):795-819.
- Aygun N, Erly WK, Farinhas JM. Imaging of the Cavernous Sinus. Radiol Clin North Am. 2026;64(4):707-718.
- Yilmaz U. [Carotid-cavernous fistulas]. Radiologie (Heidelb). 2024;64(3):182-188.
- Shi X, Han H, Zhao J, Zhou C. Microsurgical anatomy of the superior orbital fissure. Clin Anat. 2007;20(4):362-6.
- Kshettry VR, Lee JH, Ammirati M. The Dorello canal: historical development, controversies in microsurgical anatomy, and clinical implications. Neurosurg Focus. 2013;34(3):E4.
- Umansky F, Elidan J, Valarezo A. Dorello’s canal: a microanatomical study. J Neurosurg. 1991;75(2):294-8.
- Maślanka K, Zielinska N, Tubbs RS, Haładaj R, Konschake M, Niemiec M, et al. The effect of morphological variability of Dorello’s canal on surgical procedures - a review. Ann Anat. 2022;243:151939.
- Destrieux C, Velut S, Kakou MK, Lefrancq T, Arbeille B, Santini JJ. A new concept in Dorello’s canal microanatomy: the petroclival venous confluence. J Neurosurg. 1997;87(1):67-72.
- Ozveren MF, Erol FS, Alkan A, Kocak A, Onal C, Türe U. Microanatomical architecture of Dorello’s canal and its clinical implications. Neurosurgery. 2007;60(2 Suppl 1):ONS1-7; discussion ONS7-8.
- Ono K, Arai H, Endo T, Tsunoda A, Sato K, Sakai T, et al. Detailed MR imaging anatomy of the abducent nerve: evagination of CSF into Dorello canal. AJNR Am J Neuroradiol. 2004;25(4):623-6.
- Smith G, Tuna IS, Massini TC, Tufan F, Albayram MS. Detailed imaging of abducens nerve anatomy using contrast-enhanced 3D-TOF MR angiography. Clin Imaging. 2021;79:330-336.
- Rubinstein D, Stears RL, Stears JC. Trigeminal nerve and ganglion in the Meckel cave: appearance at CT and MR imaging. Radiology. 1994;193(1):155-9.
- Yousry I, Moriggl B, Schmid UD, Naidich TP, Yousry TA. Trigeminal ganglion and its divisions: detailed anatomic MR imaging with contrast-enhanced 3D constructive interference in the steady state sequences. AJNR Am J Neuroradiol. 2005;26(5):1128-35.
- Williams LS, Schmalfuss IM, Sistrom CL, Inoue T, Tanaka R, Seoane ER, et al. MR imaging of the trigeminal ganglion, nerve, and the perineural vascular plexus: normal appearance and variants with correlation to cadaver specimens. AJNR Am J Neuroradiol. 2003;24(7):1317-23.
- Malhotra A, Tu L, Kalra VB, Wu X, Mian A, Mangla R, et al. Neuroimaging of Meckel’s cave in normal and disease conditions. Insights Imaging. 2018;9(4):499-510.
- Becker M, Kohler R, Vargas MI, Viallon M, Delavelle J. Pathology of the trigeminal nerve. Neuroimaging Clin N Am. 2008;18(2):283-307, x.
- Vincentelli F, Caruso G, Grisoli F, Rabehanta P, Andriamamonjy C, Gouaze A. Microsurgical anatomy of the cisternal course of the perforating branches of the posterior communicating artery. Neurosurgery. 1990;26(5):824-31.
- Marinković S, Gibo H. The neurovascular relationships and the blood supply of the oculomotor nerve: the microsurgical anatomy of its cisternal segment. Surg Neurol. 1994;42(6):505-16.
- Tsutsumi S, Miranda JC, Ono H, Yasumoto Y. The cisternal segments of the oculomotor nerve: a magnetic resonance imaging study. Surg Radiol Anat. 2017;39(3):323-331.
- Ruscalleda J. Imaging of parasellar lesions. Eur Radiol. 2005;15(3):549-59.
- Bashari WA, Senanayake R, Fernández-Pombo A, Gillett D, Koulouri O, Powlson AS, et al. Modern imaging of pituitary adenomas. Best Pract Res Clin Endocrinol Metab. 2019;33(2):101278.
- Bouthillier A, van Loveren HR, Keller JT. Segments of the internal carotid artery: a new classification. Neurosurgery. 1996;38(3):425-32; discussion 432-3.
- Melé MV, Puigdellívol-Sánchez A, Mavar-Haramija M, Juanes-Méndez JA, Román LS, De Notaris M, et al. Review of the main surgical and angiographic-oriented classifications of the course of the internal carotid artery through a novel interactive 3D model. Neurosurg Rev. 2020;43(2):473-482.
- Ovalle Torres CS, Reyes Soto G, Campero Á, Castillo Rangel C, Gonzalez A, Cherian I, et al. The trinity of the internal carotid artery: Unifying terminologies of the main classifications to improve its surgical understanding. Surg Neurol Int. 2025;16:177.
- Baz RA, Scheau C, Niscoveanu C, Bordei P. Morphometry of the Entire Internal Carotid Artery on CT Angiography. Medicina (Kaunas). 2021;57(8).
- Song JX, Lin XM, Hao ZQ, Wu SD, Xing YX. Ocular manifestations of internal carotid artery dissection. Int J Ophthalmol. 2019;12(5):834-839.
- Baumgartner R, Bogousslavsky J. Clinical manifestations of carotid dissection. Front Neurol Neurosci. 2005;20:70-76.
- Egan RA, Lutsep HL. Prevalence of Retinal Emboli and Acute Retinal Artery Occlusion in Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020;29(2):104446.
- Romano JG, Babikian VL, Wijman CA, Hedges TR 3rd. Retinal ischemia in aortic arch atheromatous disease. J Neuroophthalmol. 1998;18(4):237-41.
- Jiménez-Castellanos J, Carmona A, Castellanos L, Catalina-Herrera CJ. Microsurgical anatomy of the human ophthalmic artery: a mesoscopic study of its origin, course and collateral branches. Surg Radiol Anat. 1995;17(2):139-43, 14-6.
- Hayreh SS. Orbital vascular anatomy. Eye (Lond). 2006;20(10):1130-44.
- Bonasia S, Bojanowski M, Robert T. Embryology and anatomical variations of the ophthalmic artery. Neuroradiology. 2020;62(2):139-152.
- Toma N. Anatomy of the Ophthalmic Artery: Embryological Consideration. Neurol Med Chir (Tokyo). 2016;56(10):585-591.
- Bonasia S, Smajda S, Ciccio G, Robert T. Anatomic and Embryologic Analysis of the Dural Branches of the Ophthalmic Artery. AJNR Am J Neuroradiol. 2021;42(3):414-421.
- Zhao WR, Wang HB, Luo CE, Kong XX, Zhan WF, Luo SK. Three-Dimensional Computed Tomographic Study on the Periorbital Branches of the Ophthalmic Artery: Arterial Variations and Clinical Relevance. Aesthet Surg J. 2019;39(10):1109-1117.
- Kareem ZM, Muthana A, Hassan SF, Ahmed FO, Hadi RT, Algburi HA, et al. Supraorbital artery: Anatomical variations and neurosurgical applications. Surg Neurol Int. 2023;14:318.
- Matsumaru Y, Alvarez H, Rodesch G, Lasjaunias PL. Embolisation of branches of the ophthalmic artery. Interv Neuroradiol. 1997;3(3):239-45.
- Giotta Lucifero A, Baldoncini M, Bruno N, Tartaglia N, Ambrosi A, Marseglia GL, et al. Microsurgical Neurovascular Anatomy of the Brain: The Posterior Circulation (Part II). Acta Biomed. 2021;92(S4):e2021413.
- Haegelen C, Berton E, Darnault P, Morandi X. A revised classification of the temporal branches of the posterior cerebral artery. Surg Radiol Anat. 2012;34(5):385-91.
- Jongen JC, Franke CL, Soeterboek AA, Versteege CW, Ramos LM, van Gijn J. Blood supply of the posterior cerebral artery by the carotid system on angiograms. J Neurol. 2002;249(4):455-60.
- van Raamt AF, Mali WP, van Laar PJ, van der Graaf Y. The fetal variant of the circle of Willis and its influence on the cerebral collateral circulation. Cerebrovasc Dis. 2006;22(4):217-24.
- Frid P, Wasselius J, Drake M, Wu O, Petersson J, Rost NS, et al. Fetal posterior cerebral artery configurations in an ischemic stroke versus an unselected hospital population. Acta Neurol Scand. 2022;145(3):297-304.
- Shaban A, Albright KC, Boehme AK, Martin-Schild S. Circle of Willis Variants: Fetal PCA. Stroke Res Treat. 2013;2013:105937.
- Danyel LA, Brachaczek IA, Röhl JE, Piper S, Connolly F. Validation of an Oscillation Test for the Sonographic Assessment of Fetal-Type Posterior Cerebral Artery Variants in Migraine Patients with Visual Aura. Ultrasound Med Biol. 2022;48(3):512-519.
- Caplan LR, DeWitt LD, Pessin MS, Gorelick PB, Adelman LS. Lateral thalamic infarcts. Arch Neurol. 1988;45(9):959-64.
- Johansson T. Occipital infarctions associated with hemiparesis. Eur Neurol. 1985;24(4):276-80.
- Lieschke F, Rauch M, Roller B, Schaefer JH, Schaller-Paule MA. Symptoms, Imaging Features, Treatment Decisions, and Outcomes of Patients with Top of the Basilar Artery Syndrome: Experiences from a Comprehensive Stroke Center. Neurocrit Care. 2025;43(1):69-79.
- Ciacciarelli A, Francalanza I, Giammello F, Galletta K, Toscano A, Musolino RF, et al. Prevalence, clinical features, and radiological pattern of artery of Percheron infarction: a challenging diagnosis. Neurol Sci. 2023;44(7):2413-2419.
- Arnold M, Bousser M. Clinical manifestations of vertebral artery dissection. Front Neurol Neurosci. 2005;20:77-86.
- Gottesman RF, Sharma P, Robinson KA, Arnan M, Tsui M, Ladha K, et al. Clinical characteristics of symptomatic vertebral artery dissection: a systematic review. Neurologist. 2012;18(5):245-54.
- Jones JD, Castanho P, Bazira P, Sanders K. Anatomical variations of the circle of Willis and their prevalence, with a focus on the posterior communicating artery: A literature review and meta-analysis. Clin Anat. 2021;34(7):978-990.
- Enyedi M, Scheau C, Baz RO, Didilescu AC. Circle of Willis: anatomical variations of configuration. A magnetic resonance angiography study. Folia Morphol (Warsz). 2023;82(1):24-29.
- Diljohn J, Rampersad F, Maharaj P, Parmesar K. Anatomical variations in the circle of Willis on magnetic resonance angiography in a south Trinidad population. BJR Open. 2024;6(1):tzad002.
- Shatri J, Cerkezi S, Ademi V, Reci V, Bexheti S. Anatomical variations and dimensions of arteries in the anterior part of the circle of Willis. Folia Morphol (Warsz). 2019;78(2):259-266.
- Hindenes LB, Ingebrigtsen T, Isaksen JG, Håberg AK, Johnsen LH, Herder M, et al. Anatomical variations in the circle of Willis are associated with increased odds of intracranial aneurysms: The Tromsø study. J Neurol Sci. 2023;452:120740.
- Chuck C, Taman M, Moody S, Ozcan E, Pham J, Teshome AA, et al. Impact of Circle of Willis Anatomical Variations on Outcomes in Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2026;44(3):888-899.
- Henry BM, Roy J, Ramakrishnan PK, Vikse J, Tomaszewski KA, Walocha JA. Association of migraine headaches with anatomical variations of the Circle of Willis: Evidence from a meta-analysis. Neurol Neurochir Pol. 2015;49(4):272-7.
- Hamming AM, van Walderveen MAA, Mulder IA, van der Schaaf IC, Kappelle LJ, Velthuis BK, et al. Circle of Willis variations in migraine patients with ischemic stroke. Brain Behav. 2019;9(3):e01223.
- Macchi C, Catini C. The anatomy and clinical significance of the collateral circulation between the internal and external carotid arteries through the ophthalmic artery. Ital J Anat Embryol. 1993;98(1):23-9.
- van Laar PJ, van der Grond J, Bremmer JP, Klijn CJ, Hendrikse J. Assessment of the contribution of the external carotid artery to brain perfusion in patients with internal carotid artery occlusion. Stroke. 2008;39(11):3003-8.
- Hilgertner L, Szostek M, Malek AK, Staszkiewicz W. Collateral role of the external carotid artery and its branches in occlusion of the internal carotid artery. Int Angiol. 1994;13(1):5-9.
- Tanaka T, Doijiri R, Saito K, Kajimoto K, Ihara M, Yamagami H, et al. Validation of ultrasound parameters to assess collateral flow via ophthalmic artery in internal carotid artery occlusion. J Stroke Cerebrovasc Dis. 2014;23(5):1177-82.
- Souma N, Tasaka Y, Nakauchi K, Kubota Y, Amano Y, Sogabe T. A Case of Reversed Ophthalmic Artery Flow without Occlusion of the Internal Carotid Artery. Jpn J Ophthalmol. 2000;44(5):572.
- Liu Y, Dong MH, Hu B, Li YZ, Liang CM, Qiu F. [Collateral circulation compensation mode in patients with severe bilateral internal carotid artery stenosis/occlusion]. Zhonghua Nei Ke Za Zhi. 2021;60(8):739-743.
- Bisschops RH, Klijn CJ, Kappelle LJ, van Huffelen AC, van der Grond J. Collateral flow and ischemic brain lesions in patients with unilateral carotid artery occlusion. Neurology. 2003;60(9):1435-41.
- Etminan N, Ruigrok YM, Hackenberg KAM, Vergouwen MDI, Krings T, Rinkel GJE. Epidemiology, pathogenesis, and emerging concepts in unruptured intracranial aneurysms. Lancet Neurol. 2025;24(11):945-957.
- Silva MA, See AP, Dasenbrock HH, Patel NJ, Aziz-Sultan MA. Vision outcomes in patients with paraclinoid aneurysms treated with clipping, coiling, or flow diversion: a systematic review and meta-analysis. Neurosurg Focus. 2017;42(6):E15.
- Lai LT, Morgan MK. Outcomes for unruptured ophthalmic segment aneurysm surgery. J Clin Neurosci. 2013;20(8):1127-33.
- Sai Kiran NA, Sivaraju L, Vidyasagar K, Raj V, Rao AS, Mohan D, et al. Intradural “limited drill” technique of anterior clinoidectomy and optic canal unroofing for microneurosurgical management of ophthalmic segment and PCOM aneurysms-review of surgical results. Neurosurg Rev. 2020;43(2):555-564.
- Adeeb N, Griessenauer CJ, Foreman PM, Moore JM, Motiei-Langroudi R, Chua MH, et al. Comparison of Stent-Assisted Coil Embolization and the Pipeline Embolization Device for Endovascular Treatment of Ophthalmic Segment Aneurysms: A Multicenter Cohort Study. World Neurosurg. 2017;105:206-212.
- Güresir E, Schuss P, Setzer M, Platz J, Seifert V, Vatter H. Posterior communicating artery aneurysm-related oculomotor nerve palsy: influence of surgical and endovascular treatment on recovery: single-center series and systematic review. Neurosurgery. 2011;68(6):1527-33; discussion 1533-4.
- Abo Kasem R, Cunningham C, Elawady SS, Sowlat MM, Babool S, Hulou S, et al. Oculomotor nerve palsy recovery following microsurgery vs. endovascular treatment of posterior communicating artery aneurysms: a comparative meta-analysis of short- and long-term outcomes. Neurosurg Rev. 2024;47(1):904.
- Nikova AS, Sioutas GS, Sfyrlida K, Tripsianis G, Karanikas M, Birbilis T. Oculomotor nerve palsy due to posterior communicating artery aneurysm: Clipping vs coiling. Neurochirurgie. 2022;68(1):86-93.
- Zhong W, Zhang J, Shen J, Zhang P, Wang D, Su W, et al. Posterior communicating aneurysm with oculomotor nerve palsy: Predictors of nerve recovery. J Clin Neurosci. 2019;59:62-67.
- Hall S, Sadek AR, Dando A, Grose A, Dimitrov BD, Millar J, et al. The Resolution of Oculomotor Nerve Palsy Caused by Unruptured Posterior Communicating Artery Aneurysms: A Cohort Study and Narrative Review. World Neurosurg. 2017;107:581-587.
- Ge Y, Lai Q, Zhang Y, Wang Y, Xu X. Oculomotor Nerve Palsy Secondary to Posterior Communicating Artery Aneurysm: A Narrative Review and Proposed Treatment Algorithm. Rev Neurol. 2025;80(10):40930.
- Hayreh SS. The blood supply of the optic nerve head and the evaluation of it - myth and reality. Prog Retin Eye Res. 2001;20(5):563-93.
- Hayreh SS. Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol. 1985;59(3):217-46.
- Ruskell G. Blood flow in the Zinn-Haller circle. Br J Ophthalmol. 1998;82(12):1351.
- Ko MK, Kim DS, Ahn YK. Morphological variations of the peripapillary circle of Zinn-Haller by flat section. Br J Ophthalmol. 1999;83(7):862-6.
- Jonas JB, Jonas SB. Histomorphometry of the circular peripapillary arterial ring of Zinn-Haller in normal eyes and eyes with secondary angle-closure glaucoma. Acta Ophthalmol. 2010;88(8):e317-22.
- Ohno-Matsui K, Futagami S, Yamashita S, Tokoro T. Zinn-Haller arterial ring observed by ICG angiography in high myopia. Br J Ophthalmol. 1998;82(12):1357-62.
- Ohno-Matsui K, Kasahara K, Moriyama M. Detection of Zinn-Haller arterial ring in highly myopic eyes by simultaneous indocyanine green angiography and optical coherence tomography. Am J Ophthalmol. 2013;155(5):920-6.
- Ishida T, Jonas JB, Ishii M, Shinohara K, Ikegaya Y, Ohno-Matsui K. PERIPAPILLARY ARTERIAL RING OF ZINN-HALLER IN HIGHLY MYOPIC EYES AS DETECTED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2017;37(2):299-304.
- Jonas JB, Holbach L, Panda-Jonas S. Peripapillary arterial circle of Zinn-Haller: location and spatial relationships with myopia. PLoS One. 2013;8(11):e78867.
- Kim JH, Yoon J, Na KI, Hong RK, Lee WJ. Association of Peripapillary Arterial Circle of Zinn-Haller With Glaucoma in Highly Myopic Eyes. J Glaucoma. 2025;34(3):205-215.
- Hiraoka M, Inoue K, Ninomiya T, Takada M. Ischaemia in the Zinn-Haller circle and glaucomatous optic neuropathy in macaque monkeys. Br J Ophthalmol. 2012;96(4):597-603.
- Hayreh SS. Segmental nature of the choroidal vasculature. Br J Ophthalmol. 1975;59(11):631-48.
- Zhao Y, Li FM. Microangioarchitecture of optic papilla. Jpn J Ophthalmol. 1987;31(1):147-59.
- Morrison JC, Johnson EC, Cepurna WO, Funk RH. Microvasculature of the rat optic nerve head. Invest Ophthalmol Vis Sci. 1999;40(8):1702-9.
- Hayreh SS. In vivo choroidal circulation and its watershed zones. Eye (Lond). 1990;4 ( Pt 2):273-89.
- Hayreh SS. Factors influencing blood flow in the optic nerve head. J Glaucoma. 1997;6(6):412-25.
- Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20(5):595-624.
- Hayreh SS. The 1994 Von Sallman Lecture. The optic nerve head circulation in health and disease. Exp Eye Res. 1995;61(3):259-72.
- Awai T. Angioarchitecture of intraorbital part of human optic nerve. Jpn J Ophthalmol. 1985;29(1):79-98.
- Awai T. Angioarchitecture of intracanalicular part of monkey optic nerve. Jpn J Ophthalmol. 1986;30(1):63-73.
- Erdogmus S, Govsa F. Anatomic characteristics of the ophthalmic and posterior ciliary arteries. J Neuroophthalmol. 2008;28(4):320-4.
- Isayama Y, Hiramatsu K, Asakura S, Takahashi T. Posterior ischemic optic neuropathy. I. Blood supply of the optic nerve. Ophthalmologica. 1983;186(4):197-203.
- Bergland R. The arterial supply of the human optic chiasm. J Neurosurg. 1969;31(3):327-34.
- Wollschlaeger PB, Wollschlaeger G, Ide CH, Hart WM. Arterial blood supply of the human optic chiasm and surrounding structures. Ann Ophthalmol. 1971;3(8):862-4 passim.
- BLUNT MJ. Implications of the vascular anatomy of the optic nerve and chiasma. Proc R Soc Med. 1956;49(7):433-9.
- Salaud C, Ploteau S, Blery P, Pilet P, Armstrong O, Hamel A. Extrinsic and intrinsic blood supply to the optic chiasm. Clin Anat. 2018;31(3):432-440.
- Baykal D, Yilmazlar S, Fedakar R. A neurosurgical assessment of the blood supply in the optochiasmatic system: a cadaveric-anatomic study. Anat Sci Int. 2021;96(2):294-300.
- Kidd D. The optic chiasm. Clin Anat. 2014;27(8):1149-58.
- Kidd D. The optic chiasm. Handb Clin Neurol. 2011;102:185-203.
- Lee KF. Ischemic chiasma syndrome. AJNR Am J Neuroradiol. 1983;4(3):777-80.
- Denion E, Defoort-Dhellemmes S, Arndt CF, Hache JC. [Quadruple sectoranopia]. J Fr Ophtalmol. 2005;28(10):1137-44.
- Denion E, Defoort-Dhellemmes S, Arndt CF, Gauvrit JY, Blond S, Hache JC. Partially reversible quadruple sectoranopia caused by vascular steal due to an arteriovenous malformation. Graefes Arch Clin Exp Ophthalmol. 2005;243(1):63-7.
- Nakae Y, Higashiyama Y, Kuroiwa Y. [Case of brain infarction in the anterior choroidal artery territory with homonymous scotomas]. Brain Nerve. 2009;61(8):979-82.
- Tanaka K, Wada I, Suenaga T. [Incongruous, incomplete, homonymous hemianopia due to an infarction localized to the lateral geniculate body]. Rinsho Shinkeigaku. 2017;57(10):595-598.
- Takeuchi I, Takagi M, Yamagata S, Hoshino H, Takagi Y. [A case of posterior choroidal artery infarction]. Rinsho Shinkeigaku. 1992;32(10):1125-9.
- Graff-Radford NR, Damasio H, Yamada T, Eslinger PJ, Damasio AR. Nonhaemorrhagic thalamic infarction. Clinical, neuropsychological and electrophysiological findings in four anatomical groups defined by computerized tomography. Brain. 1985;108 ( Pt 2):485-516.
- Horton JC, Economides JR, Adams DL. The Mechanism of Macular Sparing. Annu Rev Vis Sci. 2021;7:155-179.
- Cho J, Liao E, Trobe JD. Correlation of Macular Sparing and Homonymous Paracentral Scotomas With MRI Lesions in Posterior Cerebral Artery Infarction. J Neuroophthalmol. 2022;42(3):367-371.
- Cho J, Liao E, Trobe JD. Visual Field Defect Patterns Associated With Lesions of the Retrochiasmal Visual Pathway. J Neuroophthalmol. 2022;42(3):353-359.
- Bischoff P, Lang J, Huber A. Macular sparing as a perimetric artifact. Am J Ophthalmol. 1995;119(1):72-80.
- Perenin MT, Vadot E. Macular sparing investigated by means of Haidinger brushes. Br J Ophthalmol. 1981;65(6):429-35.
- Prada D, Harris A, Guidoboni G, Siesky B, Huang AM, Arciero J. Autoregulation and neurovascular coupling in the optic nerve head. Surv Ophthalmol. 2016;61(2):164-86.
- Anderson DR. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol. 1999;43 Suppl 1:S5-9.
- Flammer J, Orgül S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res. 1998;17(2):267-89.
- Wang L, Burgoyne CF, Cull G, Thompson S, Fortune B. Static blood flow autoregulation in the optic nerve head in normal and experimental glaucoma. Invest Ophthalmol Vis Sci. 2014;55(2):873-80.
- Bata AM, Fondi K, Witkowska KJ, Werkmeister RM, Hommer A, Vass C, et al. Optic nerve head blood flow regulation during changes in arterial blood pressure in patients with primary open-angle glaucoma. Acta Ophthalmol. 2019;97(1):e36-e41.
- Movaffaghy A, Chamot SR, Petrig BL, Riva CE. Blood flow in the human optic nerve head during isometric exercise. Exp Eye Res. 1998;67(5):561-8.
- Hashimoto R, Sugiyama T, Ubuka M, Maeno T. Autoregulation of Optic Nerve Head Blood Flow Induced by Elevated Intraocular Pressure during Vitreous Surgery. Curr Eye Res. 2017;42(4):625-628.
- Riva CE, Logean E, Falsini B. Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog Retin Eye Res. 2005;24(2):183-215.
- Riva CE, Falsini B, Logean E. Flicker-evoked responses of human optic nerve head blood flow: luminance versus chromatic modulation. Invest Ophthalmol Vis Sci. 2001;42(3):756-62.
- Riva CE, Falsini B. Functional laser Doppler flowmetry of the optic nerve: physiological aspects and clinical applications. Prog Brain Res. 2008;173:149-63.
- Sönmez HK, Arda H, Gülmez Sevim D. Evaluation of Optic Disc Perfusion with Optical Coherence Tomography Angiography in Acute Non-arteritic Anterior Ischemic Optic Neuropathy. Turk J Ophthalmol. 2022;52(1):30-36.
- Dhiman R, Chawla R, Azad SV, Kumar P, Gupta V, Kumar A, et al. Peripapillary Retinal and Choroidal Perfusion in Nonarteritic Ischemic Optic Neuropathy Using Optical Coherence Tomography Angiography. Optom Vis Sci. 2020;97(8):583-590.
- Chou Y, Zhang B, Ma J, Zhong Y. Microvascular alterations detected by optical coherence tomography angiography in non-arteritic anterior ischaemic optic neuropathy: a meta-analysis. Acta Ophthalmol. 2022;100(2):e386-e395.
- Rougier MB, Le Goff M, Korobelnik JF. Optical coherence tomography angiography at the acute phase of optic disc edema. Eye Vis (Lond). 2018;5:15.
- Uddin MA, Haq TU, Rafique MZ. Cerebral venous system anatomy. J Pak Med Assoc. 2006;56(11):516-9.
- Kiliç T, Akakin A. Anatomy of cerebral veins and sinuses. Front Neurol Neurosci. 2008;23:4-15.
- Zong C, Yu X, Liu J, Liu Y. Dural Venous Sinuses: What We Need to Know. Curr Med Imaging. 2020;16(10):1259-1270.
- Spektor S, Piontek E, Umansky F. Orbital venous drainage into the anterior cavernous sinus space: microanatomic relationships. Neurosurgery. 1997;40(3):532-9; discussion 539-40.
- Tubbs RS, Salter EG, Wellons JC 3rd, Blount JP, Oakes WJ. The sphenoparietal sinus. Neurosurgery. 2007;60(2 Suppl 1):ONS9-12; discussion ONS12.
- Romano N, Urru A, Sasso R, Castaldi A. Imaging of superior ophthalmic vein: A pictorial overview. Clin Imaging. 2022;89:136-146.
- Yeatts RP, Driver PJ. Orbital varix. Arch Ophthalmol. 1993;111(5):702-3.
- Shields JA, Dolinskas C, Augsburger JJ, Shah HG, Shapiro ML. Demonstration of orbital varix with computed tomography and valsalva maneuver. Am J Ophthalmol. 1984;97(1):108-10.
- Magrath GN, Wright HE, Proctor CM. Dynamic MRI of an orbital varix. Ophthalmic Plast Reconstr Surg. 2015;31(3):e78.
- Doğan E, Apaydın M. The evaluation of cerebral venous normal anatomy and variations by phase-contrast cranial magnetic resonance venography. Folia Morphol (Warsz). 2022;81(2):314-323.
- Paudel S, Sah R, Singh RK, Kayastha P, Katwal S. Dural Venous Sinus Variations Observed in Magnetic Resonance Venography at a Tertiary Care Hospital: An Observational Study. JNMA J Nepal Med Assoc. 2024;62(279):720-724.
- Kamaşak Arpaçay B, Aycan K. Morphological variations of the dural venous sinuses: a cadaveric study. Front Surg. 2026;13:1800026.
- Brugada-Bellsolà F, González-Crespo A, Pastor-Cabeza M, Blanco Ibáñez de Opacua A, Remollo S, Anglada-Oliván M, et al. Dural Venous Sinus Variations in Idiopathic Subarachnoid Hemorrhage: A New Indicator of the Venous Origin with Diagnostic Usefulness?. World Neurosurg. 2021;156:e266-e275.
- Cinalli G, di Martino G, Russo C, Mazio F, Nastro A, Mirone G, et al. Dural venous sinus anatomy in children with external hydrocephalus: analysis of a series of 97 patients. Childs Nerv Syst. 2021;37(10):3021-3032.
- Bateman GA, Siddique SH. Cerebrospinal fluid absorption block at the vertex in chronic hydrocephalus: obstructed arachnoid granulations or elevated venous pressure?. Fluids Barriers CNS. 2014;11:11.
- Mondejar V, Patsalides A. The Role of Arachnoid Granulations and the Glymphatic System in the Pathophysiology of Idiopathic Intracranial Hypertension. Curr Neurol Neurosci Rep. 2020;20(7):20.
- Williamson TH. A “throttle” mechanism in the central retinal vein in the region of the lamina cribrosa. Br J Ophthalmol. 2007;91(9):1190-3.
- Rothenbuehler SP, Maloca PM, Belmouhand M, Hamann S, Larsen M. Branch retinal vein occlusion precipitated by compression between a major retinal artery and underlying optic disc drusen. Acta Ophthalmol. 2021;99(8):931-933.
- Paques M, Garmyn V, Catier A, Naoun K, Vicaut E, Gaudric A. Analysis of retinal and choroidal circulation during central retinal vein occlusion using indocyanine green videoangiography. Arch Ophthalmol. 2001;119(12):1781-7.
- Schatz H, Chang LF, Ober RR, McDonald HR, Johnson RN. Central retinal vein occlusion associated with retinal arteriovenous malformation. Ophthalmology. 1993;100(1):24-30.
- Battaglia Parodi M, Ramovecchi P, Ravalico G. Primary empty sella syndrome and central retinal vein occlusion. Ophthalmologica. 1995;209(2):106-8.
- Eckberg TJ. The dangerous triangle (still dangerous). JAMA. 1969;209(4):561.
- Cameron C, Tong JY, Patel S, Foreman A, Selva D. Disseminated thrombosis of the internal jugular vein, superior ophthalmic vein and cavernous sinus as the primary manifestation of occult malignancy: a case report. Orbit. 2024;43(4):505-510.
- Hartel M, Kluczewska E, Gancarczyk-Urlik E, Pierzchała K, Bień K, Zastawnik A. Cerebral venous sinus thrombosis. Phlebology. 2015;30(1):3-10.
- Liu KC, Bhatti MT, Chen JJ, Fairbanks AM, Foroozan R, McClelland CM, et al. Presentation and Progression of Papilledema in Cerebral Venous Sinus Thrombosis. Am J Ophthalmol. 2020;213:1-8.
- Sun JA, Estrela T, Gise R. Clinical Course and Visual Outcomes of Papilledema in Pediatric Cerebral Venous Sinus Thrombosis. Am J Ophthalmol. 2024;263:126-132.
- Martins AI, Jorge A, Matos S, Damas D, Silva L, Pais I, et al. Papilledema and related clinical and paraclinical visual assessment in cerebral venous and sinus thrombosis versus idiopathic intracranial hypertension. Neurol Sci. 2026;47(8).
- Wei H, Jiang H, Zhou Y, Liu L, Zhou C, Ji X. Intracranial hypertension after cerebral venous thrombosis-Risk factors and outcomes. CNS Neurosci Ther. 2023;29(9):2540-2547.
- Stiebel-Kalish H, Setton A, Nimii Y, Kalish Y, Hartman J, Huna Bar-On R, et al. Cavernous sinus dural arteriovenous malformations: patterns of venous drainage are related to clinical signs and symptoms. Ophthalmology. 2002;109(9):1685-91.
- Volpe NJ, Sharma MC, Galetta SL, Langer DJ, Liu GT, Hurst RW, et al. Orbital drainage from cerebral arteriovenous malformations. Neurosurgery. 2000;46(4):820-4.
- Kesper C, Skalej M, Huth A, Viestenz A, Heichel J. Pressure-Lowering Effect of Interventional Fistula Occlusion in Secondary Glaucoma due to Orbital Draining Intracerebral Fistulae. Klin Monbl Augenheilkd. 2024;241(1):39-47.
- Spittau B, Millán DS, El-Sherifi S, Hader C, Singh TP, Motschall E, et al. Dural arteriovenous fistulas of the hypoglossal canal: systematic review on imaging anatomy, clinical findings, and endovascular management. J Neurosurg. 2015;122(4):883-903.
- Lee K, Kittel C, Aldridge JB, Wolfe SQ, Brown P, Fargen KM. Correlation between intracranial pressure and venous sinus pressures in patients undergoing cerebral venography and manometry. J Neurointerv Surg. 2021;13(12):1162-1166.
- Momin AA, Musmar B, El Naamani K, Mouchtouris N, Self DM, Lan M, et al. Predictors of dural venous sinus pressure gradient in patients with idiopathic intracranial hypertension. J Neurosurg. 2025;143(2):543-549.
- West JL, Greeneway GP, Garner RM, Aschenbrenner CA, Singh J, Wolfe SQ, et al. Correlation between angiographic stenosis and physiologic venous sinus outflow obstruction in idiopathic intracranial hypertension. J Neurointerv Surg. 2019;11(1):90-94.
- Wang S, Tong X, Li X, Liu L, Liu Z, Mo D, et al. Comparison of microcatheter and pressure wire for venous sinus manometric evaluation of patients with idiopathic intracranial hypertension. Interv Neuroradiol. 2023;29(4):408-412.
- Theiss P, Nico E, Abou-Mrad T, Tshibangu M, Madapoosi A, McGuire LS, et al. Analysis of cerebral venous sinus stenosis by flat panel angiographic CT (FP-CT) to guide treatment for idiopathic intracranial hypertension. Interv Neuroradiol. 2024.
- Levitt MR, McGah PM, Moon K, Albuquerque FC, McDougall CG, Kalani MYS, et al. Computational Modeling of Venous Sinus Stenosis in Idiopathic Intracranial Hypertension. AJNR Am J Neuroradiol. 2016;37(10):1876-1882.
- Zhao K, Gu W, Liu C, Kong D, Zheng C, Chen W, et al. Advances in the Understanding of the Complex Role of Venous Sinus Stenosis in Idiopathic Intracranial Hypertension. J Magn Reson Imaging. 2022;56(3):645-654.
- Ballabio E, Valvassori L, De Simone R, Bianchi Marzoli S, Frediani F. Idiopathic intracranial hypertension secondary to Superior Sagittal Sinus Stenosis: a case report. Neurol Sci. 2024;45(10):5083-5086.
- Dinkin MJ, Patsalides A. Venous Sinus Stenting for Idiopathic Intracranial Hypertension: Where Are We Now?. Neurol Clin. 2017;35(1):59-81.
- Koovor JM, Lopez GV, Riley K, Tejada J. Transverse venous sinus stenting for idiopathic intracranial hypertension: Safety and feasibility. Neuroradiol J. 2018;31(5):513-517.
- Fargen KM, Liu K, Garner RM, Greeneway GP, Wolfe SQ, Crowley RW. Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting. J Neurointerv Surg. 2018;10(12):1203-1208.
- Casado A, Cerveró A, López-de-Eguileta A, Fernández R, Fonseca S, González JC, et al. Topographic correlation and asymmetry analysis of ganglion cell layer thinning and the retinal nerve fiber layer with localized visual field defects. PLoS One. 2019;14(9):e0222347.
- Zehnder S, Wildberger H, Hanson JVM, Lukas S, Pelz S, Landau K, et al. Retinal Ganglion Cell Topography in Patients With Visual Pathway Pathology. J Neuroophthalmol. 2018;38(2):172-178.
- Xu AZ, Triolo G, Chaves-Samaniego MJ, Konarzewski MG, Gedde SJ, Mwanza JC, et al. Topographic Agreement of Retinal Nerve Fiber and Ganglion Cell Loss Improves Incipient Glaucoma Detection. Ophthalmol Glaucoma. 2026.
- Hood DC, Raza AS, de Moraes CG, Odel JG, Greenstein VC, Liebmann JM, et al. Initial arcuate defects within the central 10 degrees in glaucoma. Invest Ophthalmol Vis Sci. 2011;52(2):940-6.
- Yamagishi N, Anton A, Sample PA, Zangwill L, Lopez A, Weinreb RN. Mapping structural damage of the optic disk to visual field defect in glaucoma. Am J Ophthalmol. 1997;123(5):667-76.
- Horn FK, Mardin CY, Viestenz A, Jünemann AG. Association between localized visual field losses and thickness deviation of the nerve fiber layer in glaucoma. J Glaucoma. 2005;14(6):419-25.
- Jeoung JW, Kim TW, Kang KB, Lee JJ, Park KH, Kim DM. Overlapping of retinal nerve fibers in the horizontal plane. Invest Ophthalmol Vis Sci. 2008;49(5):1753-7.
- Takahashi N, Omodaka K, Kikawa T, Akiba M, Nakazawa T. Association between Topographic Features of the Retinal Nerve Fiber Bundle and Good Visual Acuity in Patients with Glaucoma. Curr Eye Res. 2021;46(11):1724-1731.
- Danesh-Meyer HV, Carroll SC, Foroozan R, Savino PJ, Fan J, Jiang Y, et al. Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression. Invest Ophthalmol Vis Sci. 2006;47(11):4827-35.
- Nakamura M, Ishikawa-Tabuchi K, Kanamori A, Yamada Y, Negi A. Better performance of RTVue than Cirrus spectral-domain optical coherence tomography in detecting band atrophy of the optic nerve. Graefes Arch Clin Exp Ophthalmol. 2012;250(10):1499-507.
- Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S, et al. Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship. Doc Ophthalmol. 2009;118(2):129-37.
- Keltner JL, Johnson CA, Cello KE, Dontchev M, Gal RL, Beck RW. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol. 2010;128(3):330-7.
- Miglior S, Riva I, Guareschi M, Di Matteo F, Romanazzi F, Buffagni L, et al. Retinal sensitivity and retinal nerve fiber layer thickness measured by optical coherence tomography in glaucoma. Am J Ophthalmol. 2007;144(5):733-740.
- Kamalipour A, Moghimi S, Khosravi P, Tansuebchueasai N, Vasile C, Adelpour M, et al. Retinal Nerve Fiber Layer Optical Texture Analysis and 10-2 Visual Field Assessment in Glaucoma. Am J Ophthalmol. 2024;266:118-134.
- Sadun AA, Wang MY. Abnormalities of the optic disc. Handb Clin Neurol. 2011;102:117-57.
- Koschade SE, Koch MA, Braunger BM, Tamm ER. Efficient determination of axon number in the optic nerve: A stereological approach. Exp Eye Res. 2019;186:107710.
- Davies DC, McCoubrie P, McDonald B, Jobst KA. Myelinated axon number in the optic nerve is unaffected by Alzheimer’s disease. Br J Ophthalmol. 1995;79(6):596-600.
- Provis JM, van Driel D, Billson FA, Russell P. Human fetal optic nerve: overproduction and elimination of retinal axons during development. J Comp Neurol. 1985;238(1):92-100.
- Bosler NSI, Ashton D, Neely AJ, Lueck CJ. Variation in the Anatomy of the Normal Human Optic Chiasm: An MRI Study. J Neuroophthalmol. 2021;41(2):194-199.
- Hickey TL, Guillery RW. Variability of laminar patterns in the human lateral geniculate nucleus. J Comp Neurol. 1979;183(2):221-46.
- Blakemore C, Vital-Durand F. Organization and post-natal development of the monkey’s lateral geniculate nucleus. J Physiol. 1986;380:453-91.
- Reese BE. ‘Hidden lamination’ in the dorsal lateral geniculate nucleus: the functional organization of this thalamic region in the rat. Brain Res. 1988;472(2):119-37.
- Hendry SH, Reid RC. The koniocellular pathway in primate vision. Annu Rev Neurosci. 2000;23:127-53.
- Jeffries AM, Killian NJ, Pezaris JS. Mapping the primate lateral geniculate nucleus: a review of experiments and methods. J Physiol Paris. 2014;108(1):3-10.
- Yücel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res. 2003;22(4):465-81.
- Yogarajah M, Focke NK, Bonelli S, Cercignani M, Acheson J, Parker GJ, et al. Defining Meyer’s loop-temporal lobe resections, visual field deficits and diffusion tensor tractography. Brain. 2009;132(Pt 6):1656-68.
- Jeelani NU, Jindahra P, Tamber MS, Poon TL, Kabasele P, James-Galton M, et al. ‘Hemispherical asymmetry in the Meyer’s Loop’: a prospective study of visual-field deficits in 105 cases undergoing anterior temporal lobe resection for epilepsy. J Neurol Neurosurg Psychiatry. 2010;81(9):985-91.
- Lilja Y, Ljungberg M, Starck G, Malmgren K, Rydenhag B, Nilsson DT. Visualizing Meyer’s loop: A comparison of deterministic and probabilistic tractography. Epilepsy Res. 2014;108(3):481-90.
- James JS, Radhakrishnan A, Thomas B, Madhusoodanan M, Kesavadas C, Abraham M, et al. Diffusion tensor imaging tractography of Meyer’s loop in planning resective surgery for drug-resistant temporal lobe epilepsy. Epilepsy Res. 2015;110:95-104.
- Winston GP, Yogarajah M, Symms MR, McEvoy AW, Micallef C, Duncan JS. Diffusion tensor imaging tractography to visualize the relationship of the optic radiation to epileptogenic lesions prior to neurosurgery. Epilepsia. 2011;52(8):1430-8.
- Bertani GA, Bertulli L, Scola E, Di Cristofori A, Zavanone M, Triulzi F, et al. Optic Radiation Diffusion Tensor Imaging Tractography: An Alternative and Simple Technique for the Accurate Detection of Meyer’s Loop. World Neurosurg. 2018;117:e42-e56.
- Yamada H, Yamamoto A, Okada T, Kanagaki M, Fushimi Y, Mehemed TM, et al. Diffusion tensor imaging analysis of optic radiation using readout-segmented echo-planar imaging. Surg Radiol Anat. 2014;36(10):973-80.
- Borius PY, Roux FE, Valton L, Sol JC, Lotterie JA, Berry I. Can DTI fiber tracking of the optic radiations predict visual deficit after surgery?. Clin Neurol Neurosurg. 2014;122:87-91.
- Decramer T, Van Keer K, Stalmans P, Dupont P, Sunaert S, Theys T. Tracking posttraumatic hemianopia. J Neurol. 2018;265(1):41-45.
- Engelhorn T, Michelson G, Waerntges S, Struffert T, Haider S, Doerfler A. Diffusion tensor imaging detects rarefaction of optic radiation in glaucoma patients. Acad Radiol. 2011;18(6):764-9.
- Sidek S, Ramli N, Rahmat K, Ramli NM, Abdulrahman F, Tan LK. Glaucoma severity affects diffusion tensor imaging (DTI) parameters of the optic nerve and optic radiation. Eur J Radiol. 2014;83(8):1437-41.
- Liu P, Luo B, Chen L, Wang QX, Zhai LH, Wu HY, et al. Preliminary Diffusion-Tensor Imaging Evidence for Trans-Synaptic Axonal Degeneration in Dysthyroid Optic Neuropathy Due to Thyroid-Associated Ophthalmopathy. J Magn Reson Imaging. 2023;57(3):834-844.
- Benson NC, Yoon JMD, Forenzo D, Engel SA, Kay KN, Winawer J. Variability of the Surface Area of the V1, V2, and V3 Maps in a Large Sample of Human Observers. J Neurosci. 2022;42(46):8629-8646.
- Benson NC, Butt OH, Datta R, Radoeva PD, Brainard DH, Aguirre GK. The retinotopic organization of striate cortex is well predicted by surface topology. Curr Biol. 2012;22(21):2081-5.
- Winawer J, Parvizi J. Linking Electrical Stimulation of Human Primary Visual Cortex, Size of Affected Cortical Area, Neuronal Responses, and Subjective Experience. Neuron. 2016;92(6):1213-1219.
- Clarke S. Modular organization of human extrastriate visual cortex: evidence from cytochrome oxidase pattern in normal and macular degeneration cases. Eur J Neurosci. 1994;6(5):725-36.
- Schneider KA, Kastner S. Visual responses of the human superior colliculus: a high-resolution functional magnetic resonance imaging study. J Neurophysiol. 2005;94(4):2491-503.
- Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain. 2009;132(Pt 3):628-34.
- Dinkin M. Trans-synaptic Retrograde Degeneration in the Human Visual System: Slow, Silent, and Real. Curr Neurol Neurosci Rep. 2017;17(2):16.
- Donaldson L, Chen M, Margolin E. Transsynaptic Ganglion Cell Degeneration in Adult Patients After Occipital Lobe Stroke. J Neuroophthalmol. 2023;43(2):243-247.
- Goto K, Miki A, Yamashita T, Araki S, Takizawa G, Nakagawa M, et al. Sectoral analysis of the retinal nerve fiber layer thinning and its association with visual field loss in homonymous hemianopia caused by post-geniculate lesions using spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2016;254(4):745-56.
- Yamashita T, Miki A, Goto K, Araki S, Takizawa G, Ieki Y, et al. Evaluation of Significance Maps and the Analysis of the Longitudinal Time Course of the Macular Ganglion Cell Complex Thicknesses in Acquired Occipital Homonymous Hemianopia Using Spectral-domain Optical Coherence Tomography. Neuroophthalmology. 2020;44(4):236-245.
- Handley SE, Panteli VS, Liasis A. Trans-synaptic Retrograde Degeneration Following Hemispherectomy in Childhood. Neuroophthalmology. 2017;41(2):103-107.
- Celik Buyuktepe T, Bingöl Kızıltunç P, Buyuktepe M, Atilla H. Direct and transsynaptic retrograde degeneration and optic nerve head microvascular changes in patients with hemianopia. Eur J Ophthalmol. 2021;31(4):1785-1794.
- Barton JJS. Motion perception and its disorders. Handb Clin Neurol. 2021;178:257-275.
- Heutink J, de Haan G, Marsman JB, van Dijk M, Cordes C. The effect of target speed on perception of visual motion direction in a patient with akinetopsia. Cortex. 2019;119:511-518.
- Barton JJ, Press DZ, Keenan JP, O’Connor M. Lesions of the fusiform face area impair perception of facial configuration in prosopagnosia. Neurology. 2002;58(1):71-8.
- Barton JJS. Face processing in the temporal lobe. Handb Clin Neurol. 2022;187:191-210.
- Cohen AL, Soussand L, Corrow SL, Martinaud O, Barton JJS, Fox MD. Looking beyond the face area: lesion network mapping of prosopagnosia. Brain. 2019;142(12):3975-3990.
- Robinson DL, Petersen SE. The pulvinar and visual salience. Trends Neurosci. 1992;15(4):127-32.
- Smith AT, Cotton PL, Bruno A, Moutsiana C. Dissociating vision and visual attention in the human pulvinar. J Neurophysiol. 2009;101(2):917-25.
- Fischer J, Whitney D. Attention gates visual coding in the human pulvinar. Nat Commun. 2012;3:1051.
- Cortes N, Ladret HJ, Abbas-Farishta R, Casanova C. The pulvinar as a hub of visual processing and cortical integration. Trends Neurosci. 2024;47(2):120-134.
- Zachariou V, Klatzky R, Behrmann M. Ventral and dorsal visual stream contributions to the perception of object shape and object location. J Cogn Neurosci. 2014;26(1):189-209.
- Vaziri-Pashkam M, Xu Y. Goal-Directed Visual Processing Differentially Impacts Human Ventral and Dorsal Visual Representations. J Neurosci. 2017;37(36):8767-8782.
- Cloutman LL. Interaction between dorsal and ventral processing streams: where, when and how?. Brain Lang. 2013;127(2):251-63.
- Ritchie JB, Montesinos S, Carter MJ. What Is a Visual Stream?. J Cogn Neurosci. 2024;36(12):2627-2638.
- Becker-Bense S, Buchholz HG, zu Eulenburg P, Best C, Bartenstein P, Schreckenberger M, et al. Ventral and dorsal streams processing visual motion perception (FDG-PET study). BMC Neurosci. 2012;13:81.
- Cooper SA, O’Sullivan M. Here, there and everywhere: higher visual function and the dorsal visual stream. Pract Neurol. 2016;16(3):176-83.
- Dutton GN, Jacobson LK. Cerebral visual impairment in children. Semin Neonatol. 2001;6(6):477-85.
- Philip SS, Dutton GN. Identifying and characterising cerebral visual impairment in children: a review. Clin Exp Optom. 2014;97(3):196-208.
- Schmidt TM, Do MT, Dacey D, Lucas R, Hattar S, Matynia A. Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function. J Neurosci. 2011;31(45):16094-101.
- Pickard GE, Sollars PJ. Intrinsically photosensitive retinal ganglion cells. Rev Physiol Biochem Pharmacol. 2012;162:59-90.
- Do MTH. Melanopsin and the Intrinsically Photosensitive Retinal Ganglion Cells: Biophysics to Behavior. Neuron. 2019;104(2):205-226.
- Mure LS. Intrinsically Photosensitive Retinal Ganglion Cells of the Human Retina. Front Neurol. 2021;12:636330.
- Kinder L, Palumaa T, Lindner M. [Intrinsically photosensitive retinal ganglion cells]. Ophthalmologe. 2022;119(4):358-366.
- Hannibal J, Hindersson P, Ostergaard J, Georg B, Heegaard S, Larsen PJ, et al. Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract. Invest Ophthalmol Vis Sci. 2004;45(11):4202-9.
- Hu J, Shi Y, Zhang J, Huang X, Wang Q, Zhao H, et al. Melanopsin retinal ganglion cells mediate light-promoted brain development. Cell. 2022;185(17):3124-3137.e15.
- Feigl B, Zele AJ. Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease. Optom Vis Sci. 2014;91(8):894-903.
- Brzezinski JA 4th, Brown NL, Tanikawa A, Bush RA, Sieving PA, Vitaterna MH, et al. Loss of circadian photoentrainment and abnormal retinal electrophysiology in Math5 mutant mice. Invest Ophthalmol Vis Sci. 2005;46(7):2540-51.
- McAdams H, Igdalova A, Spitschan M, Brainard DH, Aguirre GK. Pulses of Melanopsin-Directed Contrast Produce Highly Reproducible Pupil Responses That Are Insensitive to a Change in Background Radiance. Invest Ophthalmol Vis Sci. 2018;59(13):5615-5626.
- Kankipati L, Girkin CA, Gamlin PD. The post-illumination pupil response is reduced in glaucoma patients. Invest Ophthalmol Vis Sci. 2011;52(5):2287-92.
- Feigl B, Zele AJ, Fader SM, Howes AN, Hughes CE, Jones KA, et al. The post-illumination pupil response of melanopsin-expressing intrinsically photosensitive retinal ganglion cells in diabetes. Acta Ophthalmol. 2012;90(3):e230-4.
- Joyce DS, Feigl B, Kerr G, Roeder L, Zele AJ. Melanopsin-mediated pupil function is impaired in Parkinson’s disease. Sci Rep. 2018;8(1):7796.
- Park JC, Moss HE, McAnany JJ. The Pupillary Light Reflex in Idiopathic Intracranial Hypertension. Invest Ophthalmol Vis Sci. 2016;57(1):23-9.
- Steiner OL, de Zeeuw J. Melanopsin retinal ganglion cell function in Alzheimer’s vs. Parkinson’s disease an exploratory meta-analysis and review of pupillometry protocols. Parkinsonism Relat Disord. 2024;123:106063.
- Steiner OL, Klostermann F. Central involvement in peripheral disease: melanopsin pathway impairment in chronic inflammatory demyelinating polyneuropathy. Brain Commun. 2024;6(4):fcae206.
- May PJ, Warren S. Pupillary light reflex circuits in the Macaque Monkey: the olivary pretectal nucleus. Brain Struct Funct. 2020;225(1):305-320.
- Sun W, May PJ. Central pupillary light reflex circuits in the cat: I. The olivary pretectal nucleus. J Comp Neurol. 2014;522(18):3960-77.
- Trejo LJ, Cicerone CM. Cells in the pretectal olivary nucleus are in the pathway for the direct light reflex of the pupil in the rat. Brain Res. 1984;300(1):49-62.
- May PJ, Sun W, Wright NF, Erichsen JT. Pupillary light reflex circuits in the macaque monkey: the preganglionic Edinger-Westphal nucleus. Brain Struct Funct. 2020;225(1):403-425.
- Gamlin PD, Clarke RJ. The pupillary light reflex pathway of the primate. J Am Optom Assoc. 1995;66(7):415-8.
- Hultborn H, Mori K, Tsukahara N. The neuronal pathway subserving the pupillary light reflex. Brain Res. 1978;159(2):255-67.
- Allen AE, Brown TM, Lucas RJ. A distinct contribution of short-wavelength-sensitive cones to light-evoked activity in the mouse pretectal olivary nucleus. J Neurosci. 2011;31(46):16833-43.
- Kozicz T, Bittencourt JC, May PJ, Reiner A, Gamlin PD, Palkovits M, et al. The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J Comp Neurol. 2011;519(8):1413-34.
- de Gelder B, Vroomen J, Pourtois G, Weiskrantz L. Non-conscious recognition of affect in the absence of striate cortex. Neuroreport. 1999;10(18):3759-63.
- Tamietto M, Cauda F, Corazzini LL, Savazzi S, Marzi CA, Goebel R, et al. Collicular vision guides nonconscious behavior. J Cogn Neurosci. 2010;22(5):888-902.
- Tran A, MacLean MW, Hadid V, Lazzouni L, Nguyen DK, Tremblay J, et al. Neuronal mechanisms of motion detection underlying blindsight assessed by functional magnetic resonance imaging (fMRI). Neuropsychologia. 2019;128:187-197.
- Ajina S, Pestilli F, Rokem A, Kennard C, Bridge H. Human blindsight is mediated by an intact geniculo-extrastriate pathway. Elife. 2015;4.
- Büttner-Ennever JA. Anatomy of the oculomotor system. Dev Ophthalmol. 2007;40:1-14.
- Büttner-Ennever JA. Mapping the oculomotor system. Prog Brain Res. 2008;171:3-11.
- Henn V, Büttner-Ennever JA, Hepp K. The primate oculomotor system. I. Motoneurons. A synthesis of anatomical, physiological, and clinical data. Hum Neurobiol. 1982;1(2):77-85.
- Henn V, Hepp K, Büttner-Ennever JA. The primate oculomotor system. II. Premotor system. A synthesis of anatomical, physiological, and clinical data. Hum Neurobiol. 1982;1(2):87-95.
- Eberhorn AC, Büttner-Ennever JA, Horn AK. Identification of motoneurons supplying multiply- or singly-innervated extraocular muscle fibers in the rat. Neuroscience. 2006;137(3):891-903.
- Bohlen MO, Warren S, Mustari MJ, May PJ. Examination of feline extraocular motoneuron pools as a function of muscle fiber innervation type and muscle layer. J Comp Neurol. 2017;525(4):919-935.
- Büttner-Ennever JA, Büttner U. Neuroanatomy of the oculomotor system. The reticular formation. Rev Oculomot Res. 1988;2:119-76.
- Ogawa K, Suzuki Y, Takahashi K, Kamei S, Ishikawa H. Clinical Study of Eleven Patients with Midbrain Infarction-Induced Oculomotor Nerve Palsy. J Stroke Cerebrovasc Dis. 2016;25(7):1631-1638.
- Martin TJ, Corbett JJ, Babikian PV, Crawford SC, Currier RD. Bilateral ptosis due to mesencephalic lesions with relative preservation of ocular motility. J Neuroophthalmol. 1996;16(4):258-63.
- Bogousslavsky J, Regli F, Ghika J, Hungerbühler JP. Internuclear ophthalmoplegia, prenuclear paresis of contralateral superior rectus, and bilateral ptosis. J Neurol. 1983;230(3):197-203.
- Jeong SH, Kim SH, Lee SH, Park SH, Kim HJ, Kim JS. Central Trochlear Palsy: Report of Two Patients With Ipsilesional Palsy and Review of the Literature. J Neuroophthalmol. 2016;36(4):377-382.
- Yamaguchi K, Honma K. Development of the human trochlear nucleus: a morphometric study. Ann Anat. 2011;193(2):106-11.
- Bohlen MO, May PJ, Warren S, Horn AK. Precerebellar paramedian tract cell group connections: II. Abducens internuclear inputs. Brain Struct Funct. 2025;230(9):189.
- Büttner-Ennever JA, Horn AK, Schmidtke K. Cell groups of the medial longitudinal fasciculus and paramedian tracts. Rev Neurol (Paris). 1989;145(8-9):533-9.
- Frohman TC, Galetta S, Fox R, Solomon D, Straumann D, Filippi M, et al. Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology. Neurology. 2008;70(17):e57-67.
- Virgo JD, Plant GT. Internuclear ophthalmoplegia. Pract Neurol. 2017;17(2):149-153.
- Kochar PS, Kumar Y, Sharma P, Kumar V, Gupta N, Goyal P. Isolated medial longitudinal fasciculus syndrome: Review of imaging, anatomy, pathophysiology and differential diagnosis. Neuroradiol J. 2018;31(1):95-99.
- Sakaie K, Takahashi M, Remington G, Wang X, Conger A, Conger D, et al. Correlating Function and Imaging Measures of the Medial Longitudinal Fasciculus. PLoS One. 2016;11(1):e0147863.
- Krebs C. Oculomotor disorders and nystagmus. Handb Clin Neurol. 2026;216:123-130.
- Sibony PA, Lessell S, Gittinger JW Jr. Acquired oculomotor synkinesis. Surv Ophthalmol. 1984;28(5):382-90.
- Weber ED, Newman SA. Aberrant regeneration of the oculomotor nerve: implications for neurosurgeons. Neurosurg Focus. 2007;23(5):E14.
- Wasicky R, Ziya-Ghazvini F, Blumer R, Lukas JR, Mayr R. Muscle fiber types of human extraocular muscles: a histochemical and immunohistochemical study. Invest Ophthalmol Vis Sci. 2000;41(5):980-90.
- Hoh JFY. Myosin heavy chains in extraocular muscle fibres: Distribution, regulation and function. Acta Physiol (Oxf). 2021;231(2):e13535.
- Fraterman S, Khurana TS, Rubinstein NA. Identification of acetylcholine receptor subunits differentially expressed in singly and multiply innervated fibers of extraocular muscles. Invest Ophthalmol Vis Sci. 2006;47(9):3828-34.
- Porter JD, Baker RS. Prenatal morphogenesis of primate extraocular muscle: neuromuscular junction formation and fiber type differentiation. Invest Ophthalmol Vis Sci. 1992;33(3):657-70.
- Demer JL. The orbital pulley system: a revolution in concepts of orbital anatomy. Ann N Y Acad Sci. 2002;956:17-32.
- Demer JL, Oh SY, Poukens V. Evidence for active control of rectus extraocular muscle pulleys. Invest Ophthalmol Vis Sci. 2000;41(6):1280-90.
- Shin A, Yoo L, Demer JL. Independent active contraction of extraocular muscle compartments. Invest Ophthalmol Vis Sci. 2014;56(1):199-206.
- McClung JR, Allman BL, Dimitrova DM, Goldberg SJ. Extraocular connective tissues: a role in human eye movements?. Invest Ophthalmol Vis Sci. 2006;47(1):202-5.
- Eberhorn AC, Horn AK, Eberhorn N, Fischer P, Boergen KP, Büttner-Ennever JA. Palisade endings in extraocular eye muscles revealed by SNAP-25 immunoreactivity. J Anat. 2005;206(3):307-15.
- Büttner-Ennever JA, Eberhorn A, Horn AK. Motor and sensory innervation of extraocular eye muscles. Ann N Y Acad Sci. 2003;1004:40-9.
- Serra A, Ruff RL, Leigh RJ. Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles. Ann N Y Acad Sci. 2012;1275(1):129-35.
- Kaminski HJ, Kusner LL, Block CH. Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest Ophthalmol Vis Sci. 1996;37(2):345-51.
- Soltys J, Gong B, Kaminski HJ, Zhou Y, Kusner LL. Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?. Ann N Y Acad Sci. 2008;1132:220-4.
- Liu R, Xu H, Wang G, Li J, Gou L, Zhang L, et al. Extraocular muscle characteristics related to myasthenia gravis susceptibility. PLoS One. 2013;8(2):e55611.
- Oda K. Differences in acetylcholine receptor-antibody interactions between extraocular and extremity muscle fibers. Ann N Y Acad Sci. 1993;681:238-55.
- Ottaiano AC, Gomez GD, Freddi TAL. The Facial Nerve: Anatomy and Pathology. Semin Ultrasound CT MR. 2023;44(2):71-80.
- Chhabda S, Leger DS, Lingam RK. Imaging the facial nerve: A contemporary review of anatomy and pathology. Eur J Radiol. 2020;126:108920.
- Ozgen Mocan B. Imaging Anatomy and Pathology of the Intracranial and Intratemporal Facial Nerve. Neuroimaging Clin N Am. 2021;31(4):553-570.
- Toulgoat F, Sarrazin JL, Benoudiba F, Pereon Y, Auffray-Calvier E, Daumas-Duport B, et al. Facial nerve: from anatomy to pathology. Diagn Interv Imaging. 2013;94(10):1033-42.
- McDougal DH, Gamlin PD. Autonomic control of the eye. Compr Physiol. 2015;5(1):439-73.
- Wu F, Zhao Y, Zhang H. Ocular Autonomic Nervous System: An Update from Anatomy to Physiological Functions. Vision (Basel). 2022;6(1).
- Luebke JI, Wright LL. Characterization of superior cervical ganglion neurons that project to the submandibular glands, the eyes, and the pineal gland in rats. Brain Res. 1992;589(1):1-14.
- Morgan C, DeGroat WC, Jannetta PJ. Sympathetic innervation of the cornea from the superior cervical ganglion. An HRP study in the cat. J Auton Nerv Syst. 1987;20(2):179-83.
- Dave T, Sabeti S, Patel BC. Anatomy, Head and Neck: Eye, Superior Tarsal Muscle (Müller Muscle). . 2026.
- Mughal M, Longmuir R. Current pharmacologic testing for Horner syndrome. Curr Neurol Neurosci Rep. 2009;9(5):384-9.
- Smit DP. Pharmacologic testing in Horner’s syndrome - a new paradigm. S Afr Med J. 2010;100(11):738-40.
- Davagnanam I, Fraser CL, Miszkiel K, Daniel CS, Plant GT. Adult Horner’s syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye (Lond). 2013;27(3):291-8.
- Son Y, Lee EJ, Kim NH, Lee SJ. Imaging Findings in Neurogenic Ptosis. J Korean Soc Radiol. 2025;86(4):483-500.
- Sinnreich Z, Nathan H. The ciliary ganglion in man (anatomical observations). Anat Anz. 1981;150(3):287-97.
- Zhang YL, Tan CK, Wong WC. The ciliary ganglion of the monkey: a light and electron microscope study. J Anat. 1994;184 ( Pt 2)(Pt 2):251-60.
- Haładaj R. Anatomical variations of the ciliary ganglion with an emphasis on the location in the orbit. Anat Sci Int. 2020;95(2):258-264.
- Kuchiiwa S, Kuchiiwa T, Suzuki T. Comparative anatomy of the accessory ciliary ganglion in mammals. Anat Embryol (Berl). 1989;180(2):199-205.
- Kuchiiwa S. Intraocular projections from the pterygopalatine ganglion in the cat. J Comp Neurol. 1990;300(3):301-8.
- Hamel O, Corre P, Ploteau S, Armstrong O, Rogez JM, Robert R, et al. Ciliary ganglion afferents and efferents variations: a possible explanation of postganglionic mydriasis. Surg Radiol Anat. 2012;34(10):897-902.
- Mallen EA, Gilmartin B, Wolffsohn JS. Sympathetic innervation of ciliary muscle and oculomotor function in emmetropic and myopic young adults. Vision Res. 2005;45(13):1641-51.
- Schor CM, Bharadwaj SR. A pulse-step model of accommodation dynamics in the aging eye. Vision Res. 2005;45(10):1237-54.
- Scott G, Balsiger H, Kluckman M, Fan J, Gest T. Patterns of innervation of the lacrimal gland with clinical application. Clin Anat. 2014;27(8):1174-7.
- Ruskell GL. Distribution of pterygopalatine ganglion efferents to the lacrimal gland in man. Exp Eye Res. 2004;78(3):329-35.
- van der Werf F, Baljet B, Prins M, Otto JA. Innervation of the lacrimal gland in the cynomolgous monkey: a retrograde tracing study. J Anat. 1996;188 ( Pt 3)(Pt 3):591-601.
- Sibony PA, Walcott B, McKeon C, Jakobiec FA. Vasoactive intestinal polypeptide and the innervation of the human lacrimal gland. Arch Ophthalmol. 1988;106(8):1085-8.
- Beckers HJ, Klooster J, Vrensen GF, Lamers WP. Facial parasympathetic innervation of the rat choroid, lacrimal glands and ciliary ganglion. An ultrastructural pterygopalatine tracing and immunohistochemical study. Ophthalmic Res. 1993;25(5):319-30.
- Khan S, Schoenen J, Ashina M. Sphenopalatine ganglion neuromodulation in migraine: what is the rationale?. Cephalalgia. 2014;34(5):382-91.
- Marfurt CF, Cox J, Deek S, Dvorscak L. Anatomy of the human corneal innervation. Exp Eye Res. 2010;90(4):478-92.
- Müller LJ, Vrensen GF, Pels L, Cardozo BN, Willekens B. Architecture of human corneal nerves. Invest Ophthalmol Vis Sci. 1997;38(5):985-94.
- Toshida H, Nguyen DH, Beuerman RW, Murakami A. Evaluation of novel dry eye model: preganglionic parasympathetic denervation in rabbit. Invest Ophthalmol Vis Sci. 2007;48(10):4468-75.
- Belmonte C, Nichols JJ, Cox SM, Brock JA, Begley CG, Bereiter DA, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15(3):404-437.
- Ramesh S, Mancini R. Dynamic Analysis of Müller’s Muscle Response to Phenylephrine. Ophthalmic Plast Reconstr Surg. 2016;32(1):46-8.
- Matsuo K. Stretching of the Mueller muscle results in involuntary contraction of the levator muscle. Ophthalmic Plast Reconstr Surg. 2002;18(1):5-10.
- Reiner A, Fitzgerald MEC, Del Mar N, Li C. Neural control of choroidal blood flow. Prog Retin Eye Res. 2018;64:96-130.
- Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29(2):144-68.
- Bill A, Sperber GO. Control of retinal and choroidal blood flow. Eye (Lond). 1990;4 ( Pt 2):319-25.
- Steinle JJ, Krizsan-Agbas D, Smith PG. Regional regulation of choroidal blood flow by autonomic innervation in the rat. Am J Physiol Regul Integr Comp Physiol. 2000;279(1):R202-9.
- Li C, Fitzgerald MEC, Del Mar N, Haughey C, Reiner A. Defective Choroidal Blood Flow Baroregulation and Retinal Dysfunction and Pathology Following Sympathetic Denervation of Choroid. Invest Ophthalmol Vis Sci. 2018;59(12):5032-5044.
- Chou PI, Lu DW, Chen JT. Effect of sympathetic denervation on rabbit choroidal blood flow. Ophthalmologica. 2002;216(1):60-4.
- Killer HE, Jaggi GP, Miller NR, Huber AR, Landolt H, Mironov A, et al. Cerebrospinal fluid dynamics between the basal cisterns and the subarachnoid space of the optic nerve in patients with papilloedema. Br J Ophthalmol. 2011;95(6):822-7.
- Killer HE, Jaggi GP, Miller NR. Papilledema revisited: is its pathophysiology really understood?. Clin Exp Ophthalmol. 2009;37(5):444-7.
- Yamada S. Cerebrospinal fluid dynamics. Croat Med J. 2021;62(4):399-410.
- Miyajima M, Arai H. Evaluation of the Production and Absorption of Cerebrospinal Fluid. Neurol Med Chir (Tokyo). 2015;55(8):647-56.
- Pollay M. Review of spinal fluid physiology: production and absorption in relation to pressure. Clin Neurosurg. 1977;24:254-69.
- Leinonen V, Vanninen R, Rauramaa T. Cerebrospinal fluid circulation and hydrocephalus. Handb Clin Neurol. 2017;145:39-50.
- Bezerra MLS, Ferreira ACAF, de Oliveira-Souza R. Pseudotumor Cerebri and Glymphatic Dysfunction. Front Neurol. 2017;8:734.
- Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457-70.
- Hao J, Pircher A, Miller NR, Hsieh J, Remonda L, Killer HE. Cerebrospinal fluid and optic nerve sheath compartment syndrome: A common pathophysiological mechanism in five different cases?. Clin Exp Ophthalmol. 2020;48(2):212-219.
- Killer HE. Is stagnant cerebrospinal fluid involved in the pathophysiology of normal tension glaucoma. Prog Brain Res. 2020;256(1):209-220.
- Singapurwala H, Gupta S, Rathva A. MRI-based evaluation of cerebrospinal fluid dynamics and optic nerve subarachnoid space alterations in idiopathic intracranial hypertension and normal tension glaucoma: a systematic review. BMC Med Imaging. 2026;26(1).
- Donaldson L, Margolin E. Absence of papilledema in large intracranial tumours. J Neurol Sci. 2021;428:117604.
- Mishra R, Konar SK, Shrivastava A, Agrawal A, Nair S. Systematic scoping review of papilledema in vestibular schwannoma without hydrocephalus. Br J Neurosurg. 2023;37(2):127-136.
- Hayreh SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol. 1977;95(9):1553-65.
- Wirtschafter JD. Optic nerve axons and acquired alterations in the appearance of the optic disc. Trans Am Ophthalmol Soc. 1983;81:1034-91.
- Wang X, Lou N, Eberhardt A, Yang Y, Kusk P, Xu Q, et al. An ocular glymphatic clearance system removes β-amyloid from the rodent eye. Sci Transl Med. 2020;12(536).
- Yin X, Zhang S, Lee JH, Dong H, Mourgkos G, Terwilliger G, et al. Compartmentalized ocular lymphatic system mediates eye-brain immunity. Nature. 2024;628(8006):204-211.
- Subileau M, Vittet D. Lymphatics in Eye Fluid Homeostasis: Minor Contributors or Significant Actors?. Biology (Basel). 2021;10(7).
- Morgan WH, Yu DY, Cooper RL, Alder VA, Cringle SJ, Constable IJ. The influence of cerebrospinal fluid pressure on the lamina cribrosa tissue pressure gradient. Invest Ophthalmol Vis Sci. 1995;36(6):1163-72.
- Guy AH, Wiggs JL, Turalba A, Pasquale LR. Translating the Low Translaminar Cribrosa Pressure Gradient Hypothesis into the Clinical Care of Glaucoma. Semin Ophthalmol. 2016;31(1-2):131-9.
- Liu KC, Fleischman D, Lee AG, Killer HE, Chen JJ, Bhatti MT. Current concepts of cerebrospinal fluid dynamics and the translaminar cribrosa pressure gradient: a paradigm of optic disk disease. Surv Ophthalmol. 2020;65(1):48-66.
- Jóhannesson G, Eklund A, Lindén C. Intracranial and Intraocular Pressure at the Lamina Cribrosa: Gradient Effects. Curr Neurol Neurosci Rep. 2018;18(5):25.
- Price DA, Harris A, Siesky B, Mathew S. The Influence of Translaminar Pressure Gradient and Intracranial Pressure in Glaucoma: A Review. J Glaucoma. 2020;29(2):141-146.
- Jasien JV, Fazio MA, Samuels BC, Johnston JM, Downs JC. Quantification of Translaminar Pressure Gradient (TLPG) With Continuous Wireless Telemetry in Nonhuman Primates (NHPs). Transl Vis Sci Technol. 2020;9(12):18.
- Hopkins AA, Murphy R, Irnaten M, Wallace DM, Quill B, O’Brien C. The role of lamina cribrosa tissue stiffness and fibrosis as fundamental biomechanical drivers of pathological glaucoma cupping. Am J Physiol Cell Physiol. 2020;319(4):C611-C623.
- Wostyn P, Van Dam D, Audenaert K, Killer HE, De Deyn PP, De Groot V. A new glaucoma hypothesis: a role of glymphatic system dysfunction. Fluids Barriers CNS. 2015;12:16.
- Wostyn P, De Groot V, Van Dam D, Audenaert K, Killer HE, De Deyn PP. The Glymphatic Hypothesis of Glaucoma: A Unifying Concept Incorporating Vascular, Biomechanical, and Biochemical Aspects of the Disease. Biomed Res Int. 2017;2017:5123148.
- Machiele R, Frankfort BJ, Killer HE, Fleischman D. Problems in CSF and Ophthalmic Disease Research. Front Ophthalmol (Lausanne). 2022;2:896680.
- Robba C, Santori G, Czosnyka M, Corradi F, Bragazzi N, Padayachy L, et al. Optic nerve sheath diameter measured sonographically as non-invasive estimator of intracranial pressure: a systematic review and meta-analysis. Intensive Care Med. 2018;44(8):1284-1294.
- Aletreby W, Alharthy A, Brindley PG, Kutsogiannis DJ, Faqihi F, Alzayer W, et al. Optic Nerve Sheath Diameter Ultrasound for Raised Intracranial Pressure: A Literature Review and Meta-analysis of its Diagnostic Accuracy. J Ultrasound Med. 2022;41(3):585-595.
- Martínez-Palacios K, Vásquez-García S, Fariyike OA, Robba C, Rubiano AM. Using Optic Nerve Sheath Diameter for Intracranial Pressure (ICP) Monitoring in Traumatic Brain Injury: A Scoping Review. Neurocrit Care. 2024;40(3):1193-1212.
- Fan WZ, Jiang JR, Zang HL, Shen XH, Cheng H, Yang WJ, et al. Advancements in Ultrasound Techniques for Evaluating Intracranial Pressure Through Optic Nerve Sheath Diameter Measurement. World Neurosurg. 2024;189:285-290.
- Wang LJ, Chen HX, Chen Y, Yu ZY, Xing YQ. Optic nerve sheath diameter ultrasonography for elevated intracranial pressure detection. Ann Clin Transl Neurol. 2020;7(5):865-868.
- Moraes FM, Silva GS. Noninvasive intracranial pressure monitoring methods: a critical review. Arq Neuropsiquiatr. 2021;79(5):437-446.
- Canac N, Jalaleddini K, Thorpe SG, Thibeault CM, Hamilton RB. Review: pathophysiology of intracranial hypertension and noninvasive intracranial pressure monitoring. Fluids Barriers CNS. 2020;17(1):40.
- Czosnyka M, Pickard JD. Monitoring and interpretation of intracranial pressure. J Neurol Neurosurg Psychiatry. 2004;75(6):813-21.
- Seiff SR, Shah L. A model for the mechanism of optic nerve sheath fenestration. Arch Ophthalmol. 1990;108(9):1326-9.
- Bazarian RA, Burde RM. Mechanism of optic nerve sheath fenestration. Arch Ophthalmol. 1991;109(5):613.
- Brazis PW. Pseudotumor cerebri. Curr Neurol Neurosci Rep. 2004;4(2):111-6.
- Lee AG, Wall M. Papilledema: are we any nearer to a consensus on pathogenesis and treatment?. Curr Neurol Neurosci Rep. 2012;12(3):334-9.
- Prokop K, Opęchowska A, Sawicki K, Zarzecki M, Sieśkiewicz A, Łysoń T. Beyond idiopathic intracranial hypertension: optic nerve decompression for vision preservation in cerebrospinal fluid flow disorders. A mechanism-based approach. J Neurosurg. 2026;144(4):846-856.
- Masland RH. The neuronal organization of the retina. Neuron. 2012;76(2):266-80.
- Hahn J, Monavarfeshani A, Qiao M, Kao AH, Kölsch Y, Kumar A, et al. Evolution of neuronal cell classes and types in the vertebrate retina. Nature. 2023;624(7991):415-424.
- Stryer L. Cyclic GMP cascade of vision. Annu Rev Neurosci. 1986;9:87-119.
- Baylor D. How photons start vision. Proc Natl Acad Sci U S A. 1996;93(2):560-5.
- Kawamura S, Tachibanaki S. Molecular bases of rod and cone differences. Prog Retin Eye Res. 2022;90:101040.
- Ebrey T, Koutalos Y. Vertebrate photoreceptors. Prog Retin Eye Res. 2001;20(1):49-94.
- Koch KW. Phototransduction in vertebrate rod and cone cells. Handb Clin Neurol. 2026;217:241-258.
- Fain GL, Matthews HR, Cornwall MC, Koutalos Y. Adaptation in vertebrate photoreceptors. Physiol Rev. 2001;81(1):117-151.
- Fain GL, Matthews HR, Cornwall MC. Dark adaptation in vertebrate photoreceptors. Trends Neurosci. 1996;19(11):502-7.
- Yamada ES, Silveira LC, Gomes FL, Lee BB. The retinal ganglion cell classes of New World primates. Rev Bras Biol. 1996;56 Su 1 Pt 2:381-96.
- Nguyen-Ba-Charvet KT, Rebsam A. Neurogenesis and Specification of Retinal Ganglion Cells. Int J Mol Sci. 2020;21(2).
- Makam R, Rider AT, Yu-Wai-Man P, Gilhooley MJ. Retinal Ganglion Cell Diversity in Disease: Clinical Implications and Type-Specific Evaluation. J Neuroophthalmol. 2025;45(3):350-361.
- Zhang N, He X, Xing Y, Yang N. Differential susceptibility of retinal ganglion cell subtypes against neurodegenerative diseases. Graefes Arch Clin Exp Ophthalmol. 2022;260(6):1807-1821.
- Yu Wai Man CY, Chinnery PF, Griffiths PG. Optic neuropathies—importance of spatial distribution of mitochondria as well as function. Med Hypotheses. 2005;65(6):1038-42.
- Schnapp BJ, Reese TS. Dynein is the motor for retrograde axonal transport of organelles. Proc Natl Acad Sci U S A. 1989;86(5):1548-52.
- Li JY, Dahlström A. Axonal transport of synaptic vesicle proteins in the rat optic nerve. J Neurobiol. 1997;32(2):237-50.
- Luo X, Zhang J, Tolö J, Kügler S, Michel U, Bähr M, et al. Axonal autophagic vesicle transport in the rat optic nerve in vivo under normal conditions and during acute axonal degeneration. Acta Neuropathol Commun. 2024;12(1):82.
- Salinas-Navarro M, Alarcón-Martínez L, Valiente-Soriano FJ, Jiménez-López M, Mayor-Torroglosa S, Avilés-Trigueros M, et al. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp Eye Res. 2010;90(1):168-83.
- Smith MA, Plyler ES, Dengler-Crish CM, Meier J, Crish SD. Nodes of Ranvier in Glaucoma. Neuroscience. 2018;390:104-118.
- Benowitz LI, Yin Y. Optic nerve regeneration. Arch Ophthalmol. 2010;128(8):1059-64.
- Li HJ, Sun ZL, Yang XT, Zhu L, Feng DF. Exploring Optic Nerve Axon Regeneration. Curr Neuropharmacol. 2017;15(6):861-873.
- Lee J, Nguyen S, Bhattacharya S. Optic nerve regeneration: Potential treatment approaches. Curr Opin Pharmacol. 2024;74:102428.
- Chun BY, Cestari DM. Advances in experimental optic nerve regeneration. Curr Opin Ophthalmol. 2017;28(6):558-563.
- Au NPB, Ma CHE. Neuroinflammation, Microglia and Implications for Retinal Ganglion Cell Survival and Axon Regeneration in Traumatic Optic Neuropathy. Front Immunol. 2022;13:860070.
- Fischer D, Harvey AR, Pernet V, Lemmon VP, Park KK. Optic nerve regeneration in mammals: Regenerated or spared axons?. Exp Neurol. 2017;296:83-88.
- Weishaupt JH, Bähr M. Degeneration of axotomized retinal ganglion cells as a model for neuronal apoptosis in the central nervous system - molecular death and survival pathways. Restor Neurol Neurosci. 2001;19(1-2):19-27.
- Levin LA. Intrinsic survival mechanisms for retinal ganglion cells. Eur J Ophthalmol. 1999;9 Suppl 1:S12-6.
- Schmitt HM, Schlamp CL, Nickells RW. Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells. Neurosci Lett. 2016;625:11-5.
- Levin LA, Gordon LK. Retinal ganglion cell disorders: types and treatments. Prog Retin Eye Res. 2002;21(5):465-84.
- Boia R, Ruzafa N, Aires ID, Pereiro X, Ambrósio AF, Vecino E, et al. Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead. Int J Mol Sci. 2020;21(7).
- Khatib TZ, Martin KR. Protecting retinal ganglion cells. Eye (Lond). 2017;31(2):218-224.
- Bessero AC, Clarke PG. Neuroprotection for optic nerve disorders. Curr Opin Neurol. 2010;23(1):10-5.
- Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ, et al. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial. Clin Exp Ophthalmol. 2020;48(7):903-914.
- De Moraes CG, John SWM, Williams PA, Blumberg DM, Cioffi GA, Liebmann JM. Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial. JAMA Ophthalmol. 2022;140(1):11-18.
- Kodali S, Bianchi A, Raftopoulos R, Moccia M, Malladi AP, Yiannakas MC, et al. Effects of Phenytoin on the Retinal Ganglion Cell-Inner Plexiform Layer in Acute Optic Neuritis: Analysis of a Phase II Randomized Trial. Neurology. 2025;105(8):e213951.
- Sibony PA, Kupersmith MJ, Kardon RH. Optical Coherence Tomography Neuro-Toolbox for the Diagnosis and Management of Papilledema, Optic Disc Edema, and Pseudopapilledema. J Neuroophthalmol. 2021;41(1):77-92.
- Ribeiro FL, York A, Zavitz E, Bollmann S, Rosa MGP, Puckett A. Variability of visual field maps in human early extrastriate cortex challenges the canonical model of organization of V2 and V3. Elife. 2023;12.
- Dacey D, Packer OS, Diller L, Brainard D, Peterson B, Lee B. Center surround receptive field structure of cone bipolar cells in primate retina. Vision Res. 2000;40(14):1801-11.
- Takeshita D, Gollisch T. Nonlinear spatial integration in the receptive field surround of retinal ganglion cells. J Neurosci. 2014;34(22):7548-61.
- Johnson KP, Zhao L, Kerschensteiner D. A Pixel-Encoder Retinal Ganglion Cell with Spatially Offset Excitatory and Inhibitory Receptive Fields. Cell Rep. 2018;22(6):1462-1472.
- Tokutake Y, Freed MA. Retinal ganglion cells—spatial organization of the receptive field reduces temporal redundancy. Eur J Neurosci. 2008;28(5):914-23.
- Popova E. GABAergic neurotransmission and retinal ganglion cell function. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2015;201(3):261-83.
- Ikeda H, Wright MJ. Receptive field organization of ‘sustained’ and ‘transient’ retinal ganglion cells which subserve different function roles. J Physiol. 1972;227(3):769-800.
- Vanni S, Henriksson L, James AC. Multifocal fMRI mapping of visual cortical areas. Neuroimage. 2005;27(1):95-105.
- Himmelberg MM, Kurzawski JW, Benson NC, Pelli DG, Carrasco M, Winawer J. Cross-dataset reproducibility of human retinotopic maps. Neuroimage. 2021;244:118609.
- Abdollahi RO, Kolster H, Glasser MF, Robinson EC, Coalson TS, Dierker D, et al. Correspondences between retinotopic areas and myelin maps in human visual cortex. Neuroimage. 2014;99(100):509-24.
- Heitmann C, Zhan M, Linke M, Hölig C, Kekunnaya R, van Hoof R, et al. Early visual experience refines the retinotopic organization within and across visual cortical regions. Curr Biol. 2023;33(22):4950-4959.e4.
- Dumoulin SO, Wandell BA. Population receptive field estimates in human visual cortex. Neuroimage. 2008;39(2):647-60.
- Silva MF, Brascamp JW, Ferreira S, Castelo-Branco M, Dumoulin SO, Harvey BM. Radial asymmetries in population receptive field size and cortical magnification factor in early visual cortex. Neuroimage. 2018;167:41-52.
- Kim I, Kupers ER, Lerma-Usabiaga G, Grill-Spector K. Characterizing Spatiotemporal Population Receptive Fields in Human Visual Cortex with fMRI. J Neurosci. 2024;44(2).
- Dekker TM, Schwarzkopf DS, de Haas B, Nardini M, Sereno MI. Population receptive field tuning properties of visual cortex during childhood. Dev Cogn Neurosci. 2019;37:100614.
- Elul D, Levin N. The Role of Population Receptive Field Sizes in Higher-Order Visual Dysfunction. Curr Neurol Neurosci Rep. 2024;24(12):611-620.
- Cowey A, Rolls ET. Human cortical magnification factor and its relation to visual acuity. Exp Brain Res. 1974;21(5):447-454.
- Virsu V, Rovamo J. Visual resolution, contrast sensitivity, and the cortical magnification factor. Exp Brain Res. 1979;37(3):475-94.
- Duncan RO, Boynton GM. Cortical magnification within human primary visual cortex correlates with acuity thresholds. Neuron. 2003;38(4):659-71.
- Qiu A, Rosenau BJ, Greenberg AS, Hurdal MK, Barta P, Yantis S, et al. Estimating linear cortical magnification in human primary visual cortex via dynamic programming. Neuroimage. 2006;31(1):125-38.
- Slotnick SD, Klein SA, Carney T, Sutter EE. Electrophysiological estimate of human cortical magnification. Clin Neurophysiol. 2001;112(7):1349-56.
- Zeki S, Leff A. The striate cortex and hemianopia. Handb Clin Neurol. 2021;178:115-129.
- Levi DM. Crowding—an essential bottleneck for object recognition: a mini-review. Vision Res. 2008;48(5):635-54.
- Strasburger H, Rentschler I, Jüttner M. Peripheral vision and pattern recognition: a review. J Vis. 2011;11(5):13.
- Rosenholtz R. Capabilities and Limitations of Peripheral Vision. Annu Rev Vis Sci. 2016;2:437-457.
- Strasburger H. Seven Myths on Crowding and Peripheral Vision. Iperception. 2020;11(3):2041669520913052.
- Carvalho J, Invernizzi A, Martins J, Jansonius NM, Renken RJ, Cornelissen FW. Visual Field Reconstruction Using fMRI-Based Techniques. Transl Vis Sci Technol. 2021;10(1):25.
- Ballae Ganeshrao S, Turpin A, Denniss J, McKendrick AM. Enhancing Structure-Function Correlations in Glaucoma with Customized Spatial Mapping. Ophthalmology. 2015;122(8):1695-705.
- Yang J, Li Y, Zhang Q, Zeng S, Huang H, Wu C, et al. Optic Nerve Morphology Influences Structure-Function Relationship in Early Glaucoma With and Without High Myopia. Invest Ophthalmol Vis Sci. 2025;66(4):18.
- Phu J, Kalloniatis M. Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients. Ophthalmology. 2021;128(10):1405-1416.
- Phu J, Rafla D, Kalloniatis M. Which glaucoma patients benefit from 10-2 visual field testing? Proposing the functional vulnerability zone framework. Clin Exp Optom. 2024;107(2):171-183.
- WuDunn D, Takusagawa HL, Rosdahl JA, Sit AJ, Chopra V, Ou Y, et al. Central Visual Field Testing in Early Glaucoma: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024;131(2):240-248.
- Callaway EM. Structure and function of parallel pathways in the primate early visual system. J Physiol. 2005;566(Pt 1):13-9.
- Benedek G, Janáky M, Benedek K, Kéri S. [Parallel processing of visual information]. Ideggyogy Sz. 2006;59(7-8):241-8.
- Bullier J. Integrated model of visual processing. Brain Res Brain Res Rev. 2001;36(2-3):96-107.
- Shapley R. Higher order visual processing in the visual cortex. Handb Clin Neurol. 2026;217:289-305.
- Martin PR, Solomon SG. The koniocellular whiteboard. J Comp Neurol. 2019;527(3):505-507.
- Nugent TW, Feigl B, Zele AJ. Contrast sensitivity and functional aspects of cone, rod, and melanopsin vision in humans. Handb Clin Neurol. 2026;217:329-347.
- Hart WM Jr. Acquired dyschromatopsias. Surv Ophthalmol. 1987;32(1):10-31.
- Katz B. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial. Trans Am Ophthalmol Soc. 1995;93:685-708.
- Silverman SE, Hart WM Jr, Gordon MO, Kilo C. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage. Invest Ophthalmol Vis Sci. 1990;31(9):1895-902.
- Ventura DF, Gualtieri M, Oliveira AG, Costa MF, Quiros P, Sadun F, et al. Male prevalence of acquired color vision defects in asymptomatic carriers of Leber’s hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2007;48(5):2362-70.
- Ageed A, Aslam MD, El Haouari S. Acquired Dyschromatopsia and Its Link to Drug Toxicity. Cureus. 2024;16(12):e76190.
- Huna-Baron R, Glovinsky Y, Habot-Wilner Z. Comparison between Hardy-Rand-Rittler 4th edition and Ishihara color plate tests for detection of dyschromatopsia in optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2013;251(2):585-9.
- Ferreras A, Polo V, Larrosa JM, Pablo LE, Pajarin AB, Pueyo V, et al. Can frequency-doubling technology and short-wavelength automated perimetries detect visual field defects before standard automated perimetry in patients with preperimetric glaucoma?. J Glaucoma. 2007;16(4):372-83.
- Bayer AU, Erb C. Short wavelength automated perimetry, frequency doubling technology perimetry, and pattern electroretinography for prediction of progressive glaucomatous standard visual field defects. Ophthalmology. 2002;109(5):1009-17.
- Soliman MA, de Jong LA, Ismaeil AA, van den Berg TJ, de Smet MD. Standard achromatic perimetry, short wavelength automated perimetry, and frequency doubling technology for detection of glaucoma damage. Ophthalmology. 2002;109(3):444-54.
- Liu S, Lam S, Weinreb RN, Ye C, Cheung CY, Lai G, et al. Comparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucoma. Invest Ophthalmol Vis Sci. 2011;52(10):7325-31.
- Fogagnolo P, Rossetti L, Ranno S, Ferreras A, Orzalesi N. Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma. Prog Brain Res. 2008;173:101-24.
- Johnson CA. Recent developments in automated perimetry in glaucoma diagnosis and management. Curr Opin Ophthalmol. 2002;13(2):77-84.
- Hu R, Wang C, Gu Y, Racette L. Comparison of Standard Automated Perimetry, Short-Wavelength Automated Perimetry, and Frequency-Doubling Technology Perimetry to Monitor Glaucoma Progression. Medicine (Baltimore). 2016;95(7):e2618.
- Mowry EM, Loguidice MJ, Daniels AB, Jacobs DA, Markowitz CE, Galetta SL, et al. Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry. 2009;80(7):767-72.
- Pineles SL, Birch EE, Talman LS, Sackel DJ, Frohman EM, Calabresi PA, et al. One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol. 2011;152(1):133-40.
- Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol. 2011;31(4):362-73.
- Porciatti V. Electrophysiological assessment of retinal ganglion cell function. Exp Eye Res. 2015;141:164-70.
- Wilsey LJ, Fortune B. Electroretinography in glaucoma diagnosis. Curr Opin Ophthalmol. 2016;27(2):118-24.
- Al-Nosairy KO, Thieme H, Hoffmann MB. Diagnostic performance of multifocal photopic negative response, pattern electroretinogram and optical coherence tomography in glaucoma. Exp Eye Res. 2020;200:108242.
- Botelho GIS, Salomão SR, Tengan CH, Karanjia R, Moura FV, Rocha DM, et al. Impaired Ganglion Cell Function Objectively Assessed by the Photopic Negative Response in Affected and Asymptomatic Members From Brazilian Families With Leber’s Hereditary Optic Neuropathy. Front Neurol. 2020;11:628014.
- Votruba M, Fitzke FW, Holder GE, Carter A, Bhattacharya SS, Moore AT. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol. 1998;116(3):351-8.
- Patterson Gentile C, Spitschan M, Taskin HO, Bock AS, Aguirre GK. Temporal Sensitivity for Achromatic and Chromatic Flicker across the Visual Cortex. J Neurosci. 2024;44(21).
- Ribeiro MJ, Violante IR, Bernardino I, Ramos F, Saraiva J, Reviriego P, et al. Abnormal achromatic and chromatic contrast sensitivity in neurofibromatosis type 1. Invest Ophthalmol Vis Sci. 2012;53(1):287-93.
- Sahraie A, Trevethan CT, MacLeod MJ, Murray AD, Olson JA, Weiskrantz L. Increased sensitivity after repeated stimulation of residual spatial channels in blindsight. Proc Natl Acad Sci U S A. 2006;103(40):14971-6.
- Seidemann E, Geisler WS. Linking V1 Activity to Behavior. Annu Rev Vis Sci. 2018;4:287-310.
- Mohsenzadeh Y, Qin S, Cichy RM, Pantazis D. Ultra-Rapid serial visual presentation reveals dynamics of feedforward and feedback processes in the ventral visual pathway. Elife. 2018;7.
- von Seth J, Nicholls VI, Tyler LK, Clarke A. Recurrent connectivity supports higher-level visual and semantic object representations in the brain. Commun Biol. 2023;6(1):1207.
- Papale P, Williford JR, Balk S, Roelfsema PR. Modulatory feedback determines attentional object segmentation in a model of the ventral stream. PLoS One. 2025;20(12):e0337087.
- Zhang Y, Zhang X, Lu X, Chen N. Attention spotlight in V1-based cortico-cortical interactions in human visual hierarchy. Sci Rep. 2024;14(1):13140.
- Lee TS, Mumford D. Hierarchical Bayesian inference in the visual cortex. J Opt Soc Am A Opt Image Sci Vis. 2003;20(7):1434-48.
- Shipp S. Neural Elements for Predictive Coding. Front Psychol. 2016;7:1792.
- Parker AJ, Smith JE, Krug K. Neural architectures for stereo vision. Philos Trans R Soc Lond B Biol Sci. 2016;371(1697).
- Parker AJ, Cumming BG. Cortical mechanisms of binocular stereoscopic vision. Prog Brain Res. 2001;134:205-16.
- Cohen L, Henry C, Dehaene S, Martinaud O, Lehéricy S, Lemer C, et al. The pathophysiology of letter-by-letter reading. Neuropsychologia. 2004;42(13):1768-80.
- Muayqil T, Davies-Thompson J, Barton JJ. Representation of visual symbols in the visual word processing network. Neuropsychologia. 2015;69:232-41.
- Kastner S, Ungerleider LG. Mechanisms of visual attention in the human cortex. Annu Rev Neurosci. 2000;23:315-41.
- Kastner S, Pinsk MA. Visual attention as a multilevel selection process. Cogn Affect Behav Neurosci. 2004;4(4):483-500.
- Szczepanski SM, Konen CS, Kastner S. Mechanisms of spatial attention control in frontal and parietal cortex. J Neurosci. 2010;30(1):148-60.
- Keshavarzi S, Velez-Fort M, Margrie TW. Cortical Integration of Vestibular and Visual Cues for Navigation, Visual Processing, and Perception. Annu Rev Neurosci. 2023;46:301-320.
- Angelaki DE, Gu Y, Deangelis GC. Visual and vestibular cue integration for heading perception in extrastriate visual cortex. J Physiol. 2011;589(Pt 4):825-33.
- Ruehl RM, Flanagin VL, Ophey L, Raiser TM, Seiderer K, Ertl M, et al. The human egomotion network. Neuroimage. 2022;264:119715.
- Delle Monache S, Indovina I, Zago M, Daprati E, Lacquaniti F, Bosco G. Watching the Effects of Gravity. Vestibular Cortex and the Neural Representation of “Visual” Gravity. Front Integr Neurosci. 2021;15:793634.
- Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013;154 Suppl 1:S44-53.
- Karsan N, Silva E, Goadsby PJ. Evaluating migraine with typical aura with neuroimaging. Front Hum Neurosci. 2023;17:1112790.
- Chen WT, Lin YY, Fuh JL, Hämäläinen MS, Ko YC, Wang SJ. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain. 2011;134(Pt 8):2387-95.
- Brooks CJ, Chan YM, Fielding J, White OB, Badcock DR, McKendrick AM. Visual contrast perception in visual snow syndrome reveals abnormal neural gain but not neural noise. Brain. 2022;145(4):1486-1498.
- Hepschke JL, Seymour RA, He W, Etchell A, Sowman PF, Fraser CL. Cortical oscillatory dysrhythmias in visual snow syndrome: a magnetoencephalography study. Brain Commun. 2022;4(1):fcab296.
- Fraser CL. Visual Snow: Updates on Pathology. Curr Neurol Neurosci Rep. 2022;22(3):209-217.
- Sonntag A, Kelbsch C, Jung R, Wilhelm H, Strasser T, Peters T, et al. Effect of central and peripheral cone- and rod-specific stimulation on the pupillary light reflex. Int Ophthalmol. 2022;42(5):1427-1436.
- Romagnoli M, Amore G, Avanzini P, Carelli V, La Morgia C. Chromatic pupillometry for evaluating melanopsin retinal ganglion cell function in Alzheimer’s disease and other neurodegenerative disorders: a review. Front Psychol. 2023;14:1295129.
- Yotharak P, Aui-Aree N. Correlation between clinical grading and quantification by neutral density filter of relative afferent pupillary defect (RAPD). J Med Assoc Thai. 2012;95 Suppl 4:S92-5.
- Zheng D, Huang Z, Chen W, Zhang Q, Shi Y, Chen J, et al. Repeatability and clinical use of pupillary light reflex measurement using RAPDx® pupillometer. Int Ophthalmol. 2022;42(7):2227-2234.
- Cayless A, Bende T. First results of automated RAPD-SWIFT method in dynamic pupillometry. Z Med Phys. 2016;26(2):143-9.
- Kerrison JB, Buchanan K, Rosenberg ML, Clark R, Andreason K, Alfaro DV, et al. Quantification of optic nerve axon loss associated with a relative afferent pupillary defect in the monkey. Arch Ophthalmol. 2001;119(9):1333-41.
- Tatsumi Y, Nakamura M, Fujioka M, Nakanishi Y, Kusuhara A, Maeda H, et al. Quantification of retinal nerve fiber layer thickness reduction associated with a relative afferent pupillary defect in asymmetric glaucoma. Br J Ophthalmol. 2007;91(5):633-7.
- Nakanishi Y, Nakamura M, Tatsumi Y, Nagai-Kusuhara A, Negi A. Quantification of retinal nerve fiber layer thickness reduction associated with a relative afferent pupillary defect. Graefes Arch Clin Exp Ophthalmol. 2006;244(11):1480-4.
- Kernstock C, Beisse F, Wiethoff S, Mast A, Krapp E, Grund R, et al. Assessment of functional and morphometric endpoints in patients with non-arteritic anterior ischemic optic neuropathy (NAION). Graefes Arch Clin Exp Ophthalmol. 2014;252(3):515-21.
- Wilhelm H, Peters T, Lüdtke H, Wilhelm B. The prevalence of relative afferent pupillary defects in normal subjects. J Neuroophthalmol. 2007;27(4):263-7.
- Bremner FD. Pupil assessment in optic nerve disorders. Eye (Lond). 2004;18(11):1175-81.
- Feil M, Moser B, Abegg M. The interaction of pupil response with the vergence system. Graefes Arch Clin Exp Ophthalmol. 2017;255(11):2247-2253.
- Szczęśniak M, Sikorska E, Rajca M, Koper M, Kopacz W, Sikorski P, et al. The etiology, diagnostics, and treatment of the spasm of the near reflex - a narrative review. Eur J Ophthalmol. 2024;34(6):1655-1666.
- Kothari M, Mody K, Walinjkar J, Madia J, Kaul S. Paralysis of the near-vision triad in a child. J AAPOS. 2009;13(2):202-3.
- Nambiar P, Shaikh AG, Gupta P, Murray J, Ghasia FF. Binocular dysfunction in Parkinson’s Disease: Decoding near triad dynamics and divergence deficits. Exp Eye Res. 2025;258:110458.
- Jacobson DM. Pupillary responses to dilute pilocarpine in preganglionic 3rd nerve disorders. Neurology. 1990;40(5):804-8.
- Thompson HS, Kardon RH. The Argyll Robertson pupil. J Neuroophthalmol. 2006;26(2):134-8.
- Nitta T, Kase M, Shinmei Y, Yoshida K, Chin S, Ohno S. Mydriasis with light-near dissociation in Fisher’s Syndrome. Jpn J Ophthalmol. 2007;51(3):224-7.
- Prasad S, Baccon J, Galetta SL. Mydriatic pupil in giant cell arteritis. J Neurol Sci. 2009;284(1-2):196-7.
- Oliva M. Pupil size and search performance in low and high perceptual load. Cogn Affect Behav Neurosci. 2019;19(2):366-376.
- Tapper A, Gonzalez D, Nouredanesh M, Niechwiej-Szwedo E. Pupillometry provides a psychophysiological index of arousal level and cognitive effort during the performance of a visual-auditory dual-task in individuals with a history of concussion. Vision Res. 2021;184:43-51.
- Festa EK, Heindel WC, Marangi CA, Escobedo B, Galasko DR, Salmon DP, et al. Attenuated pupillary response during visual search in preclinical Alzheimer’s disease. Alzheimers Dement. 2026;22(4):e71363.
- Truong JQ, Ciuffreda KJ. Comparison of pupillary dynamics to light in the mild traumatic brain injury (mTBI) and normal populations. Brain Inj. 2016;30(11):1378-1389.
- Bitirgen G, Daraghma M, Özkağnıcı A. Evaluation of Pupillary Light Reflex in Amblyopic Eyes Using Dynamic Pupillometry. Turk J Ophthalmol. 2019;49(6):310-314.
- Rizzuto V, Laurino M, Montanari R, Gemignani A, Figus M, Covello G, et al. Pupillary Hippus as a Biomarker: Spectral Signatures and Complexity Approaches in Autonomic and Clinical Contexts. Bioengineering (Basel). 2025;12(12).
- Riker RR, Sawyer ME, Fischman VG, May T, Lord C, Eldridge A, et al. Neurological Pupil Index and Pupillary Light Reflex by Pupillometry Predict Outcome Early After Cardiac Arrest. Neurocrit Care. 2020;32(1):152-161.
- Romagnosi F, Bernini A, Bongiovanni F, Iaquaniello C, Miroz JP, Citerio G, et al. Neurological Pupil Index for the Early Prediction of Outcome in Severe Acute Brain Injury Patients. Brain Sci. 2022;12(5).
- Jahns FP, Miroz JP, Messerer M, Daniel RT, Taccone FS, Eckert P, et al. Quantitative pupillometry for the monitoring of intracranial hypertension in patients with severe traumatic brain injury. Crit Care. 2019;23(1):155.
- Kiani I, Parsaei M, Karimi H, Beikmarzehei A, Fooladi Sarabi S, Pezhdam P, et al. Prognostic role of quantitative pupillometry in traumatic brain injury: a scoping review. Neurol Sci. 2025;46(3):1169-1177.
- Leigh RJ, Kennard C. Using saccades as a research tool in the clinical neurosciences. Brain. 2004;127(Pt 3):460-77.
- Scudder CA, Moschovakis AK, Karabelas AB, Highstein SM. Anatomy and physiology of saccadic long-lead burst neurons recorded in the alert squirrel monkey. I. Descending projections from the mesencephalon. J Neurophysiol. 1996;76(1):332-52.
- Langer TP, Kaneko CR. Efferent projections of the cat oculomotor reticular omnipause neuron region: an autoradiographic study. J Comp Neurol. 1983;217(3):288-306.
- Enderle JD. Neural control of saccades. Prog Brain Res. 2002;140:21-49.
- Ramat S, Leigh RJ, Zee DS, Shaikh AG, Optican LM. Applying saccade models to account for oscillations. Prog Brain Res. 2008;171:123-30.
- Eggers SD, Horn AK, Roeber S, Härtig W, Nair G, Reich DS, et al. Saccadic Palsy following Cardiac Surgery: Possible Role of Perineuronal Nets. PLoS One. 2015;10(7):e0132075.
- Schall JD. Neural basis of saccade target selection. Rev Neurosci. 1995;6(1):63-85.
- McPeek RM, Keller EL. Deficits in saccade target selection after inactivation of superior colliculus. Nat Neurosci. 2004;7(7):757-63.
- Shen K, Paré M. Predictive saccade target selection in superior colliculus during visual search. J Neurosci. 2014;34(16):5640-8.
- Burrell JR, Hornberger M, Carpenter RH, Kiernan MC, Hodges JR. Saccadic abnormalities in frontotemporal dementia. Neurology. 2012;78(23):1816-23.
- Antoniades CA, Spering M. Eye movements in Parkinson’s disease: from neurophysiological mechanisms to diagnostic tools. Trends Neurosci. 2024;47(1):71-83.
- Filippopulos FM, Goeschy C, Schoeberl F, Eren OE, Straube A, Eggert T. Reflexive and Intentional Saccadic Eye Movements in Migraineurs. Front Neurol. 2021;12:669922.
- Fukushima K, Fukushima J, Warabi T, Barnes GR. Cognitive processes involved in smooth pursuit eye movements: behavioral evidence, neural substrate and clinical correlation. Front Syst Neurosci. 2013;7:4.
- Nuding U, Ono S, Mustari MJ, Büttner U, Glasauer S. A theory of the dual pathways for smooth pursuit based on dynamic gain control. J Neurophysiol. 2008;99(6):2798-808.
- Ilg UJ. Slow eye movements. Prog Neurobiol. 1997;53(3):293-329.
- Dix MR. The mechanism and clinical significance of optokinetic nystagmus. J Laryngol Otol. 1980;94(8):845-64.
- Halmagyi GM, Gresty MA, Leech J. Reversed optokinetic nystagmus (OKN): mechanism and clinical significance. Ann Neurol. 1980;7(5):429-35.
- Lin TF, Mohammadi M, Cullen KE, Chacron MJ, Huang MY. Optokinetic set-point adaptation functions as an internal dynamic calibration mechanism for oculomotor disequilibrium. iScience. 2022;25(11):105335.
- Braddick O, Atkinson J. Development of human visual function. Vision Res. 2011;51(13):1588-609.
- Rinaudo CN, Schubert MC, Figtree WVC, Todd CJ, Migliaccio AA. Human vestibulo-ocular reflex adaptation is frequency selective. J Neurophysiol. 2019;122(3):984-993.
- Lewis RF, Clendaniel RA, Zee DS. Vergence-dependent adaptation of the vestibulo-ocular reflex. Exp Brain Res. 2003;152(3):335-40.
- Clément G, Wood SJ, Paloski WH, Reschke MF. Changes in gain of horizontal vestibulo-ocular reflex during spaceflight. J Vestib Res. 2019;29(5):241-251.
- Quinet J, Schultz K, May PJ, Gamlin PD. Neural Control of Vergence and Ocular Accommodation. Annu Rev Vis Sci. 2025;11(1):43-72.
- Gamlin PD. Subcortical neural circuits for ocular accommodation and vergence in primates. Ophthalmic Physiol Opt. 1999;19(2):81-9.
- Gamlin PD. Neural mechanisms for the control of vergence eye movements. Ann N Y Acad Sci. 2002;956:264-72.
- Mays LE, Gamlin PD. Neuronal circuitry controlling the near response. Curr Opin Neurobiol. 1995;5(6):763-8.
- Gamlin PD, Yoon K, Zhang H. The role of cerebro-ponto-cerebellar pathways in the control of vergence eye movements. Eye (Lond). 1996;10 ( Pt 2):167-71.
- Chaturvedi V, Van Gisbergen JA. Stimulation in the rostral pole of monkey superior colliculus: effects on vergence eye movements. Exp Brain Res. 2000;132(1):72-8.
- Schor CM. Neuromuscular plasticity and rehabilitation of the ocular near response. Optom Vis Sci. 2009;86(7):E788-802.
- Mestre C, Neupane S, Manh V, Tarczy-Hornoch K, Candy TR. Vergence and accommodation responses in the control of intermittent exotropia. Ophthalmic Physiol Opt. 2023;43(4):598-614.
- Martinez-Conde S. Fixational eye movements in normal and pathological vision. Prog Brain Res. 2006;154:151-76.
- Krekelberg B. Microsaccades. Curr Biol. 2011;21(11):R416.
- Krauzlis RJ, Goffart L, Hafed ZM. Neuronal control of fixation and fixational eye movements. Philos Trans R Soc Lond B Biol Sci. 2017;372(1718).
- Alexander RG, Macknik SL, Martinez-Conde S. Fixational eye movements: Implications for applied and clinical assessments. Handb Clin Neurol. 2026;217:349-362.
- Beh SC, Frohman TC, Frohman EM. Cerebellar Control of Eye Movements. J Neuroophthalmol. 2017;37(1):87-98.
- Lewis RF, Zee DS. Ocular motor disorders associated with cerebellar lesions: pathophysiology and topical localization. Rev Neurol (Paris). 1993;149(11):665-77.
- Lemos J, Eggenberger E. Supranuclear eye movement disorders. Curr Opin Ophthalmol. 2014;25(6):471-9.
- Brodsky MC, Dell’Osso LF. A unifying neurologic mechanism for infantile nystagmus. JAMA Ophthalmol. 2014;132(6):761-8.
- Sanchez K, Rowe FJ. Role of neural integrators in oculomotor systems: a systematic narrative literature review. Acta Ophthalmol. 2018;96(2):e111-e118.
- Strupp M, Kremmyda O, Adamczyk C, Böttcher N, Muth C, Yip CW, et al. Central ocular motor disorders, including gaze palsy and nystagmus. J Neurol. 2014;261 Suppl 2(Suppl 2):S542-58.
- Delgado-García JM, Yajeya J, Navarro-López Jde D. A cholinergic mechanism underlies persistent neural activity necessary for eye fixation. Prog Brain Res. 2006;154:211-24.
- Mettens P, Godaux E, Cheron G, Galiana HL. Effect of muscimol microinjections into the prepositus hypoglossi and the medial vestibular nuclei on cat eye movements. J Neurophysiol. 1994;72(2):785-802.
- Godaux E, Mettens P, Cheron G. Differential effect of injections of kainic acid into the prepositus and the vestibular nuclei of the cat. J Physiol. 1993;472:459-82.
- Gupta P, Shaikh AG. “Leaky” and “Unstable” Neural Integrator Can Coexist-Paradox Observed in Multiple Sclerosis. J Neuroophthalmol. 2020;40(2):226-233.
- Sugimura T, Saito Y. Distinct proportions of cholinergic neurons in the rat prepositus hypoglossi nucleus according to their cerebellar projection targets. J Comp Neurol. 2021;529(7):1541-1552.
- Sugimura T, Miyashita T, Yamamoto M, Kobayashi K, Yoshimura Y, Saito Y. An Indirect Pathway from the Rat Interstitial Nucleus of Cajal to the Vestibulocerebellum Involved in Vertical Gaze Holding. eNeuro. 2024;11(11).
- Saito Y, Sugimura T, Yanagawa Y. Comparisons of Neuronal and Excitatory Network Properties between the Rat Brainstem Nuclei that Participate in Vertical and Horizontal Gaze Holding. eNeuro. 2017;4(5).
- Saito Y, Sugimura T. Different Activation Mechanisms of Excitatory Networks in the Rat Oculomotor Integrators for Vertical and Horizontal Gaze Holding. eNeuro. 2020;7(1).
- Cheron G, Ris L, Cebolla AM. Nucleus incertus provides eye velocity and position signals to the vestibulo-ocular cerebellum: a new perspective of the brainstem-cerebellum-hippocampus network. Front Syst Neurosci. 2023;17:1180627.
- Das VE, Leigh RJ, Swann M, Thurtell MJ. Muscimol inactivation caudal to the interstitial nucleus of Cajal induces hemi-seesaw nystagmus. Exp Brain Res. 2010;205(3):405-13.
- Rambold H, Helmchen C, Büttner U. Unilateral muscimol inactivations of the interstitial nucleus of Cajal in the alert rhesus monkey do not elicit seesaw nystagmus. Neurosci Lett. 1999;272(2):75-8.
- Hirose G. [Cerebellar Control of Ocular Movements: Application to the Topographical Diagnosis of Cerebellar Lesions]. Brain Nerve. 2016;68(3):271-81.
- Shemesh AA, Kocoglu K, Akdal G, Ala RT, Halmagyi GM, Zee DS, et al. Modeling the interaction among three cerebellar disorders of eye movements: periodic alternating, gaze-evoked and rebound nystagmus. J Comput Neurosci. 2021;49(3):295-307.
- Tarnutzer AA, Weber KP, Schuknecht B, Straumann D, Marti S, Bertolini G. Gaze holding deficits discriminate early from late onset cerebellar degeneration. J Neurol. 2015;262(8):1837-49.
- Bertolini G, Romano F, Feddermann-Demont N, Straumann D, Tarnutzer AA, Ramat S. Non-linearity in gaze holding: Experimental results and possible mechanisms. Prog Brain Res. 2019;248:167-181.
- Manzari L. Velocity Storage Integrator (VSI): Mechanisms, circuits, and clinical implications A narrative review. Am J Otolaryngol. 2026;47(3):104834.
- Kim JS, Yoon B, Choi KD, Oh SY, Park SH, Kim BK. Upbeat nystagmus: clinicoanatomical correlations in 15 patients. J Clin Neurol. 2006;2(1):58-65.
- Chen G, Zhang C, Gao W, Fan H, Huang F, Fan H, et al. [Research advances on mechanism and lesion location of vertical nystagmus]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;34(2):186-189.
- Glasauer S, Strupp M, Kalla R, Büttner U, Brandt T. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus. Ann N Y Acad Sci. 2005;1039:528-31.
- Strupp M, Kalla R, Glasauer S, Wagner J, Hüfner K, Jahn K, et al. Aminopyridines for the treatment of cerebellar and ocular motor disorders. Prog Brain Res. 2008;171:535-41.
- Thurtell MJ, Leigh RJ. Therapy for nystagmus. J Neuroophthalmol. 2010;30(4):361-71.
- McLean RJ, Gottlob I. The pharmacological treatment of nystagmus: a review. Expert Opin Pharmacother. 2009;10(11):1805-16.
- Ritter MS, Bertolini G, Straumann D, Bögli SY. Prevalence and Characteristics of Physiological Gaze-Evoked and Rebound Nystagmus: Implications for Testing Their Pathological Counterparts. Front Neurol. 2020;11:547015.
- Donaldson IM. The functions of the proprioceptors of the eye muscles. Philos Trans R Soc Lond B Biol Sci. 2000;355(1404):1685-754.
- Steinbach MJ. Proprioceptive knowledge of eye position. Vision Res. 1987;27(10):1737-44.
- Ashton JA, Boddy A, Dean SR, Milleret C, Donaldson IM. Afferent signals from cat extraocular muscles in the medial vestibular nucleus, the nucleus praepositus hypoglossi and adjacent brainstem structures. Neuroscience. 1988;26(1):131-45.
- Balslev D, Newman W, Knox PC. Extraocular muscle afferent signals modulate visual attention. Invest Ophthalmol Vis Sci. 2012;53(11):7004-9.
- Gilbert CD, Li W. Adult visual cortical plasticity. Neuron. 2012;75(2):250-64.
- Keck T, Mrsic-Flogel TD, Vaz Afonso M, Eysel UT, Bonhoeffer T, Hübener M. Massive restructuring of neuronal circuits during functional reorganization of adult visual cortex. Nat Neurosci. 2008;11(10):1162-7.
- Mowery TM, Garraghty PE. Adult neuroplasticity employs developmental mechanisms. Front Syst Neurosci. 2022;16:1086680.
- Eysel UT, Schweigart G, Mittmann T, Eyding D, Qu Y, Vandesande F, et al. Reorganization in the visual cortex after retinal and cortical damage. Restor Neurol Neurosci. 1999;15(2-3):153-64.
- Chino YM. Adult plasticity in the visual system. Can J Physiol Pharmacol. 1995;73(9):1323-38.
- Mikellidou K, Arrighi R, Aghakhanyan G, Tinelli F, Frijia F, Crespi S, et al. Plasticity of the human visual brain after an early cortical lesion. Neuropsychologia. 2019;128:166-177.
- Levi DM. Amblyopia. Handb Clin Neurol. 2021;178:13-30.
- Levi DM. Rethinking amblyopia 2020. Vision Res. 2020;176:118-129.
- Levi DM, Li RW. Perceptual learning as a potential treatment for amblyopia: a mini-review. Vision Res. 2009;49(21):2535-49.
- Polat U, Ma-Naim T, Spierer A. Treatment of children with amblyopia by perceptual learning. Vision Res. 2009;49(21):2599-603.
- Astle AT, Webb BS, McGraw PV. Can perceptual learning be used to treat amblyopia beyond the critical period of visual development?. Ophthalmic Physiol Opt. 2011;31(6):564-73.
- Tsaousis KT, Mousteris G, Diakonis V, Chaloulis S. Current Developments in the Management of Amblyopia with the Use of Perceptual Learning Techniques. Medicina (Kaunas). 2023;60(1).
- Gray CS, French JM, Bates D, Cartlidge NE, Venables GS, James OF. Recovery of visual fields in acute stroke: homonymous hemianopia associated with adverse prognosis. Age Ageing. 1989;18(6):419-21.
- Jorge CB, Vanessa CN, Miguel A B, Irene GO, Antonio A. Prognostic Factors for Long-Term Recovery of Homonymous Visual Field Defects After Posterior Circulation Ischemic Stroke. J Stroke Cerebrovasc Dis. 2021;30(8):105924.
- Zhang C, Lee TMC, Fu Y, Ren C, Chan CCH, Tao Q. Properties of cross-modal occipital responses in early blindness: An ALE meta-analysis. Neuroimage Clin. 2019;24:102041.
- Kupers R, Ptito M. Compensatory plasticity and cross-modal reorganization following early visual deprivation. Neurosci Biobehav Rev. 2014;41:36-52.
- Fine I, Park JM. Blindness and Human Brain Plasticity. Annu Rev Vis Sci. 2018;4:337-356.
- Grunda T, Marsalek P, Sykorova P. Homonymous hemianopia and related visual defects: Restoration of vision after a stroke. Acta Neurobiol Exp (Wars). 2013;73(2):237-49.
- Werth R, Seelos K. Restitution of visual functions in cerebrally blind children. Neuropsychologia. 2005;43(14):2011-23.
- Roth T, Sokolov AN, Messias A, Roth P, Weller M, Trauzettel-Klosinski S. Comparing explorative saccade and flicker training in hemianopia: a randomized controlled study. Neurology. 2009;72(4):324-31.
- Keller I, Lefin-Rank G. Improvement of visual search after audiovisual exploration training in hemianopic patients. Neurorehabil Neural Repair. 2010;24(7):666-73.
- Gall C, Sabel BA. Reading performance after vision rehabilitation of subjects with homonymous visual field defects. PM R. 2012;4(12):928-35.
- Trauzettel-Klosinski S. Current methods of visual rehabilitation. Dtsch Arztebl Int. 2011;108(51-52):871-8.
- Romano JG. Progress in rehabilitation of hemianopic visual field defects. Cerebrovasc Dis. 2009;27 Suppl 1:187-90.
- Fayed M, Rheault B, Ragan ED, Mejia-Vergara AJ, Ferris DP, Peng TJ. Assessment and Rehabilitation of Post-Stroke Visual Field Impairments: Current Approaches and Emerging Technologies. Neurorehabil Neural Repair. 2026;40(5):387-403.
- Bowers AR, Keeney K, Peli E. Randomized crossover clinical trial of real and sham peripheral prism glasses for hemianopia. JAMA Ophthalmol. 2014;132(2):214-22.
- Bowers AR, Keeney K, Peli E. Community-based trial of a peripheral prism visual field expansion device for hemianopia. Arch Ophthalmol. 2008;126(5):657-64.
- Giorgi RG, Woods RL, Peli E. Clinical and laboratory evaluation of peripheral prism glasses for hemianopia. Optom Vis Sci. 2009;86(5):492-502.
- Pollock A, Hazelton C, Rowe FJ, Jonuscheit S, Kernohan A, Angilley J, et al. Interventions for visual field defects in people with stroke. Cochrane Database Syst Rev. 2019;5(5):CD008388.
- Rowe FJ, Hanna K, Evans JR, Noonan CP, Garcia-Finana M, Dodridge CS, et al. Interventions for eye movement disorders due to acquired brain injury. Cochrane Database Syst Rev. 2018;3(3):CD011290.
- Hazelton C, Thomson K, Todhunter-Brown A, Campbell P, Chung CS, Dorris L, et al. Interventions for perceptual disorders following stroke. Cochrane Database Syst Rev. 2022;11(11):CD007039.
- Sabel BA, Thut G, Haueisen J, Henrich-Noack P, Herrmann CS, Hunold A, et al. Vision modulation, plasticity and restoration using non-invasive brain stimulation - An IFCN-sponsored review. Clin Neurophysiol. 2020;131(4):887-911.
- Räty S, Borrmann C, Granata G, Cárdenas-Morales L, Schoenfeld A, Sailer M, et al. Non-invasive electrical brain stimulation for vision restoration after stroke: An exploratory randomized trial (REVIS). Restor Neurol Neurosci. 2021;39(3):221-235.
- Stunkel L, Sharma RA, Mackay DD, Wilson B, Van Stavern GP, Newman NJ, et al. Patient Harm Due to Diagnostic Error of Neuro-Ophthalmologic Conditions. Ophthalmology. 2021;128(9):1356-1362.
- Stunkel L, Kung NH, Wilson B, McClelland CM, Van Stavern GP. Incidence and Causes of Overdiagnosis of Optic Neuritis. JAMA Ophthalmol. 2018;136(1):76-81.
- Schroeder RM, Stunkel L, Gowder MTA, Kendall E, Wilson B, Nagia L, et al. Misdiagnosis of Third Nerve Palsy. J Neuroophthalmol. 2022;42(1):121-125.
- Feng Y, Commiskey PW, Deveney TK, De Lott LB, Trobe JD. Evaluation of Diplopia by Emergency Medicine Physicians and Consulting Neurologists. J Neuroophthalmol. 2022;42(1):e230-e239.
- Okrent Smolar AL, Ray HJ, Dattilo M, Bouthour W, Berman G, Peragallo JH, et al. Neuro-ophthalmology Emergency Department and Inpatient Consultations at a Large Academic Referral Center. Ophthalmology. 2023;130(12):1304-1312.
- Huff JS, Austin EW. Neuro-Ophthalmology in Emergency Medicine. Emerg Med Clin North Am. 2016;34(4):967-986.
- Schiefer U, Isbert M, Mikolaschek E, Mildenberger I, Krapp E, Schiller J, et al. Distribution of scotoma pattern related to chiasmal lesions with special reference to anterior junction syndrome. Graefes Arch Clin Exp Ophthalmol. 2004;242(6):468-77.
- Gálvez-Ruiz A, Arishi N. Band atrophy of the optic nerve: A report on different anatomical locations in three patients. Saudi J Ophthalmol. 2013;27(1):65-9.
- Newman SA, Miller NR. Optic tract syndrome. Neuro-ophthalmologic considerations. Arch Ophthalmol. 1983;101(8):1241-50.
- Chen NS, McDonald HM, Micieli J, Margolin E. Diagnosis and etiologic classification of optic tract lesions. Brain Commun. 2025;7(5):fcaf354.
- Badihian S, Samaha E, Newman-Toker DE, Zee DS, Kattah JC. Radiographic Horizontal Conjugate Gaze Deviation: Clinical Correlates. Neurol Clin Pract. 2025;15(1):e200375.
- Kattah JC, Talkad AV, Wang DZ, Hsieh YH, Newman-Toker DE. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504-10.
- Kattah JC. Use of HINTS in the acute vestibular syndrome. An Overview. Stroke Vasc Neurol. 2018;3(4):190-196.
- Lee SH, Kim JS. Differential diagnosis of acute vascular vertigo. Curr Opin Neurol. 2020;33(1):142-149.
- Kim SH, Kim HJ, Kim JS. Isolated vestibular syndromes due to brainstem and cerebellar lesions. J Neurol. 2017;264(Suppl 1):63-69.
- Gräf M, Lorenz B. How to deal with diplopia. Rev Neurol (Paris). 2012;168(10):720-8.
- Hajj F, Totten P, Chavez DS, Cortés Jaimes DC, Patel D, Soria Behr GA, et al. A Systematic Approach to Managing Acute Visual Loss: A Comprehensive Review of Literature. Cureus. 2026;18(1):e102280.
- Morgan A, Hemphill RR. Acute visual change. Emerg Med Clin North Am. 1998;16(4):825-43, vii.
- Addis VM, DeVore HK, Summerfield ME. Acute visual changes in the elderly. Clin Geriatr Med. 2013;29(1):165-80.
- Helboe KS, Eddelien HS, Kruuse C. Visual symptoms in acute stroke - A systematic review of observational studies. Clin Neurol Neurosurg. 2023;229:107749.
- Lepore FE. False and non-localizing signs in neuro-ophthalmology. Curr Opin Ophthalmol. 2002;13(6):371-4.
- McClelland C, Van Stavern GP, Shepherd JB, Gordon M, Huecker J. Neuroimaging in patients referred to a neuro-ophthalmology service: the rates of appropriateness and concordance in interpretation. Ophthalmology. 2012;119(8):1701-4.
- Jones R, Al-Hayouti H, Oladiwura D, Karim R, Sawczenko A, Dahlmann-Noor A. Optic atrophy in children: Current causes and diagnostic approach. Eur J Ophthalmol. 2020;30(6):1499-1505.
- Poostchi A, Awad M, Wilde C, Dineen RA, Gruener AM. Spike in neuroimaging requests following the conviction of the optometrist Honey Rose. Eye (Lond). 2018;32(3):489-490.
- Wang X, Jing Y, Yang P, Rao F, Wang L, Zhang H, et al. Incidence, Clinician Misdiagnosis Rate, Radiologist Missed Diagnosis Rate, and Lesion Distribution of Isolated Medial Longitudinal Fasciculus Infarction: A Retrospective Study. Int J Gen Med. 2025;18:7715-7724.
- Lee JH, Tobias S, Kwon JT, Sade B, Kosmorsky G. Wilbrand’s knee: does it exist?. Surg Neurol. 2006;66(1):11-7; discussion 17.
- Shin RK, Kachhela J, Tang CM. Wilbrand Knee Revisited. J Neuroophthalmol. 2024;44(4):469-472.
- Pellegrini F, Cuna A, Cirone D, Ciabattoni C, Caruso E, Interlandi E, et al. Clinical Reasoning: Wilbrand’s Knee, Scotoma of Traquair, and Normal Tension Glaucoma. Case Rep Neurol. 2022;14(2):341-347.
- Werner EB, Beraskow J. Peripheral nasal field defects in glaucoma. Ophthalmology. 1979;86(10):1875-8.
- Hayreh SS, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol. 2005;123(11):1554-62.
- Traustason OI, Feldon SE, Leemaster JE, Weiner JM. Anterior ischemic optic neuropathy: classification of field defects by Octopus automated static perimetry. Graefes Arch Clin Exp Ophthalmol. 1988;226(3):206-12.
- Scherer RW, Feldon SE, Levin L, Langenberg P, Katz J, Keyl PM, et al. Visual fields at follow-up in the Ischemic Optic Neuropathy Decompression Trial: evaluation of change in pattern defect and severity over time. Ophthalmology. 2008;115(10):1809-17.
- Han S, Jung JJ, Kim US. Differences between Non-arteritic Anterior Ischemic Optic Neuropathy and Open Angle Glaucoma with Altitudinal Visual Field Defect. Korean J Ophthalmol. 2015;29(6):418-23.
- Purvin V, King R, Kawasaki A, Yee R. Anterior ischemic optic neuropathy in eyes with optic disc drusen. Arch Ophthalmol. 2004;122(1):48-53.
- Kesler A, Pianka P. Toxic optic neuropathy. Curr Neurol Neurosci Rep. 2003;3(5):410-4.
- Roda M, di Geronimo N, Pellegrini M, Schiavi C. Nutritional Optic Neuropathies: State of the Art and Emerging Evidences. Nutrients. 2020;12(9).
- Syed S, Lioutas V. Tobacco-alcohol amblyopia: a diagnostic dilemma. J Neurol Sci. 2013;327(1-2):41-5.
- Nakajima H, Hosokawa T, Sugino M, Kimura F, Sugasawa J, Hanafusa T, et al. Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis. BMC Neurol. 2010;10:45.
- Wall M, Hart WM Jr, Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 1983;96(5):654-69.
- Savino PJ, Glaser JS, Rosenberg MA. A clinical analysis of pseudopapilledema. II. Visual field defects. Arch Ophthalmol. 1979;97(1):71-5.
- Estrela T, Jammal AA, El-Dairi M, Medeiros FA. Rates of Visual Field Change in Eyes With Optic Disc Drusen. J Neuroophthalmol. 2023;43(3):353-358.
- Jayaraman M, Gandhi RA, Ravi P, Sen P. Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy. Indian J Ophthalmol. 2014;62(3):299-304.
- Foroozan R. Chiasmal syndromes. Curr Opin Ophthalmol. 2003;14(6):325-31.
- Uy B, Wilson B, Kim WJ, Prashant G, Bergsneider M. Visual Outcomes After Pituitary Surgery. Neurosurg Clin N Am. 2019;30(4):483-489.
- Ji X, Zhuang X, Yang S, Zhang K, Li X, Yuan K, et al. Visual field improvement after endoscopic transsphenoidal surgery in patients with pituitary adenoma. Front Oncol. 2023;13:1108883.
- Rutland JW, Schefflein J, Arrighi-Allisan AE, Ranti D, Ladner TR, Pai A, et al. Measuring degeneration of the lateral geniculate nuclei from pituitary adenoma compression detected by 7T ultra-high field MRI: a method for predicting vision recovery following surgical decompression of the optic chiasm. J Neurosurg. 2020;132(6):1747-1756.
- Yoneoka Y, Hatase T, Watanabe N, Jinguji S, Okada M, Takagi M, et al. Early morphological recovery of the optic chiasm is associated with excellent visual outcome in patients with compressive chiasmal syndrome caused by pituitary tumors. Neurol Res. 2015;37(1):1-8.
- Pelsma ICM, Verstegen MJT, de Vries F, Notting IC, Broekman MLD, van Furth WR, et al. Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: visual outcomes and timing of intervention clinical recommendations based on a systematic literature review and cohort study. Pituitary. 2020;23(4):417-429.
- Salinas-Garcia RF, Smith JL. Binasal hemianopia. Surg Neurol. 1978;10(3):187-94.
- O’Connell JE, Du Boulay EP. Binasal hemianopia. J Neurol Neurosurg Psychiatry. 1973;36(5):697-709.
- Pellegrini F, Interlandi E, Marullo M, Cirone D, Cuna A. Idiopathic binasal hemianopia: case report and literature review. Eur J Ophthalmol. 2021;31(6):NP26-NP30.
- Larochelle RD, Mandava N, Subramanian PS. Binasal Center-Involving Hemianopia of Presumed Congenital Etiology. J Neuroophthalmol. 2023;43(3):e82-e84.
- Shacklett DE, O’Connor PS, Dorwart RH, Linn D, Carter JE. Congruous and incongruous sectoral visual field defects with lesions of the lateral geniculate nucleus. Am J Ophthalmol. 1984;98(3):283-90.
- Ali K. The temporal crescent syndrome. Pract Neurol. 2015;15(1):53-5.
- Chavis PS, al-Hazmi A, Clunie D, Hoyt WF. Temporal crescent syndrome with magnetic resonance correlation. J Neuroophthalmol. 1997;17(3):151-5.
- Rao HL, Yadav RK, Begum VU, Addepalli UK, Choudhari NS, Senthil S, et al. Role of visual field reliability indices in ruling out glaucoma. JAMA Ophthalmol. 2015;133(1):40-4.
- Birt CM, Shin DH, Samudrala V, Hughes BA, Kim C, Lee D. Analysis of reliability indices from Humphrey visual field tests in an urban glaucoma population. Ophthalmology. 1997;104(7):1126-30.
- Johnson LN, Aminlari A, Sassani JW. Effect of intermittent versus continuous patient monitoring on reliability indices during automated perimetry. Ophthalmology. 1993;100(1):76-84.
- Joson PJ, Kamantigue ME, Chen PP. Learning effects among perimetric novices in frequency doubling technology perimetry. Ophthalmology. 2002;109(4):757-60.
- Kamal S, Al Othman BA, Kini AT, Lee AG. Checkerboard Visual Field Defect in Occipital Stroke. J Neuroophthalmol. 2020;40(2):e13-e14.
- Papageorgiou E, Hardiess G, Schaeffel F, Wiethoelter H, Karnath HO, Mallot H, et al. Assessment of vision-related quality of life in patients with homonymous visual field defects. Graefes Arch Clin Exp Ophthalmol. 2007;245(12):1749-58.
- Goodwin D. Homonymous hemianopia: challenges and solutions. Clin Ophthalmol. 2014;8:1919-27.
- Agarwal A, Kedar S. Prognosis and Treatment of Visual Field Defects. Semin Neurol. 2015;35(5):549-56.
- Kasneci E, Sippel K, Aehling K, Heister M, Rosenstiel W, Schiefer U, et al. Driving with binocular visual field loss? A study on a supervised on-road parcours with simultaneous eye and head tracking. PLoS One. 2014;9(2):e87470.
- Moss AM, Harrison AR, Lee MS. Patients with homonymous hemianopia become visually qualified to drive using novel monocular sector prisms. J Neuroophthalmol. 2014;34(1):53-6.
- Schmidt D. [Classical brain stem syndrome. Definitions and history]. Ophthalmologe. 2000;97(6):411-7.
- Bogousslavsky J. [Oculomotor syndromes resulting from mesencephalic lesions in man]. Rev Neurol (Paris). 1989;145(8-9):546-59.
- Choi WY, Gold DR. Ocular Motor and Vestibular Disorders in Brainstem Disease. J Clin Neurophysiol. 2019;36(6):396-404.
- Mateos V, Campos DM, Colosía VP, Salas-Puig J, Fernández JM, Lahoz CH. [Nuclear syndrome of the oculomotor nerve caused by a mesencephalic infarction confirmed by MRI]. Arch Neurobiol (Madr). 1992;55(4):183-7.
- Kern D, Raber K, Wünsch G, Schwingenschuh P. Patterns and causes of supranuclear vertical gaze palsy: A retrospective, single-institutional study in 113 patients. Clin Park Relat Disord. 2025;13:100394.
- Kato I, Okada T, Akao I, Shintani T, Kamo T, Sugihara H. Vertical gaze palsy induced by midbrain lesions and its structural imaging. Auris Nasus Larynx. 1998;25(4):339-47.
- Clark JM, Albers GW. Vertical gaze palsies from medial thalamic infarctions without midbrain involvement. Stroke. 1995;26(8):1467-70.
- van der Graaff MM, Vanneste JA, Davies GA. Unilateral thalamic infarction and vertical gaze palsy: cause or coincidence?. J Neuroophthalmol. 2000;20(2):127-9.
- Sarwal A, Garewal M, Sahota S, Sivaraman M. Eight-and-a-half syndrome. J Neuroimaging. 2009;19(3):288-90.
- Cárdenas-Rodríguez MA, Castillo-Torres SA, Chávez-Luévanos B, De León-Flores L. Eight-and-a-half syndrome: video evidence and updated literature review. BMJ Case Rep. 2020;13(5).
- Xia NG, Chen YY, Li J, Chen X, Ye ZS, Chen SY, et al. Eight-and-a-half syndrome caused by a pontine haemorrhage: a case report and review of the literature. Int J Neurosci. 2018;128(8):746-750.
- Zuo C, Zhao M, Zhao L, Meng N, Xing X, Li N. Case report: Lateral medullary syndrome with eight-and-a-half syndromes. Medicine (Baltimore). 2024;103(6):e34409.
- Lee SH, Kim JM, Kim JS. Update on the medial longitudinal fasciculus syndrome. Neurol Sci. 2022;43(6):3533-3540.
- Zwergal A, Cnyrim C, Arbusow V, Glaser M, Fesl G, Brandt T, et al. Unilateral INO is associated with ocular tilt reaction in pontomesencephalic lesions: INO plus. Neurology. 2008;71(8):590-3.
- Brazis PW. Ocular motor abnormalities in Wallenberg’s lateral medullary syndrome. Mayo Clin Proc. 1992;67(4):365-8.
- Sacco RL, Freddo L, Bello JA, Odel JG, Onesti ST, Mohr JP. Wallenberg’s lateral medullary syndrome. Clinical-magnetic resonance imaging correlations. Arch Neurol. 1993;50(6):609-14.
- Crevits L, vander Eecken H. Ocular lateropulsion in Wallenberg’s syndrome: a prospective clinical study. Acta Neurol Scand. 1982;65(3):219-22.
- Kim JS, Moon SY, Park SH, Yoon BW, Roh JK. Ocular lateropulsion in Wallenberg syndrome. Neurology. 2004;62(12):2287.
- Waespe W, Wichmann W. Oculomotor disturbances during visual-vestibular interaction in Wallenberg’s lateral medullary syndrome. Brain. 1990;113 ( Pt 3):821-46.
- Lee SH, Kim JM, Schuknecht B, Tarnutzer AA. Vestibular and Ocular Motor Properties in Lateral Medullary Stroke Critically Depend on the Level of the Medullary Lesion. Front Neurol. 2020;11:390.
- Kato I, Ogino S, Okada T, Koizuka I, Kanayama R, Nakamura T. Wallenberg’s syndrome: neurotological classification. Auris Nasus Larynx. 2003;30 Suppl:S13-8.
- Brodsky MC, Donahue SP, Vaphiades M, Brandt T. Skew deviation revisited. Surv Ophthalmol. 2006;51(2):105-28.
- Gold DR, Schubert MC. Ocular Misalignment in Dizzy Patients-Something’s A-Skew. J Neurol Phys Ther. 2019;43 Suppl 2:S27-S30.
- Feng Y, Zhao T, Wu Y, Ling X, Zhang M, Song N, et al. The diagnostic value of the ocular tilt reaction plus head tilt subjective visual vertical (±45°) in patients with acute central vascular vertigo. Front Neurol. 2022;13:1022362.
- Brandt T, Dieterich M. Perceived vertical and lateropulsion: clinical syndromes, localization, and prognosis. Neurorehabil Neural Repair. 2000;14(1):1-12.
- Sheth MS, Primiani CT, Kheradmand A, Green KE. Pearls & Oy-sters: Vertical Diplopia and Ocular Torsion: Peripheral vs Central Localization. Neurology. 2022;99(5):212-215.
- Goyal P, Lee S, Gupta N, Kumar Y, Mangla M, Hooda K, et al. Orbital apex disorders: Imaging findings and management. Neuroradiol J. 2018;31(2):104-125.
- Fernández S, Godino O, Martínez-Yélamos S, Mesa E, Arruga J, Ramón JM, et al. Cavernous sinus syndrome: a series of 126 patients. Medicine (Baltimore). 2007;86(5):278-281.
- Keane JR. Cavernous sinus syndrome. Analysis of 151 cases. Arch Neurol. 1996;53(10):967-71.
- Munawar K, Nayak G, Fatterpekar GM, Sen C, Zagzag D, Zan E, et al. Cavernous sinus lesions. Clin Imaging. 2020;68:71-89.
- Lutt JR, Lim LL, Phal PM, Rosenbaum JT. Orbital inflammatory disease. Semin Arthritis Rheum. 2008;37(4):207-22.
- Warburton RE, Brookes CC, Golden BA, Turvey TA. Orbital apex disorders: a case series. Int J Oral Maxillofac Surg. 2016;45(4):497-506.
- van der Poel NA, Mourits MP, de Win MML, Coutinho JM, Dikkers FG. Prognosis of septic cavernous sinus thrombosis remarkably improved: a case series of 12 patients and literature review. Eur Arch Otorhinolaryngol. 2018;275(9):2387-2395.
- Geng B, Wu X, Malhotra A. Septic cavernous sinus thrombosis-Case series and review of the literature. Clin Neurol Neurosurg. 2020;197:106092.
- Kmeid M, Medrea I. Review of Tolosa-Hunt Syndrome, Recent Updates. Curr Pain Headache Rep. 2023;27(12):843-849.
- Dutta P, Anand K. Tolosa-Hunt Syndrome: A Review of Diagnostic Criteria and Unresolved Issues. J Curr Ophthalmol. 2021;33(2):104-111.
- Mullen E, Green M, Hersh E, Iloreta AM, Bederson J, Shrivastava R. Tolosa-Hunt Syndrome: Appraising the ICHD-3 beta diagnostic criteria. Cephalalgia. 2018;38(10):1696-1700.
- Mullen E, Rutland JW, Green MW, Bederson J, Shrivastava R. Reappraising the Tolosa-Hunt Syndrome Diagnostic Criteria: A Case Series. Headache. 2020;60(1):259-264.
- Pascual J, Cerezal L, Canga A, Alvarez de Arcaya A, Polo JM, Berciano J. Tolosa-Hunt syndrome: focus on MRI diagnosis. Cephalalgia. 1999;19 Suppl 25:36-8.
- Tsirigotaki M, Ntoulios G, Lioumpas M, Voutoufianakis S, Vorgia P. Tolosa-Hunt Syndrome: Clinical Manifestations in Children. Pediatr Neurol. 2019;99:60-63.
- Shah NH, Bhatt N, Tipirneni A, Condes D, Khandelwal P, Romano JG. Conjugate Eye Deviation on CT Associated With Worse Outcomes Despite IV Thrombolysis. Neurohospitalist. 2017;7(2):74-77.
- Bien CG, Benninger FO, Urbach H, Schramm J, Kurthen M, Elger CE. Localizing value of epileptic visual auras. Brain. 2000;123 ( Pt 2):244-53.
- Khoja A, Albaradei O, Alsulami A, Alkhaja M, Alsumaili M, Khoja O, et al. Seizure semiology in temporal lobe vs. temporal plus epilepsy using intracranial EEG monitoring. Neurosciences (Riyadh). 2021;26(3):261-269.
- Giannakou I, Lin D, Punt D. Computer-based assessment of unilateral spatial neglect: A systematic review. Front Neurosci. 2022;16:912626.
- Longley V, Hazelton C, Heal C, Pollock A, Woodward-Nutt K, Mitchell C, et al. Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury. Cochrane Database Syst Rev. 2021;7(7):CD003586.
- Hanna KL, Hepworth LR, Rowe F. Screening methods for post-stroke visual impairment: a systematic review. Disabil Rehabil. 2017;39(25):2531-2543.
- Rowe FJ, Hepworth LR, Begoña Coco-Martin M, Gillebert CR, Leal-Vega L, Palmowski-Wolfe A, et al. European Stroke Organisation (ESO) guideline on visual impairment in stroke. Eur Stroke J. 2025;10(4):1087-1159.
- Maillard L, Ferrand M, Aron O, Cheval M, Tyvaert L, Jonas J, et al. Visual phenomena and anatomo-electro-clinical correlations in occipital lobe seizures. Rev Neurol (Paris). 2022;178(7):644-648.
- Chowdhury FA, Silva R, Whatley B, Walker MC. Localisation in focal epilepsy: a practical guide. Pract Neurol. 2021;21(6):481-491.
- Detchou D, Barrie U. Occipital lobe epilepsy surgery: treating seizures in the posterior cortex. Neurosurg Rev. 2024;47(1):514.
- Schulze-Bonhage A. [Differential diagnosis of visual aura in migraine and epilepsy]. Klin Monbl Augenheilkd. 2001;218(9):595-602.
- Makoshi Z, Leonard JR. Clinical Manifestations of Chiari I Malformation. Neurosurg Clin N Am. 2023;34(1):25-34.
- McClugage SG, Oakes WJ. The Chiari I malformation. J Neurosurg Pediatr. 2019;24(3):217-226.
- Mancarella C, Delfini R, Landi A. Chiari Malformations. Acta Neurochir Suppl. 2019;125:89-95.
- Lennerstrand G, Gallo JE. Neuro-ophthalmological evaluation of patients with myelomeningocele and Chiari malformations. Dev Med Child Neurol. 1990;32(5):415-22.
- Lee AG. Visual loss as the manifesting symptom of ventriculoperitoneal shunt malfunction. Am J Ophthalmol. 1996;122(1):127-9.
- Shi A, Kulkarni A, Feldman KW, Weiss A, McCourt EA, Schloff S, et al. Retinal Findings in Young Children With Increased Intracranial Pressure From Nontraumatic Causes. Pediatrics. 2019;143(2).
- Tzekov C, Cherninkova S, Gudeva T. Neuroophthalmological symptoms in children treated for internal hydrocephalus. Pediatr Neurosurg. 1991;17(6):317-20.
- Nordin BA. Differentiating Visual Symptoms in Retinal Migraine and Migraine With Aura: A Systematic Review of Shared Features, Distinctions, and Clinical Implications. Cureus. 2025;17(8):e91028.
- Amos JF, Fleming JB. Clinical description and review of migraine aura without headache. Optometry. 2000;71(6):372-80.
- Friedman DI. Pearls: diplopia. Semin Neurol. 2010;30(1):54-65.
- Wijeratne T, Wijeratne C, Korajkic N, Bird S, Sales C, Riederer F. Secondary headaches - red and green flags and their significance for diagnostics. eNeurologicalSci. 2023;32:100473.
- Förderreuther S. [Headache emergencies are easily overlooked]. Schmerz. 2020;34(6):517-524.
- Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis. Arthritis Rheumatol. 2022;74(12):1881-1889.
- Soowamber ML, Bond M, Touma Z, Langford C, Sanchez-Alvarez C, Abril A, et al. A glossary of signs and symptoms of giant cell arteritis. Ann Rheum Dis. 2025;84(11):1877-1887.
- Dinkin M, Johnson E. One Giant Step for Giant Cell Arteritis: Updates in Diagnosis and Treatment. Curr Treat Options Neurol. 2021;23(2):6.
- Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372(9634):234-45.
- Yang HK, Park MJ, Lee JH, Lee CT, Park JS, Hwang JM. Incidence of toxic optic neuropathy with low-dose ethambutol. Int J Tuberc Lung Dis. 2016;20(2):261-4.
- Sudhakar P, Acharya K, Kini TA. Ethambutol optic neuropathy. Front Neurol. 2025;16:1626909.
- Saxena R, Phuljhele S, Prakash A, Lodha R, Singh D, Karna S, et al. Ethambutol Optic Neuropathy: Vigilance and Screening, the Keys to Prevent Blindness with the Revised Anti-tuberculous Therapy Regimen. J Assoc Physicians India. 2021;69(2):54-57.
- Bouffard MA, Nathavitharana RR, Yassa DS, Torun N. Re-Treatment With Ethambutol After Toxic Optic Neuropathy. J Neuroophthalmol. 2017;37(1):40-42.
- Hathaway JT, Shah MP, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW Jr, et al. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide. JAMA Ophthalmol. 2024;142(8):732-739.
- Archer EL, Pepin S. Obstructive sleep apnea and nonarteritic anterior ischemic optic neuropathy: evidence for an association. J Clin Sleep Med. 2013;9(6):613-8.
- Wu Y, Zhou LM, Lou H, Cheng JW, Wei RL. The Association Between Obstructive Sleep Apnea and Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis. Curr Eye Res. 2016;41(7):987-92.
- Fraser CL. Obstructive sleep apnea and optic neuropathy: is there a link?. Curr Neurol Neurosci Rep. 2014;14(8):465.
- Hayreh SS, Fingert JH, Stone E, Jacobson DM. Familial non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2008;246(9):1295-305.
- Hazel CA, Elliott DB. The dependency of logMAR visual acuity measurements on chart design and scoring rule. Optom Vis Sci. 2002;79(12):788-92.
- Rosser DA, Cousens SN, Murdoch IE, Fitzke FW, Laidlaw DA. How sensitive to clinical change are ETDRS logMAR visual acuity measurements?. Invest Ophthalmol Vis Sci. 2003;44(8):3278-81.
- Rosser DA, Laidlaw DA, Murdoch IE. The development of a “reduced logMAR” visual acuity chart for use in routine clinical practice. Br J Ophthalmol. 2001;85(4):432-6.
- Laidlaw DA, Abbott A, Rosser DA. Development of a clinically feasible logMAR alternative to the Snellen chart: performance of the “compact reduced logMAR” visual acuity chart in amblyopic children. Br J Ophthalmol. 2003;87(10):1232-4.
- Noushad B, Thomas J, Amin SV. Reliability of a modified logMAR distant visual acuity chart for routine clinical use. Oman J Ophthalmol. 2012;5(2):87-90.
- Baker CW, Josic K, Maguire MG, Jampol LM, Martin DF, Rofagha S, et al. Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment. Ophthalmology. 2023;130(5):533-541.
- Veselý P, Ventruba J. [Comparison of the threshold interpolation and whole-line method on logMAR chart and Snellen chart for visual acuity testing]. Cesk Slov Oftalmol. 2009;65(5):191-4.
- Samanta A, Mauntana S, Barsi Z, Yarlagadda B, Nelson PC. Is your vision blurry? A systematic review of home-based visual acuity for telemedicine. J Telemed Telecare. 2023;29(2):81-90.
- Goh C, Puah M, Toh ZH, Boon J, Boey D, Tay R, et al. Mobile Apps and Visual Function Assessment: A Comprehensive Review of the Latest Advancements. Ophthalmol Ther. 2025;14(1):23-39.
- Herrero A, Berrada H, Barraquer RI, Michael R. Quantification of visual acuity: “Counting fingers” and “Hand movement” with the Berkeley Rudimentary Vision Test. J Optom. 2025;18(1):100531.
- Ravensbergen HRJC, van Bree BINA, Broekens DM, Mann DL. Detecting Cheating when Testing Vision: Variability in Acuity Measures Reveals Misrepresentation. Optom Vis Sci. 2018;95(6):536-544.
- Lachenmayr B. [Predicting visual acuity in media opacities and uncorrectable refractive errors. Assessing so-called “retinal visual acuity”]. Fortschr Ophthalmol. 1990;87 Suppl:S118-37.
- Elliott DB, Sanderson K, Conkey A. The reliability of the Pelli-Robson contrast sensitivity chart. Ophthalmic Physiol Opt. 1990;10(1):21-4.
- Thayaparan K, Crossland MD, Rubin GS. Clinical assessment of two new contrast sensitivity charts. Br J Ophthalmol. 2007;91(6):749-52.
- Njeru SM, Osman M, Brown AM. The Effect of Test Distance on Visual Contrast Sensitivity Measured Using the Pelli-Robson Chart. Transl Vis Sci Technol. 2021;10(2):32.
- Prihatningtias R, Hardiyanti D, Valencia L. Converting LEA to Pelli-Robson contrast sensitivity score in neuro-ophthalmology patients. Indian J Ophthalmol. 2024;72(Suppl 3):S505-S508.
- Wender M. Value of Pelli-Robson contrast sensitivity chart for evaluation of visual system in multiple sclerosis patients. Neurol Neurochir Pol. 2007;41(2):141-3.
- Baier ML, Cutter GR, Rudick RA, Miller D, Cohen JA, Weinstock-Guttman B, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology. 2005;64(6):992-5.
- Balcer LJ, Frohman EM. Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology. 2010;74 Suppl 3:S16-23.
- Lynch DR, Farmer JM, Rochestie D, Balcer LJ. Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia. J Neuroophthalmol. 2002;22(4):270-4.
- Hamedani AG, Bardakjian T, Balcer LJ, Gonzalez-Alegre P. Contrast Acuity and the King-Devick Test in Huntington’s Disease. Neuroophthalmology. 2020;44(4):219-225.
- Balcer LJ, Raynowska J, Nolan R, Galetta SL, Kapoor R, Benedict R, et al. Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):734-747.
- Nolan RC, Akhand O, Rizzo JR, Galetta SL, Balcer LJ. Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies. J Neuroophthalmol. 2018;38(2):202-209.
- Aroichane M, Pieramici DJ, Miller NR, Vitale S. A comparative study of Hardy-Rand-Rittler and Ishihara colour plates for the diagnosis of nonglaucomatous optic neuropathy. Can J Ophthalmol. 1996;31(7):350-5.
- Zhao J, Davé SB, Wang J, Subramanian PS. Clinical color vision testing and correlation with visual function. Am J Ophthalmol. 2015;160(3):547-552.e1.
- Glaser JS, Savino PJ, Sumers KD, McDonald SA, Knighton RW. The photostress recovery test in the clinical assessment of visual function. Am J Ophthalmol. 1977;83(2):255-60.
- Horiguchi M, Ito Y, Miyake Y. Extrafoveal photostress recovery test in glaucoma and idiopathic central serous chorioretinopathy. Br J Ophthalmol. 1998;82(9):1007-12.
- Bjerager J, Schneider M, Potapenko I, van Dijk EHC, Faber C, Grauslund J, et al. Diagnostic Accuracy of the Amsler Grid Test for Detecting Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 2023;141(4):315-323.
- Augustin AJ, Offermann I, Lutz J, Schmidt-Erfurth U, Tornambe P. Comparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degeneration. Retina. 2005;25(4):443-5.
- Su D, Greenberg A, Simonson JL, Teng CC, Liebmann JM, Ritch R, et al. Efficacy of the Amsler Grid Test in Evaluating Glaucomatous Central Visual Field Defects. Ophthalmology. 2016;123(4):737-43.
- Cooper J, Feldman J, Medlin D. Comparing stereoscopic performance of children using the Titmus, TNO, and Randot stereo tests. J Am Optom Assoc. 1979;50(7):821-5.
- Hall C. The relationship between clinical stereotests. Ophthalmic Physiol Opt. 1982;2(2):135-43.
- Bruce BB, Newman NJ. Functional visual loss. Neurol Clin. 2010;28(3):789-802.
- Miller NR. Functional neuro-ophthalmology. Handb Clin Neurol. 2011;102:493-513.
- Toldo I, Pinello L, Suppiej A, Ermani M, Cermakova I, Zanin E, et al. Nonorganic (psychogenic) visual loss in children: a retrospective series. J Neuroophthalmol. 2010;30(1):26-30.
- Zinkernagel SM, Mojon DS. Distance doubling visual acuity test: a reliable test for nonorganic visual loss. Graefes Arch Clin Exp Ophthalmol. 2009;247(6):855-8.
- Rucker JC, Kennard C, Leigh RJ. The neuro-ophthalmological examination. Handb Clin Neurol. 2011;102:71-94.
- Wilhelm H. Neuro-ophthalmology of pupillary function—practical guidelines. J Neurol. 1998;245(9):573-83.
- Kawasaki A, Kardon RH. Disorders of the pupil. Ophthalmol Clin North Am. 2001;14(1):149-68.
- Volpe NJ, Plotkin ES, Maguire MG, Hariprasad R, Galetta SL. Portable pupillography of the swinging flashlight test to detect afferent pupillary defects. Ophthalmology. 2000;107(10):1913-21; discussion 1922.
- Solyman O, Abushanab MMI, Carey AR, Henderson AD. Pilot Study of Smartphone Infrared Pupillography and Pupillometry. Clin Ophthalmol. 2022;16:303-310.
- Schmidt FA, Connolly F, Maas MB, Grittner U, Harms L, Brandt A, et al. Objective assessment of a relative afferent pupillary defect by B-mode ultrasound. PLoS One. 2018;13(8):e0202774.
- Witthayaweerasak J, Lertjittham P, Aui-Aree N. Correlation between relative afferent pupillary defect and visual field defects on Humphrey automated perimetry: A cross-sectional clinical trial. PLoS One. 2022;17(5):e0267469.
- Charalel RA, Lin HS, Singh K. Glaucoma screening using relative afferent pupillary defect. J Glaucoma. 2014;23(3):169-73.
- Skorkovská K, Wilhelm H, Lüdtke H, Wilhelm B. [Relative afferent pupillary defect in glaucoma]. Klin Monbl Augenheilkd. 2011;228(11):979-83.
- Blazek P, Davis SL, Greenberg BM, Conger A, Conger D, Vernino S, et al. Objective characterization of the relative afferent pupillary defect in MS. J Neurol Sci. 2012;323(1-2):193-200.
- Kuchalska K, Gotz-Więckowska A, Balwierz W, Urbański B, Ussowicz M, Tomoń A, et al. Diagnostic Strategies for Neuroblastoma in Children With Horner Syndrome: A Proposed Diagnostic Algorithm. J Child Neurol. 2026.
- Conway J, Krieger P, Hasanaj L, Sun L, Scharf JM, Odel JG, et al. Telemedicine Evaluations in Neuro-Ophthalmology During the COVID-19 Pandemic: Patient and Physician Surveys. J Neuroophthalmol. 2021;41(3):356-361.
- Cettomai D, Hiremath G, Ratchford J, Venkatesan A, Greenberg BM, McGready J, et al. Associations between retinal nerve fiber layer abnormalities and optic nerve examination. Neurology. 2010;75(15):1318-25.
- Chang MY, Velez FG, Demer JL, Bonelli L, Quiros PA, Arnold AC, et al. Accuracy of Diagnostic Imaging Modalities for Classifying Pediatric Eyes as Papilledema Versus Pseudopapilledema. Ophthalmology. 2017;124(12):1839-1848.
- Chang MY, Binenbaum G, Heidary G, Morrison DG, Galvin JA, Trivedi RH, et al. Imaging Methods for Differentiating Pediatric Papilledema from Pseudopapilledema: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020;127(10):1416-1423.
- Yan Y, Liao YJ. Updates on ophthalmic imaging features of optic disc drusen, papilledema, and optic disc edema. Curr Opin Neurol. 2021;34(1):108-115.
- Yan Y, Ludwig CA, Liao YJ. Multimodal Imaging Features of Optic Disc Drusen. Am J Ophthalmol. 2021;225:18-26.
- Silverman AL, Tatham AJ, Medeiros FA, Weinreb RN. Assessment of optic nerve head drusen using enhanced depth imaging and swept source optical coherence tomography. J Neuroophthalmol. 2014;34(2):198-205.
- Youn S, Loshusan B, Armstrong JJ, Fraser JA, Hamann S, Bursztyn LLCD. A Comparison of Diagnostic Accuracy of Imaging Modalities to Detect Optic Disc Drusen: The Age of Enhanced Depth Imaging Optical Coherence Tomography. Am J Ophthalmol. 2023;248:137-144.
- Van Compernolle R, Lemmens S, Cassiman C. Imaging modalities in optic disc drusen: A literature review and proposed diagnostic algorithm. Acta Ophthalmol. 2026;104(1):22-32.
- Gise R, Gaier ED, Heidary G. Diagnosis and Imaging of Optic Nerve Head Drusen. Semin Ophthalmol. 2019;34(4):256-263.
- Karam EZ, Hedges TR. Optical coherence tomography of the retinal nerve fibre layer in mild papilloedema and pseudopapilloedema. Br J Ophthalmol. 2005;89(3):294-8.
- Dreesbach M, Joachimsen L, Küchlin S, Reich M, Gross NJ, Brandt AU, et al. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension. Transl Vis Sci Technol. 2020;9(3):24.
- Chang YC, Alperin N, Bagci AM, Lee SH, Rosa PR, Giovanni G, et al. Relationship Between Optic Nerve Protrusion Measured by OCT and MRI and Papilledema Severity. Invest Ophthalmol Vis Sci. 2015;56(4):2297-302.
- Heath Jeffery RC, Chen FK. Peripapillary hyperreflective ovoid mass-like structures: Multimodal imaging-A review. Clin Exp Ophthalmol. 2023;51(1):67-80.
- Chapman JJ, Heidary G, Gise R. An overview of peripapillary hyperreflective ovoid mass-like structures. Curr Opin Ophthalmol. 2022;33(6):494-500.
- Li B, Li H, Huang Q, Zheng Y. Peripapillary hyper-reflective ovoid mass-like structures (PHOMS): clinical significance, associations, and prognostic implications in ophthalmic conditions. Front Neurol. 2023;14:1190279.
- Behrens CM, Malmqvist L, Jørgensen M, Sibony PA, Munch IC, Skovgaard AM, et al. Peripapillary Hyperreflective Ovoid Mass-like Structures (PHOMS) in Children: The Copenhagen Child Cohort 2000 Eye Study. Am J Ophthalmol. 2023;245:212-221.
- Fard MA, Jalili J, Sahraiyan A, Khojasteh H, Hejazi M, Ritch R, et al. Optical Coherence Tomography Angiography in Optic Disc Swelling. Am J Ophthalmol. 2018;191:116-123.
- Abri Aghdam K, Aghajani A, Zand A, Chaibakhsh S, Anvari P, Ijadi FZ, et al. Application of Optical Coherence Tomography Angiography in True and Pseudo-Optic Disc Swelling. J Ophthalmol. 2024;2024:1164635.
- Pujari A, Bhaskaran K, Sharma P, Singh P, Phuljhele S, Saxena R, et al. Optical coherence tomography angiography in neuro-ophthalmology: Current clinical role and future perspectives. Surv Ophthalmol. 2021;66(3):471-481.
- Sinclair AJ, Burdon MA, Nightingale PG, Matthews TD, Jacks A, Lawden M, et al. Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension. J Neurol. 2012;259(7):1406-12.
- Valencia WE, Mason SS, Brunstetter TJ, Sargsyan AE, Schaefer CM, Tarver WJ, et al. Evaluation of Optic Disc Edema in Long-Duration Spaceflight Crewmembers Using Retinal Photography. J Neuroophthalmol. 2023;43(3):364-369.
- Fraser JA, Rueløkke LL, Malmqvist L, Hamann S. Prevalence of Optic Disc Drusen in Young Patients With Nonarteritic Anterior Ischemic Optic Neuropathy: A 10-Year Retrospective Study. J Neuroophthalmol. 2021;41(2):200-205.
- Cennamo G, Rinaldi M, Concilio M, Costagliola C. Congenital Optic Disc Anomalies: Insights from Multimodal Imaging. J Clin Med. 2024;13(5).
- Jeng-Miller KW, Cestari DM, Gaier ED. Congenital anomalies of the optic disc: insights from optical coherence tomography imaging. Curr Opin Ophthalmol. 2017;28(6):579-586.
- Brazitikos PD, Safran AB, Simona F, Zulauf M. Threshold perimetry in tilted disc syndrome. Arch Ophthalmol. 1990;108(12):1698-700.
- Cohen SY, Vignal-Clermont C, Trinh L, Ohno-Matsui K. Tilted disc syndrome (TDS): New hypotheses for posterior segment complications and their implications in other retinal diseases. Prog Retin Eye Res. 2022;88:101020.
- Golnik KC. Cavitary anomalies of the optic disc: neurologic significance. Curr Neurol Neurosci Rep. 2008;8(5):409-13.
- Tanna AP, Veto K. Myelinated Retinal Nerve Fiber Layer. Mayo Clin Proc. 2022;97(5):819.
- Sarkies NJ. Optic nerve sheath meningioma: diagnostic features and therapeutic alternatives. Eye (Lond). 1987;1 ( Pt 5):597-602.
- Saeed P, Rootman J, Nugent RA, White VA, Mackenzie IR, Koornneef L. Optic nerve sheath meningiomas. Ophthalmology. 2003;110(10):2019-30.
- Rath EZ, Rehany U, Linn S, Rumelt S. Correlation between optic disc atrophy and aetiology: anterior ischaemic optic neuropathy vs optic neuritis. Eye (Lond). 2003;17(9):1019-24.
- Camós-Carreras A, Figueras-Roca M, Albà-Arbalat S, Alcubierre R, Saint-Gerons M, Sánchez-Dalmau B. Clinical and Structural Parameters in Autosomal Dominant Optic Atrophy Patients: A Cross-Sectional Study Using Optical Coherence Tomography. J Neuroophthalmol. 2024;45(3):273-277.
- Waisberg E, Micieli JA. Neuro-Ophthalmological Optic Nerve Cupping: An Overview. Eye Brain. 2021;13:255-268.
- Leaney JC, Nguyen V, Miranda E, Barnett Y, Ahmad K, Wong S, et al. Bruch’s Membrane Opening Minimum Rim Width Provides Objective Differentiation between Glaucoma and Nonglaucomatous Optic Neuropathies. Am J Ophthalmol. 2020;218:164-172.
- Rao A, Kesarwani S, Jena S, Mandal S. Glaucomatous cupping and raised IOP: sine qua non for glaucoma?. Semin Ophthalmol. 2013;28(4):203-5.
- Ha A, Kim YK, Kim JS, Jeoung JW, Park KH. Temporal Raphe Sign in Elderly Patients With Large Optic Disc Cupping: Its Evaluation as a Predictive Factor for Glaucoma Conversion. Am J Ophthalmol. 2020;219:205-214.
- Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23(2):157-63.
- Mathews MK. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2005;16(6):341-5.
- Luneau K, Newman NJ, Biousse V. Ischemic optic neuropathies. Neurologist. 2008;14(6):341-54.
- Göttsche J, Knospe V, Sauvigny T, Schweingruber N, Grensemann J, Spitzer MS, et al. Terson Syndrome in Patients with Aneurysmal Subarachnoid Hemorrhage: A 10-Year Single-Center Experience. Neurocrit Care. 2023;39(1):155-161.
- Hassan A, Lanzino G, Wijdicks EF, Rabinstein AA, Flemming KD. Terson’s syndrome. Neurocrit Care. 2011;15(3):554-8.
- Rodríguez-Adrián LJ, King RT, Tamayo-Derat LG, Miller JW, Garcia CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. Medicine (Baltimore). 2003;82(3):187-202.
- Bruce BB, Thulasi P, Fraser CL, Keadey MT, Ward A, Heilpern KL, et al. Diagnostic accuracy and use of nonmydriatic ocular fundus photography by emergency physicians: phase II of the FOTO-ED study. Ann Emerg Med. 2013;62(1):28-33.e1.
- Vasseneix C, Bruce BB, Bidot S, Newman NJ, Biousse V. Nonmydriatic Fundus Photography in Patients with Acute Vision Loss. Telemed J E Health. 2019;25(10):911-916.
- Shah PP, Gelnick SM, Zhu D, Winokur JA, Dua P, Pomeranz HD, et al. Efficacy of a portable non-mydriatic fundus camera for “rule-out papilledema” consultations: A prospective study. Eur J Ophthalmol. 2025;35(3):1122-1129.
- Biousse V, Najjar RP, Tang Z, Lin MY, Wright DW, Keadey MT, et al. Application of a Deep Learning System to Detect Papilledema on Nonmydriatic Ocular Fundus Photographs in an Emergency Department. Am J Ophthalmol. 2024;261:199-207.
- Lin MY, Ray HJ, Pendley AM, Bénard-Séguin É, Okrent Smolar AL, Duran MR, et al. Emergency Department Nonmydriatic Fundus Photography Expedites Care for Patients Referred for Papilledema. Ophthalmology. 2025;132(7):823-829.
- Milea D, Najjar RP, Zhubo J, Ting D, Vasseneix C, Xu X, et al. Artificial Intelligence to Detect Papilledema from Ocular Fundus Photographs. N Engl J Med. 2020;382(18):1687-1695.
- Biousse V, Newman NJ, Najjar RP, Vasseneix C, Xu X, Ting DS, et al. Optic Disc Classification by Deep Learning versus Expert Neuro-Ophthalmologists. Ann Neurol. 2020;88(4):785-795.
- Vasseneix C, Najjar RP, Xu X, Tang Z, Loo JL, Singhal S, et al. Accuracy of a Deep Learning System for Classification of Papilledema Severity on Ocular Fundus Photographs. Neurology. 2021;97(4):e369-e377.
- Lin MY, Najjar RP, Tang Z, Cioplean D, Dragomir M, Chia A, et al. The BONSAI (Brain and Optic Nerve Study with Artificial Intelligence) deep learning system can accurately identify pediatric papilledema on standard ocular fundus photographs. J AAPOS. 2024;28(1):103803.
- Sathianvichitr K, Najjar RP, Zhiqun T, Fraser JA, Yau CWL, Girard MJA, et al. A Deep Learning Approach for Accurate Discrimination Between Optic Disc Drusen and Papilledema on Fundus Photographs. J Neuroophthalmol. 2024;44(4):454-461.
- Chan E, Tang Z, Najjar RP, Narayanaswamy A, Sathianvichitr K, Newman NJ, et al. A Deep Learning System for Automated Quality Evaluation of Optic Disc Photographs in Neuro-Ophthalmic Disorders. Diagnostics (Basel). 2023;13(1).
- de Jongh E, Leach C, Tjon-Fo-Sang MJ, Bjerre A. Inter-examiner variability and agreement of the alternate prism cover test (APCT) measurements of strabismus performed by 4 examiners. Strabismus. 2014;22(4):158-66.
- Anderson HA, Manny RE, Cotter SA, Mitchell GL, Irani JA. Effect of examiner experience and technique on the alternate cover test. Optom Vis Sci. 2010;87(3):168-75.
- Hrynchak PK, Herriot C, Irving EL. Comparison of alternate cover test reliability at near in non-strabismus between experienced and novice examiners. Ophthalmic Physiol Opt. 2010;30(3):304-9.
- Weber KP, Rappoport D, Dysli M, Schmückle Meier T, Marks GB, Bockisch CJ, et al. Strabismus Measurements with Novel Video Goggles. Ophthalmology. 2017;124(12):1849-1856.
- Yehezkel O, Belkin M, Wygnanski-Jaffe T. Automated Diagnosis and Measurement of Strabismus in Children. Am J Ophthalmol. 2020;213:226-234.
- Ferris JD, Dawson EL, Plowman N, Adams GG, Fells P, Lee JP. Radiotherapy in thyroid eye disease: the effect on the field of binocular single vision. J AAPOS. 2002;6(2):71-6.
- Kouri AS, Bessant DA, Adams GG, Sloper JJ, Lee JP. Quantitative changes in the field of binocular single vision following a fadenoperation to a vertical rectus muscle. J AAPOS. 2002;6(5):294-9.
- Wood J, Adeoye J. Literature Review to create Evidence Based Care Pathway for Isolated Adult Orbital Blowout Fractures. Strabismus. 2021;29(2):120-124.
- Rainey BB, Schroeder TL, Goss DA, Grosvenor TP. Reliability of and comparisons among three variations of the alternating cover test. Ophthalmic Physiol Opt. 1998;18(5):430-7.
- Tengtrisorn S, Tungsattayathitthan A, Na Phatthalung S, Singha P, Rattanalert N, Bhurachokviwat S, et al. The reliability of the angle of deviation measurement from the Photo-Hirschberg tests and Krimsky tests. PLoS One. 2021;16(12):e0258744.
- Holmes JM, Leske DA, Kupersmith MJ. New methods for quantifying diplopia. Ophthalmology. 2005;112(11):2035-9.
- Holmes JM, Liebermann L, Hatt SR, Smith SJ, Leske DA. Quantifying diplopia with a questionnaire. Ophthalmology. 2013;120(7):1492-6.
- Mansukhani SA, Hatt SR, Leske DA, Holmes JM. Test-retest reliability of the revised diplopia questionnaire. J AAPOS. 2019;23(6):319.e1-319.e5.
- Aylward GW, McCarry B, Kousoulides L, Lee JP, Fells P. A scoring method for Hess charts. Eye (Lond). 1992;6 ( Pt 6):659-61.
- Dysli M, Fierz FC, Rappoport D, Meier TS, Landau K, Bockisch CJ, et al. Divergence bias in Hess compared to Harms screen strabismus testing. Strabismus. 2021;29(1):1-9.
- Lee JE, Yang HK, Kim JH, Hwang JM. Diagnostic Utility of the Three-Step Test According to the Presence of the Trochlear Nerve in Superior Oblique Palsy. J Clin Neurol. 2018;14(1):66-72.
- Akbari MR, Mirmohammadsadeghi A, Mahmoudzadeh R, Veisi A. Management of Thyroid Eye Disease-Related Strabismus. J Curr Ophthalmol. 2020;32(1):1-13.
- Arnoldi K, Reynolds JD. Unmasking Bilateral Inferior Rectus Restriction in Thyroid Eye Disease: Using Degree of Cyclotropia. Am Orthopt J. 2015;65:81-6.
- Tudor KI, Petravić D, Jukić A, Juratovac Z. Skew Deviation: Case Report and Review of the Literature. Semin Ophthalmol. 2017;32(6):734-737.
- Akbari MR, Khorrami-Nejad M, Kangari H, Baghban AA, Raeesdana K, Ranjbar-Pazooki M. The Correlation between Hypertropia and Head Tilt in Congenital Unilateral Superior Oblique Muscle Palsy. J Curr Ophthalmol. 2021;33(3):336-341.
- Ivanir Y, Trobe JD. Comparing Hypertropia in Upgaze and Downgaze Distinguishes Congenital From Acquired Fourth Nerve Palsies. J Neuroophthalmol. 2017;37(4):365-368.
- Demer JL. Vertical Comitance of Hypertropia in Congenital and Acquired Superior Oblique Palsy. J Neuroophthalmol. 2022;42(1):e240-e247.
- Engel JM. Treatment and diagnosis of congenital fourth nerve palsies: an update. Curr Opin Ophthalmol. 2015;26(5):353-6.
- Kushner BJ. Simulated superior oblique palsy. Ann Ophthalmol. 1981;13(3):337-43.
- Simons K, Arnoldi K, Brown MH. Color dissociation artifacts in double Maddox rod cyclodeviation testing. Ophthalmology. 1994;101(12):1897-901.
- Bindiganavale M, Buickians D, Lambert SR, Bodnar ZM, Moss HE. Development and Preliminary Validation of a Virtual Reality Approach for Measurement of Torsional Strabismus. J Neuroophthalmol. 2022;42(1):e248-e253.
- Frohman TC, Frohman EM, O’Suilleabhain P, Salter A, Dewey RB Jr, Hogan N, et al. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology. 2003;61(6):848-50.
- Nij Bijvank JA, van Rijn LJ, Balk LJ, Tan HS, Uitdehaag BMJ, Petzold A. Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia. Neurology. 2019;92(20):e2299-e2308.
- Meienberg O, Müri R, Rabineau PA. Clinical and oculographic examinations of saccadic eye movements in the diagnosis of multiple sclerosis. Arch Neurol. 1986;43(5):438-43.
- Servillo G, Renard D, Taieb G, Labauge P, Bastide S, Zorzon M, et al. Bedside tested ocular motor disorders in multiple sclerosis patients. Mult Scler Int. 2014;2014:732329.
- Jozefowicz-Korczynska M, Pajor AM. Evaluation of the smooth pursuit tests in multiple sclerosis patients. J Neurol. 2011;258(10):1795-800.
- Jung I, Kim JS. Abnormal Eye Movements in Parkinsonism and Movement Disorders. J Mov Disord. 2019;12(1):1-13.
- Nij Bijvank JA, Petzold A, Coric D, Tan HS, Uitdehaag BMJ, Balk LJ, et al. Quantification of Visual Fixation in Multiple Sclerosis. Invest Ophthalmol Vis Sci. 2019;60(5):1372-1383.
- Nakamagoe K, Matsumoto S, Touno N, Tateno I, Koganezawa T. Saccadic oscillations as a biomarker of clinical symptoms in amyotrophic lateral sclerosis. Neurol Sci. 2023;44(8):2787-2793.
- Weber KP, Aw ST, Todd MJ, McGarvie LA, Curthoys IS, Halmagyi GM. Head impulse test in unilateral vestibular loss: vestibulo-ocular reflex and catch-up saccades. Neurology. 2008;70(6):454-63.
- Froment Tilikete C. Is the bedside head impulse test useful in emergency decision making for nonexpert routine clinical practice?. Eur J Neurol. 2021;28(5):1437-1438.
- Huh YE, Kim JS. Bedside evaluation of dizzy patients. J Clin Neurol. 2013;9(4):203-13.
- Strupp M, Kim JS, Murofushi T, Straumann D, Jen JC, Rosengren SM, et al. Bilateral vestibulopathy: Diagnostic criteria Consensus document of the Classification Committee of the Bárány Society. J Vestib Res. 2017;27(4):177-189.
- Tarnutzer AA, Straumann D, Salman MS. Neuro-ophthalmologic assessment and investigations in children and adults with cerebellar diseases. Handb Clin Neurol. 2018;154:305-327.
- Facchin A, Buonocore J, Sgrò G, Cristofaro A, Crasà M, Camastra C, et al. Eye movement abnormalities in normal pressure hydrocephalus: a video-oculographic study. J Neurol. 2025;272(6):425.
- Janssen M, van Broekhoven F, Sillevis Smitt P, Frens M, van der Geest J. The use of eye-movement recording in patients with anti-Hu antibody-associated paraneoplastic neurological syndromes to objectively determine extent and course of disease. Eur J Neurol. 2021;28(6):2126-2132.
- Hirota M, Hayashi T, Watanabe E, Inoue Y, Mizota A. Automatic Recording of the Target Location During Smooth Pursuit Eye Movement Testing Using Video-Oculography and Deep Learning-Based Object Detection. Transl Vis Sci Technol. 2021;10(6):1.
- Parker TM, Badihian S, Hassoon A, Saber Tehrani AS, Farrell N, Newman-Toker DE, et al. Eye and Head Movement Recordings Using Smartphones for Telemedicine Applications: Measurements of Accuracy and Precision. Front Neurol. 2022;13:789581.
- Savino G, Petrone G, Volpe G, Midena G, Grimaldi G, Fiorentino V, et al. Vertical restrictive strabismus associated with proptosis: Similar clinical signs, different etiopathogenetic causes. A report of three patients. Eur J Ophthalmol. 2020.
- Pietris J, Madike R, Lam A, Al Sharifi A, Bacchi S, Gupta AK, et al. Cogan’s Lid Twitch for Myasthenia Gravis: A Systematic Review. Semin Ophthalmol. 2023;38(8):727-736.
- Fakiri MO, Tavy DL, Hama-Amin AD, Wirtz PW. Accuracy of the ice test in the diagnosis of myasthenia gravis in patients with ptosis. Muscle Nerve. 2013;48(6):902-4.
- Proudman W, Kleinig O, Lam L, Collins L, Bagster M, Gupta A, et al. The Icepack Test in the Diagnosis of Myasthenia Gravis with Ocular Features: A Systematic Review of Diagnostic Accuracy, Technique, and Economic Utility. Semin Ophthalmol. 2023;38(7):679-685.
- Giannoccaro MP, Paolucci M, Zenesini C, Di Stasi V, Donadio V, Avoni P, et al. Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis. Neurology. 2020;95(13):e1800-e1806.
- Kortnoi P, Amornvit J, Paprad T. Diagnostic Accuracy of the Combined Bedside Tests (Icepack and Fatigability) in Diagnosing Juvenile Myasthenia Gravis. J Child Neurol. 2026.
- Jienmaneechotchai T, Apinyawasisuk S, Jariyakosol S, Hirunwiwatkul P. Interobserver and Intra-Observer Reliability of Eyelid Tests for Ocular Myasthenia Gravis. J Neuroophthalmol. 2022;42(2):230-233.
- Shuey NH. Ocular myasthenia gravis: a review and practical guide for clinicians. Clin Exp Optom. 2022;105(2):205-213.
- Yadegari S. Approach to abnormal head posture. Strabismus. 2024;32(4):287-293.
- Akbari MR, Khorrami-Nejad M, Kangari H, Akbarzadeh Baghban A, Ranjbar Pazouki M. Ocular Abnormal Head Posture: A Literature Review. J Curr Ophthalmol. 2021;33(4):379-387.
- Erkan Turan K, Taylan Sekeroglu H, Koc I, Kilic M, Sanac AS. The frequency and causes of abnormal head position based on an ophthalmology clinic’s findings: is it overlooked?. Eur J Ophthalmol. 2017;27(4):491-494.
- Rubin SE, Wagner RS. Ocular torticollis. Surv Ophthalmol. 1986;30(6):366-76.
- Gantz L, Stiebel-Kalish H. Convergence insufficiency: Review of clinical diagnostic signs. J Optom. 2022;15(4):256-270.
- Trieu LH, Lavrich JB. Current concepts in convergence insufficiency. Curr Opin Ophthalmol. 2018;29(5):401-406.
- Lim JM, Hou JH, Singa RM, Aakalu VK, Setabutr P. Relative incidence of blepharoptosis subtypes in an oculoplastics practice at a tertiary care center. Orbit. 2013;32(4):231-4.
- Lee CC, Feng IJ, Lai HT, Huang SH, Kuo YR, Lai CS. The Epidemiology and Clinical Features of Blepharoptosis in Taiwanese Population. Aesthetic Plast Surg. 2019;43(4):964-972.
- Koka K, Zeppieri M, Vadeo A, Patel BC. Blepharoptosis (Ptosis): Classification, Evaluation, and Surgical Management. . 2026.
- Evinger C, Manning KA, Sibony PA. Eyelid movements. Mechanisms and normal data. Invest Ophthalmol Vis Sci. 1991;32(2):387-400.
- Park DH, Jung JM, Song CH. Anthropometric analysis of levator muscle function. Plast Reconstr Surg. 2008;121(4):1181-1187.
- Ju X, Kowanz D, Guo Y, Li X, Wawer Matos PA, Fan W, et al. Dynamic Measurement and Analysis of Upper Eyelid Changes Using Ultrasound Biomicroscopy. Ultrasound Med Biol. 2024;50(8):1240-1246.
- Lou L, Cao J, Wang Y, Gao Z, Jin K, Xu Z, et al. Deep learning-based image analysis for automated measurement of eyelid morphology before and after blepharoptosis surgery. Ann Med. 2021;53(1):2278-2285.
- Kashkouli MB, Abdolalizadeh P, Es’haghi A, Nilforushan N, Aghaei H, Karimi N. Postoperative Blepharoptosis After Modern Phacoemulsification Procedure. Am J Ophthalmol. 2020;213:17-23.
- Chodvadiya SA Jr, Manade V, Kotecha M, Ta J. Radiologic Imaging in Third Nerve Palsy: A Case Series Investigating Etiology, Patterns, and Clinical Implications. Cureus. 2023;15(8):e43986.
- Lee MS, Egan RA, Shults WT, Lessell S. Idiopathic repetitive oculomotor nerve palsies in otherwise normal patients. Ophthalmology. 2005;112(12):2225-6.
- Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol. 2005;89(11):1442-4.
- Alstadhaug KB. [Acquired Horner’s syndrome]. Tidsskr Nor Laegeforen. 2011;131(9-10):950-4.
- Camós-Carreras A, Fontana S, Ortiz-Pérez S. [What would you do in front of a patient with a Horner syndrome?]. Semergen. 2018;44(2):131-134.
- Ali A, Esmaeil A, Behbehani R. Mitochondrial Chronic Progressive External Ophthalmoplegia. Brain Sci. 2024;14(2).
- Hirano M, Pitceathly RDS. Progressive external ophthalmoplegia. Handb Clin Neurol. 2023;194:9-21.
- McClelland C, Manousakis G, Lee MS. Progressive External Ophthalmoplegia. Curr Neurol Neurosci Rep. 2016;16(6):53.
- Kim JY, Yang HK, Kim N, Kim MJ, Cho SI, Seong MW, et al. Strabismus in chronic progressive external ophthalmoplegia. Acta Ophthalmol. 2021;99(2):e274-e280.
- Gaddipati RV, Meyer DR. Eyelid retraction, lid lag, lagophthalmos, and von Graefe’s sign quantifying the eyelid features of Graves’ ophthalmopathy. Ophthalmology. 2008;115(6):1083-8.
- Guimaraes JA, Garcia DM, Cruz AAV. The von Gräfe sign measurement. Orbit. 2025;44(5):516-521.
- Byun JS, Lee JK. Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves’ orbitopathy with unilateral upper eyelid retraction. Graefes Arch Clin Exp Ophthalmol. 2018;256(10):2001-2008.
- Fattah AY, Gurusinghe ADR, Gavilan J, Hadlock TA, Marcus JR, Marres H, et al. Facial nerve grading instruments: systematic review of the literature and suggestion for uniformity. Plast Reconstr Surg. 2015;135(2):569-579.
- Reitzen SD, Babb JS, Lalwani AK. Significance and reliability of the House-Brackmann grading system for regional facial nerve function. Otolaryngol Head Neck Surg. 2009;140(2):154-8.
- Coulson SE, Croxson GR, Adams RD, O’Dwyer NJ. Reliability of the “Sydney,” “Sunnybrook,” and “House Brackmann” facial grading systems to assess voluntary movement and synkinesis after facial nerve paralysis. Otolaryngol Head Neck Surg. 2005;132(4):543-9.
- Mengi E, Orhan Kara C, Necdet Ardıç F, Topuz B, Metin U, Alptürk U, et al. Comparison of the Reliability of the House- Brackmann, Facial Nerve Grading System 2.0, and Sunnybrook Facial Grading System for the Evaluation of Patients with Peripheral Facial Paralysis. J Int Adv Otol. 2024;20(1):14-18.
- Mat Lazim N, Ismail H, Abdul Halim S, Nik Othman NA, Haron A. Comparison of 3 Grading Systems (House-Brackmann, Sunnybrook, Sydney) for the Assessment of Facial Nerve Paralysis and Prediction of Neural Recovery. Medeni Med J. 2023;38(2):111-119.
- John Delphine A, Samuel VM, Gaikwad P, Sharma SL, Thomas CT. Inter- and Intra-rater Reliability of Modified House-Brackmann and Sunnybrook Facial Nerve Grading Systems in Post Parotidectomy Patients. Indian J Otolaryngol Head Neck Surg. 2023;75(1):100-108.
- MacIntosh PW, Fay AM. Update on the ophthalmic management of facial paralysis. Surv Ophthalmol. 2019;64(1):79-89.
- Nowak-Gospodarowicz I, Rękas M. Predicting Factors Influencing Visual Function of the Eye in Patients with Unresolved Facial Nerve Palsy after Upper Eyelid Gold Weight Loading. J Clin Med. 2021;10(4).
- Eshraghi B, Ghadimi H, Nikdel M. Levator recession and minimal lateral tarsorrhaphy for the management of lagophthalmos and corneal exposure in facial palsy. Eur J Ophthalmol. 2021;31(1):57-60.
- Weyns M, Koppen C, Tassignon MJ. Scleral contact lenses as an alternative to tarsorrhaphy for the long-term management of combined exposure and neurotrophic keratopathy. Cornea. 2013;32(3):359-61.
- AlZaid A, Al Shamrani M, Alsuhaibani AH. Etiologies, periocular manifestations and surgeries for congenital and childhood acquired facial nerve palsy. J Fr Ophtalmol. 2023;46(6):605-610.
- Tripathy K, Arsiwalla T. Crocodile Tears Syndrome. . 2026.
- Montoya FJ, Riddell CE, Caesar R, Hague S. Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland. Eye (Lond). 2002;16(6):705-9.
- Shah CT, Blount AL, Nguyen EV, Hassan AS. Cranial nerve seven palsy and its influence on meibomian gland function. Ophthalmic Plast Reconstr Surg. 2012;28(3):166-8.
- Mejía-Salgado G, Tello A, Galvis V, Vergara-Arenas D, Forero-Vargas C, de-la-Torre A, et al. Corneal nerve alterations in migraine: a systematic review of in vivo confocal microscopy and esthesiometry findings. Cont Lens Anterior Eye. 2026;49(4):102694.
- Lambiase A, Sacchetti M, Mastropasqua A, Bonini S. Corneal changes in neurosurgically induced neurotrophic keratitis. JAMA Ophthalmol. 2013;131(12):1547-53.
- Aramideh M, Ongerboer de Visser BW. Brainstem reflexes: electrodiagnostic techniques, physiology, normative data, and clinical applications. Muscle Nerve. 2002;26(1):14-30.
- Paparella G, Di Stefano G, Fasolino A, Di Pietro G, Colella D, Truini A, et al. Painful stimulation increases spontaneous blink rate in healthy subjects. Sci Rep. 2020;10(1):20014.
- Zametkin AJ, Stevens JR, Pittman R. Ontogeny of spontaneous blinking and of habituation of the blink reflex. Ann Neurol. 1979;5(5):453-7.
- Green KE, Rastall D, Eggenberger E. Treatment of Blepharospasm/Hemifacial Spasm. Curr Treat Options Neurol. 2017;19(11):41.
- Deshpande RD, Kshirsagar P, Yadav SP, Dole K, Bharucha K, Shetty R. Clinical study of patients with benign essential blepharospasm and hemifacial spasm. Indian J Ophthalmol. 2023;71(6):2625-2626.
- Lefaucheur JP, Ben Daamer N, Sangla S, Le Guerinel C. Diagnosis of primary hemifacial spasm. Neurochirurgie. 2018;64(2):82-86.
- Noor MA, Abul A, Saleki M, Alkhabbaz A, Abel A, Karam M, et al. Botulinum Toxin Injection for Hemifacial Spasm and Benign Essential Blepharospasm: A Systematic Review and Meta-Analysis Comparing Pretarsal and Preseptal Injection Techniques. Aesthetic Plast Surg. 2025;49(13):3618-3628.
- Lepore FE, Duvoisin RC. “Apraxia” of eyelid opening: an involuntary levator inhibition. Neurology. 1985;35(3):423-7.
- Tawfik HA, Dutton JJ. Debunking the Puzzle of Eyelid Apraxia: The Muscle of Riolan Hypothesis. Ophthalmic Plast Reconstr Surg. 2023;39(3):211-220.
- Ugarte M, Teimory M. Apraxia of lid opening. Br J Ophthalmol. 2007;91(7):854.
- Krohel GB, Rosenberg PN. Oscillopsia associated with eyelid myokymia. Am J Ophthalmol. 1986;102(5):662-3.
- Boghen DR. Disorders of facial motor function. Curr Opin Ophthalmol. 1996;7(6):48-52.
- Kimura J, Rodnitzky RL, Okawara SH. Electrophysiologic analysis of aberrant regeneration after facial nerve paralysis. Neurology. 1975;25(10):989-93.
- Montserrat L, Benito M. Facial synkinesis and aberrant regeneration of facial nerve. Adv Neurol. 1988;49:211-24.
- Husseman J, Mehta RP. Management of synkinesis. Facial Plast Surg. 2008;24(2):242-9.
- Di Stadio A, Ralli M, De Luca P, Sossamon J, Frohman TC, Altieri M, et al. Combining early lower eyelid surgery with neuromuscular retraining for synkinesis prevention after facial palsy: the role of the eye in aberrant facial nerve regeneration. Front Neurol. 2024;15:1443591.
- Anh VTQ, Kim J, Jang S, Park J, Lee H, Baek S. Ptosis With Aberrant Facial Nerve Regeneration Following Bell Palsy. J Craniofac Surg. 2021;32(5):e437-e439.
- Quaranta-Leoni FM, Quaranta-Leoni C, Di Marino M. Marcus-Gunn jaw winking syndrome: case series study and management algorithm. Orbit. 2024;43(1):33-40.
- Alam MS, Ahuja S. Inverse Marcus Gunn jaw winking phenomenon: a rare inhibitory synkinesis. Orbit. 2024;43(4):558.
- Althaqib RN, Khan AO, Alsuhaibani AH. Marcus Gunn Jaw-Winking Synkinesis With Ipsilateral Eyelid Myokymia. Ophthalmic Plast Reconstr Surg. 2020;36(6):566-568.
- Kerr NM, Chew SS, Eady EK, Gamble GD, Danesh-Meyer HV. Diagnostic accuracy of confrontation visual field tests. Neurology. 2010;74(15):1184-90.
- Pandit RJ, Gales K, Griffiths PG. Effectiveness of testing visual fields by confrontation. Lancet. 2001;358(9290):1339-40.
- Trobe JD, Acosta PC, Krischer JP, Trick GL. Confrontation visual field techniques in the detection of anterior visual pathway lesions. Ann Neurol. 1981;10(1):28-34.
- Anderson AJ, Shuey NH, Wall M. Rapid confrontation screening for peripheral visual field defects and extinction. Clin Exp Optom. 2009;92(1):45-8.
- De Luca M, Zeri F, Matano A, Di Lorenzo C, Ciurli MP, Mulas M, et al. Sensitivity and Specificity of Qualitative Visual Field Tests for Screening Visual Hemifield Deficits in Right-Brain-Damaged Stroke Patients. Brain Sci. 2024;14(3).
- Moore M, Milosevich E, Beisteiner R, Bowen A, Checketts M, Demeyere N, et al. Rapid screening for neglect following stroke: A systematic search and European Academy of Neurology recommendations. Eur J Neurol. 2022;29(9):2596-2606.
- Dan X, Wechter N, Gray S, Mohanty JG, Croteau DL, Bohr VA. Olfactory dysfunction in aging and neurodegenerative diseases. Ageing Res Rev. 2021;70:101416.
- Amaechi O. Trigeminal Neuralgia: Rapid Evidence Review. Am Fam Physician. 2025;111(5):427-432.
- Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ Clin Evid. 2009;2009.
- Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152(1):14-27.
- Muzyka IM, Estephan B. Electrophysiology of Cranial Nerve Testing: Trigeminal and Facial Nerves. J Clin Neurophysiol. 2018;35(1):16-24.
- Brown S, Isaacson B, Kutz W, Barnett S, Rozen SM. Facial Nerve Trauma: Clinical Evaluation and Management Strategies. Plast Reconstr Surg. 2019;143(5):1498-1512.
- Cohen HS. A review on screening tests for vestibular disorders. J Neurophysiol. 2019;122(1):81-92.
- Sá MJ. Physiopathology of symptoms and signs in multiple sclerosis. Arq Neuropsiquiatr. 2012;70(9):733-40.
- Pleșa A, Antochi FA, Macovei ML, Vîrlan AG, Georgescu R, Beuran DI, et al. Eyes as Windows: Unveiling Neuroinflammation in Multiple Sclerosis via Optic Neuritis and Uhthoff’s Phenomenon. Diagnostics (Basel). 2024;14(19).
- Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol. 2009;8(7):668-78.
- Arnold M, Baumgartner RW, Stapf C, Nedeltchev K, Buffon F, Benninger D, et al. Ultrasound diagnosis of spontaneous carotid dissection with isolated Horner syndrome. Stroke. 2008;39(1):82-6.
- Marshall GL, Little JW. Deep tendon reflexes: a study of quantitative methods. J Spinal Cord Med. 2002;25(2):94-9.
- Patel RD, LaBella CR. Contributions of PCSS, BESS, Tandem Gait, and Romberg Test for Identifying Balance Deficits in Pediatric Concussions. J Head Trauma Rehabil. 2022;37(2):E129-E134.
- Ilg W, Branscheidt M, Butala A, Celnik P, de Paola L, Horak FB, et al. Consensus Paper: Neurophysiological Assessments of Ataxias in Daily Practice. Cerebellum. 2018;17(5):628-653.
- Yang H, Tian S, Flamand-Roze C, Gao L, Zhang W, Li Y, et al. A Chinese version of the Language Screening Test (CLAST) for early-stage stroke patients. PLoS One. 2018;13(5):e0196646.
- Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-9.
- Islam N, Hashem R, Gad M, Brown A, Levis B, Renoux C, et al. Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta-analysis. Alzheimers Dement. 2023;19(7):3235-3243.
- Carson N, Leach L, Murphy KJ. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2018;33(2):379-388.
- Waldron-Perrine B, Gabel NM, Seagly K, Kraal AZ, Pangilinan P, Spencer RJ, et al. Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity. Neurol Clin Pract. 2019;9(2):101-108.
- Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15(11):1021-7.
- Shulman KI. Clock-drawing: is it the ideal cognitive screening test?. Int J Geriatr Psychiatry. 2000;15(6):548-61.
- Schott JM, Crutch SJ. Posterior Cortical Atrophy. Continuum (Minneap Minn). 2019;25(1):52-75.
- Maia da Silva MN, Millington RS, Bridge H, James-Galton M, Plant GT. Visual Dysfunction in Posterior Cortical Atrophy. Front Neurol. 2017;8:389.
- Mendez MF, Khattab YI, Yerstein O. Clinical Screening for Posterior Cortical Atrophy. Cogn Behav Neurol. 2022;35(2):104-109.
- Yong KXX, Graff-Radford J, Ahmed S, Chapleau M, Ossenkoppele R, Putcha D, et al. Diagnosis and Management of Posterior Cortical Atrophy. Curr Treat Options Neurol. 2023;25(2):23-43.
- Attia J, Hatala R, Cook DJ, Wong JG. The rational clinical examination. Does this adult patient have acute meningitis?. JAMA. 1999;282(2):175-81.
- Ala A, Rahmani F, Abdollahi S, Parsian Z. Accuracy of Neck stiffness, Kernig, Brudzinski, and Jolt Accentuation of Headache Signs in Early Detection of Meningitis. Emerg (Tehran). 2018;6(1):e8.
- Curtis S, Stobart K, Vandermeer B, Simel DL, Klassen T. Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics. 2010;126(5):952-60.
- Khan M, Shakeel M, Salman M, Zakir Z, Hashmat A, Awan SK, et al. From Brudzinski to Jamil: Unveiling Classical and Emerging Clinical Signs of Meningitis. Cureus. 2025;17(9):e93196.
- Yan K, Alencastro Landim G, Lin MY, Pendley AM, Shanmugam N, McHenry JG, et al. Nonmydriatic Ocular Fundus Imaging in Consecutive Patients With Headache in an Emergency Department. Neurol Clin Pract. 2026;16(1):e200576.
- Viera AJ, Antono B. Acute Headache in Adults: A Diagnostic Approach. Am Fam Physician. 2022;106(3):260-268.
- Langner S, Kirsch M. Radiological Diagnosis and Differential Diagnosis of Headache. Rofo. 2015;187(10):879-91.
- Schmidt WA, Gromnica-Ihle E. What is the best approach to diagnosing large-vessel vasculitis?. Best Pract Res Clin Rheumatol. 2005;19(2):223-42.
- Parreau S, Curumthaullee MF, Dumonteil S, Robert PY, Fauchais AL, Ly KH, et al. Intraoperative findings during temporal artery biopsy: keys to optimise the diagnosis of giant cell arteritis. Br J Oral Maxillofac Surg. 2022;60(6):791-794.
- Rudd M, Buck D, Ford GA, Price CI. A systematic review of stroke recognition instruments in hospital and prehospital settings. Emerg Med J. 2016;33(11):818-822.
- Zhelev Z, Walker G, Henschke N, Fridhandler J, Yip S. Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack. Cochrane Database Syst Rev. 2019;4(4):CD011427.
- Hilditch M, Brand C, Devlin S, Boyd A, Venema E. BE-FAST vs FAST in prehospital stroke recognition: a systematic review. Br J Community Nurs. 2025;30(9):439-447.
- Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994;25(11):2220-6.
- Schmülling S, Grond M, Rudolf J, Kiencke P. Training as a prerequisite for reliable use of NIH Stroke Scale. Stroke. 1998;29(6):1258-9.
- Josephson SA, Hills NK, Johnston SC. NIH Stroke Scale reliability in ratings from a large sample of clinicians. Cerebrovasc Dis. 2006;22(5-6):389-95.
- Budinčević H, Meštrović A, Demarin V. Stroke Scales as Assessment Tools in Emergency Settings: A Narrative Review. Medicina (Kaunas). 2022;58(11).
- Reith FC, Van den Brande R, Synnot A, Gruen R, Maas AI. The reliability of the Glasgow Coma Scale: a systematic review. Intensive Care Med. 2016;42(1):3-15.
- Reith FC, Synnot A, van den Brande R, Gruen RL, Maas AI. Factors Influencing the Reliability of the Glasgow Coma Scale: A Systematic Review. Neurosurgery. 2017;80(6):829-839.
- Aguilar-Fuentes V, Orozco-Puga P, Jiménez-Ruiz A. The Glasgow Coma Scale: 50-year anniversary. Neurol Sci. 2024;45(6):2899-2901.
- Garone G, Ferro V, Barbato M, Vanacore N, Papini L, Pro S, et al. Acute strabismus in neurological emergencies of childhood: A retrospective, single-centre study. Eur J Paediatr Neurol. 2021;32:80-85.
- Streicher NS, Popovich M, Almeida A, Alsalaheen B, Ichesco IK, Freeman J, et al. Understanding Abnormal Examination Findings During Concussion Recovery: A Retrospective Chart Review. Neurol Clin Pract. 2024;14(3):e200284.
- Newman-Toker DE, Sharma P, Chowdhury M, Clemons TM, Zee DS, Della Santina CC. Penlight-cover test: a new bedside method to unmask nystagmus. J Neurol Neurosurg Psychiatry. 2009;80(8):900-3.
- Dieterich M. Central vestibular disorders. J Neurol. 2007;254(5):559-68.
- Zwergal A, Feil K, Schniepp R, Strupp M. Cerebellar Dizziness and Vertigo: Etiologies, Diagnostic Assessment, and Treatment. Semin Neurol. 2020;40(1):87-96.
- Molnár A, Maihoub S, Tamás L, Szirmai Á. Comparison between caloric and video-head impulse tests in Ménière’s disease and vestibular neuritis. Int J Audiol. 2023;62(5):393-399.
- McGarvie LA, Curthoys IS, MacDougall HG, Halmagyi GM. What does the dissociation between the results of video head impulse versus caloric testing reveal about the vestibular dysfunction in Ménière’s disease?. Acta Otolaryngol. 2015;135(9):859-65.
- McCaslin DL, Jacobson GP, Bennett ML, Gruenwald JM, Green AP. Predictive properties of the video head impulse test: measures of caloric symmetry and self-report dizziness handicap. Ear Hear. 2014;35(5):e185-91.
- Gottlieb M, Peksa GD, Carlson JN. Head impulse, nystagmus, and test of skew examination for diagnosing central causes of acute vestibular syndrome. Cochrane Database Syst Rev. 2023;11(11):CD015089.
- Tarnutzer AA, Edlow JA. Bedside Testing in Acute Vestibular Syndrome-Evaluating HINTS Plus and Beyond-A Critical Review. Audiol Res. 2023;13(5):670-685.
- Edlow JA, Carpenter C, Akhter M, Khoujah D, Marcolini E, Meurer WJ, et al. Guidelines for reasonable and appropriate care in the emergency department 3 (GRACE-3): Acute dizziness and vertigo in the emergency department. Acad Emerg Med. 2023;30(5):442-486.
- Steenerson KK. Acute Vestibular Syndrome. Continuum (Minneap Minn). 2021;27(2):402-419.
- Omron R, Edlow J. Dizziness. Emerg Med Clin North Am. 2026;44(1):85-106.
- Striteska M, Valis M, Chrobok V, Profant O, Califano L, Syba J, et al. Head-shaking-induced nystagmus reflects dynamic vestibular compensation: A 2-year follow-up study. Front Neurol. 2022;13:949696.
- Zuma E Maia FC, Cal R, D’Albora R, Carmona S, Schubert MC. Head-shaking tilt suppression: a clinical test to discern central from peripheral causes of vertigo. J Neurol. 2017;264(6):1264-1270.
- Sun H, Wang Y, Jiang H, Gao Z, Wu H. The clinical application of head-shaking test combined with head-shaking tilt suppression test in distinguishing between peripheral and central vertigo at bedside vs. examination room. Braz J Otorhinolaryngol. 2022;88 Suppl 3(Suppl 3):S177-S184.
- Newman-Toker DE, Edlow JA. TiTrATE: A Novel, Evidence-Based Approach to Diagnosing Acute Dizziness and Vertigo. Neurol Clin. 2015;33(3):577-99, viii.
- MacDougall HG, Weber KP, McGarvie LA, Halmagyi GM, Curthoys IS. The video head impulse test: diagnostic accuracy in peripheral vestibulopathy. Neurology. 2009;73(14):1134-41.
- Bhattacharyya N, Gubbels SP, Schwartz SR, Edlow JA, El-Kashlan H, Fife T, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017;156(3_suppl):S1-S47.
- Imai T, Inohara H. Benign paroxysmal positional vertigo. Auris Nasus Larynx. 2022;49(5):737-747.
- You P, Instrum R, Parnes L. Benign paroxysmal positional vertigo. Laryngoscope Investig Otolaryngol. 2019;4(1):116-123.
- Bhandari A, Bhandari R, Kingma H, Strupp M. Modified Interpretations of the Supine Roll Test in Horizontal Canal BPPV Based on Simulations: How the Initial Position of the Debris in the Canal and the Sequence of Testing Affects the Direction of the Nystagmus and the Diagnosis. Front Neurol. 2022;13:881156.
- Zhang X, Deng Q, Liu Q, Wen C, Wang W, Chen T. The horizontal and vertical components of nystagmus evoked by the supine roll test in horizontal semicircular canal canalolithiasis. Front Neurosci. 2022;16:957617.
- Koju G, Bing D, Zhou LQ, Mao ZY, Tao YL, Chen QG, et al. Comparisons of Supine Roll Test and Alternative Positional Tests in HC-BPPV Lateralization. Curr Med Sci. 2022;42(3):613-619.
- Lee SU, Kim HJ, Kim JS. Pseudo-spontaneous and head-shaking nystagmus in horizontal canal benign paroxysmal positional vertigo. Otol Neurotol. 2014;35(3):495-500.
- Lemos J, Strupp M. Central positional nystagmus: an update. J Neurol. 2022;269(4):1851-1860.
- Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev. 2014;2014(12):CD003162.
- Hunt WT, Zimmermann EF, Hilton MP. Modifications of the Epley (canalith repositioning) manoeuvre for posterior canal benign paroxysmal positional vertigo (BPPV). Cochrane Database Syst Rev. 2012;2012(4):CD008675.
- Ruckenstein MJ. Therapeutic efficacy of the Epley canalith repositioning maneuver. Laryngoscope. 2001;111(6):940-5.
- Lapenna R, Faralli M, Cipriani L, Marcelli V, Ricci G. Efficacy of Epley’s canalith repositioning procedure according to the number of repetitions in the same session: comparison of three protocols. Acta Otolaryngol. 2021;141(6):599-602.
- Power L, Murray K, Szmulewicz DJ. Characteristics of assessment and treatment in Benign Paroxysmal Positional Vertigo (BPPV). J Vestib Res. 2020;30(1):55-62.
- Herdman SJ, Schubert MC, Das VE, Tusa RJ. Recovery of dynamic visual acuity in unilateral vestibular hypofunction. Arch Otolaryngol Head Neck Surg. 2003;129(8):819-24.
- Herdman SJ, Hall CD, Schubert MC, Das VE, Tusa RJ. Recovery of dynamic visual acuity in bilateral vestibular hypofunction. Arch Otolaryngol Head Neck Surg. 2007;133(4):383-9.
- Drapier E, Regrain E, Seidermann L, Van Nechel C, Labrousse M, Kleiber JC, et al. Are Vestibuloocular Reflex Gain and Dynamic Visual Acuity Responsible of Oscillopsia After Complete Unilateral Vestibular Loss?. J Otolaryngol Head Neck Surg. 2024;53:19160216241265091.
- Strupp M, Feil K, Dieterich M, Brandt T. Bilateral vestibulopathy. Handb Clin Neurol. 2016;137:235-40.
- Kattah JC. Clinical Characteristics and Etiology of Bilateral Vestibular Loss in a Cohort from Central Illinois. Front Neurol. 2018;9:46.
- Strupp M, Bisdorff A, Furman J, Hornibrook J, Jahn K, Maire R, et al. Acute unilateral vestibulopathy/vestibular neuritis: Diagnostic criteria. J Vestib Res. 2022;32(5):389-406.
- Strupp M, Mandalà M, López-Escámez JA. Peripheral vestibular disorders: an update. Curr Opin Neurol. 2019;32(1):165-173.
- Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, et al. [Diagnostic criteria for Menière’s disease. Consensus document of the Bárány Society, the Japan Society for Equilibrium Research, the European Academy of Otology and Neurotology (EAONO), the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and the Korean Balance Society]. Acta Otorrinolaringol Esp. 2016;67(1):1-7.
- Eggers SDZ. Episodic Spontaneous Dizziness. Continuum (Minneap Minn). 2021;27(2):369-401.
- Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167-72.
- Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: Diagnostic criteria1. J Vestib Res. 2022;32(1):1-6.
- van de Berg R, Widdershoven J, Bisdorff A, Evers S, Wiener-Vacher S, Cushing SL, et al. Vestibular Migraine of Childhood and Recurrent Vertigo of Childhood: Diagnostic criteria Consensus document of the Committee for the Classification of Vestibular Disorders of the Bárány Society and the International Headache Society. J Vestib Res. 2021;31(1):1-9.
- Strupp M, Lopez-Escamez JA, Kim JS, Straumann D, Jen JC, Carey J, et al. Vestibular paroxysmia: Diagnostic criteria. J Vestib Res. 2016;26(5-6):409-415.
- Staab JP, Eckhardt-Henn A, Horii A, Jacob R, Strupp M, Brandt T, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res. 2017;27(4):191-208.
- Popkirov S, Staab JP, Stone J. Persistent postural-perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness. Pract Neurol. 2018;18(1):5-13.
- Eggers SDZ, Staab JP. Vestibular migraine and persistent postural perceptual dizziness. Handb Clin Neurol. 2024;199:389-411.
- Michels TC, Duffy MT, Rogers DJ. Hearing Loss in Adults: Differential Diagnosis and Treatment. Am Fam Physician. 2019;100(2):98-108.
- Hall CD, Herdman SJ, Whitney SL, Anson ER, Carender WJ, Hoppes CW, et al. Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Updated Clinical Practice Guideline From the Academy of Neurologic Physical Therapy of the American Physical Therapy Association. J Neurol Phys Ther. 2022;46(2):118-177.
- Herdman SJ. Vestibular rehabilitation. Curr Opin Neurol. 2013;26(1):96-101.
- Bell AL, Rodes ME, Collier Kellar L. Childhood eye examination. Am Fam Physician. 2013;88(4):241-8.
- Neijzen CM, de Wit FM, Hettinga YM, de Boer JH, van Genderen MM, de Wit GC. Reference values for the Teller Acuity Cards II (TAC II) in infants and preverbal children, a meta-analysis. Acta Ophthalmol. 2025;103(4):479-485.
- Vital-Durand F, Hullo A. [Measurement of visual acuity in infants in 6 minutes: Teller’s Acuity Cards]. J Fr Ophtalmol. 1989;12(3):221-5.
- Jackson GR, Jessup NS, Kavanaugh BL, Moats VL, Daum KM, Marsh-Tootle WL, et al. Measuring visual acuity in children using preferential looking and sine wave cards. Optom Vis Sci. 1990;67(8):590-4.
- Suzuki Y, Awaya S. Studies on development of visual acuity in infants measured by the Teller Acuity Cards. Jpn J Ophthalmol. 1995;39(2):166-71.
- Breyer A, Jiang X, Rütsche A, Mojon DS. [A new objective visual acuity test: an automated preferential looking]. Klin Monbl Augenheilkd. 2003;220(3):93-5.
- Wen J, Yang B, Cui J, Wang L, Li X. An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System. J Vis Exp. 2023.
- Zheng X, Xu G, Zhang K, Liang R, Yan W, Tian P, et al. Assessment of Human Visual Acuity Using Visual Evoked Potential: A Review. Sensors (Basel). 2020;20(19).
- Marmoy OR, Horvat-Gitsels LA, Cortina-Borja M, Thompson DA. Pattern visual evoked potentials show an inferior-superior topographic shift through maturation in childhood. J Physiol. 2023;601(10):1869-1880.
- Borchert M, McCulloch D, Rother C, Stout AU. Clinical assessment, optic disk measurements, and visual-evoked potential in optic nerve hypoplasia. Am J Ophthalmol. 1995;120(5):605-12.
- West SK, Hindocha M, Hogg CR, Holder GE, Moore AT, Reddy MA. Electroretinogram assessment of children with sensorineural hearing loss: implications for screening. J AAPOS. 2015;19(5):450-4.
- Shawkat FS, Kriss A, Thompson D, Russell-Eggitt I, Taylor D, Harris C. Vertical or asymmetric nystagmus need not imply neurological disease. Br J Ophthalmol. 2000;84(2):175-80.
- Chang MY, Borchert MS. Methods of visual assessment in children with cortical visual impairment. Curr Opin Neurol. 2021;34(1):89-96.
- Chang MY, Borchert MS. Advances in the evaluation and management of cortical/cerebral visual impairment in children. Surv Ophthalmol. 2020;65(6):708-724.
- Lehman SS, Yin L, Chang MY. Diagnosis and Care of Children With Cerebral/Cortical Visual Impairment: Clinical Report. Pediatrics. 2024;154(6).
- Ospina LH. Cortical visual impairment. Pediatr Rev. 2009;30(11):e81-90.
- Christy B, Ampolu N, Jayaraman D, Kekunnaya R, Mahalakshmi M, Sankar S, et al. Cortical/cerebral visual impairment: Assessment to intervention. Indian J Ophthalmol. 2026;74(8):1109-1114.
- Phillips MJ, Chang MY. Update on Cerebral/Cortical Visual Impairment (CVI) in Children. Int Ophthalmol Clin. 2026;66(2):68-77.
- Creavin AL, Brown RD. Ophthalmic abnormalities in children with Down syndrome. J Pediatr Ophthalmol Strabismus. 2009;46(2):76-82.
- Baranello G, Signorini S, Tinelli F, Guzzetta A, Pagliano E, Rossi A, et al. Visual Function Classification System for children with cerebral palsy: development and validation. Dev Med Child Neurol. 2020;62(1):104-110.
- Lee SH, Kim HS, Yun SJ. Optic nerve sheath diameter measurement for predicting raised intracranial pressure in adult patients with severe traumatic brain injury: A meta-analysis. J Crit Care. 2020;56:182-187.
- Lin JJ, Chen AE, Lin EE, Hsia SH, Chiang MC, Lin KL. Point-of-care ultrasound of optic nerve sheath diameter to detect intracranial pressure in neurocritically ill children - A narrative review. Biomed J. 2020;43(3):231-239.
- Morrow SA, Young GB. Selective abolition of the vestibular-ocular reflex by sedative drugs. Neurocrit Care. 2007;6(1):45-8.
- Rohaut B, Porcher R, Hissem T, Heming N, Chillet P, Djedaini K, et al. Brainstem response patterns in deeply-sedated critically-ill patients predict 28-day mortality. PLoS One. 2017;12(4):e0176012.
- Sharshar T, Porcher R, Siami S, Rohaut B, Bailly-Salin J, Hopkinson NS, et al. Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med. 2011;39(8):1960-7.
- Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, et al. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA. 2020;324(11):1078-1097.
- Wijdicks EF. Brain death guidelines explained. Semin Neurol. 2015;35(2):105-15.
- Smith M. Brain death: the United kingdom perspective. Semin Neurol. 2015;35(2):145-51.
- Spinello IM. Brain Death Determination. J Intensive Care Med. 2015;30(6):326-37.
- Scott JB, Gentile MA, Bennett SN, Couture M, MacIntyre NR. Apnea testing during brain death assessment: a review of clinical practice and published literature. Respir Care. 2013;58(3):532-8.
- Morelli P, Oddo M, Ben-Hamouda N. Role of automated pupillometry in critically ill patients. Minerva Anestesiol. 2019;85(9):995-1002.
- Oddo M, Sandroni C, Citerio G, Miroz JP, Horn J, Rundgren M, et al. Quantitative versus standard pupillary light reflex for early prognostication in comatose cardiac arrest patients: an international prospective multicenter double-blinded study. Intensive Care Med. 2018;44(12):2102-2111.
- Suys T, Bouzat P, Marques-Vidal P, Sala N, Payen JF, Rossetti AO, et al. Automated quantitative pupillometry for the prognostication of coma after cardiac arrest. Neurocrit Care. 2014;21(2):300-8.
- Zorzi S, Ortiz AB, Pasetto M, Anderloni M, Furlan G, López-Olivencia M, et al. Quantitative pupillometry index to prognosticate neurological outcome in unconscious cardiac arrest patients. Resuscitation. 2026;222:111027.
- Macchini E, Bertelli A, Bogossian EG, Annoni F, Minini A, Quispe Cornejo A, et al. Pain pupillary index to prognosticate unfavorable outcome in comatose cardiac arrest patients. Resuscitation. 2022;176:125-131.
- Doyle BR, Aiyagari V, Yokobori S, Kuramatsu JB, Barnes A, Puccio A, et al. Anisocoria After Direct Light Stimulus is Associated with Poor Outcomes Following Acute Brain Injury. Neurocrit Care. 2024;41(3):1020-1026.
- Mueller-Jensen A, Neunzig HP, Emskötter T. Outcome prediction in comatose patients: significance of reflex eye movement analysis. J Neurol Neurosurg Psychiatry. 1987;50(4):389-92.
- Schlosser HG, Lindemann JN, Vajkoczy P, Clarke AH. Vestibulo-ocular monitoring as a predictor of outcome after severe traumatic brain injury. Crit Care. 2009;13(6):R192.
- Trojano L, Moretta P, Loreto V, Cozzolino A, Santoro L, Estraneo A. Quantitative assessment of visual behavior in disorders of consciousness. J Neurol. 2012;259(9):1888-95.
- Ting WK, Perez Velazquez JL, Cusimano MD. Eye movement measurement in diagnostic assessment of disorders of consciousness. Front Neurol. 2014;5:137.
- Kondziella D, Bender A, Diserens K, van Erp W, Estraneo A, Formisano R, et al. European Academy of Neurology guideline on the diagnosis of coma and other disorders of consciousness. Eur J Neurol. 2020;27(5):741-756.
- Read-Brown S, Hribar MR, Reznick LG, Lombardi LH, Parikh M, Chamberlain WD, et al. Time Requirements for Electronic Health Record Use in an Academic Ophthalmology Center. JAMA Ophthalmol. 2017;135(11):1250-1257.
- Chiang MF, Boland MV, Brewer A, Epley KD, Horton MB, Lim MC, et al. Special requirements for electronic health record systems in ophthalmology. Ophthalmology. 2011;118(8):1681-7.
- Henriksen BS, Goldstein IH, Rule A, Huang AE, Dusek H, Igelman A, et al. Electronic Health Records in Ophthalmology: Source and Method of Documentation. Am J Ophthalmol. 2020;211:191-199.
- Baxter SL, Gali HE, Chiang MF, Hribar MR, Ohno-Machado L, El-Kareh R, et al. Promoting Quality Face-to-Face Communication during Ophthalmology Encounters in the Electronic Health Record Era. Appl Clin Inform. 2020;11(1):130-141.
- Gim N, Ferguson AN, Blazes M, Lee CS, Lee AY. The march to harmonized imaging standards for retinal imaging. Prog Retin Eye Res. 2025;107:101363.
- Kruger JM, Almer Z, Almog Y, Aloni E, Bachar-Zipori A, Bialer O, et al. A Consensus Statement on the Terminology for Automated Visual Field Abnormalities. J Neuroophthalmol. 2022;42(4):483-488.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-16.
- Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, et al. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology. 2018;125(4):537-548.
- Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111(6):831-6.
- European Society of Radiology (ESR). ESR paper on structured reporting in radiology-update 2023. Insights Imaging. 2023;14(1):199.
- Kohli A, Castillo S, Thakur U, Chhabra A. Structured Reporting in Musculoskeletal Radiology. Semin Musculoskelet Radiol. 2021;25(5):641-645.
- O’Connor SD, Kulkarni NM, Griffin MO Jr, Baruah D, Sudakoff GS, Tolat PP. Structured Reporting in Ultrasound. Ultrasound Q. 2020;36(1):1-5.
- Olthof AW, Leusveld ALM, de Groot JC, Callenbach PMC, van Ooijen PMA. Contextual Structured Reporting in Radiology: Implementation and Long-Term Evaluation in Improving the Communication of Critical Findings. J Med Syst. 2020;44(9):148.
- Sobez LM, Kim SH, Angstwurm M, Störmann S, Pförringer D, Schmidutz F, et al. Creating high-quality radiology reports in foreign languages through multilingual structured reporting. Eur Radiol. 2019;29(11):6038-6048.
- Sanders DS, Read-Brown S, Tu DC, Lambert WE, Choi D, Almario BM, et al. Impact of an electronic health record operating room management system in ophthalmology on documentation time, surgical volume, and staffing. JAMA Ophthalmol. 2014;132(5):586-92.
- Zafarnezhad B, Sadeghi J, Abasi S, Kiani S, Meraji M. Electronic discharge summary design: a step towards electronic health record ophthalmology patients. BMC Health Serv Res. 2025;25(1):1250.
- Moy AJ, Schwartz JM, Chen R, Sadri S, Lucas E, Cato KD, et al. Measurement of clinical documentation burden among physicians and nurses using electronic health records: a scoping review. J Am Med Inform Assoc. 2021;28(5):998-1008.
- Gesner E, Dykes PC, Zhang L, Gazarian P. Documentation Burden in Nursing and Its Role in Clinician Burnout Syndrome. Appl Clin Inform. 2022;13(5):983-990.
- Rattananan W. Completeness and Quality of Neurology Referral Letters Generated by a Large Language Model for Standardized Scenarios. Medicina (Kaunas). 2025;61(11).
- Weiland A, Blankenstein AH, Willems MH, Van Saase JL, Van Daele PL, Van der Molen HT, et al. Training specialists to write appropriate reply letters to general practitioners about patients with medically unexplained physical symptoms; A cluster-randomized trial. Patient Educ Couns. 2015;98(10):1229-35.
- Olson A, Rencic J, Cosby K, Rusz D, Papa F, Croskerry P, et al. Competencies for improving diagnosis: an interprofessional framework for education and training in health care. Diagnosis (Berl). 2019;6(4):335-341.
- Matin R, King BR, Mehta AM, Fenton SH, Hoot NR, Robinson DJ, et al. Simulated Emergency Room Sign-outs: What They Tell Us About Diagnostic Accuracy and Opportunities for Improvement. J Patient Saf. 2025;21(8):e176-84.
- Lin MY, Dattilo M, Pendley AM, Yan KY, Keadey MT, Wright DW, et al. Neuro-ophthalmology Consultations in an Academic Medical Center with an Emergency Department Equipped with Nonmydriatic Fundus Imaging. Ophthalmology. 2026;133(1):31-38.
- Deshmukh AV, Badakere A, Sheth J, Bhate M, Kulkarni S, Kekunnaya R. Pivoting to teleconsultation for paediatric ophthalmology and strabismus: Our experience during COVID-19 times. Indian J Ophthalmol. 2020;68(7):1387-1391.
- Zou M, Srinivasan S, Chin V, Lo TWS, Loke WT, Yang GD, et al. Large language model-based scribing tools for ophthalmology: performance and safety evaluation using simulated clinical encounters. Eye (Lond). 2026;40(8):1247-1255.
- Waisberg E, Ong J, Masalkhi M, Kamran SA, Zaman N, Sarker P, et al. GPT-4 and Ophthalmology Operative Notes. Ann Biomed Eng. 2023;51(11):2353-2355.
- Yang Z, Wang D, Zhou F, Song D, Zhang Y, Jiang J, et al. Understanding natural language: Potential application of large language models to ophthalmology. Asia Pac J Ophthalmol (Phila). 2024;13(4):100085.
- Shah SJ, Devon-Sand A, Ma SP, Jeong Y, Crowell T, Smith M, et al. Ambient artificial intelligence scribes: physician burnout and perspectives on usability and documentation burden. J Am Med Inform Assoc. 2025;32(2):375-380.
- Albrecht M, Shanks D, Shah T, Hudson T, Thompson J, Filardi T, et al. Enhancing clinical documentation with ambient artificial intelligence: a quality improvement survey assessing clinician perspectives on work burden, burnout, and job satisfaction. JAMIA Open. 2025;8(1):ooaf013.
- Leung TI, Coristine AJ, Benis A. AI Scribes in Health Care: Balancing Transformative Potential With Responsible Integration. JMIR Med Inform. 2025;13:e80898.
- Dysmorphology Subcommittee of the Clinical Practice Committee, American College of Medical Genetics. Informed consent for medical photographs. Genet Med. 2000;2(6):353-5.
- Lau CK, Schumacher HH, Irwin MS. Patients’ perception of medical photography. J Plast Reconstr Aesthet Surg. 2010;63(6):e507-11.
- Roguljić M, Šimunović D, Poklepović Peričić T, Viđak M, Utrobičić A, Marušić M, et al. Publishing Identifiable Patient Photographs in Scientific Journals: Scoping Review of Policies and Practices. J Med Internet Res. 2022;24(8):e37594.
- Roguljić M, Buljan I, Veček N, Dragun R, Marušić M, Wager E, et al. Deidentification of facial photographs: a survey of editorial policies and practices. J Med Ethics. 2022;48(1):56-60.
- Bennett KG, Bonawitz SC, Vercler CJ. Guidelines for the Ethical Publication of Facial Photographs and Review of the Literature. Cleft Palate Craniofac J. 2019;56(1):7-14.
- Galbusera F, Cina A. Image annotation and curation in radiology: an overview for machine learning practitioners. Eur Radiol Exp. 2024;8(1):11.
- Marshall Z, Bhattacharjee M, Wang M, Cadri A, James H, Asghari S, et al. Finding Medical Photographs of Patients Online: Randomized, Cross-Sectional Study. J Med Internet Res. 2024;26:e55352.
- Koch CA, Larrabee WF Jr. Patient privacy, photographs, and publication. JAMA Facial Plast Surg. 2013;15(5):335-6.
- Antwi-Boasiako K, Carter-Dawson L, Harwerth R, Gondo M, Patel N. The Relationship Between Macula Retinal Ganglion Cell Density and Visual Function in the Nonhuman Primate. Invest Ophthalmol Vis Sci. 2021;62(1):5.
- Wen Y, Chen Z, Zuo C, Yang Y, Xu J, Kong Y, et al. High-Pass Visual Acuity Loss and Macular Structure-Function Relationship in Patients With Primary Open-Angle Glaucoma. Transl Vis Sci Technol. 2021;10(4):26.
- Mohammadzadeh V, Moghimi S, Nishida T, Proudfoot JA, Eslani M, Kamalipour A, et al. Longitudinal Structure-Function Relationship between Macular Vessel Density and Thickness and Central Visual Field in Early Glaucoma. Ophthalmol Glaucoma. 2022;5(6):648-657.
- Phu J, Khuu SK, Bui BV, Kalloniatis M. A Method Using Goldmann Stimulus Sizes I to V-Measured Sensitivities to Predict Lead Time Gained to Visual Field Defect Detection in Early Glaucoma. Transl Vis Sci Technol. 2018;7(3):17.
- Hirasawa K, Takahashi N, Satou T, Kasahara M, Matsumura K, Shoji N. Comparison of Size Modulation Standard Automated Perimetry and Conventional Standard Automated Perimetry with a 10-2 Test Program in Glaucoma Patients. Curr Eye Res. 2017;42(8):1160-1168.
- Sample PA, Johnson CA, Haegerstrom-Portnoy G, Adams AJ. Optimum parameters for short-wavelength automated perimetry. J Glaucoma. 1996;5(6):375-83.
- Racette L, Sample PA. Short-wavelength automated perimetry. Ophthalmol Clin North Am. 2003;16(2):227-36, vi-vii.
- Wild JM. Short wavelength automated perimetry. Acta Ophthalmol Scand. 2001;79(6):546-59.
- Johnson CA. Diagnostic value of short-wavelength automated perimetry. Curr Opin Ophthalmol. 1996;7(2):54-8.
- Lombardo M, Cusumano A, Mancino R, Aiello F, Sorge RP, Nucci C, et al. Short Wavelength Automated Perimetry, Standard Automated Perimetry, and Optical Coherence Tomography in Dominant Optic Atrophy. J Clin Med. 2024;13(7).
- Zhou HP, Asaoka R, Inoue T, Asano S, Murata H, Hara T, et al. Short wavelength automated perimetry and standard automated perimetry in central serous chorioretinopathy. Sci Rep. 2020;10(1):16451.
- Peprníková S, Skorkovská K, Květon P. SHORT-WAVELENGTH AUTOMATED PERIMETRY IN DIABETIC PATIENTS WITHOUT RETINOPATHY. Cesk Slov Oftalmol. 2021;77(5):248-252.
- Turpin A, McKendrick AM, Johnson CA, Vingrys AJ. Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2002;43(3):709-15.
- Kamdeu Fansi AA, Li G, Harasymowycz PJ. The validity of screening for open-angle glaucoma in high-risk populations with single-test screening mode frequency doubling technology perimetry (FDT). J Glaucoma. 2011;20(3):167-71.
- Liu T, He XG. [Meta-analysis of diagnostic capability of frequency-doubling technology (FDT) for primary glaucoma]. Zhonghua Yan Ke Za Zhi. 2006;42(5):403-8.
- Kopplin LJ, Mansberger SL. Predictive value of screening tests for visually significant eye disease. Am J Ophthalmol. 2015;160(3):538-546.e3.
- Kim TW, Zangwill LM, Bowd C, Sample PA, Shah N, Weinreb RN. Retinal nerve fiber layer damage as assessed by optical coherence tomography in eyes with a visual field defect detected by frequency doubling technology perimetry but not by standard automated perimetry. Ophthalmology. 2007;114(6):1053-7.
- Gardiner SK, Mansberger SL. Detectability of Visual Field Defects in Glaucoma Using Moving Versus Static Stimuli for Perimetry. Transl Vis Sci Technol. 2023;12(8):12.
- Hot A, Dul MW, Swanson WH. Development and evaluation of a contrast sensitivity perimetry test for patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49(7):3049-57.
- Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol. 1989;108(2):130-5.
- Spry PG, Henson DB, Sparrow JM, North RV. Quantitative comparison of static perimetric strategies in early glaucoma: test-retest variability. J Glaucoma. 2000;9(3):247-53.
- Spry PG, Johnson CA, McKendrick AM, Turpin A. Variability components of standard automated perimetry and frequency-doubling technology perimetry. Invest Ophthalmol Vis Sci. 2001;42(6):1404-10.
- Brush MB, Chen PP. Test-retest variability in glaucoma patients tested with C-20-1 screening-mode frequency doubling technology perimetry. J Glaucoma. 2004;13(4):273-7.
- Castro DP, Kawase J, Melo LA Jr. Learning effect of standard automated perimetry in healthy individuals. Arq Bras Oftalmol. 2008;71(4):523-8.
- Roggen X, Herman K, Van Malderen L, Devos M, Spileers W. Different strategies for Humphrey automated perimetry: FASTPAC, SITA standard and SITA fast in normal subjects and glaucoma patients. Bull Soc Belge Ophtalmol. 2001.
- Pierre-Filho Pde T, Schimiti RB, de Vasconcellos JP, Costa VP. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, SITA Standard and SITA Fast perimetry in perimetrically inexperienced individuals. Acta Ophthalmol Scand. 2006;84(3):345-50.
- Wu Z, Medeiros FA. Recent developments in visual field testing for glaucoma. Curr Opin Ophthalmol. 2018;29(2):141-146.
- Meshkin RS, Zhao Y, Elze T, Boland MV, Friedman DS. Remote Video Monitoring of Simultaneous Visual Field Testing. J Glaucoma. 2022;31(7):488-493.
- Markowitz SN, Reyes SV. Microperimetry and clinical practice: an evidence-based review. Can J Ophthalmol. 2013;48(5):350-7.
- Hirasawa K, Shoji N, Kobashi C, Yamanashi A. Effects of mydriasis and miosis on kinetic perimetry findings in normal participants. Graefes Arch Clin Exp Ophthalmol. 2015;253(8):1341-6.
- Gleissner M, Lachenmayr BJ. [Light perception and flicker perimetry. Effect of refractive error, artificial media opacities and pupillary size]. Ophthalmologe. 1992;89(2):162-5.
- Heuer DK, Anderson DR, Knighton RW, Feuer WJ, Gressel MG. The influence of simulated light scattering on automated perimetric threshold measurements. Arch Ophthalmol. 1988;106(9):1247-51.
- Baraldi P, Enoch JM, Raphael S. Vision through nuclear and posterior subcapsular cataract. Int Ophthalmol. 1986;9(2-3):173-8.
- Bengtsson B, Lindgren A, Heijl A, Lindgren G, Asman P, Patella M. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand. 1997;75(2):184-8.
- Madrid-Costa D, Ruiz-Alcocer J, García-Lázaro S, Albarrán-Diego C, Ferrer-Blasco T. Effect of multizone refractive multifocal contact lenses on standard automated perimetry. Eye Contact Lens. 2012;38(5):278-81.
- Wei A, Mehta UV, Palczewska G, Palma AM, Hussey VM, Hoffmann LE, et al. Two-Photon Microperimetry: A Media Opacity-Independent Retinal Function Assay. Transl Vis Sci Technol. 2021;10(2):11.
- Pan F, Swanson WH, Dul MW. Evaluation of a two-stage neural model of glaucomatous defect: an approach to reduce test-retest variability. Optom Vis Sci. 2006;83(7):499-511.
- Salvetat ML, Zeppieri M, Parisi L, Brusini P. Rarebit perimetry in normal subjects: test-retest variability, learning effect, normative range, influence of optical defocus, and cataract extraction. Invest Ophthalmol Vis Sci. 2007;48(11):5320-31.
- Messias K, Moreto R, Corniani KF, Daccach V, Messias A. Retinal ganglion cell function in AQP4+ and MOG+ optic neuritis. Mult Scler Relat Disord. 2025;103:106676.
- Dolderer J, Vonthein R, Johnson CA, Schiefer U, Hart W. Scotoma mapping by semi-automated kinetic perimetry: the effects of stimulus properties and the speed of subjects’ responses. Acta Ophthalmol Scand. 2006;84(3):338-44.
- Rowe FJ, Noonan C, Manuel M. Comparison of octopus semi-automated kinetic perimetry and humphrey peripheral static perimetry in neuro-ophthalmic cases. ISRN Ophthalmol. 2013;2013:753202.
- Barnes CS, Schuchard RA, Birch DG, Dagnelie G, Wood L, Koenekoop RK, et al. Reliability of Semiautomated Kinetic Perimetry (SKP) and Goldmann Kinetic Perimetry in Children and Adults With Retinal Dystrophies. Transl Vis Sci Technol. 2019;8(3):36.
- Sakti DH, Cornish EE, Mustafic N, Zaheer A, Retsas S, Rajagopalan S, et al. MERTK retinopathy: biomarkers assessing vision loss. Ophthalmic Genet. 2021;42(6):706-716.
- Testa F, Carreño E, van den Born LI, Melillo P, Perea-Romero I, Di Iorio V, et al. Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy. Invest Ophthalmol Vis Sci. 2024;65(6):25.
- Lai HC, Lin KK, Yang ML, Chen HS. Functional visual disturbance due to hysteria. Chang Gung Med J. 2007;30(1):87-91.
- Sudmann TM, Jonsdottir TE, Rowe FJ, Jørstad ØK. National application of the European visual field standards for driving: a survey study. BMJ Open Ophthalmol. 2022;7(1):e000904.
- Saadi W, Bro T, Sagerfors S. Revised Swedish visual field standards for a driver’s licence: Threshold perimetry as a predictor of eligibility according to the current Swedish and current Norwegian suprathreshold standards. Acta Ophthalmol. 2026.
- Singh M, Sinha BP, Husain N, Mishra P, Kumar S, Joshi K, et al. Visual field assessment and driving licence eligibility in India: A hospital-based cross-sectional study. Indian J Ophthalmol. 2026;74(8):1214-1219.
- Harper RA, Parkes JA, Dickinson CM. Driving and exceptional cases: Supporting relicensing evaluation in patients whose visual fields fail to meet standards. Ophthalmic Physiol Opt. 2022;42(5):1009-1014.
- Silveira S, Jolly N, Heard R, Clunas NJ, Kay L. Current licensing authority standards for peripheral visual field and safe on-road senior aged automobile driving performance. Clin Exp Ophthalmol. 2007;35(7):612-20.
- Haymes SA, LeBlanc RP, Nicolela MT, Chiasson LA, Chauhan BC. Glaucoma and on-road driving performance. Invest Ophthalmol Vis Sci. 2008;49(7):3035-41.
- Sharma M, Savatovsky E, Huertas L, O’Brien R, Grajewski A, Bitrian E. Esterman Visual Field Testing Using a Virtual Reality Headset in Glaucoma. Ophthalmol Sci. 2024;4(5):100534.
- Schiefer U, Strasburger H, Becker ST, Vonthein R, Schiller J, Dietrich TJ, et al. Reaction time in automated kinetic perimetry: effects of stimulus luminance, eccentricity, and movement direction. Vision Res. 2001;41(16):2157-64.
- Nowomiejska K, Brzozowska A, Zarnowski T, Rejdak R, Weleber RG, Schiefer U. Variability in isopter position and fatigue during semi-automated kinetic perimetry. Ophthalmologica. 2012;227(3):166-72.
- Vonthein R, Rauscher S, Paetzold J, Nowomiejska K, Krapp E, Hermann A, et al. The normal age-corrected and reaction time-corrected isopter derived by semi-automated kinetic perimetry. Ophthalmology. 2007;114(6):1065-72.
- Grobbel J, Dietzsch J, Johnson CA, Vonthein R, Stingl K, Weleber RG, et al. Normal Values for the Full Visual Field, Corrected for Age- and Reaction Time, Using Semiautomated Kinetic Testing on the Octopus 900 Perimeter. Transl Vis Sci Technol. 2016;5(2):5.
- Bevers C, Blanckaert G, Van Keer K, Fils JF, Vandewalle E, Stalmans I. Semi-automated kinetic perimetry: Comparison of the Octopus 900 and Humphrey visual field analyzer 3 versus Goldmann perimetry. Acta Ophthalmol. 2019;97(4):e499-e505.
- Schiefer U, Wörner M, Zobor D. Supervised Automated Kinetic Perimetry (SAKP) Using Simulated Visual Field Data - Presentation of a New Examination Technique. Klin Monbl Augenheilkd. 2024.
- Nowomiejska K, Paetzold J, Zagórski Z, Schiefer U. [Recent developments in kinetic perimetry]. Klin Oczna. 2004;106(6):798-801.
- Peli E. Field expansion for homonymous hemianopia by optically induced peripheral exotropia. Optom Vis Sci. 2000;77(9):453-64.
- Peli E, Jung JH. Multiplexing Prisms for Field Expansion. Optom Vis Sci. 2017;94(8):817-829.
- Peli E. 2017 Charles F. Prentice Award Lecture: Peripheral Prisms for Visual Field Expansion: A Translational Journey. Optom Vis Sci. 2020;97(10):833-846.
- O’Neill EC, Connell PP, O’Connor JC, Brady J, Reid I, Logan P. Prism therapy and visual rehabilitation in homonymous visual field loss. Optom Vis Sci. 2011;88(2):263-8.
- Papageorgiou E, Hardiess G, Ackermann H, Wiethoelter H, Dietz K, Mallot HA, et al. Collision avoidance in persons with homonymous visual field defects under virtual reality conditions. Vision Res. 2012;52(1):20-30.
- Berezina TL, Khouri AS, Kolomeyer AM, Clancy PS, Fechtner RD. Peripheral visual field thresholds using Humphrey Field Analyzer program 60-4 in normal eyes. Eur J Ophthalmol. 2011;21(4):415-21.
- Köksaldı S, Arıkan G, Dadaş ÖF, Günenç Ü. Comparison of Humphrey 24-2 SITA Standard, SITA Fast, and SITA Faster Test Strategies in Patients with Glaucoma. Turk J Ophthalmol. 2025;55(2):67-73.
- Thulasidas M, Patyal S. Comparison of 24-2 Faster, Fast, and Standard Programs of Swedish Interactive Threshold Algorithm of Humphrey Field Analyzer for Perimetry in Patients With Manifest and Suspect Glaucoma. J Glaucoma. 2020;29(11):1070-1076.
- King AJ, Taguri A, Wadood AC, Azuara-Blanco A. Comparison of two fast strategies, SITA Fast and TOP, for the assessment of visual fields in glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2002;240(6):481-7.
- Foo SK, Cubbidge RP, Heitmar R. Comparison between two fast threshold strategies: SPARK and SITA in normal subjects. Eur J Ophthalmol. 2021;31(4):1870-1876.
- Jamali D S, Garmany A, Kaplan TM, Mousavi MS, Ashourizadeh H, Tarakji Z, et al. Analysis of Standard Automated Visual Field Tests in Glaucoma and the Role of Facial Contour. J Glaucoma. 2025;34(12):1017-1023.
- Hepworth LR, Rowe FJ. Programme choice for perimetry in neurological conditions (PoPiN): a systematic review of perimetry options and patterns of visual field loss. BMC Ophthalmol. 2018;18(1):241.
- Muñoz Negrete FJ, Rebolleda G. [Automated perimetry and neuro-ophthalmology. Topographic correlation]. Arch Soc Esp Oftalmol. 2002;77(8):413-28.
- Rowe FJ, Cheyne CP, García-Fiñana M, Noonan CP, Howard C, Smith J, et al. Detection of Visual Field Loss in Pituitary Disease: Peripheral Kinetic Versus Central Static. Neuroophthalmology. 2015;39(3):116-124.
- Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641-51.
- Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, et al. The idiopathic intracranial hypertension treatment trial: design considerations and methods. J Neuroophthalmol. 2014;34(2):107-17.
- Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71(6):693-701.
- Hangai M, Ikeda HO, Akagi T, Yoshimura N. Paracentral scotoma in glaucoma detected by 10-2 but not by 24-2 perimetry. Jpn J Ophthalmol. 2014;58(2):188-96.
- Traynis I, De Moraes CG, Raza AS, Liebmann JM, Ritch R, Hood DC. Prevalence and nature of early glaucomatous defects in the central 10° of the visual field. JAMA Ophthalmol. 2014;132(3):291-7.
- Blumberg DM, Liebmann JM, Hirji SH, Hood DC. Diffuse Macular Damage in Mild to Moderate Glaucoma Is Associated With Decreased Visual Function Scores Under Low Luminance Conditions. Am J Ophthalmol. 2019;208:415-420.
- De Moraes CG, Paula JS, Blumberg DM, Cioffi GA, Al-Aswad LA, Girkin CA, et al. Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm. Am J Ophthalmol. 2020;216:37-43.
- Rao A, Padhy D, Mudunuri H, Roy AK, Sarangi SP, Das G. Central Field Index Versus Visual Field Index for Central Visual Function in Stable Glaucoma. J Glaucoma. 2017;26(1):1-7.
- Nishida T, Weinreb RN, Walker E, Girkin CA, Fazio MA, Liebmann JM, et al. Comparison of Methods for Visual Field Progression in Eyes With Central Visual Field Defects. Transl Vis Sci Technol. 2025;14(11):3.
- Segura-Campillo LG, Ascencio-Gil ED, Balderas-Peña LMA, Reynoso-Topete A. [Visual field index and pituitary tumors resected by microsurgical transsphenoidal approach]. Rev Med Inst Mex Seguro Soc. 2026;64(Suppl 1):e6692.
- Zhong Y, Shen X, Min Y, Cheng Y, Jiao Q. The role of blue-on-yellow perimetry in patients with pituitary tumor. Ann Ophthalmol (Skokie). 2009;41(1):40-3.
- Yoon MK, Hwang TN, Day S, Hong J, Porco T, McCulley TJ. Comparison of Humphrey Matrix frequency doubling technology to standard automated perimetry in neuro-ophthalmic disease. Middle East Afr J Ophthalmol. 2012;19(2):211-5.
- Chung HJ, Choi JH, Lee YC, Kim SY. Effect of Cataract Opacity Type and Glaucoma Severity on Visual Field Index. Optom Vis Sci. 2016;93(6):575-8.
- Siddiqui MA, Azuara-Blanco A, Neville S. Effect of cataract extraction on frequency doubling technology perimetry in patients with glaucoma. Br J Ophthalmol. 2005;89(12):1569-71.
- Prea SM, Kong YXG, Mehta A, He M, Crowston JG, Gupta V, et al. Six-month Longitudinal Comparison of a Portable Tablet Perimeter With the Humphrey Field Analyzer. Am J Ophthalmol. 2018;190:9-16.
- Sugihara K, Kong YXG, Hosokawa M, Okanouchi T. Comparison of 10-2 Visual Field Using Melbourne Rapid Fields Online Perimetry and Humphrey Field Analyzer. Transl Vis Sci Technol. 2025;14(9):14.
- Nishida T, Eslani M, Weinreb RN, Arias J, Vasile C, Mohammadzadeh V, et al. Perimetric Comparison Between the IMOvifa and Humphrey Field Analyzer. J Glaucoma. 2023;32(2):85-92.
- Keltner JL, Johnson CA, Spurr JO, Beck RW. Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1994;112(7):946-53.
- Fang JP, Lin RH, Donahue SP. Recovery of visual field function in the optic neuritis treatment trial. Am J Ophthalmol. 1999;128(5):566-72.
- Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992;326(9):581-8.
- Solli E, Doshi H, Elze T, Pasquale L, Wall M, Kupersmith M. Archetypal Analysis Reveals Quantifiable Patterns of Visual Field Loss in Optic Neuritis. Transl Vis Sci Technol. 2022;11(1):27.
- Huda S, Fineberg A, Rocchi C, Bialer O, Klein A, Stiebel-Kalish H. Significant Visual Field Defects Persist Despite Excellent Visual Acuity Following Optic Neuritis in Myelin-Oligodendrocyte Glycoprotein Associated Disease. Neuroophthalmology. 2026;50(1):37-44.
- Mienberg O, Flammer J, Ludin HP. Subclinical visual field defects in multiple sclerosis. Demonstration and quantification with automated perimetry, and comparison with visually evoked potentials. J Neurol. 1982;227(3):125-33.
- Antal A, Aita JF, Bodis-Wollner I. The paracentral visual field in multiple sclerosis: evidence for a deficit in interneuronal spatial summation?. Vision Res. 2001;41(13):1735-42.
- Israni N, Thomas R, Kochar S. Make in India: Normative data for automated perimetry. Indian J Ophthalmol. 2022;70(3):1074.
- Budenz DL, Feuer WJ, Anderson DR. The effect of simulated cataract on the glaucomatous visual field. Ophthalmology. 1993;100(4):511-7.
- Ang GS, Shunmugam M, Azuara-Blanco A. Effect of cataract extraction on the glaucoma progression index (GPI) in glaucoma patients. J Glaucoma. 2010;19(4):275-8.
- Lee JM, Cirineo N, Ramanathan M, Nouri-Mahdavi K, Morales E, Coleman AL, et al. Performance of the visual field index in glaucoma patients with moderately advanced visual field loss. Am J Ophthalmol. 2014;157(1):39-43.
- Mansoori T. Trigger happy” visual field: Ten pointers. Indian J Ophthalmol. 2022;70(12):4471.
- Mansoori T. High false-positive response in perimetry. Indian J Ophthalmol. 2023;71(10):3424.
- Shirakami T, Omura T, Fukuda H, Asaoka R, Tanito M. Real-World Analysis of the Aging Effects on Visual Field Reliability Indices in Humans. J Clin Med. 2021;10(24).
- Shirakami T, Omura T, Fukuda H, Asaoka R, Tanito M. Real-World Analysis of the Aging Effects on Visual Field Reliability Indices in Central 10-2 Tests. J Pers Med. 2022;12(10).
- Katz J, Sommer A, Witt K. Reliability of visual field results over repeated testing. Ophthalmology. 1991;98(1):70-5.
- Kramer BC, Musch DC, Niziol LM, Weizer JS. Reliability of simultaneous visual field testing. Ophthalmology. 2012;119(2):304-7.
- Hong S, Na K, Kim CY, Seong GJ. Learning effect of Humphrey Matrix perimetry. Can J Ophthalmol. 2007;42(5):707-11.
- HARRINGTON DO. The character of visual field defects in temporal and occipital lobe lesions, localizing value of congruity and incongruity in incomplete homonymous hemianopia. Trans Am Ophthalmol Soc. 1961;59:333-69.
- HARRINGTON DO. Visual field character in temporal and occipital lobe lesions. Localizing values of congruity and incogruity in incomplete homonymous hemianopsia. Arch Ophthalmol. 1961;66:778-92.
- Yang HK, Kim YJ, Sung JY, Kim DH, Kim KG, Hwang JM. Efficacy for Differentiating Nonglaucomatous Versus Glaucomatous Optic Neuropathy Using Deep Learning Systems. Am J Ophthalmol. 2020;216:140-146.
- Andersson S, Heijl A, Bizios D, Bengtsson B. Comparison of clinicians and an artificial neural network regarding accuracy and certainty in performance of visual field assessment for the diagnosis of glaucoma. Acta Ophthalmol. 2013;91(5):413-7.
- Montgomery DM, Craig JP. Optic disc interpretation in glaucoma: is confidence misplaced?. Ophthalmic Physiol Opt. 1993;13(4):383-6.
- Mutlukan E, Keating D. Visual field interpretation with a personal computer based neural network. Eye (Lond). 1994;8 ( Pt 3):321-3.
- Fogagnolo P, Modarelli A, Oddone F, Digiuni M, Montesano G, Orzalesi N, et al. Comparison of Compass and Humphrey perimeters in detecting glaucomatous defects. Eur J Ophthalmol. 2016;26(6):598-606.
- Lee AC, Sample PA, Blumenthal EZ, Berry C, Zangwill L, Weinreb RN. Infrequent confirmation of visual field progression. Ophthalmology. 2002;109(6):1059-65.
- Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44(9):3873-9.
- Rao HL, Kumbar T, Kumar AU, Babu JG, Senthil S, Garudadri CS. Agreement between event-based and trend-based glaucoma progression analyses. Eye (Lond). 2013;27(7):803-8.
- Heijl A, Bengtsson B, Chauhan BC, Lieberman MF, Cunliffe I, Hyman L, et al. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology. 2008;115(9):1557-65.
- Strouthidis NG, Scott A, Peter NM, Garway-Heath DF. Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement. Invest Ophthalmol Vis Sci. 2006;47(7):2904-10.
- Phu J, Tan J, Kalloniatis M. Multiple (frontloaded) visual field tests increase identification of very slow mean deviation progression in glaucoma. Can J Ophthalmol. 2024;59(5):311-323.
- Phu J, Wang H, Kalloniatis M. A Staged Approach to the Number and Frequency of Visual Field Testing for Detecting Glaucoma Progression. Ophthalmol Glaucoma. 2026.
- Kang DH, Hwang YH. Effect of baseline test selection on glaucoma progression detection by optical coherence tomography-guided progression analysis. Br J Ophthalmol. 2021;105(6):783-788.
- Wu Z, Medeiros FA. Comparison of Visual Field Point-Wise Event-Based and Global Trend-Based Analysis for Detecting Glaucomatous Progression. Transl Vis Sci Technol. 2018;7(4):20.
- Casas-Llera P, Rebolleda G, Muñoz-Negrete FJ, Arnalich-Montiel F, Pérez-López M, Fernández-Buenaga R. Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population. Br J Ophthalmol. 2009;93(12):1576-9.
- Hood DC, La Bruna S, Tsamis E, Leshno A, Melchior B, Grossman J, et al. The 24-2 Visual Field Guided Progression Analysis Can Miss the Progression of Glaucomatous Damage of the Macula Seen Using OCT. Ophthalmol Glaucoma. 2022;5(6):614-627.
- Zhang C, Tatham AJ, Daga FB, Jammal AA, Medeiros FA. Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1227-1234.
- Chauhan BC, Garway-Heath DF, Goñi FJ, Rossetti L, Bengtsson B, Viswanathan AC, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92(4):569-73.
- Nouri-Mahdavi K, Caprioli J, Coleman AL, Hoffman D, Gaasterland D. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol. 2005;123(2):193-9.
- Manassakorn A, Nouri-Mahdavi K, Koucheki B, Law SK, Caprioli J. Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities. Invest Ophthalmol Vis Sci. 2006;47(7):2896-903.
- Verma S, Nongpiur ME, Atalay E, Wei X, Husain R, Goh D, et al. Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis. Ophthalmology. 2017;124(7):1065-1071.
- Asano S, Murata H, Matsuura M, Fujino Y, Asaoka R. Early Detection of Glaucomatous Visual Field Progression Using Pointwise Linear Regression With Binomial Test in the Central 10 Degrees. Am J Ophthalmol. 2019;199:140-149.
- Patil TS, Viswanathan N, George R. To compare central visual field progression using mean deviation and pointwise linear regression analysis. Indian J Ophthalmol. 2023;71(3):854-860.
- Salazar D, Morales E, Rabiolo A, Capistrano V, Lin M, Afifi AA, et al. Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma. JAMA Ophthalmol. 2020;138(5):536-543.
- Wilkins MR, Fitzke FW, Khaw PT. Pointwise linear progression criteria and the detection of visual field change in a glaucoma trial. Eye (Lond). 2006;20(1):98-106.
- Miki A, Okazaki T, Weinreb RN, Morota M, Tanimura A, Kawashima R, et al. Evaluating Visual Field Progression in Advanced Glaucoma Using Trend Analysis of Targeted Mean Total Deviation. J Glaucoma. 2022;31(4):235-241.
- Medeiros FA, Weinreb RN, Moore G, Liebmann JM, Girkin CA, Zangwill LM. Integrating event- and trend-based analyses to improve detection of glaucomatous visual field progression. Ophthalmology. 2012;119(3):458-67.
- Chen RI, Gedde SJ. Assessment of visual field progression in glaucoma. Curr Opin Ophthalmol. 2023;34(2):103-108.
- Aref AA, Budenz DL. Detecting Visual Field Progression. Ophthalmology. 2017;124(12S):S51-S56.
- Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC. Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci. 2005;46(12):4600-6.
- Danesh-Meyer HV, Wong A, Papchenko T, Matheos K, Stylli S, Nichols A, et al. Optical coherence tomography predicts visual outcome for pituitary tumors. J Clin Neurosci. 2015;22(7):1098-104.
- Lee GI, Park KA, Lee D, Oh SY, Kong DS, Hong SD. Predicting visual outcomes after decompression of pituitary tumours based on stratified inner-retinal layer thickness and age. Acta Ophthalmol. 2023;101(3):301-309.
- Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci. 2016;57(3):805-12.
- Behbehani R, Ali A, Al-Moosa A. Course and Predictors of Visual Outcome of Idiopathic Intracranial Hypertension. Neuroophthalmology. 2022;46(2):80-84.
- Gospe SM 3rd, Bhatti MT, El-Dairi MA. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension. Br J Ophthalmol. 2016;100(4):505-9.
- Solli E, Doshi H, Elze T, Pasquale LR, Branco J, Wall M, et al. Archetypal analysis of visual fields in optic neuritis reveals functional biomarkers associated with outcome and treatment response. Mult Scler Relat Disord. 2022;67:104074.
- Purvin V, Kawasaki A, Zeldes S. Dolichoectatic arterial compression of the anterior visual pathways: neuro-ophthalmic features and clinical course. J Neurol Neurosurg Psychiatry. 2004;75(1):27-32.
- Jacobson DM. Symptomatic compression of the optic nerve by the carotid artery: clinical profile of 18 patients with 24 affected eyes identified by magnetic resonance imaging. Ophthalmology. 1999;106(10):1994-2004.
- Mohammadzadeh V, Wu S, Besharati S, Davis T, Vepa A, Morales E, et al. Prediction of Visual Field Progression with Baseline and Longitudinal Structural Measurements Using Deep Learning. Am J Ophthalmol. 2024;262:141-152.
- Nguyen AT, Greenfield DS, Bhakta AS, Lee J, Feuer WJ. Detecting Glaucoma Progression Using Guided Progression Analysis with OCT and Visual Field Assessment in Eyes Classified by International Classification of Disease Severity Codes. Ophthalmol Glaucoma. 2019;2(1):36-46.
- Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol. 1993;111(2):231-4.
- Nevalainen J, Krapp E, Paetzold J, Mildenberger I, Besch D, Vonthein R, et al. Visual field defects in acute optic neuritis—distribution of different types of defect pattern, assessed with threshold-related supraliminal perimetry, ensuring high spatial resolution. Graefes Arch Clin Exp Ophthalmol. 2008;246(4):599-607.
- Lambiri DW, Levin LA. Maculopapillary Bundle Degeneration in Optic Neuropathies. Curr Neurol Neurosci Rep. 2024;24(7):203-218.
- Woon C, Tang RA, Pardo G. Nutrition and optic nerve disease. Semin Ophthalmol. 1995;10(3):195-202.
- Newman NJ, Biousse V, Newman SA, Bhatti MT, Hamilton SR, Farris BK, et al. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial. Am J Ophthalmol. 2006;141(6):1061-1067.
- Yang S, Yang H, Ma SQ, Wang SS, He H, Zhao MJ, et al. Evaluation of Leber’s hereditary optic neuropathy patients prior to a gene therapy clinical trial. Medicine (Baltimore). 2016;95(40):e5110.
- Lenaers G, Hamel C, Delettre C, Amati-Bonneau P, Procaccio V, Bonneau D, et al. Dominant optic atrophy. Orphanet J Rare Dis. 2012;7:46.
- Fledelius HC. Optic disc drusen: longitudinal aspects, with emphasis on visual field constriction and enlarged blind spot: a retrospective hospital-based clinical series. Eur J Ophthalmol. 2017;27(3):372-378.
- Lee KM, Woo SJ, Hwang JM. Factors associated with visual field defects of optic disc drusen. PLoS One. 2018;13(4):e0196001.
- Noval S, Visa J, Contreras I. Visual field defects due to optic disk drusen in children. Graefes Arch Clin Exp Ophthalmol. 2013;251(10):2445-50.
- Sustronck P, Nguyen DT, Jean-Charles A, David T, Merle H. Visual field defects due to optic nerve drusen in Afro-Caribbean patients: A case series of 16 eyes. J Fr Ophtalmol. 2021;44(7):989-994.
- Dumitriu A, Dumitriu B, Socol FG, Socol ID, Yasar II, Fizedean C, et al. A Systematic Review of Optic Disc Drusen in the Modern Imaging Era: Structure-Function Correlates, Diagnostic Performance, and NAION Co-Occurrence. Diagnostics (Basel). 2025;15(18).
- Gerling J, Meyer JH, Kommerell G. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefes Arch Clin Exp Ophthalmol. 1998;236(3):188-92.
- Kaur K, Margolin E. Nonarteritic Anterior Ischemic Optic Neuropathy. . 2026.
- Syed Mohd Khomsah SNH, Muhammed J, Wan Hitam WH, Haron J. Binasal Field Defect in Non-arteritic Anterior Ischemic Optic Neuropathy. Cureus. 2023;15(8):e43722.
- Brossard Barbosa N, Donaldson L, Margolin E. Asymptomatic Fellow Eye Involvement in Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol. 2023;43(1):82-85.
- Touzé R, Bremond-Gignac D, Robert MP. [Chiasmatic syndrome]. J Fr Ophtalmol. 2021;44(1):84-98.
- Wang MTM, Meyer JA, Danesh-Meyer HV. Neuro-ophthalmic evaluation and management of pituitary disease. Eye (Lond). 2024;38(12):2279-2288.
- Choi HY, Kim SJ, Kim SY, Lee JE. Comparison of vision-related quality of life in patients with homonymous hemianopia and monocular blindness. Sci Rep. 2022;12(1):6558.
- Ali M, Hazelton C, Lyden P, Pollock A, Brady M. Recovery from poststroke visual impairment: evidence from a clinical trials resource. Neurorehabil Neural Repair. 2013;27(2):133-41.
- Obuchowska I, Mariak Z. Homonymous hemianopsia. Klin Oczna. 2012;114(3):226-9.
- Powell HW, Parker GJ, Alexander DC, Symms MR, Boulby PA, Wheeler-Kingshott CA, et al. MR tractography predicts visual field defects following temporal lobe resection. Neurology. 2005;65(4):596-9.
- Krolak-Salmon P, Guenot M, Tiliket C, Isnard J, Sindou M, Mauguiere F, et al. Anatomy of optic nerve radiations as assessed by static perimetry and MRI after tailored temporal lobectomy. Br J Ophthalmol. 2000;84(8):884-9.
- Wang YX, Zhu XL, Deng M, Siu DY, Leung JC, Chan Q, et al. The use of diffusion tensor tractography to measure the distance between the anterior tip of the Meyer loop and the temporal pole in a cohort from Southern China. J Neurosurg. 2010;113(6):1144-51.
- Kivelev J, Koskela E, Setälä K, Niemelä M, Hernesniemi J. Long-term visual outcome after microsurgical removal of occipital lobe cavernomas. J Neurosurg. 2012;117(2):295-301.
- Pasu S, Ridha BH, Wagh V, Jindahra P, Siddiqui A, Plant G, et al. Homonymous Sectoranopia: Asymptomatic Presentation of a Lateral Geniculate Nucleus Lesion. Neuroophthalmology. 2015;39(6):289-294.
- Huang M, Ilsen PF. Sectoranopia: a stroke in the lateral geniculate nucleus or optic radiations?. Optometry. 2007;78(7):356-64.
- Costello FE, Starreveld YP. Hemorrhagic Intracranial Cavernoma Presenting as a Homonymous Horizontal Sectoranopia. J Neuroophthalmol. 2021;41(2):e225-e227.
- Preble JM, Epstein A, Tannir J, Tomsak R. Homonymous Horizontal Sectoranopia Caused by an Occipital Lobe Infarct. Neuroophthalmology. 2020;44(2):104-107.
- Huber A. [Vision disorders in retrochiasmatic lesions of the visual pathways]. Ther Umsch. 1996;53(1):31-6.
- Liang J, Zhang Y, Liu K, Xu X, Zhao X, Qiu W, et al. Comparing evolvement of visual field defect in neuromyelitis optica spectrum disorder-optic neuritis and idiopathic optic neuritis: a prospective study. BMC Ophthalmol. 2022;22(1):338.
- Safran AB, Laffi GL, Bullinger A, Viviani P, de Weisse C, Désangles D, et al. Feasibility of automated visual field examination in children between 5 and 8 years of age. Br J Ophthalmol. 1996;80(6):515-8.
- Patel DE, Cumberland PM, Walters BC, Russell-Eggitt I, Rahi JS. Study of Optimal Perimetric Testing in Children (OPTIC): Feasibility, Reliability and Repeatability of Perimetry in Children. PLoS One. 2015;10(6):e0130895.
- Patel DE, Viswanathan AC, Garway-Heath D, Cumberland PM, Walters BC, Russell-Eggitt I, et al. Study of Optimal Perimetric Testing In Children (OPTIC): development and feasibility of the kinetic perimetry reliability measure (KPRM). Br J Ophthalmol. 2017;101(2):94-96.
- Riaz M, Ross NC, Mayer DL. The diagnostic accuracy and feasibility of paediatric visual field tests: A systematic review. Ophthalmic Physiol Opt. 2025;45(3):726-741.
- Murray IC, Fleck BW, Brash HM, Macrae ME, Tan LL, Minns RA. Feasibility of saccadic vector optokinetic perimetry: a method of automated static perimetry for children using eye tracking. Ophthalmology. 2009;116(10):2017-26.
- Murray IC, Perperidis A, Cameron LA, McTrusty AD, Brash HM, Tatham AJ, et al. Comparison of Saccadic Vector Optokinetic Perimetry and Standard Automated Perimetry in Glaucoma. Part I: Threshold Values and Repeatability. Transl Vis Sci Technol. 2017;6(5):3.
- Tatham AJ, McClean P, Murray IC, McTrusty AD, Cameron LA, Perperidis A, et al. Development of an Age-corrected Normative Database for Saccadic Vector Optokinetic Perimetry (SVOP). J Glaucoma. 2020;29(12):1106-1114.
- Tatham AJ, Murray IC, McTrusty AD, Cameron LA, Perperidis A, Brash HM, et al. A case control study examining the feasibility of using eye tracking perimetry to differentiate patients with glaucoma from healthy controls. Sci Rep. 2021;11(1):839.
- Maheshwari D, Nair A, Tara TD, Pawar N, Ramakrishnan R, Selvi DRG, et al. Comparison of the effect of audiovisual and verbal instructions on patient performance while performing automated Humphrey visual field testing. Indian J Ophthalmol. 2023;71(2):569-574.
- Hanout M, Horan N, Do DV. Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration. Curr Opin Ophthalmol. 2015;26(3):149-56.
- Raman P, Khy Ching Y, Sivagurunathan PD, Ramli N, Mohd Khalid KH. The Association Between Visual Field Reliability Indices and Cognitive Impairment in Glaucoma Patients. J Glaucoma. 2019;28(8):685-690.
- Kemiläinen B, Tiainen S, Rauramaa T, Luikku AJ, Herukka SK, Koivisto A, et al. Exploring the Association Between Visual Field Testing and CERAD Neuropsychological Battery in Idiopathic Normal Pressure Hydrocephalus Patients. J Alzheimers Dis. 2024;100(1):247-260.
- van den Broek EG, Janssen CG, van Ramshorst T, Deen L. Visual impairments in people with severe and profound multiple disabilities: an inventory of visual functioning. J Intellect Disabil Res. 2006;50(Pt 6):470-5.
- Mees L, Upadhyaya S, Kumar P, Kotawala S, Haran S, Rajasekar S, et al. Validation of a Head-mounted Virtual Reality Visual Field Screening Device. J Glaucoma. 2020;29(2):86-91.
- Chen YT, Yeh PH, Cheng YC, Su WW, Hwang YS, Chen HS, et al. Application and Validation of LUXIE: A Newly Developed Virtual Reality Perimetry Software. J Pers Med. 2022;12(10).
- Heinzman Z, Linton E, Marín-Franch I, Turpin A, Alawa K, Wijayagunaratne A, et al. Validation of the Iowa Head-Mounted Open-Source Perimeter. Transl Vis Sci Technol. 2023;12(9):19.
- Narang P, Agarwal A, Srinivasan M, Agarwal A. Advanced Vision Analyzer-Virtual Reality Perimeter: Device Validation, Functional Correlation and Comparison with Humphrey Field Analyzer. Ophthalmol Sci. 2021;1(2):100035.
- Mesfin Y, Kong A, Backus BT, Deiner M, Ou Y, Oatts JT. Pilot study comparing a new virtual reality-based visual field test to standard perimetry in children. J AAPOS. 2024;28(3):103933.
- Vera J, Glazier AN, Dunbar MT, Ripkin D, Nafey M. Evaluating the Clinical Validity of Commercially Available Virtual Reality Headsets for Visual Field Testing: A Systematic Review. Vision (Basel). 2025;9(4).
- Alajlan RS, Almazrou A, Althubiti L, Alsenani L, Hazazi B, Alsarhan Y, et al. Diagnostic accuracy and reliability of portable visual field-testing devices for detecting manifest glaucomatous visual-field loss: a systematic review and meta-analysis. BMC Ophthalmol. 2026;26(1).
- Tsapakis S, Papaconstantinou D, Diagourtas A, Kandarakis S, Droutsas K, Andreanos K, et al. Home-based visual field test for glaucoma screening comparison with Humphrey perimeter. Clin Ophthalmol. 2018;12:2597-2606.
- Prea SM, Vingrys AJ, Kong GYX. Test Reliability and Compliance to a Twelve-Month Visual Field Telemedicine Study in Glaucoma Patients. J Clin Med. 2022;11(15).
- Shen X, Chen Z, Yang W, Wang M, Tan K, Fan Y, et al. Home-Based Visual Field Monitoring for Open-Angle Glaucoma Using a Web-Enabled Quantitative Perimeter (Perimouse): An Evaluation Over Six Months. Clin Ophthalmol. 2026;20:582204.
- Chen YX, Meyerov J, Skalicky SE. Online Circular Contrast Perimetry via a Web-Application: Establishing a Normative Database for Central 10-Degree Perimetry. Clin Ophthalmol. 2024;18:201-213.
- Aboobakar IF, Friedman DS. Home Monitoring for Glaucoma: Current Applications and Future Directions. Semin Ophthalmol. 2021;36(4):310-314.
- Kamdar A, Swaminathan SS. Beyond the Clinic: Home-Based Monitoring Strategies in Glaucoma Care. Int Ophthalmol Clin. 2026;66(3):8-22.
- Aldaher H, Alsaadi FA, Bashier S, Ali A. Home-Based Visual Field Monitoring Devices in Glaucoma Management: A Review of Current Evidence and Barriers to Adoption. Cureus. 2025;17(10):e95680.
- Kardon RH. Pupil perimetry. Curr Opin Ophthalmol. 1992;3(5):565-70.
- Stingl K, Peters T, Strasser T, Kelbsch C, Richter P, Wilhelm H, et al. Pupillographic campimetry: an objective method to measure the visual field. Biomed Tech (Berl). 2018;63(6):729-734.
- Yoshitomi T, Matsui T, Tanakadate A, Ishikawa S. Comparison of threshold visual perimetry and objective pupil perimetry in clinical patients. J Neuroophthalmol. 1999;19(2):89-99.
- Tatham AJ, Meira-Freitas D, Weinreb RN, Zangwill LM, Medeiros FA. Detecting glaucoma using automated pupillography. Ophthalmology. 2014;121(6):1185-93.
- Ali EN, Lueck CJ, Carle CF, Martin KL, Borbelj A, Maddess T. Response characteristics of objective perimetry in persons living with epilepsy. J Neurol Sci. 2022;436:120237.
- Quan Y, Duan H, Zhan Z, Shen Y, Lin R, Liu T, et al. Binocular head-mounted chromatic pupillometry can detect structural and functional loss in glaucoma. Front Neurosci. 2023;17:1187619.
- Kardon R, Anderson SC, Damarjian TG, Grace EM, Stone E, Kawasaki A. Chromatic pupillometry in patients with retinitis pigmentosa. Ophthalmology. 2011;118(2):376-81.
- Seiple W, Holopigian K, Clemens C, Greenstein VC, Hood DC. The multifocal visual evoked potential: an objective measure of visual fields?. Vision Res. 2005;45(9):1155-63.
- Graham SL, Klistorner A. The diagnostic significance of the multifocal pattern visual evoked potential in glaucoma. Curr Opin Ophthalmol. 1999;10(2):140-6.
- Senger C, Moreto R, Watanabe SES, Matos AG, Paula JS. Electrophysiology in Glaucoma. J Glaucoma. 2020;29(2):147-153.
- Banijamali SMA, Versek C, Babinski K, Kamarthi S, Green-LaRoche D, Sridhar S. Portable multi-focal visual evoked potential diagnostics for multiple sclerosis/optic neuritis patients. Doc Ophthalmol. 2024;149(1):23-45.
- Bro T, Lindblom B. Strain out a gnat and swallow a camel? - vision and driving in the Nordic countries. Acta Ophthalmol. 2018;96(6):623-630.
- Bron AM, Viswanathan AC, Thelen U, de Natale R, Ferreras A, Gundgaard J, et al. International vision requirements for driver licensing and disability pensions: using a milestone approach in characterization of progressive eye disease. Clin Ophthalmol. 2010;4:1361-9.
- Jørstad ØK, Jonsdottir TE, Zysset S, Rowe F. A traffic perimetry test that adheres to the European visual field requirements. Acta Ophthalmol. 2021;99(4):e555-e561.
- Owen VM, Crabb DP, White ET, Viswanathan AC, Garway-Heath DF, Hitchings RA. Glaucoma and fitness to drive: using binocular visual fields to predict a milestone to blindness. Invest Ophthalmol Vis Sci. 2008;49(6):2449-55.
- Lee AG, Johnson MC, Policeni BA, Smoker WR. Imaging for neuro-ophthalmic and orbital disease - a review. Clin Exp Ophthalmol. 2009;37(1):30-53.
- Lee AG, Brazis PW, Garrity JA, White M. Imaging for neuro-ophthalmic and orbital disease. Am J Ophthalmol. 2004;138(5):852-62.
- Wu AY, Jebodhsingh K, Le T, Law C, Tucker NA, DeAngelis DD, et al. Indications for orbital imaging by the oculoplastic surgeon. Ophthalmic Plast Reconstr Surg. 2011;27(4):260-2.
- Backens M. [Basic principles and technique of diffusion-weighted imaging and diffusion tensor imaging]. Radiologe. 2015;55(9):762-70.
- Beauchamp NJ Jr, Ulug AM, Passe TJ, van Zijl PC. MR diffusion imaging in stroke: review and controversies. Radiographics. 1998;18(5):1269-83; discussion 1283-5.
- Kloska SP, Wintermark M, Engelhorn T, Fiebach JB. Acute stroke magnetic resonance imaging: current status and future perspective. Neuroradiology. 2010;52(3):189-201.
- Fujii R, Mochizuki Y, Koide W, Kurita M, Ishii T, Kondo Y, et al. Potential of fluid-attenuated inversion recovery diffusion-weighted imaging in patients with acute cerebral infarction. Radiol Phys Technol. 2026;19(2):732-741.
- Haller S, Haacke EM, Thurnher MM, Barkhof F. Susceptibility-weighted Imaging: Technical Essentials and Clinical Neurologic Applications. Radiology. 2021;299(1):3-26.
- Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol. 2009;30(2):232-52.
- Halefoglu AM, Yousem DM. Susceptibility weighted imaging: Clinical applications and future directions. World J Radiol. 2018;10(4):30-45.
- Barnes SR, Haacke EM. Susceptibility-weighted imaging: clinical angiographic applications. Magn Reson Imaging Clin N Am. 2009;17(1):47-61.
- Simon J, Szumowski J, Totterman S, Kido D, Ekholm S, Wicks A, et al. Fat-suppression MR imaging of the orbit. AJNR Am J Neuroradiol. 1988;9(5):961-8.
- Guy J, Mao J, Bidgood WD Jr, Mancuso A, Quisling RG. Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging. Ophthalmology. 1992;99(5):713-9.
- Guy J, Fitzsimmons J, Ellis EA, Beck B, Mancuso A. Intraorbital optic nerve and experimental optic neuritis. Correlation of fat suppression magnetic resonance imaging and electron microscopy. Ophthalmology. 1992;99(5):720-5.
- Hickman SJ. Optic nerve imaging in multiple sclerosis. J Neuroimaging. 2007;17 Suppl 1:42S-45S.
- Gass A, Moseley IF, Barker GJ, Jones S, MacManus D, McDonald WI, et al. Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI. Neuroradiology. 1996;38(4):317-21.
- Gass A, Moseley IF. The contribution of magnetic resonance imaging in the differential diagnosis of optic nerve damage. J Neurol Sci. 2000;172 Suppl 1:S17-22.
- Onofrj M, Tartaro A, Thomas A, Gambi D, Fulgente T, Delli Pizzi C, et al. Long echo time STIR sequence MRI of optic nerves in optic neuritis. Neuroradiology. 1996;38(1):66-9.
- Faizy TD, Broocks G, Frischmuth I, Westermann C, Flottmann F, Schönfeld MH, et al. Spectrally fat-suppressed coronal 2D TSE sequences may be more sensitive than 2D STIR for the detection of hyperintense optic nerve lesions. Eur Radiol. 2019;29(11):6266-6274.
- Cordt J, Larsen N, Riedel C, Klintz T, Jansen O, Peters S. Detecting optic nerve lesions in multiple sclerosis patients with a 1,5 T MRI: Evaluation of a 3D DIR sequence compared to a 2D STIR sequence. Mult Scler Relat Disord. 2024;90:105832.
- Shimada A, Suda K, Nakano E, Tagawa M, Miyata M, Kashii S, et al. Accuracy of Diagnosing Optic Neuritis Using DANTE T1-SPACE Imaging. Eye Brain. 2024;16:65-73.
- Rana K, Madike R, Leyden J, Slattery J, Chan WO, Simon S, et al. Optic nerve sheath infiltration in dysthyroid optic neuropathy. Eye (Lond). 2024;38(6):1173-1175.
- Sklar EM, Schatz NJ, Glaser JS, Post MJ, ten Hove M. MR of vasculitis-induced optic neuropathy. AJNR Am J Neuroradiol. 1996;17(1):121-8.
- Grobner T, Prischl FC. Gadolinium and nephrogenic systemic fibrosis. Kidney Int. 2007;72(3):260-4.
- Starekova J, Pirasteh A, Reeder SB. Update on Gadolinium-Based Contrast Agent Safety, From the AJR Special Series on Contrast Media. AJR Am J Roentgenol. 2024;223(3):e2330036.
- Mathur M, Jones JR, Weinreb JC. Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist’s Primer. Radiographics. 2020;40(1):153-162.
- McDonald JS, McDonald RJ. MR Imaging Safety Considerations of Gadolinium-Based Contrast Agents: Gadolinium Retention and Nephrogenic Systemic Fibrosis. Magn Reson Imaging Clin N Am. 2020;28(4):497-507.
- Ramalho M, Ramalho J, Burke LM, Semelka RC. Gadolinium Retention and Toxicity-An Update. Adv Chronic Kidney Dis. 2017;24(3):138-146.
- Martí-Bonmatí L, Martí-Bonmatí E. Retention of gadolinium compounds used in magnetic resonance imaging: a critical review and the recommendations of regulatory agencies. Radiologia. 2017;59(6):469-477.
- Benzon HT, Maus TP, Kang HR, Provenzano DA, Bhatia A, Diehn F, et al. The Use of Contrast Agents in Interventional Pain Procedures: A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy After Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions. Anesth Analg. 2021;133(2):535-552.
- Vega F. Adverse reactions to radiological contrast media: Prevention and treatment. Radiologia (Engl Ed). 2024;66 Suppl 2:S98-S109.
- Bos D, Guberina N, Zensen S, Opitz M, Forsting M, Wetter A. Radiation Exposure in Computed Tomography. Dtsch Arztebl Int. 2023;120(9):135-141.
- Dieckmeyer M, Sollmann N, Kupfer K, Löffler MT, Paprottka KJ, Kirschke JS, et al. Computed Tomography of the Head : A Systematic Review on Acquisition and Reconstruction Techniques to Reduce Radiation Dose. Clin Neuroradiol. 2023;33(3):591-610.
- Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380(9840):499-505.
- Shellock FG, Spinazzi A. MRI safety update 2008: part 2, screening patients for MRI. AJR Am J Roentgenol. 2008;191(4):1140-9.
- Shellock FG, Karacozoff AM. Detection of implants and other objects using a ferromagnetic detection system: implications for patient screening before MRI. AJR Am J Roentgenol. 2013;201(4):720-5.
- Kalb B, Indik JH, Ott P, Martin DR. MRI of patients with implanted cardiac devices. J Magn Reson Imaging. 2018;47(3):595-603.
- Erhardt JB, Fuhrer E, Gruschke OG, Leupold J, Wapler MC, Hennig J, et al. Should patients with brain implants undergo MRI?. J Neural Eng. 2018;15(4):041002.
- Ford B, Dore M, Moullet P. Diagnostic Imaging: Appropriate and Safe Use. Am Fam Physician. 2021;103(1):42-50.
- Castillo C, Steffens T, Sim L, Caffery L. The effect of clinical information on radiology reporting: A systematic review. J Med Radiat Sci. 2021;68(1):60-74.
- Houssami N, Irwig L, Simpson JM, McKessar M, Blome S, Noakes J. The influence of clinical information on the accuracy of diagnostic mammography. Breast Cancer Res Treat. 2004;85(3):223-8.
- Carney PA, Cook AJ, Miglioretti DL, Feig SA, Bowles EA, Geller BM, et al. Use of clinical history affects accuracy of interpretive performance of screening mammography. J Clin Epidemiol. 2012;65(2):219-30.
- Anglaret S, Dallongeville A, Beaussier H, Touloupas C, Boulay I, Tardivel AM, et al. Influence of clinical suspicion on CT accuracy of acute mesenteric ischemia: Retrospective study of 362 patients. Eur J Radiol. 2021;138:109652.
- Cohen MD. Accuracy of information on imaging requisitions: does it matter?. J Am Coll Radiol. 2007;4(9):617-21.
- Terzis R, Kaya K, Schömig T, Janssen JP, Iuga AI, Kottlors J, et al. GPT-4 for automated sequence-level determination of MRI protocols based on radiology request forms from clinical routine. Eur Radiol. 2026;36(2):1541-1552.
- López-Úbeda P, Díaz-Galiano MC, Martín-Noguerol T, Luna A, Ureña-López LA, Martín-Valdivia MT. Automatic medical protocol classification using machine learning approaches. Comput Methods Programs Biomed. 2021;200:105939.
- Vásquez JD, Galeano Baquero CA, González D, Posada Cuartas C, Cadavid Barrios SS. Technological Model to Optimize the Request for Radiological Studies. Cureus. 2025;17(9):e92135.
- Lecler A, Mondot L, Homo C, Tourdias T, Vukusic S, Durand-Dubief F, et al. Updated French OFSEP recommendations for multiple sclerosis MRI: alignment with the 2024 McDonald criteria. J Neuroradiol. 2026;53(5):101576.
- Weidauer S, Raab P, Hattingen E. Diagnostic approach in multiple sclerosis with MRI: an update. Clin Imaging. 2021;78:276-285.
- Durand-Dubief F, Shor N, Audoin B, Bourre B, Cohen M, Kremer S, et al. MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS. J Neuroradiol. 2025;52(1):101235.
- Asseyer S, Asgari N, Bennett J, Bialer O, Blanco Y, Bosello F, et al. The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis. Front Neurol. 2023;14:1102353.
- Ryoo I, Jung HN, Suh SI, Kim B, You SH, Kim BK, et al. Dynamic Contrast-Enhanced pituitary MRI with higher temporal resolution using deep learning Reconstruction: A feasibility study. Eur J Radiol. 2026;203:112994.
- Karimian-Jazi K. [Pituitary gland tumors]. Radiologe. 2019;59(11):982-991.
- Jesser J, Schlamp K, Bendszus M. [Pituitary gland tumors]. Radiologe. 2014;54(10):981-8.
- Korbecki A, Machaj W, Korbecka J, Sobański M, Kaczorowski M, Tabakow P, et al. Evaluation of the Value of Perfusion-Weighted Magnetic Resonance Imaging in the Differential Diagnosis of Sellar and Parasellar Tumors. J Clin Med. 2023;12(8).
- Charbonneau F, Williams M, Lafitte F, Héran F. No more fear of the cavernous sinuses!. Diagn Interv Imaging. 2013;94(10):1003-16.
- Akpinar ÇK, Özbenli T, Doğru H, Incesu L. Tolosa-Hunt Syndrome - Cranial Neuroimaging Findings. Noro Psikiyatr Ars. 2017;54(3):251-254.
- Hutchins LG, Harnsberger HR, Hardin CW, Dillon WP, Smoker WR, Osborn AG. The radiologic assessment of trigeminal neuropathy. AJR Am J Roentgenol. 1989;153(6):1275-82.
- Leclercq D, Thiebaut JB, Héran F. Trigeminal neuralgia. Diagn Interv Imaging. 2013;94(10):993-1001.
- Ihn YK, Jung WS, Hwang SS. The value of T2*-weighted gradient-echo MRI for the diagnosis of cerebral venous sinus thrombosis. Clin Imaging. 2013;37(3):446-50.
- Ahmed S, Arora A, Kulanthaivelu K, Saini J, Menon D, Chakrabarti D. Utility of 3D T1-weighted turbo spin echo black blood sequence for the diagnosis of cerebral venous thrombosis. Emerg Radiol. 2023;30(4):443-451.
- Filippidis A, Kapsalaki E, Patramani G, Fountas KN. Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus. 2009;27(5):E3.
- Ferro JM, Coutinho JM, Jansen O, Bendszus M, Dentali F, Kobayashi A, et al. Dural Arteriovenous Fistulae After Cerebral Venous Thrombosis. Stroke. 2020;51(11):3344-3347.
- Rhee RL, Bathla G, Rebello R, Kurtz RM, Junek M, Warrington KJ, et al. Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group. Rheumatology (Oxford). 2025;64(5):2910-2918.
- El Haddad J, Charbonneau F, Guillaume J, Clavel G, Chazal T, Poillon G, et al. Reproducibility and accuracy of vessel wall MRI in diagnosing giant cell arteritis: a study with readers of varying expertise. Eur Radiol. 2024;34(8):5360-5369.
- Romero-Sanchez G, Dabiri M, Mossa-Basha M. Primary Large Vessel Vasculitis: Takayasu Arteritis and Giant Cell Arteritis. Neuroimaging Clin N Am. 2024;34(1):53-65.
- Guggenberger KV, Vogt ML, Song JW, Weng AM, Fröhlich M, Schmalzing M, et al. Intraorbital findings in giant cell arteritis on black blood MRI. Eur Radiol. 2023;33(4):2529-2535.
- Jianu DC, Jianu SN, Dan TF, Munteanu G, Bîrdac CD, Motoc AGM, et al. Ultrasound Technologies and the Diagnosis of Giant Cell Arteritis. Biomedicines. 2021;9(12).
- Markus HS, Hayter E, Levi C, Feldman A, Venables G, Norris J. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14(4):361-7.
- Cohen R, Padilla J, Light D, Diller R. Carotid artery occlusive disease and ocular manifestations: Importance of identifying patients at risk. Optometry. 2010;81(7):359-63.
- Golsari A, Bittersohl D, Cheng B, Griem P, Beck C, Hassenstein A, et al. Silent Brain Infarctions and Leukoaraiosis in Patients With Retinal Ischemia: A Prospective Single-Center Observational Study. Stroke. 2017;48(5):1392-1396.
- Kirkham FJ. Indications for the performance of neuroimaging in children. Handb Clin Neurol. 2016;136:1275-90.
- Barkovich MJ, Xu D, Desikan RS, Williams C, Barkovich AJ. Pediatric neuro MRI: tricks to minimize sedation. Pediatr Radiol. 2018;48(1):50-55.
- Bjur KA, Payne ET, Nemergut ME, Hu D, Flick RP. Anesthetic-Related Neurotoxicity and Neuroimaging in Children: A Call for Conversation. J Child Neurol. 2017;32(6):594-602.
- Kamali Zonouzi S, Jafari S, Margolin E, Micieli JA. Radiologists’ recommendations following MRI for optic neuritis: influence of report wording and patient accessibility in a tertiary neuro-ophthalmology clinic. Can J Ophthalmol. 2026.
- Cochon LR, Kapoor N, Carrodeguas E, Ip IK, Lacson R, Boland G, et al. Variation in Follow-up Imaging Recommendations in Radiology Reports: Patient, Modality, and Radiologist Predictors. Radiology. 2019;291(3):700-707.
- Kapoor N, Lacson R, Eskian M, Cochon L, Glazer D, Ip I, et al. Variation in Radiologists’ Follow-Up Imaging Recommendations for Small Cystic Pancreatic Lesions. J Am Coll Radiol. 2021;18(10):1405-1414.
- Calvillo AÁ, Kodaverdian LC, Garcia R, Lichtensztajn DY, Bucknor MD. Patient-level factors influencing adherence to follow-up imaging recommendations. Clin Imaging. 2022;90:5-10.
- Cox V, Haddad A, Lendoire M, Yedururi S, Marcal L, Panettieri E, et al. Impact of Imaging Review and Multidisciplinary Discussion During Hepatobiliary Tumor Board: A Prospective Study. Ann Surg Oncol. 2025;32(13):9534-9543.
- Booth TC, Thompson G, Bulbeck H, Boele F, Buckley C, Cardoso J, et al. A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future Research. Front Oncol. 2021;11:620070.
- Lo R, Ma Z, Chen L, Vasudevan A, Srinivasan A. Structured Versus Non-Structured Reporting of Inflammatory Bowel Disease Imaging: A Systematic Review. JGH Open. 2025;9(10):e70288.
- Jiang LB, Li ZX. [Artificial intelligence in neuro-ophthalmology: prospects, challenges and countermeasures]. Zhonghua Yan Ke Za Zhi. 2026;62(7):481-487.
- Hoch MJ, Bruno MT, Shepherd TM. Advanced MRI of the Optic Nerve. J Neuroophthalmol. 2017;37(2):187-196.
- Menjot de Champfleur N, Menjot de Champfleur S, Galanaud D, Leboucq N, Bonafé A. Imaging of the optic chiasm and retrochiasmal visual pathways. Diagn Interv Imaging. 2013;94(10):957-71.
- Rootman MS, Dotan G, Konen O. Neuroimaging in Children with Ophthalmological Complaints: A Review. J Neuroimaging. 2021;31(3):446-458.
- Degraeve M, Ninclaus V, Deferm J, Brusselaers N, Jacobs R, Willaert R. A systematic review on volumetric analysis in orbital MRI. Neuroradiology. 2025;67(9):2533-2549.
- Shahriari M, Sotirchos ES, Newsome SD, Yousem DM. MOGAD: How It Differs From and Resembles Other Neuroinflammatory Disorders. AJR Am J Roentgenol. 2021;216(4):1031-1039.
- Jeyakumar N, Lerch M, Dale RC, Ramanathan S. MOG antibody-associated optic neuritis. Eye (Lond). 2024;38(12):2289-2301.
- Lim YM, Pyun SY, Lim HT, Jeong IH, Kim KK. First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis. Neurol Sci. 2014;35(5):781-3.
- Deschamps R, Shor N, Vignal C, Guillaume J, Bensa C, Lecler A, et al. Acute optic neuritis: What are the clues to the aetiological diagnosis in real life?. Mult Scler Relat Disord. 2023;76:104764.
- Petroulia VD, Brügger D, Hoepner R, Vicini R, Winklehner A, Abegg M, et al. MRI signs helpful in the differentiation of patients with anterior ischaemic optic neuropathy and optic neuritis. Br J Ophthalmol. 2023;107(1):121-126.
- Purvin V, Kawasaki A, Jacobson DM. Optic perineuritis: clinical and radiographic features. Arch Ophthalmol. 2001;119(9):1299-306.
- Saitakis G, Chwalisz BK. Optic perineuritis. Curr Opin Ophthalmol. 2022;33(6):519-524.
- Lai C, Sun Y, Wang J, Purvin VA, He Y, Yang Q, et al. Optic Perineuritis in Behçet Disease. J Neuroophthalmol. 2015;35(4):342-7.
- Tuncer O, Baim A, Lee M, Gencturk M, Özütemiz C. Reliable and Accurate Differentiation of Optic Perineuritis and Optic Nerve Sheath Meningioma from the Radiologists’ Perspective. Neuroophthalmology. 2026;50(1):30-36.
- Benyarou K, El Hasnaoui S, Yousfi S, Mebrouk Y. Optic nerve sheath meningioma and optic neuropathy: A clinical and diagnosis crossroad. Radiol Case Rep. 2026;21(6):2461-2466.
- Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthalmol. 1992;37(3):167-83.
- Patel H, Chakrabarty B, Dubey R, Kumar A, Gulati S. Optic Nerve Glioma in Neurofibromatosis: Radiological Clues to Diagnosis in a Young Child. J Pediatr Neurosci. 2021;16(3):266-267.
- Kotch C, Si SJ, Desai K, Caminada P, Lo Russo FM, Li Y, et al. The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis. J Neurooncol. 2023;164(3):741-747.
- Mijiti G, Shi W, Li L, Yu JF, Ge M, Yan HG, et al. [Characteristics of primary ocular symptoms in children with optic pathway glioma at different ages]. Zhonghua Yan Ke Za Zhi. 2023;59(5):376-380.
- Karaman AK, Özgen KH, Korkmazer B, Hamid R, Kübra Yıldırım H, Kemerdere R, et al. Comparison of MRI findings of hypothalamic-optic chiasmatic gliomas and craniopharyngiomas. Acta Radiol. 2024;65(7):784-791.
- Nagahata M, Hosoya T, Kayama T, Yamaguchi K. Edema along the optic tract: a useful MR finding for the diagnosis of craniopharyngiomas. AJNR Am J Neuroradiol. 1998;19(9):1753-7.
- Neigel JM, Rootman J, Belkin RI, Nugent RA, Drance SM, Beattie CW, et al. Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology. 1988;95(11):1515-21.
- Cheng S, Ming Y, Hu M, Zhang Y, Jiang F, Wang X, et al. Risk prediction of dysthyroid optic neuropathy based on CT imaging features combined the bony orbit with the soft tissue structures. Front Med (Lausanne). 2022;9:936819.
- Starks VS, Reinshagen KL, Lee NG, Freitag SK. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease. Orbit. 2020;39(2):77-83.
- Potvin ARGG, Pakdel F, Saeed P. Dysthyroid Optic Neuropathy. Ophthalmic Plast Reconstr Surg. 2023;39(6S):S65-S80.
- Gotti Naves G, José de Oliveira Cabral H, de Oliveira HR, Scoppetta TLPD, Zuppani HB, Assunção FB. Practical Approach to Orbital Lesions by Anatomic Compartments. Radiographics. 2024;44(10):e240026.
- Biswas A, Wong OY, Aygun B, Gore S, Mankad K. Extraocular Orbital and Peri-Orbital Masses. Neuroimaging Clin N Am. 2023;33(4):643-659.
- Joseph AK, Guerin JB, Eckel LJ, Dalvin LA, Keating GF, Liebo GB, et al. Imaging Findings of Pediatric Orbital Masses and Tumor Mimics. Radiographics. 2022;42(3):880-897.
- Rumboldt Z, Dodig D, Galluzzi P, Brumini I, Clarke R, Singh S, et al. Retinoblastoma and beyond: pediatric orbital mass lesions. Neuroradiology. 2025;67(2):469-492.
- Ding ZX, Lip G, Chong V. Idiopathic orbital pseudotumour. Clin Radiol. 2011;66(9):886-92.
- Fang Y, Shen B, Dai Q, Xie Q, Wu W, Wang M. Orbital inflammatory pseudotumor: new advances in diagnosis, pathogenesis, and treatment. Eur J Med Res. 2023;28(1):395.
- Hsuan JD, Selva D, McNab AA, Sullivan TJ, Saeed P, O’Donnell BA. Idiopathic sclerosing orbital inflammation. Arch Ophthalmol. 2006;124(9):1244-50.
- Mombaerts I, McNab AA. Idiopathic Orbital Myositis Revisited. Curr Rheumatol Rep. 2022;24(1):20-26.
- Huang S, Tong JY, Ang TW, Hardy TG, McNab A, Selva D. Idiopathic apical orbital inflammation: clinical features and outcomes. Can J Ophthalmol. 2025;60(3):e436-e442.
- Eustis HS, Mafee MF, Walton C, Mondonca J. MR imaging and CT of orbital infections and complications in acute rhinosinusitis. Radiol Clin North Am. 1998;36(6):1165-83, xi.
- Hornblass A, Herschorn BJ, Stern K, Grimes C. Orbital abscess. Surv Ophthalmol. 1984;29(3):169-78.
- Yadalla D, Jayagayathri R, Padmanaban K, Ramasamy R, Rammohan R, Nisar SP, et al. Bacterial orbital cellulitis - A review. Indian J Ophthalmol. 2023;71(7):2687-2693.
- Winegar BA. Imaging of Painful Ophthalmologic Disorders. Neurol Clin. 2022;40(3):641-660.
- Kubal WS. Imaging of orbital trauma. Radiographics. 2008;28(6):1729-39.
- Reddy RP, Bodanapally UK, Shanmuganathan K, Van der Byl G, Dreizin D, Katzman L, et al. Traumatic optic neuropathy: facial CT findings affecting visual acuity. Emerg Radiol. 2015;22(4):351-6.
- Bodanapally UK, Van der Byl G, Shanmuganathan K, Katzman L, Geraymovych E, Saksobhavivat N, et al. Traumatic optic neuropathy prediction after blunt facial trauma: derivation of a risk score based on facial CT findings at admission. Radiology. 2014;272(3):824-31.
- Yan W, Chen Y, Qian Z, Selva D, Pelaez D, Tu Y, et al. Incidence of optic canal fracture in the traumatic optic neuropathy and its effect on the visual outcome. Br J Ophthalmol. 2017;101(3):261-267.
- Myllylä V, Pyhtinen J, Päivänsalo M, Tervonen O, Koskela P. CT detection and location of intraorbital foreign bodies. Experiments with wood and glass. Rofo. 1987;146(6):639-43.
- You Y, Wang X, Cheng S, Zhu R, Wang B, Li S, et al. Clinical analysis of 96 patients with intraorbital foreign bodies: A 10-year retrospective study. Front Med (Lausanne). 2022;9:1018905.
- Kendall CJ, Prager TC, Cheng H, Gombos D, Tang RA, Schiffman JS. Diagnostic Ophthalmic Ultrasound for Radiologists. Neuroimaging Clin N Am. 2015;25(3):327-65.
- Fledelius HC. Ultrasound in ophthalmology. Ultrasound Med Biol. 1997;23(3):365-75.
- Byrne SF. Standardized echography. Part I: A-Scan examination procedures. Int Ophthalmol Clin. 1979;19(4):267-81.
- Hasenfratz G. Orbital tumours—the importance of standardized echography. Acta Ophthalmol Suppl (1985). 1992.
- Faje A, Tritos NA, Swearingen B, Klibanski A. Neuroendocrine disorders: pituitary imaging. Handb Clin Neurol. 2016;136:873-85.
- Ucciferro P, Anastasopoulou C. Empty Sella Syndrome. . 2026.
- Constantinescu SM, Maiter D. Pituitary incidentaloma. Presse Med. 2021;50(4):104081.
- Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33(4):610-7; discussion 617-8.
- Micko A, Oberndorfer J, Weninger WJ, Vila G, Höftberger R, Wolfsberger S, et al. Challenging Knosp high-grade pituitary adenomas. J Neurosurg. 2020;132(6):1739-1746.
- Spuler K, White R, Lim WT, Deeb J, McNeil J, Bouras G, et al. A Retrospective cohort study of Knosp grade reporting of cavernous sinus invasion in pituitary macroadenomas. Pituitary. 2026;29(3).
- Kim M, Kim HS, Park JE, Park SY, Kim YH, Kim SJ, et al. Thin-Slice Pituitary MRI with Deep Learning-Based Reconstruction for Preoperative Prediction of Cavernous Sinus Invasion by Pituitary Adenoma: A Prospective Study. AJNR Am J Neuroradiol. 2022;43(2):280-285.
- Zoli M, Milanese L, Bonfatti R, Sturiale C, Pasquini E, Frank G, et al. Cavernous sinus invasion by pituitary adenomas: role of endoscopic endonasal surgery. J Neurosurg Sci. 2016;60(4):485-94.
- Goyal P, Utz M, Gupta N, Kumar Y, Mangla M, Gupta S, et al. Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. Quant Imaging Med Surg. 2018;8(2):219-231.
- Briet C, Salenave S, Chanson P. Pituitary apoplexy. Endocrinol Metab Clin North Am. 2015;44(1):199-209.
- Hong CS, Omay SB. Pituitary Apoplexy. N Engl J Med. 2022;387(25):2366.
- Chanson P, Lepeintre JF, Ducreux D. Management of pituitary apoplexy. Expert Opin Pharmacother. 2004;5(6):1287-98.
- Dietemann JL, Cromero C, Tajahmady T, Baumgartner J, Gangi A, Kastler B, et al. CT and MRI of suprasellar lesions. J Neuroradiol. 1992;19(1):1-22.
- Schwetye KE, Dahiya SM. Sellar Tumors. Surg Pathol Clin. 2020;13(2):305-329.
- Karmarkar VS, Deopujari CE. Sellar Pathologies Mimicking Pituitary Tumors. Neurol India. 2020;68(Supplement):S154-S160.
- Van Effenterre R, Boch AL. [Craniopharyngiomas]. Ann Endocrinol (Paris). 2007;68(6):412-21.
- Xu S, Yang W, Luo Y, Wang X, Li Y, Meng X, et al. A novel MRI feature, the cut green pepper sign, can help differentiate a suprasellar pilocytic astrocytoma from an adamantinomatous craniopharyngioma. BMC Med Imaging. 2023;23(1):191.
- Larkin S, Karavitaki N, Ansorge O. Rathke’s cleft cyst. Handb Clin Neurol. 2014;124:255-69.
- Hacioglu A, Tekiner H, Altinoz MA, Ekinci G, Bonneville JF, Yaltirik K, et al. Rathke’s cleft cyst: From history to molecular genetics. Rev Endocr Metab Disord. 2025;26(2):229-260.
- Brou C, Tatar IG. Different Faces of Rathke’s Cleft Cyst. J Belg Soc Radiol. 2023;107(1):15.
- Caranci F, Leone G, Ponsiglione A, Muto M, Tortora F, Muto M, et al. Imaging findings in hypophysitis: a review. Radiol Med. 2020;125(3):319-328.
- Iglesias P. Immune-Mediated Hypophysitis: An Updated Review. J Clin Med. 2026;15(9).
- Schlosser RJ, Bolger WE. Significance of empty sella in cerebrospinal fluid leaks. Otolaryngol Head Neck Surg. 2003;128(1):32-8.
- Bhatia H, Kaur R, Bedi R. MR imaging of cavernous sinus thrombosis. Eur J Radiol Open. 2020;7:100226.
- Heckmann JG, Tomandl B. Cavernous sinus thrombosis. Lancet. 2003;362(9400):1958.
- Qu H, Li Y, Chen M, Sun H, Du S, Cheng Y, et al. Cavernous sinus thrombosis: An insidious and dangerous “do-not-miss” diagnosis. Headache. 2021;61(7):1144-1149.
- Heran MKS, Volders D, Haw C, Shewchuk JR. Imaging-Guided Superior Ophthalmic Vein Access for Embolization of Dural Carotid Cavernous Fistulas: Report of 20 Cases and Review of the Literature. AJNR Am J Neuroradiol. 2019;40(4):699-702.
- Han M, Chen T, Ediriwickrema L. Intra-operative visualization of the superior ophthalmic vein in carotid-cavernous fistula. Orbit. 2025.
- Park S, Ku I, Park JU. Neglected Superior Ophthalmic Vein Enlargement before Delayed Symptom of Carotid-Cavernous Fistula in a Blowout Fracture: A Case Report and Literature Review. Arch Plast Surg. 2024;51(4):397-401.
- Sailer AM, Wagemans BA, Nelemans PJ, de Graaf R, van Zwam WH. Diagnosing intracranial aneurysms with MR angiography: systematic review and meta-analysis. Stroke. 2014;45(1):119-26.
- van Gelder JM. Computed tomographic angiography for detecting cerebral aneurysms: implications of aneurysm size distribution for the sensitivity, specificity, and likelihood ratios. Neurosurgery. 2003;53(3):597-605; discussion 605-6.
- Bizjak Ž, Špiclin Ž. A Systematic Review of Deep-Learning Methods for Intracranial Aneurysm Detection in CT Angiography. Biomedicines. 2023;11(11).
- Raz N, Bick AS, Klistorner A, Spektor S, Reich DS, Ben-Hur T, et al. Physiological Correlates and Predictors of Functional Recovery After Chiasmal Decompression. J Neuroophthalmol. 2015;35(4):348-52.
- Meyer J, Diouf I, King J, Drummond K, Stylli S, Kaye A, et al. A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours. Pituitary. 2022;25(4):563-572.
- Moon CH, Hwang SC, Kim BT, Ohn YH, Park TK. Visual prognostic value of optical coherence tomography and photopic negative response in chiasmal compression. Invest Ophthalmol Vis Sci. 2011;52(11):8527-33.
- Hirai T, Ito Y, Arai M, Ota Y, Kojima T, Sato M, et al. Loss of stereopsis with optic chiasmal lesions and stereoscopic tests as a differential test. Ophthalmology. 2002;109(9):1692-702.
- Guniganti R, Kiser K, Goyal M, Reynolds MM, Van Stavern GP. Chiasmal Compression by the Third Ventricle in Obstructive Hydrocephalus: Case Report and Review of the Literature. J Pediatr Ophthalmol Strabismus. 2023;60(5):e49-e54.
- Davis SM, Donnan GA. Ischemic Penumbra: A Personal View. Cerebrovasc Dis. 2021;50(6):656-665.
- Fisher M, Albers GW. Advanced imaging to extend the therapeutic time window of acute ischemic stroke. Ann Neurol. 2013;73(1):4-9.
- Chalet L, Boutelier T, Christen T, Raguenes D, Debatisse J, Eker OF, et al. Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy. Front Cardiovasc Med. 2022;9:861913.
- Wannamaker R, Buck B, Butcher K. Multimodal CT in Acute Stroke. Curr Neurol Neurosci Rep. 2019;19(9):63.
- Heiss WD, Zaro-Weber O. Extension of therapeutic window in ischemic stroke by selective mismatch imaging. Int J Stroke. 2019;14(4):351-358.
- Mansour M. Reperfusion Therapies in Acute Ischemic Stroke Beyond the Conventional Time Window: A Narrative Review. Cureus. 2023;15(9):e45864.
- Lee E, Kang DW, Kwon SU, Kim JS. Posterior cerebral artery infarction: diffusion-weighted MRI analysis of 205 patients. Cerebrovasc Dis. 2009;28(3):298-305.
- Kim JS, Caplan LR. Clinical Stroke Syndromes. Front Neurol Neurosci. 2016;40:72-92.
- Benke T, Bodner T, Wiesen D, Karnath HO. The amnestic syndrome of posterior cerebral artery infarction. Eur J Neurol. 2022;29(10):2987-2995.
- Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173.
- Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
- Gill S, Agarwal M. Multiple Sclerosis Part 1: Essentials and the McDonald Criteria. Magn Reson Imaging Clin N Am. 2024;32(2):207-220.
- Rai P, Bathla G, Chan VEY, Bagnato F, Vattoth S, Deng F, et al. The 2024 Update to the McDonald Criteria for Multiple Sclerosis Diagnosis: A Guide for Radiologists. AJR Am J Roentgenol. 2026;226(4):e2533997.
- Tseriotis VS, Arrambide G, Carnero Contentti E, Tur C, Wattjes MP, Cortese R, et al. MRI lesion distribution criteria for MS, NMOSD and MOGAD differentiation: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2025;97(1):59-70.
- Carnero Contentti E, Okuda DT, Rojas JI, Chien C, Paul F, Alonso R. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. J Neuroimaging. 2023;33(5):688-702.
- Redenbaugh V, Chia NH, Cacciaguerra L, McCombe JA, Tillema JM, Chen JJ, et al. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS. Mult Scler. 2023;29(7):799-808.
- Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 2020;143(5):1431-1446.
- Mukherjee A, Roy D, Chakravarty A. Uncommon Non-MS Demyelinating Disorders of the Central Nervous System. Curr Neurol Neurosci Rep. 2025;25(1):45.
- Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015;28(3):193-205.
- Sinnecker T, Oberwahrenbrock T, Metz I, Zimmermann H, Pfueller CF, Harms L, et al. Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning—an ultrahigh-field MR pilot study. Eur Radiol. 2015;25(1):122-31.
- Smirniotopoulos JG, Murphy FM, Rushing EJ, Rees JH, Schroeder JW. Patterns of contrast enhancement in the brain and meninges. Radiographics. 2007;27(2):525-51.
- Bonneville F, Jäger HR, Smirniotopoulos JG. Differential Diagnosis of Intracranial Masses. . 2024.
- Lenga P, Scherer M, Peretzke R, Neher P, Jesser J, Beisse C, et al. Correlation of visual field deficits and q-ball high-resolution fiber tractography of the optic radiation for adjacently located intracerebral lesions: preliminary results from a single-center prospective study. Neurosurg Rev. 2024;47(1):31.
- Kim Y, Im S, Oh J, Jung Y, Jun SY. Detection of post-stroke visual field loss by quantification of the retrogeniculate visual pathway. J Neurol Sci. 2022;439:120297.
- Jindahra P, Petrie A, Plant GT. The time course of retrograde trans-synaptic degeneration following occipital lobe damage in humans. Brain. 2012;135(Pt 2):534-41.
- Kupersmith MJ, Vargas M, Hoyt WF, Berenstein A. Optic tract atrophy with cerebral arteriovenous malformations: direct and transsynaptic degeneration. Neurology. 1994;44(1):80-3.
- Kurokawa T, Park M, Ueda N. [Four-year changes in ganglion cell complex thickness in homonymous hemianopia]. Nippon Ganka Gakkai Zasshi. 2013;117(11):918-24.
- Guedes ME, Almeida AC, Patricio MS, Costa JM. Acquired retrograde transsynaptic degeneration. BMJ Case Rep. 2011;2011.
- Donaldson L, Margolin E. Visual fields and optical coherence tomography (OCT) in neuro-ophthalmology: Structure-function correlation. J Neurol Sci. 2021;429:118064.
- Dalman JE, Verhagen WI, Huygen PL. Cortical blindness. Clin Neurol Neurosurg. 1997;99(4):282-6.
- Mankoo D. Anton syndrome with bilateral occipital infarct: A case report. Radiol Case Rep. 2023;18(12):4461-4464.
- Petri S, Tinelli F. Visual impairment and periventricular leukomalacia in children: A systematic review. Res Dev Disabil. 2023;135:104439.
- Jacobson LK, Dutton GN. Periventricular leukomalacia: an important cause of visual and ocular motility dysfunction in children. Surv Ophthalmol. 2000;45(1):1-13.
- Khurana R, Shyamsundar K, Taank P, Singh A. Periventricular leukomalacia: an ophthalmic perspective. Med J Armed Forces India. 2021;77(2):147-153.
- Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: A clinical review. Neurology. 2019;92(24):1146-1156.
- Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol. 1988;45(7):789-93.
- Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurol. 2009;8(7):643-53.
- Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320-7.
- Liman TG, Siebert E, Endres M. Posterior reversible encephalopathy syndrome. Curr Opin Neurol. 2019;32(1):25-35.
- Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J. 2001;77(903):24-8.
- Kastrup O, Gerwig M, Frings M, Diener HC. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol. 2012;259(7):1383-9.
- Chen JJ, Chang HF, Hsu YC, Chen DL. Anton-Babinski syndrome in an old patient: a case report and literature review. Psychogeriatrics. 2015;15(1):58-61.
- Chaney KA, Rosenblum J. Commonly asked questions: imaging stroke and other types of neurovascular disorders. Expert Rev Neurother. 2014;14(3):277-86.
- Delfan N, Abbasi F, Emamzadeh N, Bahri A, Parvaresh Rizi M, Motamedi A, et al. Advancing Intracranial Aneurysm Detection: A Comprehensive Systematic Review and Meta-analysis of Deep Learning Models Performance, Clinical Integration, and Future Directions. J Clin Neurosci. 2025;136:111243.
- Shakir HJ, Davies JM, Shallwani H, Siddiqui AH, Levy EI. Carotid and Vertebral Dissection Imaging. Curr Pain Headache Rep. 2016;20(12):68.
- Ben Hassen W, Machet A, Edjlali-Goujon M, Legrand L, Ladoux A, Mellerio C, et al. Imaging of cervical artery dissection. Diagn Interv Imaging. 2014;95(12):1151-61.
- Gottesman RF, Sharma P, Robinson KA, Arnan M, Tsui M, Saber-Tehrani A, et al. Imaging characteristics of symptomatic vertebral artery dissection: a systematic review. Neurologist. 2012;18(5):255-60.
- Clark M, Unnam S, Ghosh S. A review of carotid and vertebral artery dissection. Br J Hosp Med (Lond). 2022;83(4):1-11.
- Yaghi S, Engelter S, Del Brutto VJ, Field TS, Jadhav AP, Kicielinski K, et al. Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association. Stroke. 2024;55(3):e91-e106.
- Buelens T, Scifo L, Schetgen J, Ould Hamou M, Kampouridis S, Willermain F. Internal Carotid Artery Dissection Presenting with Transient or Subclinical Horner Syndrome. Case Rep Ophthalmol. 2024;15(1):29-35.
- Bowman KM, Dawkins D, Schaefer S, Scheuermann J, Sulaimanov U, Ahmed AS, et al. Intravenous 3-Dimensional Digital Subtraction Angiography: A Noninvasive, High-Quality Alternative to Cerebral Catheter Angiography. Oper Neurosurg. 2026.
- Ozsvath RR, Casey SO, Lustrin ES, Alberico RA, Hassankhani A, Patel M. Cerebral venography: comparison of CT and MR projection venography. AJR Am J Roentgenol. 1997;169(6):1699-707.
- Farrag A, Irfan M, Guliani GK, Tariq N, Taylor RA, Suri MF, et al. Occurrence of post-acute recanalization and collateral formation in patients with cerebral venous and sinus thrombosis. A serial venographic study. Neurocrit Care. 2010;13(3):373-9.
- Matloob SA, Toma AK, Thompson SD, Gan CL, Robertson F, Thorne L, et al. Effect of venous stenting on intracranial pressure in idiopathic intracranial hypertension. Acta Neurochir (Wien). 2017;159(8):1429-1437.
- Horev A, Ben-Arie G, Walter E, Tsumi E, Regev T, Aloni E, et al. Emergent cerebral venous stenting: A valid treatment option for fulminant idiopathic intracranial hypertension. J Neurol Sci. 2023;452:120761.
- Yuan H, Nisar A, Sharan I, Arunkumar N, Chan J, Qiu E, et al. Venous manometry triage in refractory idiopathic intracranial hypertension: imaging and criteria validity. J Neurointerv Surg. 2025.
- Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995;194(3):671-80.
- Serulle Y, Miller TR, Gandhi D. Dural Arteriovenous Fistulae: Imaging and Management. Neuroimaging Clin N Am. 2016;26(2):247-58.
- Alkhaibary A, Alnefaie N, Alharbi A, Alammar H, Arishy AM, Alshaya W, et al. Intracranial dural arteriovenous fistula: a comprehensive review of the history, management, and future prospective. Acta Neurol Belg. 2023;123(2):359-366.
- Alexander MD, Darflinger R, Cooke DL, Halbach VV. Cerebral arteriovenous fistulae. Handb Clin Neurol. 2021;176:179-198.
- Barkatullah AF, Leishangthem L, Moss HE. MRI findings as markers of idiopathic intracranial hypertension. Curr Opin Neurol. 2021;34(1):75-83.
- Bidot S, Saindane AM, Peragallo JH, Bruce BB, Newman NJ, Biousse V. Brain Imaging in Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2015;35(4):400-11.
- Rehder D. Idiopathic Intracranial Hypertension: Review of Clinical Syndrome, Imaging Findings, and Treatment. Curr Probl Diagn Radiol. 2020;49(3):205-214.
- Passi N, Degnan AJ, Levy LM. MR imaging of papilledema and visual pathways: effects of increased intracranial pressure and pathophysiologic mechanisms. AJNR Am J Neuroradiol. 2013;34(5):919-24.
- Palombi D, Ciccani J, Massimi L. Idiopathic Intracranial Hypertension: Updates on Pathophysiology and Diagnosis. Adv Tech Stand Neurosurg. 2026;56:27-59.
- Kwee RM, Kwee TC. Systematic review and meta-analysis of MRI signs for diagnosis of idiopathic intracranial hypertension. Eur J Radiol. 2019;116:106-115.
- Beier D, Korsbæk JJ, Bsteh G, Macher S, Marik W, Pemp B, et al. Magnetic Resonance Imaging Signs of Idiopathic Intracranial Hypertension. JAMA Netw Open. 2024;7(7):e2420138.
- Micieli JA. Posterior Globe Flattening without Papilledema in Idiopathic Intracranial Hypertension. Neuroophthalmology. 2020;44(2):69-70.
- Albano de Guimarães J, Teixeira GC, Silva TKLD, Moura FC. Optic Disc Edema and Posterior Globe Flattening Secondary to Ocular Hypotony: Case Report and Discussion Regarding Pathophysiology and Clinical Findings. J Neuroophthalmol. 2021;41(2):e220-e222.
- Hoffmann J, Schmidt C, Kunte H, Klingebiel R, Harms L, Huppertz HJ, et al. Volumetric assessment of optic nerve sheath and hypophysis in idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2014;35(3):513-8.
- Hoffmann J, Huppertz HJ, Schmidt C, Kunte H, Harms L, Klingebiel R, et al. Morphometric and volumetric MRI changes in idiopathic intracranial hypertension. Cephalalgia. 2013;33(13):1075-84.
- Schartz D, Finkelstein AJ, Schartz E, Lingineni S, Sipple M, Williams Z, et al. Optic Nerve Sheath Dilation Is a Possible Marker of CSF Dyshomeostasis in Idiopathic Intracranial Hypertension. Clin Neuroradiol. 2025;35(2):239-245.
- Baysal B, Dogan MB, Turkyılmaz O, Yuksel Karatoprak E, Esen F. Distinctive MRI findings and clinical correlations in pediatric idiopathic intracranial hypertension: optic nerve sheath dilatation and scleral flattening as diagnostic indicators. Acta Radiol. 2026;67(2):124-132.
- Çakmak M, Karagülle M, Kaya FS, Arıcan P, Perk P, Kafadar İ. Clinical and MRI Features in Pediatric Idiopathic Intracranial Hypertension: Focus on Optic Nerve ADC Values. Childs Nerv Syst. 2025;41(1):382.
- Roemer SN, Friedrich EB, Kettner M, Rauzi M, Schub P, Kulikovski J, et al. Transorbital sonography and MRI reliability to assess optic nerve sheath diameter in idiopathic intracranial hypertension. J Neuroimaging. 2023;33(3):375-380.
- Cohen I, Kraus M, Greenberg G, Hoffmann C, Shrot S. Effect of General Anesthesia on MR Optic Nerve Sheath Diameter in the Pediatric Population. J Magn Reson Imaging. 2023;58(6):1875-1881.
- Onder H, Gocmen R, Gursoy-Ozdemir Y. Reversible transverse sinus collapse in a patient with idiopathic intracranial hypertension. J Neurointerv Surg. 2016;8(4):e16.
- Taishaku A, Ohno T, Iwata T, Shibata H, Ishida M, Aihara N. Reversible Bilateral Transverse Sinus Occlusion Treated by Lumboperitoneal Shunt in Idiopathic Intracranial Hypertension: A Case Report. NMC Case Rep J. 2023;10:327-330.
- Chagot C, Blonski M, Machu JL, Bracard S, Lacour JC, Richard S. Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management. J Obes. 2017;2017:5348928.
- Habibi P, Verdoorn J, Madhavan AA, Benson J, Brinjikji W, Johnson-Tesch B, et al. The Diagnostic Burden of Spontaneous Intracranial Hypotension: Imaging Volume and Specialists’ Involvement prior to Diagnosis. AJNR Am J Neuroradiol. 2026;47(3):830-835.
- Kranz PG, Amrhein TJ, Brinjikji W, Callen AL, Carroll I, Chazen JL, et al. Consensus Guidelines on Diagnostic Brain and Spine Imaging of Spontaneous Intracranial Hypotension. AJNR Am J Neuroradiol. 2025;46(12):2457-2467.
- Cheema S, Anderson J, Angus-Leppan H, Armstrong P, Butteriss D, Carlton Jones L, et al. Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension. J Neurol Neurosurg Psychiatry. 2023;94(10):835-843.
- Schievink WI, Dodick DW, Mokri B, Silberstein S, Bousser MG, Goadsby PJ. Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspective. Headache. 2011;51(9):1442-4.
- D’Antona L, Jaime Merchan MA, Vassiliou A, Watkins LD, Davagnanam I, Toma AK, et al. Clinical Presentation, Investigation Findings, and Treatment Outcomes of Spontaneous Intracranial Hypotension Syndrome: A Systematic Review and Meta-analysis. JAMA Neurol. 2021;78(3):329-337.
- Timpone VM, Parsons MS, Boulter DJ, Burns J, Eldaya RW, Grossberg JA, et al. ACR Appropriateness Criteria® Imaging of Suspected Intracranial Hypotension. J Am Coll Radiol. 2024;21(11S):S396-S412.
- Michali-Stolarska M, Bladowska J, Stolarski M, Sąsiadek MJ. Diagnostic Imaging and Clinical Features of Intracranial Hypotension - Review of Literature. Pol J Radiol. 2017;82:842-849.
- Dobrocky T, Rovira À. Problem Solving Disorders of CSF. . 2024.
- Smilkov E, Tolnai D, Jensen RH, Grundtvig N, Baram A, Carlsen J, et al. Optic Tract Edema on MRI in Spontaneous Intracranial Hypotension with Sagging Brain. AJNR Am J Neuroradiol. 2026.
- Leep Hunderfund AN, Mokri B. Orthostatic headache without CSF leak. Neurology. 2008;71(23):1902-6.
- Sánchez García FJ, Jornet Fayos J, Pastor Del Campo A, LLopis Calatayud JE. Brain MRI features of postdural puncture headache. Reg Anesth Pain Med. 2025;50(4):352-357.
- Schievink WI. Spontaneous spinal cerebrospinal fluid leaks. Cephalalgia. 2008;28(12):1345-56.
- Yoon YS, Khil EK, Jo SW, Lee SA, Cho SJ. Standardized spinal MRI protocol: diagnosing spontaneous intracranial hypotension and correlating with brain MRI. Eur Spine J. 2025;34(12):5402-5411.
- Yoo HM, Kim SJ, Choi CG, Lee DH, Lee JH, Suh DC, et al. Detection of CSF leak in spinal CSF leak syndrome using MR myelography: correlation with radioisotope cisternography. AJNR Am J Neuroradiol. 2008;29(4):649-54.
- Hwang SH, Kim SW, Kim DH. Efficacy of Imaging Methods in the Detection and Diagnosis of Cerebrospinal Fluid Rhinorrhea. Laryngoscope. 2023;133(6):1281-1287.
- Scoffings DJ. Imaging of Acquired Skull Base Cerebrospinal Fluid Leaks. Neuroimaging Clin N Am. 2021;31(4):509-522.
- Totten DJ, Koontz NA, Elms HL, Cumpston EC, Schneider W, Whitted C, et al. Intrathecal Gadolinium-Enhanced MR Cisternography Improves the Detection of Skull Base CSF Leaks. Otol Neurotol. 2025;46(10):1274-1279.
- Gilbert AL, Heidary G. Update on the evaluation of pediatric idiopathic intracranial hypertension. Curr Opin Ophthalmol. 2016;27(6):493-497.
- Trip SA, Wheeler-Kingshott C, Jones SJ, Li WY, Barker GJ, Thompson AJ, et al. Optic nerve diffusion tensor imaging in optic neuritis. Neuroimage. 2006;30(2):498-505.
- Smith SA, Williams ZR, Ratchford JN, Newsome SD, Farrell SK, Farrell JA, et al. Diffusion tensor imaging of the optic nerve in multiple sclerosis: association with retinal damage and visual disability. AJNR Am J Neuroradiol. 2011;32(9):1662-8.
- Lu P, Yuan T, Liu X, Tian G, Zhang J, Sha Y. Role of Diffusional Kurtosis Imaging in Differentiating Neuromyelitis Optica-Related and Multiple Sclerosis-Related Acute Optic Neuritis: Comparison With Diffusion-Weighted Imaging. J Comput Assist Tomogr. 2020;44(1):47-52.
- Olman CA, Bao P, Engel SA, Grant AN, Purington C, Qiu C, et al. Hemifield columns co-opt ocular dominance column structure in human achiasma. Neuroimage. 2018;164:59-66.
- Ahmadi K, Fracasso A, Puzniak RJ, Gouws AD, Yakupov R, Speck O, et al. Triple visual hemifield maps in a case of optic chiasm hypoplasia. Neuroimage. 2020;215:116822.
- Piper RJ, Yoong MM, Kandasamy J, Chin RF. Application of diffusion tensor imaging and tractography of the optic radiation in anterior temporal lobe resection for epilepsy: a systematic review. Clin Neurol Neurosurg. 2014;124:59-65.
- Shi J, Lu D, Pan R, Chen H, Teng H, Xu Y, et al. Applications of diffusion tensor imaging integrated with neuronavigation to prevent visual damage during tumor resection in the optic radiation area. Front Oncol. 2022;12:955418.
- Dayan M, Kreutzer S, Clark CA. Tractography of the optic radiation: a repeatability and reproducibility study. NMR Biomed. 2015;28(4):423-31.
- Kamali A, Hasan KM, Adapa P, Razmandi A, Keser Z, Lincoln J, et al. Distinguishing and quantification of the human visual pathways using high-spatial-resolution diffusion tensor tractography. Magn Reson Imaging. 2014;32(7):796-803.
- Kuchling J, Backner Y, Oertel FC, Raz N, Bellmann-Strobl J, Ruprecht K, et al. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system. Neuroimage Clin. 2018;19:538-550.
- Aoki S, Masutani Y, Abe O. [Magnetic resonance diffusion tractography in the brain—its application and limitation]. Brain Nerve. 2007;59(5):467-76.
- Rocca MA, Mesaros S, Preziosa P, Pagani E, Stosic-Opincal T, Dujmovic-Basuroski I, et al. Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study. Mult Scler. 2013;19(12):1610-7.
- Miki A, Liu GT, Modestino EJ, Liu CS, Bonhomme GR, Dobre CM, et al. Functional magnetic resonance imaging of the visual system. Curr Opin Ophthalmol. 2001;12(6):423-31.
- Ritter M, Hummer A, Ledolter AA, Holder GE, Windischberger C, Schmidt-Erfurth UM. Correspondence between retinotopic cortical mapping and conventional functional and morphological assessment of retinal disease. Br J Ophthalmol. 2019;103(2):208-215.
- Halbertsma HN, Bridge H, Carvalho J, Cornelissen FW, Ajina S. Visual Field Reconstruction in Hemianopia Using fMRI Based Mapping Techniques. Front Hum Neurosci. 2021;15:713114.
- Papanikolaou A, Keliris GA, Papageorgiou TD, Shao Y, Krapp E, Papageorgiou E, et al. Population receptive field analysis of the primary visual cortex complements perimetry in patients with homonymous visual field defects. Proc Natl Acad Sci U S A. 2014;111(16):E1656-65.
- Willis HE, Hameed J, Starling L, Kaltenbach C, Moore MJ, Khan A, et al. Voxel-Based Lesion-Symptom Mapping Localizes Residual Visual Function in Hemianopia. J Neurosci. 2025;45(9).
- Sabbah N, Sanda N, Authié CN, Mohand-Saïd S, Sahel JA, Habas C, et al. Reorganization of early visual cortex functional connectivity following selective peripheral and central visual loss. Sci Rep. 2017;7:43223.
- Julkunen L, Tenovuo O, Vorobyev V, Hiltunen J, Teräs M, Jääskeläinen SK, et al. Functional brain imaging, clinical and neurophysiological outcome of visual rehabilitation in a chronic stroke patient. Restor Neurol Neurosci. 2006;24(2):123-32.
- Chokron S, Perez C, Obadia M, Gaudry I, Laloum L, Gout O. From blindsight to sight: cognitive rehabilitation of visual field defects. Restor Neurol Neurosci. 2008;26(4-5):305-20.
- Weinberg BD, Kuruva M, Shim H, Mullins ME. Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors: From Diagnosis to Treatment. Radiol Clin North Am. 2021;59(3):349-362.
- Lequin M, Hendrikse J. Advanced MR Imaging in Pediatric Brain Tumors, Clinical Applications. Neuroimaging Clin N Am. 2017;27(1):167-190.
- Manias KA, Peet A. What is MR spectroscopy?. Arch Dis Child Educ Pract Ed. 2018;103(4):213-216.
- Ravanfar P, Loi SM, Syeda WT, Van Rheenen TE, Bush AI, Desmond P, et al. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases. Front Neurosci. 2021;15:618435.
- Guan X, Lancione M, Ayton S, Dusek P, Langkammer C, Zhang M. Neuroimaging of Parkinson’s disease by quantitative susceptibility mapping. Neuroimage. 2024;289:120547.
- Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain. 2004;127(Pt 10):2331-8.
- Sheikhbahaei S, Marcus CV, Fragomeni RS, Rowe SP, Javadi MS, Solnes LB. Whole-Body (18)F-FDG PET and (18)F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic Accuracy. J Nucl Med. 2017;58(7):1031-1036.
- Opalińska M, Sowa-Staszczak A, Wężyk K, Jagiełła J, Słowik A, Hubalewska-Dydejczyk A. Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging. J Clin Med. 2022;11(6).
- Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008;10(3):131-7.
- Daraghma M, Aswani Y, Jain S, Laudicella R, Gholamrezanezhad A, Menda Y, et al. PET/CT and Paraneoplastic Syndromes: A Comprehensive Review. Cancers (Basel). 2025;17(16).
- Chapleau M, La Joie R, Yong K, Agosta F, Allen IE, Apostolova L, et al. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet Neurol. 2024;23(2):168-177.
- Best J, Chapleau M, Rabinovici GD. Posterior cortical atrophy: clinical, neuroimaging, and neuropathological features. Expert Rev Neurother. 2023;23(3):227-236.
- Shir D, Graff-Radford J, Machulda MM, Pham NTT, Jack CR Jr, Lowe VJ, et al. Posterior cortical atrophy: Primary occipital variant. Eur J Neurol. 2022;29(7):2138-2143.
- Scapicchio C, Gabelloni M, Barucci A, Cioni D, Saba L, Neri E. A deep look into radiomics. Radiol Med. 2021;126(10):1296-1311.
- Lohmann P, Galldiks N, Kocher M, Heinzel A, Filss CP, Stegmayr C, et al. Radiomics in neuro-oncology: Basics, workflow, and applications. Methods. 2021;188:112-121.
- Wang Z, Wang L, Wang Y. Radiomics in glioma: emerging trends and challenges. Ann Clin Transl Neurol. 2025;12(3):460-477.
- Kiryu S, Akai H, Yasaka K, Tajima T, Kunimatsu A, Yoshioka N, et al. Clinical Impact of Deep Learning Reconstruction in MRI. Radiographics. 2023;43(6):e220133.
- Johnson PM, Lin DJ, Zbontar J, Zitnick CL, Sriram A, Muckley M, et al. Deep Learning Reconstruction Enables Prospectively Accelerated Clinical Knee MRI. Radiology. 2023;307(2):e220425.
- Rai P, Mark IT, Soni N, Diehn F, Messina SA, Benson JC, et al. Deep Learning-Based Acceleration in MRI: Current Landscape and Clinical Applications in Neuroradiology. AJNR Am J Neuroradiol. 2026;47(1):9-16.
- Degnan AJ, Ghobadi EH, Hardy P, Krupinski E, Scali EP, Stratchko L, et al. Perceptual and Interpretive Error in Diagnostic Radiology-Causes and Potential Solutions. Acad Radiol. 2019;26(6):833-845.
- Zhang L, Wen X, Li JW, Jiang X, Yang XF, Li M. Diagnostic error and bias in the department of radiology: a pictorial essay. Insights Imaging. 2023;14(1):163.
- Bruno MA. 256 Shades of gray: uncertainty and diagnostic error in radiology. Diagnosis (Berl). 2017;4(3):149-157.
- Ogbole GI, Soneye MA, Okorie CN, Sammet S. Intraventricular cerebrospinal fluid pulsation artifacts on low-field magnetic resonance imaging: Potential pitfall in diagnosis?. Niger Med J. 2016;57(1):59-63.
- Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821-8.
- Rowley PA, Paukner MJ, Eisenmenger LB, Field AS, Davidson RJ, Johnson SC, et al. Incidental Findings from 16,400 Brain MRI Examinations of Research Volunteers. AJNR Am J Neuroradiol. 2023;44(4):417-423.
- Soumaré A, Beguedou N, Laurent A, Brochet B, Bordes C, Mournet S, et al. Prevalence, Severity, and Clinical Management of Brain Incidental Findings in Healthy Young Adults: MRi-Share Cross-Sectional Study. Front Neurol. 2021;12:675244.
- Ivanovic V, Seiler S, Tarraf W, Crivello E, Martinez O, Lipton RB, et al. Prevalence of incidental brain MRI findings of clinical relevance in a diverse Hispanic/Latino population. J Neuroimaging. 2021;31(6):1166-1175.
- Alabousi M, Wilson E, Al-Ghetaa RK, Patlas MN. General Review on the Current Management of Incidental Findings on Cross-Sectional Imaging: What Guidelines to Use, How to Follow Them, and Management and Medical-Legal Considerations. Radiol Clin North Am. 2021;59(4):501-509.
- Hitzeman N, Cotton E. Incidentalomas: initial management. Am Fam Physician. 2014;90(11):784-9.
- Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894-904.
- Sivakumar W, Chamoun R, Nguyen V, Couldwell WT. Incidental pituitary adenomas. Neurosurg Focus. 2011;31(6):E18.
- Jung H, Yang SY, Cho KT. Suggestion of Follow-Up Period in Nonfunctioning Pituitary Incidentaloma Based on MRI Characteristics. Brain Tumor Res Treat. 2024;12(1):40-49.
- Baldo F, Marin M, Murru FM, Barbi E, Tornese G. Dealing With Brain MRI Findings in Pediatric Patients With Endocrinological Conditions: Less Is More?. Front Endocrinol (Lausanne). 2021;12:780763.
- Marin M, Murru FM, Baldo F, Tamaro G, Faleschini E, Barbi E, et al. Minimizing unnecessary brain magnetic resonance imaging in pediatric endocrinology: a retrospective cohort analysis. Front Endocrinol (Lausanne). 2024;15:1456541.
- Virarkar M, Jensen C, Klekers A, Wagner-Bartak NA, Devine CE, Lano EA, et al. Clinical importance of second-opinion interpretations of abdominal imaging studies in a cancer hospital and its impact on patient management. Clin Imaging. 2022;86:13-19.
- Eakins C, Ellis WD, Pruthi S, Johnson DP, Hernanz-Schulman M, Yu C, et al. Second opinion interpretations by specialty radiologists at a pediatric hospital: rate of disagreement and clinical implications. AJR Am J Roentgenol. 2012;199(4):916-20.
- Carter BW, Erasmus JJ, Truong MT, Shepard JO, Hofstetter W, Clarke R, et al. Quality and Value of Subspecialty Reinterpretation of Thoracic CT Scans of Patients Referred to a Tertiary Cancer Center. J Am Coll Radiol. 2017;14(8):1109-1118.
- Mehrsheikh AL, Strnad BS, Shetty AS, Itani M. Second-opinion interpretation of outside facility general ultrasound studies: rate of discrepancies and management change. Abdom Radiol (NY). 2023;48(8):2716-2723.
- Taylor GA. Perceptual errors in pediatric radiology. Diagnosis (Berl). 2017;4(3):141-147.
- Taylor GA, Voss SD, Melvin PR, Graham DA. Diagnostic errors in pediatric radiology. Pediatr Radiol. 2011;41(3):327-34.
- Berbaum KS, Franken EA Jr, Dorfman DD, Rooholamini SA, Kathol MH, Barloon TJ, et al. Satisfaction of search in diagnostic radiology. Invest Radiol. 1990;25(2):133-40.
- Berbaum KS, Franken EA Jr, Dorfman DD, Rooholamini SA, Coffman CE, Cornell SH, et al. Time course of satisfaction of search. Invest Radiol. 1991;26(7):640-8.
- Adamo SH, Gereke BJ, Shomstein S, Schmidt J. From “satisfaction of search” to “subsequent search misses”: a review of multiple-target search errors across radiology and cognitive science. Cogn Res Princ Implic. 2021;6(1):59.
- Biggs AT. Getting satisfied with “satisfaction of search”: How to measure errors during multiple-target visual search. Atten Percept Psychophys. 2017;79(5):1352-1365.
- Sajid IM, Frost K, Paul AK. ‘Diagnostic downshift’: clinical and system consequences of extrapolating secondary care testing tactics to primary care. BMJ Evid Based Med. 2022;27(3):141-148.
- Shin HJ, Costello F. Imaging the optic nerve with optical coherence tomography. Eye (Lond). 2024;38(12):2365-2379.
- Unterlauft JD, Tegetmeyer H. [Optic Nerve Head Diagnostics with Optical Coherence Tomography]. Klin Monbl Augenheilkd. 2018;235(1):47-57.
- Rebolleda G, Diez-Alvarez L, Casado A, Sánchez-Sánchez C, de Dompablo E, González-López JJ, et al. OCT: New perspectives in neuro-ophthalmology. Saudi J Ophthalmol. 2015;29(1):9-25.
- Banc A, Biousse V, Newman NJ, Kedar S. Ocular Optical Coherence Tomography in the Evaluation of Sellar and Parasellar Masses: A Review. Neurosurgery. 2023;92(1):42-67.
- Vazquez LE, Bye A, Aref AA. Recent developments in the use of optical coherence tomography for glaucoma. Curr Opin Ophthalmol. 2021;32(2):98-104.
- Nakanishi H, Akagi T, Hangai M, Kimura Y, Suda K, Kumagai KK, et al. Sensitivity and specificity for detecting early glaucoma in eyes with high myopia from normative database of macular ganglion cell complex thickness obtained from normal non-myopic or highly myopic Asian eyes. Graefes Arch Clin Exp Ophthalmol. 2015;253(7):1143-52.
- Poon LY, Wang CH, Lin PW, Wu PC. The Prevalence of Optical Coherence Tomography Artifacts in High Myopia and its Influence on Glaucoma Diagnosis. J Glaucoma. 2023;32(9):725-733.
- Akashi A, Kanamori A, Ueda K, Matsumoto Y, Yamada Y, Nakamura M. The detection of macular analysis by SD-OCT for optic chiasmal compression neuropathy and nasotemporal overlap. Invest Ophthalmol Vis Sci. 2014;55(7):4667-72.
- Monteiro MLR, Sousa RM, Araújo RB, Ferraz D, Sadiq MA, Zacharias LC, et al. Diagnostic ability of confocal near-infrared reflectance fundus imaging to detect retrograde microcystic maculopathy from chiasm compression. A comparative study with OCT findings. PLoS One. 2021;16(6):e0253323.
- Suzuki ACF, Zacharias LC, Preti RC, Cunha LP, Monteiro MLR. Circumpapillary and macular vessel density assessment by optical coherence tomography angiography in eyes with temporal hemianopia from chiasmal compression. Correlation with retinal neural and visual field loss. Eye (Lond). 2020;34(4):695-703.
- Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012;135(Pt 2):521-33.
- Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, et al. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol. 2016;263(7):1323-31.
- Chung YS, Na M, Yoo J, Kim W, Jung IH, Moon JH, et al. Optical Coherent Tomography Predicts Long-Term Visual Outcome of Pituitary Adenoma Surgery: New Perspectives From a 5-Year Follow-up Study. Neurosurgery. 2020;88(1):106-112.
- Yoo YJ, Hwang JM, Yang HK, Joo JD, Kim YH, Kim CY. Prognostic value of macular ganglion cell layer thickness for visual outcome in parasellar tumors. J Neurol Sci. 2020;414:116823.
- Witthayaweerasak J, Larpudomphun P, Kaewborisutsakul A, Oearsakul T. Structural and vascular retinal changes and visual outcomes after treatment of compressive anterior visual pathway lesions: A prospective longitudinal study. Medicine (Baltimore). 2026;105(8):e47769.
- Dal Fabbro M, Moura FC, Atihe C, Sampaio MH, Garmes HM. Optical coherence tomography in preoperative workup and visual outcome of pituitary macroadenomas. Surg Neurol Int. 2025;16:533.
- Han J, Byun MK, Lee J, Han SY, Lee JB, Han SH. Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2293-9.
- Guo T, Fu Y, Xu X, Liu X, Zhang Y, Yang H. Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy. Eur J Med Res. 2025;30(1):321.
- Costello F, Hodge W, Pan YI, Metz L, Kardon RH. Retinal nerve fiber layer and future risk of multiple sclerosis. Can J Neurol Sci. 2008;35(4):482-7.
- Huhn K, Lämmer R, Zimmermann H, Lämmer A, Waschbisch A, Utz K, et al. Retinal imaging and axonal degeneration in later onset multiple sclerosis. J Neurol Sci. 2016;370:1-6.
- Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci. 2008;49(10):4412-7.
- von Glehn F, Jarius S, Cavalcanti Lira RP, Alves Ferreira MC, von Glehn FH, Costa E Castro SM, et al. Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders. Mult Scler. 2014;20(9):1189-97.
- Ross R, Kenney R, Balcer LJ, Galetta SL, Krupp L, O’Neill KA, et al. Myelin Oligodendrocyte Glycoprotein Antibody Disease Optic Neuritis: A Structure-Function Paradox?. J Neuroophthalmol. 2024;44(2):172-177.
- Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber’s hereditary optic neuropathy. Ophthalmology. 2005;112(1):120-6.
- Andorrà M, Alba-Arbalat S, Camos-Carreras A, Gabilondo I, Fraga-Pumar E, Torres-Torres R, et al. Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis. JAMA Neurol. 2020;77(2):234-244.
- Alshareef RA, Dumpala S, Rapole S, Januwada M, Goud A, Peguda HK, et al. Prevalence and Distribution of Segmentation Errors in Macular Ganglion Cell Analysis of Healthy Eyes Using Cirrus HD-OCT. PLoS One. 2016;11(5):e0155319.
- Millington RS, Yasuda CL, Jindahra P, Jenkinson M, Barbur JL, Kennard C, et al. Quantifying the pattern of optic tract degeneration in human hemianopia. J Neurol Neurosurg Psychiatry. 2014;85(4):379-86.
- Narag JCR, Cruz FMO. Optical Coherence Tomography of the Macular Ganglion Cell Complex Demonstrating Transsynaptic Retrograde Degeneration from a Temporal Lobe Tumor: A Case Report. Acta Med Philipp. 2025;59(10):119-124.
- Vien L, DalPorto C, Yang D. Retrograde Degeneration of Retinal Ganglion Cells Secondary to Head Trauma. Optom Vis Sci. 2017;94(1):125-134.
- Eliseeva NM, Serova NK, Erichev VP, Panyushkina LA. [Structural retinal and optic nerve changes in patients with post-geniculate visual pathway damage]. Vestn Oftalmol. 2017;133(4):25-30.
- Wang F, Zhang H, Cao S, Zhou H, Xu Q, Wei S, et al. Exploring the characteristics of retrograde trans-synaptic degeneration from retinal ganglion cells loss in patients with homonymous hemianopia caused by acquired cerebral lesions. Int J Neurosci. 2026;136(2):179-188.
- Jaumandreu L, Sánchez-Gutiérrez V, Muñoz-Negrete FJ, de Juan V, Rebolleda G. Reduced Peripapillary and Macular Vessel Density in Unilateral Postgeniculate Lesions With Retrograde Transsynaptic Degeneration. J Neuroophthalmol. 2019;39(4):462-469.
- Singh P, Karkhur S, Verma V, Gupta S, Duddumpudi RTS, Agarwal R. Pituitary and Optic Tract Lesions Masquerading As Glaucoma: Highlighting Diagnostic Challenges. Cureus. 2025;17(9):e93227.
- Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Martinez-Lapiscina EH, Lagreze WA, et al. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2016;86(24):2303-9.
- Aytulun A, Cruz-Herranz A, Aktas O, Balcer LJ, Balk L, Barboni P, et al. APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies. Neurology. 2021;97(2):68-79.
- Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012;7(4):e34823.
- Schippling S, Balk LJ, Costello F, Albrecht P, Balcer L, Calabresi PA, et al. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler. 2015;21(2):163-70.
- Petzold A, Albrecht P, Balcer L, Bekkers E, Brandt AU, Calabresi PA, et al. Artificial intelligence extension of the OSCAR-IB criteria. Ann Clin Transl Neurol. 2021;8(7):1528-1542.
- Bacchetti A, Lin TY, McCormack B, Ezzedin O, Doosti R, Ahmadi G, et al. Influence of OSCAR-IB Criteria on Test-Retest Reliability of Cirrus HD-OCT Retinal Thickness Measurements in People With Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2025;12(6):e200458.
- Malmqvist L, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser C, et al. The Optic Disc Drusen Studies Consortium Recommendations for Diagnosis of Optic Disc Drusen Using Optical Coherence Tomography. J Neuroophthalmol. 2018;38(3):299-307.
- Ahuja S, Anand D, Dutta TK, Roopesh Kumar VR, Kar SS. Retinal nerve fiber layer thickness analysis in cases of papilledema using optical coherence tomography – A case control study. Clin Neurol Neurosurg. 2015;136:95-9.
- Wang JK, Kardon RH, Kupersmith MJ, Garvin MK. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(7):4069-75.
- Fraser JA, Sibony PA, Petzold A, Thaung C, Hamann S. Peripapillary Hyper-reflective Ovoid Mass-like Structure (PHOMS): An Optical Coherence Tomography Marker of Axoplasmic Stasis in the Optic Nerve Head. J Neuroophthalmol. 2021;41(4):431-441.
- Petzold A, Biousse V, Bursztyn L, Costello F, Crum A, Digre K, et al. Multirater Validation of Peripapillary Hyperreflective Ovoid Mass-like Structures (PHOMS). Neuroophthalmology. 2020;44(6):413-414.
- Fraser JA, Costello F, Hamann S. PHOMS: An apt and accurate acronym. Arch Soc Esp Oftalmol (Engl Ed). 2024;99(10):464-466.
- Khatib TZ, Safi A, Nixon TRW, Georgoulas S, Montesano G, Martin H, et al. Peripapillary Hyperreflective Ovoid Mass-Like Structures in Stickler Syndrome. Ophthalmol Retina. 2024;8(10):1013-1020.
- Saalfeld R, Hirata Choi AH, Zeni LP, Vilela MAP. Peripapillary Hyperreflective Ovoid Mass-Like Structure as an Optic Disc Pseudo-Edema Case Report and Review. Case Rep Ophthalmol Med. 2026;2026:9417297.
- Hamann S, Malmqvist L, Wegener M, Fard MA, Biousse V, Bursztyn L, et al. Young Adults With Anterior Ischemic Optic Neuropathy: A Multicenter Optic Disc Drusen Study. Am J Ophthalmol. 2020;217:174-181.
- Yazdanfard NW, Hamann S. Optic Disc Drusen in Children: An Updated Clinical and Imaging Perspective. Int Ophthalmol Clin. 2026;66(2):115-125.
- Sibony P, Kupersmith MJ, Rohlf FJ. Shape analysis of the peripapillary RPE layer in papilledema and ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2011;52(11):7987-95.
- Sibony P, Strachovsky M, Honkanen R, Kupersmith MJ. Optical coherence tomography shape analysis of the peripapillary retinal pigment epithelium layer in presumed optic nerve sheath meningiomas. J Neuroophthalmol. 2014;34(2):130-6.
- Sibony PA, Kupersmith MJ. “Paton’s Folds” Revisited: Peripapillary Wrinkles, Folds, and Creases in Papilledema. Ophthalmology. 2016;123(6):1397-9.
- Sibony PA, Kupersmith MJ, Feldon SE, Wang JK, Garvin M. Retinal and Choroidal Folds in Papilledema. Invest Ophthalmol Vis Sci. 2015;56(10):5670-80.
- Kupersmith MJ, Sibony PA, Feldon SE, Wang JK, Garvin M, Kardon R. The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds. Am J Ophthalmol. 2017;176:77-86.
- Graven-Nielsen M, Dubra A, Dodd RL, Hamann S, Moss HE. Application of novel non-invasive ophthalmic imaging to visualize peripapillary wrinkles, retinal folds and peripapillary hyperreflective ovoid mass-like structures associated with elevated intracranial pressure. Front Neurol. 2024;15:1383210.
- Zhou J, Vadhul R, Rogers D, Varma H. Diagnostic Utility of Paton’s Folds and Quantitative OCT Metrics in Pediatric Papilledema. Ophthalmology. 2026;133(5):661-667.
- Kupersmith MJ, Sibony PA, Dave S. Nonarteritic Anterior Ischemic Optic Neuropathy Induced Retinal Folds and Deformations. Invest Ophthalmol Vis Sci. 2017;58(10):4286-4291.
- Cheng JY, Hsu D, Feo A, Liu V, Mafi M, Sarraf D. Chorioretinal folds: A review and update of new and old etiologies. Surv Ophthalmol. 2026;71(2):405-422.
- Del Turco C, Rabiolo A, Carnevali A, La Spina C, Bettin P, Querques G, et al. Optical coherence tomography angiography features of chorioretinal folds: a case series. Eur J Ophthalmol. 2017;27(2):e35-e38.
- Chan NCY, Chan CKM. The use of optical coherence tomography in neuro-ophthalmology. Curr Opin Ophthalmol. 2017;28(6):552-557.
- Kardon RH. Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol. 2011;31(4):353-61.
- El Ayoubi NK, Ismail A, Sader G, Abi Chakra N, El Ahdab J, Abboud J, et al. Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis. Neurol Neuroimmunol Neuroinflamm. 2025;12(4):e200416.
- Bsteh G, Hegen H, Krajnc N, Föttinger F, Haider L, Kornek B, et al. Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis. Neurology. 2025;105(8):e214069.
- Bollo L, Pareto D, Tagliani P, Sceppacuercia S, Alberich M, Cabello S, et al. Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis. Mult Scler. 2026;32(3):279-288.
- Tan H, Yin Z, Zhangbao J, Li X, Li Y, He F, et al. Retinal nerve fiber layer thinning in multiple sclerosis: clinical implications, cognitive associations, and effects of disease-modifying therapies. J Neurol. 2025;273(1):25.
- Miscioscia A, Mainero C, Treaba CA, Silvestri E, Scialpi G, Berardi A, et al. The contribution of paramagnetic rim and cortical lesions to physical and cognitive disability at multiple sclerosis clinical onset: evaluating the power of MRI and OCT biomarkers. J Neurol. 2024;271(10):6702-6714.
- Deschamps R, Shor N, Vignal C, Guillaume J, Boudot de la Motte M, Salviat F, et al. Prospective longitudinal study on prognostic factors of visual recovery and structural change after a first episode of optic neuritis. Eur J Neurol. 2022;29(9):2781-2791.
- Thomson KL, Yeo JM, Waddell B, Cameron JR, Pal S. A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. Alzheimers Dement (Amst). 2015;1(2):136-43.
- Ashraf G, McGuinness M, Khan MA, Obtinalla C, Hadoux X, van Wijngaarden P. Retinal imaging biomarkers of Alzheimer’s disease: A systematic review and meta-analysis of studies using brain amyloid beta status for case definition. Alzheimers Dement (Amst). 2023;15(2):e12421.
- Chen S, Zhang D, Zheng H, Cao T, Xia K, Su M, et al. The association between retina thinning and hippocampal atrophy in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review. Front Aging Neurosci. 2023;15:1232941.
- Leal-Bernal C, Noriega-Ramírez S, Álvarez-Martínez JV, Cifuentes-González C, Rojas-Carabali W, Manrique-Samer A, et al. Retinal and Vascular Findings in Optical Coherence Tomography in Healthy Cognitive Patients With Alzheimer Disease Biomarkers: A Systematic Review and Meta-Analysis. Alzheimer Dis Assoc Disord. 2025;39(2):140-149.
- Nikparast F, Ganji Z, Zare H, Akbari-Sharak N. Systematic review and network meta-analysis of retinal imaging biomarkers in neurodegenerative diseases: Correlation with brain changes. Photodiagnosis Photodyn Ther. 2025;54:104632.
- Mejia-Vergara AJ, Restrepo-Jimenez P, Pelak VS. Optical Coherence Tomography in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Front Neurol. 2020;11:578698.
- Ko F, Muthy ZA, Gallacher J, Sudlow C, Rees G, Yang Q, et al. Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography. JAMA Neurol. 2018;75(10):1198-1205.
- Schroeter ML, Girbardt J, Luck T, Rodriguez FS, Plant GT, Wicklein B, et al. Retinal nerve fibre layer thickness is associated with attention and predicts risk states of dementia. Brain Commun. 2025;7(6):fcaf464.
- Pan Z, Li Z, Xie H, Huang Y, Xue CC, Wu X, et al. Reexamine the link between retinal layer thickness and cognitive function after correction of axial length: the Beijing Eye Study 2011. Graefes Arch Clin Exp Ophthalmol. 2025;263(5):1297-1305.
- Hilal S, Cheung CY, Wong TY, Schmetterer L, Chen C. Retinal parameters, cortical cerebral microinfarcts, and their interaction with cognitive impairment. Int J Stroke. 2023;18(1):70-77.
- Chrysou A, Jansonius NM, van Laar T. Retinal layers in Parkinson’s disease: A meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord. 2019;64:40-49.
- Yu JG, Feng YF, Xiang Y, Huang JH, Savini G, Parisi V, et al. Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One. 2014;9(1):e85718.
- Murueta-Goyena A, Teijeira-Portas S, Blanco Martín E, Vázquez-Picón R, Ruiz Bajo B, Bocos J, et al. Dynamics of retinal changes in early-stage Parkinson’s disease. Acta Neuropathol Commun. 2025;13(1):20.
- Koska V, Albrecht P. Inner Retinal Thickness Changes in Prevalent and Incident Parkinson Disease: A Potential Biomarker With Prognostic Value?. Neurology. 2023;101(16):685-686.
- Subramaniam MD, Aishwarya Janaki P, Abishek Kumar B, Gopalarethinam J, Nair AP, Mahalaxmi I, et al. Retinal Changes in Parkinson’s Disease: A Non-invasive Biomarker for Early Diagnosis. Cell Mol Neurobiol. 2023;43(8):3983-3996.
- Elanwar R, Al Masry H, Ibrahim A, Hussein M, Ibrahim S, Masoud MM. Retinal functional and structural changes in patients with Parkinson’s disease. BMC Neurol. 2023;23(1):330.
- Matlach J, Wagner M, Malzahn U, Schmidtmann I, Steigerwald F, Musacchio T, et al. Retinal changes in Parkinson’s disease and glaucoma. Parkinsonism Relat Disord. 2018;56:41-46.
- Douglas VP, Douglas KAA, Torun N. Optical coherence tomography angiography in neuro-ophthalmology. Curr Opin Ophthalmol. 2023;34(4):354-360.
- Bilici S, Duman R. The current clinical role of optical coherence tomography angiography in neuro-ophthalmological diseases. Taiwan J Ophthalmol. 2022;12(3):264-272.
- Kleerekooper I, Houston S, Dubis AM, Trip SA, Petzold A. Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Front Neurol. 2020;11:604049.
- Toma C, Vujosevic S. Optical coherence tomography and OCT-angiography in neurologic and neuro-ophthalmologic diseases: Current applications and future perspectives. Handb Clin Neurol. 2026;218:13-32.
- Rao HL, Pradhan ZS, Suh MH, Moghimi S, Mansouri K, Weinreb RN. Optical Coherence Tomography Angiography in Glaucoma. J Glaucoma. 2020;29(4):312-321.
- Ling L, Ji K, Xie L, Gao F, Zhang Q, Xing Y, et al. Optical Coherence Tomography Angiography Assessment of the Peripapillary Vessel Density and Structure in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy: A Meta-Analysis. Biomed Res Int. 2020;2020:1359120.
- Al-Nashar HY, Hemeda S. Assessment of peripapillary vessel density in acute non-arteritic anterior ischemic optic neuropathy. Int Ophthalmol. 2020;40(5):1269-1276.
- Su Y, Zhang S, Zhang G, Liu Y, Du Z, Li D, et al. Quantification of peripapillary vessel density in non-arteritic anterior ischemic optic neuropathy patients with optical coherence tomography angiography. Quant Imaging Med Surg. 2022;12(2):1549-1557.
- Anvari P, Sardarinia M, Zand A, Aghdam KA, Falavarjani KG. Accuracy of peripapillary OCTA in patients with acute nonarteritic anterior ischemic optic neuropathy. Can J Ophthalmol. 2023;58(6):577-581.
- Aghsaei Fard M, Ghahvechian H, Subramanian PS. Follow-up of Nonarteritic Anterior Ischemic Optic Neuropathy With Optical Coherence Tomography Angiography. J Neuroophthalmol. 2021;41(4):e433-e439.
- Pugazhendhi S, Yu M, Zhou G, Chen Y, Wang R, Liao YJ. Peripapillary and macular microvasculature features of non-arteritic anterior ischemic optic neuropathy. Front Med (Lausanne). 2022;9:1033838.
- Liu CH, Kao LY, Sun MH, Wu WC, Chen HS. Retinal Vessel Density in Optical Coherence Tomography Angiography in Optic Atrophy after Nonarteritic Anterior Ischemic Optic Neuropathy. J Ophthalmol. 2017;2017:9632647.
- Fard MA, Ghahvechian H, Sahrayan A, Subramanian PS. Early Macular Vessel Density Loss in Acute Ischemic Optic Neuropathy Compared to Papilledema: Implications for Pathogenesis. Transl Vis Sci Technol. 2018;7(5):10.
- Rodriguez Torres Y, Lee P, Mihlstin M, Tomsak RL. Correlation Between Optic Disc Peripapillary Capillary Network and Papilledema Grading in Patients With Idiopathic Intracranial Hypertension: A Study of Optical Coherence Tomography Angiography. J Neuroophthalmol. 2021;41(1):48-53.
- Remolí-Sargues L, Monferrer-Adsuara C, López-Salvador B, García-Villanueva C, Gracia-García A, Castro-Navarro V, et al. Optical coherence tomography angiography analysis in patients with intracranial hypertension. Eur J Ophthalmol. 2024;34(5):1586-1593.
- El-Haddad NSEM, Ismael SA, El-Wahab AA, Shalaby S, Farag MMA, Mohammd NS, et al. Optic disc vessel density changes after shunt surgery in idiopathic intracranial hypertension. Photodiagnosis Photodyn Ther. 2023;42:103625.
- He Y, Karanjia R, Zhang X, Wanderer D, Walker E, Lee SH, et al. Optic Nerve Vasculature and Countermeasure Assessment in a Bedrest Analogue of Spaceflight-Associated Neuro-Ocular Syndrome. Am J Ophthalmol. 2025;278:317-327.
- Cesareo M, Giannini C, Di Marino M, Aloe G, Martucci A, Aiello F, et al. Optical coherence tomography angiography in the multimodal assessment of the retinal posterior pole in autosomal dominant optic atrophy. Acta Ophthalmol. 2022;100(3):e798-e806.
- Costello F, Rothenbuehler SP, Sibony PA, Hamann S. Diagnosing Optic Disc Drusen in the Modern Imaging Era: A Practical Approach. Neuroophthalmology. 2021;45(1):1-16.
- Nefzi D, Chaabani L, Jouini A, Abroug N, Ksiaa I, Khairallah M. Papillary optical coherence tomography angiography in optic neuropathies. Tunis Med. 2024;102(10):653-658.
- Lauermann JL, Woetzel AK, Treder M, Alnawaiseh M, Clemens CR, Eter N, et al. Prevalences of segmentation errors and motion artifacts in OCT-angiography differ among retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2018;256(10):1807-1816.
- Hu X, Shang K, Chen X, Sun X, Dai Y. Clinical features of microvasculature in subzones of parapapillary atrophy in myopic eyes: an OCT-angiography study. Eye (Lond). 2021;35(2):455-463.
- Holmen IC, Konda SM, Pak JW, McDaniel KW, Blodi B, Stepien KE, et al. Prevalence and Severity of Artifacts in Optical Coherence Tomographic Angiograms. JAMA Ophthalmol. 2020;138(2):119-126.
- Kamalipour A, Moghimi S, Hou H, Penteado RC, Oh WH, Proudfoot JA, et al. OCT Angiography Artifacts in Glaucoma. Ophthalmology. 2021;128(10):1426-1437.
- Turski CA, Holz FG, Brinkmann CK. Inter-Device Comparison of Blue-Light Autofluorescence in Optic Disc Drusen. Ophthalmologica. 2020;243(2):110-119.
- Lopez JM, Rabinovich M, Mehanna CJ, Ricciotti G, Crincoli E, Semoun O, et al. Retro-mode imaging for the diagnosis of optic disc drusen: a case series. Arch Soc Esp Oftalmol (Engl Ed). 2024;99(5):187-194.
- Pipelart V, Leroux B, Leruez S, Henni S, Navasiolava N, Martin L, et al. A study of optic nerve head drusen in 38 pseudoxanthoma elasticum (PXE) patients (64 eyes). Location of optic nerve head drusen in PXE. J Fr Ophtalmol. 2019;42(3):262-268.
- Li Y, Dai S. Clinical approach for suspected optic disc swelling in children: recommendations based on a six-year review. Clin Exp Optom. 2023;106(7):793-799.
- Pineles SL, Arnold AC. Fluorescein angiographic identification of optic disc drusen with and without optic disc edema. J Neuroophthalmol. 2012;32(1):17-22.
- Tarhan M, Halfwassen C, Meller D, Bechrakis NE, Rahal A. [Importance of fluorescein angiography for differentiating between early papilledema and papillitis]. Ophthalmologie. 2024;121(2):135-140.
- Elhusseiny AM, Fong JW, Hsu C, Grigorian F, Grigorian AP, Soliman MK, et al. Oral Fluorescein Angiography for the Diagnosis of Papilledema Versus Pseudopapilledema in Children. Am J Ophthalmol. 2023;245:8-13.
- Heinz C, Kogelboom K, Heiligenhaus A. Influence of optic disc leakage on objective optic nerve head assessment in patients with uveitis. Graefes Arch Clin Exp Ophthalmol. 2016;254(2):361-4.
- Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, et al. Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis. J Neuroophthalmol. 2018;38(3):276-281.
- Hayreh SS. Pathogenesis of optic disc edema in raised intracranial pressure. Prog Retin Eye Res. 2016;50:108-44.
- Arnold AC, Hepler RS. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;117(2):222-30.
- Arnold AC. Fluorescein angiographic characteristics of the optic disc in ischemic and glaucomatous optic neuropathy. Curr Opin Ophthalmol. 1995;6(2):30-5.
- Shin SY, Kim DS, Ko MK. Fluorescein angiographic features of choroidal insufficiency in anterior ischemic optic neuropathy. Korean J Ophthalmol. 1999;13(2):100-4.
- Oto S, Yilmaz G, Cakmakci S, Aydin P. Indocyanine green and fluorescein angiography in nonarteritic anterior ischemic optic neuropathy. Retina. 2002;22(2):187-91.
- Kim MK, Kim US. Analysis of Fundus Photography and Fluorescein Angiography in Nonarteritic Anterior Ischemic Optic Neuropathy and Optic Neuritis. Korean J Ophthalmol. 2016;30(4):289-94.
- Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology. 2003;110(1):15-21; quiz 22-3.
- Desmettre T, Cohen SY, Devoisselle JM, Gaudric A. [Current uses and indications for indocyanine green angiography]. J Fr Ophtalmol. 2011;34(8):568-82.
- Fineman MS, Maguire JI, Fineman SW, Benson WE. Safety of indocyanine green angiography during pregnancy: a survey of the retina, macula, and vitreous societies. Arch Ophthalmol. 2001;119(3):353-5.
- Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol. 2007;27(2-3):173-82.
- Gans MS, Byrne SF, Glaser JS. Standardized A-scan echography in optic nerve disease. Arch Ophthalmol. 1987;105(9):1232-6.
- Atta HR. Imaging of the optic nerve with standardised echography. Eye (Lond). 1988;2 ( Pt 4):358-66.
- Coppola A, Abbinante G, De Pascale I, Gagliardi V, Salerno G, Pellegrino A, et al. Ocular Ultrasound in the Diagnosis of Optic Neuropathies: A Review of the Literature. J Pers Med. 2024;14(9).
- Spector RH. Echographic diagnosis of dural carotid-cavernous sinus fistulas. Am J Ophthalmol. 1991;111(1):77-83.
- Pansell J, Bell M, Rudberg P, Friman O, Cooray C. Optic nerve sheath diameter measurement by ultrasound: Evaluation of a standardized protocol. J Neuroimaging. 2022;32(1):104-110.
- Montgomery SP, Moore B, Hampton SM, Macy G, Li W, Bronshteyn YS. Optic Nerve Sheath Point of Care Ultrasound: Image Acquisition. J Vis Exp. 2023.
- Bhargava V, Tawfik D, Tan YJ, Dunbar T, Haileselassie B, Su E. Ultrasonographic Optic Nerve Sheath Diameter Measurement to Detect Intracranial Hypertension in Children With Neurological Injury: A Systematic Review. Pediatr Crit Care Med. 2020;21(9):e858-e868.
- Hirzallah MI, Lochner P, Hafeez MU, Lee AG, Krogias C, Dongarwar D, et al. Quality assessment of optic nerve sheath diameter ultrasonography: Scoping literature review and Delphi protocol. J Neuroimaging. 2022;32(5):808-824.
- Zoica BS, Chalattil B. Measuring optic nerve sheath diameter in children: a simple ultrasound protocol for ICP assessment. Front Pediatr. 2025;13:1741048.
- Hua Y, Wang J, Li Y, Shen Y, Jiang L, Wu J. Application of ultrasound measurement of optic nerve sheath diameter to guide hyperosmolar therapy in children with intracranial hypertension. Front Pediatr. 2025;13:1632992.
- Ho J, Castro DP, Castro LC, Chen Y, Liu J, Mattox C, et al. Clinical assessment of mirror artifacts in spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51(7):3714-20.
- Yadav SK, Kafieh R, Zimmermann HG, Kauer-Bonin J, Nouri-Mahdavi K, Mohammadzadeh V, et al. Intraretinal Layer Segmentation Using Cascaded Compressed U-Nets. J Imaging. 2022;8(5).
- Engelmann J, Burke J, Hamid C, Reid-Schachter M, Pugh D, Dhaun N, et al. Choroidalyzer: An Open-Source, End-to-End Pipeline for Choroidal Analysis in Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 2024;65(6):6.
- Coscas G, Lupidi M, Coscas F. Image Analysis of Optical Coherence Tomography Angiography. Dev Ophthalmol. 2016;56:30-6.
- Tan BB, Natividad M, Chua KC, Yip LW. Comparison of retinal nerve fiber layer measurement between 2 spectral domain OCT instruments. J Glaucoma. 2012;21(4):266-73.
- Kenney R, Liu M, Hasanaj L, Joseph B, Al-Hassan AA, Balk L, et al. Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort. J Neuroophthalmol. 2022;42(4):442-453.
- Pearce JG, Maddess T. Inter-visit Test-Retest Variability of OCT in Glaucoma. Optom Vis Sci. 2017;94(3):404-410.
- Wadhwani M, Bali SJ, Satyapal R, Angmo D, Sharma R, Pandey V, et al. Test-retest variability of retinal nerve fiber layer thickness and macular ganglion cell-inner plexiform layer thickness measurements using spectral-domain optical coherence tomography. J Glaucoma. 2015;24(5):e109-15.
- Savini G, Carbonelli M, Parisi V, Barboni P. Repeatability of optic nerve head parameters measured by spectral-domain OCT in healthy eyes. Ophthalmic Surg Lasers Imaging. 2011;42(3):209-15.
- Abadia B, Ferreras A, Calvo P, Fogagnolo P, Figus M, Pajarin AB. Effect of the Eye Tracking System on the Reproducibility of Measurements Obtained With Spectral-domain Optical Coherence Tomography in Glaucoma. J Glaucoma. 2017;26(7):638-645.
- Li X, Lei CS, Ning R, Liu L, Chen A, Yang X, et al. Repeatability and reproducibility of a new spectral-domain optical coherence tomography biometer and agreement with swept-source optical coherence tomography based biometer. Eye Vis (Lond). 2025;12(1):6.
- Tomita R, Rawlyk B, Sharpe GP, Hutchison DM, Shuba LM, Nicolela MT, et al. Progressive Changes in the Neuroretinal Rim and Retinal Nerve Fiber Layer in Glaucoma: Impact of Baseline Values and Floor Effects. Ophthalmology. 2024;131(6):700-707.
- Wong D, Chua J, Hemelings R, Tan B, Zhang C, Ling T, et al. Update on the structure-function relationship in glaucoma. Surv Ophthalmol. 2026.
- Braun M, Saini C, Sun JA, Shen LQ. The Role of Optical Coherence Tomography Angiography in Glaucoma. Semin Ophthalmol. 2024;39(6):412-423.
- Šuštar Habjan M, Bach M, van Genderen MM, Li S, Mizota A, Nilsson J, et al. ISCEV standard for clinical visual evoked potentials (2025 update). Doc Ophthalmol. 2025;151(2):97-112.
- Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, et al. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016;133(1):1-9.
- Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Tormene AP, et al. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol. 2010;120(1):111-9.
- Yap GH, Chen LY, Png R, Loo JL, Tow S, Mathur R, et al. Clinical value of electrophysiology in determining the diagnosis of visual dysfunction in neuro-ophthalmology patients. Doc Ophthalmol. 2015;131(3):189-96.
- Jurkute N, Robson AG. Electrophysiology in neuro-ophthalmology. Handb Clin Neurol. 2021;178:79-96.
- Elgohary AA, Heinrich SP. Minor effect of inaccurate fixation on VEP-based acuity estimates. Doc Ophthalmol. 2021;142(2):275-282.
- Mermeklieva EA. Reference values of pattern reversal visual evoked potentials in Bulgarian population. Eur J Ophthalmol. 2019;29(6):600-605.
- You Y, Klistorner A, Thie J, Graham SL. Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis. Invest Ophthalmol Vis Sci. 2011;52(9):6911-8.
- Alshuaib WB. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis. Electromyogr Clin Neurophysiol. 2000;40(4):243-52.
- Filgueiras TG, Oyamada MK, Hokazono K, Cunha LP, Apóstolos-Pereira SL, Callegaro D, et al. Comparison of Visual Evoked Potentials in Patients Affected by Optic Neuritis From Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder. J Neuroophthalmol. 2022;42(1):e32-e39.
- Ringelstein M, Harmel J, Zimmermann H, Brandt AU, Paul F, Haarmann A, et al. Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders. Neurology. 2020;94(4):e407-e418.
- Vural G, Gumusyayla S, Karakoyunlu Eren F, Barakli S, Demir Unal E, Neselioglu S, et al. Relationship between pattern reversal visual evoked potential P100 wave latency and dysfunctional HDL in patients with multiple sclerosis subjected to an optic neuritis attack: A case-control study. Medicine (Baltimore). 2024;103(6):e37115.
- Alshowaeir D, Yiannikas C, Garrick R, Parratt J, Barnett MH, Graham SL, et al. Latency of multifocal visual evoked potentials in nonoptic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions. Invest Ophthalmol Vis Sci. 2014;55(6):3758-64.
- Klistorner A, Triplett JD, Barnett MH, Yiannikas C, Barton J, Parratt J, et al. Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies. J Clin Neurophysiol. 2021;38(3):186-191.
- Holder GE. The effects of chiasmal compression on the pattern visual evoked potential. Electroencephalogr Clin Neurophysiol. 1978;45(2):278-80.
- Acheson J. Optic nerve and chiasmal disease. J Neurol. 2000;247(8):587-96.
- Sirek S, Kolonko A, Pojda-Wilczek D. Visual evoked potentials as a method for the prospective assessment of tacrolimus neurotoxicity in patients after kidney transplantation. Doc Ophthalmol. 2022;145(3):197-209.
- Hamilton R, Bach M, Heinrich SP, Hoffmann MB, Odom JV, McCulloch DL, et al. VEP estimation of visual acuity: a systematic review. Doc Ophthalmol. 2021;142(1):25-74.
- Jayaraman M, Ambika S, Gandhi RA, Bassi SR, Ravi P, Sen P. Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma. Doc Ophthalmol. 2010;121(3):197-204.
- Sousa RM, Oyamada MK, Cunha LP, Monteiro MLR. Multifocal Visual Evoked Potential in Eyes With Temporal Hemianopia From Chiasmal Compression: Correlation With Standard Automated Perimetry and OCT Findings. Invest Ophthalmol Vis Sci. 2017;58(11):4436-4449.
- Danesh-Meyer HV, Carroll SC, Gaskin BJ, Gao A, Gamble GD. Correlation of the multifocal visual evoked potential and standard automated perimetry in compressive optic neuropathies. Invest Ophthalmol Vis Sci. 2006;47(4):1458-63.
- Lachowicz E, Lubiński W, Gosławski W, Andrysiak-Mamos E, Kaźmierczyk-Puchalska A, Syrenicz A. The electrophysiological tests in the early detection of the visual pathway dysfunction in patients with microadenoma. Doc Ophthalmol. 2021;143(2):115-127.
- Baker RS, Schmeisser ET, Epstein AD. Visual system electrodiagnosis in neurologic disease of childhood. Pediatr Neurol. 1995;12(2):99-110.
- Hartmann EE. Infant visual development: an overview of studies using visual evoked potential measures from Harter to the present. Int J Neurosci. 1995;80(1-4):203-35.
- Gottlob I, Fendick MG, Guo S, Zubcov AA, Odom JV, Reinecke RD. Visual acuity measurements by swept spatial frequency visual-evoked-cortical potentials (VECPs): clinical application in children with various visual disorders. J Pediatr Ophthalmol Strabismus. 1990;27(1):40-7.
- Thompson DA, Møller H, Russell-Eggitt I, Kriss A. Visual acuity in unilateral cataract. Br J Ophthalmol. 1996;80(9):794-8.
- Straßer T, Leinberger DT, Hillerkuss D, Zrenner E, Zobor D. Comparison of CRT and LCD monitors for objective estimation of visual acuity using the sweep VEP. Doc Ophthalmol. 2022;145(2):133-145.
- Somers A, Casteels K, Van Roie E, Spileers W, Casteels I. Non-organic visual loss in children: prospective and retrospective analysis of associated psychosocial problems and stress factors. Acta Ophthalmol. 2016;94(5):e312-6.
- Neveu MM, Jeffery G, Burton LC, Sloper JJ, Holder GE. Age-related changes in the dynamics of human albino visual pathways. Eur J Neurosci. 2003;18(7):1939-49.
- Liasis A, Handley SE, Nischal KK. Occipital Petalia and Albinism: A Study of Interhemispheric VEP Asymmetries in Albinism with No Nystagmus. J Clin Med. 2019;8(6).
- Duffau H. Intraoperative monitoring of visual function. Acta Neurochir (Wien). 2011;153(10):1929-30.
- Schumann P, Kokemüller H, Tavassol F, Lindhorst D, Lemound J, Essig H, et al. Optic nerve monitoring. Craniomaxillofac Trauma Reconstr. 2013;6(2):75-86.
- Jashek-Ahmed F, Cabrilo I, Bal J, Sanders B, Grieve J, Dorward NL, et al. Intraoperative monitoring of visual evoked potentials in patients undergoing transsphenoidal surgery for pituitary adenoma: a systematic review. BMC Neurol. 2021;21(1):287.
- Zhu H, Qiao N, Yang X, Li C, Ma G, Kang J, et al. The clinical application of intraoperative visual evoked potential in recurrent craniopharyngiomas resected by extended endoscopic endonasal surgery. Clin Neurol Neurosurg. 2022;214:107149.
- Hayashi H, Kawaguchi M. Intraoperative monitoring of flash visual evoked potential under general anesthesia. Korean J Anesthesiol. 2017;70(2):127-135.
- Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, et al. ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol. 2022;144(3):165-177.
- Thompson DA, Bach M, McAnany JJ, Šuštar Habjan M, Viswanathan S, Robson AG. ISCEV standard for clinical pattern electroretinography (2024 update). Doc Ophthalmol. 2024;148(2):75-85.
- Holder GE. Electrophysiological assessment of optic nerve disease. Eye (Lond). 2004;18(11):1133-43.
- Marmoy OR, Viswanathan S. Clinical electrophysiology of the optic nerve and retinal ganglion cells. Eye (Lond). 2021;35(9):2386-2405.
- McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130(1):1-12.
- Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118(1):69-77.
- Baker RA, Leo SM, Clowes WIN, Chow I, Jiang X, Georgiou AL, et al. ISCEV standard full-field ERG reference limits from 407 healthy subjects, derived from transference and validation of reference data between electrode types and centres. Doc Ophthalmol. 2025;150(2):47-64.
- Frishman L, Sustar M, Kremers J, McAnany JJ, Sarossy M, Tzekov R, et al. ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc Ophthalmol. 2018;136(3):207-211.
- Leo SM, Neveu MM, Yu-Wai-Man P, Mahroo OA, Robson AG. The diagnostic accuracy of photopic negative responses evoked by broadband and chromatic stimuli in a clinically heterogeneous population. Doc Ophthalmol. 2023;147(3):165-177.
- Jolly JK, Grigg JR, McKendrick AM, Fujinami K, Cideciyan AV, Thompson DA, et al. ISCEV and IPS guideline for the full-field stimulus test (FST). Doc Ophthalmol. 2024;148(1):3-14.
- Bach M, Brigell MG, Hawlina M, Holder GE, Johnson MA, McCulloch DL, et al. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol. 2013;126(1):1-7.
- Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M. ISCEV standard for clinical pattern electroretinography—2007 update. Doc Ophthalmol. 2007;114(3):111-6.
- Holder GE. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res. 2001;20(4):531-61.
- Porciatti V, Chou TH. Modeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies. Cells. 2021;10(6).
- Asanad S, Karanjia R. Pattern Electroretinogram. . 2026.
- Monsalve P, Ren S, Jiang H, Wang J, Kostic M, Gordon P, et al. Retinal ganglion cell function in recovered optic neuritis: Faster is not better. Clin Neurophysiol. 2018;129(9):1813-1818.
- Thompson DA, Prise KL, Tucker L, Roche D, Bowman R, Evans BEW, et al. Predicting OCT retinal ganglion cell volume from pattern ERGs and VEPs in children with suspected optic neuropathy in a tertiary referral setting. BMJ Open Ophthalmol. 2025;10(1).
- Karaśkiewicz J, Penkala K, Mularczyk M, Lubiński W. Evaluation of retinal ganglion cell function after intraocular pressure reduction measured by pattern electroretinogram in patients with primary open-angle glaucoma. Doc Ophthalmol. 2017;134(2):89-97.
- Roy R, Dutta Majumder P. Current understanding of acute zonal occult outer retinopathy (AZOOR). Indian J Ophthalmol. 2024;72(7):935-937.
- Tsang SH, Sharma T. Acute Zonal Occult Outer Retinopathy (AZOOR) and Related Diseases. Adv Exp Med Biol. 2018;1085:233-237.
- Lee AG, Prager TC. Acute zonal occult outer retinopathy. Acta Ophthalmol Scand. 1996;74(1):93-5.
- Holz FG, Kim RY, Schwartz SD, Harper CA, Wroblewski J, Arden GB, et al. Acute zonal occult outer retinopathy (AZOOR) associated with multifocal choroidopathy. Eye (Lond). 1994;8 ( Pt 1):77-83.
- Miyake Y, Horiguchi M, Tomita N, Kondo M, Tanikawa A, Takahashi H, et al. Occult macular dystrophy. Am J Ophthalmol. 1996;122(5):644-53.
- Miyake Y, Tsunoda K. Occult macular dystrophy. Jpn J Ophthalmol. 2015;59(2):71-80.
- Tsang SH, Sharma T. Occult Macular Dystrophy. Adv Exp Med Biol. 2018;1085:103-104.
- Toland A. Case Report: Occult Macular Dystrophy. Optom Vis Sci. 2022;99(4):405-412.
- Kominami A, Ueno S, Kominami T, Nakanishi A, Ito Y, Fujinami K, et al. Case of cone dystrophy with normal fundus appearance associated with biallelic POC1B variants. Ophthalmic Genet. 2018;39(2):255-262.
- Langwińska-Wośko E, Szulborski K, Broniek-Kowalik K. Late onset cone dystrophy. Doc Ophthalmol. 2010;120(3):215-8.
- Sun Z, Yang L, Li H, Zou X, Wang L, Wu S, et al. Clinical and genetic analysis of the ABCA4 gene associated retinal dystrophy in a large Chinese cohort. Exp Eye Res. 2021;202:108389.
- Hoffmann MB, Bach M, Kondo M, Li S, Walker S, Holopigian K, et al. ISCEV standard for clinical multifocal electroretinography (mfERG) (2021 update). Doc Ophthalmol. 2021;142(1):5-16.
- Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, et al. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol. 2012;124(1):1-13.
- Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, et al. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol. 2008;116(1):1-11.
- Robson AG, Nilsson J, Li S, Jalali S, Fulton AB, Tormene AP, et al. ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol. 2018;136(1):1-26.
- Lyons JS. Non-familial occult macular dystrophy. Doc Ophthalmol. 2005;111(1):49-56.
- Wildberger H, Niemeyer G, Junghardt A. Multifocal electroretinogram (mfERG) in a family with occult macular dystrophy (OMD). Klin Monbl Augenheilkd. 2003;220(3):111-5.
- Kim YG, Baek SH, Moon SW, Lee HK, Kim US. Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy. Acta Ophthalmol. 2011;89(1):e52-6.
- Miyake Y. Review of Four Refined Clinical Entities in Hereditary Retinal Disorders from Japan. Int J Mol Sci. 2025;26(11).
- Nishiguchi KM, Aoki M, Nakazawa T, Abe T. Macular degeneration as a common cause of visual loss in spinocerebellar ataxia type 1 (SCA1) patients. Ophthalmic Genet. 2019;40(1):49-53.
- Marmor MF. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG. Am J Ophthalmol. 2005;140(5):894-5.
- So SC, Hedges TR, Schuman JS, Quireza ML. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging. 2003;34(3):251-8.
- Moschos MN, Moschos MM, Apostolopoulos M, Mallias JA, Bouros C, Theodossiadis GP. Assessing hydroxychloroquine toxicity by the multifocal ERG. Doc Ophthalmol. 2004;108(1):47-53.
- Couturier A, Giocanti-Aurégan A, Dupas B, Girmens JF, Le Mer Y, Massamba N, et al. [Update on recommendations for screening for hydroxychloroquine retinopathy]. J Fr Ophtalmol. 2017;40(9):793-800.
- Mohapatra A, Gupta P, Ratra D. Accelerated hydroxychloroquine toxic retinopathy. Doc Ophthalmol. 2024;148(1):37-45.
- Lee CN, Wafa HA, Murphy G, Galloway J, Mahroo OA, Jackson TL. Novel electroretinography devices to detect hydroxychloroquine retinopathy: study protocol for a diagnostic accuracy and feasibility study. BMJ Open Ophthalmol. 2024;9(1).
- Goldstein SM, Syed NA, Milam AH, Maguire AM, Lawton TJ, Nichols CW. Cancer-associated retinopathy. Arch Ophthalmol. 1999;117(12):1641-5.
- Ohguro H, Takaya T, Ogawa K, Suzuki J, Nakagawa T. [Cancer-associated retinopathy]. Nippon Ganka Gakkai Zasshi. 1997;101(4):283-7.
- Singh D, Tripathy K. Cancer-Associated Retinopathy. . 2026.
- Kim RY, Retsas S, Fitzke FW, Arden GB, Bird AC. Cutaneous melanoma-associated retinopathy. Ophthalmology. 1994;101(11):1837-43.
- Tajfirouz D, Chen JJ. Paraneoplastic vision loss. Handb Clin Neurol. 2024;200:203-210.
- Mukundan A, Sobrin L. Paraneoplastic Syndromes. Ocul Immunol Inflamm. 2026;34(2):403-407.
- Constable PA, Bach M, Frishman LJ, Jeffrey BG, Robson AG. ISCEV Standard for clinical electro-oculography (2017 update). Doc Ophthalmol. 2017;134(1):1-9.
- Brigell M, Bach M, Barber C, Kawasaki K, Kooijman A. Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision. Calibration Standard Committee of the International Society for Clinical Electrophysiology of Vision (ISCEV). Doc Ophthalmol. 1998;95(1):1-14.
- Marmor MF, Brigell MG, McCulloch DL, Westall CA, Bach M. ISCEV standard for clinical electro-oculography (2010 update). Doc Ophthalmol. 2011;122(1):1-7.
- Brown M, Marmor M, Vaegan, Zrenner E, Brigell M, Bach M. ISCEV Standard for Clinical Electro-oculography (EOG) 2006. Doc Ophthalmol. 2006;113(3):205-12.
- Constable PA, Ngo D, Quinn S, Thompson DA. A meta-analysis of clinical electro-oculography values. Doc Ophthalmol. 2017;135(3):219-232.
- Creel DJ. The electrooculogram. Handb Clin Neurol. 2019;160:495-499.
- Tsang SH, Sharma T. Best Vitelliform Macular Dystrophy. Adv Exp Med Biol. 2018;1085:157-158.
- Tripathy K, Salini B. Best Disease. . 2026.
- Ratra D, Karra A. Unilateral best vitelliform macular dystrophy- a case series. Doc Ophthalmol. 2025;150(2):111-116.
- Tatemoto Y, Hayashi T, Mizobuchi K, Den S, Nakano T. Best vitelliform macular dystrophy caused by a BEST1 p.(Ser246Asn) variant coexisting with diabetic retinopathy. Doc Ophthalmol. 2026;152(3):393-400.
- Albuainain A, Alhatlan HM, Alkhars W. A novel variant of autosomal recessive best vitelliform macular dystrophy and management of early-onset complications. Saudi J Ophthalmol. 2021;35(2):159-163.
- Stingl K, Stingl K, Nowomiejska K, Kuehlewein L, Kohl S, Kempf M, et al. Clinical Protocols for the Evaluation of Rod Function. Ophthalmologica. 2021;244(5):396-407.
- Bakdalieh A, Khawaja LM, Yu M. Dark Adaptometry as a Diagnostic Tool in Retinal Diseases: Mechanisms and Clinical Utility. J Clin Med. 2025;14(11).
- Nigalye AK, Hess K, Pundlik SJ, Jeffrey BG, Cukras CA, Husain D. Dark Adaptation and Its Role in Age-Related Macular Degeneration. J Clin Med. 2022;11(5).
- Chew EY, Cukras C, Duncan JL, Dysli C, He Y, Henry E, et al. Assessing structure - Function relationships in non-neovascular age-related macular degeneration. Exp Eye Res. 2025;255:110349.
- Verghese AP, Lasalle CC, Ramsey DJ. Dark Adaptometry Kinetics Differentiates Age-Related Macular Degeneration from Central Serous Chorioretinopathy. Ophthalmol Sci. 2025;5(6):100835.
- Ansari G, Oertli J, Mächler L, Lipsky T, Jeffrey BG, Cukras CA, et al. Parafoveal Dark Adaptation in Early and Intermediate Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2026;67(5):74.
- Berson EL. Visual function testing: clinical correlations. J Clin Neurophysiol. 1994;11(5):472-81.
- Longhin E, Convento E, Pilotto E, Bonin G, Vujosevic S, Kotsafti O, et al. Static and dynamic retinal fixation stability in microperimetry. Can J Ophthalmol. 2013;48(5):375-80.
- Morales MU, Saker S, Wilde C, Pellizzari C, Pallikaris A, Notaroberto N, et al. Reference Clinical Database for Fixation Stability Metrics in Normal Subjects Measured with the MAIA Microperimeter. Transl Vis Sci Technol. 2016;5(6):6.
- Schönbach EM, Strauss RW, Ibrahim MA, Janes JL, Cideciyan AV, Birch DG, et al. The Effect of Attention on Fixation Stability During Dynamic Fixation Testing in Stargardt Disease. Am J Ophthalmol. 2020;217:305-316.
- Pfau M, Jolly JK, Wu Z, Denniss J, Lad EM, Guymer RH, et al. Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials. Prog Retin Eye Res. 2021;82:100907.
- Scuderi L, Gattazzo I, de Paula A, Iodice CM, Di Tizio F, Perdicchi A. Understanding the role of microperimetry in glaucoma. Int Ophthalmol. 2022;42(7):2289-2301.
- Taylor LJ, Josan AS, Pfau M, Simunovic MP, Jolly JK. Scotopic microperimetry: evolution, applications and future directions. Clin Exp Optom. 2022;105(8):793-800.
- Lai HY, Saavedra-Pena G, Sodini CG, Sze V, Heldt T. Measuring Saccade Latency Using Smartphone Cameras. IEEE J Biomed Health Inform. 2020;24(3):885-897.
- Berkman O, Raveh E, Harpaz E, Kreitman R, Ben-Ami E, Nechushtan E, et al. Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progression. Amyotroph Lateral Scler Frontotemporal Degener. 2024;25(7-8):760-766.
- Zhang J, Zhang B, Ren Q, Zhong Q, Li Y, Liu G, et al. Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson’s disease. Neurol Sci. 2021;42(6):2337-2345.
- Zhang L, Yao H, Liang X, Hu C, Luo G. Association between oculomotor function testing parameters and Parkinson’s disease. Clin Neurol Neurosurg. 2026;263:109325.
- Li H, Zhang X, Yang Y, Xie A. Abnormal eye movements in Parkinson’s disease: From experimental study to clinical application. Parkinsonism Relat Disord. 2023;115:105791.
- Culicetto L, Cardile D, Marafioti G, Lo Buono V, Ferraioli F, Massimino S, et al. Recent advances (2022-2024) in eye-tracking for Parkinson’s disease: a promising tool for diagnosing and monitoring symptoms. Front Aging Neurosci. 2025;17:1534073.
- Brien DC, Riek HC, Yep R, Huang J, Coe B, Areshenkoff C, et al. Classification and staging of Parkinson’s disease using video-based eye tracking. Parkinsonism Relat Disord. 2023;110:105316.
- Pinkhardt EH, Kassubek J, Süssmuth S, Ludolph AC, Becker W, Jürgens R. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson’s disease. J Neurol. 2009;256(9):1438-46.
- Shafiq-Antonacci R, Maruff P, Masters C, Currie J. Spectrum of saccade system function in Alzheimer disease. Arch Neurol. 2003;60(9):1272-8.
- Rodríguez-Labrada R, Velázquez-Pérez L, Auburger G, Ziemann U, Canales-Ochoa N, Medrano-Montero J, et al. Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials. Mov Disord. 2016;31(4):570-8.
- Anastasopoulos D, Kimmig H, Mergner T, Psilas K. Abnormalities of ocular motility in myotonic dystrophy. Brain. 1996;119 ( Pt 6):1923-32.
- Macher S, Milenkovic I, Zrzavy T, Höftberger R, Seidel S, Berger-Sieczkowski E, et al. Ocular Motor Abnormalities in Anti-IgLON5 Disease. Front Immunol. 2021;12:753856.
- Cecchetti S, Duchowski AT, Cavallo M. Eye-Tracking Metrics as a Digital Biomarker for Neurocognitive Disorders in Multiple Sclerosis: A Scoping Review. Brain Sci. 2025;15(2).
- Giacomini PS, Voss P, Devonshire V, Schneider R, Macaron G, Hussein S, et al. Eye tracking as a digital biomarker in neurodegenerative diseases. J Neurol. 2026;273(2):133.
- Theodorou M, Clement R. Classification of infantile nystagmus waveforms. Vision Res. 2016;123:20-5.
- Abel LA, Wang ZI, Dell’Osso LF. Wavelet analysis in infantile nystagmus syndrome: limitations and abilities. Invest Ophthalmol Vis Sci. 2008;49(8):3413-23.
- Kelly JP, Phillips JO, Weiss AH. The relationship of nystagmus waveform on the VEP response in infantile nystagmus syndrome: a small case series. Doc Ophthalmol. 2017;134(1):37-44.
- Choi JH, Jung JH, Oh EH, Shin JH, Kim HS, Seo JH, et al. Genotype and Phenotype Spectrum of FRMD7-Associated Infantile Nystagmus Syndrome. Invest Ophthalmol Vis Sci. 2018;59(7):3181-3188.
- Hertle RW, Yang D, Kelly K, Hill VM, Atkin J, Seward A. X-linked infantile periodic alternating nystagmus. Ophthalmic Genet. 2005;26(2):77-84.
- Weiss N, Tadie JM, Faugeras F, Diehl JL, Fagon JY, Guerot E. Can fast-component of nystagmus on caloric vestibulo-ocular responses predict emergence from vegetative state in ICU?. J Neurol. 2012;259(1):70-6.
- Lisowski Ł, Lisowska J, Charytonowicz A, Mariak Z, Obuchowska I, Konopińska J. The diagnostic significance of pupillary reflex pathways: insights from classical examination and advanced pupillometry. Front Neurosci. 2025;19:1677431.
- Güler AD, Ecker JL, Lall GS, Haq S, Altimus CM, Liao HW, et al. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature. 2008;453(7191):102-5.
- La Morgia C, Carelli V, Carbonelli M. Melanopsin Retinal Ganglion Cells and Pupil: Clinical Implications for Neuro-Ophthalmology. Front Neurol. 2018;9:1047.
- Taylor WR, Chen JW, Meltzer H, Gennarelli TA, Kelbch C, Knowlton S, et al. Quantitative pupillometry, a new technology: normative data and preliminary observations in patients with acute head injury. Technical note. J Neurosurg. 2003;98(1):205-13.
- Anderson M, Elmer J, Shutter L, Puccio A, Alexander S. Integrating Quantitative Pupillometry Into Regular Care in a Neurotrauma Intensive Care Unit. J Neurosci Nurs. 2018;50(1):30-36.
- Maxin AJ, Gulek BG, Lee C, Lim D, Mariakakis A, Levitt MR, et al. Validation of a Smartphone Pupillometry Application in Diagnosing Severe Traumatic Brain Injury. J Neurotrauma. 2023;40(19-20):2118-2125.
- Barry C, Wang E. Racially fair pupillometry measurements for RGB smartphone cameras using the far red spectrum. Sci Rep. 2023;13(1):13841.
- Lei S, Goltz HC, Chandrakumar M, Wong AM. Full-field chromatic pupillometry for the assessment of the postillumination pupil response driven by melanopsin-containing retinal ganglion cells. Invest Ophthalmol Vis Sci. 2014;55(7):4496-503.
- Rukmini AV, Milea D, Gooley JJ. Chromatic Pupillometry Methods for Assessing Photoreceptor Health in Retinal and Optic Nerve Diseases. Front Neurol. 2019;10:76.
- Najjar RP, Sharma S, Atalay E, Rukmini AV, Sun C, Lock JZ, et al. Pupillary Responses to Full-Field Chromatic Stimuli Are Reduced in Patients with Early-Stage Primary Open-Angle Glaucoma. Ophthalmology. 2018;125(9):1362-1371.
- Herbst K, Sander B, Lund-Andersen H, Wegener M, Hannibal J, Milea D. Unilateral anterior ischemic optic neuropathy: chromatic pupillometry in affected, fellow non-affected and healthy control eyes. Front Neurol. 2013;4:52.
- Ba-Ali S, Lund-Andersen H. Pupillometric evaluation of the melanopsin containing retinal ganglion cells in mitochondrial and non-mitochondrial optic neuropathies. Mitochondrion. 2017;36:124-129.
- Iwaki Y, Ueda K, Mori S, Sakamoto M, Yamada-Nakanishi Y, Kondo M, et al. Difference in pupillary response to red and blue color stimuli between glaucoma and Leber hereditary optic neuropathy patients with comparable central visual dysfunction. Doc Ophthalmol. 2026.
- Chougule PS, Najjar RP, Finkelstein MT, Kandiah N, Milea D. Light-Induced Pupillary Responses in Alzheimer’s Disease. Front Neurol. 2019;10:360.
- Romagnoli M, Stanzani Maserati M, De Matteis M, Capellari S, Carbonelli M, Amore G, et al. Chromatic Pupillometry Findings in Alzheimer’s Disease. Front Neurosci. 2020;14:780.
- Siebald F, Grittner U, Otto C, Bereuter C, Zimmermann HG, Harms L, et al. Ultrasound pupillometry for the detection of a relative afferent pupillary defect (RAPD): Systematic evaluation in patients with optic neuritis and comparison with infrared video pupillometry. PLoS One. 2025;20(1):e0315712.
- Citerio G, Taccone FS. How we use the neurological pupil index (NPi). Crit Care. 2026;30(1).
- Oddo M, Taccone FS, Petrosino M, Badenes R, Blandino-Ortiz A, Bouzat P, et al. The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort study. Lancet Neurol. 2023;22(10):925-933.
- Vrettou CS, Fragkou PC, Mallios I, Barba C, Giannopoulos C, Gavrielatou E, et al. The Role of Automated Infrared Pupillometry in Traumatic Brain Injury: A Narrative Review. J Clin Med. 2024;13(2).
- Vieira RC, Duarte Dos Santos CS, Stracieri Janchevis Preiss M, Rabello PHM, Carlotti CG Jr, Figueiredo EG. Prognostic value of automated pupillometry in traumatic brain injury: a systematic review and meta-analysis. Neurosurg Rev. 2026;49(1).
- Nyholm B, Grand J, Obling LER, Hassager C, Møller JE, Schmidt H, et al. Quantitative pupillometry for neuroprognostication in comatose post-cardiac arrest patients: A protocol for a predefined sub-study of the Blood pressure and Oxygenations Targets after Out-of-Hospital Cardiac Arrest (BOX)-trial. Resusc Plus. 2023;16:100475.
- Benghanem S, Novy J, Cariou A, Ben-Hamouda N, Rossetti AO. Correlation Between Quantitative Pupillometry and Other Markers for Neuroprognostication of Comatose Patients After Cardiac Arrest: A Bicentric Study. Crit Care Med. 2026.
- Miroz JP, Ben-Hamouda N, Bernini A, Romagnosi F, Bongiovanni F, Roumy A, et al. Neurological Pupil index for Early Prognostication After Venoarterial Extracorporeal Membrane Oxygenation. Chest. 2020;157(5):1167-1174.
- Martínez-Palacios K, Vásquez-García S, Fariyike OA, Robba C, Rubiano AM. Quantitative Pupillometry for Intracranial Pressure (ICP) Monitoring in Traumatic Brain Injury: A Scoping Review. Neurocrit Care. 2024;41(1):255-271.
- Robba C, Picetti E, Vásquez-García S, Abulhasan YB, Ain A, Adeleye AO, et al. The Brussels consensus for non-invasive ICP monitoring when invasive systems are not available in the care of TBI patients (the B-ICONIC consensus, recommendations, and management algorithm). Intensive Care Med. 2025;51(1):4-20.
- Brasil S, Patriota GC, Godoy DA, Paranhos JL, Rubiano AM, Paiva WS. Monro-Kellie 4.0: moving from intracranial pressure to intracranial dynamics. Crit Care. 2025;29(1):229.
- El Ahmadieh TY, Bedros N, Stutzman SE, Nyancho D, Venkatachalam AM, MacAllister M, et al. Automated Pupillometry as a Triage and Assessment Tool in Patients with Traumatic Brain Injury. World Neurosurg. 2021;145:e163-e169.
- Ong C, Hutch M, Barra M, Kim A, Zafar S, Smirnakis S. Effects of Osmotic Therapy on Pupil Reactivity: Quantification Using Pupillometry in Critically Ill Neurologic Patients. Neurocrit Care. 2019;30(2):307-315.
- González Tobar WD, Salazar AF, González AM, Mateo MB, Guevara K, De Souza BJ, et al. Noninvasive Neuromonitoring in Pediatric Traumatic Brain Injury: A Scoping Review of Quantitative Pupillometry and the Evidence Gap in Noninvasive Intracranial Pressure Waveform Analysis. Pediatr Neurol. 2026;182:133-140.
- Packiasabapathy S, Rangasamy V, Sadhasivam S. Pupillometry in perioperative medicine: a narrative review. Can J Anaesth. 2021;68(4):566-578.
- Kim JH, Jwa EK, Choung Y, Yeon HJ, Kim SY, Kim E. Comparison of Pupillometry With Surgical Pleth Index Monitoring on Perioperative Opioid Consumption and Nociception During Propofol-Remifentanil Anesthesia: A Prospective Randomized Controlled Trial. Anesth Analg. 2020;131(5):1589-1598.
- Jiao Y, He B, Tong X, Xia R, Zhang C, Shi X. Intraoperative monitoring of nociception for opioid administration: a meta-analysis of randomized controlled trials. Minerva Anestesiol. 2019;85(5):522-530.
- Vide S, Castro A, Correia R, Cabral T, Lima D, Nunes CS, et al. Foreseeing postoperative pain in neurosurgical patients: pupillometry predicts postoperative pain ratings-an observational study. J Clin Monit Comput. 2021;35(5):1111-1118.
- Snoek MAJ, van den Berg VJ, Dahan A, Boon M. Comparison of different monitors for measurement of nociception during general anaesthesia: a network meta-analysis of randomised controlled trials. Br J Anaesth. 2025;134(1):180-191.
- Laferrière-Langlois P, Morisson L, Jeffries S, Duclos C, Espitalier F, Richebé P. Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 2050. Anesth Analg. 2024;138(2):295-307.
- Abad-Gurumeta A, Ripollés-Melchor J, Casans-Francés R, Calvo-Vecino JM. Monitoring of nociception, reality or fiction?. Rev Esp Anestesiol Reanim. 2017;64(7):406-414.
- Lerner AG, Bernabé-Ortiz A, Ticse R, Hernandez A, Huaylinos Y, Pinto ME, et al. Type 2 diabetes and cardiac autonomic neuropathy screening using dynamic pupillometry. Diabet Med. 2015;32(11):1470-8.
- Erdem S, Karahan M, Ava S, Pekkolay Z, Demirtas AA, Keklikci U. The effectiveness of automatic pupillometry as a screening method to detect diabetic autonomic neuropathy. Int Ophthalmol. 2020;40(11):3127-3134.
- Yuan D, Spaeth EB, Vernino S, Muppidi S. Disproportionate pupillary involvement in diabetic autonomic neuropathy. Clin Auton Res. 2014;24(6):305-9.
- Coito A, Brügger D, Brémovà-Ertl T, Massatsch P, Abegg M, Weber KP, et al. Advances in ocular motor and pupil biomarkers for neurological disorders. Brain Commun. 2026;8(2):fcag102.
- Omary R, Bockisch CJ, Landau K, Kardon RH, Weber KP. Buzzing Sympathetic Nerves: A New Test to Enhance Anisocoria in Horner’s Syndrome. Front Neurol. 2019;10:107.
- Sousa AI, Marques-Neves C, Vieira PM. Development of a Smartphone-Based System for Intrinsically Photosensitive Retinal Ganglion Cells Targeted Chromatic Pupillometry. Bioengineering (Basel). 2024;11(3).
- Cohen DA, Gise R, Gaier ED. Serum Biomarkers in Neuro-Ophthalmology: When to Test. Semin Ophthalmol. 2021;36(4):322-328.
- van der Geest KSM, Sandovici M, Brouwer E, Mackie SL. Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis: A Systematic Review and Meta-analysis. JAMA Intern Med. 2020;180(10):1295-1304.
- Currier CE, Bays AM, Thomason JL. Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot. Rheumatol Int. 2025;45(8):175.
- Hansen MS, Klefter ON, Terslev L, Jensen MR, Brittain JM, Døhn UM, et al. Is Erythrocyte Sedimentation Rate Necessary for the Initial Diagnosis of Giant Cell Arteritis?. Life (Basel). 2023;13(3).
- Tombetti E, Hysa E, Mason JC, Cimmino MA, Camellino D. Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides. Curr Rheumatol Rep. 2021;23(3):17.
- Hemmig AK, Gozzoli D, Werlen L, Ewald H, Aschwanden M, Blockmans D, et al. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. Semin Arthritis Rheum. 2022;55:152017.
- Hall JK. Giant-cell arteritis. Curr Opin Ophthalmol. 2008;19(6):454-60.
- Rapoport Y, Lavin PJ. Nutritional Optic Neuropathy Caused by Copper Deficiency After Bariatric Surgery. J Neuroophthalmol. 2016;36(2):178-81.
- Moss HE. Bariatric Surgery and the Neuro-Ophthalmologist. J Neuroophthalmol. 2016;36(1):78-84.
- Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-89.
- Liu J, Tan G, Li B, Zhang J, Gao Y, Cao Y, et al. Serum Aquaporin 4-Immunoglobulin G Titer and Neuromyelitis Optica Spectrum Disorder Activity and Severity: A Systematic Review and Meta-Analysis. Front Neurol. 2021;12:746959.
- Yamout B, Gouider R, Al-Roughani R, Aljarallah S, Shalaby N, Al-Khabouri J, et al. Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines. CNS Drugs. 2026;40(3):283-303.
- Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268-282.
- Sechi E, Buciuc M, Pittock SJ, Chen JJ, Fryer JP, Jenkins SM, et al. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing. JAMA Neurol. 2021;78(6):741-746.
- Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15(1):134.
- Kwon YN, Ju W, Jeon JH, Hahm C, Sung JJ, Kim SM. Clear-positive cut off determination of flow cytometric MOG-antibody assay in Korea: Alignment with international MOGAD diagnostic standards. J Neuroimmunol. 2026;410:578806.
- Sechi E, Cacciaguerra L, Chen JJ, Mariotto S, Fadda G, Dinoto A, et al. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management. Front Neurol. 2022;13:885218.
- Sechi E, Gastaldi M, Cortese R, Bisecco A, Vogrig A, Giannoccaro MP, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Practical recommendations for diagnosis and management. J Neuroimmunol. 2026;410:578781.
- Petzold A, Fraser CL, Abegg M, Alroughani R, Alshowaeir D, Alvarenga R, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022;21(12):1120-1134.
- Orlandi R, Mariotto S, Ferrari S, Gobbin F, Sechi E, Capra R, et al. Diagnostic features of initial demyelinating events associated with serum MOG-IgG. J Neuroimmunol. 2020;344:577260.
- Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JG, Desestret V, Dubey D, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4).
- Campetella L, Papi C, Sabatelli E, Marini S, Iorio R. Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes. J Neuroimmunol. 2022;372:577972.
- Zhao-Fleming H, Rezk M, Shah S, Gupta P, Zekeridou A, Flanagan EP, et al. Comprehensive Analysis of Paraneoplastic Neurologic Syndrome and PNS-CARE Diagnostic Criteria in Clinical Practice. Neurol Neuroimmunol Neuroinflamm. 2024;11(6):e200316.
- Cai MT, Qiao S, Lai QL, Zheng Y, Yang F, Fang GL, et al. Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China. Front Immunol. 2022;13:790400.
- Cross SA, Salomao DR, Parisi JE, Kryzer TJ, Bradley EA, Mines JA, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol. 2003;54(1):38-50.
- Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, Flanagan EP, et al. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema. Ophthalmology. 2020;127(2):221-229.
- Yan R, Mao Y, Zeng H, Liu Q, Jiang H, Peng J, et al. Collapsin response mediator protein 5-associated optic neuropathy: clinical characteristics, radiologic clues, and outcomes. Front Neurol. 2023;14:1163615.
- Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58(1):96-107.
- Bartalena L, Tanda ML. Current concepts regarding Graves’ orbitopathy. J Intern Med. 2022;292(5):692-716.
- Roos JCP, Paulpandian V, Murthy R. Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy. Eye (Lond). 2019;33(2):212-217.
- Moledina M, Roos J, Murthy R. Thyrotropin Receptor Autoantibody Assessment in Thyroid Eye Disease: Does the Assay Type Matter?. Korean J Ophthalmol. 2023;37(2):147-156.
- Davis JL. Ocular syphilis. Curr Opin Ophthalmol. 2014;25(6):513-8.
- Smit D, De Graaf M, Meyer D, de Groot-Mijnes JDF. Immunoblot and Polymerase Chain Reaction to Diagnose Ocular Syphilis and Neurosyphilis in HIV-positive and HIV-negative Patients. Ocul Immunol Inflamm. 2020;28(7):1049-1055.
- Lantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Arthritis Rheumatol. 2021;73(1):12-20.
- Koedel U, Pfister HW. Lyme neuroborreliosis. Curr Opin Infect Dis. 2017;30(1):101-107.
- Jaulhac B, Bouiller K, Lenormand C, Baux E, Sevestre J, Gautier A, et al. Guidelines for Lyme borreliosis: Diagnostic strategies. Infect Dis Now. 2025;55(8S):105203.
- Pasnoor M, Dimachkie MM, Farmakidis C, Barohn RJ. Diagnosis of Myasthenia Gravis. Neurol Clin. 2018;36(2):261-274.
- Binks S, Vincent A, Palace J. Myasthenia gravis: a clinical-immunological update. J Neurol. 2016;263(4):826-34.
- Peeler CE, De Lott LB, Nagia L, Lemos J, Eggenberger ER, Cornblath WT. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis. JAMA Neurol. 2015;72(10):1170-4.
- Behbehani R, Ali A, Al-Moosa A. Ocular Myasthenia: Clinical Course and the Diagnostic Utility of Assaying Acetylcholine Receptor Antibodies. Neuroophthalmology. 2022;46(4):220-226.
- Vincent A, McConville J, Farrugia ME, Newsom-Davis J. Seronegative myasthenia gravis. Semin Neurol. 2004;24(1):125-33.
- Lazaridis K, Tzartos SJ. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. Front Immunol. 2020;11:212.
- Fichtner ML, Horstkorte L, Sánchez Navarro BG, Schmidt H, Cabraal I, Waters PJ, et al. Autoantibodies in myasthenia gravis. Int Rev Neurobiol. 2025;182:89-119.
- Lu C, Yang Y, Dong Y, Tang T, Chen J, Wang Y, et al. Anti-Acetylcholine Receptor Antibodies in Tear for the Diagnosis of Ocular Myasthenia Gravis. Am J Ophthalmol. 2025;277:139-147.
- La Morgia C, Cascavilla ML, De Negri AM, Romano M, Canalini F, Rossi S, et al. Recognizing Leber’s Hereditary Optic Neuropathy to avoid delayed diagnosis and misdiagnosis. Front Neurol. 2024;15:1466275.
- Yu-Wai-Man P, Chinnery PF. Leber hereditary optic neuropathy. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Zheng Y, Wang P, Li S, Long Y, Jiang Y, Guo D, et al. Clinical and genetic landscape of optic atrophy in 826 families: insights from 50 nuclear genes. Brain. 2025;148(5):1604-1620.
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24.
- McCormick EM, Lott MT, Dulik MC, Shen L, Attimonelli M, Vitale O, et al. Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretation. Hum Mutat. 2020;41(12):2028-2057.
- Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-65.
- Avery RA. Reference range of cerebrospinal fluid opening pressure in children: historical overview and current data. Neuropediatrics. 2014;45(4):206-11.
- Deisenhammer F, Hegen H, Arrambide G, Banwell BL, Coetzee T, Gnanapavan S, et al. Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis. EBioMedicine. 2025;120:105905.
- Hegen H, Walde J, Berek K, Arrambide G, Gnanapavan S, Kaplan B, et al. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis. Mult Scler. 2023;29(2):169-181.
- Konen FF, Wurster U, Schwenkenbecher P, Gerritzen A, Groß CC, Eichhorn P, et al. Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?. Autoimmun Rev. 2025;24(5):103765.
- Giovannoni G. Cerebrospinal fluid analysis. Handb Clin Neurol. 2014;122:681-702.
- Shah SM, Khanna CL. Ophthalmic Emergencies for the Clinician. Mayo Clin Proc. 2020;95(5):1050-1058.
- Papageorgiou E, Anthis N, Stathi T, Tsironi E, Asproudis I. Case Series: Bilateral Homonymous Visual Field Defects Due to Bilateral Ischemic Strokes. Optom Vis Sci. 2018;95(11):1077-1082.
- Dunlap AB, Kosmorsky GS, Kashyap VS. The fate of patients with retinal artery occlusion and Hollenhorst plaque. J Vasc Surg. 2007;46(6):1125-9.
- Zhou GY, Aman S, Alryalat SA, Al Deyabat O, Hamann S, Lee AG. Neuro-Ophthalmic Presentations of Polycythemia. J Neuroophthalmol. 2025;45(4):473-482.
- Markey K, Hutchcroft C, Emsley H. Idiopathic intracranial hypertension: expanding our understanding. Curr Opin Neurol. 2023;36(6):622-630.
- Fraser CL, Hepschke JL, Jenkins B, Prasad S. Migraine Aura: Pathophysiology, Mimics, and Treatment Options. Semin Neurol. 2019;39(6):739-748.
- Barral E, Martins Silva E, García-Azorín D, Viana M, Puledda F. Differential Diagnosis of Visual Phenomena Associated with Migraine: Spotlight on Aura and Visual Snow Syndrome. Diagnostics (Basel). 2023;13(2).
- Mac Grory B, Schrag M, Biousse V, Furie KL, Gerhard-Herman M, Lavin PJ, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. Stroke. 2021;52(6):e282-e294.
- Doshi S, Bisen JB, Bains HK, Keshwani A, Cherayil N, Mirza RG. Secondary stroke evaluation in patients admitted for CRAO in a large national inpatient sample. Stroke Vasc Neurol. 2026;11(2):191-200.
- Alhayek N, Sobczak JM, Vanood A, O’Carroll CB, Demaerschalk BM, Chen J, et al. Thrombolytic Therapy for Central Retinal Artery Occlusion in an Academic Multi-Site Stroke Centre. Neuroophthalmology. 2024;48(2):111-121.
- Capatina C, Inder W, Karavitaki N, Wass JA. Management of endocrine disease: pituitary tumour apoplexy. Eur J Endocrinol. 2015;172(5):R179-90.
- Flores-Sánchez BC, Tatham AJ. Acute angle closure glaucoma. Br J Hosp Med (Lond). 2019;80(12):C174-C179.
- McAllister IL. Central retinal vein occlusion: a review. Clin Exp Ophthalmol. 2012;40(1):48-58.
- Modi YS, Klufas MA, Sridhar J, Singh RP, Yonekawa Y, Pecen P. Current Best Clinical Practices-Management of Retinal Vein Occlusion. J Vitreoretin Dis. 2020;4(3):214-219.
- Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol. 1993;111(6):773-5.
- Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology. 2008;115(2):298-305.e2.
- Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res. 2014;41:1-25.
- Huang HM, Wu PC, Kuo HK, Chen YJ, Poon LY. Natural history and visual outcome of nonarteritic anterior ischemic optic neuropathy in Southern Taiwan: a pilot study. Int Ophthalmol. 2020;40(10):2667-2676.
- Baj J, Forma A, Kobak J, Tyczyńska M, Dudek I, Maani A, et al. Toxic and Nutritional Optic Neuropathies-An Updated Mini-Review. Int J Environ Res Public Health. 2022;19(5).
- Heran F, Schaison-Cusin M, Williams M, Piekarski JD. [Imaging of neuro-ophthalmological emergencies]. J Neuroradiol. 2004;31(4):291-300.
- Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010;55(1):2-34.
- Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997;104(5):859-64.
- Ávila-Figueroa E, Flores-Calvo M, Sánchez-Rodríguez CC, Domínguez-Varela IA, Salazar-Ramírez P, Zamora Cortina F, et al. Ocular ischemic syndrome secondary to carotid artery disease: a comprehensive review addressing critical early detection, management, and education. Front Ophthalmol (Lausanne). 2026;6:1717841.
- Fugate JE, Hawkes MA, Rabinstein AA. Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes. Lancet Neurol. 2025;24(9):789-800.
- Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol. 2022;22(3):183-189.
- Singhal AB. Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome as Syndromes of Cerebrovascular Dysregulation. Continuum (Minneap Minn). 2021;27(5):1301-1320.
- Kunkel RS. Migraine aura without headache: benign, but a diagnosis of exclusion. Cleve Clin J Med. 2005;72(6):529-34.
- Lai J, Dilli E. Migraine Aura: Updates in Pathophysiology and Management. Curr Neurol Neurosci Rep. 2020;20(6):17.
- Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol. 2016;16(1):220.
- Fraiman P, Valente AL, Barreto MESF, Silva NL, Rezende Filho FM, Braga VL, et al. Sarcoid optic neuropathy. Pract Neurol. 2024;24(2):141-143.
- González-Gay MÁ, Heras-Recuero E, García-Fernández A, Blázquez-Sánchez T, Torres-Roselló A, Caraballo-Salazar C, et al. Revisiting the epidemiology of giant cell arteritis. Clin Exp Rheumatol. 2025;43(4):742-748.
- Monti S, Bartoletti A, Bellis E, Delvino P, Montecucco C. Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse. Front Med (Lausanne). 2020;7:589794.
- O’Neill KG, Brown RJ, Moss HE. Characterizing the Role of Ophthalmologists in the Care of Patients With Suspected Giant Cell Arteritis at an Academic Medical Center. J Neuroophthalmol. 2026.
- Monti S, Águeda AF, Luqmani RA, Buttgereit F, Cid M, Dejaco C, et al. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis. RMD Open. 2019;5(2):e001003.
- Tabatabaei SA, Amini M, Haydar AA, Soleimani M, Cheraqpour K, Shahriari M, et al. Outbreak of methanol-induced optic neuropathy in early COVID-19 era; effectiveness of erythropoietin and methylprednisolone therapy. World J Clin Cases. 2023;11(15):3502-3510.
- Alsubhi AH, Mohammedsaleh A, Alorainy J, Badeeb N. The efficacy of erythropoietin in methanol induced optic neuropathy: a systematic review. Cutan Ocul Toxicol. 2025;44(4):353-360.
- Kla KM, Lee LA. Perioperative visual loss. Best Pract Res Clin Anaesthesiol. 2016;30(1):69-77.
- Goyal A, Elminawy M, Alvi MA, Long TR, Chen JJ, Bradley E, et al. Ischemic Optic Neuropathy Following Spine Surgery: Case Control Analysis and Systematic Review of the Literature. Spine (Phila Pa 1976). 2019;44(15):1087-1096.
- Nickels TJ, Manlapaz MR, Farag E. Perioperative visual loss after spine surgery. World J Orthop. 2014;5(2):100-6.
- Chokron S. [Cortical blindness]. J Fr Ophtalmol. 2014;37(2):166-72.
- Raviskanthan S, Wendt S, Ugoh PM, Mortensen PW, Moss HE, Lee AG. Functional vision disorders in adults: a paradigm and nomenclature shift for ophthalmology. Surv Ophthalmol. 2022;67(1):8-18.
- Pomeranz HD, Henson JW, Lessell S. Radiation-associated cerebral blindness. Am J Ophthalmol. 1998;126(4):609-11.
- Saionz EL, Busza A, Huxlin KR. Rehabilitation of visual perception in cortical blindness. Handb Clin Neurol. 2022;184:357-373.
- Kerkhoff G, Schenk T. Line bisection in homonymous visual field defects - Recent findings and future directions. Cortex. 2011;47(1):53-8.
- Frisén L. Identification of functional visual field loss by automated static perimetry. Acta Ophthalmol. 2014;92(8):805-9.
- Yeo JM, Carson A, Stone J. Seeing again: treatment of functional visual loss. Pract Neurol. 2019;19(2):168-172.
- Nieves-Moreno M, Santos-Bueso E, Sáenz-Francés F, García-Feijoo J. [Monocular non-organic visual loss after a cranioencephalic trauma]. Arch Soc Esp Oftalmol. 2015;90(9):448-9.
- Muñoz-Hernández AM, García-Catalán R, Santos-Bueso E, López-Abad C, Gil-De-Bernabé JG, Díaz-Valle D, et al. [Simulation in ophthalmology]. Arch Soc Esp Oftalmol. 2011;86(10):320-6.
- Molander LD, Hagen SM, Hansen NS, Korsbaek JJ, Grauslund J, Digre KB, et al. Patterns of Retinal Damage and Visual Long-Term Consequences in Patients With Idiopathic Intracranial Hypertension. Neurology. 2025;105(10):e214335.
- Saitakis G, Chwalisz BK. Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis. Int J Mol Sci. 2022;23(17).
- Dickersin K, Li T. Surgery for nonarteritic anterior ischemic optic neuropathy. Cochrane Database Syst Rev. 2015;2015(3):CD001538.
- Gracitelli CP, Tatham AJ, Zangwill LM, Weinreb RN, Abe RY, Diniz-Filho A, et al. Asymmetric Macular Structural Damage Is Associated With Relative Afferent Pupillary Defects in Patients With Glaucoma. Invest Ophthalmol Vis Sci. 2016;57(4):1738-46.
- Hart WM Jr, Burde RM. Three-dimensional topography of the central visual field. Sparing of foveal sensitivity in macular disease. Ophthalmology. 1983;90(8):1028-38.
- Chapelle AC, Rakic JM, Plant GT. Utility of ganglion cells for the evaluation of anterior visual pathway pathology: a review. Acta Neurol Belg. 2024;124(4):1113-1123.
- Almaliotis D, Almpanidou S, Chatzimbalis T, Nikolaidou A, Talimtzi P, Karampatakis V. Correlation between color vision, visual acuity, contrast sensitivity and photostress recovery in the visually impaired: a cross-sectional study. Ann Med Surg (Lond). 2024;86(2):742-747.
- Loewenstein A, Malach R, Goldstein M, Leibovitch I, Barak A, Baruch E, et al. Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology. 2003;110(5):966-70.
- Robison CD, Jivrajka RV, Bababeygy SR, Fink W, Sadun AA, Sebag J. Distinguishing wet from dry age-related macular degeneration using three-dimensional computer-automated threshold Amsler grid testing. Br J Ophthalmol. 2011;95(10):1419-23.
- Jivrajka RV, Kim JK, Fink W, Sadun AA, Sebag J. Quantitative analysis of central visual field defects in macular edema using three-dimensional computer-automated threshold Amsler grid testing. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):165-70.
- Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120(12):2611-2619.
- Premi E, Donati S, Azzi L, Porta G, Metrangolo C, Fontanel L, et al. Macular Holes: Main Clinical Presentations, Diagnosis, and Therapies. J Ophthalmol. 2022;2022:2270861.
- Donaldson LC, Eshtiaghi A, Sacco S, Micieli JA, Margolin EA. Junctional Scotoma and Patterns of Visual Field Defects Produced by Lesions Involving the Optic Chiasm. J Neuroophthalmol. 2022;42(1):e203-e208.
- Kim KE, Ahn SJ. Visual Field Examinations for Retinal Diseases: A Narrative Review. J Clin Med. 2025;14(15).
- Hänsli C, Lavan S, Pfister IB, Schild C, Garweg JG. Outer retinal features in OCT predict visual recovery after primary macula-involving retinal detachment repair. PLoS One. 2022;17(5):e0268028.
- Ciulla TA, Kapik B, Grewal DS, Ip MS. Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis. Ophthalmol Retina. 2021;5(7):633-647.
- Scott RA, Bhat N, Harish Bindiganavile S, Li HK, Lee AG. Paracentral Acute Middle Maculopathy Mimicking Retrobulbar Optic Neuropathy. J Neuroophthalmol. 2021;41(2):e205-e208.
- Kıyat P, Değirmenci C, Nalçacı S, Afrashi F, Akkın C. Paracentral Acute Middle Maculopathy. Turk J Ophthalmol. 2020;50(3):193-196.
- Cuenca N, Ortuño-Lizarán I, Sánchez-Sáez X, Kutsyr O, Albertos-Arranz H, Fernández-Sánchez L, et al. Interpretation of OCT and OCTA images from a histological approach: Clinical and experimental implications. Prog Retin Eye Res. 2020;77:100828.
- Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009;73(4):302-8.
- Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, et al. Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. J Neurol Neurosurg Psychiatry. 2018;89(12):1259-1265.
- Berninger TA, Arden GB. The pattern electroretinogram. Eye (Lond). 1988;2 Suppl:S257-83.
- Porciatti V, Ventura LM. Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model. J Neuroophthalmol. 2012;32(4):354-8.
- Guy J, Feuer WJ, Porciatti V, Schiffman J, Abukhalil F, Vandenbroucke R, et al. Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2014;55(2):841-8.
- Hartung KJ, Tsang SH, Sharma T, Diaconita V. Occult Macular Dystrophy. Adv Exp Med Biol. 2025;1467:107-109.
- Luoma-Overstreet G, Jewell A, Brar V, Couser N. Occult Macular Dystrophy: a case report and major review. Ophthalmic Genet. 2022;43(5):703-708.
- Ahn SJ, Yang L, Tsunoda K, Kondo M, Fujinami-Yokokawa Y, Nakamura N, et al. Visual Field Characteristics in East Asian Patients With Occult Macular Dystrophy (Miyake Disease): EAOMD Report No. 3. Invest Ophthalmol Vis Sci. 2022;63(1):12.
- Ong SS, Ahmed I, Scott AW. Association of Acute Macular Neuroretinopathy or Paracentral Acute Middle Maculopathy with Sickle Cell Disease. Ophthalmol Retina. 2021;5(11):1146-1155.
- Pandya BU, Grinton M, Mandelcorn ED, Felfeli T. RETINAL OPTICAL COHERENCE TOMOGRAPHY IMAGING BIOMARKERS: A Review of the Literature. Retina. 2024;44(3):369-380.
- Daruich A, Matet A, Behar-Cohen F. Central Serous Chorioretinopathy. Dev Ophthalmol. 2017;58:27-38.
- Sahoo NK, Singh SR, Rajendran A, Shukla D, Chhablani J. Masqueraders of central serous chorioretinopathy. Surv Ophthalmol. 2019;64(1):30-44.
- Monson DM, Smith JR. Acute zonal occult outer retinopathy. Surv Ophthalmol. 2011;56(1):23-35.
- Matoba R, Morizane Y. Epiretinal membrane: an overview and update. Jpn J Ophthalmol. 2024;68(6):603-613.
- Elliott DB. Evaluating visual function in cataract. Optom Vis Sci. 1993;70(11):896-902.
- Abrahamsson M, Sjöstrand J. Impairment of contrast sensitivity function (CSF) as a measure of disability glare. Invest Ophthalmol Vis Sci. 1986;27(7):1131-6.
- Superstein R, Boyaner D, Overbury O, Collin C. Glare disability and contrast sensitivity before and after cataract surgery. J Cataract Refract Surg. 1997;23(2):248-53.
- Adamsons IA, Vitale S, Stark WJ, Rubin GS. The association of postoperative subjective visual function with acuity, glare, and contrast sensitivity in patients with early cataract. Arch Ophthalmol. 1996;114(5):529-36.
- Meacock WR, Spalton DJ, Boyce J, Marshall J. The effect of posterior capsule opacification on visual function. Invest Ophthalmol Vis Sci. 2003;44(11):4665-9.
- Lu C, Yu S, Song H, Zhao Y, Xie S, Tang X, et al. Posterior capsular opacification comparison between morphology and objective visual function. BMC Ophthalmol. 2019;19(1):40.
- Koh S. Irregular Astigmatism and Higher-Order Aberrations in Eyes With Dry Eye Disease. Invest Ophthalmol Vis Sci. 2018;59(14):DES36-DES40.
- Shneor E, Piñero DP, Doron R. Contrast sensitivity and higher-order aberrations in Keratoconus subjects. Sci Rep. 2021;11(1):12971.
- Schümmer L, Kreps EO, Pesudovs K, Berwouts J, Estramil N, Mathysen DGP, et al. Investigating the Link Between Visual Quality and Vision-Related Quality of Life in Patients With Keratoconus. Cornea. 2023;42(10):1280-1285.
- Salman A, Kailani O, Ghabra M, Omran R, Darwish TR, Shaaban R, et al. Corneal higher order aberrations by Sirius topography and their relation to different refractive errors. BMC Ophthalmol. 2023;23(1):104.
- Patel SV, Hodge DO, Treichel EJ, Baratz KH. Visual Function in Pseudophakic Eyes with Fuchs’ Endothelial Corneal Dystrophy. Am J Ophthalmol. 2022;239:98-107.
- Oie Y, Watanabe S, Nishida K. Evaluation of Visual Quality in Patients With Fuchs Endothelial Corneal Dystrophy. Cornea. 2016;35 Suppl 1:S55-S58.
- Weller JM, Bennemann M, Tourtas T, Kruse FE, Schlötzer-Schrehardt U. Differences in Guttae Ultramorphology in Relation to Visual Function in Fuchs Endothelial Corneal Dystrophy. Cornea. 2024;43(11):1348-1354.
- Repka MX, Goldenberg-Cohen N, Edwards AR. Retinal nerve fiber layer thickness in amblyopic eyes. Am J Ophthalmol. 2006;142(2):247-51.
- Sahin G, Dal D. Analysis of retinal nerve fiber layer thickness in anisometropic amblyopia via optic coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2019;257(10):2103-2110.
- Kantarci FA, Tatar MG, Uslu H, Colak HN, Yildirim A, Goker H, et al. Choroidal and peripapillary retinal nerve fiber layer thickness in adults with anisometropic amblyopia. Eur J Ophthalmol. 2015;25(5):437-42.
- Celik NB, Kose AO, Celik HU, Imamoglu S. Evaluation of Bruch’s membrane opening-minimum rim width and retinal nerve fiber layer thickness in adults with anisometropic amblyopia. Photodiagnosis Photodyn Ther. 2020;32:102023.
- Chedid A, Fronius M, Wenner Y, Cirina L, Kohnen T, Kuhli-Hattenbach C. Optical coherence tomography (OCT) parameters in amblyopia. Strabismus. 2025;33(4):247-257.
- Matthews GP, Sandberg MA, Berson EL. Foveal cone electroretinograms in patients with central visual loss of unexplained etiology. Arch Ophthalmol. 1992;110(11):1568-70.
- Sotelo-Monge KG, Espinosa-Barberi G, Pinilla Cortés LM, Puntí Badosa A, Anton A. Compressive optic neuropathy. Not everything that progresses is glaucoma. Arch Soc Esp Oftalmol (Engl Ed). 2021;96(4):219-223.
- Anderson DR. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol. 2003;14(2):86-90.
- Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131(6):699-708.
- Momin SNA, Choudhary RA, Siddiqui MAR, Hashmi S, Memon AS, Tayyab H. Post-operative visual outcomes based on morphological staging of idiopathic epiretinal membranes on OCT. Int J Ophthalmol. 2022;15(12):1966-1970.
- Patheja RS. Preoperative ocular coherence tomographic prognosticators of visual acuity after idiopathic epiretinal membrane surgery. Int Ophthalmol. 2022;42(10):3243-3252.
- Zhang Z, Mao J, Lao J, Deng X, Fang Y, Chen N, et al. A classification of idiopathic epiretinal membrane based on foveal avascular zone area using optical coherence tomography angiography. Ann Med. 2024;56(1):2316008.
- Haydinger CD, Ferreira LB, Williams KA, Smith JR. Mechanisms of macular edema. Front Med (Lausanne). 2023;10:1128811.
- Zur D, Loewenstein A. Postsurgical Cystoid Macular Edema. Dev Ophthalmol. 2017;58:178-190.
- Saxena S, Meyer CH, Akduman L. External limiting membrane and ellipsoid zone structural integrity in diabetic macular edema. Eur J Ophthalmol. 2022;32(1):15-16.
- Garcia JH, Johnson M, Shah G, Meyer CH, Melo GB, Rodrigues EB. Macular microhole and foveal red spot syndrome: a critical review of the literature. Graefes Arch Clin Exp Ophthalmol. 2021;259(7):1685-1694.
- Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82-118.
- Fung AT, Yang Y, Kam AW. Central serous chorioretinopathy: A review. Clin Exp Ophthalmol. 2023;51(3):243-270.
- Nkrumah G, Maltsev DS, Manuel PA, Rasheed MA, Cozzi M, Ivernizzi A, et al. Current Choroidal Imaging Findings in Central Serous Chorioretinopathy. Vision (Basel). 2020;4(4).
- Park JB, Kim K, Kang MS, Kim ES, Yu SY. Central serous chorioretinopathy: Treatment. Taiwan J Ophthalmol. 2022;12(4):394-408.
- Khan N, Huang JJ, Foster CS. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol. 2006;21(3):135-41.
- Shildkrot Y, Sobrin L, Gragoudas ES. Cancer-associated retinopathy: update on pathogenesis and therapy. Semin Ophthalmol. 2011;26(4-5):321-8.
- Hung WC, Cheng HC, Wang AG. Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction. Doc Ophthalmol. 2022;145(3):263-270.
- Chen JJ, McKeon A, Greenwood TM, Flanagan EP, Bhatti MT, Dubey D, et al. Clinical Utility of Antiretinal Antibody Testing. JAMA Ophthalmol. 2021;139(6):658-662.
- Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. Am J Ophthalmol. 2014;157(2):266-272.e1.
- Braithwaite T, Holder GE, Lee RW, Plant GT, Tufail A. Diagnostic features of the autoimmune retinopathies. Autoimmun Rev. 2014;13(4-5):534-8.
- Fox AR, Gordon LK, Heckenlively JR, Davis JL, Goldstein DA, Lowder CY, et al. Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach. Am J Ophthalmol. 2016;168:183-190.
- Dutta Majumder P, Marchese A, Pichi F, Garg I, Agarwal A. An update on autoimmune retinopathy. Indian J Ophthalmol. 2020;68(9):1829-1837.
- Zeng HY, Liu Q, Peng XY, Zhang ZJ, Cao K, Hou SM, et al. Comparison of Clinical and Immunological Features of Para- and Non-Paraneoplastic Autoimmune Retinopathy in Chinese - A Series of 48 Cases. Ocul Immunol Inflamm. 2024;32(5):664-672.
- Kalogeropoulos D, Lotery AJ, Pavesio C, Kalogeropoulos C, Kanavaros P, Afshar F, et al. Diagnosis and treatment of autoimmune retinopathy: review of current approaches. Int Ophthalmol. 2025;45(1):341.
- Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol. 2013;58(5):430-58.
- Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects. Retina. 2018;38(6):1063-1078.
- Haliyur R, Elner SG, Sassalos T, Kodati S, Johnson MW. Pathogenic Mechanisms of Immune Checkpoint Inhibitor (ICI)-Associated Retinal and Choroidal Adverse Reactions. Am J Ophthalmol. 2025;272:8-18.
- Ameri M, Al-Zubidi N, Lee AG. Immune checkpoint monoclonal antibody-related adverse effects in neuro-ophthalmology. Saudi J Ophthalmol. 2024;38(1):25-28.
- Jacobson SG, Morales DS, Sun XK, Feuer WJ, Cideciyan AV, Gass JD, et al. Pattern of retinal dysfunction in acute zonal occult outer retinopathy. Ophthalmology. 1995;102(8):1187-98.
- Boudreault KA, Schuerch K, Zhao J, Lee W, Cabral T, Yannuzzi LA, et al. Quantitative Autofluorescence Intensities in Acute Zonal Occult Outer Retinopathy vs Healthy Eyes. JAMA Ophthalmol. 2017;135(12):1330-1338.
- Ramtohul P, Marchese A, Introini U, Goldstein DA, Freund KB, Jampol LM, et al. MULTIZONAL OUTER RETINOPATHY AND RETINAL PIGMENT EPITHELIOPATHY (MORR): A Newly Recognized Entity or an Unusual Variant of AZOOR?. Retina. 2023;43(11):1890-1903.
- Fabiani C, Shantha J, Gangaputra S, Vitale A, Thorne JE, Jabs DA, et al. Is it Time to Adopt a New Nomenclature and Classification for White Dot Syndromes Using Multimodal Imaging Techniques? Report 1 from Multimodal Imaging in Uveitis (MUV) Task Force. Ocul Immunol Inflamm. 2025;33(4):561-569.
- Invernizzi A, Agarwal A, Jampol LM, Sadda SR, Cimino L, Gangaputra S, et al. Deconstructing White Dot Syndromes-Multimodal Imaging in Uveitis (MUV) Taskforce: Report 11. Am J Ophthalmol. 2026;289:168-181.
- Raven ML, Ringeisen AL, Yonekawa Y, Stem MS, Faia LJ, Gottlieb JL. Multi-modal imaging and anatomic classification of the white dot syndromes. Int J Retina Vitreous. 2017;3:12.
- Munk MR, Stillenmunkes R, Tillmann A, Jampol LM, Cicinelli MV, Lin P, et al. Evidence and Consensus Based Imaging Guidelines in Multiple Evanescent White Dot Syndrome Multimodal imaging in Uveitis (MUV) Taskforce Report 6. Am J Ophthalmol. 2025;278:191-202.
- Gangaputra S, Agarwal A, Norel JO, Tsui E, Thorne JE, de-la-Torre A, et al. Evidence and Consensus-Based Imaging Guidelines in Multifocal Choroiditis With Panuveitis and Punctate Inner Choroiditis-Multimodal Imaging in Uveitis (MUV) Taskforce Report 5. Am J Ophthalmol. 2025;276:272-285.
- Vianna RNG, Moraes RT, Nascimento H, Messias A, Oréfice J, Brazuna M, et al. From white dot syndromes to primary inflammatory choriocapillaropathies (PICCPs): updating and expanding the spectrum through multimodal imaging. Int J Retina Vitreous. 2026.
- Cicinelli MV, Ramtohul P, Marchese A, Bandello F, Bailey Freund K, Miserocchi E, et al. Latest advances in white spot syndromes: New findings and interpretations. Prog Retin Eye Res. 2023;97:101207.
- Russell JF, Pichi F, Scott NL, Hartley MJ, Bell D, Agarwal A, et al. Masqueraders of multiple evanescent white dot syndrome (MEWDS). Int Ophthalmol. 2020;40(3):627-638.
- Gilbert RM, Niederer RL, Kramer M, Sharief L, Sharon Y, Bar A, et al. Differentiating Multifocal Choroiditis and Punctate Inner Choroidopathy: A Cluster Analysis Approach. Am J Ophthalmol. 2020;213:244-251.
- Lee SY, Cheng JL, Gehrs KM, Folk JC, Sohn EH, Russell SR, et al. Choroidal Features of Acute Macular Neuroretinopathy via Optical Coherence Tomography Angiography and Correlation With Serial Multimodal Imaging. JAMA Ophthalmol. 2017;135(11):1177-1183.
- Iijima H, Yamaguchi S, Kogure S, Hosaka O, Shibutani T. Electroretinogram in cone dystrophy. Jpn J Ophthalmol. 1991;35(4):453-66.
- Lee EK, Lee SY, Ma DJ, Yoon CK, Park UC, Yu HG. RETINITIS PIGMENTOSA SINE PIGMENTO: Clinical Spectrum and Pigment Development. Retina. 2022;42(4):807-815.
- Del Pozo-Valero M, Riveiro-Alvarez R, Blanco-Kelly F, Aguirre-Lamban J, Martin-Merida I, Iancu IF, et al. Genotype-Phenotype Correlations in a Spanish Cohort of 506 Families With Biallelic ABCA4 Pathogenic Variants. Am J Ophthalmol. 2020;219:195-204.
- Marmor MF, Ahn SJ, Ehlers JP, Melles RB, Mieler WF, Sarraf D, et al. Special AAO Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2025 Revision). Ophthalmology. 2026;133(4):439-450.
- Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology. 2016;123(6):1386-94.
- Eo DR, Lee MG, Ham DI, Kang SW, Lee J, Cha HS, et al. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases. J Korean Med Sci. 2017;32(3):522-527.
- Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye (Lond). 2017;31(6):828-845.
- Lee JM, Kwon HY, Ahn SJ. Atypical Presentations of Hydroxychloroquine Retinopathy: A Case Series Study. J Clin Med. 2024;13(12).
- Kjellström U, Andréasson S, Ponjavic V. Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication. Acta Ophthalmol. 2014;92(2):149-57.
- Plant GT, Sergott RC. Understanding and interpreting vision safety issues with vigabatrin therapy. Acta Neurol Scand Suppl. 2011.
- Gonzalez P, Sills GJ, Parks S, Kelly K, Stephen LJ, Keating D, et al. Binasal visual field defects are not specific to vigabatrin. Epilepsy Behav. 2009;16(3):521-6.
- Lindeke-Myers A, Hanif AM, Jain N. Pentosan polysulfate maculopathy. Surv Ophthalmol. 2022;67(1):83-96.
- Abou-Jaoude M, Fraser C, Maldonado RS. Update on maculopathy secondary to pentosan polysulfate toxicity. Curr Opin Ophthalmol. 2021;32(3):233-239.
- Hall BP, Shiromani S, Vanderbeek BL, Datta S, Girardot PE, Rajagopalan A, et al. Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality. Prog Retin Eye Res. 2025;109:101400.
- Lee AG, Chau FY, Golnik KC, Kardon RH, Wall M. The diagnostic yield of the evaluation for isolated unexplained optic atrophy. Ophthalmology. 2005;112(5):757-9.
- Bikbov MM, Iakupova EM, Gilmanshin TR, Bikbova GM, Kazakbaeva GM, Panda-Jonas S, et al. Prevalence and Associations of Nonglaucomatous Optic Nerve Atrophy in High Myopia: The Ural Eye and Medical Study. Ophthalmology. 2023;130(11):1174-1181.
- Van Stavern GP. Metabolic, hereditary, traumatic, and neoplastic optic neuropathies. Continuum (Minneap Minn). 2014;20(4 Neuro-ophthalmology):877-906.
- Ueda K, Kanamori A, Akashi A, Matsumoto Y, Yamada Y, Nakamura M. Evaluation of the distribution pattern of the circumpapillary retinal nerve fibre layer from the nasal hemiretina. Br J Ophthalmol. 2015;99(10):1419-23.
- Leal BC, Moura FC, Monteiro ML. Retinal nerve fiber layer loss documented by Stratus OCT in patients with pituitary adenoma: case report. Arq Bras Oftalmol. 2006;69(2):251-4.
- Danesh-Meyer HV, Yoon JJ, Lawlor M, Savino PJ. Visual loss and recovery in chiasmal compression. Prog Retin Eye Res. 2019;73:100765.
- Lee GI, Kim J, Lee D, Park KA, Oh SY, Kong DS, et al. Ganglion cell inner plexiform layer thickness measured by optical coherence tomography to predict visual outcome in chiasmal compression. Sci Rep. 2022;12(1):14826.
- Lee GI, Park KA, Oh SY, Kong DS. Parafoveal and Peripapillary Perfusion Predict Visual Field Recovery in Chiasmal Compression due to Pituitary Tumors. J Clin Med. 2020;9(3).
- Rakusiewicz-Krasnodębska K, Bogusz-Wójcik A, Chmielarz-Czarnocińska A, Moszczyńska E, Hautz W. Clinical Value of Optical Coherence Tomography in Craniopharyngioma. Cancers (Basel). 2026;18(6).
- Bulters DO, Shenouda E, Evans BT, Mathad N, Lang DA. Visual recovery following optic nerve decompression for chronic compressive neuropathy. Acta Neurochir (Wien). 2009;151(4):325-34.
- Kim JH, Hong CK, Shin HJ, Kong DS. Feasibility and efficacy of endoscopic transorbital optic canal decompression for meningiomas causing compressive optic neuropathy. J Neurosurg. 2024;140(2):412-419.
- Lefevre E, Terrier LM, Bekaert O, Simonneau A, Rogers A, Vignal-Clermont C, et al. Microsurgical Transcranial Approach of 112 Paraoptic Meningiomas: A Single-Center Case Series. Oper Neurosurg. 2020;19(6):651-658.
- Jiang L, Shi J, Liu W, Kang J, Wang N. [Clinical feature of chronic compressive optic neuropathy without optic atrophy]. Zhonghua Yan Ke Za Zhi. 2014;50(12):889-93.
- Carey AR, Page BR, Miller N. Radiation-induced optic neuropathy: a review. Br J Ophthalmol. 2023;107(6):743-749.
- Margolin E, Handzic A. Post-radiation optic neuropathy. Pract Neurol. 2025;25(3):257-259.
- Brown GC, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Schatz NJ. Radiation optic neuropathy. Ophthalmology. 1982;89(12):1489-93.
- Kline LB, Kim JY, Ceballos R. Radiation optic neuropathy. Ophthalmology. 1985;92(8):1118-26.
- Sotirchos ES, Gonzalez Caldito N, Filippatou A, Fitzgerald KC, Murphy OC, Lambe J, et al. Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy. Ann Neurol. 2020;87(6):885-896.
- Mbekeani JN, Fattah MA, Poulsen DM, Hazzaa SA, Dababo MA, Eldali A, et al. Etiology of optic atrophy: a prospective observational study from Saudi Arabia. Ann Saudi Med. 2017;37(3):232-239.
- Mustafa S, Pandit L. Approach to diagnosis and management of optic neuropathy. Neurol India. 2014;62(6):599-605.
- Becker M, Masterson K, Delavelle J, Viallon M, Vargas MI, Becker CD. Imaging of the optic nerve. Eur J Radiol. 2010;74(2):299-313.
- Mudgil AV, Repka MX. Childhood optic atrophy. Clin Exp Ophthalmol. 2000;28(1):34-7.
- Zheng L, Do HH, Sandercoe T, Jamieson RV, Grigg JR. Changing patterns in paediatric optic atrophy aetiology: 1979 to 2015. Clin Exp Ophthalmol. 2016;44(7):574-581.
- Azizi AA, Walker DA, Liu JF, Sehested A, Jaspan T, Pemp B, et al. NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat. Neuro Oncol. 2021;23(1):100-111.
- Gizicki R, Robert MC, Gómez-López L, Orquin J, Decarie JC, Mitchell GA, et al. Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type. Ophthalmology. 2014;121(1):381-386.
- Urano F. Wolfram Syndrome: Diagnosis, Management, and Treatment. Curr Diab Rep. 2016;16(1):6.
- Toomes C, Marchbank NJ, Mackey DA, Craig JE, Newbury-Ecob RA, Bennett CP, et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet. 2001;10(13):1369-78.
- Amati-Bonneau P, Milea D, Bonneau D, Chevrollier A, Ferré M, Guillet V, et al. OPA1-associated disorders: phenotypes and pathophysiology. Int J Biochem Cell Biol. 2009;41(10):1855-65.
- Nasca A, Rizza T, Doimo M, Legati A, Ciolfi A, Diodato D, et al. Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations. Orphanet J Rare Dis. 2017;12(1):89.
- Han J, Li Y, You Y, Fan K, Lei B. Autosomal dominant optic atrophy caused by six novel pathogenic OPA1 variants and genotype-phenotype correlation analysis. BMC Ophthalmol. 2022;22(1):322.
- Russo A, Delcassi L, Marchina E, Semeraro F. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation. Ophthalmic Genet. 2013;34(1-2):69-74.
- Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet. 1997;34(10):838-41.
- de Muijnck C, Haer-Wigman L, van Everdingen JAM, Lushchyk T, Heutinck PAT, van Dooren MF, et al. Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy. Sci Rep. 2024;14(1):22956.
- de Muijnck C, Brink JBT, Bergen AA, Boon CJF, van Genderen MM. Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum. Surv Ophthalmol. 2023;68(4):641-654.
- Hull S, Sheck L, Braatvedt G, Mouat F, Jefferies C, Yap P, et al. The phenotypic spectrum of syndromic optic atrophy associated with variants in WFS1: with reclassification of p.Val606Gly as a likely benign variant. Ophthalmic Genet. 2025;46(4):362-369.
- Kabanovski A, Donaldson L, Margolin E. Neuro-ophthalmological manifestations of Wolfram syndrome: Case series and review of the literature. J Neurol Sci. 2022;437:120267.
- Seo Y, Kim TY, Won D, Shin S, Choi JR, Lee ST, et al. Genetic spectrum and characteristics of autosomal optic neuropathy in Korean: Use of next-generation sequencing in suspected hereditary optic atrophy. Front Neurol. 2022;13:978532.
- Fiorini C, Jurkute N, Torraco A, La Morgia C, Ghezzi D, Tioli G, et al. Recessive variants in mitochondrial complex I nuclear subunits are an underrated cause of optic atrophy. Brain. 2026;149(7):2463-2479.
- Zhang YX, Huang HB, Wei SH. Clinical characteristics of nonglaucomatous optic disc cupping. Exp Ther Med. 2014;7(4):995-999.
- Danesh-Meyer HV, Savino PJ, Sergott RC. The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108(3):593-8.
- Sebag J, Thomas JV, Epstein DL, Grant WM. Optic disc cupping in arteritic anterior ischemic optic neuropathy resembles glaucomatous cupping. Ophthalmology. 1986;93(3):357-61.
- Orgül S, Gass A, Flammer J. Optic disc cupping in arteritic anterior ischemic optic neuropathy. Ophthalmologica. 1994;208(6):336-8.
- Hayreh SS, Jonas JB. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108(9):1586-94.
- Ortiz RG, Newman NJ, Manoukian SV, Diesenhouse MC, Lott MT, Wallace DC. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber’s hereditary optic neuropathy. Am J Ophthalmol. 1992;113(5):561-6.
- Weiner NC, Newman NJ, Lessell S, Johns DR, Lott MT, Wallace DC. Atypical Leber’s hereditary optic neuropathy with molecular confirmation. Arch Neurol. 1993;50(5):470-3.
- Lin YH, Wang NK, Yeung L, Lai CC, Chuang LH. Juvenile open-angle Glaucoma associated with Leber’s hereditary optic neuropathy: a case report and literature review. BMC Ophthalmol. 2018;18(1):323.
- Sharma M, Volpe NJ, Dreyer EB. Methanol-induced optic nerve cupping. Arch Ophthalmol. 1999;117(2):286.
- Galvez-Ruiz A, Elkhamary SM, Asghar N, Bosley TM. Cupping of the optic disk after methanol poisoning. Br J Ophthalmol. 2015;99(9):1220-3.
- Shin YW, Uhm KB. A case of optic nerve atrophy with severe disc cupping after methanol poisoning. Korean J Ophthalmol. 2011;25(2):146-50.
- Jafarizadeh A, Homaie M, Abdollahi M, Niyousha M. Time course study of optical coherence tomography angiography in patients with methanol induced optic neuropathy. BMC Ophthalmol. 2023;23(1):178.
- Danesh-Meyer HV, Boland MV, Savino PJ, Miller NR, Subramanian PS, Girkin CA, et al. Optic disc morphology in open-angle glaucoma compared with anterior ischemic optic neuropathies. Invest Ophthalmol Vis Sci. 2010;51(4):2003-10.
- Fard MA, Afzali M, Abdi P, Chen R, Yaseri M, Azaripour E, et al. Optic Nerve Head Morphology in Nonarteritic Anterior Ischemic Optic Neuropathy Compared to Open-Angle Glaucoma. Invest Ophthalmol Vis Sci. 2016;57(11):4632-40.
- Resch H, Mitsch C, Pereira I, Schwarzhans F, Wasserman L, Hommer A, et al. Optic nerve head morphology in primary open-angle glaucoma and nonarteritic anterior ischaemic optic neuropathy measured with spectral domain optical coherence tomography. Acta Ophthalmol. 2018;96(8):e1018-e1024.
- Smeets F, Margot A, Barbosa-Breda J, Stalmans I, Lemmens S. Differentiating Ischemic Optic Neuropathy from Glaucoma Using Diagnostic Tests. Ophthalmic Res. 2024;67(1):154-171.
- Law SK, Kornmann HL, Nilforushan N, Moghimi S, Caprioli J. Evaluation of the “IS” Rule to Differentiate Glaucomatous Eyes From Normal. J Glaucoma. 2016;25(1):27-32.
- Matheu Fabra A, Saint-Gerons Trecu M, Quiroz Quiroga MJ, Armentia Pérez de Mendiola J, Martínez Palmer A, Martín Baranera M. Discrimination of glaucomatous from non-glaucomatous optic neuropathy with swept-source optical coherence tomography. J Fr Ophtalmol. 2023;46(8):941-948.
- Enz TJ, Clavadetscher SC, Gugleta K, Jaggi GP. Sequential Bilateral Non-Arteritic Anterior Ischaemic Optic Neuropathy in Superficial Intracranial Siderosis. Klin Monbl Augenheilkd. 2016;233(4):399-401.
- Patil A, Takkar A, Goyal M, Singh R, Lal V. Sequential NAION presenting as pseudo Foster Kennedy syndrome. J Neurol Sci. 2017;376:49-51.
- Pietraszkiewicz A, Ayesha A, Digre KB, Warner JE, Seay MD, Crum AV, et al. Diagnostic dilemma: Leber’s hereditary optic neuropathy in a 70-year-Old woman. Am J Ophthalmol Case Rep. 2024;36:102143.
- Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40(4):415-46.
- Desai T, Sudhalkar A, Vyas U, Khamar B. Methanol poisoning: predictors of visual outcomes. JAMA Ophthalmol. 2013;131(3):358-64.
- Zniber A, Benhadda S, Badrane N, Ennafiri M, Chaoui H, Tahri MY, et al. Methanol poisoning outbreak in a northwestern Moroccan town: report of 22 cases treated with hemodialysis. Clin Toxicol (Phila). 2025;63(10):727-733.
- Baglin G, Betermiez P, Bertout A, Toussaint P, Bremond-Gignac D, Milazzo S. [Pituitary apoplexy and severe bilateral visual loss: a case report]. J Fr Ophtalmol. 2009;32(8):572-6.
- Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68(3):229-32.
- Seay MD, Digre KB. Idiopathic Intracranial Hypertension from Benign to Fulminant: Diagnostic and Management Issues. Ann Indian Acad Neurol. 2022;25(Suppl 2):S59-S64.
- Mukherjee N, Bhatti MT. Update on the surgical management of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep. 2014;14(3):438.
- Sadun AA. Metabolic optic neuropathies. Semin Ophthalmol. 2002;17(1):29-32.
- Oliveira C. Toxic-Metabolic and Hereditary Optic Neuropathies. Continuum (Minneap Minn). 2019;25(5):1265-1288.
- Sawicka-Pierko A, Obuchowska I, Hady RH, Mariak Z, Dadan J. Nutritional optic neuropathy following bariatric surgery. Wideochir Inne Tech Maloinwazyjne. 2014;9(4):662-6.
- Rempe T, Tarhan B, Rodriguez E, Viswanathan VT, Gyang TV, Carlson A, et al. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience. Mult Scler Relat Disord. 2021;48:102718.
- Ojha PT, Aglave VB, Soni G, Jagiasi KA, Singh RK, Singh RK, et al. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder. Neurol India. 2020;68(5):1106-1114.
- Newman NJ. Perioperative visual loss after nonocular surgeries. Am J Ophthalmol. 2008;145(4):604-610.
- Roth S. Perioperative visual loss: what do we know, what can we do?. Br J Anaesth. 2009;103 Suppl 1(Suppl 1):i31-40.
- Torossian A, Schmidt J, Schaffartzik W, Wulf H. [Loss of vision after non-ophthalmic surgery: systematic review of the literature on incidence, pathogenesis, treatment and prevention]. Anaesthesist. 2006;55(4):457-64.
- Buono LM, Foroozan R, Savino PJ, Danesh-Meyer HV, Stanescu D. Posterior ischemic optic neuropathy after hemodialysis. Ophthalmology. 2003;110(6):1216-8.
- Basile C, Addabbo G, Montanaro A. Anterior ischemic optic neuropathy and dialysis: role of hypotension and anemia. J Nephrol. 2001;14(5):420-3.
- Carell EM. Case Report: Combined Ischemic Optic Neuropathy and Central Retinal Artery Occlusion after Starting Hemodialysis. Optom Vis Sci. 2021;98(3):212-216.
- Reale C, Brigandì A, Gorgoglione N, Laganà A, Girlanda P. Terson’s syndrome. Pract Neurol. 2020;20(2):163-164.
- Hayreh SS. Pathogenesis of Terson syndrome. Indian J Ophthalmol. 2022;70(12):4130-4137.
- Lima S, Azoia C, Guimarães P, Ramos C, Rocha L. Recovering vision function after post-traumatic bilateral occipital infarction. Acta Neurol Belg. 2026;126(3):871-876.
- Friedman DI. The Pseudotumor Cerebri Syndrome. Neurol Clin. 2024;42(2):433-471.
- Wang MTM, Bhatti MT, Danesh-Meyer HV. Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management. J Clin Neurosci. 2022;95:172-179.
- Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Arch Dis Child. 2017;102(9):853-857.
- Garcia-Filion P, Borchert M. Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations. Curr Treat Options Neurol. 2013;15(1):78-89.
- Kumar V, Karunakaran A, Valakada J. Septo-optic dysplasia. Int Ophthalmol. 2018;38(1):337-338.
- Ferran Kd, Paiva IA, Gilban DL, Resende M, Souza MA, Beserra IC, et al. Septo-optic dysplasia. Arq Neuropsiquiatr. 2010;68(3):400-5.
- Fard MA, Wu-Chen WY, Man BL, Miller NR. Septo-optic dysplasia. Pediatr Endocrinol Rev. 2010;8(1):18-24.
- Beuchat L, Safran AB. Optic nerve hypoplasia: papillary diameter and clinical correlation. J Clin Neuroophthalmol. 1985;5(4):249-53.
- Pang Y, Frantz KA. Value of the Heidelberg Retinal Tomograph in optic nerve hypoplasia. Optom Vis Sci. 2008;85(7):508-11.
- Skriapa-Manta A, Nilsson M, Svoboda J, Olsson M, Nilsson M, Teär Fahnehjelm K. Optical Coherence Tomography Can Predict Visual Acuity in Children with Optic Nerve Hypoplasia. Clin Ophthalmol. 2022;16:3785-3794.
- Kaur S, Jain S, Sodhi HB, Rastogi A, Kamlesh. Optic nerve hypoplasia. Oman J Ophthalmol. 2013;6(2):77-82.
- Tornqvist K, Ericsson A, Källén B. Optic nerve hypoplasia: Risk factors and epidemiology. Acta Ophthalmol Scand. 2002;80(3):300-4.
- Kim RY, Hoyt WF, Lessell S, Narahara MH. Superior segmental optic hypoplasia. A sign of maternal diabetes. Arch Ophthalmol. 1989;107(9):1312-5.
- Foroozan R. Superior segmental optic nerve hypoplasia and diabetes mellitus. J Diabetes Complications. 2005;19(3):165-7.
- Yepez JB, Murati FA, Pettito M, Peñaranda CF, de Yepez J, Maestre G, et al. Ophthalmic Manifestations of Congenital Zika Syndrome in Colombia and Venezuela. JAMA Ophthalmol. 2017;135(5):440-445.
- Salman MS, Ruth CA, Yogendran MS, Rozovsky K, Lix LM. Risk factors in children with optic nerve hypoplasia and septo-optic dysplasia. Dev Med Child Neurol. 2024;66(1):106-116.
- Saranac L, Gucev Z. New insights into septo-optic dysplasia. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(1):123-7.
- Bosch I Ara L, Katugampola H, Dattani MT. Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome. Front Pediatr. 2020;8:600962.
- Alatzoglou KS, Dattani MT. Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev. 2009;85(11):705-12.
- Koizumi M, Ida S, Shoji Y, Etani Y, Hatsukawa Y, Okamoto N. Endocrine status of patients with septo-optic dysplasia: fourteen Japanese cases. Clin Pediatr Endocrinol. 2017;26(2):89-98.
- Qian X, Fouzdar Jain S, Morgan LA, Kruse T, Cabrera M, Suh DW. Neuroimaging and endocrine disorders in paediatric optic nerve hypoplasia. Br J Ophthalmol. 2018;102(7):906-910.
- Braga TPC, Beserra ICR. Clinical, laboratory and neuroimaging profile of patient’s cohort with septo-optic dysplasia treated at a pediatric university hospital. J Pediatr (Rio J). 2025;101(2):209-215.
- Nalawade R, Bhate M. Septo-Optic Dysplasia: A Case Series of 33 Patients. Neuroophthalmology. 2024;48(1):13-18.
- Nanduri VR, Stanhope R. Why is the retention of gonadotrophin secretion common in children with panhypopituitarism due to septo-optic dysplasia?. Eur J Endocrinol. 1999;140(1):48-50.
- Vedin AM, Garcia-Filion P, Fink C, Borchert M, Geffner ME. Serum prolactin concentrations in relation to hypopituitarism and obesity in children with optic nerve hypoplasia. Horm Res Paediatr. 2012;77(5):277-80.
- Gasco V, Matarazzo P, De Sanctis L, Ghigo E. Growth hormone deficiency in a case of septo-optic-dysplasia due to SOX2 mutation: should we re-test patients during the transition period?. BMJ Case Rep. 2022;15(12).
- Salman MS, Hossain S, Rozovsky K. Neuroimaging Features in Children with Optic Nerve Hypoplasia and Septo-Optic-Pituitary Dysplasia. Can J Neurol Sci. 2024;51(3):416-424.
- Salman MS, Hossain S, Carson E, Ruth CA, Clark IH. Visual Acuity Outcomes in Children With Optic Nerve Hypoplasia and Septo-Optic-Pituitary Dysplasia. Pediatr Neurol. 2023;149:167-175.
- Weiss AH, Kelly JP. Acuity, ophthalmoscopy, and visually evoked potentials in the prediction of visual outcome in infants with bilateral optic nerve hypoplasia. J AAPOS. 2003;7(2):108-15.
- McCulloch DL, Garcia-Filion P, Fink C, Chaplin CA, Borchert MS. Clinical electrophysiology and visual outcome in optic nerve hypoplasia. Br J Ophthalmol. 2010;94(8):1017-23.
- Bradfield YS, Ver Hoeve JN, Aul B, Struck MC. Use of sweep visual evoked potential in preverbal children with optic nerve hypoplasia. J AAPOS. 2022;26(3):131.e1-131.e6.
- Kurent A, Brecelj J, Stirn-Kranjc B. Electroretinograms in idiopathic infantile nystagmus, optic nerve hypoplasia and albinism. Eur J Ophthalmol. 2020;30(1):147-154.
- Papageorgiou E, McLean RJ, Gottlob I. Nystagmus in childhood. Pediatr Neonatol. 2014;55(5):341-51.
- Wu JH, Lin CW, Liu CH, Weinreb RN, Welsbie DS. Superior segmental optic nerve hypoplasia: A review. Surv Ophthalmol. 2022;67(5):1467-1475.
- Takagi M, Abe H, Hatase T, Yaoeda K, Miki A, Shirakashi M. Superior segmental optic nerve hypoplasia in youth. Jpn J Ophthalmol. 2008;52(6):468-474.
- Seo S, Lee CE, Kim DW, Kim YK, Jeoung JW, Kim CY, et al. Prevalence and risk factors of superior segmental optic hypoplasia in a Korean population: the Korea National Health and Nutrition Examination Survey. BMC Ophthalmol. 2014;14:157.
- Slusher MM, Weaver RG Jr, Greven CM, Mundorf TK, Cashwell LF. The spectrum of cavitary optic disc anomalies in a family. Ophthalmology. 1989;96(3):342-7.
- Palanivel S, Rajendran A, Maitra P, Rajamani A. Hybrid cavitary disc anomaly - A case series and proposal of a novel classification system. Indian J Ophthalmol. 2025;73(11):1627-1632.
- Lee BJ, Traboulsi EI. Update on the morning glory disc anomaly. Ophthalmic Genet. 2008;29(2):47-52.
- Zou Y, She K, Hu Y, Ren J, Fei P, Xu Y, et al. Clinical and Echographic Features of Morning Glory Disc Anomaly in Children: A Retrospective Study of 249 Chinese Patients. Front Med (Lausanne). 2021;8:800623.
- Kumar J, Adenuga OO, Singh K, Ahuja AA, Kannan NB, Ramasamy K. Clinical characteristics of morning glory disc anomaly in South India. Taiwan J Ophthalmol. 2021;11(1):57-63.
- Kim MR, Park SE, Oh SY. Clinical feature analysis of congenital optic nerve abnormalities. Jpn J Ophthalmol. 2006;50(3):250-5.
- Käsmann-Kellner B, Moslemani K, Seitz B. [Clinical and Genetic Characteristics of Ocular Developmental Disorders: MAC-Spectrum, Anterior Segment Dysgenesis]. Klin Monbl Augenheilkd. 2019;236(3):269-285.
- Komiyama M, Yasui T, Sakamoto H, Fujita K, Sato T, Ota M, et al. Basal meningoencephalocele, anomaly of optic disc and panhypopituitarism in association with moyamoya disease. Pediatr Neurosurg. 2000;33(2):100-4.
- Pavanello M, Fiaschi P, Accogli A, Severino M, Tortora D, Piatelli G, et al. A rare triad of morning glory disc anomaly, moyamoya vasculopathy, and transsphenoidal cephalocele: pathophysiological considerations and surgical management. Neurol Sci. 2021;42(12):5433-5439.
- Hanson MR, Price RL, Rothner AD, Tomsak RL. Developmental anomalies of the optic disc and carotid circulation. A new association. J Clin Neuroophthalmol. 1985;5(1):3-8.
- Fernández-Fernández S, Vázquez-López M, Carrasco-Marina LL, Vela-Valdecabres C, Cortés-Valdés E, Arregui-Sierra A. [An association between moya-moya disease and morning glory anomaly]. Rev Neurol. 2003;37(6):541-4.
- Ponnatapura J. Morning glory syndrome with Moyamoya disease: A rare association with role of imaging. Indian J Radiol Imaging. 2018;28(2):165-168.
- Radder N, Radder S. Morning Glory Disc Anomaly With Ipsilateral Carotid Vasculopathy: MRI Characteristics and Clinical Implications. Cureus. 2025;17(10):e93932.
- Metry D, Heyer G, Hess C, Garzon M, Haggstrom A, Frommelt P, et al. Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics. 2009;124(5):1447-56.
- Altun A, Altun G, Kurna SA, Olcaysu OO, Aki SF. Unilateral morning glory optic disc anomaly in a case with Down syndrome. BMC Ophthalmol. 2014;14:48.
- Amanallah MR, Chraa M, Louhab N, Balili K. Microphthalmia and Infantile Spasms Leading to the Diagnosis of Aicardi Syndrome: A Case Report and Literature Review of a Rare Entity. Cureus. 2025;17(12):e99822.
- Chang S, Gregory-Roberts E, Chen R. Retinal detachment associated with optic disc colobomas and morning glory syndrome. Eye (Lond). 2012;26(4):494-500.
- Etheridge T, Oakey Z, Altaweel MM. Management of Retinal Detachment Associated with Morning Glory Disc Syndrome. Case Rep Ophthalmol. 2021;12(2):457-463.
- Babu N, Kohli P. Surgical challenges in the management of morning glory disc anomaly-associated retinal detachment. Indian J Ophthalmol. 2021;69(9):2540-2541.
- Wu S, Wang W, Liu L, Wang W, Jiang K, Peng C, et al. Progress in the Management of Retinal Detachment Associated With Morning Glory Syndrome. Clin Ophthalmol. 2025;19:459-468.
- Cavazos-Adame H, Olvera-Barrios A, Martinez-Lopez-Portillo A, Mohamed-Hamsho J. Morning Glory Disc Anomaly, A Report of a Successfully Treated Case of Functional Amblyopia. J Clin Diagn Res. 2015;9(10):ND01-3.
- Chesneau B, Ivashchenko V, Habib C, Gaston V, Escudié F, Morel G, et al. Evaluation of somatic and/or germline mosaicism in congenital malformation of the eye. Eur J Hum Genet. 2023;31(5):526-530.
- Kumar K, Tanwar M, Naithani P, Insaan R, Garg S, Venkatesh P, et al. PAX6 gene analysis in irido-fundal coloboma. Mol Vis. 2011;17:1414-9.
- Schimmenti LA. Renal coloboma syndrome. Eur J Hum Genet. 2011;19(12):1207-12.
- Giovanella S, Pasini A, Ligabue G, Testa F, Mori G, Tagliafico E, et al. PAX2/Renal Coloboma Syndrome Expresses Extreme Intrafamilial Phenotypic Variability. Nephron. 2023;147(2):120-126.
- Benador-Shen CL, Reichel E, Reed D, Milner LS, Pinnell N, Choi CS. Ocular phenotype in a patient with PAX2 gene mutation-associated papillorenal syndrome. Ophthalmic Genet. 2022;43(3):385-388.
- Lee HJ, Heo JW, Jung JH. Vitrectomy for Retinoschisis in Papillorenal Syndrome Related to PAX2 Mutation. Ophthalmology. 2023;130(8):843.
- Bassi ST, George R, Sen S, Asokan R, Lingam V. Prevalence of the optic disc anomalies in the adult South Indian population. Br J Ophthalmol. 2019;103(1):94-98.
- Wang Y, Xu L, Jonas JB. Prevalence of congenital optic disc pits in adult Chinese: The Beijing Eye Study. Eur J Ophthalmol. 2006;16(6):863-4.
- Chopra A, Shahriar I, Nisanova A, Estrada M, Gandhi N, Shankar SP, et al. Congenital Optic Nerve Anomalies and Associated Systemic Conditions. Int Ophthalmol Clin. 2026;66(2):78-93.
- Gowdar JP, Rajesh B, Giridhar A, Gopalakrishnan M, Hussain R, Thachil T. An insight into the pathogenesis of optic disc pit-associated maculopathy with enhanced depth imaging. JAMA Ophthalmol. 2015;133(4):466-9.
- Prabhu V, Mangla R, Acharya I, Handa A, Thadani A, Parmar Y, et al. Evaluation of baseline optic disc pit and optic disc coloboma maculopathy features by spectral domain optical coherence tomography. Int J Retina Vitreous. 2023;9(1):46.
- Sanghi G, Padhi TR, Warkad VU, Vazirani J, Gupta V, Dogra MR, et al. Optical coherence tomography findings and retinal changes after vitrectomy for optic disc pit maculopathy. Indian J Ophthalmol. 2014;62(3):287-90.
- Theodossiadis GP, Theodossiadis PG, Ladas ID, Zafirakis PK, Kollia AC, Koutsandrea C, et al. Cyst formation in optic disc pit maculopathy. Doc Ophthalmol. 1999;97(3-4):329-35.
- Moisseiev E, Moisseiev J, Loewenstein A. Optic disc pit maculopathy: when and how to treat? A review of the pathogenesis and treatment options. Int J Retina Vitreous. 2015;1:13.
- Kalogeropoulos D, Ch’ng SW, Lee R, Elaraoud I, Purohit M, Felicida V, et al. Optic Disc Pit Maculopathy: A Review. Asia Pac J Ophthalmol (Phila). 2019;8(3):247-255.
- Chatziralli I, Theodossiadis P, Theodossiadis GP. Optic disk pit maculopathy: current management strategies. Clin Ophthalmol. 2018;12:1417-1422.
- Bloch E, Georgiadis O, Lukic M, da Cruz L. Optic Disc Pit Maculopathy: New Perspectives on the Natural History. Am J Ophthalmol. 2019;207:159-169.
- Benatti E, Garoli E, Viola F. SPONTANEOUS RESOLUTION OF OPTIC DISK PIT MACULOPATHY IN A CHILD AFTER A SIX-YEAR FOLLOW-UP. Retin Cases Brief Rep. 2021;15(4):453-456.
- Card KR, Zeiger JS, Vempuluru VS, Shields CL. Spontaneous onset and resolution of optic disk pit maculopathy in a young patient. J AAPOS. 2024;28(3):103902.
- Yuen CH, Kaye SB. Spontaneous resolution of serous maculopathy associated with optic disc pit in a child: a case report. J AAPOS. 2002;6(5):330-1.
- Rii T, Hirakata A, Inoue M. Comparative findings in childhood-onset versus adult-onset optic disc pit maculopathy. Acta Ophthalmol. 2013;91(5):429-33.
- Kang HG, Kim JD, Lee J, Byeon SH, Kim SS, Kim M. Clinical features, treatment factors, and long-term outcomes of optic disc pit maculopathy. Graefes Arch Clin Exp Ophthalmol. 2022;260(9):2867-2875.
- Oli A, Balakrishnan D. Treatment outcomes of optic disc pit maculopathy over two decades. Ther Adv Ophthalmol. 2021;13:25158414211027715.
- Meng L, Zhao X, Zhang W, Wang D, Chen Y. The characteristics of optic disc pit maculopathy and the efficacy of vitrectomy: a systematic review and meta-analysis. Acta Ophthalmol. 2021;99(7):e1176-e1189.
- D’souza P, Verghese S, Ranjan R, Kumarswamy K, Saravanan VR, Manayath GJ, et al. Optic Disc Pit Maculopathy: One-Year Outcomes of Pars Plana Vitrectomy with Foveal Sparing Inverted Internal Limiting Membrane Flap. Cureus. 2021;13(3):e14057.
- Chaves L, Costa J, Bastos T, Albuquerque M, Scott I, Jorge R. Gas tamponade followed by laser treatment for macular retinal detachment secondary to optic pit. Arq Bras Oftalmol. 2023;86(5):e20230066.
- Gklavas K, Athanasiou A, Neubauer J, Lilou E, Pohl L, Bartz-Schmidt KU, et al. Long-term outcomes of autologous platelet treatment for optic disc pit maculopathy. Graefes Arch Clin Exp Ophthalmol. 2023;261(11):3177-3185.
- Orazbekov L, Bayanova A, Dauletbekov D. Surgical Treatment of Optic Disc Pit Associated with Macular Detachment. Case Rep Ophthalmol. 2022;13(3):829-833.
- Theodossiadis GP, Chatziralli IP, Theodossiadis PG. Macular buckling in optic disc pit maculopathy in association with the origin of macular elevation: 13-year mean postoperative results. Eur J Ophthalmol. 2015;25(3):241-8.
- Yokoi T, Ni RL, Sivalingam MD, Yonekawa Y. Recent advancements in optic disc pit maculopathy management. Curr Opin Ophthalmol. 2025;36(3):210-218.
- Kalogeropoulos D, Ch’ng SW, Lee R, Elaraoud I, Felicida V, Purohit M, et al. Optic Disc Pit Maculopathy - Case Series, Clinical Approach, and Management. Middle East Afr J Ophthalmol. 2020;27(1):34-39.
- Arora S, Zur D, Iovino C, Chhablani J. Peripapillary fluid: Obvious and not so obvious!. Surv Ophthalmol. 2024;69(3):311-329.
- Kumawat D, Anjum S, Sahay P, Chawla R. Central serous chorioretinopathy in a patient of juxtapapillary excavation misdiagnosed as optic disc pit maculopathy. BMJ Case Rep. 2018;2018.
- Feo A, Quarta A, Boscia G, Forte P, Borrelli E, Bousquet E, et al. Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies. Surv Ophthalmol. 2026.
- Mazzeo TJMM, Leber HM, da Silva AG, Freire RCM, Barbosa GCS, Criado GG, et al. Pachychoroid disease spectrum: review article. Graefes Arch Clin Exp Ophthalmol. 2022;260(3):723-735.
- Ober MD, Freund KB, Shah M, Ahmed S, Mahmoud TH, Aaberg TM Jr, et al. Stellate nonhereditary idiopathic foveomacular retinoschisis. Ophthalmology. 2014;121(7):1406-13.
- El-Gendy RS, El-Hamid ASA, Galhom AEA, Hassan NA, Ghoneim EM. Diagnostic dilemma of papilledema and pseudopapilledema. Int Ophthalmol. 2024;44(1):272.
- Sowka JW, Luong VV. Bitemporal visual field defects mimicking chiasmal compression in eyes with tilted disc syndrome. Optometry. 2009;80(5):232-42.
- Tan NYQ, Sng CCA, Jonas JB, Wong TY, Jansonius NM, Ang M. Glaucoma in myopia: diagnostic dilemmas. Br J Ophthalmol. 2019;103(10):1347-1355.
- Iwase A, Araie M. Implications of myopia in diagnosis and screening of open angle glaucoma. Curr Opin Ophthalmol. 2025;36(2):107-114.
- Kaimbo DK. Tilted disc syndrome in Congolese patients. J Fr Ophtalmol. 2010;33(3):174-7.
- Baca-Moreno J, Henaine-Berra A, Osorio-Landa HK, Berrones-Medina D, García-Aguirre G. Prevalence of Dome-Shaped Macula and Tilted Disc Syndrome in High Myopia. Ophthalmic Surg Lasers Imaging Retina. 2023;54(10):568-572.
- Cheng D, Ruan K, Wu M, Qiao Y, Gao W, Lian H, et al. Characteristics of the Optic Nerve Head in Myopic Eyes Using Swept-Source Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 2022;63(6):20.
- Hwang YH, Yoo C, Kim YY. Characteristics of peripapillary retinal nerve fiber layer thickness in eyes with myopic optic disc tilt and rotation. J Glaucoma. 2012;21(6):394-400.
- Jonas JB, Wang YX, Zhang Q, Fan YY, Xu L, Wei WB, et al. Parapapillary Gamma Zone and Axial Elongation-Associated Optic Disc Rotation: The Beijing Eye Study. Invest Ophthalmol Vis Sci. 2016;57(2):396-402.
- Sastre-Ibañez M, Martinez-de-la-Casa JM, Rebolleda G, Cifuentes-Canorea P, Nieves-Moreno M, Morales-Fernandez L, et al. Utility of Bruch membrane opening-based optic nerve head parameters in myopic subjects. Eur J Ophthalmol. 2018;28(1):42-46.
- Mosin IM. [Anomalies of optic nerve excavation: the clinical manifestations and differential diagnosis]. Vestn Oftalmol. 1999;115(5):10-4.
- Cohen SY, Quentel G, Guiberteau B, Delahaye-Mazza C, Gaudric A. Macular serous retinal detachment caused by subretinal leakage in tilted disc syndrome. Ophthalmology. 1998;105(10):1831-4.
- Nonaka K, Maruko I, Kakehashi M, Kawai M, Hasegawa T, Iida T. Asymmetric choroidal vascular pattern in tilted disc syndrome. Graefes Arch Clin Exp Ophthalmol. 2025;263(3):699-704.
- Milani P, Pece A, Pierro L, Seidenari P, Radice P, Scialdone A. Bevacizumab for macular serous neuroretinal detachment in tilted disk syndrome. J Ophthalmol. 2010;2010:970580.
- Lee EK, Yu HG. Outcomes of Anti-vascular Endothelial Growth Factor Treatment for Foveal Serous Retinal Detachment Associated with Inferior Staphyloma. Korean J Ophthalmol. 2019;33(3):228-237.
- Donati MC, Miele A, Abbruzzese G, Giuntoli M, Giansanti F, Menchini U. Treatment of macular serous neuroretinal detachment in tilted disk syndrome: report of 3 cases. Eur J Ophthalmol. 2013;23(2):267-70.
- Kathare R, Gandhi P, Prabhu V, Bavaskar S, Chhablani J, Venkatesh R. Posterior staphyloma-induced serous maculopathy: Evolution and successful treatment with subthreshold micro pulse Laser. Eur J Ophthalmol. 2024;34(6):NP48-NP53.
- Escribano Villafruela JC, Fuentes Zamora A, Gómez Fernández L, Ruiz Batrés JR, Urcelay Segura JL. Peripapillary intrachoroidal cavitation. Arch Soc Esp Oftalmol (Engl Ed). 2025;100(8):485-491.
- Lakraa R, Kanboui M, Abdallah EH. Peripapillary Intrachoroidal Cavitation in High Myopia: A Case Report. Cureus. 2026;18(3):e105212.
- Ohno-Matsui K, Fang Y, Shinohara K, Takahashi H, Uramoto K, Yokoi T. Imaging of Pathologic Myopia. Asia Pac J Ophthalmol (Phila). 2019;8(2):172-177.
- Arias Aristizábal JD, Cordoba-Ortega CM, Gómez Velasco MA, Barahona Campos JM. Classification of posterior staphyloma in pathologic myopia using 3D wide-field fundus imaging. Arch Soc Esp Oftalmol (Engl Ed). 2025;100(8):458-465.
- Jonas JB, Jonas RA, Bikbov MM, Wang YX, Panda-Jonas S. Myopia: Histology, clinical features, and potential implications for the etiology of axial elongation. Prog Retin Eye Res. 2023;96:101156.
- Cho SD, Yun YI, Kim M, Kim SH, Lee KM. Beta Zone and Gamma Zone Parapapillary Atrophy in Nonmyopic Eyes. J Glaucoma. 2026;35(5):326-334.
- Jonas JB, Jonas RA, Panda-Jonas S. Clinical and histological aspects of the anatomy of myopia, myopic macular degeneration and myopia-associated optic neuropathy. Prog Retin Eye Res. 2025;109:101402.
- Ohno-Matsui K. Pathologic Myopia. Asia Pac J Ophthalmol (Phila). 2016;5(6):415-423.
- Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, García-Layana A, Ruiz-Moreno JM. Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res. 2019;69:80-115.
- Wang NK, Wu YM, Wang JP, Liu L, Yeung L, Chen YP, et al. Clinical Characteristics of Posterior Staphylomas in Myopic Eyes With Axial Length Shorter Than 26.5 Millimeters. Am J Ophthalmol. 2016;162:180-190.e1.
- Hwang YH, Yoo C, Kim YY. Myopic optic disc tilt and the characteristics of peripapillary retinal nerve fiber layer thickness measured by spectral-domain optical coherence tomography. J Glaucoma. 2012;21(4):260-5.
- Yapp M, Rennie G, Hennessy MP, Kalloniatis M, Zangerl B. The impact of optic nerve and related characteristics on disc area measurements derived from different imaging techniques. PLoS One. 2018;13(1):e0190273.
- Jun JH, Lee SY. The effects of optic disc factors on retinal nerve fiber layer thickness measurement in children. Korean J Ophthalmol. 2008;22(2):115-22.
- Li F, Kong K, Jiang J, Han Y, Raman R, Chen HS, et al. Diagnostic Performance of Prespecified OCT Rules for Glaucomatous Optic Neuropathy in Nonpathologic Myopia. JAMA Ophthalmol. 2026.
- Hamann S, Malmqvist L, Costello F. Optic disc drusen: understanding an old problem from a new perspective. Acta Ophthalmol. 2018;96(7):673-684.
- Malmqvist L, Hamann S. The Optic Disc Drusen Studies Consortium Recommendations for Diagnosis of Optic Disc Drusen Using Optical Coherence Tomography: Response. J Neuroophthalmol. 2024;44(3):e492-e493.
- Zheng T, Yu H. Comment on: The Optic Disc Drusen Studies Consortium Recommendations for Diagnosis of Optic Disc Drusen Using Optical Coherence Tomography. J Neuroophthalmol. 2024;44(3):e492.
- Auw-Haedrich C, Staubach F, Witschel H. Optic disk drusen. Surv Ophthalmol. 2002;47(6):515-32.
- Lam BL, Morais CG Jr, Pasol J. Drusen of the optic disc. Curr Neurol Neurosci Rep. 2008;8(5):404-8.
- Thurtell MJ, Biousse V, Bruce BB, Newman NJ. Optic nerve head drusen in black patients. J Neuroophthalmol. 2012;32(1):13-6.
- Antcliff RJ, Spalton DJ. Are optic disc drusen inherited?. Ophthalmology. 1999;106(7):1278-81.
- Steensberg AH, Malmqvist L, Bertelsen M, Grønskov K, Hamann S. Prevalence Screening for Familial Optic Disc Drusen: A Cross-Sectional Study. Neuroophthalmology. 2025;49(1):43-50.
- Steensberg AH, Ovens C, Fraser CL, Malmqvist L, Bertelsen M, Grønskov K, et al. Whole genome sequencing of 10 families with optic disc drusen. Ophthalmic Genet. 2025;46(2):174-179.
- Hess K, Raming K, Charbel Issa P, Herrmann P, Holz FG, Pfau M. Inner retinal degeneration associated with optic nerve head drusen in pseudoxanthoma elasticum. Br J Ophthalmol. 2023;107(4):570-575.
- Ortiz-Toquero S, Muñoz-Negrete FJ, Rebolleda G. Enhanced Depth Imaging Optical Coherence Tomography Technology Reveals a Significant Association Between Optic Nerve Drusen Anterior Displacement and Retinal Nerve Fiber Layer Thinning Over Time. J Neuroophthalmol. 2021;41(4):e483-e489.
- Rudolph L, Baldassarre V, Halfter K, Lottspeich C, Rudolph G, Priglinger CS. Retinal peripapillary nerve fiber and retinal ganglion cell layer thickening preceed atrophy in children and teenagers with optic disc drusen. Sci Rep. 2025;15(1):39001.
- Farazdaghi MK, Trimboli-Heidler C, Liu GT, Garcia A, Ying GS, Avery RA. Utility of Ultrasound and Optical Coherence Tomography in Differentiating Between Papilledema and Pseudopapilledema in Children. J Neuroophthalmol. 2021;41(4):488-495.
- Thompson AC, Bhatti MT, El-Dairi MA. Bruch’s membrane opening on optical coherence tomography in pediatric papilledema and pseudopapilledema. J AAPOS. 2018;22(1):38-43.e3.
- Kaplan AT, Öskan Yalçın S, Güneş Sağer S. Clinical Findings and Optical Coherence Tomography Measurements of Pediatric Patients with Papilledema and Pseudopapilledema. Turk J Ophthalmol. 2023;53(5):294-300.
- Xiao D, Lhamo T, Meng Y, Xu Y, Chen C. Peripapillary hyperreflective ovoid mass-like structures: multimodal imaging and associated diseases. Front Neurol. 2024;15:1379801.
- Ahn YJ, Park YY, Shin SY. Peripapillary hyperreflective ovoid mass-like structures (PHOMS) in children. Eye (Lond). 2022;36(3):533-539.
- Vienne-Jumeau A, Lebranchu P, Akhenak I, Bremond-Gignac D, Robert MP. Peripapillary hyperreflective ovoid mass-like structure (PHOMS) and optic disc drusen in pediatric pseudo-papilledema. Graefes Arch Clin Exp Ophthalmol. 2025;263(6):1725-1732.
- Mateo C, Moreno JG, Lechuga M, Adán A, Corcóstegui B. Surgical removal of peripapillary choroidal neovascularization associated with optic nerve drusen. Retina. 2004;24(5):739-45.
- Law DZ, Yang FP, Teoh SC. Case report of optic disc drusen with simultaneous peripapillary subretinal hemorrhage and central retinal vein occlusion. Case Rep Ophthalmol Med. 2014;2014:156178.
- Duncan JE, Freedman SF, El-Dairi MA. The incidence of neovascular membranes and visual field defects from optic nerve head drusen in children. J AAPOS. 2016;20(1):44-8.
- Rueløkke LL, Malmqvist L, Wegener M, Hamann S. Optic Disc Drusen Associated Anterior Ischemic Optic Neuropathy: Prevalence of Comorbidities and Vascular Risk Factors. J Neuroophthalmol. 2020;40(3):356-361.
- Harris MJ, Fine SL, Owens SL. Hemorrhagic complications of optic nerve drusen. Am J Ophthalmol. 1981;92(1):70-6.
- Munteanu M. [Hemorrhagic complications of drusen of the optic disk]. J Fr Ophtalmol. 2007;30(1):58-67.
- Marr B, Reinherz B, Belinsky I, Saffra NA. PSEUDO UVEAL MELANOMA CAUSED BY OPTIC DISK DRUSEN WITH JUXTAPAPILLARY CHOROIDAL NEOVASCULAR MEMBRANE. Retin Cases Brief Rep. 2016;10(2):168-70.
- Phillips PH, Sheldon CA. Pediatric Pseudotumor Cerebri Syndrome. J Neuroophthalmol. 2017;37 Suppl 1:S33-S40.
- Komur M, Sari A, Okuyaz C. Simultaneous papilledema and optic disc drusen in a child. Pediatr Neurol. 2012;46(3):187-8.
- Rossiter JD, Lockwood AJ, Evans AR. Coexistence of optic disc drusen and idiopathic intracranial hypertension in a child. Eye (Lond). 2005;19(2):234-5.
- Escobar Gómez HD, Jaramillo Velásquez DL, Cárdenas Angelone PL, Martínez Malo LK, Vélez Álvarez C. Coexistence of idiopathic intracranial hypertension and optic disc drusen in a latin american patient: case report. Arch Soc Esp Oftalmol (Engl Ed). 2021;96(6):326-331.
- Simão LM, Andrade TN, Oliveira AFAOE, Garcez AGA, Jacometti R. Coexistence of papilledema and pseudopapilledema after remission of idiopathic intracranial hypertension by bariatric surgery. Arq Bras Oftalmol. 2020;83(2):157-159.
- Tea HRH, Roberson K, El-Dairi M. Using Optical Coherence Tomography in Pediatric Neuro-ophthalmology. Int Ophthalmol Clin. 2026;66(2):140-164.
- Apple DJ, Rabb MF, Walsh PM. Congenital anomalies of the optic disc. Surv Ophthalmol. 1982;27(1):3-41.
- Denis D, Hugo J, Beylerian M, Ramtohul P, Aziz A, Matonti F, et al. [Congenital abnormalities of the optic disc]. J Fr Ophtalmol. 2019;42(7):778-789.
- Straatsma BR, Foos RY, Heckenlively JR, Taylor GN. Myelinated retinal nerve fibers. Am J Ophthalmol. 1981;91(1):25-38.
- Grzybowski A, Winiarczyk I. Myelinated retinal nerve fibers (MRNF) - Dilemmas related to their influence on visual function. Saudi J Ophthalmol. 2015;29(1):85-8.
- Arda H, Oner A, Gumus K, Karakucuk S, Mirza E. The results of electrophysiological tests in unilateral extensive peripapillary myelinated nerve fibers: report of three cases. Doc Ophthalmol. 2009;119(3):225-8.
- Tarabishy AB, Alexandrou TJ, Traboulsi EI. Syndrome of myelinated retinal nerve fibers, myopia, and amblyopia: a review. Surv Ophthalmol. 2007;52(6):588-96.
- Xu K, Almeida DRP. Myelinated retinal nerve fibre, myopia, and amblyopia syndrome. Can J Ophthalmol. 2017;52(4):e127.
- Osaguona VB, Uhumwangho OM. Syndrome of myelinated retinal nerve fibres, myopia, amblyopia and strabismus in a Nigerian. Niger Med J. 2014;55(6):517-8.
- Shen Y, Zhao J, Sun L, Zeng L, Chen Z, Tian M, et al. The long-term observation in Chinese children with monocular myelinated retinal nerve fibers, myopia and amblyopia. Transl Pediatr. 2021;10(4):860-869.
- Santos-Bueso E, Asorey-García A, Vinuesa-Silva JM, García-Sánchez J. Bergmeister’s papilla. Arch Soc Esp Oftalmol. 2015;90(8):395-6.
- Chun YS, Moon NJ, Kim US, Yeo JH, Jeong JH. Effect of Bergmeister papilla on disc parameters in spectral domain optical coherence tomography. Eye (Lond). 2024;38(5):980-987.
- Saito H, Ueta T, Araie M, Enomoto N, Kambayashi M, Murata H, et al. Association of Bergmeister Papilla and Deep Optic Nerve Head Structures With Prelaminar Schisis of Normal and Glaucomatous Eyes. Am J Ophthalmol. 2024;257:91-102.
- Yu G, Zhai Z, Ge J. Morning Glory Syndrome With Bergmeister Papilla and Retinal Detachment. JAMA Ophthalmol. 2023;141(2):e225555.
- da Cruz NFS, Sengillo JD, Hudson JL, Carletti P, de Oliveira G, Negron CI, et al. Intraoperative OCT Angiography in Pediatric Patients with Persistent Fetal Vasculature. Ophthalmol Retina. 2023;7(12):1109-1115.
- Shields JA, Demirci H, Mashayekhi A, Shields CL. Melanocytoma of optic disc in 115 cases: the 2004 Samuel Johnson Memorial Lecture, part 1. Ophthalmology. 2004;111(9):1739-46.
- Shields JA, Shields CL, Ehya H, Dhaliwal RS. Total blindness from presumed optic nerve melanocytoma. Am J Ophthalmol. 2005;139(6):1113-4.
- Lee CS, Bae JH, Jeon IH, Byeon SH, Koh HJ, Lee SC. Melanocytoma of the optic disk in the Korean population. Retina. 2010;30(10):1714-20.
- Shields JA, Shields CL, Eagle RC Jr, Lieb WE, Stern S. Malignant melanoma associated with melanocytoma of the optic disc. Ophthalmology. 1990;97(2):225-30.
- Loeffler KU, Tecklenborg H. Melanocytoma-like growth of a juxtapapillary malignant melanoma. Retina. 1992;12(1):29-34.
- Sutter C, Jean-Charles A, Merle H. [Clinical and paraclinical course of melanocytoma of the optic disk. Contribution of spectral- and time-domain OCT in the study of 10 patients]. J Fr Ophtalmol. 2011;34(9):615-23.
- Lubinsky M, Encha-Razavi F. Delineating septo-optic dysplasia. Birth Defects Res. 2022;114(20):1343-1353.
- Ali M, Chang M, Leys M. De Novo PAX2 Mutation With Associated Papillorenal Syndrome: A Case Report and Literature Review of Penetrance and Expressivity. Cureus. 2022;14(9):e29026.
- Liu S, Zhang P, Wu J, Chang Q. A novel PAX2 heterozygous mutation in a family with Papillorenal syndrome: A case report and review of the literature. Am J Ophthalmol Case Rep. 2021;22:101091.
- Iatropoulos P, Daina E, Mele C, Maranta R, Remuzzi G, Noris M. Discordant phenotype in monozygotic twins with renal coloboma syndrome and a PAX2 mutation. Pediatr Nephrol. 2012;27(10):1989-93.
- Hale CL, Niederriter AN, Green GE, Martin DM. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria. Am J Med Genet A. 2016;170A(2):344-354.
- Delahaye A, Sznajer Y, Lyonnet S, Elmaleh-Bergès M, Delpierre I, Audollent S, et al. Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability. Clin Genet. 2007;72(2):112-21.
- Kim D, Yoon JH, Bae H, Hwang S, Seo GH, Koh JY, et al. Beyond CHD7 gene: unveiling genetic diversity in clinically suspected CHARGE syndrome. J Hum Genet. 2025;70(5):243-248.
- Sutton VR, Van den Veyver IB. Aicardi syndrome. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Rosser T. Aicardi syndrome. Arch Neurol. 2003;60(10):1471-3.
- de Leeuw C, Kurver A, Verrips A. Chorioretinal Lacunae in Aicardi’s Syndrome: Key for the Diagnosis. Neuropediatrics. 2020;51(4):311-312.
- Sukhija J, Isher HK, Kaur S, Korla S, Kaur A, Raj S. Ocular presentation of Walker-Warburg syndrome with POM2 mutation. Indian J Ophthalmol. 2022;70(7):2626-2627.
- Brasseur-Daudruy M, Vivier PH, Ickowicz V, Eurin D, Verspyck E. Walker-Warburg syndrome diagnosed by findings of typical ocular abnormalities on prenatal ultrasound. Pediatr Radiol. 2012;42(4):488-90.
- Neuhann L, Laner A, Holinski-Feder E, Neuhann T. Next-Generation Sequencing in Congenital Eye Malformations: Identification of Genetic Causes and Comparison of Different Panel-Based Diagnostic Strategies. Int J Mol Sci. 2025;26(20).
- Hassan MB, Stern C, Flanagan EP, Pittock SJ, Kunchok A, Foster RC, et al. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. Am J Ophthalmol. 2020;220:110-114.
- Lee JY, Han J, Yang M, Oh SY. Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis. Ophthalmology. 2020;127(3):417-425.
- Galetta SL. A new classification for diagnosis of optic neuritis. Lancet Neurol. 2022;21(12):1066-1068.
- Bennett JL, Costello F, Chen JJ, Petzold A, Biousse V, Newman NJ, et al. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. Lancet Neurol. 2023;22(1):89-100.
- Soelberg K, Jarius S, Skejoe H, Engberg H, Mehlsen JJ, Nilsson AC, et al. A population-based prospective study of optic neuritis. Mult Scler. 2017;23(14):1893-1901.
- Rodríguez-Rodríguez CA, Cifuentes-González C, Mejía-Salgado G, Garzón-Dangond JM, Verbel-Yaneth AV, Machado-Galindo S, et al. Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis Incidence Between 2015-2020. Ocul Immunol Inflamm. 2024;32(8):1749-1754.
- Jang Y, Yoo Y, Lee HJ, Kim WJ, Kim US. Baseline Features of Optic Neuritis in South Korea: A Retrospective Multicenter Study. J Neuroophthalmol. 2026;46(2):249-254.
- Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol. 1991;109(12):1673-8.
- Fraser CL, Davagnanam I, Radon M, Plant GT. The time course and phenotype of Uhthoff phenomenon following optic neuritis. Mult Scler. 2012;18(7):1042-4.
- Jain A, Rosso M, Santoro JD. Wilhelm Uhthoff and Uhthoff’s phenomenon. Mult Scler. 2020;26(13):1790-1796.
- Opara JA, Brola W, Wylegala AA, Wylegala E. Uhthoff`s phenomenon 125 years later - what do we know today?. J Med Life. 2016;9(1):101-105.
- Fraser CL, Klistorner A, Graham SL, Garrick R, Billson FA, Grigg JR. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis. Ophthalmology. 2006;113(2):323.e1-323.e2.
- Saidha S, Green AJ, Leocani L, Vidal-Jordana A, Kenney RC, Bsteh G, et al. The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis. Lancet Neurol. 2025;24(10):880-892.
- Lessell S. Corticosteroid treatment of acute optic neuritis. N Engl J Med. 1992;326(9):634-5.
- Trobe JD. High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial. Arch Ophthalmol. 1994;112(1):35-6.
- Optic Neuritis Study Group. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology. 2008;115(6):1079-1082.e5.
- Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev. 2015;2015(8):CD001430.
- Delikaya M, Hamdi R, Bereuter C, Schroeter J, Oertel FC. An update on the developments and challenges with the diagnosis and classification of autoimmune optic neuritis. Expert Rev Neurother. 2026;26(4):381-398.
- Marques IB, Matias F, Silva ED, Cunha L, Sousa L. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI. J Clin Neurosci. 2014;21(4):583-6.
- Swanton JK, Fernando KT, Dalton CM, Miszkiel KA, Altmann DR, Plant GT, et al. Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis. Mult Scler. 2010;16(2):156-65.
- Koseoglu M, Tutuncu M. Conversion of Optic Neuritis to Relapsing Remitting Multiple Sclerosis: A Retrospective Comorbidity Cohort Study. Eur Neurol. 2020;83(3):287-292.
- Söderström M, Ya-Ping J, Hillert J, Link H. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology. 1998;50(3):708-14.
- Montalban X, Lebrun-Frénay C, Oh J, Arrambide G, Moccia M, Amato MP, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850-865.
- Arun T, Petheram K, Braithwaite T, Brownlee WJ, Ford HL, Gallagher P, et al. The 2024 McDonald criteria for the diagnosis of multiple sclerosis: implications for clinical practice. Pract Neurol. 2026.
- Brownlee WJ, Vidal-Jordana A, Shatila M, Strijbis E, Schoof L, Killestein J, et al. Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis. Ann Neurol. 2025;97(3):571-582.
- Filippi M, Preziosa P, Margoni M, Rocca MA. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease. Neuroimaging Clin N Am. 2024;34(3):293-316.
- Morrow SA, Fraser JA, Day C, Bowman D, Rosehart H, Kremenchutzky M, et al. Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical Trial. JAMA Neurol. 2018;75(6):690-696.
- Skorupka N, Miclea A, Jalowiec KA, Bocksrucker C, Kamber N, Chan A, et al. Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric Analysis. Transfus Med Hemother. 2019;46(6):417-422.
- Lipphardt M, Mühlhausen J, Kitze B, Heigl F, Mauch E, Helms HJ, et al. Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica. J Clin Apher. 2019;34(4):381-391.
- Diem R, Molnar F, Beisse F, Gross N, Drüschler K, Heinrich SP, et al. Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol. BMJ Open. 2016;6(3):e010956.
- Küchlin S, Ihorst G, Grotejohann B, Beisse F, Heinrich SP, Albrecht P, et al. Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-up. Neurol Neuroimmunol Neuroinflamm. 2023;10(4).
- Aktas O, Albrecht P, Hartung HP. Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives. Curr Opin Neurol. 2016;29(3):199-204.
- García Ortega A, Montañez Campos FJ, Muñoz S, Sanchez-Dalmau B. Autoimmune and demyelinating optic neuritis. Arch Soc Esp Oftalmol (Engl Ed). 2020;95(8):386-395.
- Sanchez-Dalmau B, Martinez-Lapiscina EH, Torres-Torres R, Ortiz-Perez S, Zubizarreta I, Pulido-Valdeolivas IV, et al. Early retinal atrophy predicts long-term visual impairment after acute optic neuritis. Mult Scler. 2018;24(9):1196-1204.
- Bsteh G, Krajnc N, Riedl K, Altmann P, Kornek B, Leutmezer F, et al. Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis. Neurology. 2022;99(16):e1803-e1812.
- Reinsberg HK, Oertel FC, Casillas D, Kaufhold G, Condor Montes S, Bereuter C, et al. Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomography. Mult Scler. 2025;31(12):1493-1505.
- Peng C, Wang W, Xu Q, Yang M, Zhou H, Zhao S, et al. Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode. Acta Ophthalmol. 2017;95(6):583-590.
- Küchlin S, Ihorst G, Heinrich SP, Farassat N, Márquez Neila P, Hug MJ, et al. Clinical Predictors in Acute Optic Neuritis: Analysis Based on Clinical Trial Data. Ophthalmology. 2025;132(6):631-643.
- Balcer LJ. Clinical trials to clinical use: using vision as a model for multiple sclerosis and beyond. J Neuroophthalmol. 2014;34 Suppl:S18-23.
- Shams PN, Plant GT. Optic neuritis: a review. Int MS J. 2009;16(3):82-9.
- Muñoz-Ortiz J, Reyes-Guanes J, Zapata-Bravo E, Mora-Muñoz L, Reyes-Hurtado JA, Tierradentro-García LO, et al. Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature. Syst Rev. 2021;10(1):280.
- Zarbin MA, Jampol LM, Jager RD, Reder AT, Francis G, Collins W, et al. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology. 2013;120(7):1432-9.
- Tran E, Hadi A, Nair G, Bursztyn LLCD, Fraser JA, Ing EB. Incidence of Alemtuzumab-Induced Thyroid-Associated Orbitopathy: A Systematic Review and Meta-Analysis. Ophthalmic Plast Reconstr Surg. 2026;42(3):253-261.
- Noval S, Contreras I, Muñoz S, Oreja-Guevara C, Manzano B, Rebolleda G. Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update. Mult Scler Int. 2011;2011:472790.
- Nerrant E, Tilikete C. Ocular Motor Manifestations of Multiple Sclerosis. J Neuroophthalmol. 2017;37(3):332-340.
- Subei AM, Eggenberger E. Efferent manifestations of multiple sclerosis. Curr Opin Ophthalmol. 2012;23(6):506-9.
- Polet K, Hesse S, Cohen M, Morisot A, Joly H, Kullmann B, et al. Video-oculography in multiple sclerosis: Links between oculomotor disorders and brain magnetic resonance imaging (MRI). Mult Scler Relat Disord. 2020;40:101969.
- Cohen M, Hesse S, Polet K, Louchart de la Chapelle S, Morisot A, Bresch S, et al. Reliability of mobile video-oculography in multiple sclerosis patients using an iPad: A prospective validation study. Mult Scler Relat Disord. 2022;64:103944.
- Serra A, Chisari CG, Matta M. Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment. Front Neurol. 2018;9:31.
- Vidović T, Cerovski B, Jukić T. The appearance of pars planitis in multiple sclerosis. Coll Antropol. 2005;29(1):203-6.
- Yargi-Ozkocak B, Altan C, Kemer-Atik B, Basarir B. Clinical characteristics of intermediate uveitis in adults according to criteria of the SUN working group. Int Ophthalmol. 2023;43(10):3681-3693.
- Yargi-Ozkocak B, Altan C, Kemer-Atik B, Basarir B. Evaluation of Optical Coherence Tomography Angiography Findings in Pars Planitis and Multiple Sclerosis Associated Intermediate Uveitis in Remission. Curr Eye Res. 2024;49(7):717-724.
- Solmaz I, Özdamar Erol Y, Konuşkan B, Kaya P, Menderes D, Özdel S, et al. Central Nervous System Demyelination in Paediatric Pars Planitis. Ocul Immunol Inflamm. 2025;33(10):2250-2256.
- Kraker JA, Xu SC, Flanagan EP, Foster R, Wang F, Chen JJ. Ocular Manifestations of Multiple Sclerosis: A Population-Based Study. J Neuroophthalmol. 2024;44(2):157-161.
- Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol. 2005;16(5):315-20.
- Costello F. Vision Disturbances in Multiple Sclerosis. Semin Neurol. 2016;36(2):185-95.
- Freeman L, Longbrake EE, Coyle PK, Hendin B, Vollmer T. High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis. CNS Drugs. 2022;36(12):1285-1299.
- Dalla Costa G, Leocani L, Rodegher M, Chiveri L, Gradassi A, Comi G. An overview on disease modifying and symptomatic drug treatments for multiple sclerosis. Expert Rev Clin Pharmacol. 2024.
- Bellanca CM, Augello E, Mariottini A, Bonaventura G, La Cognata V, Di Benedetto G, et al. Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?. Curr Neuropharmacol. 2024;22(8):1286-1326.
- Krajnc N, Bsteh G, Berger T, Mares J, Hartung HP. Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management. Neurotherapeutics. 2022;19(3):753-773.
- Kappos L, Radue EW, O’Connor P, Polman C, Hohlfeld R, Calabresi P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med. 2010;362(5):387-401.
- Kappos L, Cohen J, Collins W, de Vera A, Zhang-Auberson L, Ritter S, et al. Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings. Mult Scler Relat Disord. 2014;3(4):494-504.
- Li X, Sun YQ, Huang QL, Zhang ZJ, Shi LQ, Tang JF, et al. Drug-related macular edema: a real-world FDA Adverse Event Reporting System database study. BMC Pharmacol Toxicol. 2025;26(1):23.
- Trinh T, Haridas AS, Sullivan TJ. Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2016;32(6):e128-e129.
- Glenn T, Berger JR, McEntire CRS. Natalizumab-associated progressive multifocal leukoencephalopathy. Front Neurol. 2025;16:1575653.
- Jangirashvili T, Parthiv O, Shengelia L, Tabeshadze Z, Kontchoshvili A, Waked CA, et al. Visual and Neuro-Ophthalmic Manifestations of John Cunningham (JC) Virus-Related Natalizumab-Associated Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Systematic Review. Cureus. 2026;18(6):e110720.
- Sharma K, Tolaymat S, Yu H, Elkhooly M, Jaiswal S, Jena A, et al. Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: A review. J Neurol Sci. 2022;443:120459.
- Herold TR, Jakl V, Graser A, Eibl-Lindner K. Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis. Clin Ophthalmol. 2012;6:1131-3.
- Balcer LJ, Baier ML, Pelak VS, Fox RJ, Shuwairi S, Galetta SL, et al. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Mult Scler. 2000;6(3):163-71.
- Waldman AT, Chahin S, Lavery AM, Liu G, Banwell BL, Liu GT, et al. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis. Mult Scler Relat Disord. 2016;10:73-78.
- Uzawa A, Oertel FC, Mori M, Paul F, Kuwabara S. NMOSD and MOGAD: an evolving disease spectrum. Nat Rev Neurol. 2024;20(10):602-619.
- Chihara N, Yamamura T. Immuno-pathogenesis of neuromyelitis optica and emerging therapies. Semin Immunopathol. 2022;44(5):599-610.
- Arellano G, Loda E, Chen Y, Neef T, Cogswell AC, Primer G, et al. Interferon-γ controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder. Brain. 2024;147(4):1344-1361.
- Pittock SJ, Zekeridou A, Weinshenker BG. Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials. Nat Rev Neurol. 2021;17(12):759-773.
- Siriratnam P, Huda S, Butzkueven H, van der Walt A, Jokubaitis V, Monif M. A comprehensive review of the advances in neuromyelitis optica spectrum disorder. Autoimmun Rev. 2023;22(12):103465.
- Weinshenker BG, Wingerchuk DM. Neuromyelitis Spectrum Disorders. Mayo Clin Proc. 2017;92(4):663-679.
- Carnero Contentti E, Correale J. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflammation. 2021;18(1):208.
- Papp V, Magyari M, Aktas O, Berger T, Broadley SA, Cabre P, et al. Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review. Neurology. 2021;96(2):59-77.
- Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, et al. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. Front Neurol. 2020;11:501.
- Bagherieh S, Afshari-Safavi A, Vaheb S, Kiani M, Ghaffary EM, Barzegar M, et al. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis. Neurol Sci. 2023;44(6):1905-1915.
- Camara-Lemarroy CR, Burton JM. Area postrema syndrome: A short history of a pearl in demyelinating diseases. Mult Scler. 2019;25(3):325-329.
- Prabhu K, Woodman M. Area postrema syndrome: Intractable hiccups and vomiting as a result of neuromyelitis Optica Spectrum disorder. JRSM Open. 2023;14(4):20542704231159601.
- Dandu V, Siddamreddy S, Meegada S, Muppidi V, Challa T. Isolated Area Postrema Syndrome Presenting as Intractable Nausea and Vomiting. Cureus. 2020;12(2):e7058.
- Filippatou AG, Mukharesh L, Saidha S, Calabresi PA, Sotirchos ES. AQP4-IgG and MOG-IgG Related Optic Neuritis-Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis. Front Neurol. 2020;11:540156.
- Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A. Neuromyelitis optica spectrum disorders. Clin Med (Lond). 2019;19(2):169-176.
- Jarius S, Aktas O, Ayzenberg I, Bellmann-Strobl J, Berthele A, Giglhuber K, et al. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. J Neurol. 2023;270(7):3341-3368.
- Wu Y, Geraldes R, Juryńczyk M, Palace J. Double-negative neuromyelitis optica spectrum disorder. Mult Scler. 2023;29(11-12):1353-1362.
- Romano G, Lus G, Cirillo M, Coppola C, Bonavita S, Signoriello E. Double-negative NMOSD: from case report to a proposed diagnostic and therapeutic algorithm. BMC Neurol. 2025;25(1):465.
- Maillart E, Durand-Dubief F, Louapre C, Audoin B, Bourre B, Derache N, et al. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies. J Neuroinflammation. 2020;17(1):128.
- Matsumoto Y, Kaneko K, Takahashi T, Takai Y, Namatame C, Kuroda H, et al. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids. Brain. 2023;146(9):3938-3948.
- Oertel FC, Specovius S, Zimmermann HG, Chien C, Motamedi S, Bereuter C, et al. Retinal Optical Coherence Tomography in Neuromyelitis Optica. Neurol Neuroimmunol Neuroinflamm. 2021;8(6).
- Eslami M, Lichtman-Mikol S, Razmjou S, Bernitsas E. Optical Coherence Tomography in Chronic Relapsing Inflammatory Optic Neuropathy, Neuromyelitis Optica and Multiple Sclerosis: A Comparative Study. Brain Sci. 2022;12(9).
- Filippatou AG, Gakis G, Bacchetti A, Kim A, Said Y, McCormack B, et al. Ganglion Cell Layer Compared With Inner Plexiform Layer Atrophy After Optic Neuritis Associated With NMOSD, MOGAD, and MS. Neurol Neuroimmunol Neuroinflamm. 2026;13(3):e200567.
- Lu A, Zimmermann HG, Specovius S, Motamedi S, Chien C, Bereuter C, et al. Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2022;93(2):188-195.
- Oertel FC, Sotirchos ES, Zimmermann HG, Motamedi S, Specovius S, Asseyer ES, et al. Longitudinal Retinal Changes in MOGAD. Ann Neurol. 2022;92(3):476-485.
- Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, et al. Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions. Neurol Neuroimmunol Neuroinflamm. 2018;5(6):e504.
- Aungsumart S, Apiwattanakul M. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature. Mult Scler Relat Disord. 2017;13:93-97.
- Siritho S, Nopsopon T, Pongpirul K. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis. J Neurol. 2021;268(12):4549-4562.
- Kleiter I, Gold R. Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders. Neurotherapeutics. 2016;13(1):70-83.
- Bonnan M, Mejdoubi M, Cabre P. Fulminant and fatal onset of pan-aquaporinopathy. Mult Scler Relat Disord. 2019;34:116-118.
- Kümpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, Häußler V, et al. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management. J Neurol. 2024;271(1):141-176.
- Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, et al. Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. N Engl J Med. 2019;381(7):614-625.
- Pittock SJ, Fujihara K, Palace J, Berthele A, Kim HJ, Oreja-Guevara C, et al. Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension. Mult Scler. 2022;28(3):480-486.
- Pittock SJ, Barnett M, Bennett JL, Berthele A, de Sèze J, Levy M, et al. Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. Ann Neurol. 2023;93(6):1053-1068.
- Yamamura T, Weinshenker B, Yeaman MR, De Seze J, Patti F, Lobo P, et al. Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar. Mult Scler Relat Disord. 2022;66:104025.
- Kleiter I, Traboulsee A, Palace J, Yamamura T, Fujihara K, Saiz A, et al. Long-term Efficacy of Satralizumab in AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar. Neurol Neuroimmunol Neuroinflamm. 2023;10(1).
- Bennett JL, Fujihara K, Saiz A, Traboulsee AL, Greenberg BM, Weinshenker BG, et al. Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study. Neurol Neuroimmunol Neuroinflamm. 2025;12(5):e200450.
- Fung S, Shirley M. Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder. CNS Drugs. 2023;37(4):363-370.
- Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, et al. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. Lancet. 2019;394(10206):1352-1363.
- Cree BAC, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, et al. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial. Lancet Neurol. 2024;23(6):588-602.
- Rensel M, Zabeti A, Mealy MA, Cimbora D, She D, Drappa J, et al. Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4-immunoglobulin G-seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial. Mult Scler. 2022;28(6):925-932.
- Fujihara K, Kim HJ, Saida T, Misu T, Nagano Y, Totsuka N, et al. Efficacy and safety of inebilizumab in Asian participants with neuromyelitis optica spectrum disorder: Subgroup analyses of the N-MOmentum study. Mult Scler Relat Disord. 2023;79:104938.
- Tahara M, Oeda T, Okada K, Kiriyama T, Ochi K, Maruyama H, et al. Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19(4):298-306.
- Clardy SL, Pittock SJ, Aktas O, Nakahara J, Isobe N, Centonze D, et al. Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder. Neurol Ther. 2024;13(3):535-549.
- John N, Lim A, Sunthar SR, Zhang L, Cheng J, Boktor J, et al. Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis. J Neurol. 2025;272(9):563.
- Romeo AR, Segal BM. Treatment of neuromyelitis optica spectrum disorders. Curr Opin Rheumatol. 2019;31(3):250-255.
- Nakashima I, Nakahara J, Yasunaga H, Yamashita M, Nishijima N, Satomura A, et al. Real-world management of patients with neuromyelitis optica spectrum disorder using satralizumab: Results from a Japanese claims database. Mult Scler Relat Disord. 2024;84:105502.
- Trewin BP, Brilot F, Reddel SW, Dale RC, Ramanathan S. MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally. Autoimmun Rev. 2025;24(1):103693.
- Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, et al. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol. 2018;195:8-15.
- Chun BY, Cestari DM. Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis. Curr Opin Ophthalmol. 2018;29(6):508-513.
- Kezuka T, Ishikawa H. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. Jpn J Ophthalmol. 2018;62(2):101-108.
- Hor JY, Fujihara K. Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Front Neurol. 2023;14:1260358.
- Orlandi R, Mariotto S, Gajofatto A. Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy. Mult Scler Relat Disord. 2022;63:103884.
- Vilaseca A, Filippatou AG, Said Y, Sechi E, Syc-Mazurek SB, Cacciaguerra L, et al. TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results. Neurol Neuroimmunol Neuroinflamm. 2026;13(3):e200563.
- Cai MT, Hua Y, Lai QL, Su SY, Shen CH, Qiao S, et al. Performance of the 2023 diagnostic criteria for MOGAD: real-world application in a Chinese multicenter cohort of pediatric and adult patients. BMC Med. 2025;23(1):40.
- Giorgi L, Marignier R, Pique J, Maurey H, Papeix C, Ciron J, et al. French guidelines for the diagnosis and management of MOG antibody-associated disease. Rev Neurol (Paris). 2025;181(7):597-607.
- Lei M, Cui Y, Dong Z, Zhi X, Shu J, Cai C, et al. Clinical and Magnetic Resonance Imaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein. Front Pediatr. 2022;10:859932.
- Gaudioso CM, Mar S, Casper TC, Codden R, Nguyen A, Aaen G, et al. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. 2023;93(2):271-284.
- Gericke FC, Hanson JVM, Hackenberg A, Gerth-Kahlert C. Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Eur J Paediatr Neurol. 2024;48:113-120.
- Klein da Costa B, Banwell BL, Sato DK. Treatment of MOG-IgG associated disease in paediatric patients: A systematic review. Mult Scler Relat Disord. 2021;56:103216.
- Ohashi E, Kohyama K, Mori T, Matsuda S, Nishida H, Miyama S, et al. Serum and CSF cytokine profile impact clinical phenotype in pediatric MOGAD. J Neuroinflammation. 2026;23(1).
- Satukijchai C, Mariano R, Messina S, Sa M, Woodhall MR, Robertson NP, et al. Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom. JAMA Netw Open. 2022;5(1):e2142780.
- Sun W, Xie Y, Han A, Zhou X, Zhang S, Xie Y, et al. Clinical characteristics and factors associated with recurrence and long-term prognosis in patients with MOGAD. Front Immunol. 2025;16:1535571.
- Martin K, Srikanth P, Kanwar A, Falardeau J, Pettersson D, Yadav V. Clinical and radiographic features of a cohort of adult and pediatric subjects in the Pacific Northwest with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Mult Scler Relat Disord. 2024;81:105130.
- Brill L, Ganelin-Cohen E, Dabby R, Rabinowicz S, Zohar-Dayan E, Rein N, et al. Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel. Front Neurol. 2020;11:612304.
- Darakdjian M, Chaves H, Hernandez J, Cejas C. MRI pattern in acute optic neuritis: Comparing multiple sclerosis, NMO and MOGAD. Neuroradiol J. 2023;36(3):267-272.
- Zhou L, Huang Y, Li H, Fan J, Zhangbao J, Yu H, et al. MOG-antibody associated demyelinating disease of the CNS: A clinical and pathological study in Chinese Han patients. J Neuroimmunol. 2017;305:19-28.
- Chan F, Fraser C, Brilot F, Dale RC, Ramanathan S. Structural and functional biomarkers of visual dysfunction in MOG antibody-positive optic neuritis: a scoping review. J Neuroimmunol. 2025;408:578715.
- Gomes de Brito Ventura LM, Solla D, Silva GD, Salles L, Sato D, Pereira S, et al. Autoantibody profile (MOG-IgG-positivity, AQP4-IgG-positivity, and double-seronegativity) as an outcome predictor after optic neuritis. Clin Neurol Neurosurg. 2025;250:108787.
- Thakolwiboon S, Redenbaugh V, Chen B, Hewitt S, Shah S, Lotan I, et al. Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurology. 2025;105(6):e213903.
- Iancu R, Pirvulescu R, Anton N, Iancu G, Istrate S, Romanitan MO, et al. Visual Function Improvement after Plasma Exchange Therapy for Acute Optic Neuritis in Neuromyelitis Optica Spectrum Disorders: Case Series and Review. Diagnostics (Basel). 2024;14(9).
- Chang X, Zhang J, Li S, Wu P, Wang R, Zhang C, et al. Meta-analysis of the effectiveness of relapse prevention therapy for myelin-oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord. 2023;72:104571.
- Thakolwiboon S, Zhao-Fleming H, Karukote A, Mao-Draayer Y, Flanagan EP, Avila M. Meta-analysis of effectiveness of steroid-sparing attack prevention in MOG-IgG-associated disorder. Mult Scler Relat Disord. 2021;56:103310.
- Nepal G, Kharel S, Coghlan MA, Rayamajhi P, Ojha R. Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis. J Neuroimmunol. 2022;364:577812.
- Kang YR, Kim KH, Hyun JW, Kim SH, Kim HJ. Efficacy of tocilizumab in highly relapsing MOGAD with an inadequate response to intravenous immunoglobulin therapy: A case series. Mult Scler Relat Disord. 2024;91:105859.
- Abel A, McClelland C, Lee MS. Critical review: Typical and atypical optic neuritis. Surv Ophthalmol. 2019;64(6):770-779.
- Phuljhele S, Saxena R, Bhatia R, Khurana D, Dewan T, Meena SK, et al. Consensus statement for the diagnosis and management of optic neuritis. Indian J Ophthalmol. 2026;74(8):1115-1121.
- Lawrence AL, Savino PJ, Danesh-Meyer HV. Non-Arteritic Anterior Ischaemic Optic Neuropathy and Its Masquerades: A Comprehensive Diagnostic Review. Clin Exp Ophthalmol. 2026;54(4):537-553.
- Xie JS, Donaldson L, Margolin E. Optic perineuritis: A Canadian case series and literature review. J Neurol Sci. 2021;430:120035.
- Bataller L, Dalmau J. Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol. 2004;17(1):3-8.
- Tao BK, Xie JS, Margolin E. Functional vision disorder: a review of diagnosis, management and costs. Br J Ophthalmol. 2024;108(11):1479-1485.
- Khaleeli Z, Tucker WR, Del Porto L, Virgo JD, Plant GT. Remember the retina: retinal disorders presenting to neurologists. Pract Neurol. 2018;18(2):84-96.
- Northey LC, Skalicky SE, Gurbaxani A, McCluskey PJ. Syphilitic uveitis and optic neuritis in Sydney, Australia. Br J Ophthalmol. 2015;99(9):1215-9.
- Ohira K, Hashimoto N, Kanai D, Inoue Y. Novel and characteristic radiological features of neurosyphilis: a case series. BMC Neurol. 2024;24(1):248.
- Davis EJ, Rathinam SR, Okada AA, Tow SL, Petrushkin H, Graham EM, et al. Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect. 2012;2(4):183-9.
- Karti O, Ataş F, Saatci AO. Posterior Segment Manifestations of Cat-scratch Disease: A Mini-review of the Clinical and Multi-modal Imaging Features. Neuroophthalmology. 2021;45(6):361-371.
- Okrent Smolar AL, Breitschwerdt EB, Phillips PH, Newman NJ, Biousse V. Cat scratch disease: What to do with the cat?. Am J Ophthalmol Case Rep. 2022;28:101702.
- Kerkhoff FT, Ossewaarde JM, de Loos WS, Rothova A. Presumed ocular bartonellosis. Br J Ophthalmol. 1999;83(3):270-5.
- Myers KA, Nikolic A, Romanchuk K, Weis E, Brundler MA, Lafay-Cousin L, et al. Optic neuropathy in the context of leukemia or lymphoma: diagnostic approach to a neuro-oncologic emergency. Neurooncol Pract. 2017;4(1):60-66.
- Lee V, Farooq AV, Shah HA. Leukemic and Lymphomatous Optic Neuropathy: A Case Series. J Neuroophthalmol. 2021;41(4):e796-e802.
- Johnson GM, Rossen JL, Simon SS, Weinstein JL, Ralay Ranaivo H, Yoon HH. Leukemic Optic Neuropathy in Pediatric Patients: A Case Series. J Pediatr Ophthalmol Strabismus. 2024;61(1):67-72.
- Rachwani Anil R, Rocha-de-Lossada C, Zamorano Martín F, Santos Ortega A, Luque Aranda G, España Contreras M, et al. Infiltrative optic neuropathy as a relapse of acute lymphoblastic leukemia. J Fr Ophtalmol. 2021;44(2):293-295.
- Delestre F, Blanche P, Bouayed E, Bouscary D, Mouthon L, Brezin A, et al. Ophthalmic involvement of chronic lymphocytic leukemia: A systematic review of 123 cases. Surv Ophthalmol. 2021;66(1):124-131.
- Jarius S, Wandinger KP, Borowski K, Stoecker W, Wildemann B. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg. 2012;114(4):331-5.
- Sami F, Sami SA, Manadan AM, Arora S. Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren’s syndrome. Clin Rheumatol. 2024;43(1):59-65.
- Nóbrega ILP, Nascimento MMP, Santiago IB, de Carvalho JF, Sales Pitombeira M, Rodrigues CEM. Neurological and paraclinical features differentiating Systemic lupus erythematosus, Sjögren’s disease, and neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2026;107:106972.
- Theodoridou A, Settas L. Demyelination in rheumatic diseases. Postgrad Med J. 2008;84(989):127-32.
- Cikes N, Bosnic D, Sentic M. Non-MS autoimmune demyelination. Clin Neurol Neurosurg. 2008;110(9):905-12.
- Raftopoulou S, Kapsali I, Evangelopoulos ME, Mavragani CP. Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an update. Expert Rev Clin Immunol. 2025;21(7):855-873.
- Horiuchi K, Nakamura S, Yamada K. Leber Hereditary Optic Neuropathy With Magnetic Resonance Imaging Findings Suggestive of Optic Perineuritis and Optic Neuritis: A Diagnostic Challenge. Cureus. 2025;17(3):e80439.
- Hervas-Garcia JV, Pagani-Cassara F. [Chronic relapsing inflammatory optic neuropathy: a literature review]. Rev Neurol. 2019;68(12):524-530.
- Birnbaum FA, Meekins LC, Srinivasan A, Murchison AP. A lot of nerve. Surv Ophthalmol. 2020;65(2):272-277.
- Hudzaifah-Nordin M, Wendy-Ong CF, Nurul-Ain M, Wan Hitam WH. Clinical Profile of Optic Neuritis in Malaysian Patients Older Than 45 Years of Age. Cureus. 2022;14(3):e23571.
- Greco G, Colombo E, Gastaldi M, Ahmad L, Tavazzi E, Bergamaschi R, et al. Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis. Int J Mol Sci. 2023;24(21).
- Ray S, Gragoudas E. Neuroretinitis. Int Ophthalmol Clin. 2001;41(1):83-102.
- Ksiaa I, Abroug N, Mahmoud A, Zina S, Hedayatfar A, Attia S, et al. Update on Bartonella neuroretinitis. J Curr Ophthalmol. 2019;31(3):254-261.
- Çam F, Altintas A, Celiker H. Neuroretinitis: Etiologies, Treatment Approaches, and Visual Outcomes from a Tertiary Referral Center. Ocul Immunol Inflamm. 2026;34(5):938-946.
- Zone Abid I, Gargouri S, Kaibi I, Feki J. [Clinical features and etiologies of acute neuroretinitis in southern Tunisia]. J Fr Ophtalmol. 2019;42(8):839-843.
- Habot-Wilner Z, Zur D, Goldstein M, Goldenberg D, Shulman S, Kesler A, et al. Macular findings on optical coherence tomography in cat-scratch disease neuroretinitis. Eye (Lond). 2011;25(8):1064-8.
- Celiker H, Kazokoglu H, Eraslan M, Cerman E, Karabas L. Bartonella henselae Neuroretinitis in Patients without Cat Scratch. Jpn J Infect Dis. 2018;71(6):397-401.
- Reed JB, Scales DK, Wong MT, Lattuada CP Jr, Dolan MJ, Schwab IR. Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae. Ophthalmology. 1998;105(3):459-66.
- Habot-Wilner Z, Trivizki O, Goldstein M, Kesler A, Shulman S, Horowitz J, et al. Cat-scratch disease: ocular manifestations and treatment outcome. Acta Ophthalmol. 2018;96(4):e524-e532.
- Curi AL, Machado D, Heringer G, Campos WR, Lamas C, Rozental T, et al. Cat-scratch disease: ocular manifestations and visual outcome. Int Ophthalmol. 2010;30(5):553-8.
- Tan CL, Fhun LC, Tai EL, Abdul Gani NH, Muhammed J, Tuan Jaafar TN, et al. Clinical Profile and Visual Outcome of Ocular Bartonellosis in Malaysia. J Trop Med. 2017;2017:7946123.
- Mahjoub A, Bellazreg F, Ben Abdesslem N, Sellem I, Mahjoub A, Ben Mrad S, et al. Cat scratch disease neuroretinitis: A case report. Ann Med Surg (Lond). 2021;69:102722.
- Ye Z, Yang M, Zou Y, Zhang J, Deng J, Zong Y, et al. Syphilis and the Eye: Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Paradigms. Pathogens. 2025;14(9).
- Agostini FA, Queiroz RP, Azevedo DOM, Henriques JF, Campos WR, Vasconcelos-Santos DV. Intravenous Ceftriaxone for Syphilitic Uveitis. Ocul Immunol Inflamm. 2018;26(7):1059-1065.
- Fish RH, Hoskins JC, Kline LB. Toxoplasmosis neuroretinitis. Ophthalmology. 1993;100(8):1177-82.
- Sivakumar RR, Prajna L, Arya LK, Muraly P, Shukla J, Saxena D, et al. Molecular diagnosis and ocular imaging of West Nile virus retinitis and neuroretinitis. Ophthalmology. 2013;120(9):1820-6.
- Lázaro-Rodríguez V, Berrada H, Capella MJ. A case report of isolated primary herpes-simplex virus neuroretinitis in an immunocompetent adult. BMC Ophthalmol. 2022;22(1):47.
- Gabison S, Khellaf R, Arndt C, Bérot A, Silva G, Bednarek N, et al. Hypertensive retinopathy as a masquerade neuroretinitis in a child: a case report. BMC Ophthalmol. 2026;26(1).
- Younes S, Abdellaoui M, Zahir F, Benatiya I, Tahri H. Bilateral stellate neuroretinitis revealing a pheochromocytoma. Pan Afr Med J. 2015;20:13.
- Nguyen C, Borruat FX. Bilateral peripapillary subretinal neovessel membrane associated with chronic papilledema: report of two cases. Klin Monbl Augenheilkd. 2005;222(3):275-8.
- Lee AG, Beaver HA. Acute bilateral optic disk edema with a macular star figure in a 12-year-old girl. Surv Ophthalmol. 2002;47(1):42-9.
- I-Linn ZL, Long QB. An unusual cause of acute bilateral optic disk swelling with macular star in a 9-year-old girl. J Pediatr Ophthalmol Strabismus. 2007;44(4):245-7.
- Gupta S, Sethi P, Duvesh R, Sethi HS, Naik M, Rai HK. Optic perineuritis. BMJ Open Ophthalmol. 2021;6(1):e000745.
- Cheng AC, Chan NC, Chan CK. Acute and subacute inflammation of the optic nerve and its sheath: clinical features in Chinese patients. Hong Kong Med J. 2012;18(2):115-22.
- Li H, Zhou H, Sun J, Wang H, Wang Y, Wang Z, et al. Optic Perineuritis and Its Association With Autoimmune Diseases. Front Neurol. 2020;11:627077.
- Johns TT, Citrin CM, Black J, Sherman JL. CT evaluation of perineural orbital lesions: evaluation of the “tram-track” sign. AJNR Am J Neuroradiol. 1984;5(5):587-90.
- Purohit BS, Vargas MI, Ailianou A, Merlini L, Poletti PA, Platon A, et al. Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging. Insights Imaging. 2016;7(1):43-68.
- Wei L, Wei S, Wang Z. Clinical and multimodal imaging features of ocular syphilis with posterior segment involvement: a 10-case series. Int Ophthalmol. 2026;46(1).
- Noshiro S, Wanibuchi M, Akiyama Y, Okawa S, Ohtaki S, Sugino T, et al. IgG4-related disease initially presented as an orbital mass lesion mimicking optic nerve sheath meningioma. Brain Tumor Pathol. 2015;32(4):286-90.
- Li J, Zhang Y, Zhou H, Wang L, Wang Z, Li H. Magnetic resonance imaging indicator of the causes of optic neuropathy in IgG4-related ophthalmic disease. BMC Med Imaging. 2019;19(1):49.
- Yamamoto M, Hashimoto M, Takahashi H, Shinomura Y. IgG4 disease. J Neuroophthalmol. 2014;34(4):393-9.
- Saitakis G, Chwalisz BK. The neurology of IGG4-related disease. J Neurol Sci. 2021;424:117420.
- Anthony J, Esper GJ, Ioachimescu A. Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review. Pituitary. 2016;19(1):19-29.
- Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, et al. Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018;75(12):1546-1553.
- Fournier N, Jamilloux Y, Gerfaud-Valentin M, Streichenberger N, Vukusic S, Marignier R, et al. Minor Salivary Gland Biopsy for the Diagnosis of Neurosarcoidosis. Eur Neurol. 2023;86(3):171-177.
- Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418-1422.
- Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160-9.
- Handa-Miyauchi M MD, Takase H MD, PhD, Tanaka M MD, Akiyama M PhD, Ohno-Matsui K MD, PhD, Mochizuki M MD,PhD. A Validation Study of the Revised Diagnostic Criteria from the International Workshop on Ocular Sarcoidosis at a Single Institute in Japan. Ocul Immunol Inflamm. 2021;29(7-8):1501-1506.
- Agrawal R, Gonzalez-Lopez JJ, Meier F, Gupta B, Pavesio CE. Ocular and systemic features of sarcoidosis and correlation with the International Workshop for Ocular Sarcoidosis diagnostic criteria. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32(3):237-45.
- Acharya NR, Browne EN, Rao N, Mochizuki M. Distinguishing Features of Ocular Sarcoidosis in an International Cohort of Uveitis Patients. Ophthalmology. 2018;125(1):119-126.
- Sandu CA, Donica VC, Ganea CV, Bîlha MI, Alexa AI, Bogdănici CM. Ocular Sarcoidosis: Contemporary Insights and Future Directions. Rom J Ophthalmol. 2025;69(4):488-494.
- Sève P, Kodjikian L, Jamilloux Y. [Ocular sarcoidosis: What the internist should know?]. Rev Med Interne. 2018;39(9):728-737.
- Noroozi Gilandehi S, Wong KH, Francis T, Wright MA, Lord J, Stehlik J, et al. Cardiac Involvement in Neurosarcoidosis: A Single-Center Investigation. Neurol Neuroimmunol Neuroinflamm. 2024;11(2):e200196.
- McNab AA, McKelvie P. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects. Ophthalmic Plast Reconstr Surg. 2015;31(3):167-78.
- Takahira M, Goto H, Azumi A. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2024;68(4):293-301.
- Detiger SE, Karim AF, Verdijk RM, van Hagen PM, van Laar JAM, Paridaens D. The treatment outcomes in IgG4-related orbital disease: a systematic review of the literature. Acta Ophthalmol. 2019;97(5):451-459.
- Hara S, Yoshida M, Sanada H, Suzuki Y, Sato Y, Mizushima I, et al. Pediatric IgG4-related disease: a descriptive review. Expert Rev Clin Immunol. 2024;20(1):97-119.
- Junek ML, Zhao L, Garner S, Cuthbertson D, Pagnoux C, Koening CL, et al. Ocular manifestations of ANCA-associated vasculitis. Rheumatology (Oxford). 2023;62(7):2517-2524.
- Moin KA, Yeakle MM, Parrill AM, Garofalo VA, Tsiyer AR, Bishev D, et al. Ocular and orbital manifestations of granulomatosis with polyangiitis: a systematic review of published cases. Rom J Ophthalmol. 2023;67(3):214-221.
- Liu S, Xu M, Zhao X, Yang J, Zhang W, Chen Y. Ocular manifestations in ANCA-associated vasculitis: a comprehensive analysis from Chinese medical centers. Clin Rheumatol. 2024;43(9):2899-2910.
- Kubal AA, Perez VL. Ocular manifestations of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010;36(3):573-86.
- Espinoza GM, Desai A, Akduman L. Ocular vasculitis. Curr Rheumatol Rep. 2013;15(9):355.
- Turk MA, Hayworth JL, Nevskaya T, Pope JE. Ocular Manifestations in Rheumatoid Arthritis, Connective Tissue Disease, and Vasculitis: A Systematic Review and Metaanalysis. J Rheumatol. 2021;48(1):25-34.
- Nakamura T, Takahashi K, Kishi S. Optic nerve involvement in neuro-Behcet’s disease. Jpn J Ophthalmol. 2002;46(1):100-2.
- Khairallah M, Ben Yahia S, Kahloun R, Khairallah-Ksiaa I, Messaoud R. [The eye and Behçet’s disease]. J Fr Ophtalmol. 2012;35(10):826-37.
- Jabs DA, Miller NR, Newman SA, Johnson MA, Stevens MB. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol. 1986;104(4):564-8.
- Man BL, Mok CC, Fu YP. Neuro-ophthalmologic manifestations of systemic lupus erythematosus: a systematic review. Int J Rheum Dis. 2014;17(5):494-501.
- Lin YC, Wang AG, Yen MY. Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review. Acta Ophthalmol. 2009;87(2):204-10.
- Suri D, Abujam B, Gupta A, Rawat A, Saikia B, Walker Minz R, et al. Optic nerve involvement in childhood onset systemic lupus erythematosus: Three cases and a review of the literature. Lupus. 2016;25(1):93-6.
- Al-Zubi K, Sarayrah F. Ocular Manifestations of Antiphospholipid Syndrome in Jordan. Middle East Afr J Ophthalmol. 2022;29(4):205-208.
- Cohen Aubart F, Bouvry D, Galanaud D, Dehais C, Mathey G, Psimaras D, et al. Long-term outcomes of refractory neurosarcoidosis treated with infliximab. J Neurol. 2017;264(5):891-897.
- Chaiyanarm S, Satiraphan P, Apiraksattaykul N, Jitprapaikulsan J, Owattanapanich W, Rungjirajittranon T, et al. Infliximab in neurosarcoidosis: a systematic review and meta-analysis. Ann Clin Transl Neurol. 2024;11(2):466-476.
- Gomez H, Noël N, Schmidt J, Aouba A, Bourre B, Langlois V, et al. Comparing the efficacy and safety of cyclophosphamide, infliximab and methotrexate in neurosarcoidosis: a multicenter retrospective study. J Neurol. 2025;272(8):531.
- Arun T, Palace J. Effects of immunotherapies and clinical outcomes in neurosarcoidosis: a retrospective cohort study. J Neurol. 2021;268(7):2466-2472.
- Sodhi M, Pearson K, White ES, Culver DA. Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis. Respir Med. 2009;103(2):268-73.
- Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol. 2014;261(1):17-26.
- Petzold A, Plant GT. Diagnosis and classification of autoimmune optic neuropathy. Autoimmun Rev. 2014;13(4-5):539-45.
- Lee HJ, Kim B, Waters P, Woodhall M, Irani S, Ahn S, et al. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. J Neuroinflammation. 2018;15(1):302.
- Molina-Carrión LE, Lira-Tecpa J, Jiménez-Arellano MP, Cruz-Domínguez MP, Medina G. Disease course of Chronic Relapsing Inflammatory Optic Neuropathy (CRION) in a single care center. Arq Neuropsiquiatr. 2022;80(5):510-515.
- Waschbisch A, Atiya M, Schaub C, Derfuss T, Schwab S, Lee DH, et al. Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity. J Neurol Sci. 2013;331(1-2):72-5.
- Pimentel Maldonado DA, Lisak R, Galetta S, Balcer L, Varkey T, Goodman A, et al. Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2023;10(1).
- Wildemann B, Horstmann S, Korporal-Kuhnke M, Viehöver A, Jarius S. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment]. Klin Monbl Augenheilkd. 2020;237(11):1290-1305.
- Häußler V, Trebst C, Engels D, Pellkofer H, Havla J, Duchow A, et al. Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD. J Neurol Neurosurg Psychiatry. 2025;96(6):582-592.
- Hoshina Y, Seay M, Vegunta S, Stulberg EL, Wright MA, Wong KH, et al. Isolated Optic Neuritis: Etiology, Characteristics, and Outcomes in a US Mountain West Cohort. J Neuroophthalmol. 2025;45(1):36-43.
- Longbrake E. Myelin Oligodendrocyte Glycoprotein-Associated Disorders. Continuum (Minneap Minn). 2022;28(4):1171-1193.
- Zhou H, Xu Q, Zhao S, Wang W, Wang J, Chen Z, et al. Distinct clinical characteristics of atypical optic neuritis with seronegative aquaporin-4 antibody among Chinese patients. Br J Ophthalmol. 2017;101(12):1720-1724.
- Wendel EM, Baumann M, Barisic N, Blaschek A, Coelho de Oliveira Koch E, Della Marina A, et al. High association of MOG-IgG antibodies in children with bilateral optic neuritis. Eur J Paediatr Neurol. 2020;27:86-93.
- Gise RA, Heidary G. Update on Pediatric Optic Neuritis. Curr Neurol Neurosci Rep. 2020;20(3):4.
- Pineles SL, Henderson RJ, Repka MX, Heidary G, Liu GT, Waldman AT, et al. The Pediatric Optic Neuritis Prospective Outcomes Study: Two-Year Results. Ophthalmology. 2022;129(8):856-864.
- Joo HJ, Song JR, Lim BC, Kim WJ, Choi MY, Lee HJ, et al. Six-Month Visual Outcomes in Pediatric Optic Neuritis: A Multicenter Study From South Korea. J Neuroophthalmol. 2026.
- Bonhomme GR, Waldman AT, Balcer LJ, Daniels AB, Tennekoon GI, Forman S, et al. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis. Neurology. 2009;72(10):881-5.
- Absoud M, Cummins C, Desai N, Gika A, McSweeney N, Munot P, et al. Childhood optic neuritis clinical features and outcome. Arch Dis Child. 2011;96(9):860-2.
- Borchert M, Liu GT, Pineles S, Waldman AT. Pediatric Optic Neuritis: What Is New. J Neuroophthalmol. 2017;37 Suppl 1(Suppl 1):S14-S22.
- Nair A, Sankhyan N, Sukhija J, Saini AG, Vyas S, Suthar R, et al. Clinical outcomes and Anti-MOG antibodies in pediatric optic neuritis: A prospective observational study. Eur J Paediatr Neurol. 2024;49:1-5.
- Serin HM, Yilmaz S, Simsek E, Kanmaz S, Eraslan C, Aktan G, et al. Clinical spectrum, treatment and outcome of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease in children: a tertiary care experience. Acta Neurol Belg. 2021;121(1):231-239.
- De Meo E, Filippi M, Trojano M, Comi G, Patti F, Brescia Morra V, et al. Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis. Ann Neurol. 2022;91(4):483-495.
- Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, et al. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016;86(3):245-52.
- Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, et al. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology. 2016;87(9 Suppl 2):S38-45.
- Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology. 2007;68(16 Suppl 2):S23-36.
- Wang CX. Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient. Paediatr Drugs. 2021;23(3):213-221.
- Kanmaz S, Yılmaz S, Dündar NO, Aksoy A, Canpolat M, Per H, et al. Acute Disseminated Encephalomyelitis in Children and Adolescents: A Multicenter Retrospective Study of Relapse and Outcome. J Child Neurol. 2025;40(10):838-851.
- Monge Galindo L, Martínez de Morentín AL, Pueyo Royo V, García Iñiguez JP, Sánchez Marco S, López-Pisón J, et al. Optic neuritis in paediatric patients: Experience over 27 years and a management protocol. Neurologia (Engl Ed). 2021;36(4):253-261.
- Aldebasi T, Altuwaijri W, Gangadharan S, Alhammad D, Alakel A, Albekairy NA, et al. Management and outcomes of pediatric optic neuritis in a tertiary hospital in Riyadh, Saudi Arabia: a retrospective study. BMC Neurol. 2024;24(1):474.
- Jacquet C, Garnier A, Cheuret E. Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy: Four French Cases. Neuropediatrics. 2016;47(3):175-8.
- Direk MÇ, Besen Ş, Öncel İ, Günbey C, Özdoğan O, Orgun LT, et al. Optic neuritis in Turkish children and adolescents: A multicenter retrospective study. Mult Scler Relat Disord. 2024;81:105149.
- Lehman SS, Lavrich JB. Pediatric optic neuritis. Curr Opin Ophthalmol. 2018;29(5):419-422.
- Yu CW, Yau M, Mezey N, Joarder I, Micieli JA. Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review. Eye Brain. 2020;12:139-167.
- Garcia CR, Al-Zubidi N. Neuro-Ophthalmic Complications of Immune Checkpoint Inhibitors. Neurol Clin. 2026;44(2):279-290.
- Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, et al. Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford). 2013;52(5):868-74.
- Ramos-Casals M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by biological agents: a double-edged sword?. Autoimmun Rev. 2010;9(3):188-93.
- Kim YJ, Lee JS, Lee J, Lee SC, Kim TI, Byeon SH, et al. Factors associated with ocular adverse event after immune checkpoint inhibitor treatment. Cancer Immunol Immunother. 2020;69(12):2441-2452.
- Kuo HT, Chen CY, Hsu AY, Wang YH, Lin CJ, Hsia NY, et al. Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database. Front Immunol. 2023;14:1302293.
- Lipe DN, Galvis-Carvajal E, Rajha E, Wechsler AH, Gaeta S. Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome. Am J Emerg Med. 2021;46:51-55.
- Cooksley T, Weaver J, McNamara M, Lorigan P. Immune checkpoint inhibitor-related myasthenia gravis, myositis and myocarditis: a triad but not at the same time?. QJM. 2024;117(5):373-374.
- Rubino S, Cannon GW, Sauer BC, Rojas J, Stoddard GJ, Kunkel GA, et al. Immune Checkpoint Inhibitor-Related Myositis and Associated Triad Overlap Syndrome. Arthritis Care Res (Hoboken). 2026.
- Albastaki E, Rishu R, Tun Y, Abdullah A, Bhattacharjee S. Triple M Syndrome After Immune Checkpoint Inhibition: A Rare and Life-Threatening Triad of Myocarditis, Myositis, and Myasthenia Gravis. Cureus. 2025;17(11):e96514.
- Soman B, Dias MC, Rizvi SAJ, Kardos A. Myasthenia gravis, myositis and myocarditis: a fatal triad of immune-related adverse effect of immune checkpoint inhibitor treatment. BMJ Case Rep. 2022;15(12).
- Basnet A, Sharma NR, Gautam S, Lamichhane S, Kansakar S, Tiwari K, et al. Immune checkpoint inhibitor-induced myasthenia gravis, myocarditis, and myositis: A case report. Clin Case Rep. 2024;12(6):e8968.
- Daood R, Naffaa ME, Azrilin O, Hassan F, Jeries H, Chaim P. Overlapping autoimmunity and demyelination syndromes associated with TNF inhibitor therapy. Clin Rheumatol. 2026;45(4):2413-2420.
- Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA. Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther. 2014;16(3):R125.
- Faillace C, de Almeida JR, de Carvalho JF. Optic neuritis after infliximab therapy. Rheumatol Int. 2013;33(4):1101-3.
- Dündar S, Yaşar M, Çakmak H, Kıylıoğlu N, Ünsal A. Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis. GMS Ophthalmol Cases. 2023;13:Doc24.
- Schneider BJ, Naidoo J, Santomasso BD, Lacchetti C, Adkins S, Anadkat M, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol. 2021;39(36):4073-4126.
- Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714-1768.
- Neo YN, Martinez-Alvarez L, Davagnanam I, Girafa G, Bremner F, Braithwaite T, et al. Treatment of post-vaccination optic neuritis: implications from the global SARS-CoV-2 vaccination effort. Graefes Arch Clin Exp Ophthalmol. 2026;264(3):851-862.
- Tisavipat N, Anamnart C, Owattanapanich W, Apiwattanakul M, Savangned P, Prayoonwiwat N, et al. Author’s response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports. Mult Scler Relat Disord. 2022;66:104055.
- Spila-Alegiani S, Massari M, Cutillo M, Menniti-Ippolito F, Da Cas R, Mayer F, et al. Safety of influenza vaccine during the vaccination campaign 2021/2022 in Italy: a self-controlled case series study. Vaccine. 2026;88:128806.
- Atkins EJ. Nonarteritic anterior ischemic optic neuropathy. Curr Treat Options Neurol. 2011;13(1):92-100.
- Feola AJ, Girkin CA, Ethier CR, Samuels BC. A Potential Role of Acute Choroidal Expansion in Nonarteritic Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci. 2022;63(4):23.
- Guo Y, Mehrabian Z, Johnson MA, Miller NR, Henderson AD, Hamlyn J, et al. Biomarkers of lesion severity in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION). PLoS One. 2021;16(3):e0243186.
- Gabbay J, Walter E, Kerman T, Amitai N, Gabay O, Hazan I, et al. Hypoperfusion states could increase the risk of non-arteritic anterior ischemic optic neuropathy. PLoS One. 2024;19(11):e0313098.
- Liu YA, Mesentier-Louro LA, Shariati MA, Moss HE, Beres SJ, Liao YJ. High Altitude as a Risk Factor for the Development of Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol. 2023;43(1):69-75.
- Özdemir A, Bodur MF, Güngör İ. The importance of nutritional status in NAION: risk assessment with PNI and CONUT scores. Clin Exp Optom. 2026;109(2):237-243.
- Tournaire-Marques E. [Ischemic optic neuropathies]. J Fr Ophtalmol. 2020;43(6):552-558.
- Hayreh SS. Ischaemic optic neuropathy. Indian J Ophthalmol. 2000;48(3):171-94.
- Hayreh SS. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol. 1999;10(6):474-82.
- Elliott WJ. Circadian variation in blood pressure: implications for the elderly patient. Am J Hypertens. 1999;12(2 Pt 2):43S-49S.
- Labowsky MT, Rizzo JF 3rd. The Controversy of Chronotherapy: Emerging Evidence regarding Bedtime Dosing of Antihypertensive Medications in Non-Arteritic Anterior Ischemic Optic Neuropathy. Semin Ophthalmol. 2023;38(1):99-104.
- Hayreh SS, Podhajsky P, Zimmerman MB. Beta-blocker eyedrops and nocturnal arterial hypotension. Am J Ophthalmol. 1999;128(3):301-9.
- Wong B, Fraser CL. Obstructive Sleep Apnea in Neuro-Ophthalmology. J Neuroophthalmol. 2019;39(3):370-379.
- Wang AG, Cheng HC. Amiodarone-Associated Optic Neuropathy: Clinical Review. Neuroophthalmology. 2017;41(2):55-58.
- Mitchell R, Chacko J. Clinical and Mechanistic Review of Amiodarone-Associated Optic Neuropathy. Biomolecules. 2022;12(9).
- Cheng HC, Yeh HJ, Huang N, Chou YJ, Yen MY, Wang AG. Amiodarone-Associated Optic Neuropathy: A Nationwide Study. Ophthalmology. 2015;122(12):2553-9.
- Fasler K, Traber GL, Jaggi GP, Landau K. Amiodarone-associated Optic Neuropathy-A Clinical Criteria-based Diagnosis?. Neuroophthalmology. 2018;42(1):2-10.
- Gandhi JS. Sildenafil-associated NAION. Ophthalmology. 2003;110(9):1860-1; author reply 1861.
- Etminan M, Sodhi M, Mikelberg FS, Maberley D. Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US. JAMA Ophthalmol. 2022;140(5):480-484.
- Pomeranz HD. The Relationship Between Phosphodiesterase-5 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol. 2016;36(2):193-6.
- Pomeranz HD. Erectile Dysfunction Agents and Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Clin. 2017;35(1):17-27.
- Laties A, Sharlip I. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med. 2006;3(1):12-27.
- Laties AM. Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date. Drug Saf. 2009;32(1):1-18.
- Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, et al. Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. JAMA Ophthalmol. 2025;143(4):304-314.
- Abbass NJ, Nahlawi R, Shaia JK, Allan KC, Kaelber DC, Talcott KE, et al. The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy. Am J Ophthalmol. 2025;274:24-31.
- Hsu AY, Kuo HT, Wang YH, Lin CJ, Shao YC, Chiang CC, et al. Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes. JAMA Ophthalmol. 2025;143(5):400-407.
- Simonsen E, Lund LC, Ernst MT, Hjellvik V, Hegedüs L, Hamann S, et al. Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study. Diabetes Obes Metab. 2025;27(6):3094-3103.
- Wang L, Volkow ND, Kaelber DC, Xu R. Semaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes. JAMA Netw Open. 2025;8(8):e2526327.
- Lieberman RA, Korona-Bailey J, Banaag A, Furhman B, Corrado R, Koehlmoos TP. Semaglutide Decreases Risk of Non-Arteritic Anterior Ischemic Optic Neuroapthy in Type 2 Diabetic Patients. Mil Med. 2026;191(5-6):e1020-e1025.
- Amini A, Hamann S, Larsen M. Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association. Acta Ophthalmol. 2025;103(6):615-621.
- Singh AK, Kesavadev J, Tiwaskar M. Nonarteritic Anterior Ischemic Optic Neuropathy and Semaglutide: What is This All About?. J Assoc Physicians India. 2024;72(8):11-12.
- Arnold AC. The 14th Hoyt Lecture: Ischemic Optic Neuropathy: The Evolving Profile, 1966-2015. J Neuroophthalmol. 2016;36(2):208-15.
- Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA. 1995;273(8):625-32.
- Tian GH, Jia N, Lu CF, Zhang XJ. [Clinical characteristics of non-arteritic anterior ischemic optic neuropathy]. Zhonghua Yan Ke Za Zhi. 2009;45(12):1064-7.
- Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology. 2008;115(10):1818-25.
- Yüksel B, Bıçak F, Gümüş F, Küsbeci T. Non-Arteritic Anterior Ischaemic Optic Neuropathy with Progressive Macular Ganglion Cell Atrophy due to COVID-19. Neuroophthalmology. 2022;46(2):104-108.
- Chang YS, Weng SF, Chang C, Wang JJ, Su SB, Huang CC, et al. Risk of Nonarteritic Anterior Ischemic Optic Neuropathy Following End-Stage Renal Disease. Medicine (Baltimore). 2016;95(12):e3174.
- Foster RC, Bhatti MT, Crum OM, Lesser ER, Hodge DO, Chen JJ. Reexamining the Incidence of Nonarteritic Anterior Ischemic Optic Neuropathy: A Rochester Epidemiology Project Study. J Neuroophthalmol. 2024;44(3):337-341.
- Woods B, Szanto D, Wang JK, Erekat A, Golden A, Garvin MK, et al. Early Optic Nerve Head Swelling Rate Is Associated with Worsening of Visual Outcomes in Nonarteritic Anterior Ischemic Optic Neuropathy. Ophthalmology. 2026.
- Yang S, Ren D, Li C, Yang Z, Hou X, Zhao C, et al. In Vivo Macro-Micro Neurovascular Mapping and Visual Field Correspondence in Non-Arteritic Anterior Ischemic Optic Neuropathy. Ophthalmol Ther. 2026;15(2):719-743.
- Kessel L, Hamann S, Wegener M, Tong J, Fraser CL. Microcystic macular oedema in optic neuropathy: case series and literature review. Clin Exp Ophthalmol. 2018;46(9):1075-1086.
- Bhatti MT, Miller NR. Post-cataract surgery optic neuropathy: a chronological narrative review of the literature and speculation on pathogenesis. Curr Opin Ophthalmol. 2022;33(6):485-493.
- Moradi A, Kanagalingam S, Diener-West M, Miller NR. Post-Cataract Surgery Optic Neuropathy: Prevalence, Incidence, Temporal Relationship, and Fellow Eye Involvement. Am J Ophthalmol. 2017;175:183-193.
- Ing EB, Kam JWK, Cheng JZ, Wong SWK, Strungaru H, Slomovic A, et al. Incidence of nonarteritic ischemic optic neuropathy following topical clear corneal cataract surgery: survey and meta-analysis. Can J Ophthalmol. 2020;55(1):87-92.
- Mansukhani SA, Chen JJ, Fairbanks AM, Foster RC, Erie JC, Baratz KH, et al. A Population-Based Study of Anterior Ischemic Optic Neuropathy Following Cataract Surgery. Am J Ophthalmol. 2021;222:157-165.
- Al-Madani MV, Al-Raqqad NK, Al-Fgarra NA, Al-Thawaby AM, Jaafar AA. The risk of ischemic optic neuropathy post phacoemulsification cataract surgery. Pan Afr Med J. 2017;28:53.
- Chang MY, Keltner JL. Risk Factors for Fellow Eye Involvement in Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol. 2019;39(2):147-152.
- Farahvash A, Micieli JA. Neuro-Ophthalmological Manifestations of Obstructive Sleep Apnea: Current Perspectives. Eye Brain. 2020;12:61-71.
- Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28(1):34-62.
- Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 1994;101(11):1779-85.
- Hayreh SS. Vascular disorders in neuro-ophthalmology. Curr Opin Neurol. 2011;24(1):6-11.
- Ponte C, Martins-Martinho J, Luqmani RA. Diagnosis of giant cell arteritis. Rheumatology (Oxford). 2020;59(Suppl 3):iii5-iii16.
- van der Geest KSM, Sandovici M, Bley TA, Stone JR, Slart RHJA, Brouwer E. Large vessel giant cell arteritis. Lancet Rheumatol. 2024;6(6):e397-e408.
- Narváez J, Estrada P, Vidal-Montal P, Nolla JM. Performance of the new 2022 ACR/EULAR classification criteria for giant cell arteritis in clinical practice in relation to its clinical phenotypes. Autoimmun Rev. 2023;22(10):103413.
- Molina-Collada J, Castrejón I, Monjo I, Fernández-Fernández E, Torres Ortiz G, Álvaro-Gracia JM, et al. Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care. RMD Open. 2023;9(2).
- van Nieuwland M, van Bon L, Vermeer M, Brouwer E, Alves C. External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic. RMD Open. 2023;9(3).
- Issa M, Donaldson L, Jeeva-Patel T, Margolin E. Ischemic ocular manifestations of giant cell arteritis: A Canadian case series. J Neurol Sci. 2022;436:120222.
- Yan Y, Li Z, Luo Y, Chen P, Liu L. Biopsy-Proven Giant Cell Arteritis Associated Vision Loss in Chinese Subjects: A Case Series and Review of the Literature. Neuroophthalmology. 2023;47(2):79-87.
- Ha JW, Song JJ, Park YB, Lee SW. Validation of the 2022 ACR/EULAR classification criteria for giant cell arteritis in Korean patients with giant cell arteritis. Mod Rheumatol. 2025;35(3):524-528.
- Andel PM, Diamantopoulos AP, Myklebust G, Haugeberg G. Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria. Front Med (Lausanne). 2023;10:1286601.
- Sugihara T, Harigai M, Uchida HA, Yoshifuji H, Maejima Y, Ishizaki J, et al. Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis. Arthritis Res Ther. 2025;27(1):19.
- Ing EB, Wang DN, Kirubarajan A, Benard-Seguin E, Ma J, Farmer JP, et al. Systematic Review of the Yield of Temporal Artery Biopsy for Suspected Giant Cell Arteritis. Neuroophthalmology. 2019;43(1):18-25.
- Chung SH, Morcos MB, Ng B. Determinants of Positive Temporal Artery Biopsies in the Veterans Health Administration National Database Cohort. Arthritis Care Res (Hoboken). 2020;72(5):699-704.
- Shen A, Gruener AM, Carey AR, Henderson AD, Poostchi A, McCulley TJ, et al. Effect of Temporal Artery Biopsy Length and Laterality on Diagnostic Yield. J Neuroophthalmol. 2022;42(2):208-211.
- Mehta K, Eid M, Gangadharan A, Pritchard A, Lin CC, Goodney P, et al. The utility of the bilateral temporal artery biopsy for diagnosis of giant cell arteritis. J Vasc Surg. 2022;76(6):1704-1709.
- Danesh-Meyer HV, Savino PJ, Eagle RC Jr, Kubis KC, Sergott RC. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20(3):213-5.
- Pouncey AL, Yeldham G, Magan T, Lucenteforte E, Jaffer U, Virgili G. Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis. Cochrane Database Syst Rev. 2024;2(2):CD013199.
- Rinagel M, Chatelus E, Jousse-Joulin S, Sibilia J, Gottenberg JE, Chasset F, et al. Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. Autoimmun Rev. 2019;18(1):56-61.
- Slart RHJA. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45(7):1250-1269.
- Dejaco C, Ramiro S, Bond M, Bosch P, Ponte C, Mackie SL, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2024;83(6):741-751.
- Nakajima E, Moon FH, Junior NC, Macedo CR, de Souza AWS, Iared W. Accuracy of Doppler ultrasound in the diagnosis of giant cell arteritis: a systematic review and meta-analysis. Adv Rheumatol. 2023;63(1):5.
- Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636-643.
- González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado-Rodriguez M, Figueroa M, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 1998;41(8):1497-504.
- Palmowski A, Buttgereit F. Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis. Curr Rheumatol Rep. 2020;22(12):85.
- Harris E, Tiganescu A, Tubeuf S, Mackie SL. The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy. Curr Rheumatol Rep. 2015;17(6):513.
- Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19-30.
- Mukhtyar CB, Nikiphorou E, Bartoletti A, Dey M, Ducker G, Misra DP, et al. 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis. Ann Rheum Dis. 2026.
- Nesher G, Rubinow A, Sonnenblick M. Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study. Clin Exp Rheumatol. 1997;15(3):303-6.
- Liozon E, Ly KH, Robert PY. [Ocular complications of giant cell arteritis]. Rev Med Interne. 2013;34(7):421-30.
- Makhzoum JP, Baati Y, Tanase O, Mendel A, Pagnoux C, Ross C. Antiplatelet therapy to prevent ischemic events in giant cell arteritis: protocol for a systematic review and meta-analysis. Syst Rev. 2024;13(1):173.
- Springer J, Villa-Forte A. Thrombosis in vasculitis. Curr Opin Rheumatol. 2013;25(1):19-25.
- Stone JH, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial. Lancet Rheumatol. 2021;3(5):e328-e336.
- Unizony SH, Dasgupta B, Fisheleva E, Rowell L, Schett G, Spiera R, et al. Design of the tocilizumab in giant cell arteritis trial. Int J Rheumatol. 2013;2013:912562.
- Mariano VJ, Frishman WH. Tocilizumab in Giant Cell Arteritis. Cardiol Rev. 2018;26(6):321-330.
- Spiera R, Unizony SH, Bao M, Luder Y, Han J, Pavlov A, et al. Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial. Semin Arthritis Rheum. 2021;51(2):469-476.
- Calderón-Goercke M, Castañeda S, Aldasoro V, Villa I, Prieto-Peña D, Atienza-Mateo B, et al. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. Clin Exp Rheumatol. 2020;38 Suppl 124(2):112-119.
- Unizony SH, Bao M, Han J, Luder Y, Pavlov A, Stone JH. Treatment failure in giant cell arteritis. Ann Rheum Dis. 2021;80(11):1467-1474.
- Gérard AL, Simon-Tillaux N, Yordanov Y, Cacoub P, Tubach F, Saadoun D, et al. Efficacy and safety of steroid-sparing treatments in giant cell arteritis according to the glucocorticoids tapering regimen: A systematic review and meta-analysis. Eur J Intern Med. 2021;88:96-103.
- Ness T, Bley TA, Schmidt WA, Lamprecht P. The diagnosis and treatment of giant cell arteritis. Dtsch Arztebl Int. 2013;110(21):376-85; quiz 386.
- Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, et al. A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis. N Engl J Med. 2025;392(20):2013-2024.
- Schmidt WA, Setty AR, Dejaco C, Rubbert-Roth A, Cid MC, Ishii T, et al. Clinical outcomes of upadacitinib continuation vs withdrawal in giant cell arteritis through 2 years. Ann Rheum Dis. 2026.
- Cayrou C, Gallet F, Ly K, Fauchais AL, Bouanat S, Parreau S. Unraveling giant cell arteritis: From immunopathology to emerging targeted therapies (2026 update). Autoimmun Rev. 2026;25(9):104122.
- Mirouse A, Cacoub P, Desbois AC, Comarmond C, Pagnoux C, Saadoun D. Investigational drugs in systemic vasculitis. Expert Opin Investig Drugs. 2017;26(9):1049-1061.
- Kötter I, Henes JC, Wagner AD, Loock J, Gross WL. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature. Clin Exp Rheumatol. 2012;30(1 Suppl 70):S114-29.
- Moreel L, Betrains A, Molenberghs G, Vanderschueren S, Blockmans D. Epidemiology and predictors of relapse in giant cell arteritis: A systematic review and meta-analysis. Joint Bone Spine. 2023;90(1):105494.
- Aussedat M, Lobbes H, Samson M, Euvrard R, Lega JC, Mainbourg S. Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis. Autoimmun Rev. 2022;21(1):102930.
- Floris A, Piga M, Chessa E, Congia M, Erre GL, Angioni MM, et al. Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis. Clin Rheumatol. 2022;41(1):19-31.
- Yin Y, Zhang Y, Wang D, Han X, Chu X, Shen M, et al. Complete blood count reflecting the disease status of giant cell arteritis: A retrospective study of Chinese patients. Medicine (Baltimore). 2020;99(39):e22406.
- Luqmani RA. Discontinuation of therapies in vasculitis. Clin Exp Rheumatol. 2013;31(4 Suppl 78):S93-7.
- Rinden T, Miller E, Nasr R. Giant cell arteritis: An updated review of an old disease. Cleve Clin J Med. 2019;86(7):465-472.
- Schmidt J, Duhaut P. [Aortitis in giant cell arteritis]. Rev Med Interne. 2016;37(4):239-44.
- Carlson K, Kaymakci M, Sattui SE, Putman M. Incidence of aortic aneurysm, dissection, or rupture among patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum. 2025;72:152714.
- Marie I, Proux A, Duhaut P, Primard E, Lahaxe L, Girszyn N, et al. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine (Baltimore). 2009;88(3):182-192.
- Espitia O, Blonz G, Urbanski G, Landron C, Connault J, Lavigne C, et al. Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event. Arthritis Res Ther. 2021;23(1):14.
- Samson M, Greigert H, Ghesquière T, Bonnotte B. [Treatment of giant cell arteritis]. Presse Med. 2019;48(9):968-979.
- Sailler L, Pugnet G, Bienvenu B. [Treatment of giant cell arteritis]. Rev Med Interne. 2013;34(7):431-7.
- De Smit E, O’Sullivan E, Mackey DA, Hewitt AW. Giant cell arteritis: ophthalmic manifestations of a systemic disease. Graefes Arch Clin Exp Ophthalmol. 2016;254(12):2291-2306.
- Schmidt D, Ness T. [Ocular findings and differential diagnoses in giant cell arteritis (Arteriitis cranialis)]. Z Rheumatol. 2009;68(2):117-23.
- von der Emde L, Petzinna SM, Herwig-Carl MC, Adamson MS, Bauer CJ, Esser J, et al. Advances in diagnosing and treating giant cell arteritis: New hope for arteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2026;71(2):483-497.
- Bajpai V, Madan S, Rana G. Noninvasive Markers of Arteritic Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis. J Ophthalmic Vis Res. 2022;17(2):306-308.
- Mandura RA. Giant Cell Arteritis Presenting as Unilateral Arteritic Anterior Ischemic Optic Neuropathy. Cureus. 2021;13(7):e16653.
- Kwok JM, Sundaram ANE. Bilateral cilioretinal artery occlusions in giant cell arteritis. Can J Ophthalmol. 2021;56(2):144.
- Kasimov M, Popovic MM, Micieli JA. Cilioretinal Sparing Central Retinal Artery Occlusion from Giant Cell Arteritis. Case Rep Ophthalmol. 2022;13(1):23-27.
- Pm G, R A, Dhar S, Sharma N. “Cilioretinal artery occlusion: Current scenario”. Eur J Ophthalmol. 2025;35(5):1896-1900.
- Han JY, Gillette JS, Scott IU, Greenberg PB. The Spectrum of Isolated Retinal Artery Occlusion Secondary to Giant Cell Arteritis. Ophthalmic Surg Lasers Imaging Retina. 2024;55(9):536-540.
- Lazaar H, Moumni A, Aziz A, Boutaj T, Amazouzi A, Boutimzine N, et al. Unilateral Central Retinal Artery Occlusion Revealing Giant Cell Arteritis: A Case Report. Cureus. 2025;17(3):e80452.
- McKillop E, Tejwani D, Weir C, Jay J. Anterior segment ischaemia with giant cell arteritis. Can J Ophthalmol. 2006;41(2):201-3.
- Hamed LM, Guy JR, Moster ML, Bosley T. Giant cell arteritis in the ocular ischemic syndrome. Am J Ophthalmol. 1992;113(6):702-5.
- Wilkinson EC, McLucas M, Ayton T, Dunlop A. Ocular ischaemic syndrome due to giant cell arteritis. BMJ Case Rep. 2025;18(3).
- Thomson GT, Johnston JL, Sharpe JA, Inman RD. Internuclear ophthalmoplegia in giant cell arteritis. J Rheumatol. 1989;16(5):693-5.
- Tamhankar MA, Biousse V, Ying GS, Prasad S, Subramanian PS, Lee MS, et al. Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study. Ophthalmology. 2013;120(11):2264-9.
- Peter J, David S, Danda D, Peter JV, Horo S, Joseph G. Ocular manifestations of Takayasu arteritis: a cross-sectional study. Retina. 2011;31(6):1170-8.
- Chun YS, Park SJ, Park IK, Chung H, Lee J. The clinical and ocular manifestations of Takayasu arteritis. Retina. 2001;21(2):132-40.
- Dammacco R, Cimino L, De Simone L, Alessio G, Dammacco F. Ocular Manifestations in an Italian Cohort of Patients with Takayasu Arteritis. Ocul Immunol Inflamm. 2023;31(5):945-954.
- Sharma U, Rishi E, Rishi P, Gupta V, Raman R. Posterior segment manifestations of Takayasu arteritis: A narrative review. Indian J Ophthalmol. 2024;72(5):637-647.
- Águeda AF, Monti S, Luqmani RA, Buttgereit F, Cid M, Dasgupta B, et al. Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis. RMD Open. 2019;5(2):e001020.
- As C, Danda D. Current Diagnosis and Management of Takayasu Arteritis. Int Heart J. 2023;64(4):519-534.
- Serra R, Butrico L, Fugetto F, Chibireva MD, Malva A, De Caridi G, et al. Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis. Ann Vasc Surg. 2016;35:210-25.
- Russo RAG, Katsicas MM. Takayasu Arteritis. Front Pediatr. 2018;6:265.
- Zeng Y, Duan J, Ge G, Zhang M. Therapeutic Management of Ocular Ischemia in Takayasu’s Arteritis: A Case-Based Systematic Review. Front Immunol. 2021;12:791278.
- Pugh D, Grayson P, Basu N, Dhaun N. Aortitis: recent advances, current concepts and future possibilities. Heart. 2021;107(20):1620-1629.
- Issa M, Donaldson L, Margolin E. Incidence of giant cell arteritis mimicking non-arteritic anterior optic neuropathy. J Neurol Sci. 2023;449:120661.
- Wang MY, Brewer R, Sadun AA. Posterior ischemic optic neuropathy: Perioperative risk factors. Taiwan J Ophthalmol. 2020;10(3):167-173.
- Patel HR, Margo CE. Pathology of Ischemic Optic Neuropathy. Arch Pathol Lab Med. 2017;141(1):162-166.
- Lee LA, Newman NJ, Wagner TA, Dettori JR, Dettori NJ. Postoperative ischemic optic neuropathy. Spine (Phila Pa 1976). 2010;35(9 Suppl):S105-16.
- Rubin DS, Matsumoto MM, Moss HE, Joslin CE, Tung A, Roth S. Ischemic Optic Neuropathy in Cardiac Surgery: Incidence and Risk Factors in the United States from the National Inpatient Sample 1998 to 2013. Anesthesiology. 2017;126(5):810-821.
- Roth S, Raphael J. Cardiac Surgery and Ischemic Optic Neuropathy. J Cardiothorac Vasc Anesth. 2021;35(1):39-40.
- Shah SH, Xiao L, Chen YF, Moss HE, Rubin DS, Roth S. Perioperative Ischemic Optic Neuropathy after Cardiac Surgery: Development and Validation of a Preoperative Risk Prediction Model. J Cardiothorac Vasc Anesth. 2022;36(12):4266-4272.
- Stambough JL, Dolan D, Werner R, Godfrey E. Ophthalmologic complications associated with prone positioning in spine surgery. J Am Acad Orthop Surg. 2007;15(3):156-65.
- Kamel I, Barnette R. Positioning patients for spine surgery: Avoiding uncommon position-related complications. World J Orthop. 2014;5(4):425-43.
- Nguyen A, Hasoon J, Li T, Robinson CL, Nguyen V. Perioperative Visual Loss After Spine Surgery: A Case-Based Review of Posterior Ischemic Optic Neuropathy. Orthop Rev (Pavia). 2026;18:163036.
- Fandino W. Strategies to prevent ischemic optic neuropathy following major spine surgery: A narrative review. J Clin Anesth. 2017;43:50-58.
- Kline LB. Ischemic optic neuropathy. Ala J Med Sci. 1980;17(2):129-32.
- Martinelli V, Bianchi Marzoli S. Non-demyelinating optic neuropathy: clinical entities. Neurol Sci. 2001;22 Suppl 2:S55-9.
- Préterre C, Gaultier A, Obadia M, Vignal C, Mourand I, Plat J, et al. Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial. Lancet Neurol. 2025;24(11):909-919.
- Xie JS, Zaslavsky K, Chaban YV, Lusterio A, Kaur H, Motekalem Y, et al. Early Thrombolysis and Outcomes in Central Retinal Artery Occlusion: An Individual Participant Data Meta-Analysis. Stroke. 2025;56(11):3175-3186.
- Wai KM, Knapp A, Ludwig CA, Koo E, Parikh R, Rahimy E, et al. Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion. JAMA Ophthalmol. 2023;141(12):1110-1116.
- Lavin P, Patrylo M, Hollar M, Espaillat KB, Kirshner H, Schrag M. Stroke Risk and Risk Factors in Patients With Central Retinal Artery Occlusion. Am J Ophthalmol. 2018;196:96-100.
- Chen H, Colasurdo M, Falardeau J, McIntyre MK, Malhotra A, Nguyen TN, et al. Risk of Stroke Recurrence Following Isolated Retinal Artery Occlusion Versus Minor Stroke or Transient Ischemic Attack. Stroke. 2025;56(12):3394-3403.
- Gupta A, Singh P, Sanepalli SR, Raj A. Central retinal artery occlusion with cilioretinal sparing in a patient with Eisenmenger syndrome. BMJ Case Rep. 2022;15(2).
- Zakaria NA, Cheng TC, Nasaruddin RA, Che Hamzah J. Neovascular Glaucoma Complicating Central Retinal Artery Occlusion Despite Cilioretinal Artery Sparing. Cureus. 2023;15(8):e43303.
- Tesfaw AK, Batra NN, Phan CT. Clinical Features and Treatment Outcome of a Concurrent Central Retinal Vein Occlusion and Cilioretinal Artery Occlusion. Case Rep Ophthalmol. 2022;13(3):770-776.
- Cornut PL, Bieber J, Beccat S, Fortoul V, Poli M, Feldman A, et al. [Spectral domain OCT in eyes with retinal artery occlusion]. J Fr Ophtalmol. 2012;35(8):606-13.
- Ahn SJ, Woo SJ, Park KH, Jung C, Hong JH, Han MK. Retinal and choroidal changes and visual outcome in central retinal artery occlusion: an optical coherence tomography study. Am J Ophthalmol. 2015;159(4):667-76.
- Wakefield MC, O’Donnell SD, Goff JM Jr. Re-evaluation of carotid duplex for visual complaints: who really needs to be studied?. Ann Vasc Surg. 2003;17(6):635-40.
- McCullough HK, Reinert CG, Hynan LS, Albiston CL, Inman MH, Boyd PI, et al. Ocular findings as predictors of carotid artery occlusive disease: is carotid imaging justified?. J Vasc Surg. 2004;40(2):279-86.
- Bull DA, Fante RG, Hunter GC, VanDalen J, Lee D, Bernhard VM, et al. Correlation of ophthalmic findings with carotid artery stenosis. J Cardiovasc Surg (Torino). 1992;33(4):401-6.
- Jorgensen R, Towne JB, Kay M, Bandyk DF. Monocular ischemia—the influence of carotid atherosclerosis versus primary ocular disease on prognosis. Surgery. 1988;104(3):507-11.
- Dumitrascu OM, Newman NJ, Biousse V. Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!. J Neuroophthalmol. 2020;40(3):333-345.
- Hakim N, Hakim J. Intra-Arterial Thrombolysis for Central Retinal Artery Occlusion. Clin Ophthalmol. 2019;13:2489-2509.
- Dagra A, Lucke-Wold B, McGrath K, Mehkri I, Mehkri Y, Davidson CG, et al. Central Retinal Artery Occlusion: A Review of Pathophysiological Features and Management. Stroke Vasc Interv Neurol. 2024;4(1):e000977.
- Ryan SJ, Jørstad ØK, Skjelland M, Simonsen CZ, Bek T, Blauenfeldt RA, et al. Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trial. Eur Stroke J. 2025;10(4):1502-1510.
- Klijn CJ, Kappelle LJ, van Schooneveld MJ, Hoppenreijs VP, Algra A, Tulleken CA, et al. Venous stasis retinopathy in symptomatic carotid artery occlusion: prevalence, cause, and outcome. Stroke. 2002;33(3):695-701.
- Lawrence PF, Oderich GS. Ophthalmologic findings as predictors of carotid artery disease. Vasc Endovascular Surg. 2002;36(6):415-24.
- Qian XZ, Chen C, Li HL, Zhong L, Wei H, Ge QM, et al. OCTA changes of retinal microvessels and thickness in moyamoya disease. Sci Rep. 2025;15(1):22143.
- Kim YH, Sung MS, Park SW. Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma. Korean J Ophthalmol. 2017;31(4):343-350.
- Cheng XR, Meng ZY, Feng WT, Tang XL, Li Z, Zhao L, et al. Ophthalmic Artery Morphology and Hemodynamics in Ocular Ischemic Syndrome: A Computational Fluid Dynamics and Particle Image Velocimetry Study. Invest Ophthalmol Vis Sci. 2026;67(2):5.
- Chen KJ, Chen SN, Kao LY, Ho CL, Chen TL, Lai CC, et al. Ocular ischemic syndrome. Chang Gung Med J. 2001;24(8):483-91.
- Iorga ER, Costin D. Vascular emergencies in neuro-ophthalmology. Rom J Ophthalmol. 2020;64(4):323-332.
- Padaki AS, Fitch RW, Stack LB, Thurman RJ. Horner’s Syndrome after Scalene Block and Carotid Dissection. J Emerg Med. 2016;50(5):e215-8.
- Choi JH, Jung J, Park KP, Baik SK, Choi KU, Choi KD, et al. Intracranial fibromuscular dysplasia presenting as various ocular manifestations. J Neurol Sci. 2014;337(1-2):232-4.
- Collins GJ Jr, Rich NM, Clagett GP, Spebar MJ, Salander JM. Fibromuscular dysplasia of the internal carotid arteries. Clinical experience and follow-up. Ann Surg. 1981;194(1):89-96.
- Schievink WI, Meyer FB, Parisi JE, Wijdicks EF. Fibromuscular dysplasia of the internal carotid artery associated with alpha1-antitrypsin deficiency. Neurosurgery. 1998;43(2):229-33; discussion 233-4.
- Wang YY, Zhou KY, Ye Y, Song F, Yu J, Chen JC, et al. Moyamoya Disease Associated With Morning Glory Disc Anomaly and Other Ophthalmic Findings: A Mini-Review. Front Neurol. 2020;11:338.
- Kumar M A, Ganesh B A. CRAO in Moyamoya Disease. J Clin Diagn Res. 2013;7(3):545-7.
- Rajagopal R, Apte RS. Seeing through thick and through thin: Retinal manifestations of thrombophilic and hyperviscosity syndromes. Surv Ophthalmol. 2016;61(2):236-47.
- Pérez-Rueda A. Leukemic retinopathy secondary to hyperviscosity syndrome in acute lymphoblastic leukemia before and after treatment. J Fr Ophtalmol. 2021;44(3):477-479.
- Kleffner I, Dörr J, Ringelstein M, Gross CC, Böckenfeld Y, Schwindt W, et al. Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry. 2016;87(12):1287-1295.
- Marrodan M, Fiol MP, Correale J. Susac syndrome: challenges in the diagnosis and treatment. Brain. 2022;145(3):858-871.
- Rennebohm R, Susac JO, Egan RA, Daroff RB. Susac’s Syndrome—update. J Neurol Sci. 2010;299(1-2):86-91.
- Hernández JL, Sanlés I, Pérez-Montes R, Martínez-Taboada VM, Olmos JM, Salmón Z, et al. Antiphospholipid syndrome and antiphospholipid antibody profile in patients with retinal vein occlusion. Thromb Res. 2020;190:63-68.
- Choudhary RA, Siddiqui MAR, Moiz B, Ishaq S. Combined central retinal artery and vein occlusion associated with antiphospholipid syndrome. BMJ Case Rep. 2022;15(3).
- Suhail S, Tallarita T, Kanzafarova I, Lau J, Mansukhani S, Olatunji S, et al. Ocular Ischemic Syndrome and the Role of Carotid Artery Revascularization. Ann Vasc Surg. 2024;105:165-176.
- Al Ibraheem B, Tallarita T, Mansukhani SA, Ramachandran M, Manz JW, Lau J, et al. Neuro-ophthalmic outcomes after carotid intervention for ocular symptoms. J Vasc Surg. 2025;81(3):643-649.
- Machalińska A, Kowalska-Budek A, Kawa MP, Kazimierczak A, Safranow K, Kirkiewicz M, et al. Effect of carotid endarterectomy on retinal function in asymptomatic patients with hemodynamically significant carotid artery stenosis. Pol Arch Intern Med. 2017;127(11):722-729.
- Besada E, Fisher JP. Absent relative afferent pupillary defect in an asymptomatic case of lateral chiasmal syndrome from cerebral aneurysm. Optom Vis Sci. 2001;78(4):195-205.
- Parija S, Chakraborty K, Sahu RN, Nayak B, Rathod RS. Ganglion cell complex and retinal nerve fiber layer thickness in predicting visual outcome in brain tumors after surgery. World J Exp Med. 2025;15(4):108702.
- Kanamori A, Nakamura M, Matsui N, Nagai A, Nakanishi Y, Kusuhara S, et al. Optical coherence tomography detects characteristic retinal nerve fiber layer thickness corresponding to band atrophy of the optic discs. Ophthalmology. 2004;111(12):2278-83.
- Monteiro ML, Leal BC, Rosa AA, Bronstein MD. Optical coherence tomography analysis of axonal loss in band atrophy of the optic nerve. Br J Ophthalmol. 2004;88(7):896-9.
- Monteiro ML, Medeiros FA, Ostroscki MR. Quantitative analysis of axonal loss in band atrophy of the optic nerve using scanning laser polarimetry. Br J Ophthalmol. 2003;87(1):32-7.
- Predoi DV, Badiu C, Dărăban C, Stângu C, Dumitrache M. [Assessment of compressive optic neuropathy in hipofizar tumors]. Oftalmologia. 2008;52(4):110-7.
- Kecer F, Tomčíková D. OCT in the Differential Diagnosis of Optic Neuropathies. A Review. Cesk Slov Oftalmol. 2025;81(2):51-59.
- Butenschoen VM, Schwendinger N, von Werder A, Bette S, Wienke M, Meyer B, et al. Visual acuity and its postoperative outcome after transsphenoidal adenoma resection. Neurosurg Rev. 2021;44(4):2245-2251.
- Ito M, Suda K, Nakano E, Tagawa M, Miyata M, Kashii S, et al. Influence of Tumor Characteristics on Visual Field Outcomes After Pituitary Adenoma Surgery. J Neuroophthalmol. 2023;43(3):376-382.
- Watanabe T, Uehara H, Takeishi G, Chuman H, Azuma M, Yokogami K, et al. Characteristics of Preoperative Visual Disturbance and Visual Outcome After Endoscopic Endonasal Transsphenoidal Surgery for Nonfunctioning Pituitary Adenoma in Elderly Patients. World Neurosurg. 2019;126:e706-e712.
- Luomaranta T, Raappana A, Saarela V, Liinamaa MJ. Factors Affecting the Visual Outcome of Pituitary Adenoma Patients Treated with Endoscopic Transsphenoidal Surgery. World Neurosurg. 2017;105:422-431.
- Ng BCF, Mak CH, Steffi CSY, Wing SK, Shing TT, Ching CF. A Factorial Analysis on Visual Outcomes of Transsphenoidal Surgery for Pituitary Macroadenoma. Asian J Neurosurg. 2022;17(2):280-285.
- Wilhelm H, Dörr S, Paulsen F, Becker G, Classen J. [Early symptoms and findings in optic nerve meningiomas]. Klin Monbl Augenheilkd. 2009;226(11):869-74.
- de Melo LP, Arruda Viani G, de Paula JS. Radiotherapy for the treatment of optic nerve sheath meningioma: A systematic review and meta-analysis. Radiother Oncol. 2021;165:135-141.
- Bloch O, Sun M, Kaur G, Barani IJ, Parsa AT. Fractionated radiotherapy for optic nerve sheath meningiomas. J Clin Neurosci. 2012;19(9):1210-5.
- Hamilton SN, Nichol A, Truong P, McKenzie M, Hsu F, Cheung A, et al. Visual Outcomes and Local Control After Fractionated Stereotactic Radiotherapy for Optic Nerve Sheath Meningioma. Ophthalmic Plast Reconstr Surg. 2018;34(3):217-221.
- Egan RA, Lessell S. A contribution to the natural history of optic nerve sheath meningiomas. Arch Ophthalmol. 2002;120(11):1505-8.
- Turbin RE, Pokorny K. Diagnosis and treatment of orbital optic nerve sheath meningioma. Cancer Control. 2004;11(5):334-41.
- Li P, Wang Z, Zhou Q, Li S, Zhang J, Wang Y, et al. A Retrospective Analysis of Vision-Impairing Tumors Among 467 Patients with Neurofibromatosis Type 2. World Neurosurg. 2017;97:557-564.
- Narayan DS, Traber GL, Figueira E, Pirbhai A, Landau K, Davis G, et al. Natural history of primary paediatric optic nerve sheath meningioma: case series and review. Br J Ophthalmol. 2018;102(8):1147-1153.
- Menon G, Nair S, Sudhir J, Rao BR, Mathew A, Bahuleyan B. Childhood and adolescent meningiomas: a report of 38 cases and review of literature. Acta Neurochir (Wien). 2009;151(3):239-44; discussion 244.
- Solli E, Turbin RE. Primary and Secondary Optic Nerve Sheath Meningioma. J Neurol Surg B Skull Base. 2021;82(1):27-71.
- Hawy E, Sharma RA, Peragallo JH, Dattilo M, Newman NJ, Biousse V. Unilateral Isolated Paucisymptomatic Optic Disc Edema. J Neuroophthalmol. 2021;41(4):e523-e534.
- Tsukahara S, Kobayashi S, Nakagawa F, Sugita K. Optociliary veins associated with meningioma of the optic nerve sheath. Ophthalmologica. 1980;181(3-4):188-94.
- de Alba Campomanes AG, Larson DA, Horton JC. Immediate shrinkage of optociliary shunt vessels after fractionated external beam radiation for meningioma of the optic nerve sheath. AJNR Am J Neuroradiol. 2008;29(7):1360-2.
- Lee JJ, Yap EY. Optociliary shunt vessels in diabetes mellitus. Singapore Med J. 2004;45(4):166-9.
- Anderson SF, Townsend JC, Selvin GJ, Jew RL. Congenital optociliary shunt vessels. J Am Optom Assoc. 1991;62(2):109-15.
- Coombs RA, Chen JJ, Salomão DR, Tajfirouz DA, Eggenberger ER, DiNome MA, et al. Optic Nerve and Optic Nerve Sheath Biopsy Indications and Outcomes. J Neuroophthalmol. 2025;45(3):267-272.
- Kheir V, Faouzi M, Borruat FX. Visual Outcomes of Fractionated Radiotherapy in Optic Nerve Sheath Meningioma: A Retrospective Study. Klin Monbl Augenheilkd. 2019;236(4):526-529.
- Pitz S, Becker G, Schiefer U, Wilhelm H, Jeremic B, Bamberg M, et al. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol. 2002;86(11):1265-8.
- Litré CF, Noudel R, Colin P, Sherpereel B, Peruzzi P, Rousseaux P. [Fractionated stereotactic radiotherapy for optic nerve sheath meningioma: eight cases]. Neurochirurgie. 2007;53(5):333-8.
- Landert M, Baumert BG, Bosch MM, Lütolf UM, Landau K. The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas. J Neuroophthalmol. 2005;25(2):86-91.
- Dai Q, Li X, Fang Y, Shen B, Wei J, Xie Q, et al. Gross-total resection in optic nerve sheath meningiomas: minimally invasive and cosmetic pleasing. Graefes Arch Clin Exp Ophthalmol. 2024;262(8):2661-2673.
- de Blank PMK, Fisher MJ, Liu GT, Gutmann DH, Listernick R, Ferner RE, et al. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision. J Neuroophthalmol. 2017;37 Suppl 1(Suppl 1):S23-S32.
- Zeid JL. Current update on the visual outcome of optic pathway glioma associated with neurofibromatosis type-1. Front Surg. 2022;9:908573.
- Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol. 2007;61(3):189-98.
- Gkikas MA, Nikolaidou A, Sandali A, Benekos K, Tsinopoulos I, Lamprogiannis L. Prevalence of optic pathway glioma in NF1: a systematic review and meta-analysis focused on MRI surveillance. J AAPOS. 2025;29(6):104701.
- Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125(1):63-6.
- Cassiman C, Legius E, Spileers W, Casteels I. Ophthalmological assessment of children with neurofibromatosis type 1. Eur J Pediatr. 2013;172(10):1327-33.
- Genç A, Ünal Y, Ceylan AC, Altan M, Gürkaş E, Özyörük D, et al. Clinical and molecular characterization of 148 pediatric neurofibromatosis type 1 patients: a single-center study identifying 14 novel variants. Eur J Pediatr. 2025;184(12):751.
- Brosius SN, Vossough A, Fisher MJ, Lang SS, Beslow LA, George BJ, et al. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1. Pediatr Neurol. 2022;134:85-92.
- Rasool N, Odel JG, Kazim M. Optic pathway glioma of childhood. Curr Opin Ophthalmol. 2017;28(3):289-295.
- Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol. 2012;14(6):790-7.
- Shofty B, Ben-Sira L, Freedman S, Yalon M, Dvir R, Weintraub M, et al. Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer. 2011;57(3):481-5.
- Dodgshun AJ, Elder JE, Hansford JR, Sullivan MJ. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive. Cancer. 2015;121(23):4190-6.
- José P, Couceiro R, Passos J, Jorge Teixeira F. Visual Outcomes of Optic Pathway Glioma Treated With Chemotherapy in Neurofibromatosis Type 1. J Pediatr Ophthalmol Strabismus. 2022;59(2):128-135.
- Rakotonjanahary J, Gravier N, Lambron J, De Carli E, Toulgoat F, Delion M, et al. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort. PLoS One. 2019;14(3):e0212107.
- Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol. 2007;9(4):430-7.
- Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, et al. A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2021;23(10):1777-1788.
- Trapani L, Gortani G, Magnolato A, Murru FM, Cattaruzzi E, Diplotti L, et al. Selumetinib as a Target Therapy in Progressive Paediatric Low-Grade Gliomas-Case Series (pLGG). J Paediatr Child Health. 2026.
- Thiagalingam S, Flaherty M, Billson F, North K. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology. 2004;111(3):568-77.
- Mahdi J, Goyal MS, Griffith J, Morris SM, Gutmann DH. Nonoptic pathway tumors in children with neurofibromatosis type 1. Neurology. 2020;95(8):e1052-e1059.
- Wabbels B, Demmler A, Seitz J, Woenckhaus M, Bloss HG, Lorenz B. Unilateral adult malignant optic nerve glioma. Graefes Arch Clin Exp Ophthalmol. 2004;242(9):741-8.
- Hartel PH, Rosen C, Larzo C, Nestor S. Malignant optic nerve glioma (glioblastoma multiforme): A case report and literature review. W V Med J. 2006;102(4):29-31.
- Sun MJ, Tran AQ, Dinkin MJ, Kazim M, Tooley AA. An elusive case of malignant optic nerve glioma with a suprasellar mass. Orbit. 2024;43(2):240-243.
- Shiferaw MY, Teklemariam TL, Aklilu AT, Gebrewahd DT, Mekuria BH, Yesuf EF, et al. A sellar-suprasellar malignant optic pathway glioblastoma in the absence of prior radiation therapy: illustrative case. J Neurosurg Case Lessons. 2024;7(3).
- Gasimova U, Adah O, Muradova M, Roberts K, Dahiya S, Verma R, et al. Optic Chiasm Glioma in an Older Adult Patient. Cureus. 2024;16(1):e51614.
- Mastorakos P, Hays MA, Caruso JP, Chen CJ, Ding D, Taylor DG, et al. Transtentorial dissemination of optic nerve glioblastoma: case report. J Neurosurg. 2018;128(2):406-413.
- Bonavolontà G, Strianese D, Grassi P, Comune C, Tranfa F, Uccello G, et al. An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011. Ophthalmic Plast Reconstr Surg. 2013;29(2):79-86.
- Vest SD, Mikkelsen LH, Holm F, Rasmussen PK, Hindso TG, Knudsen MKH, et al. Lymphoma of the Lacrimal Gland - An International Multicenter Retrospective Study. Am J Ophthalmol. 2020;219:107-120.
- Mariniello G, Bonavolontà G, Tranfa F, Maiuri F. Management of the optic canal invasion and visual outcome in spheno-orbital meningiomas. Clin Neurol Neurosurg. 2013;115(9):1615-20.
- Unteroberdörster M, Müller O, Özkan N, Pierscianek D, Hadamitzky M, Kleist B, et al. Impact of optic canal decompression on visual outcome in subtotal resected skull base meningiomas. J Neurosurg Sci. 2020;64(5):440-445.
- Magill ST, Schwartz TH, Couldwell WT, Gardner PA, Heilman CB, Sen C, et al. International Tuberculum Sellae Meningioma Study: Preoperative Grading Scale to Predict Outcomes and Propensity-Matched Outcomes by Endonasal Versus Transcranial Approach. Neurosurgery. 2023;93(6):1271-1284.
- Hayhurst C, Teo C. Tuberculum sella meningioma. Otolaryngol Clin North Am. 2011;44(4):953-63, viii-ix.
- Tan YC, Yu CC, Chang CN, Ma L, Chen YR. Optic nerve compression in craniofacial fibrous dysplasia: the role and indications for decompression. Plast Reconstr Surg. 2007;120(7):1957-1962.
- Chen YR, Breidahl A, Chang CN. Optic nerve decompression in fibrous dysplasia: indications, efficacy, and safety. Plast Reconstr Surg. 1997;99(1):22-30; discussion 31-3.
- Acheson JF. Optic nerve disorders: role of canal and nerve sheath decompression surgery. Eye (Lond). 2004;18(11):1169-74.
- Tsai YJ, Chao A, Chu YC, Chao AN. Classification, diagnosis, and management of orbital venous-lymphatic malformations: Current state-of-the-art. Taiwan J Ophthalmol. 2025;15(1):4-13.
- Colletti G, Biglioli F, Poli T, Dessy M, Cucurullo M, Petrillo M, et al. Vascular malformations of the orbit (lymphatic, venous, arteriovenous): Diagnosis, management and results. J Craniomaxillofac Surg. 2019;47(5):726-740.
- Park JY, Cho KS, Son YB, Choi HY. Endonasal Endoscopic Removal of Orbital Cavernous Venous Malformation With Optic Neuropathy. J Craniofac Surg. 2022;33(6):e641-e644.
- Hill RH 3rd, Shiels WE 2nd, Foster JA, Czyz CN, Stacey A, Everman KR, et al. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations. Ophthalmic Plast Reconstr Surg. 2012;28(2):119-25.
- Ranjan A, Chhabra AK, Kumar M. Orbital venous lymphatic malformations: case series on minimally invasive treatment approach. Rom J Ophthalmol. 2025;69(2):280-286.
- Kiratli H, Tarlan B. Total clinical regression of an orbital macrocystic lymphatic malformation following intralesional sodium tetradecyl sulphate injection. J AAPOS. 2015;19(1):78-80.
- Bouallou M, Berrajaa I, Youssef MB, Sbai AA, Benfadil D, Lachkar A. Orbital lymphangioma mimicking cellulitis: Diagnostic contribution of MRI and successful management with bleomycin sclerotherapy. Radiol Case Rep. 2026;21(9):3679-3685.
- Bhattacharjee K, Rehman O, Venkatraman V, Das D, Mohapatra SSD, Gogoi R, et al. Blood within the bone: orbital intraosseous venous malformation. Orbit. 2024;43(3):316-328.
- Choi YA, Yang MK, Sa HS. Clinicoradiologic characteristics and management of orbital incidentaloma. Sci Rep. 2025;15(1):41986.
- Leung KCP, Ko TCS. Orbital hybrid peripheral nerve sheath tumors. Taiwan J Ophthalmol. 2020;10(3):181-183.
- Stevenson LJ, McElnea EM, McKelvie PA, Hardy TG. Hybrid Neurofibroma/Schwannoma of the Orbit. Ophthalmic Plast Reconstr Surg. 2019;35(2):e49-e52.
- Sweeney AR, Gupta D, Keene CD, Cimino PJ, Chambers CB, Chang SH, et al. Orbital peripheral nerve sheath tumors. Surv Ophthalmol. 2017;62(1):43-57.
- Leruez S, Gohier P, Menei P, Milea D. [Optic nerve schwannoma]. J Fr Ophtalmol. 2013;36(3):e49-53.
- Mehta JS, Abou-Rayyah Y, Rose GE. Orbital carcinoid metastases. Ophthalmology. 2006;113(3):466-72.
- Valenzuela AA, Archibald CW, Fleming B, Ong L, O’Donnell B, Crompton J J, et al. Orbital metastasis: clinical features, management and outcome. Orbit. 2009;28(2-3):153-9.
- El-Hadad C, Koka K, Dong W, Do T, Haider M, Ursua JD, et al. Multidisciplinary Management of Orbital Metastasis and Survival Outcomes. Ophthalmic Plast Reconstr Surg. 2021;37(6):541-545.
- Li E, Howard MA, Vining EM, Becker RD, Silbert J, Lesser RL. Visual prognosis in compressive optic neuropathy secondary to sphenoid sinus mucocele: A systematic review. Orbit. 2018;37(4):280-286.
- Shaikh N, Nguyen J, Bailey CE, Patel A, Ellis B, Makary CA. Rhinogenic Optic Neuropathy with No Light Perception Secondary to Onodi Cell Mucocele with Visual Recovery after Optic Nerve Decompression. Ear Nose Throat J. 2025;104(12):759-762.
- Urbinati F, Rachwani-Anil R, Martín FZ, Aranda GL, Gómez JE. Total recovery of visual acuity in a pediatric patient with compressive optic neuropathy secondary to sphenoid sinus mucocele. Arq Bras Oftalmol. 2022;87(4).
- Levy J, Monos T, Puterman M. Bilateral consecutive blindness due to sphenoid sinus mucocele with unilateral partial recovery. Can J Ophthalmol. 2005;40(4):506-8.
- Yamaguchi K, Ohnuma I, Takahashi S, Fuse T, Aoyagi M, Nagahata M, et al. Magnetic resonance imaging in acute optic neuropathy by sphenoidal mucocele. Int Ophthalmol. 1997;21(1):9-11.
- Kloek CE, Bilyk JR, Pribitkin EA, Rubin PA. Orbital decompression as an alternative management strategy for patients with benign tumors located at the orbital apex. Ophthalmology. 2006;113(7):1214-9.
- Lardinois B, Miller L, Randazzo A, Laurent T, Debois R, Henry S. Leptomeningeal Carcinomatosis: A Call for Optimizing Diagnostic Sensitivity by the Hematology Laboratory. Case Rep Oncol. 2021;14(2):1248-1253.
- Subirá D, Serrano C, Castañón S, Gonzalo R, Illán J, Pardo J, et al. Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis. Neuro Oncol. 2012;14(1):43-52.
- Clarke JL. Leptomeningeal metastasis from systemic cancer. Continuum (Minneap Minn). 2012;18(2):328-42.
- Kuan HC, Mustapha M, Oli Mohamed S, Abdul Aziz RA, Loh CK, Mohammed F, et al. Isolated Infiltrative Optic Neuropathy in an Acute Lymphoblastic Leukemia Relapse. Cureus. 2022;14(6):e25625.
- Richardson-May J, Musa AM, Suresh P, Sniatecki JJ, Krishnan R. Leukaemic Optic Neuropathy in a Patient with Treated Acute Lymphoblastic Leukaemia: Optical Coherence Tomography as an Aid to Diagnosis. Neuroophthalmology. 2024;48(5):352-359.
- García Molina E, Penas-Prado M. Neoplastic meningitis in solid tumours: Updated review of diagnosis, prognosis, therapeutic management, and future directions. Neurologia (Engl Ed). 2020.
- Chowdhary S, Chamberlain M. Leptomeningeal metastases: current concepts and management guidelines. J Natl Compr Canc Netw. 2005;3(5):693-703.
- Kondoh T, Sonoda T. Treatment Options for Leptomeningeal Metastases of Solid Cancers: Literature Review and Personal Experience. Acta Neurochir Suppl. 2021;128:71-84.
- Razis E, Escudero MJ, Palmieri C, Mueller V, Bartsch R, Rossi G, et al. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force. ESMO Open. 2022;7(3):100483.
- Suresh S, Kosmorsky GS, Lee MS. Isolated optic nerve sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):179-183.
- Berri MA, Rouimi A. [Cerebral neurosarcoidosis]. Pan Afr Med J. 2018;30:67.
- Choi KD, Choi JH, Choi SY, Jung JH. Toxocara optic neuropathy: clinical features and ocular findings. Int J Ophthalmol. 2018;11(3):520-523.
- Malhotra J, Muddasani R, Fricke J, Mambetsariev I, Reyes A, Babikian R, et al. Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2024;8:e2400373.
- Shahan B, Choi EY, Nieves G. Cerebrospinal Fluid Analysis. Am Fam Physician. 2021;103(7):422-428.
- Rosencher L, Maisonobe T, Lavole A, Milleron B, Ferroir JP. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment]. Rev Neurol (Paris). 2012;168(4):371-4.
- Ohguro H, Nakazawa M. Pathological roles of recoverin in cancer-associated retinopathy. Adv Exp Med Biol. 2002;514:109-24.
- Dhingra A, Fina ME, Neinstein A, Ramsey DJ, Xu Y, Fishman GA, et al. Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci. 2011;31(11):3962-7.
- Xiong WH, Duvoisin RM, Adamus G, Jeffrey BG, Gellman C, Morgans CW. Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice. PLoS One. 2013;8(8):e69506.
- Duvoisin RM, Haley TL, Ren G, Strycharska-Orczyk I, Bonaparte JP, Morgans CW. Autoantibodies in Melanoma-Associated Retinopathy Recognize an Epitope Conserved Between TRPM1 and TRPM3. Invest Ophthalmol Vis Sci. 2017;58(5):2732-2738.
- Varin J, Reynolds MM, Bouzidi N, Tick S, Wohlschlegel J, Becquart O, et al. Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy. PLoS One. 2020;15(4):e0231750.
- Irie S, Furukawa T. TRPM1. Handb Exp Pharmacol. 2014;222:387-402.
- Braithwaite T, Vugler A, Tufail A. Autoimmune retinopathy. Ophthalmologica. 2012;228(3):131-42.
- Nakamura T, Yoshida T, Kitamoto K, Masuda K, Chen YN, Goto Y. Exacerbation of cancer-associated retinopathy with anti-recoverin antibodies during atezolizumab treatment for extensive-stage small cell lung cancer: A case report. Respir Investig. 2025;63(5):1033-1036.
- Ramos-Ruperto L, Busca-Arenzana C, Boto-de Los Bueis A, Schlincker A, Arnalich-Fernández F, Robles-Marhuenda Á. Cancer-Associated Retinopathy and Treatment with Intravenous Immunoglobulin Therapy. A Seldom Used Approach?. Ocul Immunol Inflamm. 2021;29(2):399-402.
- Doroslovački P, Tamhankar MA, Liu GT, Shindler KS, Ying GS, Alonso-Basanta M. Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at “Safe” Radiation Dosage. Semin Ophthalmol. 2018;33(4):581-588.
- Zhao Z, Lan Y, Bai S, Shen J, Xiao S, Lv R, et al. Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma. J Clin Neurosci. 2013;20(5):702-6.
- Ballian N, Androulakis II, Chatzistefanou K, Samara C, Tsiveriotis K, Kaltsas GA. Optic neuropathy following radiotherapy for Cushing’s disease: case report and literature review. Hormones (Athens). 2010;9(3):269-73.
- Guy J, Mancuso A, Beck R, Moster ML, Sedwick LA, Quisling RG, et al. Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg. 1991;74(3):426-32.
- Beecher M, Rana K, Gowda R, Chan WO, Selva D. Ophthalmic complications of radiotherapy. Graefes Arch Clin Exp Ophthalmol. 2026;264(3):603-615.
- Mihalcea O, Arnold AC. Side effect of head and neck radiotherapy: optic neuropathy. Oftalmologia. 2008;52(1):36-40.
- Li Z, Zhan Z, Lai Y, Fang Q, Lan Y. Radiation optic neuropathy diagnosis in nasopharyngeal carcinoma patients with radiation encephalopathy. Eur J Ophthalmol. 2022;32(6):3657-3666.
- Ayoub E, Guy JB, Moulin N, Ghenassia L, Le Hello C, Bertoletti L. Radiation optic neuropathy and stroke suspicion. J Med Vasc. 2020;45(4):232-233.
- Yu CW, Joarder I, Micieli JA. Treatment and prophylaxis of radiation optic neuropathy: A systematic review and meta-analysis. Eur J Ophthalmol. 2022;32(6):3129-3141.
- Indaram M, Ali FS, Levin MH. In search of a treatment for radiation-induced optic neuropathy. Curr Treat Options Neurol. 2015;17(1):325.
- Butler FK Jr, Hagan C, Murphy-Lavoie H. Hyperbaric oxygen therapy and the eye. Undersea Hyperb Med. 2008;35(5):333-87.
- Eckstein D, Riechardt AI, Heufelder J, Zeitz O, Böker A, Brockmann C, et al. Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?. Am J Ophthalmol. 2019;208:289-294.
- Powell BE, Chin KJ, Finger PT. Early anti-VEGF treatment for radiation maculopathy and optic neuropathy: lessons learned. Eye (Lond). 2023;37(5):866-874.
- Carey AR. Case Report: Successful treatment of external beam radiation-induced optic papillopathy with intravitreal anti-VEGF. Front Ophthalmol (Lausanne). 2023;3:1144241.
- AlAmeer AM, Davis JB, Carey AR, Henderson AD. Outcomes of systemic bevacizumab in radiation-induced optic neuropathy, case series. J Neurooncol. 2023;163(2):439-446.
- Aldrees S, Micieli JA. Catastrophic vision loss from radiation-induced optic neuropathy. BMJ Case Rep. 2020;13(2).
- Ebner R, Slamovits TL, Friedland S, Pearlman JL, Fowble B. Visual loss following treatment of sphenoid sinus carcinoma. Surv Ophthalmol. 1995;40(1):62-8.
- Dolman PJ. Dysthyroid optic neuropathy: evaluation and management. J Endocrinol Invest. 2021;44(3):421-429.
- Bartalena L, Gallo D, Kahaly GJ, Marinò M, Tanda ML. Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves’ orbitopathy. Eur Thyroid J. 2025;14(6).
- Ko J, Surl D, Lee MJ, Lee JK, Son J, Kim N, et al. A Korean Clinical Practice Framework for Thyroid Eye Disease: Integrating International Recommendations with Survey-Informed Consensus. Endocrinol Metab (Seoul). 2026;41(3):367-382.
- Weis E, Heran MK, Jhamb A, Chan AK, Chiu JP, Hurley MC, et al. Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: refinement of the constellation of findings at presentation. Arch Ophthalmol. 2011;129(10):1332-6.
- Chung IY, Hardy TG, Khong JJ. Dysthyroid optic neuropathy: a case series at a tertiary ophthalmic referral centre. Eye (Lond). 2024;38(6):1168-1172.
- Landray I, Vahdani K, Carpenter J, Miszkiel K, Ratnam LA, Rose GE. Subjective Assessment of Eight CT Features in the Prediction of Dysthyroid Optic Neuropathy. Ophthalmic Plast Reconstr Surg. 2026;42(1):71-78.
- Potvin ARGG, de Win MML, Bisschop PH, Tanck MWT, Loontjens R, de Graaf P, et al. Diagnostic value of MRI and diffusion-weighted imaging in dysthyroid optic neuropathy: a cross-sectional study providing insights into predictive parameters and pathogenesis. Neuroradiology. 2025;67(9):2563-2572.
- Kemchoknatee P, Tangon D, Srisombut T. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy. BMC Ophthalmol. 2023;23(1):32.
- Rezar-Dreindl S, Papp A, Baumann A, Neumayer T, Eibenberger K, Stifter E, et al. Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery. Graefes Arch Clin Exp Ophthalmol. 2022;260(11):3683-3691.
- Pelewicz M, Rymuza J, Pelewicz K, Miśkiewicz P. Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome. J Clin Med. 2022;11(8).
- Liu S, He L, Wei R. A combined model of BCVA, TRAb, and NLR predicts response to intravenous methylprednisolone in dysthyroid optic neuropathy. Front Med (Lausanne). 2026;13:1811285.
- Pelewicz-Sowa M, Miśkiewicz P. Dysthyroid optic neuropathy: emerging treatment strategies. J Endocrinol Invest. 2023;46(7):1305-1316.
- Singh S, Curragh DS, Selva D. Augmented endoscopic orbital apex decompression in dysthyroid optic neuropathy. Eye (Lond). 2019;33(10):1613-1618.
- Currò N, Guastella C, Pirola G, Calonghi B, Bottari de Castello A, Fazio MC, et al. Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression. Thyroid. 2023;33(6):743-751.
- Tagami M, Honda S, Azumi A. Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy. BMC Ophthalmol. 2020;20(1):30.
- Fearington FW, Peraza LR, Hernandez-Herrera GA, Awadallah AS, Stokken JK, Wagner LH, et al. Predicting visual acuity recovery in orbital decompression surgery for dysthyroid optic neuropathy. Thyroid Res. 2025;18(1):33.
- Kossler AL, Douglas R, Dosiou C. Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease. J Clin Endocrinol Metab. 2022;107(Suppl_1):S36-S46.
- Teo HM, Smith TJ, Joseph SS. Efficacy and Safety of Teprotumumab in Thyroid Eye Disease. Ther Clin Risk Manag. 2021;17:1219-1230.
- Zong Y, Qiu S, Yang M, Zhang J, Zou Y, Jing Y, et al. Teprotumumab for Thyroid Eye Disease: Mechanism, Clinical Efficacy, and Current Challenges. Antibodies (Basel). 2025;14(3).
- Barbesino G, Salvi M, Freitag SK. Future Projections in Thyroid Eye Disease. J Clin Endocrinol Metab. 2022;107(Suppl_1):S47-S56.
- Subramanian PS, Cho RI, Kahana A. Efficacy of teprotumumab therapy in patients with long-duration thyroid eye disease. Curr Opin Ophthalmol. 2023;34(6):487-492.
- Tamhankar MA, Pradeep T, Chen Y, Briceño CA. Real-World Experience With Teprotumumab in Patients With Dysthyroid Optic Neuropathy. J Neuroophthalmol. 2024;44(1):74-79.
- Hesarghatta Shyamasunder A, Abraham P. Measuring TSH receptor antibody to influence treatment choices in Graves’ disease. Clin Endocrinol (Oxf). 2017;86(5):652-657.
- Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46(3):145-58.
- Yu-Wai-Man P, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet. 2002;39(3):162-9.
- Bi R, Logan I, Yao YG. Leber Hereditary Optic Neuropathy: A Mitochondrial Disease Unique in Many Ways. Handb Exp Pharmacol. 2017;240:309-336.
- Yen MY, Wang AG, Wei YH. Leber’s hereditary optic neuropathy: a multifactorial disease. Prog Retin Eye Res. 2006;25(4):381-96.
- Newman NJ, Carelli V, Taiel M, Yu-Wai-Man P. Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation. J Neuroophthalmol. 2020;40(4):547-557.
- Khan NA, Govindaraj P, Soumittra N, Sharma S, Srilekha S, Ambika S, et al. Leber’s Hereditary Optic Neuropathy-Specific Mutation m.11778G>A Exists on Diverse Mitochondrial Haplogroups in India. Invest Ophthalmol Vis Sci. 2017;58(10):3923-3930.
- Stephenson KAJ, McAndrew J, Kenna PF, Cassidy L. The Natural History of Leber’s Hereditary Optic Neuropathy in an Irish Population and Assessment for Prognostic Biomarkers. Neuroophthalmology. 2022;46(3):159-170.
- Watson EC, Davis RL, Ravishankar S, Copty J, Kummerfeld S, Sue CM. Low disease risk and penetrance in Leber hereditary optic neuropathy. Am J Hum Genet. 2023;110(1):166-169.
- Takai Y, Yamagami A, Iwasa M, Inoue K, Yasumoto R, Ishikawa H, et al. Ten-year natural history of visual function in Japanese patients with Leber hereditary optic neuropathy: A retrospective cohort study. PLoS One. 2026;21(4):e0348093.
- Sanders FWB, Votruba M. Outcomes of idebenone therapy for Leber hereditary optic neuropathy in a cohort of patients from Wales. Eye (Lond). 2025;39(16):2952-2957.
- Balducci N, Savini G, Cascavilla ML, La Morgia C, Triolo G, Giglio R, et al. Macular nerve fibre and ganglion cell layer changes in acute Leber’s hereditary optic neuropathy. Br J Ophthalmol. 2016;100(9):1232-7.
- Pfeffer G, Burke A, Yu-Wai-Man P, Compston DA, Chinnery PF. Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology. 2013;81(24):2073-81.
- Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol. 1999;19(1):28-33.
- Mojon DS, Herbert J, Sadiq SA, Miller JR, Madonna M, Hirano M. Leber’s hereditary optic neuropathy mitochondrial DNA mutations at nucleotides 11778 and 3460 in multiple sclerosis. Ophthalmologica. 1999;213(3):171-5.
- McClelland CM, Van Stavern GP, Tselis AC. Leber hereditary optic neuropathy mimicking neuromyelitis optica. J Neuroophthalmol. 2011;31(3):265-8.
- Cock H, Mandler R, Ahmed W, Schapira AH. Neuromyelitis optica (Devic’s syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy. J Neurol Neurosurg Psychiatry. 1997;62(1):85-7.
- Yu-Wai-Man P, Newman NJ, Carelli V, La Morgia C, Biousse V, Bandello FM, et al. Natural history of patients with Leber hereditary optic neuropathy-results from the REALITY study. Eye (Lond). 2022;36(4):818-826.
- Carelli V, La Morgia C, Yu-Wai-Man P. Mitochondrial optic neuropathies. Handb Clin Neurol. 2023;194:23-42.
- Hage R, Vignal-Clermont C. Leber Hereditary Optic Neuropathy: Review of Treatment and Management. Front Neurol. 2021;12:651639.
- Gueven N. Idebenone for Leber’s hereditary optic neuropathy. Drugs Today (Barc). 2016;52(3):173-81.
- Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, et al. A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy. Brain. 2011;134(Pt 9):2677-86.
- Rudolph G, Dimitriadis K, Büchner B, Heck S, Al-Tamami J, Seidensticker F, et al. Effects of idebenone on color vision in patients with leber hereditary optic neuropathy. J Neuroophthalmol. 2013;33(1):30-6.
- Yu-Wai-Man P, Carelli V, Newman NJ, Silva MJ, Linden A, Van Stavern G, et al. Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial. Cell Rep Med. 2024;5(3):101437.
- Catarino CB, von Livonius B, Priglinger C, Banik R, Matloob S, Tamhankar MA, et al. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy. J Neuroophthalmol. 2020;40(4):558-565.
- Ribeiro PVZ, Pari Mitre L, Gauza MM, Furukawa PH, Ferraz VEF, Gomy I. Therapeutic benefit of idebenone in Leber hereditary optic neuropathy: a systematic review and meta-analysis. Ophthalmic Genet. 2025;46(6):517-522.
- Chen BS, Newman NJ. Clinical trials in Leber hereditary optic neuropathy: outcomes and opportunities. Curr Opin Neurol. 2025;38(1):79-86.
- Moster ML, Sergott RC, Newman NJ, Yu-Wai-Man P, Carelli V, Bryan MS, et al. Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies. J Neuroophthalmol. 2021;41(3):298-308.
- Biousse V, Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Vignal-Clermont C, et al. Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study. J Neuroophthalmol. 2021;41(3):309-315.
- Newman NJ, Yu-Wai-Man P, Subramanian PS, Moster ML, Wang AG, Donahue SP, et al. Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy. Brain. 2023;146(4):1328-1341.
- Yu-Wai-Man P, Newman NJ, Biousse V, Carelli V, Moster ML, Vignal-Clermont C, et al. Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy. JAMA Ophthalmol. 2025;143(2):99-108.
- Vignal-Clermont C, Yu-Wai-Man P, Newman NJ, Carelli V, Moster ML, Biousse V, et al. Safety of Lenadogene Nolparvovec Gene Therapy Over 5 Years in 189 Patients With Leber Hereditary Optic Neuropathy. Am J Ophthalmol. 2023;249:108-125.
- Lam BL, Feuer WJ, Davis JL, Porciatti V, Yu H, Levy RB, et al. Leber Hereditary Optic Neuropathy Gene Therapy: Adverse Events and Visual Acuity Results of All Patient Groups. Am J Ophthalmol. 2022;241:262-271.
- Carelli V, Newman NJ, Yu-Wai-Man P, Biousse V, Moster ML, Subramanian PS, et al. Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation. Ophthalmol Ther. 2023;12(1):401-429.
- Newman NJ, Yu-Wai-Man P, Carelli V, Biousse V, Moster ML, Vignal-Clermont C, et al. Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison. Front Neurol. 2021;12:662838.
- Yu-Wai-Man P, Newman NJ, Carelli V, Biousse V, Pierache A, Montestruc F, et al. Efficacy of lenadogene nolparvovec gene therapy versus idebenone in Leber hereditary optic neuropathy due to the m.11778G>A MT-ND4 variant: two matching adjusted indirect comparisons. Br J Ophthalmol. 2026.
- Yang S, Ma SQ, Wan X, He H, Pei H, Zhao MJ, et al. Long-term outcomes of gene therapy for the treatment of Leber’s hereditary optic neuropathy. EBioMedicine. 2016;10:258-68.
- Jiang L, Guo S, Li B, Xiao S, Wang F, Wei W. Efficacy and safety of intravitreal rAAV2-ND4 therapy for Leber’s hereditary optic neuropathy. Eye (Lond). 2025;39(17):3099-3104.
- Sergott RC, Carelli V, Newman NJ, Biousse V, Yu-Wai-Man P, Vignal-Clermont C, et al. Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy. Invest Ophthalmol Vis Sci. 2025;66(9):42.
- Chen BS, Perot S, Taiel M, Yu-Wai-Man P, Horton M. Rasch analysis of the NEI-VFQ-25: vision-related quality of life in Leber hereditary optic neuropathy after lenadogene nolparvovec gene therapy. BMJ Open Ophthalmol. 2025;10(1).
- Calkins DJ, Yu-Wai-Man P, Newman NJ, Taiel M, Singh P, Chalmey C, et al. Biodistribution of intravitreal (lenadogene) nolparvovec gene therapy in nonhuman primates. Mol Ther Methods Clin Dev. 2021;23:307-318.
- Ezan P, Hardy E, Bemelmans A, Taiel M, Dossi E, Rouach N. Retinal damage promotes mitochondrial transfer in the visual system of a mouse model of Leber hereditary optic neuropathy. Neurobiol Dis. 2024;201:106681.
- Kerrison JB, Miller NR, Hsu F, Beaty TH, Maumenee IH, Smith KH, et al. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol. 2000;130(6):803-12.
- Newman NJ. Leber hereditary optic neuropathy: bad habits, bad vision?. Brain. 2009;132(Pt 9):2306-8.
- Rabenstein A, Catarino CB, Rampeltshammer V, Schindler D, Gallenmüller C, Priglinger C, et al. Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study. Orphanet J Rare Dis. 2021;16(1):127.
- Zaslavsky K, Margolin EA. Leber’s Hereditary Optic Neuropathy in Older Individuals Because of Increased Alcohol Consumption During the COVID-19 Pandemic. J Neuroophthalmol. 2021;41(3):316-320.
- Reinert MC, Pacheu-Grau D, Catarino CB, Klopstock T, Ohlenbusch A, Schittkowski M, et al. Sulthiame impairs mitochondrial function in vitro and may trigger onset of visual loss in Leber hereditary optic neuropathy. Orphanet J Rare Dis. 2021;16(1):64.
- Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol. 2015;9:1165-76.
- Lan X, Ao WL, Li J. Preimplantation genetic testing as a preventive strategy for the transmission of mitochondrial DNA disorders. Syst Biol Reprod Med. 2024;70(1):38-51.
- Smeets HJM, Sallevelt SCEH, Herbert M. Reproductive options in mitochondrial disease. Handb Clin Neurol. 2023;194:207-228.
- Castelluccio N, Spath K, Li D, De Coo IFM, Butterworth L, Wells D, et al. Genetic and reproductive strategies to prevent mitochondrial diseases. Hum Reprod Update. 2025;31(4):269-306.
- Hyslop LA, Blakely EL, Aushev M, Marley J, Takeda Y, Pyle A, et al. Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA Disease. N Engl J Med. 2025;393(5):438-449.
- Craven L, Tang MX, Gorman GS, De Sutter P, Heindryckx B. Novel reproductive technologies to prevent mitochondrial disease. Hum Reprod Update. 2017;23(5):501-519.
- Craven L, Murphy J, Turnbull DM, Taylor RW, Gorman GS, McFarland R. Scientific and Ethical Issues in Mitochondrial Donation. New Bioeth. 2018;24(1):57-73.
- Trauzettel-Klosinski S. Rehabilitative techniques. Handb Clin Neurol. 2011;102:263-78.
- Tagliani S, Malaventura C, Ceccato C, Parmeggiani F, Suppiej A. Leber Mitochondrial Optic Neuropathy in Pediatric Females With Focus on Very Early Onset Cases. J Child Neurol. 2023;38(1-2):5-15.
- Stenton SL, Tesarova M, Sheremet NL, Catarino CB, Carelli V, Ciara E, et al. DNAJC30 defect: a frequent cause of recessive Leber hereditary optic neuropathy and Leigh syndrome. Brain. 2022;145(5):1624-1631.
- Yu-Wai-Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L, et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology. 2010;117(8):1538-46, 1546.e1.
- Cohn AC, Toomes C, Hewitt AW, Kearns LS, Inglehearn CF, Craig JE, et al. The natural history of OPA1-related autosomal dominant optic atrophy. Br J Ophthalmol. 2008;92(10):1333-6.
- Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissière A, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain. 2008;131(Pt 2):338-51.
- Thiselton DL, Alexander C, Morris A, Brooks S, Rosenberg T, Eiberg H, et al. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Hum Genet. 2001;109(5):498-502.
- Almind GJ, Ek J, Rosenberg T, Eiberg H, Larsen M, Lucamp L, et al. Dominant optic atrophy in Denmark - report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%. BMC Med Genet. 2012;13:65.
- Gallus GN, Cardaioli E, Rufa A, Collura M, Da Pozzo P, Pretegiani E, et al. High frequency of OPA1 mutations causing high ADOA prevalence in south-eastern Sicily, Italy. Clin Genet. 2012;82(3):277-82.
- Kjer B, Eiberg H, Kjer P, Rosenberg T. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand. 1996;74(1):3-7.
- Ham M, Han J, Osann K, Smith M, Kimonis V. Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy. Mitochondrion. 2019;46:262-269.
- Xu X, Wang P, Jia X, Sun W, Li S, Xiao X, et al. Pathogenicity evaluation and the genotype-phenotype analysis of OPA1 variants. Mol Genet Genomics. 2021;296(4):845-862.
- Puomila A, Huoponen K, Mäntyjärvi M, Hämäläinen P, Paananen R, Sankila EM, et al. Dominant optic atrophy: correlation between clinical and molecular genetic studies. Acta Ophthalmol Scand. 2005;83(3):337-46.
- Amore G, Romagnoli M, Carbonelli M, Cascavilla ML, De Negri AM, Carta A, et al. AFG3L2 and ACO2-Linked Dominant Optic Atrophy: Genotype-Phenotype Characterization Compared to OPA1 Patients. Am J Ophthalmol. 2024;262:114-124.
- Ovens CA, Grigg JR, Fraser CL. Longitudinal Visual Biomarkers in Dominant Optic Atrophy: A Systematic Review and Meta-Analysis. Clin Exp Ophthalmol. 2025;53(6):652-659.
- Kline LB, Glaser JS. Dominant optic atrophy. The clinical profile. Arch Ophthalmol. 1979;97(9):1680-6.
- Barboni P, Savini G, Cascavilla ML, Caporali L, Milesi J, Borrelli E, et al. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype-phenotype correlation. Am J Ophthalmol. 2014;158(3):628-36.e3.
- Yu-Wai-Man P, Bailie M, Atawan A, Chinnery PF, Griffiths PG. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations. Eye (Lond). 2011;25(5):596-602.
- Corajevic N, Larsen M, Rönnbäck C. Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy. Acta Ophthalmol. 2018;96(3):251-256.
- Pretegiani E, Rosini F, Rufa A, Gallus GN, Cardaioli E, Da Pozzo P, et al. Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families. J Neurol Sci. 2017;382:29-35.
- Rönnbäck C, Nissen C, Almind GJ, Grønskov K, Milea D, Larsen M. Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy. Acta Ophthalmol. 2015;93(8):762-6.
- Battista M, Coutinho CP, Berni A, Borrelli E, Galzignato A, Lari G, et al. Sectorial Ganglion Cell Complex Thickness as Biomarker of Vision Outcome in Patients With Dominant Optic Atrophy. Invest Ophthalmol Vis Sci. 2024;65(1):24.
- Camós-Carreras A, Figueras-Roca M, Albà-Arbalat S, Alcubierre R, Saint-Gerons M, Sánchez-Dalmau B. Correlation between quality of vision and clinical and structural parameters in patients with Autosomal Dominant Optic Atrophy. Eye (Lond). 2025;39(9):1837-1842.
- Eckmann-Hansen C, Bek T, Sander B, Grønskov K, Larsen M. Prevalence of Macular Microcystoid Lacunae in Autosomal Dominant Optic Atrophy Assessed With Adaptive Optics. J Neuroophthalmol. 2022;42(3):328-333.
- Asanad S, Tian JJ, Frousiakis S, Jiang JP, Kogachi K, Felix CM, et al. Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber’s Hereditary Optic Neuropathy and Dominant Optic Atrophy. Curr Eye Res. 2019;44(6):638-644.
- Barboni P, Amore G, Cascavilla ML, Battista M, Frontino G, Romagnoli M, et al. The Pattern of Retinal Ganglion Cell Loss in Wolfram Syndrome is Distinct From Mitochondrial Optic Neuropathies. Am J Ophthalmol. 2022;241:206-216.
- Holder GE, Votruba M, Carter AC, Bhattacharya SS, Fitzke FW, Moore AT. Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter. Doc Ophthalmol. 1998;95(3-4):217-28.
- Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010;133(Pt 3):771-86.
- Amati-Bonneau P, Guichet A, Olichon A, Chevrollier A, Viala F, Miot S, et al. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol. 2005;58(6):958-63.
- Santarelli R, Rossi R, Scimemi P, Cama E, Valentino ML, La Morgia C, et al. OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation. Brain. 2015;138(Pt 3):563-76.
- Maeda-Katahira A, Nakamura N, Hayashi T, Katagiri S, Shimizu S, Ohde H, et al. Autosomal dominant optic atrophy with OPA1 gene mutations accompanied by auditory neuropathy and other systemic complications in a Japanese cohort. Mol Vis. 2019;25:559-573.
- Wang H, Shi T, Wang W, Li J, Chen Z, Lan L, et al. Distinct genetic patterns and natural history of OPA1-related auditory neuropathy in Chinese population. Orphanet J Rare Dis. 2025;20(1):520.
- Carelli V, Sabatelli M, Carrozzo R, Rizza T, Schimpf S, Wissinger B, et al. ‘Behr syndrome’ with OPA1 compound heterozygote mutations. Brain. 2015;138(Pt 1):e321.
- Othman BA, Ong JE, Dumitrescu AV. Biallelic Optic Atrophy 1 (OPA1) Related Disorder-Case Report and Literature Review. Genes (Basel). 2022;13(6).
- Fournier AV, Damji KF, Epstein DL, Pollock SC. Disc excavation in dominant optic atrophy: differentiation from normal tension glaucoma. Ophthalmology. 2001;108(9):1595-602.
- Geidel K, Wiedemann P, Unterlauft JD. [Differential diagnosis of juvenile normal pressure glaucoma]. Ophthalmologe. 2017;114(9):828-831.
- Barboni P, Valentino ML, La Morgia C, Carbonelli M, Savini G, De Negri A, et al. Idebenone treatment in patients with OPA1-mutant dominant optic atrophy. Brain. 2013;136(Pt 2):e231.
- Valentin K, Georgi T, Riedl R, Aminfar H, Singer C, Klopstock T, et al. Idebenone Treatment in Patients with OPA1-Dominant Optic Atrophy: A Prospective Phase 2 Trial. Neuroophthalmology. 2023;47(5-6):237-247.
- Amore G, Romagnoli M, Carbonelli M, Barboni P, Carelli V, La Morgia C. Therapeutic Options in Hereditary Optic Neuropathies. Drugs. 2021;81(1):57-86.
- Sampige R, Seaborn LEA, Pluenneke M, Jyothi A, Saland S, Chinedu-Obi CM, et al. IT TAKES TWO TO TANGO: potential novel therapies for autosomal dominant optic atrophy. Front Ophthalmol (Lausanne). 2025;5:1688232.
- Wong DCS, Makam R, Yu-Wai-Man P. Advanced therapies for inherited optic neuropathies. Eye (Lond). 2026;40(2):177-184.
- Barron MJ, Griffiths P, Turnbull DM, Bates D, Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol. 2004;88(2):286-90.
- Zhu CC, Traboulsi EI, Parikh S. Ophthalmological findings in 74 patients with mitochondrial disease. Ophthalmic Genet. 2017;38(1):67-69.
- Al-Enezi M, Al-Saleh H, Nasser M. Mitochondrial disorders with significant ophthalmic manifestations. Middle East Afr J Ophthalmol. 2008;15(2):81-6.
- Lee SJ, Na JH, Han J, Lee YM. Ophthalmoplegia in Mitochondrial Disease. Yonsei Med J. 2018;59(10):1190-1196.
- Goldstein A, Falk MJ. Single large-scale mitochondrial DNA deletion syndromes. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Rodríguez-López C, García-Cárdaba LM, Blázquez A, Serrano-Lorenzo P, Gutiérrez-Gutiérrez G, San Millán-Tejado B, et al. Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia. J Med Genet. 2020;57(9):643-646.
- Pfeffer G, Gorman GS, Griffin H, Kurzawa-Akanbi M, Blakely EL, Wilson I, et al. Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain. 2014;137(Pt 5):1323-36.
- Najjar RP, Reynier P, Caignard A, Procaccio V, Amati-Bonneau P, Mack H, et al. Retinal Neuronal Loss in Visually Asymptomatic Patients With Myoclonic Epilepsy With Ragged-Red Fibers. J Neuroophthalmol. 2019;39(1):18-22.
- Chang YH, Kang EY, Liu PK, Levi SR, Wang HH, Tseng YJ, et al. Photoreceptor Manifestations of Primary Mitochondrial Optic Nerve Disorders. Invest Ophthalmol Vis Sci. 2022;63(5):5.
- Caballero PE, Candela MS, Alvarez CI, Tejerina AA. Chronic progressive external ophthalmoplegia: a report of 6 cases and a review of the literature. Neurologist. 2007;13(1):33-6.
- Bau V, Deschauer M, Zierz S. [Chronic progressive external ophthalmoplegia—symptom or syndrome?]. Klin Monbl Augenheilkd. 2009;226(10):822-8.
- Horga A, Pitceathly RD, Blake JC, Woodward CE, Zapater P, Fratter C, et al. Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia. Brain. 2014;137(Pt 12):3200-12.
- Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nat Rev Neurol. 2019;15(1):40-52.
- Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C, et al. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat. 2008;29(9):E150-72.
- Schulte C, Synofzik M, Gasser T, Schöls L. Ataxia with ophthalmoplegia or sensory neuropathy is frequently caused by POLG mutations. Neurology. 2009;73(11):898-900.
- Bender F, Timmann D, van de Warrenburg BP, Adarmes-Gómez AD, Bender B, Thieme A, et al. Natural History of Polymerase Gamma-Related Ataxia. Mov Disord. 2021;36(11):2642-2652.
- Tsang SH, Aycinena ARP, Sharma T. Mitochondrial Disorder: Kearns-Sayre Syndrome. Adv Exp Med Biol. 2018;1085:161-162.
- Nadeem A, Umar S, Rehmani S, Javaid M. Ophthalmoplegia, pigmentary retinopathy, and abnormal cardiac conduction: A rare case of Kearns-Sayre syndrome. eNeurologicalSci. 2023;30:100448.
- Kabunga P, Lau AK, Phan K, Puranik R, Liang C, Davis RL, et al. Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy. Int J Cardiol. 2015;181:303-10.
- Finsterer J. Involvement of the cardiac conduction system in Kearns-Sayre syndrome is progressive. Europace. 2021;23(6):979-980.
- Krishna MR. Kearns Sayre Syndrome: Looking beyond A-V conduction. Indian Pacing Electrophysiol J. 2017;17(3):78-80.
- Harvey JN, Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol (Oxf). 1992;37(1):97-103.
- Yoshimi A, Ishikawa K, Niemeyer C, Grünert SC. Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure. Orphanet J Rare Dis. 2022;17(1):379.
- Alves CAPF, Rossi-Espagnet MC, Perez F, Manteghinejad A, Peterson JT, Ganetzky R, et al. Single Large-Scale Mitochondrial Deletion Syndromes: Neuroimaging Phenotypes and Longitudinal Progression in Pediatric Patients. AJNR Am J Neuroradiol. 2025;46(6):1272-1281.
- de Laat P, Smeitink JAM, Janssen MCH, Keunen JEE, Boon CJF. Mitochondrial retinal dystrophy associated with the m.3243A>G mutation. Ophthalmology. 2013;120(12):2684-2696.
- Othmani NB, Mathew S. Clinical insights into mitochondrial retinopathy: A case report on m.3243A>G mutation and macular dystrophy. Saudi J Ophthalmol. 2025;39(4):416-418.
- Scarcella S, Dell’Arti L, Gagliardi D, Magri F, Govoni A, Velardo D, et al. Ischemic optic neuropathy as first presentation in patient with m.3243 A > G MELAS classic mutation. BMC Neurol. 2023;23(1):165.
- Hsieh YT, Yang MT, Peng YJ, Hsu WC. Central retinal vein occlusion as the initial manifestation of LHON / MELAS overlap syndrome with mitochondrial DNA G13513A mutation—case report and literature review. Ophthalmic Genet. 2011;32(1):31-8.
- Merdžo I, Jurišić D, Ćavar I, Striber N. Visual disturbances in a 12-year-old male patient with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome. Taiwan J Ophthalmol. 2026;16(2):342-346.
- Isashiki Y, Nakagawa M, Ohba N, Kamimura K, Sakoda Y, Higuchi I, et al. Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. Acta Ophthalmol Scand. 1998;76(1):6-13.
- Wong LJ, Scaglia F, Graham BH, Craigen WJ. Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab. 2010;100(2):111-7.
- Thompson K, Stroud DA, Thorburn DR, Taylor RW. Investigation of oxidative phosphorylation activity and complex composition in mitochondrial disease. Handb Clin Neurol. 2023;194:127-139.
- Eshaghi M, Arabi A, Eshaghi S. Surgical management of ptosis in chronic progressive external ophthalmoplegia. Eur J Ophthalmol. 2021;31(4):2064-2068.
- Ahn J, Kim NJ, Choung HK, Hwang SW, Sung M, Lee MJ, et al. Frontalis sling operation using silicone rod for the correction of ptosis in chronic progressive external ophthalmoplegia. Br J Ophthalmol. 2008;92(12):1685-8.
- Park RB, Akella SS, Aakalu VK. A review of surgical management of progressive myogenic ptosis. Orbit. 2023;42(1):11-24.
- Chatzistefanou KI, Brouzas D, Asproudis I, Tsina E, Droutsas KD, Koutsandrea C. Strabismus surgery for diplopia in chronic progressive external ophthalmoplegia. Int Ophthalmol. 2019;39(1):213-217.
- Sorkin JA, Shoffner JM, Grossniklaus HE, Drack AV, Lambert SR. Strabismus and mitochondrial defects in chronic progressive external ophthalmoplegia. Am J Ophthalmol. 1997;123(2):235-42.
- Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2017;19(12).
- Sue CM, Balasubramaniam S, Bratkovic D, Bonifant C, Christodoulou J, Coman D, et al. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations. Intern Med J. 2022;52(1):110-120.
- Karaa A, Goldstein A, Balcells C, Mann K, Stanley L, Yeske PE, et al. Harmonizing care for rare diseases: How we developed the mitochondrial care network in the United States. Mol Genet Metab. 2019;127(2):122-127.
- Sedel F, Fontaine B, Saudubray JM, Lyon-Caen O. Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach. J Inherit Metab Dis. 2007;30(6):855-64.
- Ferreira CR, van Karnebeek CDM. Inborn errors of metabolism. Handb Clin Neurol. 2019;162:449-481.
- Carelli V, La Morgia C, Valentino ML, Barboni P, Ross-Cisneros FN, Sadun AA. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. Biochim Biophys Acta. 2009;1787(5):518-28.
- Leruez S, Amati-Bonneau P, Verny C, Reynier P, Procaccio V, Bonneau D, et al. Mitochondrial dysfunction affecting visual pathways. Rev Neurol (Paris). 2014;170(5):344-54.
- Minton JA, Rainbow LA, Ricketts C, Barrett TG. Wolfram syndrome. Rev Endocr Metab Disord. 2003;4(1):53-9.
- Rigoli L, Lombardo F, Di Bella C. Wolfram syndrome and WFS1 gene. Clin Genet. 2011;79(2):103-17.
- d’Annunzio G, Minuto N, D’Amato E, de Toni T, Lombardo F, Pasquali L, et al. Wolfram syndrome (diabetes insipidus, diabetes, optic atrophy, and deafness): clinical and genetic study. Diabetes Care. 2008;31(9):1743-5.
- Kõks S. Genomics of Wolfram Syndrome 1 (WFS1). Biomolecules. 2023;13(9).
- Schmidt-Kastner R, Kreczmanski P, Preising M, Diederen R, Schmitz C, Reis D, et al. Expression of the diabetes risk gene wolframin (WFS1) in the human retina. Exp Eye Res. 2009;89(4):568-74.
- Barrett T, Tranebjærg L, Gupta R, McCarthy L, Rendtorff ND, Williams D, et al. WFS1 spectrum disorder. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Roberts JP, Tang AF, Hernandez D, Carman B, Oiknine L, Brown C, et al. Natural history of 15 patients with autosomal dominant WFS1 pathogenic variants associated with sensorineural hearing loss and optic atrophy. Orphanet J Rare Dis. 2026;21(1).
- Levergood NR, Ko MW, Payne KK, Mackay DD. Optic Atrophy Predominant WFS1 Disorder-A Case-Control Study. J Neuroophthalmol. 2026;46(2):188-194.
- Pallotta MT, Tascini G, Crispoldi R, Orabona C, Mondanelli G, Grohmann U, et al. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J Transl Med. 2019;17(1):238.
- Anikster Y. Costeff syndrome. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Anikster Y, Kleta R, Shaag A, Gahl WA, Elpeleg O. Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet. 2001;69(6):1218-24.
- Ho G, Walter JH, Christodoulou J. Costeff optic atrophy syndrome: new clinical case and novel molecular findings. J Inherit Metab Dis. 2008;31 Suppl 2:S419-23.
- Gaier ED, Sahai I, Wiggs JL, McGeeney B, Hoffman J, Peeler CE. Novel homozygous OPA3 mutation in an Afghani family with 3-methylglutaconic aciduria type III and optic atrophy. Ophthalmic Genet. 2019;40(6):570-573.
- Huna-Baron R, Yahalom G, Anikster Y, Ben Zeev B, Hoffmann C, Hassin-Baer S. Neuro-Ophthalmic Phenotype of OPA3. J Neuroophthalmol. 2022;42(1):e147-e152.
- Wortmann SB, Duran M, Anikster Y, Barth PG, Sperl W, Zschocke J, et al. Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature. J Inherit Metab Dis. 2013;36(6):923-8.
- Skorczyk-Werner A, Tońska K, Maciejczuk A, Nowomiejska K, Korwin M, Ołdak M, et al. DNAJC30 Gene Variants Are a Frequent Cause of a Rare Disease: Leber Hereditary Optic Neuropathy in Polish Patients. Int J Mol Sci. 2023;24(24).
- Mauring L, Puusepp S, Parik M, Roomets E, Teek R, Reimand T, et al. Autosomal recessive Leber’s hereditary optic neuropathy caused by a homozygous variant in DNAJC30 gene. Eur J Med Genet. 2023;66(9):104821.
- Sereikaite L, Vilkeviciute A, Glebauskiene B, Traberg R, Gelzinis A, Piskiniene R, et al. First Case in Lithuania of an Autosomal Recessive Mutation in the DNAJC30 Gene as a Cause of Leber’s Hereditary Optic Neuropathy. Genes (Basel). 2025;16(9).
- Carroll WM, Kriss A, Baraitser M, Barrett G, Halliday AM. The incidence and nature of visual pathway involvement in Friedreich’s ataxia. A clinical and visual evoked potential study of 22 patients. Brain. 1980;103(2):413-34.
- Fortuna F, Barboni P, Liguori R, Valentino ML, Savini G, Gellera C, et al. Visual system involvement in patients with Friedreich’s ataxia. Brain. 2009;132(Pt 1):116-23.
- Thomas-Black G, Altmann DR, Crook H, Solanky N, Carrasco FP, Battiston M, et al. Multimodal Analysis of the Visual Pathways in Friedreich’s Ataxia Reveals Novel Biomarkers. Mov Disord. 2023;38(6):959-969.
- Ziccardi L, Barbano L, Antonelli G, Cioffi E, Di Renzo A, Gioiosa V, et al. Retinal and Visual Pathways Involvement in Carriers of Friedreich’s Ataxia. Diagnostics (Basel). 2022;12(12).
- Hedera P. SPG7-related neurologic disorder. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Choquet K, Tétreault M, Yang S, La Piana R, Dicaire MJ, Vanstone MR, et al. SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases. Eur J Hum Genet. 2016;24(7):1016-21.
- Bogdanova-Mihaylova P, Chen H, Plapp HM, Gorman C, Alexander MD, McHugh JC, et al. Neurophysiological and ophthalmological findings of SPG7-related spastic ataxia: a phenotype study in an Irish cohort. J Neurol. 2021;268(10):3897-3907.
- Züchner S, De Jonghe P, Jordanova A, Claeys KG, Guergueltcheva V, Cherninkova S, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol. 2006;59(2):276-81.
- Züchner S. MFN2 hereditary motor and sensory neuropathy. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Kimura Y, Nishikawa A, Hashiguchi A, Etoh M, Yoshimura A, Asai K, et al. An MFN2-related Charcot-Marie-Tooth Disease Patient with Optic Nerve Atrophy, Neurogenic Bladder Dysfunction, and Diaphragmatic Weakness. Intern Med. 2022;61(11):1743-1747.
- Tucci A, Liu YT, Preza E, Pitceathly RD, Chalasani A, Plagnol V, et al. Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy. J Neurol Neurosurg Psychiatry. 2014;85(5):486-92.
- Pareyson D, Saveri P, Sagnelli A, Piscosquito G. Mitochondrial dynamics and inherited peripheral nerve diseases. Neurosci Lett. 2015;596:66-77.
- Bettinger CM, Dulz S, Atiskova Y, Guerreiro H, Schön G, Guder P, et al. Overview of Neuro-Ophthalmic Findings in Leukodystrophies. J Clin Med. 2024;13(17).
- Summers CG, Ashworth JL. Ocular manifestations as key features for diagnosing mucopolysaccharidoses. Rheumatology (Oxford). 2011;50 Suppl 5:v34-40.
- Lin HY, Chan WC, Chen LJ, Lee YC, Yeh SI, Niu DM, et al. Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses. Mol Genet Genomic Med. 2019;7(5):e00617.
- Seeliger M, Rüther K, Apfelstedt-Sylla E, Schlote W, Wohlrab M, Zrenner E. [Juvenile neuronal ceroid lipofuscinosis (Batten-Mayou) disease. Ophthalmologic diagnosis and findings]. Ophthalmologe. 1997;94(8):557-62.
- Weisfeld-Adams JD, McCourt EA, Diaz GA, Oliver SC. Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance. Mol Genet Metab. 2015;114(4):537-46.
- Ku CA, Ng JK, Karr DJ, Reznick L, Harding CO, Weleber RG, et al. Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia. Ophthalmic Genet. 2016;37(4):404-414.
- Kalantari S, Brezzi B, Bracciamà V, Barreca A, Nozza P, Vaisitti T, et al. Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists. Orphanet J Rare Dis. 2022;17(1):33.
- Marelli C, Salsano E, Politi LS, Labauge P. Spinal cord involvement in adult-onset metabolic and genetic diseases. J Neurol Neurosurg Psychiatry. 2019;90(2):211-218.
- Demily C, Sedel F. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry. 2014;13:27.
- Méjécase C, Malka S, Guan Z, Slater A, Arno G, Moosajee M. Practical guide to genetic screening for inherited eye diseases. Ther Adv Ophthalmol. 2020;12:2515841420954592.
- Gillespie RL, Hall G, Black GC. Genetic testing for inherited ocular disease: delivering on the promise at last?. Clin Exp Ophthalmol. 2014;42(1):65-77.
- Mavraki E, Labrum R, Sergeant K, Alston CL, Woodward C, Smith C, et al. Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines. Eur J Hum Genet. 2023;31(2):148-163.
- de Muijnck C, Brink JBT, de Haan HG, Rodenburg RJ, Wolf NI, Bergen AA, et al. Mutations in NSUN3, a Mitochondrial Methyl Transferase Gene, Cause Inherited Optic Neuropathy. Genes (Basel). 2024;15(5).
- Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med. 2017;19(10):1105-1117.
- Tavtigian SV, Greenblatt MS, Harrison SM, Nussbaum RL, Prabhu SA, Boucher KM, et al. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med. 2018;20(9):1054-1060.
- Cornelis SS, Bauwens M, Haer-Wigman L, De Bruyne M, Pantrangi M, De Baere E, et al. Compendium of Clinical Variant Classification for 2,246 Unique ABCA4 Variants to Clarify Variant Pathogenicity in Stargardt Disease Using a Modified ACMG/AMP Framework. Hum Mutat. 2023;2023:6815504.
- Prosper C, Zereg E, Chaussenot A, Bannwarth S, Lannes B, Streichenberger N, et al. Challenging mtDNA tRNA variant guidelines: Emphasizing single-cell analysis through four novel variants. Mitochondrion. 2026;90:102170.
- Shen L, McCormick EM, Muraresku CC, Falk MJ, Gai X. Clinical Bioinformatics in Precise Diagnosis of Mitochondrial Disease. Clin Lab Med. 2020;40(2):149-161.
- Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):249-255.
- Kodida R, Reble E, Clausen M, Shickh S, Mighton C, Sam J, et al. A model for the return and referral of all clinically significant secondary findings of genomic sequencing. J Med Genet. 2023;60(8):733-739.
- Wolf SM. Return of individual research results and incidental findings: facing the challenges of translational science. Annu Rev Genomics Hum Genet. 2013;14:557-77.
- Panneman DM, Hitti-Malin RJ, Holtes LK, de Bruijn SE, Reurink J, Boonen EGM, et al. Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis. Front Cell Dev Biol. 2023;11:1112270.
- Davison N, Payne K, Eden M, McAllister M, Roberts SA, Ingram S, et al. Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example. Genet Med. 2017;19(9):1032-1039.
- Gocuk SA, Jiao Y, Britten-Jones AC, Kerr NM, Lim L, Skalicky S, et al. Genetic Testing of Inherited Retinal Disease in Australian Private Tertiary Ophthalmology Practice. Clin Ophthalmol. 2022;16:1127-1138.
- Alabek M, Andersen K, Everett L, Marra M. The genetic counselor workforce in inherited retinal disease clinics: a descriptive assessment. Ophthalmic Genet. 2023;44(6):553-558.
- Macarov M, Schneider N, Eilat A, Yahalom C. Genetic counseling practice for inherited eye diseases in an Israeli medical center during the COVID-19 pandemic. J Genet Couns. 2021;30(4):969-973.
- Thompson R, Robertson A, Lochmüller H. Natural History, Trial Readiness and Gene Discovery: Advances in Patient Registries for Neuromuscular Disease. Adv Exp Med Biol. 2017;1031:97-124.
- Zilber S, Woleben K, Johnson SC, de Souza CFM, Boyce D, Freiert K, et al. Leigh syndrome global patient registry: uniting patients and researchers worldwide. Orphanet J Rare Dis. 2023;18(1):264.
- Rath A, Salamon V, Peixoto S, Hivert V, Laville M, Segrestin B, et al. A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?. Trials. 2017;18(1):556.
- Garcia M, Downs J, Russell A, Wang W. Impact of biobanks on research outcomes in rare diseases: a systematic review. Orphanet J Rare Dis. 2018;13(1):202.
- Klopstock T, Priglinger C, Yilmaz A, Kornblum C, Distelmaier F, Prokisch H. Mitochondrial Disorders. Dtsch Arztebl Int. 2021;118(44):741-748.
- Altiparmak UE. Toxic optic neuropathies. Curr Opin Ophthalmol. 2013;24(6):534-9.
- Sadun A. Acquired mitochondrial impairment as a cause of optic nerve disease. Trans Am Ophthalmol Soc. 1998;96:881-923.
- Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2):81-114.
- Muench NA, Patel S, Maes ME, Donahue RJ, Ikeda A, Nickells RW. The Influence of Mitochondrial Dynamics and Function on Retinal Ganglion Cell Susceptibility in Optic Nerve Disease. Cells. 2021;10(7).
- Kulniwatcharoen P, Hansapinyo L, Chattipakorn N, Chattipakorn SC. Potential underlying mechanisms of ethambutol induced optic neuropathy: Evidence from in vitro to clinical studies. Food Chem Toxicol. 2023;182:114176.
- Johns DR, Sadun AA. Cuban epidemic optic neuropathy. Mitochondrial DNA analysis. J Neuroophthalmol. 1994;14(3):130-4.
- Santiesteban-Freixas R, Mendoza-Santiesteban CE, Columbie-Garbey Y, Quevedo AG, Garcia AG, Rodríguez RC. Cuban epidemic optic neuropathy and its relationship to toxic and hereditary optic neuropathy. Semin Ophthalmol. 2010;25(4):112-22.
- Kim U, Hwang JM. Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography. Eur J Ophthalmol. 2009;19(3):466-9.
- Zoumalan CI, Agarwal M, Sadun AA. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2005;243(5):410-6.
- Mandal S, Saxena R, Dhiman R, Mohan A, Padhy SK, Phuljhele S, et al. Prospective study to evaluate incidence and indicators for early detection of ethambutol toxicity. Br J Ophthalmol. 2021;105(7):1024-1028.
- Sachdeva G, Dhiman R, Raj D, Lavanya G, Mohan A, Pujari A, et al. Evaluation of visual function and OCT parameters in ethambutol-induced optic neuropathy: a longitudinal study. Br J Ophthalmol. 2026;110(2):185-190.
- Abecia E, Martinez-Jarreta B, Pinilla I, Larrosa M, Castellano M, Honrubia M. Bilateral optic neuritis in occupational exposure to trichloroethylene. Med Lav. 1996;87(5):432-6.
- Onofrj M, Thomas A, Paci C, D’Andreamatteo G, Toma L, Rotilio D. Optic neuritis with residual tunnel vision in perchloroethylene toxicity. Eur Neurol. 1999;41(1):51-3.
- Gupta SR, Palmer CA, Curé JK, Balos LL, Lincoff NS, Kline LB. Toluene optic neurotoxicity: magnetic resonance imaging and pathologic features. Hum Pathol. 2011;42(2):295-8.
- Ma Z, Jiang H, Wang J. Clinical analysis of severe visual loss caused by inhalational methanol poisoning in a chronic process with acute onset:a retrospective clinical analysis. BMC Ophthalmol. 2019;19(1):124.
- González-Quevedo A, Santiesteban-Freixas R, Eells JT, Lima L, Sadun AA. Cuban Epidemic Neuropathy: Insights into the Toxic-Nutritional Hypothesis through International Collaboration. MEDICC Rev. 2018;20(2):27-31.
- Román GC. An epidemic in Cuba of optic neuropathy, sensorineural deafness, peripheral sensory neuropathy and dorsolateral myeloneuropathy. J Neurol Sci. 1994;127(1):11-28.
- Hedges TR 3rd, Hirano M, Tucker K, Caballero B. Epidemic optic and peripheral neuropathy in Cuba: a unique geopolitical public health problem. Surv Ophthalmol. 1997;41(4):341-53.
- Sadun AA, Martone JF, Muci-Mendoza R, Reyes L, DuBois L, Silva JC, et al. Epidemic optic neuropathy in Cuba. Eye findings. Arch Ophthalmol. 1994;112(5):691-9.
- van Heijst AN, Maes RA, Mtanda AT, Chuwa LM, Rwiza HT, Moshi NH. Chronic cyanide poisoning in relation to blindness and tropical neuropathy. J Toxicol Clin Toxicol. 1994;32(5):549-56.
- Román GC. Nutritional disorders in tropical neurology. Handb Clin Neurol. 2013;114:381-404.
- An HR, Lee BJ, Moon Y. Visual Recovery Time in Patients with Ethambutol-induced Toxic Optic Neuropathy. Korean J Ophthalmol. 2024;38(2):91-97.
- Sheth J, Sachdeva V, Goyal A, Parikh A, Nalawade R, Nanavati H, et al. Clinical profile and visual outcomes in ethambutol-induced toxic optic neuropathy. Indian J Ophthalmol. 2025;73(Suppl 3):S484-S491.
- Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358-62.
- Chamberlain PD, Sadaka A, Berry S, Lee AG. Ethambutol optic neuropathy. Curr Opin Ophthalmol. 2017;28(6):545-551.
- Kramarz C, Murphy E, Reilly MM, Rossor AM. Nutritional peripheral neuropathies. J Neurol Neurosurg Psychiatry. 2023;95(1):61-72.
- Mendes J, Fischer A, Mortensen PW, Jaiswal S, Arogundade E, Newman NJ, et al. Case Report: Disulfiram-induced optic neuropathy. Front Neurol. 2026;17:1793252.
- Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf. 2008;31(2):127-41.
- Kang CW, Kim H, Shin K, Ryu J, Jung-Choi K, Lim KH, et al. Toxic Effects of Methanol among Illegally Dispatched Workers at Aluminum CNC Cutting Process in Small-Scale, Third-Tier Subcontractor Factories of Smartphone Manufacturers in the Republic of Korea. Int J Environ Res Public Health. 2018;15(7).
- Melamud A, Kosmorsky GS, Lee MS. Ocular ethambutol toxicity. Mayo Clin Proc. 2003;78(11):1409-11.
- Bhargava A, Sahoo NK, Das AV, Tyagi M, Kammari P, Sheth J, et al. From Scylla to Charybdis: Fixed drug combinations for tuberculosis and increased ethambutol-induced optic neuropathy in India. Indian J Ophthalmol. 2022;70(8):3073-3076.
- Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol. 2008;28(4):269-77.
- Shanmugam MK, Sajja S, Kowsalya A, Balakrishnan HK, Jayasri KN. Ethambutol induced toxic optic neuropathy - A retrospective study in a tertiary eye care centre in Southern India. Nepal J Ophthalmol. 2022;14(28):108-115.
- Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J. 2006;12(1):56-60.
- Fraunfelder FW, Sadun AA, Wood T. Update on ethambutol optic neuropathy. Expert Opin Drug Saf. 2006;5(5):615-8.
- Miller HV, Cao AA, McClelland CM, Lee MS. Linezolid optic neuropathy. Curr Opin Ophthalmol. 2023;34(6):481-486.
- Brandariz-Núñez D, Hernández-Corredoira V, Guarc-Prades E, García-Navarro B. Optic neuropathy associated with linezolid: systematic review of cases. Farm Hosp. 2019;43(2):61-65.
- Rucker JC, Hamilton SR, Bardenstein D, Isada CM, Lee MS. Linezolid-associated toxic optic neuropathy. Neurology. 2006;66(4):595-8.
- Veerman K, Goosen J, Spijkers K, Jager N, Heesterbeek P, Telgt D. Prolonged use of linezolid in bone and joint infections: a retrospective analysis of adverse effects. J Antimicrob Chemother. 2023;78(11):2660-2666.
- Jaspard M, Butel N, El Helali N, Marigot-Outtandy D, Guillot H, Peytavin G, et al. Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France. Emerg Infect Dis. 2020;26(8):1792-1800.
- Ibrahim HO, Alnuaimi AE, Alzaabi A, Elbashari M, Abouelnaga M, Almaazmi A. Bilateral optic neuropathy following prolonged linezolid use: A case report. IDCases. 2026;43:e02524.
- Alshehri M, Joury A. Ocular Adverse Effects of Amiodarone: A Systematic Review of Case Reports. Optom Vis Sci. 2020;97(7):536-542.
- Pietris J, Santhosh S, Ferdinando Cirocco G, Lam A, Bacchi S, Tan Y, et al. Immune Checkpoint Inhibitors and Optic Neuropathy: A Systematic Review. Semin Ophthalmol. 2023;38(6):547-558.
- Chang EL, Liu R, Keyhanian K, Huynh K, Berkenstock M, Bhatti MT, et al. Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2025;13(4).
- Winges KM, Gordon LK. Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions. Front Ophthalmol (Lausanne). 2022;2:1044904.
- Oskam JA, Danesh-Meyer HV. Neuro-ophthalmic complications of modern anti-cancer drugs. Graefes Arch Clin Exp Ophthalmol. 2024;262(7):2269-2281.
- Gabison EE, Rousseau A, Labetoulle M, Gazzah A, Besse B. Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategies. Prog Retin Eye Res. 2024;103:101302.
- Zhou J, Wang H, Xie H, Xu X, Xiao H. Ocular toxicity associated with antibody-drug conjugates in cancer therapy: a comprehensive review. Front Immunol. 2026;17:1698458.
- Bouguerra Zina B, Rousseau F, Fauquier S, Sabatier R, Kfoury M. Practical clinical management of ocular adverse events related to Antibody-Drug Conjugates in gynaecological malignancies. Cancer Treat Rev. 2025;134:102867.
- Pasricha ND, Kim SK, Farooq AV, Lindgren ES, Yan R, Seitzman GD, et al. Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting. JAMA Ophthalmol. 2026;144(1):62-68.
- Dathi P, Gopathoti S, Nandyala A, Burra S, Gopathoti J, Paidimarri SP. Balancing Graft Survival and Neural Outcomes: Insights From a Systematic Review of Tacrolimus-Induced Neurotoxicity. Cureus. 2025;17(10):e94637.
- Lawden MC, Eke T, Degg C, Harding GF, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry. 1999;67(6):716-22.
- Sergott RC, Bittman RM, Christen EM, Sagar SM. Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy. Epilepsy Res. 2010;92(2-3):170-6.
- Conway M, Cubbidge RP, Hosking SL. Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy. Epilepsia. 2008;49(1):108-16.
- Riikonen R, Rener-Primec Z, Carmant L, Dorofeeva M, Hollody K, Szabo I, et al. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study. Dev Med Child Neurol. 2015;57(1):60-7.
- Verrotti A, Manco R, Matricardi S, Franzoni E, Chiarelli F. Antiepileptic drugs and visual function. Pediatr Neurol. 2007;36(6):353-60.
- Liberski S, Kaluzny BJ, Kocięcki J. Methanol-induced optic neuropathy: a still-present problem. Arch Toxicol. 2022;96(2):431-451.
- Sobhi N, Abdollahi M, Arman A, Mahmoodpoor A, Jafarizadeh A. Methanol Induced Optic Neuropathy: Molecular Mysteries, Public Health Perspective, Clinical Insights and Treatment Strategies. Semin Ophthalmol. 2025;40(1):18-29.
- Sharma R, Marasini S, Sharma AK, Shrestha JK, Nepal BP. Methanol poisoning: ocular and neurological manifestations. Optom Vis Sci. 2012;89(2):178-82.
- Zakharov S, Pelclova D, Urban P, Navratil T, Diblik P, Kuthan P, et al. Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features. Clin Toxicol (Phila). 2014;52(10):1013-24.
- Gulen M, Satar S, Avci A, Acehan S, Orhan U, Nazik H. Methanol poisoning in Turkey: Two outbreaks, a single center experience. Alcohol. 2020;88:83-90.
- Hantson P, Haufroid V, Wallemacq P. Formate kinetics in methanol poisoning. Hum Exp Toxicol. 2005;24(2):55-9.
- Murray TG, Burton TC, Rajani C, Lewandowski MF, Burke JM, Eells JT. Methanol poisoning. A rodent model with structural and functional evidence for retinal involvement. Arch Ophthalmol. 1991;109(7):1012-6.
- Hantson P, de Tourtchaninoff M, Simoens G, Mahieu P, Boschi A, Beguin C, et al. Evoked potentials investigation of visual dysfunction after methanol poisoning. Crit Care Med. 1999;27(12):2707-15.
- Zakharov S, Kurcova I, Navratil T, Salek T, Komarc M, Pelclova D. Is the measurement of serum formate concentration useful in the diagnostics of acute methanol poisoning? A prospective study of 38 patients. Basic Clin Pharmacol Toxicol. 2015;116(5):445-51.
- Onder F, Ilker S, Kansu T, Tatar T, Kural G. Acute blindness and putaminal necrosis in methanol intoxication. Int Ophthalmol. 1998;22(2):81-4.
- Bhatia R, Kumar M, Garg A, Nanda A. Putaminal necrosis due to methanol toxicity. Pract Neurol. 2008;8(6):386-7.
- da Silva RO, Ohannesian VA, Aguirre BN, Gerente BGDSM, Meira OT, Soares C, et al. Cranial magnetic resonance imaging findings in methanol poisoning: Systematic review and meta-analysis of radiological prevalence. Neuroradiol J. 2026.
- Jarwani BS, Motiani P, Divetia R, Thakkar G. Rare combination of bilateral putaminal necrosis, optic neuritis, and polyneuropathy in a case of acute methanol intoxication among patients met with hooch tragedy in Gujarat, India. J Emerg Trauma Shock. 2012;5(4):356-9.
- Mégarbane B. Treatment of patients with ethylene glycol or methanol poisoning: focus on fomepizole. Open Access Emerg Med. 2010;2:67-75.
- Zakharov S, Pelclova D, Navratil T, Belacek J, Komarc M, Eddleston M, et al. Fomepizole versus ethanol in the treatment of acute methanol poisoning: Comparison of clinical effectiveness in a mass poisoning outbreak. Clin Toxicol (Phila). 2015;53(8):797-806.
- Zakharov S, Navratil T, Pelclova D. Fomepizole in the treatment of acute methanol poisonings: experience from the Czech mass methanol outbreak 2012-2013. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(4):641-9.
- Zakharov S, Navratil T, Salek T, Kurcova I, Pelclova D. Fluctuations in serum ethanol concentration in the treatment of acute methanol poisoning: a prospective study of 21 patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(4):666-76.
- Lepik KJ, Sobolev BG, Levy AR, Purssell RA, Dewitt CR, Erhardt GD, et al. Medication errors associated with the use of ethanol and fomepizole as antidotes for methanol and ethylene glycol poisoning. Clin Toxicol (Phila). 2011;49(5):391-401.
- Zakharov S, Pelclova D, Urban P, Navratil T, Nurieva O, Kotikova K, et al. Use of Out-of-Hospital Ethanol Administration to Improve Outcome in Mass Methanol Outbreaks. Ann Emerg Med. 2016;68(1):52-61.
- Zakharov S, Nurieva O, Kotikova K, Belacek J, Navratil T, Pelclova D. Positive serum ethanol concentration on admission to hospital as the factor predictive of treatment outcome in acute methanol poisoning. Monatsh Chem. 2017;148(3):409-419.
- Ghannoum M, Gosselin S, Hoffman RS, Lavergne V, Mégarbane B, Hassanian-Moghaddam H, et al. Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup. Crit Care. 2023;27(1):56.
- Brent J. Current management of ethylene glycol poisoning. Drugs. 2001;61(7):979-88.
- Jacobsen D. New treatment for ethylene glycol poisoning. N Engl J Med. 1999;340(11):879-81.
- Beaulieu J, Roberts DM, Gosselin S, Hoffman RS, Lavergne V, Hovda KE, et al. Treating ethylene glycol poisoning with alcohol dehydrogenase inhibition, but without extracorporeal treatments: a systematic review. Clin Toxicol (Phila). 2022;60(7):784-797.
- Battistella M. Fomepizole as an antidote for ethylene glycol poisoning. Ann Pharmacother. 2002;36(6):1085-9.
- Liu JJ, Daya MR, Carrasquillo O, Kales SN. Prognostic factors in patients with methanol poisoning. J Toxicol Clin Toxicol. 1998;36(3):175-81.
- Sarıbaş K, Akpınar AA, Özşeker PE, Taşkın Ö, Dişel NR, Devecioğlu GF. Methanol poisoning in the emergency department: methanol blood levels, prognosis, and sequelae outcomes. Ir J Med Sci. 2025;194(4):1461-1470.
- Zakharov S, Pelclova D, Diblik P, Urban P, Kuthan P, Nurieva O, et al. Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients. Clin Toxicol (Phila). 2015;53(9):884-92.
- Shirvani M, Mohammadi M, Khalili M, Emadi Z, Ghoshouni H, Gohari M, et al. Visual Outcomes and Retinal Nerve Fiber Layer Changes Following Methanol Induced Optic Neuropathy: A Covid-19 Era Experience. Neuroophthalmology. 2026;50(1):45-55.
- Sheremet NL, Andreeva NA, Zhorzholadze NV, Shmelkova MS, Fomin AV. [Structural and functional changes in the retina and optic nerve in patients with toxic optic neuropathy caused by acute methanol poisoning]. Vestn Oftalmol. 2020;136(4. Vyp. 2):243-250.
- Rulisek J, Balik M, Polak F, Waldauf P, Pelclova D, Belohlavek J, et al. Cost-effectiveness of hospital treatment and outcomes of acute methanol poisoning during the Czech Republic mass poisoning outbreak. J Crit Care. 2017;39:190-198.
- Grzybowski A, Holder GE. Tobacco optic neuropathy (TON) - the historical and present concept of the disease. Acta Ophthalmol. 2011;89(5):495-9.
- Nicolaou N, Nicolaou D, Douglas L, Christou S. Ethanol and Cyanide: A Case Report on Toxic and Nutritional Optic Neuropathy Associated With Alcohol and Tobacco. Cureus. 2025;17(11):e97067.
- Sheremet NL, Andreeva NA, Zhorzholadze NV, Murakhovskaya YK, Shmelkova MS, Krylova TD, et al. [Metabolic disorders in hereditary optic neuropathies]. Vestn Oftalmol. 2022;138(4):29-34.
- Herrmann W, Obeid R. Causes and early diagnosis of vitamin B12 deficiency. Dtsch Arztebl Int. 2008;105(40):680-5.
- Chatthanawaree W. Biomarkers of cobalamin (vitamin B12) deficiency and its application. J Nutr Health Aging. 2011;15(3):227-31.
- Pavlov CS, Damulin IV, Shulpekova YO, Andreev EA. Neurological disorders in vitamin B12 deficiency. Ter Arkh. 2019;91(4):122-129.
- Tsang BK, Crump N, Macdonell RA. Subacute combined degeneration of the spinal cord despite prophylactic vitamin B12 treatment. J Clin Neurosci. 2012;19(6):908-10.
- Hsu CT, Miller NR, Wray ML. Optic neuropathy from folic acid deficiency without alcohol abuse. Ophthalmologica. 2002;216(1):65-7.
- Ueda N, Kitamura Y, Baba T. A Case of Nutritional Optic Neuropathy Caused by Vitamin B12 and Folate Deficiency Presenting With Bitemporal Hemianopia-Like Visual Field Defects. Cureus. 2026;18(5):e109561.
- Santiesteban-Freixas R, Pamias-González E, Luis-González S, Serrano-Verdecia C, González-Quevedo A, Alfaro-Capdegelle I, et al. [Epidemic neuropathy: proposal and arguments to rename Strachan disease as Strachan and Madan disease]. Rev Neurol. 1997;25(148):1950-6.
- Oluwole OS, Onabolu AO, Link H, Rosling H. Persistence of tropical ataxic neuropathy in a Nigerian community. J Neurol Neurosurg Psychiatry. 2000;69(1):96-101.
- Román GC. Tropical myelopathies. Handb Clin Neurol. 2014;121:1521-48.
- Robson D, Welch E, Beeching NJ, Gill GV. Consequences of captivity: health effects of far East imprisonment in World War II. QJM. 2009;102(2):87-96.
- O’Kane M, Parretti HM, Pinkney J, Welbourn R, Hughes CA, Mok J, et al. British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21(11):e13087.
- Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. Surg Obes Relat Dis. 2017;13(5):727-741.
- Ha J, Kwon Y, Kwon JW, Kim D, Park SH, Hwang J, et al. Micronutrient status in bariatric surgery patients receiving postoperative supplementation per guidelines: Insights from a systematic review and meta-analysis of longitudinal studies. Obes Rev. 2021;22(7):e13249.
- Reytor-González C, Frias-Toral E, Nuñez-Vásquez C, Parise-Vasco JM, Zambrano-Villacres R, Simancas-Racines D, et al. Preventing and Managing Pre- and Postoperative Micronutrient Deficiencies: A Vital Component of Long-Term Success in Bariatric Surgery. Nutrients. 2025;17(5).
- Argyrakopoulou G, Konstantinidou SK, Dalamaga M, Kokkinos A. Nutritional Deficiencies Before and After Bariatric Surgery: Prevention and Treatment. Curr Nutr Rep. 2022;11(2):95-101.
- Serlin T, Moisseiev E. Fundus Findings in Wernicke Encephalopathy. Case Rep Ophthalmol. 2017;8(2):406-409.
- Kleinert-Altamirano AP, Juárez-Jiménez H. [Wernicke’s encephalopathy and Caine criteria. Report of six cases]. Rev Med Inst Mex Seguro Soc. 2014;52(1):104-7.
- Kohnke S, Meek CL. Don’t seek, don’t find: The diagnostic challenge of Wernicke’s encephalopathy. Ann Clin Biochem. 2021;58(1):38-46.
- Li S, Xing C. Wernicke encephalopathy: a mini review of the clinical spectrum, atypical manifestations, and diagnostic challenges. Front Neurol. 2025;16:1566366.
- Singh S, Kumar A. Wernicke encephalopathy after obesity surgery: a systematic review. Neurology. 2007;68(11):807-11.
- Abouelbaqua K, Rebahi H, Louhab N, Kissani N, El Adib AR. Wernicke Encephalopathy Related to Hyperemesis Gravidarum: A Retrospective Study of 12 Cases. Case Rep Crit Care. 2025;2025:7607058.
- Isenberg-Grzeda E, Alici Y, Hatzoglou V, Nelson C, Breitbart W. Nonalcoholic Thiamine-Related Encephalopathy (Wernicke-Korsakoff Syndrome) Among Inpatients With Cancer: A Series of 18 Cases. Psychosomatics. 2016;57(1):71-81.
- Chia AZ, Ann LS, Sim B, Davis C. Xeropthalmia and optic neuropathy secondary to ARFID: a case report. J Eat Disord. 2024;12(1):90.
- Fattal-Valevski A, Kesler A, Sela BA, Nitzan-Kaluski D, Rotstein M, Mesterman R, et al. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics. 2005;115(2):e233-8.
- Kesler A, Stolovitch C, Hoffmann C, Avni I, Morad Y. Acute ophthalmoplegia and nystagmus in infants fed a thiamine-deficient formula: an epidemic of Wernicke encephalopathy. J Neuroophthalmol. 2005;25(3):169-72.
- Chamorro AJ, Rosón-Hernández B, Medina-García JA, Muga-Bustamante R, Fernández-Solá J, Martín-González MC, et al. Differences Between Alcoholic and Nonalcoholic Patients With Wernicke Encephalopathy: A Multicenter Observational Study. Mayo Clin Proc. 2017;92(6):899-907.
- Yin H, Xu Q, Cao Y, Qi Y, Yu T, Lu W. Nonalcoholic Wernicke’s encephalopathy: a retrospective study of 17 cases. J Int Med Res. 2019;47(10):4886-4894.
- Becker DA, Balcer LJ, Galetta SL. The Neurological Complications of Nutritional Deficiency following Bariatric Surgery. J Obes. 2012;2012:608534.
- Koffman BM, Greenfield LJ, Ali II, Pirzada NA. Neurologic complications after surgery for obesity. Muscle Nerve. 2006;33(2):166-76.
- Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik SI. Neurologic complications of gastric bypass surgery for morbid obesity. Neurology. 2007;68(21):1843-50.
- Kulkarni S, Lee AG, Holstein SA, Warner JE. You are what you eat. Surv Ophthalmol. 2005;50(4):389-93.
- Sawicka-Pierko A, Obuchowska I, Mariak Z. Nutritional optic neuropathy. Klin Oczna. 2014;116(2):104-10.
- Van Stavern G, Kumar G, Thuruthumaly C. Visual disturbance after bariatric surgery. JAMA Ophthalmol. 2015;133(3):345-6.
- Khalid MJ, Ayub MA, Kataria S, Hebert M, Parvathaneni A. Concomitant Occurrence of Peripheral Neuropathy and Vision Loss Due to Multivitamin Deficiency After Bariatric Surgery. Cureus. 2024;16(5):e59959.
- Zainuddin MZA, Che Hamzah J, Nik Mahmood NRK, Cheng TC, Bastion MC. Nutritional Optic Neuropathy: Bariatric Surgery Gone Wrong. Cureus. 2025;17(5):e84548.
- Shah AR, Tamhankar MA. Optic neuropathy associated with copper deficiency after gastric bypass surgery. Retin Cases Brief Rep. 2014;8(1):73-6.
- Yarandi SS, Griffith DP, Sharma R, Mohan A, Zhao VM, Ziegler TR. Optic neuropathy, myelopathy, anemia, and neutropenia caused by acquired copper deficiency after gastric bypass surgery. J Clin Gastroenterol. 2014;48(10):862-5.
- Pineles SL, Wilson CA, Balcer LJ, Slater R, Galetta SL. Combined optic neuropathy and myelopathy secondary to copper deficiency. Surv Ophthalmol. 2010;55(4):386-92.
- Naismith RT, Shepherd JB, Weihl CC, Tutlam NT, Cross AH. Acute and bilateral blindness due to optic neuropathy associated with copper deficiency. Arch Neurol. 2009;66(8):1025-7.
- Myint ZW, Oo TH, Thein KZ, Tun AM, Saeed H. Copper deficiency anemia: review article. Ann Hematol. 2018;97(9):1527-1534.
- Lee WB, Hamilton SM, Harris JP, Schwab IR. Ocular complications of hypovitaminosis a after bariatric surgery. Ophthalmology. 2005;112(6):1031-4.
- Eckert MJ, Perry JT, Sohn VY, Boden J, Martin MJ, Rush RM, et al. Incidence of low vitamin A levels and ocular symptoms after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(6):653-7.
- Brandão LP, Vilar L, Cavalcanti BM, Brandão PH, Arantes TE, Campos JM. Serum levels of vitamin A, visual function and ocular surface after bariatric surgery. Arq Gastroenterol. 2017;54(1):65-69.
- Ramos-Leví AM, Pérez-Ferre N, Sánchez-Pernaute A, Torres García AJ, Rubio Herrera MA. Severe vitamin A deficiency after malabsortive bariatric surgery. Nutr Hosp. 2013;28(4):1337-40.
- Fok JS, Li JY, Yong TY. Visual deterioration caused by vitamin A deficiency in patients after bariatric surgery. Eat Weight Disord. 2012;17(2):e144-6.
- Sanchez JC, Nusair O, Kumar D, Soleimani M. Bilateral keratomalacia years after biliopancreatic diversion with duodenal switch surgery: A case of severe vitamin A deficiency and literature review. J Int Med Res. 2025;53(10):3000605251387932.
- Mora Correa JM, Humayun A, Schwartz SG, Martinez JD. Ocular complications in a patient with history of bariatric surgery. Am J Ophthalmol Case Rep. 2025;40:102420.
- McLaren DS, Kraemer K. Xerophthalmia. World Rev Nutr Diet. 2012;103:65-75.
- Sherwin JC, Reacher MH, Dean WH, Ngondi J. Epidemiology of vitamin A deficiency and xerophthalmia in at-risk populations. Trans R Soc Trop Med Hyg. 2012;106(4):205-14.
- Blanch RJ, Joseph IJ, Cockerham K. Traumatic optic neuropathy management: a systematic review. Eye (Lond). 2024;38(12):2312-2318.
- Karimi S, Arabi A, Ansari I, Shahraki T, Safi S. A Systematic Literature Review on Traumatic Optic Neuropathy. J Ophthalmol. 2021;2021:5553885.
- Chen B, Zhang H, Zhai Q, Li H, Wang C, Wang Y. Traumatic optic neuropathy: a review of current studies. Neurosurg Rev. 2022;45(3):1895-1913.
- He M, Yang Z, Shi Z, Chen Y, Zhao X. Clinical features, management, and prognosis factors of traumatic optic neuropathy. Surv Ophthalmol. 2026;71(1):168-178.
- Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology. 1999;106(7):1268-77.
- Wladis EJ, Aakalu VK, Sobel RK, McCulley TJ, Foster JA, Tao JP, et al. Interventions for Indirect Traumatic Optic Neuropathy: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021;128(6):928-937.
- Bacorn C, Morisada MV, Dedhia RD, Steele TO, Strong EB, Lin LK. Traumatic Optic Neuropathy Management: A Survey Assessment of Current Practice Patterns. J Emerg Trauma Shock. 2021;14(3):136-142.
- Hetzer SM, Shalosky EM, Torrens JN, Evanson NK. Chronic Histological Outcomes of Indirect Traumatic Optic Neuropathy in Adolescent Mice: Persistent Degeneration and Temporally Regulated Glial Responses. Cells. 2021;10(12).
- Thale A, Jungmann K, Paulsen F. Morphological studies of the optic canal. Orbit. 2002;21(2):131-7.
- Guy WM, Soparkar CN, Alford EL, Patrinely JR, Sami MS, Parke RB. Traumatic optic neuropathy and second optic nerve injuries. JAMA Ophthalmol. 2014;132(5):567-71.
- Kumaran AM, Sundar G, Chye LT. Traumatic optic neuropathy: a review. Craniomaxillofac Trauma Reconstr. 2015;8(1):31-41.
- Sosin M, De La Cruz C, Mundinger GS, Saadat SY, Nam AJ, Manson PN, et al. Treatment Outcomes following Traumatic Optic Neuropathy. Plast Reconstr Surg. 2016;137(1):231-238.
- Naik SN, Nayak DV. Unravelling the Unseen: A Case Series Exploring the Enigmas of Traumatic Optic Neuropathy. Cureus. 2024;16(12):e75546.
- Cook MW, Levin LA, Joseph MP, Pinczower EF. Traumatic optic neuropathy. A meta-analysis. Arch Otolaryngol Head Neck Surg. 1996;122(4):389-92.
- Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321-8.
- Roberts I. The CRASH trial: the first large-scale, randomised, controlled trial in head injury. Crit Care. 2001;5(6):292-3.
- Wasserberg J. The MRC CRASH trial—a large, simple randomised trial of steroids in head injury. Acta Neurochir Suppl. 2004;89:109-12.
- Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev. 2005;2005(1):CD000196.
- Yates D, Farrell B, Teasdale G, Sandercock P, Roberts I. Corticosteroids in head injury—the CRASH trial. J Accid Emerg Med. 1999;16(2):83-4.
- Cavaliere F, Masieri S. The potential dangers of treating head injury patients with corticosteroids. Expert Opin Drug Saf. 2005;4(6):1125-33.
- Fallahzadeh M, Veisi A, Tajari F, Khorrami Z, Farhang Ranjbar M, Tavanaei R, et al. The Management of Traumatic Optic Neuropathy: A Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2025;13(1):e19.
- Lin J, Hu W, Wu Q, Zhang J, Yan W. An evolving perspective of endoscopic transnasal optic canal decompression for traumatic optic neuropathy in clinic. Neurosurg Rev. 2021;44(1):19-27.
- Sun J, Cai X, Zou W, Zhang J. Outcome of Endoscopic Optic Nerve Decompression for Traumatic Optic Neuropathy. Ann Otol Rhinol Laryngol. 2021;130(1):56-59.
- Yu B, Ma Y, Tu Y, Wu W. The Outcome of Endoscopic Transethmosphenoid Optic Canal Decompression for Indirect Traumatic Optic Neuropathy with No-Light-Perception. J Ophthalmol. 2016;2016:6492858.
- Yu B, Chen Y, Ma Y, Tu Y, Wu W. Outcome of endoscopic trans-ethmosphenoid optic canal decompression for indirect traumatic optic neuropathy in children. BMC Ophthalmol. 2018;18(1):152.
- Li Y, Sun BW, Sun S, Zhao SF, Dai CX, Kang J. [Efficacy and prognostic factors of endoscopic optic canal decompression in children with traumatic optic neuropathy]. Zhonghua Yi Xue Za Zhi. 2022;102(47):3769-3773.
- Ma YJ, Yu B, Tu YH, Mao BX, Yu XY, Wu WC. Prognostic factors of trans-ethmosphenoid optic canal decompression for indirect traumatic optic neuropathy. Int J Ophthalmol. 2018;11(7):1222-1226.
- Lin J, Hu W, Wu Q, Yi J, Liu Z, Zhou G, et al. Analysis of Prognostic Factors for the Indirect Traumatic Optic Neuropathy Underwent Endoscopic Transnasal Optic Canal Decompression. J Craniofac Surg. 2020;31(5):1266-1269.
- Yang QT, Zhang GH, Liu X, Ye J, Li Y. The therapeutic efficacy of endoscopic optic nerve decompression and its effects on the prognoses of 96 cases of traumatic optic neuropathy. J Trauma Acute Care Surg. 2012;72(5):1350-5.
- Muthukumar R, Mahesh Kumari R, Shenbagavalli S, Nerthipriya R. Surgical Outcome in Patients with Traumatic and Atraumatic Optic Neuropathy Following Endoscopic Optic Nerve Decompression. Indian J Otolaryngol Head Neck Surg. 2024;76(2):1569-1574.
- Gupta D, Gadodia M. Transnasal Endoscopic Optic Nerve Decompression in Post Traumatic Optic Neuropathy. Indian J Otolaryngol Head Neck Surg. 2018;70(1):49-52.
- Chen CT, Huang F, Tsay PK, Tsai YJ, Lin CH, Chen YC, et al. Endoscopically assisted transconjunctival decompression of traumatic optic neuropathy. J Craniofac Surg. 2007;18(1):19-26; discussion 27-8.
- Chen HH, Lee MC, Tsai CH, Pan CH, Lin YT, Chen CT. Surgical Decompression or Corticosteroid Treatment of Indirect Traumatic Optic Neuropathy: A Randomized Controlled Trial. Ann Plast Surg. 2020;84(1S Suppl 1):S80-S83.
- Liu X, Wang J, Zhang W, Li L, Zhang L, Xiao C. Prognostic factors of traumatic optic neuropathy based on multimodal analysis-Especially the influence of postoperative dressing change and optic nerve blood supply on prognosis. Front Neurol. 2023;14:1114384.
- Cheng Z, Xu F, Gao M, Bi Y, Jiang Y, Yuan L, et al. Analysis of Prognostic Factors and Treatment Outcomes in Indirect Traumatic Optic Neuropathy: A Retrospective Review of 105 Patients. Curr Eye Res. 2025;50(2):231-238.
- Surya A, Salman S, Phadke R, Sporn K, Yaldo L, Kumar R, et al. Perioperative ischemic optic neuropathy: a comprehensive review of anesthetic implications, hemodynamic pathophysiology, and risk stratification. Int Ophthalmol. 2026;46(1).
- American Society of Anesthesiologists Task Force on Perioperative Visual Loss. Practice Advisory for Perioperative Visual Loss Associated with Spine Surgery 2019: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Visual Loss, the North American Neuro-Ophthalmology Society, and the Society for Neuroscience in Anesthesiology and Critical Care. Anesthesiology. 2019;130(1):12-30.
- American Society of Anesthesiologists Task Force on Perioperative Visual Loss. Practice advisory for perioperative visual loss associated with spine surgery: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Visual Loss. Anesthesiology. 2012;116(2):274-85.
- American Society of Anesthesiologists Task Force on Perioperative Blindness. Practice advisory for perioperative visual loss associated with spine surgery: a report by the American Society of Anesthesiologists Task Force on Perioperative Blindness. Anesthesiology. 2006;104(6):1319-28.
- Rubin DS, Parakati I, Lee LA, Moss HE, Joslin CE, Roth S. Perioperative Visual Loss in Spine Fusion Surgery: Ischemic Optic Neuropathy in the United States from 1998 to 2012 in the Nationwide Inpatient Sample. Anesthesiology. 2016;125(3):457-64.
- Shah SH, Chen YF, Moss HE, Rubin DS, Joslin CE, Roth S. Predicting Risk of Perioperative Ischemic Optic Neuropathy in Spine Fusion Surgery: A Cohort Study Using the National Inpatient Sample. Anesth Analg. 2020;130(4):967-974.
- Wang T, Cao H, Zhang H, Tang M, Zhong Z, Yang Q, et al. Incidence and risk factors of postoperative visual loss in cardiac surgery in the United States from the national inpatient sample 2013 to 2022. J Cardiothorac Surg. 2026;21(1).
- Gupta B, Singla D, Gupta A, Mahaseth R. Incidence and Risk Factors for Postoperative Visual Loss after Cardiac Surgical Procedures: A Systematic Review. Ann Card Anaesth. 2024;27(2):101-110.
- Kalyani SD, Miller NR, Dong LM, Baumgartner WA, Alejo DE, Gilbert TB. Incidence of and risk factors for perioperative optic neuropathy after cardiac surgery. Ann Thorac Surg. 2004;78(1):34-7.
- Ho VT, Newman NJ, Song S, Ksiazek S, Roth S. Ischemic optic neuropathy following spine surgery. J Neurosurg Anesthesiol. 2005;17(1):38-44.
- Mohan K, Rawall S, Nene A. Visual loss after spine surgery. Indian J Orthop. 2012;46(1):106-8.
- Pierce V, Kendrick P. Ischemic optic neuropathy after spine surgery. AANA J. 2010;78(2):141-5.
- Rupp-Montpetit K, Moody ML. Visual loss as a complication of nonophthalmologic surgery: a review of the literature. AANA J. 2004;72(4):285-92.
- Epstein NE. Perioperative visual loss following prone spinal surgery: A review. Surg Neurol Int. 2016;7(Suppl 13):S347-60.
- Lee LA. Perioperative visual loss and anesthetic management. Curr Opin Anaesthesiol. 2013;26(3):375-81.
- Kitaba A, Martin DP, Gopalakrishnan S, Tobias JD. Perioperative visual loss after nonocular surgery. J Anesth. 2013;27(6):919-26.
- Rmili MF, Chebil A, El Matri K, Werda S, Falfoul Y, Matri LE. Central retinal artery occlusion after spinal surgery: Case report and literature review. Eur J Ophthalmol. 2024;34(2):NP63-NP67.
- Lee SH, Chung I, Choi DS, Shin IW, Kim S, Kang S, et al. Visual loss due to optic nerve infarction and central retinal artery occlusion after spine surgery in the prone position: A case report. Medicine (Baltimore). 2017;96(31):e7379.
- Asok T, Aziz S, Faisal HA, Tan AK, Mallika PS. Central retinal artery occlusion and ophthalmoplegia following spinal surgery in the prone position. Med J Malaysia. 2009;64(4):323-4.
- Raj A, Arya SK, Sood S. Unilateral visual loss due to central retinal artery occlusion with total ophthalmoplegia following cervical spine surgery in prone position. Nepal J Ophthalmol. 2015;7(14):191-3.
- Ooi EI, Ahem A, Zahidin AZ, Bastion ML. Unilateral visual loss after spine surgery in the prone position for extradural haematoma in a healthy young man. BMJ Case Rep. 2013;2013.
- Assaf SN, Assaf AN, Assaf MN, Pickett J, Pierce JM. Non-postoperative Central Retinal Artery and Ophthalmic Artery Occlusion With Compression Ischemia Due to Prolonged Sedation In Prone Position. Cureus. 2023;15(1):e33482.
- Tang X, Hao Y, Yu Y, Lin K, Kang X. Perioperative central retinal artery occlusion after prone posterior cervical spine surgery treated with delayed hyperbaric oxygen therapy: a case report and targeted literature review. BMC Anesthesiol. 2026.
- Wong VC. Cortical blindness in children: a study of etiology and prognosis. Pediatr Neurol. 1991;7(3):178-85.
- Epstein NE. How to avoid perioperative visual loss following prone spinal surgery. Surg Neurol Int. 2016;7(Suppl 13):S328-30.
- Uribe AA, Baig MN, Puente EG, Viloria A, Mendel E, Bergese SD. Current intraoperative devices to reduce visual loss after spine surgery. Neurosurg Focus. 2012;33(2):E14.
- Berdahl JP, Yu DY, Morgan WH. The translaminar pressure gradient in sustained zero gravity, idiopathic intracranial hypertension, and glaucoma. Med Hypotheses. 2012;79(6):719-24.
- Killer HE, Laeng HR, Flammer J, Groscurth P. Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations. Br J Ophthalmol. 2003;87(6):777-81.
- Killer HE, Jaggi GP, Flammer J, Miller NR, Huber AR, Mironov A. Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve. Is it always bidirectional?. Brain. 2007;130(Pt 2):514-20.
- Boye D, Montali M, Miller NR, Pircher A, Gruber P, Killer HE, et al. Flow dynamics of cerebrospinal fluid between the intracranial cavity and the subarachnoid space of the optic nerve measured with a diffusion magnetic resonance imaging sequence in patients with normal tension glaucoma. Clin Exp Ophthalmol. 2018;46(5):511-518.
- Sheng J, Li Q, Liu T, Wang X. Cerebrospinal fluid dynamics along the optic nerve. Front Neurol. 2022;13:931523.
- Rossinelli D, Fourestey G, Killer HE, Neutzner A, Iaccarino G, Remonda L, et al. Large-scale in-silico analysis of CSF dynamics within the subarachnoid space of the optic nerve. Fluids Barriers CNS. 2024;21(1):20.
- Neutzner A, Power L, Dürrenberger M, Scholl HPN, Meyer P, Killer HE, et al. A perfusion bioreactor-based 3D model of the subarachnoid space based on a meningeal tissue construct. Fluids Barriers CNS. 2019;16(1):17.
- Pircher A, Montali M, Berberat J, Huber A, Miller NR, Mader TH, et al. Elevated perioptic lipocalin-type prostaglandin D synthase concentration in patients with idiopathic intracranial hypertension. Brain Commun. 2022;4(5):fcac240.
- Hoffmann J, Kreutz KM, Csapó-Schmidt C, Becker N, Kunte H, Fekonja LS, et al. The effect of CSF drain on the optic nerve in idiopathic intracranial hypertension. J Headache Pain. 2019;20(1):59.
- Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure. III. A pathologic study of experimental papilledema. Arch Ophthalmol. 1977;95(8):1448-57.
- Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema. Arch Ophthalmol. 1977;95(8):1458-62.
- Hayreh SS, Hayreh MS. Optic disc edema in raised intracranial pressure. II. Early detection with fluorescein fundus angiography and stereoscopic color photography. Arch Ophthalmol. 1977;95(7):1245-54.
- Hayreh SS. Optic disc edema in raised intracranial pressure. VI. Associated visual disturbances and their pathogenesis. Arch Ophthalmol. 1977;95(9):1566-79.
- HAYREH SS. PATHOGENESIS OF OEDEMA OF THE OPTIC DISC (PAPILLOEDEMA). A PRELIMINARY REPORT. Br J Ophthalmol. 1964;48(10):522-43.
- Mollan SP. Papilledema. Continuum (Minneap Minn). 2025;31(2):436-462.
- Reier L, Fowler JB, Arshad M, Hadi H, Whitney E, Farmah AV, et al. Optic Disc Edema and Elevated Intracranial Pressure (ICP): A Comprehensive Review of Papilledema. Cureus. 2022;14(5):e24915.
- Kupersmith MJ, Sibony P, Mandel G, Durbin M, Kardon RH. Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema. Invest Ophthalmol Vis Sci. 2011;52(9):6558-64.
- Villarruel JM, Li XQ, Bach-Holm D, Hamann S. Anterior lamina cribrosa surface position in idiopathic intracranial hypertension and glaucoma. Eur J Ophthalmol. 2017;27(1):55-61.
- Panyala R, Sharma P, Sihota R, Saxena R, Prasad K, Phuljhele S, et al. Role of spectral domain optical coherence tomography in the diagnosis and prognosis of papilledema. Indian J Ophthalmol. 2021;69(9):2372-2377.
- Siaudvytyte L, Januleviciene I, Ragauskas A, Bartusis L, Siesky B, Harris A. Update in intracranial pressure evaluation methods and translaminar pressure gradient role in glaucoma. Acta Ophthalmol. 2015;93(1):9-15.
- Xie Y, Li Z, Wu J, Zhang Y, Zhang K, Shao Y, et al. Optic nerve intraneural pressure trend under intraocular-intracranial pressure effects. Br J Ophthalmol. 2026.
- Waisberg E, Ong J, Masalkhi M, Paladugu P, Lee AG, Berdahl J. Precisional modulation of translaminar pressure gradients for ophthalmic diseases. Eur J Ophthalmol. 2024;34(5):1328-1336.
- Radke PM, Rubinstein TJ, Hamilton SR, Jamil AL, Sires BS. The Translaminar Pressure Gradient: Papilledema After Trabeculectomy Treated With Optic Nerve Sheath Fenestration. J Glaucoma. 2018;27(10):e154-e157.
- Bidot S, Bruce BB, Saindane AM, Newman NJ, Biousse V. Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35(1):31-6.
- Marcelis J, Silberstein SD. Idiopathic intracranial hypertension without papilledema. Arch Neurol. 1991;48(4):392-9.
- Labella Alvarez F, Berman G, Lowe M, Kulniwatcharoen P, Mollan SP. Adult Idiopathic Intracranial Hypertension Without Papilledema: Systematic Review of Literature and Future Perspectives. J Neuroophthalmol. 2026;46(2):149-164.
- Aylward SC, Aronowitz C, Roach ES. Intracranial Hypertension Without Papilledema in Children. J Child Neurol. 2016;31(2):177-83.
- Sayal AP, Jhaveri A, Diouf AA, Lam CTY, Suthiphosuwan S, Micieli JA. Empty Sella in Neuro-Ophthalmology Patients Without Raised Intracranial Pressure. J Neuroophthalmol. 2024;44(1):61-65.
- Wu M, Zhao X, Peng S, Zhang X, Ru J, Xie L, et al. Progressive Optic Neuropathy in Hydrocephalic Ccdc13 Mutant Mice Caused by Impaired Axoplasmic Transport at the Optic Nerve Head. Invest Ophthalmol Vis Sci. 2024;65(13):5.
- Jacks AS, Miller NR. Spontaneous retinal venous pulsation: aetiology and significance. J Neurol Neurosurg Psychiatry. 2003;74(1):7-9.
- McCulley TJ, Lam BL, Bose S, Feuer WJ. The effect of optic disk edema on spontaneous venous pulsations. Am J Ophthalmol. 2003;135(5):706-8.
- Choudhari NS, Raman R, George R. Interrelationship between optic disc edema, spontaneous venous pulsation and intracranial pressure. Indian J Ophthalmol. 2009;57(5):404-6.
- McHugh JA, D’Antona L, Toma AK, Bremner FD. Spontaneous Venous Pulsations Detected With Infrared Videography. J Neuroophthalmol. 2020;40(2):174-177.
- Panahi A, Rezaee A, Hajati F, Shariflou S, Agar A, Golzan SM. Autonomous assessment of spontaneous retinal venous pulsations in fundus videos using a deep learning framework. Sci Rep. 2023;13(1):14445.
- Berdahl TJ, Shafer BM, Berdahl JP, Lee AG, Zamora MI, Terveen DC. Noninvasive Estimation of Intracranial Pressure Using Optic-Disc Venous Pulsation Thresholds. J Neuroophthalmol. 2026.
- Tang L, Kardon RH, Wang JK, Garvin MK, Lee K, Abràmoff MD. Quantitative evaluation of papilledema from stereoscopic color fundus photographs. Invest Ophthalmol Vis Sci. 2012;53(8):4490-7.
- Optical Coherence Tomography Substudy Committee. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial. Ophthalmology. 2015;122(9):1939-45.e2.
- Skau M, Sander B, Milea D, Jensen R. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol. 2011;258(2):277-83.
- Thaller M, Homer V, Hyder Y, Yiangou A, Liczkowski A, Fong AW, et al. The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol. 2023;270(2):851-863.
- Talks SJ, Mossa F, Elston JS. The contribution of macular changes to visual loss in benign intracranial hypertension. Eye (Lond). 1998;12 ( Pt 5):806-8.
- Malem A, De Salvo G, West S. Use of MultiColor imaging in the assessment of suspected papilledema in 20 consecutive children. J AAPOS. 2016;20(6):532-536.
- Chiang J, Wong E, Whatham A, Hennessy M, Kalloniatis M, Zangerl B. The usefulness of multimodal imaging for differentiating pseudopapilloedema and true swelling of the optic nerve head: a review and case series. Clin Exp Optom. 2015;98(1):12-24.
- Bontzos G, Smoustopoulos G, Detorakis TE. Unilateral optic disc drusen mis-diagnosed as optic neuritis: Diagnostic and therapeutic implications. Rom J Ophthalmol. 2020;64(4):449-454.
- Alkhayat MI, Almuhawas HA, Almazrouei SS, Soliman SE. Chiari Malformation Type I With Concurrent Bilateral Optic Disc Drusen: Is Follow-up Necessary?. Cureus. 2024;16(7):e63937.
- Braithwaite T, Plant GT. Chronic optic disc swelling overlooked in a diabetic patient with a devastating outcome. BMJ Case Rep. 2010;2010.
- Herzau V, Baykal HE. [Long-term outcome of optic nerve sheath fenestration in pseudotumor cerebri]. Klin Monbl Augenheilkd. 1998;213(3):154-60.
- D’Antona L, Asif H, Craven CL, McHugh JA, Vassiliou A, Thorne L, et al. Brain MRI and Ophthalmic Biomarkers of Intracranial Pressure. Neurology. 2021;96(22):e2714-e2723.
- Golden E, Krivochenitser R, Mathews N, Longhurst C, Chen Y, Yu JJ, et al. Contrast-Enhanced 3D-FLAIR Imaging of the Optic Nerve and Optic Nerve Head: Novel Neuroimaging Findings of Idiopathic Intracranial Hypertension. AJNR Am J Neuroradiol. 2019;40(2):334-339.
- Lama C, Derakhshan J, Wilson B, Snyder D, Tang Y, Van Stavern G. Apparent Diffusion Coefficient of the Optic Nerve Head in Idiopathic Intracranial Hypertension. Neuroophthalmology. 2024;48(6):401-406.
- Galetta SL, Balcer LJ. All choked up about the pseudotumor cerebri syndrome. Neurology. 2013;81(13):1112-3.
- Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87(9):982-92.
- Kilgore KP, Lee MS, Leavitt JA, Mokri B, Hodge DO, Frank RD, et al. Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity. Ophthalmology. 2017;124(5):697-700.
- Goudie C, Burr J, Blaikie A. Incidence of idiopathic intracranial hypertension in Fife. Scott Med J. 2019;64(2):62-66.
- Andrews LE, Liu GT, Ko MW. Idiopathic intracranial hypertension and obesity. Horm Res Paediatr. 2014;81(4):217-25.
- Fisayo A, Bruce BB, Newman NJ, Biousse V. Overdiagnosis of idiopathic intracranial hypertension. Neurology. 2016;86(4):341-50.
- Eshtiaghi A, Margolin E, Micieli JA. Inaccuracy of idiopathic intracranial hypertension diagnosis in case reports. Eye (Lond). 2023;37(15):3243-3248.
- Macher S, Marik W, Krajnc N, Mitsch C, Michl M, Mueller N, et al. The additive value of complementing diagnostic idiopathic intracranial hypertension criteria by MRI - an external validation study. J Headache Pain. 2024;25(1):70.
- Favoni V, Pierangeli G, Toni F, Cirillo L, La Morgia C, Abu-Rumeileh S, et al. Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache. Front Neurol. 2018;9:503.
- Giridharan N, Patel SK, Ojugbeli A, Nouri A, Shirani P, Grossman AW, et al. Understanding the complex pathophysiology of idiopathic intracranial hypertension and the evolving role of venous sinus stenting: a comprehensive review of the literature. Neurosurg Focus. 2018;45(1):E10.
- Dinkin M, Oliveira C. Men Are from Mars, Idiopathic Intracranial Hypertension Is from Venous: The Role of Venous Sinus Stenosis and Stenting in Idiopathic Intracranial Hypertension. Semin Neurol. 2019;39(6):692-703.
- Schartz D, Finkelstein A, Bender MT. A unifying disease model of idiopathic intracranial hypertension: A narrative review. Headache. 2026;66(4):990-995.
- Grech O, Mollan SP, Wakerley BR, Alimajstorovic Z, Lavery GG, Sinclair AJ. Emerging themes in idiopathic intracranial hypertension. J Neurol. 2020;267(12):3776-3784.
- Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clin Proc. 1994;69(2):169-80.
- Ball AK, Clarke CE. Idiopathic intracranial hypertension. Lancet Neurol. 2006;5(5):433-42.
- Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia. 2015;35(3):248-61.
- Attar A, Alowfi AA, Bogari AM, Alharbi F, Zagzoog N, Aladdin Y. Prevalence of anemia in patients with idiopathic intracranial hypertension: A retrospective cohort study. Medicine (Baltimore). 2025;104(43):e44814.
- Al-Hashel JY, Ismail II, Ibrahim M, John JK, Husain F, Kamel WA, et al. Demographics, Clinical Characteristics, and Management of Idiopathic Intracranial Hypertension in Kuwait: A Single-Center Experience. Front Neurol. 2020;11:672.
- Sabt BI, Al Busaidi AS, Azeem S, Al Dhabbari L. Idiopathic intracranial hypertension in Omani adults: A tertiary center experience. Oman J Ophthalmol. 2024;17(1):19-24.
- Pollak L, Zohar E, Glovinsky Y, Huna-Baron R. Reevaluation of presentation and course of idiopathic intracranial hypertension—a large cohort comprehensive study. Acta Neurol Scand. 2013;127(6):406-12.
- Korsbæk JJ, Beier D, Hagen SM, Molander LD, Jensen RH. Psychiatric Comorbidities in Patients With Idiopathic Intracranial Hypertension: A Prospective Cohort Study. Neurology. 2022;99(2):e199-e208.
- Radojicic A, Vukovic-Cvetkovic V, Pekmezovic T, Trajkovic G, Zidverc-Trajkovic J, Jensen RH. Predictive role of presenting symptoms and clinical findings in idiopathic intracranial hypertension. J Neurol Sci. 2019;399:89-93.
- Raoof N, Hoffmann J. Diagnosis and treatment of idiopathic intracranial hypertension. Cephalalgia. 2021;41(4):472-478.
- Bénard-Séguin É, Costello F. Idiopathic Intracranial Hypertension with Papilledema. Neurosurg Clin N Am. 2025;36(2):281-298.
- Keltner JL, Johnson CA, Cello KE, Wall M. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci. 2014;55(5):3200-7.
- Doshi H, Solli E, Elze T, Pasquale LR, Wall M, Kupersmith MJ. Unsupervised Machine Learning Identifies Quantifiable Patterns of Visual Field Loss in Idiopathic Intracranial Hypertension. Transl Vis Sci Technol. 2021;10(9):37.
- Doshi H, Solli E, Elze T, Pasquale LR, Wall M, Kupersmith MJ. Unsupervised Machine Learning Shows Change in Visual Field Loss in the Idiopathic Intracranial Hypertension Treatment Trial. Ophthalmology. 2022;129(8):903-911.
- Wall M, Thurtell MJ. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial. Br J Ophthalmol. 2017;101(9):1256-1260.
- Bsteh G, Marik W, Krajnc N, Macher S, Mitsch C, Pruckner P, et al. MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome. J Headache Pain. 2023;24(1):97.
- Moreno ME, Del Carpio-O’Donovan R. Neuroimaging in the diagnosis and treatment of intracranial pressure disorders. Neurol Sci. 2023;44(3):845-858.
- Balık AÖ, Akıncı O, Yıldız S, Hasırcı Bayır BR, Ulutaş C. Role of neuroimaging markers on predicting of idiopathic intracranial hypertension. Acta Radiol. 2024;65(8):999-1006.
- Knoche T, Guelsoy N, Siebert E, Hollinski R, Danyel LA. MRI features in atypical idiopathic intracranial hypertension. Eur Radiol. 2026;36(7):5432-5441.
- Ebrahimzadeh SA, Du E, Chang YM, Bouffard M, Loth F, Bhadelia RA. MRI findings differentiating tonsillar herniation caused by idiopathic intracranial hypertension from Chiari I malformation. Neuroradiology. 2022;64(12):2307-2314.
- Schwartz KM, Luetmer PH, Hunt CH, Kotsenas AL, Diehn FE, Eckel LJ, et al. Position-related variability of CSF opening pressure measurements. AJNR Am J Neuroradiol. 2013;34(4):904-7.
- Ellis R 3rd. Lumbar cerebrospinal fluid opening pressure measured in a flexed lateral decubitus position in children. Pediatrics. 1994;93(4):622-3.
- Lee MW, Vedanarayanan VV. Cerebrospinal fluid opening pressure in children: experience in a controlled setting. Pediatr Neurol. 2011;45(4):238-40.
- Bruce BB, Biousse V, Newman NJ. Update on idiopathic intracranial hypertension. Am J Ophthalmol. 2011;152(2):163-9.
- Mollan SP, Mitchell JL, Ottridge RS, Aguiar M, Yiangou A, Alimajstorovic Z, et al. Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial. JAMA Neurol. 2021;78(6):678-686.
- Mollan SP, Mitchell JL, Yiangou A, Ottridge RS, Alimajstorovic Z, Cartwright DM, et al. Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension. Neurology. 2022;99(11):e1090-e1099.
- Abbott S, Chan F, Tahrani AA, Wong SH, Campbell FEJ, Parmar C, et al. Weight Management Interventions for Adults With Idiopathic Intracranial Hypertension: A Systematic Review and Practice Recommendations. Neurology. 2023;101(21):e2138-e2150.
- Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088-1100.
- Chen JJ, Mollan SP. Treatment and Monitoring of Idiopathic Intracranial Hypertension. Continuum (Minneap Minn). 2025;31(3):728-756.
- Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15(1):78-91.
- Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50(4):1094-8.
- Aguiar M, Frew E, Mollan SP, Mitchell JL, Ottridge RS, Alimajstorovic Z, et al. The Health Economic Evaluation of Bariatric Surgery Versus a Community Weight Management Intervention Analysis from the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT). Life (Basel). 2021;11(5).
- Rao A, Lowe M, Sinclair A, Mollan SP, Berman G. Infographic: Landmark Trials in Neuro-Ophthalmology-Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial. Eye (Lond). 2025.
- Weil R, Kovacs B, Miller N, McDermott MP, Wall M, Kupersmith M, et al. A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension. Obes Sci Pract. 2016;2(2):95-103.
- Koc F, Isik MR, Sefi-Yurdakul N. Weight reduction for a better visual outcome in idiopathic intracranial hypertension. Arq Bras Oftalmol. 2018;81(1):18-23.
- Killeen OJ, Gonzalez LA, Rothberg AE, Khanna S, Cornblath WT, Deveney T, et al. Facilitators and Barriers to Weight Loss Among Patients With Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2025;45(1):23-29.
- Thurtell MJ. Idiopathic Intracranial Hypertension. Continuum (Minneap Minn). 2019;25(5):1289-1309.
- Kanagalingam S, Subramanian PS. Update on Idiopathic Intracranial Hypertension. Curr Treat Options Neurol. 2018;20(7):24.
- Yiangou A, Mitchell JL, Nicholls M, Chong YJ, Vijay V, Wakerley BR, et al. Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT). J Neurol. 2022;269(4):1945-1956.
- Westgate CSJ, Markey K, Mitchell JL, Yiangou A, Singhal R, Stewart P, et al. Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension. Eur J Endocrinol. 2022;187(2):323-333.
- Smith SV, Friedman DI. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes. Headache. 2017;57(8):1303-1310.
- Piper RJ, Kalyvas AV, Young AM, Hughes MA, Jamjoom AA, Fouyas IP. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. 2015;2015(8):CD003434.
- ten Hove MW, Friedman DI, Patel AD, Irrcher I, Wall M, McDermott MP. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuroophthalmol. 2016;36(1):13-9.
- Eldweik L. Transient myopia induced by acetazolamide in a pregnant patient with idiopathic intracranial hypertension: A case of successful rechallenge. Am J Ophthalmol Case Rep. 2026;42:102577.
- Almaqhawi A, Alokley A, Alamri R, Alabdulqader R, Alali A, Aleid A, et al. Effectiveness of Topiramate Versus Acetazolamide in the Management of Idiopathic Intracranial Hypertension: ASystematic Review and Meta-Analysis. Medicina (Kaunas). 2025;61(3).
- Morsy MM, Azzam AY, Essibayi MA, Abadi AM, Alsabaani NA, Alsaleem SA, et al. Topiramate Versus Acetazolamide for Idiopathic Intracranial Hypertension. A Real-World Data-Based Multicenter Retrospective Study. Indian J Pharm Educ. 2026;60(2):614-629.
- Jeon-Chapman J, Estrela T, Heidary G, Gise R. Efficacy and Side Effects of Topiramate in Treatment of Children With Pseudotumor Cerebri Syndrome. Pediatr Neurol. 2024;160:32-37.
- Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, et al. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain. 2023;146(5):1821-1830.
- Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, et al. Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension. J Headache Pain. 2023;24(1):89.
- Stefanou MI, Chatziralli I, Lambadiari V, Mengel A, Foska A, Chondrogianni M, et al. Efficacy and Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis. Eur J Neurol. 2025;32(9):e70358.
- Ognard J, Alipour Khabir S, Ghozy S, El Hajj G, Kallmes KM, Chen JJ, et al. Use of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension : a systematic review. J Headache Pain. 2025;26(1):202.
- de Oliveira HM, Gallo Ruelas M, Fonseca PEO, Diaz CAV, de Paula GO, da Costa PRF, et al. Effect of GLP-1 receptor agonists on idiopathic intracranial hypertension: A systematic review. Headache. 2026;66(1):286-297.
- Sioutas GS, Mualem W, Reavey-Cantwell J, Rivet DJ 2nd. GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. JAMA Neurol. 2025;82(9):887-894.
- Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G, et al. Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension. Eye (Lond). 2024;38(7):1374-1379.
- Chatziralli I, Theodossiadis P, Theodossiadis G, Asproudis I. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1217-1224.
- Friedman DI. Special Considerations in the Treatment of Idiopathic Intracranial Hypertension. Curr Neurol Neurosci Rep. 2024;25(1):8.
- Lai LT, Danesh-Meyer HV, Kaye AH. Visual outcomes and headache following interventions for idiopathic intracranial hypertension. J Clin Neurosci. 2014;21(10):1670-8.
- Feldon SE. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus. 2007;23(5):E6.
- Tsermoulas G, Mollan SP, Homer V, Kristunas C, White P, Wakerley BR, et al. Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention): protocol for an open-label, multicentre, randomised controlled phase IIb trial. BMJ Open. 2026;16(8):e111013.
- McCluskey PJ, Lam D, Ang T, Todd MJ, Halmágyi GM. Optic nerve sheath fenestration for treating papilloedema in the era of cerebral venous sinus stenting. Clin Exp Ophthalmol. 2023;51(4):349-358.
- Özdemir HN, Çelebisoy N, Gökçay F, Yakut A, Bajin MS, Yaman A. Does optic nerve sheath fenestration alleviate headaches in patients with idiopathic intracranial hypertension? A retrospective study. J Clin Neurosci. 2025;139:111447.
- Daou BJ, Sweid A, Weinberg JH, Starke RM, Sergott RC, Doermann AS, et al. Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension. World Neurosurg. 2020;142:e73-e80.
- Malik AI, Xu J, Lee AG. Outcomes of optic nerve sheath fenestration from superomedial eyelid crease approach. Orbit. 2022;41(4):413-421.
- Tarrats L, Hernández G, Busquets JM, Portela JC, Serrano LA, González-Sepúlveda L, et al. Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension. Int Forum Allergy Rhinol. 2017;7(6):615-623.
- Ahmedov ML, Tahmazoglu B, Aydin S, Kartum TA, Mergen B, Yildirim SR, et al. Endoscopic Endonasal Optic Nerve Decompression in Idiopathic Intracranial Hypertension: When to Implement Optic Nerve Sheath Fenestration. Oper Neurosurg. 2023;25(4):315-323.
- El-Masri S, Wilson M, Goh J, Sanfilippo P, Fok A, Hardy T, et al. A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomes. Ther Adv Neurol Disord. 2023;16:17562864231197994.
- Anzeljc AJ, Frias P, Hayek BR, Canter Weiner N, Wojno TH, Kim HJ. A 15-year review of secondary and tertiary optic nerve sheath fenestration for idiopathic intracranial hypertension. Orbit. 2018;37(4):266-272.
- Sharma M, Chhabra A, Raina N. Optic nerve sheath fenestration: A second lease at sight. Indian J Ophthalmol. 2023;71(7):2845-2849.
- Landau Prat D, Liu GT, Avery RA, Ying GS, Chen Y, Tomlinson LA, et al. Recovery of Vision after Optic Nerve Sheath Fenestration in Children and Adolescents with Elevated Intracranial Pressure. Am J Ophthalmol. 2022;237:173-182.
- Parca O, Seker-Un E. Surgical outcomes of optic nerve sheath fenestration in pediatric pseudotumor cerebri syndrome. BMC Ophthalmol. 2025;25(1):667.
- Gupta L, Vora P, Benningfield M, Altman EA, Sudhakar P, Timoney PJ. Optic Nerve Sheath Fenestration: A Retrospective Review of Its Safety, Efficacy, and Impact on Optical Coherence Tomography. Ophthalmic Plast Reconstr Surg. 2025;41(2):213-220.
- Bsteh G, Hansen NS, Zaic S, Hamann S, Korsbæk JJ, Krajnc N, et al. Surgical Interventions in Idiopathic Intracranial Hypertension-A Comprehensive Multi-Center Study of Outcome and the Role of Treatment Indication. Eur J Neurol. 2026;33(3):e70541.
- Andreão FF, Ferreira MY, Brenner LBO, Sousa MP, Palavani LB, Rairan LG, et al. Effectiveness and Safety of Ventriculoperitoneal Shunt Versus Lumboperitoneal Shunt for Idiopathic Intracranial Hypertension: A Systematic Review and Comparative Meta-Analysis. World Neurosurg. 2024;185:359-369.e2.
- Tarnaris A, Toma AK, Watkins LD, Kitchen ND. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin Neurol Neurosurg. 2011;113(6):477-9.
- Haq NU, Khan BA, Ali MZ, Sadbar S, Khan S, Sajjad W. Visual and headache outcomes following lumboperitoneal shunting in idiopathic intracranial hypertension: a prospective observational study. BMC Neurol. 2026;26(1).
- Alkherayf F, Abou Al-Shaar H, Awad M. Management of idiopathic intracranial hypertension with a programmable lumboperitoneal shunt: Early experience. Clin Neurol Neurosurg. 2015;136:5-9.
- Galloway L, Karia K, White AM, Byrne ME, Sinclair AJ, Mollan SP, et al. Cerebrospinal fluid shunting protocol for idiopathic intracranial hypertension for an improved revision rate. J Neurosurg. 2022;136(6):1790-1795.
- Elshanawany A, Mohammad F. Spontaneous cerebrospinal fluid rhinorrhea as a primary presentation of idiopathic intracranial hypertension, management strategies, and clinical outcome. Surg Neurol Int. 2024;15:458.
- Friedman DI. Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol. 2006;26(1):61-4.
- McDougall CM, Ban VS, Beecher J, Pride L, Welch BG. Fifty shades of gradients: does the pressure gradient in venous sinus stenting for idiopathic intracranial hypertension matter? A systematic review. J Neurosurg. 2019;130(3):999-1005.
- Inam ME, Martinez-Gutierrez JC, Kole MJ, Sanchez F, Lekka E, Truong VTT, et al. Venous Sinus Stenting for Low Pressure Gradient Stenoses in Idiopathic Intracranial Hypertension. Neurosurgery. 2022;91(5):734-740.
- Wang S, Tong X, Li X, Liu L, Liu Z, Mo D, et al. Association of post-intervention pressure gradient with symptom-free at 6 months in idiopathic intracranial hypertension with venous sinus stenosis treated by stenting. Interv Neuroradiol. 2023;29(4):413-418.
- Song S, Tu K, He J, Guan Z, Gan Y, Chen F, et al. Baseline factors associated with post-stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis. Headache. 2025;65(10):1734-1743.
- Azzam AY, Mortezaei A, Morsy MM, Essibayi MA, Ghozy S, Elamin O, et al. Venous sinus stenting for idiopathic intracranial hypertension: An updated Meta-analysis. J Neurol Sci. 2024;459:122948.
- Liu X, Di H, Wang J, Cao X, Du Z, Zhang R, et al. Endovascular stenting for idiopathic intracranial hypertension with venous sinus stenosis. Brain Behav. 2019;9(5):e01279.
- Dinkin MJ, Patsalides A. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial. J Neuroophthalmol. 2017;37(2):113-121.
- Martin J, Sanborn MR. Dural Venous Sinus Stent Placement Reduces Dosage Requirements for Carbonic Anhydrase Inhibitors in Patients with Idiopathic Intracranial Hypertension. J Vasc Interv Radiol. 2023;34(8):1359-1363.
- Lee KE, Zehri A, Soldozy S, Syed H, Catapano JS, Maurer R, et al. Dural venous sinus stenting for treatment of pediatric idiopathic intracranial hypertension. J Neurointerv Surg. 2021;13(5):465-470.
- Schwarz J, Al Balushi A, Sundararajan S, Dinkin M, Oliveira C, Greenfield JP, et al. Management of idiopathic intracranial hypertension in children utilizing venous sinus stenting. Interv Neuroradiol. 2021;27(2):257-265.
- Barrero Ruiz E, Iglesias Moroño S, Ros López B, Morales Martinez A, Díaz T, Arráez Sánchez MÁ. Life-threatening idiopathic intracranial hypertension: the role of venous sinus stenting. Childs Nerv Syst. 2022;38(8):1433-1443.
- Carlos Martinez-Gutierrez J, Kole MJ, Lopez-Rivera V, Inam ME, Tang R, Al-Zubidi N, et al. Primary balloon angioplasty of venous Sinus stenosis in idiopathic intracranial hypertension. Interv Neuroradiol. 2023;29(4):358-362.
- Intrapiromkul J, Rai AT, Lakhani DA. Transverse venous sinus stenting versus cerebrospinal fluid shunting in idiopathic intracranial hypertension: a multi-institutional and multinational database study. J Neurointerv Surg. 2026;18(5):1390-1394.
- Bsteh G, Pemp B, Marik W, Novak K, Leutner M, Leis S, et al. Diagnosis, treatment and monitoring of idiopathic intracranial hypertension: Consensus recommendations of the Austrian IIH network (AN4IH). Cephalalgia. 2025;45(11):3331024251391374.
- Srivastava O, Micieli JA. Resolution of Fulminant Idiopathic Intracranial Hypertension Treated with Acetazolamide. Case Rep Neurol. 2022;14(3):424-428.
- Elder BD, Goodwin CR, Kosztowski TA, Radvany MG, Gailloud P, Moghekar A, et al. Venous sinus stenting is a valuable treatment for fulminant idiopathic intracranial hypertension. J Clin Neurosci. 2015;22(4):685-9.
- Aldhahwani B, Gupta A, Badeeb N, Jordan D, Albreiki D. A surge in fulminant idiopathic intracranial hypertension cases within 1 year from the coronavirus disease 2019 pandemic lockdown: A case series. Saudi J Ophthalmol. 2025;39(4):395-400.
- Palermo M, Trevisi G, D’Arrigo S, Sturiale CL. Idiopathic Intracranial Hypertension in Pregnancy. A Systematic Review on Clinical Course, Treatments, Delivery and Maternal-Fetal Outcome. Eur J Neurol. 2025;32(5):e70186.
- Vukovic-Cvetkovic V, Beier D, Buchgreitz L, Korsbaek JJ, Jensen RH. Management and Outcome of Pregnancy in Patients With Idiopathic Intracranial Hypertension: A Prospective Case Series Study. Neurol Clin Pract. 2024;14(1):e200226.
- Huna-Baron R, Kupersmith MJ. Idiopathic intracranial hypertension in pregnancy. J Neurol. 2002;249(8):1078-81.
- Golan S, Maslovitz S, Kupferminc MJ, Kesler A. Management and outcome of consecutive pregnancies complicated by idiopathic intracranial hypertension. Isr Med Assoc J. 2013;15(4):160-3.
- Tang RA. Management of idiopathic intracranial hypertension in pregnancy. MedGenMed. 2005;7(4):40.
- Tang RA, Dorotheo EU, Schiffman JS, Bahrani HM. Medical and surgical management of idiopathic intracranial hypertension in pregnancy. Curr Neurol Neurosci Rep. 2004;4(5):398-409.
- Revuelta D, López-Baamonde M, Vendrell M, Plaza A, Cobo T, Magaldi M. Anesthetic management of idiopathic intracranial hypertension during pregnancy. A case report. Rev Esp Anestesiol Reanim (Engl Ed). 2025;72(1):101623.
- Bassan H, Berkner L, Stolovitch C, Kesler A. Asymptomatic idiopathic intracranial hypertension in children. Acta Neurol Scand. 2008;118(4):251-5.
- Soiberman U, Stolovitch C, Balcer LJ, Regenbogen M, Constantini S, Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst. 2011;27(11):1913-8.
- Gaier ED, Heidary G. Pediatric Idiopathic Intracranial Hypertension. Semin Neurol. 2019;39(6):704-710.
- Malem A, Sheth T, Muthusamy B. Paediatric Idiopathic Intracranial Hypertension (IIH)-A Review. Life (Basel). 2021;11(7).
- Heidary G. Update on Pediatric Idiopathic Intracranial Hypertension. Int Ophthalmol Clin. 2026;66(2):64-67.
- Ko MW, Liu GT. Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Horm Res Paediatr. 2010;74(6):381-9.
- Wolf A, Hutcheson KA. Advances in evaluation and management of pediatric idiopathic intracranial hypertension. Curr Opin Ophthalmol. 2008;19(5):391-7.
- Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007;52(6):597-617.
- Rook BS, Phillips PH. Pediatric pseudotumor cerebri. Curr Opin Ophthalmol. 2016;27(5):416-9.
- Agraz D, Morgan LA, Fouzdar Jain S, Suh DW. Clinical features of pediatric idiopathic intracranial hypertension. Clin Ophthalmol. 2019;13:881-886.
- Shimony N, Martinez-Sosa M, Osburn B, Jallo GI. Non-traumatic pediatric intracranial hypertension: key points for different etiologies, diagnosis, and treatment. Acta Neurol Belg. 2021;121(4):823-836.
- Jordan CO, Aylward SC. Intracranial hypertension: a current review. Curr Opin Pediatr. 2018;30(6):764-774.
- Nitzan-Luques A, Bulkowstein Y, Barnoy N, Aran A, Reif S, Gilboa T. Improving pediatric idiopathic intracranial hypertension care: a retrospective cohort study. Sci Rep. 2022;12(1):19218.
- Horev A, Ben-Arie G, Zlotnik Y, Koltochnik M, Ben Chaim O, Biederko R, et al. Clinical and Radiological Characteristics of Non-Obese Female Patients with Idiopathic Intracranial Hypertension. J Clin Med. 2024;13(6).
- Ma Z, Jiang H, Cui S, Peng J, Wang J. Clinical characteristics and outcomes of non-obese patients with idiopathic intracranial hypertension: a retrospective cohort study. Neurol Sci. 2026;47(7).
- Ma Z, Jiang H, Meng C, Cui S, Peng J, Wang J. Idiopathic intracranial hypertension in patients with anemia: A retrospective observational study. PLoS One. 2020;15(7):e0236828.
- Han G, Song J, Wan S, Ji X, Zhou D, Meng R. Inflammation in Idiopathic Intracranial Hypertension: An Immunometabolic Mechanistic Framework and Clinical Implications. CNS Neurosci Ther. 2026;32(3):e70827.
- Zur D, Naftaliev E, Kesler A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35(1):26-30.
- Kosyakova N, Shaw JS, Reisch A, Richey LN, Kentis S, Bryant BR, et al. A Systematic Review of Neuropsychiatric Symptoms in Idiopathic Intracranial Hypertension. J Acad Consult Liaison Psychiatry. 2023.
- Mrejen S, Vignal C, Bruce BB, Gineys R, Audren F, Preechawat P, et al. Idiopathic intracranial hypertension: a comparison between French and North-American white patients. Rev Neurol (Paris). 2009;165(6-7):542-8.
- Lowe M, Berman G, Sumithran P, Mollan SP. Current Understanding of the Pathophysiology of Idiopathic Intracranial Hypertension. Curr Neurol Neurosci Rep. 2025;25(1):31.
- Dinkin M, Patsalides A, Ertel M. Diagnosis and Management of Cerebral Venous Diseases in Neuro-Ophthalmology: Ongoing Controversies. Asia Pac J Ophthalmol (Phila). 2019;8(1):73-85.
- Sachdeva V, Nalawade R, Kannam M, Kapoor R, Chattannavar G, Kale SB, et al. Clinical profile, diagnostic challenges, and outcomes in subacute/chronic cerebral sinus venous thrombosis. Indian J Ophthalmol. 2021;69(12):3598-3606.
- Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Cantú C, Bousser MG, et al. Cerebral venous and sinus thrombosis in women. Stroke. 2009;40(7):2356-61.
- Capecchi M, Abbattista M, Martinelli I. Cerebral venous sinus thrombosis. J Thromb Haemost. 2018;16(10):1918-1931.
- Zuurbier SM, Coutinho JM. Cerebral Venous Thrombosis. Adv Exp Med Biol. 2017;906:183-193.
- Coutinho JM, Zuurbier SM, Bousser MG, Ji X, Canhão P, Roos YB, et al. Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial. JAMA Neurol. 2020;77(8):966-973.
- Siegler JE, Shu L, Yaghi S, Salehi Omran S, Elnazeir M, Bakradze E, et al. Endovascular Therapy for Cerebral Vein Thrombosis: A Propensity-Matched Analysis of Anticoagulation in the Treatment of Cerebral Venous Thrombosis. Neurosurgery. 2022;91(5):749-755.
- Kan Y, Song B, Jiang M, Zhang Y, Li C, Wu C, et al. Evolution and advances in endovascular mechanical thrombectomy of cerebral venous sinus thrombosis. Int J Med Sci. 2024;21(13):2450-2463.
- Vellema J, Munckhof AV, Coutinho JM. Cerebral venous thrombosis: Current management, recent advances and future directions. Int J Stroke. 2025;20(10):1177-1187.
- Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203-1213.
- Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195-221.
- Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158-92.
- Einhäupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010;17(10):1229-35.
- Weimar C, Beyer-Westendorf J, Bohmann FO, Hahn G, Halimeh S, Holzhauer S, et al. New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline. Neurol Res Pract. 2024;6(1):23.
- Ropper AH, Klein JP. Cerebral Venous Thrombosis. N Engl J Med. 2021;385(1):59-64.
- Liberman AL. Diagnosis and Treatment of Cerebral Venous Thrombosis. Continuum (Minneap Minn). 2023;29(2):519-539.
- Coutinho JM. Cerebral venous thrombosis. J Thromb Haemost. 2015;13 Suppl 1:S238-44.
- Jaiswal V, Nepal G, Dijamco P, Ishak A, Dagar M, Sarfraz Z, et al. Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review. J Prim Care Community Health. 2022;13:21501319221074450.
- Angelette AL, Rando LL, Wadhwa RD, Barras AA, Delacroix BM, Talbot NC, et al. Tetracycline-, Doxycycline-, Minocycline-Induced Pseudotumor Cerebri and Esophageal Perforation. Adv Ther. 2023;40(4):1366-1378.
- Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology. 2004;111(6):1248-50.
- Fraunfelder FW, Fraunfelder FT. Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension. J Neuroophthalmol. 2004;24(3):214-6.
- Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology. 1984;34(11):1509-11.
- Malozowski S, Tanner LA, Wysowski DK, Fleming GA, Stadel BV. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr. 1995;126(6):996-9.
- Clayton PE, Cowell CT. Safety issues in children and adolescents during growth hormone therapy—a review. Growth Horm IGF Res. 2000;10(6):306-17.
- Souza FM, Collett-Solberg PF. Adverse effects of growth hormone replacement therapy in children. Arq Bras Endocrinol Metabol. 2011;55(8):559-65.
- Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6(1):29-37.
- Benrabah R, Lumbroso L, Limon S, Hamard H, Morin Y. [Unexplained bilateral optic disk edema. So-called idiopathic intracranial hypertension of drug origin should be suspected]. J Fr Ophtalmol. 1995;18(4):282-5.
- Chroni E, Monastirli A, Tsambaos D. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians. Drug Saf. 2010;33(1):25-34.
- Krasnow MD, McGuirk L, Alexandrov A, Naparst M, Patale T, Mehta S, et al. Growth hormone therapy does not impact the development of intracranial hypertension in children with Chiari malformation. J Pediatr Endocrinol Metab. 2024;37(7):630-634.
- Jankovic SM, Vujovic B, Zamora Coronado AR, Mendes Duarte G, Pontes de Oliveira Tenório B, Rekik A, et al. No pharmacovigilance signal of intracranial hypertension associated with glycylcyclines: a FAERS-based disproportionality analysis. J Antimicrob Chemother. 2026;81(1).
- Cognard C, Casasco A, Toevi M, Houdart E, Chiras J, Merland JJ. Dural arteriovenous fistulas as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol Neurosurg Psychiatry. 1998;65(3):308-16.
- Ahmed RM, Khoury B, Wilkinson M, Parker GD, Halmagyi GM. Venous hypertension as the cause of intracranial hypertension in patients with transverse sinus dural arteriovenous fistula. J Neuroophthalmol. 2013;33(2):102-5.
- Gelwan MJ, Choi IS, Berenstein A, Pile-Spellman JM, Kupersmith MJ. Dural arteriovenous malformations and papilledema. Neurosurgery. 1988;22(6 Pt 1):1079-84.
- Chimowitz MI, Little JR, Awad IA, Sila CA, Kosmorsky G, Furlan AJ. Intracranial hypertension associated with unruptured cerebral arteriovenous malformations. Ann Neurol. 1990;27(5):474-9.
- Ghorbani M, Griessenauer CJ, Wipplinger C, Bahrami R, Mirsardoo H, Sahraei R, et al. Intracranial hypertension and papilledema secondary to an unruptured arteriovenous malformation: Review of the literature. Neuroradiol J. 2025;38(4):387-393.
- Kandasamy J, Kneen R, Gladstone M, Newman W, Mohamed T, Mallucci C. Chiari I malformation without hydrocephalus: acute intracranial hypertension managed with endoscopic third ventriculostomy (ETV). Childs Nerv Syst. 2008;24(12):1493-7.
- Schimmel S, Ram N, Smith T, Hayman E, Peto I, Piper K. Endoscopic third ventriculostomy (ETV) for Chiari 1 malformation: a systematic review and meta-analysis. Neurosurg Rev. 2024;47(1):408.
- Salpietro V, Mankad K, Kinali M, Adams A, Valenzise M, Tortorella G, et al. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study. J Pediatr Endocrinol Metab. 2014;27(1-2):107-15.
- Lundholm MD, Yogi-Morren D. A Comprehensive Review of Empty Sella and Empty Sella Syndrome. Endocr Pract. 2024;30(5):497-502.
- Romozzi M, Zeoli F, Martinelli R, Tosto F, Funcis A, Garignano G, et al. Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review. Headache. 2025;65(8):1462-1476.
- Mokri B. Spontaneous Intracranial Hypotension. Continuum (Minneap Minn). 2015;21(4 Headache):1086-108.
- Wang SJ. Spontaneous Intracranial Hypotension. Continuum (Minneap Minn). 2021;27(3):746-766.
- Wu JW, Wang SJ. Spontaneous Intracranial Hypotension: Clinical Presentation, Diagnosis, and Treatment Strategies. Neurol Clin. 2024;42(2):473-486.
- Cheema S, Mehta D, Qureshi A, Sayal P, Kamourieh S, Davagnanam I, et al. Spontaneous intracranial hypotension. Pract Neurol. 2024;24(2):98-105.
- Roytman M, Salama G, Robbins MS, Chazen JL. CSF-Venous Fistula. Curr Pain Headache Rep. 2021;25(1):5.
- Farb RI, Nicholson PJ, Peng PW, Massicotte EM, Lay C, Krings T, et al. Spontaneous Intracranial Hypotension: A Systematic Imaging Approach for CSF Leak Localization and Management Based on MRI and Digital Subtraction Myelography. AJNR Am J Neuroradiol. 2019;40(4):745-753.
- Dobrocky T, Nicholson P, Häni L, Mordasini P, Krings T, Brinjikji W, et al. Spontaneous intracranial hypotension: searching for the CSF leak. Lancet Neurol. 2022;21(4):369-380.
- Kranz PG, Gray L, Malinzak MD, Amrhein TJ. Spontaneous Intracranial Hypotension: Pathogenesis, Diagnosis, and Treatment. Neuroimaging Clin N Am. 2019;29(4):581-594.
- Amrhein TJ, Kranz PG. Spontaneous Intracranial Hypotension: Imaging in Diagnosis and Treatment. Radiol Clin North Am. 2019;57(2):439-451.
- Urbach H, Fung C, Dovi-Akue P, Lützen N, Beck J. Spontaneous Intracranial Hypotension. Dtsch Arztebl Int. 2020;117(27-28):480-487.
- Rajpal S, Nambiar M, Castanelli D, Khabaza A, Asadi H, Jhamb A, et al. Spontaneous Intracranial Hypotension and Spinal Epidural CSF Leaks: Diagnosis and Management. J Clin Neurosci. 2023;111:46-56.
- Choi SY, Seong M, Kim EY, Youn MS, Cho S, Jang H, et al. Outcome of epidural blood patch for imaging-negative spontaneous intracranial hypotension. Cephalalgia. 2023;43(2):3331024221140471.
- Su H, Lan X, Cao Y, Zhang M, Chen X, Lan C. Cervical epidural blood patch treatment is a choice for spontaneous intracranial hypotension. Technol Health Care. 2025;33(1):567-575.
- McRae-Posani B, Kim A, Edasery D, Strauss S, Roytman M, Park JK, et al. Spinal CSF leaks in spontaneous intracranial hypotension: A single-institution analysis of incidence, typology and treatment outcomes. Clin Neurol Neurosurg. 2025;255:108978.
- Limaye K, Samant R, Lee RW. Spontaneous intracranial hypotension: diagnosis to management. Acta Neurol Belg. 2016;116(2):119-25.
- Lee AG, Mader TH, Gibson CR, Tarver W. Space Flight-Associated Neuro-ocular Syndrome. JAMA Ophthalmol. 2017;135(9):992-994.
- Lee AG, Mader TH, Gibson CR, Brunstetter TJ, Tarver WJ. Space flight-associated neuro-ocular syndrome (SANS). Eye (Lond). 2018;32(7):1164-1167.
- Lee AG, Mader TH, Gibson CR, Tarver W, Rabiei P, Riascos RF, et al. Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update. NPJ Microgravity. 2020;6:7.
- Mader TH, Gibson CR, Miller NR, Subramanian PS, Patel NB, Lee AG. An overview of spaceflight-associated neuro-ocular syndrome (SANS). Neurol India. 2019;67(Supplement):S206-S211.
- Scott RA, Tarver WJ, Brunstetter TJ, Urquieta E. Optic Nerve Tortuosity on Earth and in Space. Aerosp Med Hum Perform. 2020;91(2):91-97.
- Wostyn P, Nedergaard M, Gibson CR, Mader TH. Asymmetric Optic Disc Edema in Astronauts: A Narrative Review Proposing an Interplay Between Ocular Venous Congestion and Glymphatic Transport. Life (Basel). 2026;16(5).
- Wostyn P, Mader TH, Gibson CR, Nedergaard M. Does Long-Duration Exposure to Microgravity Lead to Dysregulation of the Brain and Ocular Glymphatic Systems?. Eye Brain. 2022;14:49-58.
- Stern C, Yücel YH, Zu Eulenburg P, Pavy-Le Traon A, Petersen LG. Eye-brain axis in microgravity and its implications for Spaceflight Associated Neuro-ocular Syndrome. NPJ Microgravity. 2023;9(1):56.
- Waisberg E, Ong J, Masalkhi M, Lee AG. Anemia and Spaceflight Associated Neuro-Ocular Syndrome (SANS). Prehosp Disaster Med. 2023;38(5):680-682.
- Galdamez LA, Mader TH, Ong J, Kadipasaoglu CM, Lee AG. A multifactorial, evidence-based analysis of pathophysiology in Spaceflight Associated Neuro-Ocular Syndrome (SANS). Eye (Lond). 2025;39(4):700-709.
- Ong J, Tarver W, Brunstetter T, Mader TH, Gibson CR, Mason SS, et al. Spaceflight associated neuro-ocular syndrome: proposed pathogenesis, terrestrial analogues, and emerging countermeasures. Br J Ophthalmol. 2023;107(7):895-900.
- Ong J, Mader TH, Gibson CR, Mason SS, Lee AG. Spaceflight associated neuro-ocular syndrome (SANS): an update on potential microgravity-based pathophysiology and mitigation development. Eye (Lond). 2023;37(12):2409-2415.
- Nguyen T, Ong J, Brunstetter T, Gibson CR, Macias BR, Laurie S, et al. Spaceflight Associated Neuro-ocular Syndrome (SANS) and its countermeasures. Prog Retin Eye Res. 2025;106:101340.
- Wojcik P, Kini A, Al Othman B, Galdamez LA, Lee AG. Spaceflight associated neuro-ocular syndrome. Curr Opin Neurol. 2020;33(1):62-67.
- Zhang LF, Hargens AR. Spaceflight-Induced Intracranial Hypertension and Visual Impairment: Pathophysiology and Countermeasures. Physiol Rev. 2018;98(1):59-87.
- Milner DC, Subramanian PS. Insights into spaceflight-associated neuro-ocular syndrome with review of intraocular and orbital findings. Curr Opin Ophthalmol. 2023;34(6):493-499.
- Mehare A, Chakole S, Wandile B. Navigating the Unknown: A Comprehensive Review of Spaceflight-Associated Neuro-Ocular Syndrome. Cureus. 2024;16(2):e53380.
- Gew J, Hyder YF, Grech O, Brunstetter T, Tarver W, Mason SS, et al. Spaceflight-associated neuro-ocular syndrome (SANS): expert consensus on diagnosis and management. Eye (Lond). 2026;40(12):1794-1805.
- Scott JM, Tucker WJ, Martin D, Crowell JB, Goetchius E, Ozgur O, et al. Association of Exercise and Swimming Goggles With Modulation of Cerebro-ocular Hemodynamics and Pressures in a Model of Spaceflight-Associated Neuro-ocular Syndrome. JAMA Ophthalmol. 2019;137(6):652-659.
- Masood MT, Wang JW, Zoumi EA, Jain K, Suh A, Ong J, et al. Impedance threshold device as a countermeasure for spaceflight associated neuro-ocular syndrome (SANS): Mitigating mechanisms in proposed pathophysiology. Life Sci Space Res (Amst). 2024;42:99-107.
- Ong J, Lee AG, Moss HE. Head-Down Tilt Bed Rest Studies as a Terrestrial Analog for Spaceflight Associated Neuro-Ocular Syndrome. Front Neurol. 2021;12:648958.
- Huang AS, Stenger MB, Macias BR. Gravitational Influence on Intraocular Pressure: Implications for Spaceflight and Disease. J Glaucoma. 2019;28(8):756-764.
- Marshall-Goebel K, Damani R, Bershad EM. Brain Physiological Response and Adaptation During Spaceflight. Neurosurgery. 2019;85(5):E815-E821.
- Joe B. Spaceflight associated neuro-ocular syndrome: connections with terrestrial eye and brain disorders. Front Ophthalmol (Lausanne). 2024;4:1487992.
- Ng VWS, Mollan SP. An eye on long-duration spaceflight: Controversies, countermeasures and challenges. Exp Physiol. 2025.
- Ong J, Tavakkoli A, Strangman G, Zaman N, Kamran SA, Zhang Q, et al. Neuro-ophthalmic imaging and visual assessment technology for spaceflight associated neuro-ocular syndrome (SANS). Surv Ophthalmol. 2022;67(5):1443-1466.
- Soares B, Ong J, Waisberg E, Sarker P, Zaman N, Tavakkoli A, et al. Imaging in spaceflight associated neuro-ocular syndrome (SANS): Current technology and future directions in modalities. Life Sci Space Res (Amst). 2024;42:40-46.
- Dermarkarian CR, Kini AT, Al Othman BA, Lee AG. Neuro-Ophthalmic Manifestations of Intracranial Malignancies. J Neuroophthalmol. 2020;40(3):e31-e48.
- Long H, Qi ST, Song Y, Pan J, Zhang XA, Yang KJ. Topographic variations of the optic chiasm and the pituitary stalk: a morphometric study based on midsagittal T2-weighted MR images. Surg Radiol Anat. 2014;36(8):775-81.
- Kasab R, Yilmazlar S, Altunyuva O, Fedakar R. Relationship between optic nerve length and interoptic angle in the prediction of optic chiasm location. Neurocirugia (Engl Ed). 2025;36(1):39-46.
- Chen W, Zhang H, Zhang W, Su M, Xie R, Li K, et al. Development of a contouring guide for three different types of optic chiasm: A practical approach. J Med Imaging Radiat Oncol. 2019;63(5):657-664.
- Hershenfeld SA, Sharpe JA. Monocular temporal hemianopia. Br J Ophthalmol. 1993;77(7):424-7.
- Gesslein B, Naumovska M, Neumann O, Bizios D, Bengtsson B, Siesjö P, et al. Comparison of perimetric 24-2 and 30-2 test patterns in detecting visual field defects in patients with tumours in the pituitary region. Acta Ophthalmol. 2024;102(3):326-333.
- Ogra S, Nichols AD, Stylli S, Kaye AH, Savino PJ, Danesh-Meyer HV. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma. J Clin Neurosci. 2014;21(5):735-40.
- Thomas R, Shenoy K, Seshadri MS, Muliyil J, Rao A, Paul P. Visual field defects in non-functioning pituitary adenomas. Indian J Ophthalmol. 2002;50(2):127-30.
- Gedik S, Gur S, Atalay B, Colak M, Altinors N, Akova YA. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma. Saudi Med J. 2007;28(9):1380-4.
- Poon A, McNeill P, Harper A, O’Day J. Patterns of visual loss associated with pituitary macroadenomas. Aust N Z J Ophthalmol. 1995;23(2):107-15.
- Monteiro ML, Moura FC, Cunha LP. Frequency doubling perimetry in patients with mild and moderate pituitary tumor-associated visual field defects detected by conventional perimetry. Arq Bras Oftalmol. 2007;70(2):323-9.
- Costa-Cunha LV, Cunha LP, Malta RF, Monteiro ML. Comparison of Fourier-domain and time-domain optical coherence tomography in the detection of band atrophy of the optic nerve. Am J Ophthalmol. 2009;147(1):56-63.e2.
- Monteiro ML, Moura FC. Comparison of the GDx VCC scanning laser polarimeter and the stratus optical coherence tomograph in the detection of band atrophy of the optic nerve. Eye (Lond). 2008;22(5):641-8.
- Monteiro ML, Cunha LP, Vessani RM. Comparison of retinal nerve fiber layer measurements using Stratus OCT fast and regular scan protocols in eyes with band atrophy of the optic nerve and normal controls. Arq Bras Oftalmol. 2008;71(4):534-9.
- Nagai-Kusuhara A, Nakamura M, Tatsumi Y, Nakanishi Y, Negi A. Disagreement between Heidelberg Retina Tomograph and optical coherence tomography in assessing optic nerve head configuration of eyes with band atrophy and normal eyes. Br J Ophthalmol. 2008;92(10):1382-6.
- Sasagawa Y, Nakahara M, Takemoto D, Nakada M. Optical coherence tomography detects early optic nerve damage before visual field defect in patients with pituitary tumors. Neurosurg Rev. 2023;46(1):85.
- Moura FC, Medeiros FA, Monteiro ML. Evaluation of macular thickness measurements for detection of band atrophy of the optic nerve using optical coherence tomography. Ophthalmology. 2007;114(1):175-81.
- Monteiro ML, Hokazono K, Fernandes DB, Costa-Cunha LV, Sousa RM, Raza AS, et al. Evaluation of inner retinal layers in eyes with temporal hemianopic visual loss from chiasmal compression using optical coherence tomography. Invest Ophthalmol Vis Sci. 2014;55(5):3328-36.
- Mello LGM, Suzuki ACF, de Mello GR, Preti RC, Zacharias LC, Monteiro MLR. Choroidal Thickness in Eyes with Band Atrophy of the Optic Nerve from Chiasmal Compression. J Ophthalmol. 2022;2022:5625803.
- Mambour N, Maiter D, Duprez T, Costa E, Fomekong E, Raftopoulos C, et al. Functional Prognostic value of optical coherence tomography in optic chiasmal decompression: A preliminary study. J Fr Ophtalmol. 2021;44(3):321-330.
- Lim KSA, Tng WXA, Theng WB, Lee BTK, Chin CF, Li KZ, et al. The role of optical coherence tomography in the evaluation of para-chiasmal lesions: a systematic review and meta-analysis. Front Ophthalmol (Lausanne). 2025;5:1691582.
- Hr D, Singh AK, Singh A, Shah SK, Indurkar A, Patel BK. Retinal biomarkers for visual prognosis in pituitary surgery: a narrative review. Pituitary. 2026;29(4).
- Rutland JW, Delman BN, Huang KH, Verma G, Benson NC, Villavisanis DF, et al. Primary visual cortical thickness in correlation with visual field defects in patients with pituitary macroadenomas: a structural 7-Tesla retinotopic analysis. J Neurosurg. 2020;133(5):1371-1381.
- Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, et al. Clinical Biology of the Pituitary Adenoma. Endocr Rev. 2022;43(6):1003-1037.
- Daly AF, Beckers A. The Epidemiology of Pituitary Adenomas. Endocrinol Metab Clin North Am. 2020;49(3):347-355.
- Graffeo CS, Yagnik KJ, Carlstrom LP, Lakomkin N, Bancos I, Davidge-Pitts C, et al. Pituitary Adenoma Incidence, Management Trends, and Long-term Outcomes: A 30-Year Population-Based Analysis. Mayo Clin Proc. 2022;97(10):1861-1871.
- Jiang S, Chen X, Wu Y, Wang R, Bao X. An Update on Silent Corticotroph Adenomas: Diagnosis, Mechanisms, Clinical Features, and Management. Cancers (Basel). 2021;13(23).
- Ntali G, Wass JA. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary. 2018;21(2):111-118.
- Chin SO. Epidemiology of Functioning Pituitary Adenomas. Endocrinol Metab (Seoul). 2020;35(2):237-242.
- Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol. 2018;35(2):57-61.
- Lim CT, Korbonits M. UPDATE ON THE CLINICOPATHOLOGY OF PITUITARY ADENOMAS. Endocr Pract. 2018;24(5):473-488.
- Saeger W, Petersenn S, Schöfl C, Knappe UJ, Theodoropoulou M, Buslei R, et al. Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification. Endocr Pathol. 2016;27(2):115-22.
- Kim YS, Ahn S, Lee YS, Jeun SS, Park JS. Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification. Pituitary. 2024;27(5):665-672.
- Ferrante E, Ferraroni M, Castrignanò T, Menicatti L, Anagni M, Reimondo G, et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol. 2006;155(6):823-9.
- Qin J, Li K, Wang X, Bao Y. A comparative study of functioning and non-functioning pituitary adenomas. Medicine (Baltimore). 2021;100(14):e25306.
- Njami VA, Epee E, Nguifo Fongang EJ, Bello F, Ekoumelon R, Bukam ED, et al. Visual outcome of surgically managed pituitary adenomas followed-up at the Yaoundé Central Hospital. Br J Neurosurg. 2018;32(5):521-527.
- Jahangiri A, Lamborn KR, Blevins L, Kunwar S, Aghi MK. Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss. J Neurosurg. 2012;116(2):283-9.
- Zhang Y, Chen C, Huang W, Teng Y, Shu X, Zhao F, et al. Preoperative volume of the optic chiasm is an easily obtained predictor for visual recovery of pituitary adenoma patients following endoscopic endonasal transsphenoidal surgery: a cohort study. Int J Surg. 2023;109(4):896-904.
- Zhang Y, Zheng J, Huang Z, Teng Y, Chen C, Xu J. Predicting visual recovery in pituitary adenoma patients post-endoscopic endonasal transsphenoidal surgery: Harnessing delta-radiomics of the optic chiasm from MRI. Eur Radiol. 2023;33(11):7482-7493.
- Fleseriu M, Gurnell M, McCormack A, Fukuoka H, Glezer A, Langlois F, et al. Pituitary incidentaloma: a Pituitary Society international consensus guideline statement. Nat Rev Endocrinol. 2025;21(10):638-655.
- Huang HY, Lin SJ, Zhao WG, Wu ZB. Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review. Metab Brain Dis. 2018;33(3):969-976.
- Colao A, Vitale G, Cappabianca P, Briganti F, Ciccarelli A, De Rosa M, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab. 2004;89(4):1704-11.
- Cuevas JL, Fernández V, Rojas D, Wohllk N, González O, Torche E. [Visual outcome in patients with macroprolactinoma treated with dopamine agonists]. Rev Med Chil. 2013;141(6):687-94.
- Wildemberg LE, Fialho C, Gadelha MR. Prolactinomas. Presse Med. 2021;50(4):104080.
- Almalki MH, Alzahrani S, Alshahrani F, Alsherbeni S, Almoharib O, Aljohani N, et al. Managing Prolactinomas during Pregnancy. Front Endocrinol (Lausanne). 2015;6:85.
- Gadelha MR, Wildemberg LE, Bronstein MD, Gatto F, Ferone D. Somatostatin receptor ligands in the treatment of acromegaly. Pituitary. 2017;20(1):100-108.
- Colao A, Auriemma RS, Pivonello R. The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Pituitary. 2016;19(2):210-21.
- Castle-Kirszbaum M, Wang YY, King J, Goldschlager T. Predictors of visual and endocrine outcomes after endoscopic transsphenoidal surgery for pituitary adenomas. Neurosurg Rev. 2022;45(1):843-853.
- Kemchoknatee P, Singhakul C, Arjkongharn N, Vongsa N, Tangon D, Srisombut T. Insights into Visual Outcomes and Determinants in Pituitary Adenoma Surgery: A 5-Year Retrospective Cohort Study. Clin Ophthalmol. 2024;18:1779-1788.
- Uvelius E, Valdemarsson S, Bengzon J, Hammar B, Siesjö P. Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery. Brain Spine. 2023;3:102667.
- Bi WL, Dunn IF, Laws ER Jr. Pituitary apoplexy. Endocrine. 2015;48(1):69-75.
- Muthukumar N. Pituitary Apoplexy: A Comprehensive Review. Neurol India. 2020;68(Supplement):S72-S78.
- Pyrgelis ES, Mavridis I, Meliou M. Presenting Symptoms of Pituitary Apoplexy. J Neurol Surg A Cent Eur Neurosurg. 2018;79(1):52-59.
- Wildemberg LE, Glezer A, Bronstein MD, Gadelha MR. Apoplexy in nonfunctioning pituitary adenomas. Pituitary. 2018;21(2):138-144.
- Bujawansa S, Thondam SK, Steele C, Cuthbertson DJ, Gilkes CE, Noonan C, et al. Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom. Clin Endocrinol (Oxf). 2014;80(3):419-24.
- Hadj Kacem F, Trimeche O, Gargouri I, Ben Salah D, Charfi N, Rekik N, et al. Diagnosis and management of pituitary apoplexy: a Tunisian data. Chin Neurosurg J. 2023;9(1):17.
- Raj R, Elshimy G, Jacob A, Arya PVA, Unnikrishnan DC, Correa R, et al. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review. J Cancer Res Clin Oncol. 2021;147(8):2337-2347.
- Jemel M, Kandara H, Riahi M, Gharbi R, Nagi S, Kamoun I. Gestational pituitary apoplexy: Case series and review of the literature. J Gynecol Obstet Hum Reprod. 2019;48(10):873-881.
- Boyke AE, Michel M, Mamelak AN. Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era. Pituitary. 2024;27(6):898-908.
- Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf). 2011;74(1):9-20.
- Sahyouni R, Goshtasbi K, Choi E, Mahboubi H, Le R, Khahera AS, et al. Vision Outcomes in Early versus Late Surgical Intervention of Pituitary Apoplexy: Meta-Analysis. World Neurosurg. 2019;127:52-57.
- Brown NJ, Patel S, Gendreau J, Abraham ME. The role of intervention timing and treatment modality in visual recovery following pituitary apoplexy: a systematic review and meta-analysis. J Neurooncol. 2024;170(3):469-482.
- Almeida JP, Sanchez MM, Karekezi C, Warsi N, Fernández-Gajardo R, Panwar J, et al. Pituitary Apoplexy: Results of Surgical and Conservative Management Clinical Series and Review of the Literature. World Neurosurg. 2019;130:e988-e999.
- Lithgow K, Hamblin R, Pohl U, Karavitaki N. Craniopharyngiomas. En: Endotext [Internet]. South Dartmouth: MDText.com; 2000.
- Müller HL. Childhood craniopharyngioma. Pituitary. 2013;16(1):56-67.
- Müller HL. Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma. Front Endocrinol (Lausanne). 2026;17:1768254.
- Gött H, Nasi-Kordhishti I, Honegger J. Hypothalamus-sparing surgery in craniopharyngiomas: Oncological and hypothalamic long-term outcomes. Best Pract Res Clin Endocrinol Metab. 2025;39(5):102039.
- Bogusz A, Boekhoff S, Warmuth-Metz M, Calaminus G, Eveslage M, Müller HL. Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma. Endocr Connect. 2019;8(5):481-492.
- Beckhaus J, Friedrich C, Boekhoff S, Calaminus G, Bison B, Eveslage M, et al. Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage. Eur J Endocrinol. 2023;188(3).
- De Alcubierre D, Gkasdaris G, Mordrel M, Joncour A, Briet C, Almairac F, et al. BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study. Eur J Endocrinol. 2024;191(2):251-261.
- Calvanese F, Jacquesson T, Manet R, Vasiljevic A, Lasolle H, Ducray F, et al. Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm. Front Endocrinol (Lausanne). 2022;13:882381.
- Stec NE, Barker FG 2nd, Brastianos PK. Targeted treatment for craniopharyngioma. J Neurooncol. 2025;172(3):503-513.
- Jannelli G, Calvanese F, Paun L, Raverot G, Jouanneau E. Current Advances in Papillary Craniopharyngioma: State-Of-The-Art Therapies and Overview of the Literature. Brain Sci. 2023;13(3).
- Gritsch S, Brastianos PK. Pathogenesis of Craniopharyngiomas and Targeted Approaches to Therapy. Endocrinol Metab Clin North Am. 2025;54(4):703-714.
- Xu SS, Wang LM, Zhao LH, He ZL, Gong LP, Lu DH, et al. [Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma]. Zhonghua Bing Li Xue Za Zhi. 2019;48(9):682-687.
- Xu C, Ge S, Cheng J, Gao H, Zhang F, Han A. Pathological and Prognostic Characterization of Craniopharyngioma Based on the Expression of TrkA, β-Catenin, Cell Cycle Markers, and BRAF V600E Mutation. Front Endocrinol (Lausanne). 2022;13:859381.
- Piloni M, Gagliardi F, Bailo M, Losa M, Boari N, Spina A, et al. Craniopharyngioma in Pediatrics and Adults. Adv Exp Med Biol. 2023;1405:299-329.
- de Vries L, Lazar L, Phillip M. Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab. 2003;16(5):703-10.
- Müller HL. Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients. Minerva Endocrinol. 2017;42(4):356-375.
- Mediero S, Noval S, Bravo-Ljubetic L, Contreras I, Carceller F. Visual Outcomes, Visual Fields, and Optical Coherence Tomography in Paediatric Craniopharyngioma. Neuroophthalmology. 2015;39(3):132-139.
- Bialer OY, Goldenberg-Cohen N, Toledano H, Snir M, Michowiz S. Retinal NFL thinning on OCT correlates with visual field loss in pediatric craniopharyngioma. Can J Ophthalmol. 2013;48(6):494-9.
- Pang JC, Chung DD, Wang J, Abiri A, Lien BV, Himstead AS, et al. Characteristics and Outcomes in Pediatric Versus Adult Craniopharyngiomas: A Systematic Review and Meta-Analysis. Neurosurgery. 2023;92(6):1112-1129.
- Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf). 2005;62(4):397-409.
- Alboqami MN, Khalid S Albaiahy A, Bukhari BH, Alkhaibary A, Alharbi A, Khairy S, et al. Craniopharyngioma: A comprehensive review of the clinical presentation, radiological findings, management, and future Perspective. Heliyon. 2024;10(11):e32112.
- Elarjani T, Alhuthayl MR, Dababo M, Kanaan IN. Rathke cleft cyst apoplexy: Hormonal and clinical presentation. Surg Neurol Int. 2021;12:504.
- Aydin S, Darko K, Detchou D, Barrie U. Rathke’s cleft cysts: from pathophysiology to management. Neurosurg Rev. 2024;47(1):522.
- Zada G. Rathke cleft cysts: a review of clinical and surgical management. Neurosurg Focus. 2011;31(1):E1.
- Sade B, Albrecht S, Assimakopoulos P, Vézina JL, Mohr G. Management of Rathke’s cleft cysts. Surg Neurol. 2005;63(5):459-66; discussion 466.
- Ratha V, Patil S, Karmarkar VS, Shah NJ, Deopujari CE. Surgical Management of Rathke Cleft Cysts. World Neurosurg. 2017;107:276-284.
- Mendelson ZS, Husain Q, Elmoursi S, Svider PF, Eloy JA, Liu JK. Rathke’s cleft cyst recurrence after transsphenoidal surgery: a meta-analysis of 1151 cases. J Clin Neurosci. 2014;21(3):378-85.
- Zheng Y, Foo JQX, Xu X, Nga VDW. Surgical management of symptomatic recurrent Rathke’s cleft cysts: A systematic review and individual-participant data meta-analysis. J Clin Neurosci. 2024;130:110917.
- Benveniste RJ, King WA, Walsh J, Lee JS, Naidich TP, Post KD. Surgery for Rathke cleft cysts: technical considerations and outcomes. J Neurosurg. 2004;101(4):577-84.
- Shepard MJ, Elzoghby MA, Kiehna EN, Payne SC, Jane JA. Presentation and outcomes in surgically and conservatively managed pediatric Rathke cleft cysts. J Neurosurg Pediatr. 2018;21(3):308-314.
- Brandel MG, Lin C, Rennert RC, Plonsker JH, Khan UA, Crawford JR, et al. Surgical management of Rathke cleft cysts in pediatric patients: a single institution experience. Childs Nerv Syst. 2024;40(5):1367-1375.
- Schmutzer-Sondergeld M, Weller J, Thorsteinsdottir J, Schichor C, Rachinger W, Thon N, et al. Long-term outcome of surgically treated and conservatively managed Rathke cleft cysts. Acta Neurochir (Wien). 2024;166(1):159.
- Kelly KA, Sherburn MM, Sellyn GE, Ahluwalia R, Foster J, Shannon CN, et al. Management of Suprasellar Arachnoid Cysts in Children: A Systematic Literature Review Highlighting Modern Endoscopic Approaches. World Neurosurg. 2020;141:e316-e323.
- Ozek MM, Urgun K. Neuroendoscopic management of suprasellar arachnoid cysts. World Neurosurg. 2013;79(2 Suppl):S19.e13-8.
- Ahmed AK, Cohen AR. Intracranial arachnoid cysts. Childs Nerv Syst. 2023;39(10):2771-2778.
- Uzuner A, Yilmaz E, Gokbel A, Emengen A, Ozturk SD, Ergen A, et al. Endoscopic endonasal management of sellar/suprasellar arachnoid cysts: tailored surgical strategies and systematic review. J Clin Neurosci. 2026;151:112110.
- Cao H, Guo G, Wu W, Cheng Z. Classification of the relationship between suprasellar arachnoid cyst and hydrocephalus based on treatment modalities: shunting versus neuroendoscopic approaches. Childs Nerv Syst. 2024;40(9):2893-2903.
- Müller HL. Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary. 2017;20(2):267-281.
- O’steen L, Indelicato DJ. Advances in the management of craniopharyngioma. F1000Res. 2018;7.
- Shinojima N, Yano S, Uchida D, Mizukami N, Mabe H, Kawashima J, et al. Long-term outcomes of multidisciplinary treatment combining surgery and stereotactic radiotherapy with Novalis for craniopharyngioma. J Clin Neurosci. 2024;120:138-146.
- Fukuhara N, Nishihara T, Sato K, Inoshita N, Tatsushima K, Yamaguchi-Okada M, et al. Long-term outcomes of neuroendoscopic cyst partial resection combined with stereotactic radiotherapy for craniopharyngioma. Acta Neurochir (Wien). 2024;166(1):218.
- Gorelyshev S, Savateev AN, Mazerkina N, Medvedeva O, Konovalov AN. Craniopharyngiomas: Surgery and Radiotherapy. Adv Tech Stand Neurosurg. 2022;45:97-137.
- Gülsuna B, Stevens B, Gülsuyu B, Wood E, Aksoy T, Horta ES, et al. Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review. J Neurooncol. 2025;176(1):58.
- Lin Y, Luo N, Zhang B, An W, Lin Z. Targeted Therapy for Recurrent and Refractory Papillary Craniopharyngioma: A Systematic Narrative Review. World Neurosurg. 2025;202:124414.
- Webb KL, Pruter WW, Hinkle ML, Walsh MT. Comparing Surgical Approaches for Craniopharyngioma Resection Among Adults and Children: A Meta-analysis and Systematic Review. World Neurosurg. 2023;175:e876-e896.
- Jensterle M, Jazbinsek S, Bosnjak R, Popovic M, Zaletel LZ, Vesnaver TV, et al. Advances in the management of craniopharyngioma in children and adults. Radiol Oncol. 2019;53(4):388-396.
- Karavitaki N. Management of craniopharyngiomas. J Endocrinol Invest. 2014;37(3):219-28.
- Chen C, Okera S, Davies PE, Selva D, Crompton JL. Craniopharyngioma: a review of long-term visual outcome. Clin Exp Ophthalmol. 2003;31(3):220-8.
- Qiao N, Li C, Xu J, Ma G, Kang J, Jin L, et al. Prognostic Utility of Optical Coherence Tomography for Visual Outcome After Extended Endoscopic Endonasal Surgery for Adult Craniopharyngiomas. Front Oncol. 2021;11:764582.
- Gil-Simoes R, Pascual JM, Casas AP, de Sola RG. Intrachiasmatic craniopharyngioma: Assessment of visual outcome with optical coherence tomography after complete surgical removal. Surg Neurol Int. 2019;10:7.
- Zhang QL, Wang JH, Sun LY, Wang JB, Ma Y, Zhang YQ. Optical Coherence Tomography Angiography Predicts Visual Outcomes for Craniopharyngioma in Children by Quantifying Choroidal Capillaries. Front Med (Lausanne). 2021;8:819662.
- Mimouni M, Stiebel-Kalish H, Serov I, Chodick G, Zbedat M, Gaton DD. Optical Coherence Tomography May Help Distinguish Glaucoma from Suprasellar Tumor-Associated Optic Disc. J Ophthalmol. 2019;2019:3564809.
- Hidalgo ET, Orillac C, Kvint S, McQuinn MW, Dastagirzada Y, Phillips S, et al. Quality of life, hypothalamic obesity, and sexual function in adulthood two decades after primary gross-total resection for childhood craniopharyngioma. Childs Nerv Syst. 2020;36(2):281-289.
- Douglas VP, Douglas KAA, Cestari DM. Optic nerve sheath meningioma. Curr Opin Ophthalmol. 2020;31(6):455-461.
- Vaishnav YJ, Singh R, Didwania P, Lehrer EJ, Bakaeva T, Harris TJ, et al. Radiotherapy and Radiosurgery in the Management of Optic Nerve Sheath Meningiomas: An International Systematic Review and Meta-Analysis of Twenty Studies. World Neurosurg. 2022;164:e929-e944.
- Hajikarimloo B, Tos SM, Mohammadzadeh I, Shahabi K, Amjadzadeh M, Golkar Z, et al. Stereotactic radiosurgery for optic nerve sheath meningiomas: A comprehensive systematic review and meta-analysis. J Clin Neurosci. 2025;139:111432.
- Koç İ, Yüce Sarı S, Yazıcı G, Kapucu Y, Kıratlı H, Zorlu F. Role of hypofractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Neurooncol Pract. 2024;11(2):150-156.
- Wei Z, Taori S, Song S, Deng H, Niranjan A, Lunsford LD. Does Adjuvant Gamma Knife Stereotactic Radiosurgery Have a Role in Treating Optic Nerve Sheath Meningiomas?. J Neuroophthalmol. 2024;44(2):195-200.
- Goodyear K, Roelofs KA, Chen AC, Goldberg RA. Visual Outcomes Following Surgical Debulking in Exophytic Optic Nerve Sheath Meningiomas. Ophthalmic Plast Reconstr Surg. 2024;40(2):150-155.
- Paredes I, Alén JAF, García A, García E, Lagares A. Optic nerve sheath meningioma endoscopic endonasal surgical management. Surg Neurol Int. 2020;11:90.
- Lando L, Munoz DG, Dangboon W, Krema H, Altomare F. Optic Nerve Sheath Meningioma Presenting as a Slow-Growing Intraocular Mass. J Neuroophthalmol. 2024;44(1):e101-e102.
- Furdová A, Babál P, Kobzová D. Optic nerve orbital meningioma. Cesk Slov Oftalmol. 2018;74(1):23-30.
- Hurley DJ, Whitlow S, O’Rourke D, Flitcroft I. Bilateral paediatric optic nerve sheath meningioma. BMJ Case Rep. 2022;15(8).
- Tonagel F, Wilhelm H, Kelbsch C, Richter P. Characteristics of peripapillary retinal nerve fiber layer atrophy in glaucoma, optic nerve sheath meningioma, and sphenoid wing meningioma. Graefes Arch Clin Exp Ophthalmol. 2022;260(2):577-581.
- von Wowern F. The Foster Kennedy syndrome an evaluation of its diagnostic value. Acta Neurol Scand. 1967;43(2):205-14.
- Jarus GD, Feldon SE. Clinical and computed tomographic findings in the Foster Kennedy syndrome. Am J Ophthalmol. 1982;93(3):317-22.
- Musa MJ, Zeppieri M. Foster Kennedy syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Pinzon RT, Afifudin M, Digdoyo A, Naibaho FKC, Parikesit PG, Allendio YS. Foster Kennedy Syndrome from Frontal Lobe Meningioma: A Rare Case Report. Rom J Ophthalmol. 2025;69(2):271-274.
- Lotfipour S, Chiles K, Kahn JA, Bey T, Rudkin S. An unusual presentation of subfrontal meningioma: a case report and literature review for Foster Kennedy syndrome. Intern Emerg Med. 2011;6(3):267-9.
- Fukuyama J, Hayasaka S, Setogawa T, Ando S, Moritake K. Foster Kennedy syndrome and optociliary shunt vessels in a patient with an olfactory groove meningioma. Ophthalmologica. 1991;202(3):125-31.
- Ramdasi R, Thorve S, Vekariya M, Karnavat C. Reverse Foster Kennedy Syndrome Caused by an Intra-axial Tumor. Neurol India. 2022;70(4):1655-1657.
- Magill ST, Schwartz TH, Couldwell WT, Gardner PA, Heilman CB, Sen C, et al. International Tuberculum Sellae Meningioma Study: Surgical Outcomes and Management Trends. Neurosurgery. 2023;93(6):1259-1270.
- Clark AJ, Jahangiri A, Garcia RM, George JR, Sughrue ME, McDermott MW, et al. Endoscopic surgery for tuberculum sellae meningiomas: a systematic review and meta-analysis. Neurosurg Rev. 2013;36(3):349-59.
- Turel MK, Tsermoulas G, Yassin-Kassab A, Reddy D, Andrade-Barazarte H, Gonen L, et al. Tuberculum sellae meningiomas: a systematic review of transcranial approaches in the endoscopic era. J Neurosurg Sci. 2019;63(2):200-215.
- Mo J, Hasegawa H, Shin M, Shinya Y, Arisawa K, Umekawa M, et al. Endoscopic Endonasal Approach Is Superior to Transcranial Approach for Small to Medium Tuberculum Sellae Meningiomas in Terms of Visual Outcome and Complications: A Retrospective Study in a Single Center. World Neurosurg. 2024;189:e814-e824.
- Kong DS, Hong CK, Hong SD, Nam DH, Lee JI, Seol HJ, et al. Selection of endoscopic or transcranial surgery for tuberculum sellae meningiomas according to specific anatomical features: a retrospective multicenter analysis (KOSEN-002). J Neurosurg. 2019;130(3):838-847.
- Wang Q, Lu XJ, Ji WY, Yan ZC, Xu J, Ding YS, et al. Visual outcome after extended endoscopic endonasal transsphenoidal surgery for tuberculum sellae meningiomas. World Neurosurg. 2010;73(6):694-700.
- Lee CC, Chang TW, Wang YC, Lin YJ, Huang YC, Hsu PW, et al. Visual outcomes following endoscopic endonasal approach for tuberculum sellae meningiomas a systematic review and meta-analysis. Int J Surg. 2026;112(4):10560-71.
- Sankhla SK, Jayashankar N, Khan MA, Khan GM. Surgical Management of Tuberculum Sellae Meningioma: Our Experience and Review of the Literature. Neurol India. 2021;69(6):1592-1600.
- Marx S, Clemens S, Schroeder HWS. The value of endoscope assistance during transcranial surgery for tuberculum sellae meningiomas. J Neurosurg. 2018;128(1):32-39.
- Silvestri M, Signorelli F, Rapisarda A, D’Onofrio GF, Visocchi M. Tuberculum Sellae Meningioma: Report of Two Cases and Literature Review of Limits of the Transcranial and Endonasal Endoscopic Approaches. Acta Neurochir Suppl. 2023;135:75-79.
- Milano MT, Grimm J, Soltys SG, Yorke E, Moiseenko V, Tomé WA, et al. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways. Int J Radiat Oncol Biol Phys. 2021;110(1):87-99.
- Kaisman-Elbaz T, Blumenfeld P, Wygoda M, Feldman J, Shoshan Y. Recovery of cranial nerve neuropathies after LINAC-based stereotactic radiosurgery for benign cavernous sinus meningioma. J Neurooncol. 2024;170(1):119-128.
- Nakasu S, Nakasu Y. Natural History of Meningiomas: Review with Meta-analyses. Neurol Med Chir (Tokyo). 2020;60(3):109-120.
- Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT. Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg. 2010;113(5):1036-42.
- Olivero WC, Lister JR, Elwood PW. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg. 1995;83(2):222-4.
- Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery. 2003;53(1):62-70; discussion 70-1.
- Kim KH, Kang SJ, Choi JW, Kong DS, Seol HJ, Nam DH, et al. Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention. J Neurosurg. 2019;130(5):1740-1749.
- Nowak A, Dziedzic T, Czernicki T, Kunert P, Marchel A. Clinical course and management of intracranial meningiomas in neurofibromatosis type 2 patients. Neurol Neurochir Pol. 2015;49(6):367-72.
- Landau K, Horton JC, Hoyt WF, Wilson CB. Aneurysm mimicking intracranial growth of optic nerve sheath meningioma. J Clin Neuroophthalmol. 1990;10(3):185-7.
- Agarwal H, Chugh C, Singh S, Singh P. Neurosurgical image: giant pituitary adenoma and multiple aneurysms. Br J Neurosurg. 2019;33(3):312-314.
- Kupersmith MJ, Siegel IM, Carr RE. Reduced contrast sensitivity in compressive lesions of the anterior visual pathway. Neurology. 1981;31(5):550-4.
- Hagihara N, Abe T, Yoshioka F, Watanabe M, Tabuchi K. Photophobia as the visual manifestation of chiasmal compression by unruptured anterior communicating artery aneurysm. Case report. Neurol Med Chir (Tokyo). 2009;49(4):159-61.
- Lee AG, Siebert KJ, Sanan A. Radiologic-clinical correlation. Junctional visual field loss. AJNR Am J Neuroradiol. 1997;18(6):1171-4.
- Huna-Baron R, Lesser RL, Warren FA, Muszynski CA, Kupersmith MJ. Infantile cerebral aneurysms with visual pathway compression. Pediatr Neurosurg. 1999;31(6):322-5.
- Patel S, Fargen KM, Peters K, Krall P, Samy H, Hoh BL. Return of visual function after bilateral visual loss following flow diversion embolization of a giant ophthalmic aneurysm due to both reduction in mass effect and reduction in aneurysm pulsation. BMJ Case Rep. 2014;2014.
- Feng TY, Han XF, Lang R, Wang F, Wu Q. Subtraction CT angiography for the detection of intracranial aneurysms: A meta-analysis. Exp Ther Med. 2016;11(5):1930-1936.
- White PM, Teasdale EM, Wardlaw JM, Easton V. Intracranial aneurysms: CT angiography and MR angiography for detection prospective blinded comparison in a large patient cohort. Radiology. 2001;219(3):739-49.
- Lim JH, Yoon DY, Kim ES, Jeon HJ, Lee JY, Seo YL, et al. CT Angiography, MR Angiography, and Their Combined Use for Detection of Unruptured Intracranial Aneurysms: Comparison with Digital Subtraction Angiography and 3-dimensional Rotational Angiography. Clin Neuroradiol. 2025;35(2):355-362.
- Goto M, Kunimatsu A, Shojima M, Mori H, Abe O, Aoki S, et al. Depiction of branch vessels arising from intracranial aneurysm sacs: Time-of-flight MR angiography versus CT angiography. Clin Neurol Neurosurg. 2014;126:177-84.
- Kamide T, Tabani H, Safaee MM, Burkhardt JK, Lawton MT. Microsurgical clipping of ophthalmic artery aneurysms: surgical results and visual outcomes with 208 aneurysms. J Neurosurg. 2018;129(6):1511-1521.
- Luzzi S, Del Maestro M, Galzio R. Microneurosurgery for Paraclinoid Aneurysms in the Context of Flow Diverters. Acta Neurochir Suppl. 2021;132:47-53.
- Silva MA, See AP, Khandelwal P, Mahapatra A, Frerichs KU, Du R, et al. Comparison of flow diversion with clipping and coiling for the treatment of paraclinoid aneurysms in 115 patients. J Neurosurg. 2019;130(5):1505-1512.
- Tanaka Y, Nagatsuka H, Miki Y, Tetsuo Y, Yabuzaki H, Nakayama S, et al. Two patients of visual disturbance and optic perineuritis after placement of a flow diverter. Radiol Case Rep. 2022;17(5):1487-1490.
- Higaki A, Namba K. Oculomotor Palsy after Flow Diverter Treatment for Paraclinoid Aneurysm: Case Report and Literature Review. J Neuroendovasc Ther. 2025;19(1).
- Etminan N, de Sousa DA, Tiseo C, Bourcier R, Desal H, Lindgren A, et al. European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms. Eur Stroke J. 2022;7(3):V.
- Thompson BG, Brown RD Jr, Amin-Hanjani S, Broderick JP, Cockroft KM, Connolly ES Jr, et al. Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46(8):2368-400.
- Tawk RG, Hasan TF, D’Souza CE, Peel JB, Freeman WD. Diagnosis and Treatment of Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage. Mayo Clin Proc. 2021;96(7):1970-2000.
- Malhotra A, Wu X, Gandhi D. Management of Unruptured Intracranial Aneurysms. Neuroimaging Clin N Am. 2021;31(2):139-146.
- Brooks H, Ortiz M, Siddiq F, Guthikonda B. Unruptured intracranial aneurysm size should not be the most important factor influencing management decisions: A systematic review of the literature and meta-analysis. J Clin Neurosci. 2026;144:111816.
- Gaberel T, Borha A, di Palma C, Emery E. Clipping Versus Coiling in the Management of Posterior Communicating Artery Aneurysms with Third Nerve Palsy: A Systematic Review and Meta-Analysis. World Neurosurg. 2016;87:498-506.e4.
- Tian LQ, Fu QX. Recovery of posterior communicating artery aneurysm induced oculomotor nerve palsy: a comparison between surgical clipping and endovascular embolization. BMC Neurol. 2020;20(1):351.
- Ko JH, Kim YJ. Oculomotor nerve palsy caused by posterior communicating artery aneurysm: evaluation of symptoms after endovascular treatment. Interv Neuroradiol. 2011;17(4):415-9.
- Bruce BB, Biousse V, Newman NJ. Third nerve palsies. Semin Neurol. 2007;27(3):257-68.
- Donaldson L, Mandell DM, Iizuka M, Margolin E. Third Nerve Palsy Secondary to Compression by Dolichoectatic Posterior Communicating Artery. Can J Neurol Sci. 2022;49(3):463-464.
- Regli L, de Tribolet N, Regli F, Bogousslavsky J. Chiasmal apoplexy: haemorrhage from a cavernous malformation in the optic chiasm. J Neurol Neurosurg Psychiatry. 1989;52(9):1095-9.
- Warner JE, Rizzo JF 3rd, Brown EW, Ogilvy CS. Recurrent chiasmal apoplexy due to cavernous malformation. J Neuroophthalmol. 1996;16(2):99-106.
- Liu JK, Lu Y, Raslan AM, Gultekin SH, Delashaw JB Jr. Cavernous malformations of the optic pathway and hypothalamus: analysis of 65 cases in the literature. Neurosurg Focus. 2010;29(3):E17.
- Muta D, Nishi T, Koga K, Yamashiro S, Fujioka S, Kuratsu J. Cavernous malformation of the optic chiasm: case report. Br J Neurosurg. 2006;20(5):312-5.
- Venkataramana NK, Rao SA, Arun LN, Krishna C. Cavernous malformation of the optic chiasm: Neuro-endoscopic removal. Asian J Neurosurg. 2016;11(1):68-9.
- Fiorindi A, Gallinaro P, Marton E, Canova G, Fontanella MM, Longatti P. Opto-chiasmatic apoplexy as a compartment syndrome? Anatomical and surgical considerations on two bleeding cavernous malformations. Clin Neurol Neurosurg. 2021;201:106439.
- Newman H, Nevo M, Constantini S, Maimon S, Kesler A. Chiasmal cavernoma: a rare cause of acute visual loss improved by prompt surgery. Pediatr Neurosurg. 2008;44(5):414-7.
- Ruparelia J, Patidar R, Gosal JS, Garg M, Jha DK, Vishwajeet V, et al. Optochiasmatic Cavernomas: Updated systematic review and proposal of a novel classification with surgical approaches. Neurosurg Rev. 2024;47(1):53.
- Maistriau C, Duprez T, Hantson P. Terson’s syndrome in aneurysmal subarachnoid haemorrhage. Acta Neurol Belg. 2016;116(3):345-6.
- Al-Shalchy AK, Al-Wassiti AS. Intracranial Aneurysm Predisposing to Terson’s Syndrome: Insights From a Systematic Review. Cureus. 2025;17(5):e84828.
- Lee JY, Park JE, Shim WH, Jung SC, Choi CG, Kim SJ, et al. Joint approach based on clinical and imaging features to distinguish non-neoplastic from neoplastic pituitary stalk lesions. PLoS One. 2017;12(11):e0187989.
- Bıyıklı E, Aybal T, Aslan B, Ekinci G. Pituitary stalk thickening: can a multiparametric MRI approach improve etiologic prediction?. Pituitary. 2026;29(1):26.
- Jian F, Bian L, Sun S, Yang J, Chen X, Chen Y, et al. Surgical biopsies in patients with central diabetes insipidus and thickened pituitary stalks. Endocrine. 2014;47(1):325-35.
- Mizukoshi T, Fukuoka H, Takahashi Y. Immune checkpoint inhibitor-related hypophysitis. Best Pract Res Clin Endocrinol Metab. 2022;36(3):101668.
- Wright JJ, Powers AC, Johnson DB. Endocrine toxicities of immune checkpoint inhibitors. Nat Rev Endocrinol. 2021;17(7):389-399.
- Langlois F, Varlamov EV, Fleseriu M. Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease. J Clin Endocrinol Metab. 2022;107(1):10-28.
- Carmichael JD. Update on the diagnosis and management of hypophysitis. Curr Opin Endocrinol Diabetes Obes. 2012;19(4):314-21.
- Guaraldi F, Giordano R, Grottoli S, Ghizzoni L, Arvat E, Ghigo E. Pituitary Autoimmunity. Front Horm Res. 2017;48:48-68.
- Glezer A, Bronstein MD. Pituitary autoimmune disease: nuances in clinical presentation. Endocrine. 2012;42(1):74-9.
- Kyriacou A, Gnanalingham K, Kearney T. Lymphocytic hypophysitis: modern day management with limited role for surgery. Pituitary. 2017;20(2):241-250.
- Molitch ME, Gillam MP. Lymphocytic hypophysitis. Horm Res. 2007;68 Suppl 5:145-50.
- Ng WH, Gonzales M, Kaye AH. Lymphocytic hypophysitis. J Clin Neurosci. 2003;10(4):409-13.
- Rivera JA. Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy. Pituitary. 2006;9(1):35-45.
- Panigrahi M, Kumari M, Vooturi S. Corticosteroids in the management of lymphocytic hypophysitis: Case series. Neurol India. 2018;66(2):400-404.
- Tkatch J, Szuman G, Agüero M, Alfieri A, Ballarino MC, Bamberger E, et al. [Primary hypophysitis: diagnosis and treatment multicenter study]. Medicina (B Aires). 2023;83(5):744-752.
- Baruah MP, Singh A, Medhi N, Das CJ. Autoimmune Hypophysitis Presenting as Solid-Cystic Mass Managed Conservatively. Pol J Radiol. 2017;82:473-477.
- Amirbaigloo A, Esfahanian F, Mouodi M, Rakhshani N, Zeinalizadeh M. IgG4-related hypophysitis. Endocrine. 2021;73(2):270-291.
- Shikuma J, Kan K, Ito R, Hara K, Sakai H, Miwa T, et al. Critical review of IgG4-related hypophysitis. Pituitary. 2017;20(2):282-291.
- Bhargava R, Hussein Z, Dorward NL, Grieve JP, Jaunmuktane Z, Marcus HJ, et al. IgG4-related hypophysitis: a retrospective cohort study. Acta Neurochir (Wien). 2022;164(8):2095-2103.
- Kanie K, Bando H, Iguchi G, Shiomi H, Masuda A, Fukuoka H, et al. IgG4-related hypophysitis in patients with autoimmune pancreatitis. Pituitary. 2019;22(1):54-61.
- Allen ME, Beck RT, Zwagerman NT, Coss D, Fisco A, Ioachimescu AG. Isolated IgG4-related Infundibulo-hypophysitis. JCEM Case Rep. 2024;2(10):luae182.
- Arya VB, El-Gasim SA, Das S, Reisz Z, Zebian B, D’Cruz D, et al. IgG4-related hypophysitis in adolescence. J Pediatr Endocrinol Metab. 2021;34(3):395-399.
- Tahara S, Osamura RY, Hattori Y, Ishisaka E, Inomoto C, Sugihara H, et al. Concurrent IgG4-related hypophysitis and clinically nonfunctioning gonadotroph pituitary neuroendocrine tumor. BMC Endocr Disord. 2023;23(1):96.
- Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, et al. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. JAMA Oncol. 2018;4(2):173-182.
- Joshi MN, Whitelaw BC, Palomar MT, Wu Y, Carroll PV. Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clin Endocrinol (Oxf). 2016;85(3):331-9.
- Esteves-Ferreira S, Rosinha P. Immune checkpoint inhibitor-induced hypophysitis: clinical and biochemical features. J Cancer Res Clin Oncol. 2023;149(10):7925-7932.
- Chen P, Li J, Tan H. Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis. J Clin Med. 2023;12(10).
- Kotwal A. Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management. Curr Opin Endocrinol Diabetes Obes. 2021;28(4):427-434.
- Dudoignon D, Guégan S, Barat M. Immune checkpoint inhibitor-induced hypophysitis. Diagn Interv Imaging. 2021;102(11):697-698.
- SirDeshpande P, Hegde SBS, Akhtar H. Immune Checkpoint Inhibitor-Related Hypophysitis and Pituitary Dysfunction: A Systematic Review of Diagnosis and Management. Cureus. 2025;17(12):e98717.
- Pawate S. Sarcoidosis and the Nervous System. Continuum (Minneap Minn). 2020;26(3):695-715.
- Ach T, Ben Yahia W, Halloul I, Sghaier F, Atig A. Neurosarcoidosis-Induced Hypophysitis Mimicking Pituitary Macroadenoma. Cureus. 2023;15(6):e39865.
- Blazin T, Prajapati D, Mohammed LLM, Dhavale M, Abdelaal MK, Alam ABMN, et al. Hypothalamic-Pituitary Axis Dysfunction, Central Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion as the First Clinical Presentation of Neurosarcoidosis: Why Early Diagnosis and Treatment is Important?. Cureus. 2020;12(11):e11481.
- de Miguel Ibañez R, Espinosa Cárdenas PE, García Sáenz MR, Sandoval Bonilla BA. Panhypopituitarism in Neurosarcoidosis: Pituitary-Hypothalamic Involvement Successfully Managed With Rituximab. JCEM Case Rep. 2025;3(2):luaf014.
- Yavropoulou MP, Tsoli M, Kaltsas G. Neuroendocrine manifestations of Langerhans cell histiocytosis. Handb Clin Neurol. 2021;181:127-135.
- Brys ADH, Vermeersch S, Forsyth R, Velkeniers B, Bravenboer B. Central diabetes insipidus: beware of Langerhans cell histiocytosis!. Neth J Med. 2018;76(10):445-449.
- Kadowaki Y, Nishiyama M, Nakamura M, Morisaka H, Fujimoto S, Terada Y, et al. Adult-onset Langerhans cell histiocytosis changing CNS lesion from pituitary to suprasellar extension. Endocrinol Diabetes Metab Case Rep. 2022;2022.
- Kanakis M, Petrou P, Lourida G, Georgalas I. Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective. Surv Ophthalmol. 2022;67(2):388-410.
- Amer RR, Qubaiban SM, Bakhsh EA. Homonymous Superior Quadrantanopia due to Erdheim-Chester Disease with Asymptomatic Pituitary Involvement. Case Rep Neurol Med. 2017;2017:2807461.
- Brodkin CL, Wszolek ZK. Neurologic presentation of Erdheim-Chester disease. Neurol Neurochir Pol. 2006;40(5):397-403.
- Henry A, Nugent A, Wallace IR, Oladipo B, Sheehy O, Johnston PC. Pituitary metastasis: a clinical overview. Ulster Med J. 2021;90(3):146-150.
- Parthasarathy S, Lee DH, Levitt AH, Manavalan A. Pituitary Metastasis Presenting With Central Diabetes Insipidus and Panhypopituitarism. AACE Clin Case Rep. 2022;8(1):15-18.
- Hermet M, Delévaux I, Trouillier S, André M, Chazal J, Aumaître O. [Pituitary metastasis presenting as diabetes insipidus: a report of four cases and literature review]. Rev Med Interne. 2009;30(5):425-9.
- Carpinteri R, Patelli I, Casanueva FF, Giustina A. Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary. Best Pract Res Clin Endocrinol Metab. 2009;23(5):639-50.
- Deb AK, Neena A, Sarkar S, Devraj A, Panicker G, Stephen AM. Bilateral compressive optic neuropathy secondary to sphenoid sinus mucocele mimicking bilateral retrobulbar neuritis. Saudi J Ophthalmol. 2021;35(4):368-370.
- Chen K, Cao Y, Wu J, Xiang H, Huang XF, Chen B. Clinical Analysis of Sphenoid Sinus Mucocele With Initial Neurological Symptoms. Headache. 2019;59(8):1270-1278.
- Mowatt L, Foster T. Sphenoidal sinus mucocele presenting with acute visual loss in a scuba diver. BMJ Case Rep. 2013;2013.
- Yoo YJ, Kim GT, Park MJ. Sudden Unilateral Visual Loss Due to an Onodi Cell Mucocele. Ear Nose Throat J. 2025;104(2_suppl):463S-468S.
- Evanson J. Radiology of the pituitary. En: Endotext [Internet]. South Dartmouth: MDText.com; 2000.
- Gupta K, Ashraf M, Farahnak D, Rahmanipour E, Alamdar M, Rawson C, et al. Improved visual outcomes after endoscopic endonasal transsphenoidal surgery for pituitary macroadenomas: a single-arm meta-analysis. Acta Neurochir (Wien). 2026;168(1).
- Galal A, Ahmed OEF. Determinants of visual and endocrinological outcome after early endoscopic endonasal surgery for pituitary apoplexy. Surg Neurol Int. 2022;13:433.
- Moon CH, Hwang SC, Ohn YH, Park TK. The time course of visual field recovery and changes of retinal ganglion cells after optic chiasmal decompression. Invest Ophthalmol Vis Sci. 2011;52(11):7966-73.
- Namvar M, Iranmehr A, Fathi MR, Sadrhosseini SM, Tabari A, Shirzad N, et al. Complications in Endoscopic Endonasal Pituitary Adenoma Surgery: An Institution Experience in 310 Patients. J Neurol Surg B Skull Base. 2023;84(3):255-265.
- d’Avella E, Berardinelli J, Zoli M, Zenga F, Doglietto F, Stefini R, et al. Complications in endoscopic endonasal surgery for pituitary neuroendocrine tumors: an Italian multicenter study. J Neurosurg. 2026;145(1):68-78.
- Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Mota JI. Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas. J Neurosurg. 2015;123(1):31-8.
- Esquenazi Y, Essayed WI, Singh H, Mauer E, Ahmed M, Christos PJ, et al. Endoscopic Endonasal Versus Microscopic Transsphenoidal Surgery for Recurrent and/or Residual Pituitary Adenomas. World Neurosurg. 2017;101:186-195.
- Adams CB. The management of pituitary tumours and post-operative visual deterioration. Acta Neurochir (Wien). 1988;94(3-4):103-16.
- Pal A, Capatina C, Tenreiro AP, Guardiola PD, Byrne JV, Cudlip S, et al. Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences. Clin Endocrinol (Oxf). 2011;75(4):501-4.
- Hacioglu A, Karaca Z, Uysal S, Ozkaya HM, Kadioglu P, Selcukbiricik OS, et al. Evaluation and follow-up of patients diagnosed with hypophysitis: a cohort study. Eur J Endocrinol. 2024;191(3):312-322.
- Fouda MA, Day EL, Staffa SJ, Scott RM, Marcus KJ, Baird LC. Postoperative MR imaging surveillance of pediatric craniopharyngioma: new institutional guidelines. Childs Nerv Syst. 2021;37(3):853-861.
- Ioachimescu AG. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing’s Disease. Endocrinol Metab Clin North Am. 2018;47(2):335-347.
- De Nigris Vasconcellos F, Vilela MAD, Garcia Torrico F, Scalise MA, Vargas VPS, Mendieta CD, et al. Stereotactic radiosurgery for recurrent/residual nonfunctioning pituitary adenoma: a single-arm systematic review and meta-analysis. Acta Neurochir (Wien). 2024;166(1):392.
- Tatsumi Y, Kanamori A, Kusuhara A, Nakanishi Y, Kusuhara S, Nakamura M. Retinal nerve fiber layer thickness in optic tract syndrome. Jpn J Ophthalmol. 2005;49(4):294-6.
- Kedar S, Zhang X, Lynn MJ, Newman NJ, Biousse V. Congruency in homonymous hemianopia. Am J Ophthalmol. 2007;143(5):772-80.
- Cohen-Sinai N, Man-Peles I, Zahavi A, Luckman J, Goldenberg-Cohen N. Simplifying the diagnosis of optic tract lesions. Front Med (Lausanne). 2022;9:1029829.
- Romero RS, Gutierrez I, Wang E, Reder AT, Bhatti MT, Bernard JT, et al. Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica. J Neuroophthalmol. 2012;32(2):150-3.
- Sugiyama Y, Moriwaki H, Imakita S, Yamada N, Tanaka M, Naritomi H. [Incongruous homonymous quadrantanopia due to suprasellar calcificated lesions]. Rinsho Shinkeigaku. 2005;45(8):590-5.
- Luco C, Hoppe A, Schweitzer M, Vicuña X, Fantin A. Visual field defects in vascular lesions of the lateral geniculate body. J Neurol Neurosurg Psychiatry. 1992;55(1):12-5.
- Naguib MM, Woodland MB, Foroozan R. Characteristic Visual Field Defect From Lateral Geniculate Body Stroke. J Neuroophthalmol. 2021;41(4):e756-e758.
- Tokida H, Kanaya Y, Shimoe Y, Yamori S, Tagawa K, Kuriyama M. [Lateral geniculate body presenting only hemorrhage homonymous hemianopia-A case report]. Rinsho Shinkeigaku. 2016;56(11):781-784.
- Mulholland C, Best J, Rennie I, Mc Kenna E, Lacey B. Bilateral sectoranopia caused by bilateral geniculate body infarction in a 14-year-old boy with inflammatory bowel disease. J AAPOS. 2010;14(5):435-7.
- Grković D, Mihić N, Polzović A, Draganić V. [Characteristics of the human lateral geniculate nucleus vascular network]. Med Pregl. 1993;46(3-4):96-7.
- Milisavljević M, Marinković S, Marinković Z, Malobabić S. Anatomic basis for surgical approach to the distal segment of the posterior cerebral artery. Surg Radiol Anat. 1988;10(4):259-66.
- McLaurin EB, Harrington DO. Intracranial sarcoidosis with optic tract and temporal lobe involvement. Am J Ophthalmol. 1978;86(5):656-60.
- Dhanapalaratnam R, Markoulli M, Krishnan AV. Disorders of vision in multiple sclerosis. Clin Exp Optom. 2022;105(1):3-12.
- Jermakowicz WJ, Wu C, Neal E, Cajigas I, D’Haese PF, Donahue DJ, et al. Clinically Significant Visual Deficits after Laser Interstitial Thermal Therapy for Mesiotemporal Epilepsy. Stereotact Funct Neurosurg. 2019;97(5-6):347-355.
- Gutiérrez L, Arruga J, Sánchez JJ, Muñoz S, Puyalto-de-Pablo P. Axonal Injury in the Lateral Geniculate Body: Radiological Diagnosis. Neuroophthalmology. 2017;41(4):215-218.
- Li S, Zhang W, Yao S, He J, Gao J, Xue T, et al. Tractography-Based Automated Identification of Retinogeniculate Visual Pathway With Novel Microstructure-Informed Supervised Contrastive Learning. Hum Brain Mapp. 2024;45(17):e70071.
- Papadopoulou A, Pfister A, Tsagkas C, Gaetano L, Sellathurai S, D’Souza M, et al. Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus. Clin Neurophysiol. 2024;161:122-132.
- Miante S, Margoni M, Moretto M, Pengo M, Carmisciano L, Spolettini P, et al. Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2023;77:104877.
- Abed Rabbo F, Koch G, Lefèvre C, Seizeur R. Direct geniculo-extrastriate pathways: a review of the literature. Surg Radiol Anat. 2015;37(8):891-9.
- Zhang X, Kedar S, Lynn MJ, Newman NJ, Biousse V. Homonymous hemianopias: clinical-anatomic correlations in 904 cases. Neurology. 2006;66(6):906-10.
- Herlin B, Uszynski I, Chauvel M, Poupon C, Dupont S. Cross-subject variability of the optic radiation anatomy in a cohort of 1065 healthy subjects. Surg Radiol Anat. 2023;45(7):849-858.
- Barton JJ, Hefter R, Chang B, Schomer D, Drislane F. The field defects of anterior temporal lobectomy: a quantitative reassessment of Meyer’s loop. Brain. 2005;128(Pt 9):2123-33.
- Meesters S, Ossenblok P, Wagner L, Schijns O, Boon P, Florack L, et al. Stability metrics for optic radiation tractography: Towards damage prediction after resective surgery. J Neurosci Methods. 2017;288:34-44.
- Urbach H, Mast H, Egger K, Mader I. Presurgical MR Imaging in Epilepsy. Clin Neuroradiol. 2015;25 Suppl 2:151-5.
- Schurr R, Duan Y, Norcia AM, Ogawa S, Yeatman JD, Mezer AA. Tractography optimization using quantitative T1 mapping in the human optic radiation. Neuroimage. 2018;181:645-658.
- Sherbondy AJ, Dougherty RF, Napel S, Wandell BA. Identifying the human optic radiation using diffusion imaging and fiber tractography. J Vis. 2008;8(10):12.1-11.
- Yamamoto A, Miki Y, Urayama S, Fushimi Y, Okada T, Hanakawa T, et al. Diffusion tensor fiber tractography of the optic radiation: analysis with 6-, 12-, 40-, and 81-directional motion-probing gradients, a preliminary study. AJNR Am J Neuroradiol. 2007;28(1):92-6.
- Dayan M, Munoz M, Jentschke S, Chadwick MJ, Cooper JM, Riney K, et al. Optic radiation structure and anatomy in the normally developing brain determined using diffusion MRI and tractography. Brain Struct Funct. 2015;220(1):291-306.
- Gomez CR, Bhat MH, Chung HD. Homonymous quadrantic visual field defect resulting from vertebrobasilar insufficiency: report of a case. Angiology. 1990;41(2):151-5.
- Franco RM, d’Almeida OC, Raimundo M, Fonseca P, Matos S, Martins AI, et al. The Clinical Use of Retinotopy in Functional Hemianopia. Neuroophthalmology. 2026;50(1):72-76.
- Kurokawa T, Kobayashi R, Ueda N, Ohi T. Comparative study of retinal ganglion cell complex thinning by visual field patterns following post-geniculate lesions. Jpn J Ophthalmol. 2025;69(2):268-278.
- Lawlor M, Perry R, Hunt BJ, Plant GT. Strokes and vision: The management of ischemic arterial disease affecting the retina and occipital lobe. Surv Ophthalmol. 2015;60(4):296-309.
- McAuley DL, Russell RW. Correlation of CAT scan and visual field defects in vascular lesions of the posterior visual pathways. J Neurol Neurosurg Psychiatry. 1979;42(4):298-311.
- Khan B, Arif A, Elnagi F. Between the Borders: Balint Syndrome as a Rare Manifestation of Posterior Circulation Stroke. Cureus. 2025;17(11):e97550.
- Majoul MS, Ben Lakhal A, Ben Mohamed D, Nagi S, Ben Sassi S. Fetal posterior cerebral artery infarction due to carotid dissection: a case report. J Med Case Rep. 2025;19(1):608.
- Spengos K, Wohrle JC, Tsivgoulis G, Stouraitis G, Vemmos K, Zis V. Bilateral paramedian midbrain infarct: an uncommon variant of the “top of the basilar” syndrome. J Neurol Neurosurg Psychiatry. 2005;76(5):742-3.
- Holt LJ, Anderson SF. Bilateral occipital lobe stroke with inferior altitudinal defects. Optometry. 2000;71(11):690-702.
- Sarkar S, Tripathy K. Cortical blindness. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Das JM, Naqvi IA. Anton syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Atallah O, Badary A, Almealawy YF, Farooq M, Hammoud Z, Alrubaye SN, et al. Insights into Anton Syndrome: When the brain denies blindness. J Clin Neurosci. 2024;120:181-190.
- Gainotti G. History of Anosognosia. Front Neurol Neurosci. 2019;44:75-82.
- Ziaul YH, Mittal J, Afroze T, Kumar V. Anton-Babinski Syndrome: A Visual Anosognosia. Cureus. 2024;16(3):e55679.
- Pollard KC, Brown Bissonnette GA, Norberg SR. Bilateral cortical visual impairment resulting in Anton’s syndrome. Clin Exp Optom. 2020;103(6):927-928.
- Maddula M, Lutton S, Keegan B. Anton’s syndrome due to cerebrovascular disease: a case report. J Med Case Rep. 2009;3:9028.
- Chaudhry FB, Raza S, Ahmad U. Anton’s syndrome: a rare and unusual form of blindness. BMJ Case Rep. 2019;12(12).
- Galetović D, Karlica D, Bojić L, Znaor L. Bilateral cortical blindness—Anton syndrome: case report. Coll Antropol. 2005;29 Suppl 1:145-7.
- Lo Buono V, De Salvo S, Paladina G, Corallo F, Palmeri R, Morabito R, et al. Anton’s Syndrome associated with autotopagnosia. Appl Neuropsychol Adult. 2020;27(3):294-298.
- SUGAR HS, GOLDSTEIN AS. VISUAL ANOSOGNOSIA IN CORTICAL BLINDNESS; ANTON’S SYMPTOM. Am J Ophthalmol. 1965;60:335-7.
- Argenta PA, Morgan MA. Cortical blindness and Anton syndrome in a patient with obstetric hemorrhage. Obstet Gynecol. 1998;91(5 Pt 2):810-2.
- Kwong Yew K, Abdul Halim S, Liza-Sharmini AT, Tharakan J. Recurrent bilateral occipital infarct with cortical blindness and anton syndrome. Case Rep Ophthalmol Med. 2014;2014:795837.
- Ajina S, Bridge H. Subcortical pathways to extrastriate visual cortex underlie residual vision following bilateral damage to V1. Neuropsychologia. 2019;128:140-149.
- Ajina S, Bridge H. Blindsight and Unconscious Vision: What They Teach Us about the Human Visual System. Neuroscientist. 2016;23(5):529-541.
- Schmid D, Hesse C, Schenk T. The redundant target paradigm and its use as a blindsight-test: A meta-analytic study. Cortex. 2023;169:326-352.
- Schmid D, Hesse C, Schenk T. Blindsight and residual vision: How reliable is the redundant target effect as a diagnostic tool?. Cortex. 2026;201:228-247.
- Fendrich R, Wessinger CM, Gazzaniga MS. Residual vision in a scotoma: implications for blindsight. Science. 1992;258(5087):1489-91.
- Chokron S, Perez C, Peyrin C. Behavioral Consequences and Cortical Reorganization in Homonymous Hemianopia. Front Syst Neurosci. 2016;10:57.
- Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494-500.
- Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol. 1999;14(5):277-81.
- Karuppannasamy D, Vikrant K, Raghuram A, Kumaar TM. Cortical visual loss in posterior reversible encephalopathy syndrome in late postpartum eclampsia: case series. Indian J Ophthalmol. 2014;62(5):635-8.
- Bandyopadhyay S, Mondal KK, Das S, Gupta A, Biswas J, Bhattacharyya SK, et al. Reversible cortical blindness: posterior reversible encephalopathy syndrome. J Indian Med Assoc. 2010;108(11):778-80.
- Lysandropoulos AP, Rossetti AO. Postictal cortical visual impairment: a symptom of posterior reversible encephalopathy. Epilepsy Behav. 2010;17(2):276-7.
- Raffin E, Bevilacqua M, Windel F, Menoud P, Salamanca-Giron RF, Feroldi S, et al. Boosting hemianopia recovery: the power of interareal cross-frequency brain stimulation. Brain. 2025;148(12):4548-4561.
- Dutton GN. Cognitive vision, its disorders and differential diagnosis in adults and children: knowing where and what things are. Eye (Lond). 2003;17(3):289-304.
- Teoh LJ, Solebo AL, Rahi JS. Temporal trends in the epidemiology of childhood severe visual impairment and blindness in the UK. Br J Ophthalmol. 2023;107(5):717-724.
- Yahalom C, Braun R, Patal R, Saadeh I, Blumenfeld A, Macarov M, et al. Childhood visual impairment and blindness: 5-year data from a tertiary low vision center in Israel. Eye (Lond). 2022;36(10):2052-2056.
- Chong C, McGhee CNJ, Dai SH. Causes of childhood low vision and blindness in New Zealand. Clin Exp Ophthalmol. 2019;47(2):165-170.
- Pehere NK, Dutton GN. Perceptual visual dysfunction in children - An Indian perspective. Indian J Ophthalmol. 2021;69(8):2004-2011.
- Schenk-Rootlieb AJ, van Nieuwenhuizen O, van Waes PF, van der Graaf Y. Cerebral visual impairment in cerebral palsy: relation to structural abnormalities of the cerebrum. Neuropediatrics. 1994;25(2):68-72.
- Macintyre-Béon C, Young D, Dutton GN, Mitchell K, Simpson J, Loffler G, et al. Cerebral visual dysfunction in prematurely born children attending mainstream school. Doc Ophthalmol. 2013;127(2):89-102.
- Williams C, Pease A, Warnes P, Harrison S, Pilon F, Hyvarinen L, et al. Cerebral visual impairment-related vision problems in primary school children: a cross-sectional survey. Dev Med Child Neurol. 2021;63(6):683-689.
- Dutton GN, Saaed A, Fahad B, Fraser R, McDaid G, McDade J, et al. Association of binocular lower visual field impairment, impaired simultaneous perception, disordered visually guided motion and inaccurate saccades in children with cerebral visual dysfunction-a retrospective observational study. Eye (Lond). 2004;18(1):27-34.
- Armstrong RA. Visual problems associated with traumatic brain injury. Clin Exp Optom. 2018;101(6):716-726.
- McKenna K, Cooke DM, Fleming J, Jefferson A, Ogden S. The incidence of visual perceptual impairment in patients with severe traumatic brain injury. Brain Inj. 2006;20(5):507-18.
- Kurylo DD, Waxman R, Kezin O. Spatial-temporal characteristics of perceptual organization following acquired brain injury. Brain Inj. 2006;20(3):237-44.
- Dubé C, Jin Y, Powers BG, Li G, Labelle A, Rivers MS, et al. Vision Evaluation Tools for Adults With Acquired Brain Injury: A Scoping Review. Can J Occup Ther. 2021;88(4):340-351.
- Yoo PY, Scott K, Myszak F, Mamann S, Labelle A, Holmes M, et al. Interventions Addressing Vision, Visual-perceptual Impairments Following Acquired Brain Injury: A Cross-sectional Survey. Can J Occup Ther. 2020;87(2):117-126.
- Moon JH, Kim GH, Kim SK, Kim S, Kim YH, Kim J, et al. Development of the Parental Questionnaire for Cerebral Visual Impairment in Children Younger than 72 Months. J Clin Neurol. 2021;17(3):354-362.
- Philip SS, Tsherlinga S, Thomas MM, Dutton GN, Bowman R. A Validation of an Examination Protocol for Cerebral Visual Impairment Among Children in a Clinical Population in India. J Clin Diagn Res. 2016;10(12):NC01-NC04.
- Vancleef K, Janssens E, Petré Y, Wagemans J, Ortibus E. Assessment tool for visual perception deficits in cerebral visual impairment: reliability and validity. Dev Med Child Neurol. 2020;62(1):118-124.
- Bauer CM, Merabet LB. Aberrant White Matter Development in Cerebral Visual Impairment: A Proposed Mechanism for Visual Dysfunction Following Early Brain Injury. J Integr Neurosci. 2024;23(1):1.
- Pilling RF. Make it easier: 3-word strategies to help children with cerebral visual impairment use their vision more effectively. Eye (Lond). 2023;37(2):285-289.
- Vervloed MP, Janssen N, Knoors H. Visual rehabilitation of children with visual impairments. J Dev Behav Pediatr. 2006;27(6):493-506.
- Oliver H, Seccurro D, Dorich J, Rice M, Schwartz T, Harpster K. “Even though a lot of kids have it, not a lot of people have knowledge of it”: A qualitative study exploring the perspectives of parents of children with cerebral/cortical visual impairment. Res Dev Disabil. 2023;135:104443.
- Berger S, Kaldenberg J, Selmane R, Carlo S. Effectiveness of Interventions to Address Visual and Visual-Perceptual Impairments to Improve Occupational Performance in Adults With Traumatic Brain Injury: A Systematic Review. Am J Occup Ther. 2016;70(3):7003180010p1-7.
- Riggs RV, Andrews K, Roberts P, Gilewski M. Visual deficit interventions in adult stroke and brain injury: a systematic review. Am J Phys Med Rehabil. 2007;86(10):853-60.
- Warren M. A hierarchical model for evaluation and treatment of visual perceptual dysfunction in adult acquired brain injury, Part 1. Am J Occup Ther. 1993;47(1):42-54.
- Warren M. A hierarchical model for evaluation and treatment of visual perceptual dysfunction in adult acquired brain injury, Part 2. Am J Occup Ther. 1993;47(1):55-66.
- Philip SS. Setting up of a cerebral visual impairment clinic for children: Challenges and future developments. Indian J Ophthalmol. 2017;65(1):30-34.
- Charles A. The Migraine Aura. Continuum (Minneap Minn). 2018;24(4, Headache):1009-1022.
- Sanchez Del Rio M, Cutrer FM. Pathophysiology of migraine aura. Handb Clin Neurol. 2023;198:71-83.
- Cutrer FM, Huerter K. Migraine aura. Neurologist. 2007;13(3):118-25.
- Bidot S, Biotti D. [Migraine with visual aura]. J Fr Ophtalmol. 2016;39(6):554-9.
- Moskowitz MA. Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches. Cephalalgia. 2025;45(9):3331024251370629.
- Shankar Kikkeri N, Nagalli S. Migraine with aura. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Lim J, Jo KD, Lee MK, Jang W. Persistent negative visual aura in migraine without headache: a case report. J Med Case Rep. 2014;8:61.
- Severino M, Green MW. Persistent aura without infarction. Curr Opin Neurol. 2025;38(3):249-253.
- Thissen S, Vos IG, Schreuder TH, Schreurs WM, Postma LA, Koehler PJ. Persistent migraine aura: new cases, a literature review, and ideas about pathophysiology. Headache. 2014;54(8):1290-309.
- Nair BS, Sudheer V, Maramattom BV. Arterial Spin Labelling Perfusion Changes in Persistent Migrainous Aura Without Infarction. Cureus. 2025;17(7):e88129.
- Nandyala A, Shah T, Ailani J. Hemiplegic Migraine. Curr Neurol Neurosci Rep. 2023;23(7):381-387.
- Chiang CC, Chen SP. Migrainous infarction. Handb Clin Neurol. 2024;199:465-474.
- Hill DL, Daroff RB, Ducros A, Newman NJ, Biousse V. Most cases labeled as “retinal migraine” are not migraine. J Neuroophthalmol. 2007;27(1):3-8.
- Grosberg BM, Veronesi M. Retinal migraine. Handb Clin Neurol. 2024;199:381-387.
- Chong YJ, Mollan SP, Logeswaran A, Sinclair AB, Wakerley BR. Current Perspective on Retinal Migraine. Vision (Basel). 2021;5(3).
- Agudelo Quintero E, Vasquez Builes S, Castaño Parra A. Retinal Migraine: A Case Report with Brief Literature Review and Illustrative Findings. Neuroophthalmology. 2026;50(4):387-392.
- Traber GL, Piccirelli M, Michels L. Visual snow syndrome: a review on diagnosis, pathophysiology, and treatment. Curr Opin Neurol. 2020;33(1):74-78.
- Silva EM, Puledda F. Visual snow syndrome and migraine: a review. Eye (Lond). 2023;37(12):2374-2378.
- Barrachina-Esteve O, Hidalgo-Torrico I, Acero C, Aranceta S, Cánovas-Vergé D, Ribera G. Visual snow syndrome and its relationship with migraine. Neurologia (Engl Ed). 2024;39(2):190-195.
- Yoo YJ, Yang HK, Choi JY, Kim JS, Hwang JM. Neuro-ophthalmologic Findings in Visual Snow Syndrome. J Clin Neurol. 2020;16(4):646-652.
- Graber M, Scutelnic A, Klein A, Puledda F, Goadsby PJ, Schankin CJ. Natural course of visual snow syndrome: a long-term follow-up study. Brain Commun. 2022;4(5):fcac230.
- Ciuffreda KJ, Han ME, Tannen B, Rutner D. Visual snow syndrome: evolving neuro-optometric considerations in concussion/mild traumatic brain injury. Concussion. 2021;6(2):CNC89.
- Usui N, Mihara T, Baba K, Matsuda K, Tottori T, Umeoka S, et al. Versive seizures in occipital lobe epilepsy: lateralizing value and pathophysiology. Epilepsy Res. 2011;97(1-2):157-61.
- Adcock JE, Panayiotopoulos CP. Occipital lobe seizures and epilepsies. J Clin Neurophysiol. 2012;29(5):397-407.
- Williamson PD, Thadani VM, Darcey TM, Spencer DD, Spencer SS, Mattson RH. Occipital lobe epilepsy: clinical characteristics, seizure spread patterns, and results of surgery. Ann Neurol. 1992;31(1):3-13.
- Sveinbjornsdottir S, Duncan JS. Parietal and occipital lobe epilepsy: a review. Epilepsia. 1993;34(3):493-521.
- Angus-Leppan H, Clay TA. Adult occipital lobe epilepsy: 12-years on. J Neurol. 2021;268(10):3926-3934.
- Akyuz E, Arulsamy A, Hasanli S, Yilmaz EB, Shaikh MF. Elucidating the visual phenomena in epilepsy: A mini review. Epilepsy Res. 2023;190:107093.
- Yalçın AD, Ertaşoğlu Toydemir H. Panayiotopoulos Syndrome with a special emphasis of ictal semiologic features. Epilepsy Res. 2017;131:37-43.
- Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain. 2008;131(Pt 9):2264-86.
- Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: differentiation from migraine. J Neurol Neurosurg Psychiatry. 1999;66(4):536-40.
- Panayiotopoulos CP. Visual phenomena and headache in occipital epilepsy: a review, a systematic study and differentiation from migraine. Epileptic Disord. 1999;1(4):205-16.
- Caraballo R, Koutroumanidis M, Panayiotopoulos CP, Fejerman N. Idiopathic childhood occipital epilepsy of Gastaut: a review and differentiation from migraine and other epilepsies. J Child Neurol. 2009;24(12):1536-42.
- Andermann F, Zifkin B. The benign occipital epilepsies of childhood: an overview of the idiopathic syndromes and of the relationship to migraine. Epilepsia. 1998;39 Suppl 4:S9-23.
- D’Agnano D, Lo Cascio S, Correnti E, Raieli V, Sciruicchio V. A Narrative Review of Visual Hallucinations in Migraine and Epilepsy: Similarities and Differences in Children and Adolescents. Brain Sci. 2023;13(4).
- Wang CP, Hsieh PF, Chen CC, Lin WY, Hu WH, Yang DY, et al. Hyperglycemia with occipital seizures: images and visual evoked potentials. Epilepsia. 2005;46(7):1140-4.
- Montassir H, Maegaki Y, Ohno K, Ogura K. Long term prognosis of symptomatic occipital lobe epilepsy secondary to neonatal hypoglycemia. Epilepsy Res. 2010;88(2-3):93-9.
- Panayiotopoulos CP, Sharoqi IA, Agathonikou A. Occipital seizures imitating migraine aura. J R Soc Med. 1997;90(5):255-7.
- Cianchetti C, Pruna D, Ledda M. Epileptic seizures and headache/migraine: a review of types of association and terminology. Seizure. 2013;22(9):679-85.
- Gilliam F, Wyllie E. Ictal amaurosis: MRI, EEG, and clinical features. Neurology. 1995;45(8):1619-21.
- Bauer J, Schüler P, Feistel H, Hilz MJ, Stefan H. Blindness as an ictal phenomenon: investigations with EEG and SPECT in two patients suffering from epilepsy. J Neurol. 1991;238(1):44-6.
- Ghosh P, Motamedi G, Osborne B, Mora CA. Reversible blindness: simple partial seizures presenting as ictal and postictal hemianopsia. J Neuroophthalmol. 2010;30(3):272-5.
- Badran A, Bartolini L, Ksendzovsky A, Ray-Chaudhury A, Abdennadher M, Zaghloul KA, et al. Transient postictal blindness after a focal posterior cingulate gyrus seizure. Seizure. 2018;54:58-60.
- Shahar E, Barak S. Favorable outcome of epileptic blindness in children. J Child Neurol. 2003;18(1):12-6.
- Muro VL, Yip S, Huh L, Connolly MB. Status epilepticus amauroticus and posterior reversible encephalopathy syndrome in children. J Clin Neurophysiol. 2013;30(4):344-7.
- Joseph JM, Louis S. Transient ictal cortical blindness during middle age. A case report and review of the literature. J Neuroophthalmol. 1995;15(1):39-42.
- Kim TE, Kim HJ, Park JH, Lee TK, Lee JD, Park SA. Cognitive dysfunction with complex visual hallucinations due to focal nonconvulsive status epilepticus: a neuropsychological study and SISCOM. Seizure. 2012;21(8):658-60.
- Tsai MH, Hsu SP, Huang CR, Chang CS, Chuang YC. Transient attenuation of visual evoked potentials during focal status epilepticus in a patient with occipital lobe epilepsy. Acta Neurol Taiwan. 2010;19(2):131-6.
- Lawson J, Triner W, Kluge B. Occipital Lobe Status Epilepticus, A Stroke Mimic with Novel Imaging Findings: A Case Report. Clin Pract Cases Emerg Med. 2022;6(3):212-215.
- de Haan GA, Heutink J, Melis-Dankers BJ, Brouwer WH, Tucha O. Difficulties in Daily Life Reported by Patients With Homonymous Visual Field Defects. J Neuroophthalmol. 2015;35(3):259-64.
- Gall C, Wagenbreth C, Sgorzaly S, Franke GH, Sabel BA. Parafoveal vision impairments and their influence on reading performance and self-evaluated reading abilities. Graefes Arch Clin Exp Ophthalmol. 2010;248(6):863-75.
- Yan MK, Kumar H, Kerr N, Medeiros FA, Sandhu SS, Crowston J, et al. Transnational review of visual standards for driving: How Australia compares with the rest of the world. Clin Exp Ophthalmol. 2019;47(7):847-863.
- Wood JM, Black AA, Dingle K, Rutter C, DiStefano M, Koppel S, et al. Impact of vision disorders and vision impairment on motor vehicle crash risk and on-road driving performance: A systematic review. Acta Ophthalmol. 2022;100(2):e339-e367.
- Nguyen H, Di Tanna GL, Coxon K, Brown J, Ren K, Ramke J, et al. Associations between vision impairment and vision-related interventions on crash risk and driving cessation: systematic review and meta-analysis. BMJ Open. 2023;13(8):e065210.
- Manners S, Meuleners LB, Ng JQ, Wood J, Morgan W, Morlet N. Binocular Visual Field Loss and Crash Risk: An eFOVID Population-Based Study. Ophthalmic Epidemiol. 2025;32(5):502-509.
- Bowers AR. Driving with homonymous visual field loss: a review of the literature. Clin Exp Optom. 2016;99(5):402-18.
- Ungewiss J, Kübler T, Sippel K, Aehling K, Heister M, Rosenstiel W, et al. Agreement of driving simulator and on-road driving performance in patients with binocular visual field loss. Graefes Arch Clin Exp Ophthalmol. 2018;256(12):2429-2435.
- Desapriya E, Harjee R, Brubacher J, Chan H, Hewapathirane DS, Subzwari S, et al. Vision screening of older drivers for preventing road traffic injuries and fatalities. Cochrane Database Syst Rev. 2014;2014(2):CD006252.
- Bowers AR, Mandel AJ, Goldstein RB, Peli E. Driving with hemianopia, I: Detection performance in a driving simulator. Invest Ophthalmol Vis Sci. 2009;50(11):5137-47.
- Alberti CF, Peli E, Bowers AR. Driving with hemianopia: III. Detection of stationary and approaching pedestrians in a simulator. Invest Ophthalmol Vis Sci. 2014;55(1):368-74.
- Bowers AR, Ananyev E, Mandel AJ, Goldstein RB, Peli E. Driving with hemianopia: IV. Head scanning and detection at intersections in a simulator. Invest Ophthalmol Vis Sci. 2014;55(3):1540-8.
- Bahnemann M, Hamel J, De Beukelaer S, Ohl S, Kehrer S, Audebert H, et al. Compensatory eye and head movements of patients with homonymous hemianopia in the naturalistic setting of a driving simulation. J Neurol. 2015;262(2):316-25.
- Hamel J, Kraft A, Ohl S, De Beukelaer S, Audebert HJ, Brandt SA. Driving simulation in the clinic: testing visual exploratory behavior in daily life activities in patients with visual field defects. J Vis Exp. 2012.
- Bro T, Andersson J. The Effects of Visual Field Loss from Stroke on Performance in a Driving Simulator. Optom Vis Sci. 2022;99(9):679-686.
- Schulte T, Strasburger H, Müller-Oehring EM, Kasten E, Sabel BA. Automobile driving performance of brain-injured patients with visual field defects. Am J Phys Med Rehabil. 1999;78(2):136-42.
- Hölzl R, Steckhan L, Lehsing C, Savage SW, Bowers AR. Driving with hemianopia VIII: Effects of a vibro-tactile assistance system on safety and gaze behavior in pedestrian crossing situations. Safety (Basel). 2021;7(1).
- Biebl B, Arcidiacono E, Kacianka S, Rieger JW, Bengler K. Opportunities and Limitations of a Gaze-Contingent Display to Simulate Visual Field Loss in Driving Simulator Studies. Front Neuroergon. 2022;3:916169.
- Dougherty BE, Flom RE, Bullimore MA, Raasch TW. Vision, training hours, and road testing results in bioptic drivers. Optom Vis Sci. 2015;92(4):395-403.
- Pollock A, Hazelton C, Henderson CA, Angilley J, Dhillon B, Langhorne P, et al. Interventions for visual field defects in patients with stroke. Cochrane Database Syst Rev. 2011.
- Tchao D, Garcia-Giler E, Cheung K, Zhang B, Bajin IY, Misawa M, et al. Reporting on the Acceptance and Usability of a Virtual Reality Visual Rehabilitation Program in Pediatric Patients With Homonymous Hemianopia. J Med Ext Real. 2024;1(1):147-162.
- Bolognini N, Rasi F, Coccia M, Làdavas E. Visual search improvement in hemianopic patients after audio-visual stimulation. Brain. 2005;128(Pt 12):2830-42.
- Passamonti C, Bertini C, Làdavas E. Audio-visual stimulation improves oculomotor patterns in patients with hemianopia. Neuropsychologia. 2009;47(2):546-55.
- Grasso PA, Làdavas E, Bertini C. Compensatory Recovery after Multisensory Stimulation in Hemianopic Patients: Behavioral and Neurophysiological Components. Front Syst Neurosci. 2016;10:45.
- Làdavas E, Tosatto L, Bertini C. Behavioural and functional changes in neglect after multisensory stimulation. Neuropsychol Rehabil. 2022;32(5):662-689.
- Diana L, Casati C, Melzi L, Marzoli SB, Bolognini N. Enhancing multisensory rehabilitation of visual field defects with transcranial direct current stimulation: A randomized clinical trial. Eur J Neurol. 2025;32(1):e16559.
- Abbas AW, Aboeldahab H, Zeid MA, Hassan AK, Hindawi MD, Elrosasy A, et al. Non-invasive brain stimulation for treating visual defects: a systematic review and meta-analysis. Neurol Sci. 2025;46(7):3039-3052.
- Trauzettel-Klosinski S. [Rehabilitation of lesions in the visual pathways]. Klin Monbl Augenheilkd. 2009;226(11):897-907.
- Zihl J. [Homonymous hemianopsia and its rehabilitation]. Klin Monbl Augenheilkd. 1988;192(5):555-8.
- Bowers AR, Manda S, Shekar S, Hwang AD, Jung JH, Peli E. A randomized crossover clinical trial of multi-periscopic and Fresnel peripheral prism glasses for hemianopia. Optom Vis Sci. 2026;103(6):e70072.
- Bowers AR, Manda S, Shekar S, Hwang AD, Jung JH, Peli E. Pilot study of a pedestrian collision detection test for a multisite trial of field expansion devices for hemianopia. Optom Vis Sci. 2024;101(6):408-416.
- de Jong D, Kaufmann-Ezra S, Meichtry JR, von Arx S, Cazzoli D, Gutbrod K, et al. The influence of reading direction on hemianopic reading disorders. J Clin Exp Neuropsychol. 2016;38(10):1077-83.
- Schuett S, Heywood CA, Kentridge RW, Zihl J. Rehabilitation of hemianopic dyslexia: are words necessary for re-learning oculomotor control?. Brain. 2008;131(Pt 12):3156-68.
- Barton JJS. Cerebral Visual Loss. Ann Indian Acad Neurol. 2022;25(Suppl 2):S106-S112.
- Barton JJ. Disorder of higher visual function. Curr Opin Neurol. 2011;24(1):1-5.
- Stasheff SF, Barton JJ. Deficits in cortical visual function. Ophthalmol Clin North Am. 2001;14(1):217-42, x.
- Barton JJ. Disorders of color and object recognition: syndromes of the ventral occipitotemporal pathway. Continuum (Minneap Minn). 2010;16(4 Behavioral Neurology):111-27.
- James TW, Culham J, Humphrey GK, Milner AD, Goodale MA. Ventral occipital lesions impair object recognition but not object-directed grasping: an fMRI study. Brain. 2003;126(Pt 11):2463-75.
- De Renzi E. [Agnosia]. Recenti Prog Med. 1989;80(12):633-7.
- Karnath HO, Rüter J, Mandler A, Himmelbach M. The anatomy of object recognition—visual form agnosia caused by medial occipitotemporal stroke. J Neurosci. 2009;29(18):5854-62.
- Martinaud O. Visual agnosia and focal brain injury. Rev Neurol (Paris). 2017;173(7-8):451-460.
- Suzuki K. [Symptoms and lesion localization in visual agnosia]. Rinsho Shinkeigaku. 2004;44(11):842-4.
- Rice GE, Kerry SJ, Robotham RJ, Leff AP, Lambon Ralph MA, Starrfelt R. Category-selective deficits are the exception and not the rule: Evidence from a case-series of 64 patients with ventral occipito-temporal cortex damage. Cortex. 2021;138:266-281.
- Sugimoto A, Futamura A, Kawamura M. [Progressive visual agnosia]. Brain Nerve. 2011;63(10):1079-86.
- Decramer T, Premereur E, Lagae L, van Loon J, Janssen P, Sunaert S, et al. Patient MW: transient visual hemi-agnosia. J Neurol. 2019;266(3):691-698.
- Meichtry JR, Cazzoli D, Chaves S, von Arx S, Pflugshaupt T, Kalla R, et al. Pure optic ataxia and visual hemiagnosia - extending the dual visual hypothesis. J Neuropsychol. 2018;12(2):271-290.
- Rapcsak SZ. Face Recognition. Curr Neurol Neurosci Rep. 2019;19(7):41.
- Rossion B. Understanding face perception by means of prosopagnosia and neuroimaging. Front Biosci (Elite Ed). 2014;6(2):258-307.
- Behrmann M, Scherf KS, Avidan G. Neural mechanisms of face perception, their emergence over development, and their breakdown. Wiley Interdiscip Rev Cogn Sci. 2016;7(4):247-63.
- De Renzi E, Faglioni P, Grossi D, Nichelli P. Apperceptive and associative forms of prosopagnosia. Cortex. 1991;27(2):213-21.
- Barton JJ, Cherkasova MV, Hefter R. The covert priming effect of faces in prosopagnosia. Neurology. 2004;63(11):2062-8.
- DeGutis J, Bahierathan K, Barahona K, Lee E, Evans TC, Shin HM, et al. What is the prevalence of developmental prosopagnosia? An empirical assessment of different diagnostic cutoffs. Cortex. 2023;161:51-64.
- Gerlach C, Nørkær E, Starrfelt R. Class A, Class B. Is that the only chemistry?: A commentary on DeGutis et al. (2023): What is the prevalence of developmental prosopagnosia? An empirical assessment of different diagnostic cutoffs. Cortex. 2024;177:385-388.
- Bate S, Tree JJ. The definition and diagnosis of developmental prosopagnosia. Q J Exp Psychol (Hove). 2017;70(2):193-200.
- Maw KJ, Beattie G, Burns E. Prosopagnosia is highly comorbid in individuals with probable developmental coordination disorder. Q J Exp Psychol (Hove). 2025;78(8):1501-1522.
- Bate S, Portch E, Bennetts RJ, Parris BA. A taxometric analysis of developmental prosopagnosia: Evidence for a categorically distinct impairment. Cortex. 2025;183:131-145.
- Smith C, Susilo T. Normal colour perception in developmental prosopagnosia. Sci Rep. 2021;11(1):13741.
- Geskin J, Behrmann M. Congenital prosopagnosia without object agnosia? A literature review. Cogn Neuropsychol. 2018;35(1-2):4-54.
- Albonico A, Barton J. Progress in perceptual research: the case of prosopagnosia. F1000Res. 2019;8.
- Towler J, Fisher K, Eimer M. The cognitive and neural basis of developmental prosopagnosia. Q J Exp Psychol (Hove). 2017;70(2):316-344.
- Avidan G, Behrmann M. Impairment of the face processing network in congenital prosopagnosia. Front Biosci (Elite Ed). 2014;6(2):236-57.
- Zhang J, Liu J, Xu Y. Neural decoding reveals impaired face configural processing in the right fusiform face area of individuals with developmental prosopagnosia. J Neurosci. 2015;35(4):1539-48.
- Barton JJS, Corrow SL. The problem of being bad at faces. Neuropsychologia. 2016;89:119-124.
- Bartolomeo P. Visual objects and their colors. Handb Clin Neurol. 2022;187:179-189.
- Siuda-Krzywicka K, Bartolomeo P. What Cognitive Neurology Teaches Us about Our Experience of Color. Neuroscientist. 2020;26(3):252-265.
- Bouvier SE, Engel SA. Behavioral deficits and cortical damage loci in cerebral achromatopsia. Cereb Cortex. 2006;16(2):183-91.
- Short RA, Graff-Radford NR. Localization of hemiachromatopsia. Neurocase. 2001;7(4):331-7.
- Munk AH, Starup EB, Lambon Ralph MA, Leff AP, Starrfelt R, Robotham RJ. Colour perception deficits after posterior stroke: Not so rare after all?. Cortex. 2023;159:118-130.
- Takahashi N, Kawamura M. Pure topographical disorientation—the anatomical basis of landmark agnosia. Cortex. 2002;38(5):717-25.
- van der Ham IJM, Martens MAG, Claessen MHG, van den Berg E. Landmark Agnosia: Evaluating the Definition of Landmark-based Navigation Impairment. Arch Clin Neuropsychol. 2017;32(4):472-482.
- Kawakami N, Okada Y, Morihara K, Katsuse K, Kakinuma K, Matsubara S, et al. Long-lasting pure topographical disorientation due to heading disorientation following left retrosplenial infarction: A report of two cases. Brain Cogn. 2024;181:106211.
- van der Ham IJM, Claessen MHG. Always Getting Lost: Defining Developmental Topographical Disorientation (DTD)-A Systematic Literature Review. Neuropsychol Rev. 2026;36(1):85-93.
- Piccardi L, Palmiero M, Cofini V, Verde P, Boccia M, Palermo L, et al. “Where am I?” A snapshot of the developmental topographical disorientation among young Italian adults. PLoS One. 2022;17(7):e0271334.
- Aguirre GK, Zarahn E, D’Esposito M. Neural components of topographical representation. Proc Natl Acad Sci U S A. 1998;95(3):839-46.
- Lopez A, Caffò AO, Bosco A. Topographical disorientation in aging. Familiarity with the environment does matter. Neurol Sci. 2018;39(9):1519-1528.
- Volfart A, Rossion B. The neuropsychological evaluation of face identity recognition. Neuropsychologia. 2024;198:108865.
- Robotham RJ, Starrfelt R. Tests of whole upright face processing in prosopagnosia: A literature review. Neuropsychologia. 2018;121:106-121.
- Dalrymple KA, Palermo R. Guidelines for studying developmental prosopagnosia in adults and children. Wiley Interdiscip Rev Cogn Sci. 2016;7(1):73-87.
- Suzuki K, Nomura H, Yamadori A, Nakasato N, Takase S. [“Associative” visual agnosia for objects, pictures, faces and letters with altitudinal hemianopia]. Rinsho Shinkeigaku. 1997;37(1):31-6.
- Byrne S, Porter M. Rehabilitation and intervention of developmental and acquired prosopagnosia: A systematic review. Neuropsychol Rehabil. 2025;35(9):1715-1758.
- Bouwmeester L, van de Wege A, Haaxma R, Snoek JW. Rehabilitation in a complex case of topographical disorientation. Neuropsychol Rehabil. 2015;25(1):1-14.
- Trobe JR, Bauer RM. Seeing but not recognizing. Surv Ophthalmol. 1986;30(5):328-36.
- Bub D. Alexia and related reading disorders. Neurol Clin. 2003;21(2):549-68.
- Johansson T, Fahlgren H. Alexia without agraphia: lateral and medial infarction of left occipital lobe. Neurology. 1979;29(3):390-3.
- Weisberg LA, Wall M. Alexia without agraphia: clinical-computed tomographic correlations. Neuroradiology. 1987;29(3):283-6.
- Stommel EW, Friedman RJ, Reeves AG. Alexia without agraphia associated with spleniogeniculate infarction. Neurology. 1991;41(4):587-8.
- Maeshima S, Osawa A, Sujino K, Fukuoka T, Deguchi I, Tanahashi N. Pure alexia caused by separate lesions of the splenium and optic radiation. J Neurol. 2011;258(2):223-6.
- Bowsher D. A case of Dejerine’s. Clin Anat. 2006;19(4):370-1.
- Turkeltaub PE, Goldberg EM, Postman-Caucheteux WA, Palovcak M, Quinn C, Cantor C, et al. Alexia due to ischemic stroke of the visual word form area. Neurocase. 2014;20(2):230-5.
- Huang M, Baskin DS, Fung S. Glioblastoma Presenting with Pure Alexia and Palinopsia Involving the Left Inferior Occipital Gyrus and Visual Word Form Area Evaluated with Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Tractography. World Neurosurg. 2016;89:725.e5-725.e10.
- Marchive M, Angelini L, Lochy A, Maillard L, Colnat-Coulbois S, Rossion B, et al. Intracerebral Electrical Stimulation of the Left Occipito-Temporal Cortex Induces Pure Alexia. Neurobiol Lang (Camb). 2025;6.
- Shapiro JN, Sharma A, Trobe JD, Walsh RD, Khanna S. Brain MRI Lesions in Alexia Without Agraphia: A Case-Control Study. J Neuroophthalmol. 2024;45(3):316-320.
- Gandhi K, Gillihan L, Wozniak MA, Zhuo J, Raghavan P. Progressive Wallerian Degeneration of the Corpus Callosal Splenium in a Patient with Alexia Without Agraphia: Advanced MR Findings. Neuroradiol J. 2014;27(6):653-6.
- Robinson JS, Collins RL, Mukhi SV. Alexia Without Agraphia in a Right-Handed Individual Following Right Occipital Stroke. Appl Neuropsychol Adult. 2016;23(1):65-9.
- Leśniak M, Soluch P, Stępień U, Czepiel W, Seniów J. Pure alexia after damage to the right fusiform gyrus in a right-handed male. Neurol Neurochir Pol. 2014;48(5):373-7.
- Bonandrini R, Veronelli L, Licciardo D, Caporali A, Judica E, Corbo M, et al. Can the right hemisphere read? A behavioral and disconnectome study on implicit reading in a patient with pure alexia. Neurocase. 2020;26(6):321-327.
- Shan C, Zhu R, Xu M, Luo B, Weng X. Implicit reading in Chinese pure alexia. Brain Lang. 2010;114(3):147-56.
- Swick D, Miller KM, Larsen J. Auditory repetition priming is impaired in pure alexic patients. Brain Lang. 2004;89(3):543-53.
- Johnson RL, Rayner K. Top-down and bottom-up effects in pure alexia: evidence from eye movements. Neuropsychologia. 2007;45(10):2246-57.
- Henry C, Gaillard R, Volle E, Chiras J, Ferrieux S, Dehaene S, et al. Brain activations during letter-by-letter reading: a follow-up study. Neuropsychologia. 2005;43(14):1983-9.
- Spang KM, Grimsen C, Brunner F, Fahle MW. Pure alexia with intact perception of complex visual stimuli: a case study. Neurocase. 2019;25(5):159-168.
- Sharma B, Handa R, Prakash S, Nagpal K, Bhana I, Gupta PK, et al. Posterior cerebral artery stroke presenting as alexia without agraphia. Am J Emerg Med. 2014;32(12):1553.e3-4.
- Milandre L, Brosset C, Botti G, Khalil R. [A study of 82 cerebral infarctions in the area of posterior cerebral arteries]. Rev Neurol (Paris). 1994;150(2):133-41.
- Gnieber KO, Barakat AA, Khan AA, Sabeeh S, Kirmani SA. ‘I Can See Letters but Cannot Read Sentences’: A Case of Pure Alexia Without Agraphia Due to Left Posterior Cerebral Artery Infarction. Cureus. 2025;17(8):e89974.
- Rupareliya C, Naqvi S, Hejazi S. Alexia Without Agraphia: A Rare Entity. Cureus. 2017;9(6):e1304.
- Kirshner HS, Staller J, Webb W, Sachs P. Transtentorial herniation with posterior cerebral artery territory infarction. A new mechanism of the syndrome of alexia without agraphia. Stroke. 1982;13(2):243-46.
- Jauregui R, Greenberg J, Kuball P, Newbold DJ, Patel R, Staudinger R. Alexia without agraphia: from infarctions to malignancies. Pract Neurol. 2025;25(3):246-249.
- Mao-Draayer Y, Panitch H. Alexia without agraphia in multiple sclerosis: case report with magnetic resonance imaging localization. Mult Scler. 2004;10(6):705-7.
- Tamhankar MA, Coslett HB, Fisher MJ, Sutton LN, Liu GT. Alexia without agraphia following biopsy of a left thalamic tumor. Pediatr Neurol. 2004;30(2):140-2.
- Leff AP, Crewes H, Plant GT, Scott SK, Kennard C, Wise RJ. The functional anatomy of single-word reading in patients with hemianopic and pure alexia. Brain. 2001;124(Pt 3):510-21.
- Leff AP, Spitsyna G, Plant GT, Wise RJ. Structural anatomy of pure and hemianopic alexia. J Neurol Neurosurg Psychiatry. 2006;77(9):1004-7.
- Leiguarda R, Starkstein S, Berthier M. Anterior callosal haemorrhage. A partial interhemispheric disconnection syndrome. Brain. 1989;112 ( Pt 4):1019-37.
- Starkstein SE, Berthier ML, Leiguarda R. Disconnection syndrome in a right-handed patient with right hemispheric speech dominance. Eur Neurol. 1988;28(4):187-90.
- Forget J, Lippé S, Lassonde M. Perceptual priming does not transfer interhemispherically in the acallosal brain. Exp Brain Res. 2009;192(3):443-54.
- Mohamad NA, Che Adinan SN, Yusof Khan AHK, Nik Abdul Ghani NNH, Kamis MFA, Wan Sulaiman WA, et al. Transcranial direct current stimulation with multiple oral re-reading therapy for pure alexia without agraphia: a case report. Neurocase. 2021;27(5):391-395.
- Seki K, Yajima M, Sugishita M. The efficacy of kinesthetic reading treatment for pure alexia. Neuropsychologia. 1995;33(5):595-609.
- Kerry SJ, Aguilar OM, Penny W, Crinion JT, Leff AP, Woodhead ZVJ. How Does iReadMore Therapy Change the Reading Network of Patients with Central Alexia?. J Neurosci. 2019;39(29):5719-5727.
- Hux K, Mahrt T. Alexia and Agraphia Intervention Following Traumatic Brain Injury: A Single Case Study. Am J Speech Lang Pathol. 2019;28(3):1152-1166.
- Getz H, Snider S, Brennan D, Friedman R. Successful remote delivery of a treatment for phonological alexia via telerehab. Neuropsychol Rehabil. 2016;26(4):584-609.
- Kerkhoff G, Rode G, Clarke S. Treating neurovisual deficits and spatial neglect. En: Clinical Pathways in Stroke Rehabilitation [Internet]. Cham: Springer; 2021.
- Cohen L, Dehaene S, McCormick S, Durant S, Zanker JM. Brain mechanisms of recovery from pure alexia: A single case study with multiple longitudinal scans. Neuropsychologia. 2016;91:36-49.
- Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012;11(2):170-8.
- Shir D, Lee N, McCarter SJ, Ramanan VK, Botha H, Knopman DS, et al. Longitudinal Evolution of Posterior Cortical Atrophy: Diagnostic Delays, Overlapping Phenotypes, and Clinical Outcomes. Neurology. 2025;104(9):e213559.
- Ruis C, van den Berg E, van Zandvoort MJ, Boshuisen K, Frijns CJ. Ophthalmic impairment or higher-order visual deficit? Posterior cortical atrophy: a case report. Appl Neuropsychol Adult. 2012;19(2):153-7.
- Balslev D, Odoj B, Rennig J, Karnath HO. Abnormal center-periphery gradient in spatial attention in simultanagnosia. J Cogn Neurosci. 2014;26(12):2778-88.
- Chechlacz M, Rotshtein P, Hansen PC, Riddoch JM, Deb S, Humphreys GW. The neural underpinings of simultanagnosia: disconnecting the visuospatial attention network. J Cogn Neurosci. 2012;24(3):718-35.
- Neitzel J, Ortner M, Haupt M, Redel P, Grimmer T, Yakushev I, et al. Neuro-cognitive mechanisms of simultanagnosia in patients with posterior cortical atrophy. Brain. 2016;139(Pt 12):3267-3280.
- Rizzo M, Vecera SP. Psychoanatomical substrates of Bálint’s syndrome. J Neurol Neurosurg Psychiatry. 2002;72(2):162-78.
- Chechlacz M. Bilateral parietal dysfunctions and disconnections in simultanagnosia and Bálint syndrome. Handb Clin Neurol. 2018;151:249-267.
- Chechlacz M, Humphreys GW. The enigma of Bálint’s syndrome: neural substrates and cognitive deficits. Front Hum Neurosci. 2014;8:123.
- Ghoneim A, Pollard C, Greene J, Jampana R. Balint syndrome (chronic visual-spatial disorder) presenting without known cause. Radiol Case Rep. 2018;13(6):1242-1245.
- Espay AJ, Allen SR. Amaurotic and ophthalmoplegic presentation of Balint syndrome. Neurology. 2014;82(20):1844-5.
- Udesen H, Madsen AL. [Balint’s syndrome—visual disorientation]. Ugeskr Laeger. 1992;154(21):1492-4.
- Panico F, Arini A, Cantone P, Crisci C, Trojano L. Integrating visual search, eye movement training and reversing prism exposure in the treatment of Balint-Holmes syndrome: a single case report. Top Stroke Rehabil. 2022;29(4):280-285.
- Veronelli L, Daini R, Gallucci M, Toneatto C, Pino S, Ghielmi L, et al. Computerized Open-Source Navon Test (COSNaT): Normative data for the assessment of global processing abilities and simultanagnosia in the Italian population. Behav Res Methods. 2025;57(10):284.
- Pellegrini F, Cuna A, Musa M, D’Esposito F, Giglio R, Tognetto D, et al. Ishihara color plates utilized as an assessment for simultanagnosia in posterior cortical atrophy: A case report. World J Clin Cases. 2025;13(27):108868.
- Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017;13(8):870-884.
- Kelly MJ, Fearon C, O’Dowd S. Seeing the Woods for the Trees? Applying Diagnostic Criteria for Dementia with Lewy Bodies to Patients Presenting with Posterior Cortical Atrophy. Alzheimer Dis Assoc Disord. 2023;37(1):88-91.
- Yerstein O, Parand L, Liang LJ, Isaac A, Mendez MF. Benson’s Disease or Posterior Cortical Atrophy, Revisited. J Alzheimers Dis. 2021;82(2):493-502.
- Kirshner HS, Lavin PJ. Posterior cortical atrophy: a brief review. Curr Neurol Neurosci Rep. 2006;6(6):477-80.
- Borruat FX. Posterior cortical atrophy: review of the recent literature. Curr Neurol Neurosci Rep. 2013;13(12):406.
- Jones D, Pelak V, Rogalski E. Atypical Presentations of Alzheimer Disease. Continuum (Minneap Minn). 2024;30(6):1614-1641.
- Pelak VS. The clinical approach to the identification of higher-order visual dysfunction in neurodegenerative disease. Curr Neurol Neurosci Rep. 2022;22(4):229-242.
- Liu Y, Pelak VS, van Stavern G, Moss HE. Higher Cortical Dysfunction Presenting as Visual Symptoms in Neurodegenerative Diseases. Front Neurol. 2020;11:679.
- Pelak VS, Tang-Wai DF, Boeve BF, Bouwman FH, Graff-Radford J, Rabinovici G, et al. Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the Atypical AD PIA of ISTAART. Alzheimers Dement (Amst). 2023;15(3):e12474.
- Pelak VS, Smyth SF, Boyer PJ, Filley CM. Computerized visual field defects in posterior cortical atrophy. Neurology. 2011;77(24):2119-22.
- Wan SL, Bukowska DM, Ford S, Chen FK. Posterior Cortical Atrophy Presenting with Superior Arcuate Field Defect. Case Rep Ophthalmol Med. 2015;2015:796381.
- den Haan J, Csinscik L, Parker T, Paterson RW, Slattery CF, Foulkes A, et al. Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer’s disease. Alzheimers Res Ther. 2019;11(1):62.
- Mendez MF, Khattab YI, Yerstein O. Impaired visual search in posterior cortical atrophy vs. typical Alzheimer’s disease. J Neurol Sci. 2021;428:117574.
- Firth NC, Primativo S, Marinescu RV, Shakespeare TJ, Suarez-Gonzalez A, Lehmann M, et al. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy. Brain. 2019;142(7):2082-2095.
- Olds JJ, Hills WL, Warner J, Falardeau J, Alasantro LH, Moster ML, et al. Posterior Cortical Atrophy: Characteristics From a Clinical Data Registry. Front Neurol. 2020;11:358.
- Hardy CJD, Yong KXX, Goll JC, Crutch SJ, Warren JD. Impairments of auditory scene analysis in posterior cortical atrophy. Brain. 2020;143(9):2689-2695.
- St-Georges MA, Wang L, Chapleau M, Migliaccio R, Carrier T, Montembeault M. Social cognition and behavioral changes in patients with posterior cortical atrophy. J Neurol. 2024;271(3):1439-1450.
- Holden SK, Pelak VS, Sooy T, Heffernan KS, McConnell BV, Pressman PS, et al. Development of the Colorado posterior cortical questionnaire within an Alzheimer’s disease study cohort. J Clin Exp Neuropsychol. 2022;44(3):226-236.
- Wong B, Lucente DE, MacLean J, Padmanabhan J, Quimby M, Brandt KD, et al. Diagnostic evaluation and monitoring of patients with posterior cortical atrophy. Neurodegener Dis Manag. 2019;9(4):217-239.
- Singh TD, Josephs KA, Machulda MM, Drubach DA, Apostolova LG, Lowe VJ, et al. Clinical, FDG and amyloid PET imaging in posterior cortical atrophy. J Neurol. 2015;262(6):1483-92.
- Cui Y, Liu Y, Yang C, Cui C, Jing D, Zhang X, et al. Brain structural and functional anomalies associated with simultanagnosia in patients with posterior cortical atrophy. Brain Imaging Behav. 2022;16(3):1148-1162.
- Salvioni Chiabotti P, Nasuti M, Rouaud O, Allali G. Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center. J Alzheimers Dis. 2025;106(2):512-517.
- Harding E, Sullivan MP, Camic PM, Yong KXX, Stott J, Crutch SJ. Exploring experiential differences in everyday activities - A focused ethnographic study in the homes of people living with memory-led Alzheimer’s disease and posterior cortical atrophy. J Aging Stud. 2024;69:101226.
- Mitchell A, Kelso W, Paynter C, Hayes L, Velakoulis D, Loi SM. Peer Support for Caregivers of People Living with Posterior Cortical Atrophy in Melbourne, Australia: A Feasibility Study. Int J Environ Res Public Health. 2024;21(4).
- Beh SC, Muthusamy B, Calabresi P, Hart J, Zee D, Patel V, et al. Hiding in plain sight: a closer look at posterior cortical atrophy. Pract Neurol. 2015;15(1):5-13.
- Cárdenas-Belaunzarán J, Cerrillo-Avila KA. Visual Agnosia Mimicking Memory Impairment: A Case Report of Posterior Cortical Atrophy. Neuroophthalmology. 2024;48(1):30-36.
- Barrett AM. Spatial Neglect and Anosognosia After Right Brain Stroke. Continuum (Minneap Minn). 2021;27(6):1624-1645.
- Benjamin R, Gillespie E. Spatial neglect. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Gillen RW, Fusco-Gessick B, Harmon EY. How We Assess Spatial Neglect Matters: Prevalence of Spatial Neglect as Measured by the Catherine Bergego Scale and Impact on Rehabilitation Outcomes. Am J Phys Med Rehabil. 2021;100(5):443-449.
- Beis JM, Keller C, Morin N, Bartolomeo P, Bernati T, Chokron S, et al. Right spatial neglect after left hemisphere stroke: qualitative and quantitative study. Neurology. 2004;63(9):1600-5.
- Halligan PW, Marshall JC. Visuospatial neglect: the ultimate deconstruction?. Brain Cogn. 1998;37(3):419-38.
- Binder J, Marshall R, Lazar R, Benjamin J, Mohr JP. Distinct syndromes of hemineglect. Arch Neurol. 1992;49(11):1187-94.
- Langer KG, Piechowski-Jozwiak B, Bogousslavsky J. Hemineglect and Attentional Dysfunction. Front Neurol Neurosci. 2019;44:89-99.
- Caggiano P, Jehkonen M. The ‘Neglected’ Personal Neglect. Neuropsychol Rev. 2018;28(4):417-435.
- Mark VW, Heilman KM. Diagonal spatial neglect. J Neurol Neurosurg Psychiatry. 1998;65(3):348-52.
- Dai CY, Liu WM, Chen SW, Yang CA, Tung YC, Chou LW, et al. Anosognosia, neglect and quality of life of right hemisphere stroke survivors. Eur J Neurol. 2014;21(5):797-801.
- Vossel S, Weiss PH, Eschenbeck P, Fink GR. Anosognosia, neglect, extinction and lesion site predict impairment of daily living after right-hemispheric stroke. Cortex. 2013;49(7):1782-9.
- Kortte K, Hillis AE. Recent advances in the understanding of neglect and anosognosia following right hemisphere stroke. Curr Neurol Neurosci Rep. 2009;9(6):459-65.
- Saxena S, Keser Z, Rorden C, Bonilha L, Fridriksson J, Walker A, et al. Disruptions of the Human Connectome Associated With Hemispatial Neglect. Neurology. 2022;98(2):e107-e114.
- Umarova RM, Saur D, Kaller CP, Vry MS, Glauche V, Mader I, et al. Acute visual neglect and extinction: distinct functional state of the visuospatial attention system. Brain. 2011;134(Pt 11):3310-25.
- Kerkhoff G, Schindler I. [Hemi-neglect versus hemianopia. Differential diagnosis]. Fortschr Neurol Psychiatr. 1997;65(6):278-89.
- Müller-Oehring EM, Kasten E, Poggel DA, Schulte T, Strasburger H, Sabel BA. Neglect and hemianopia superimposed. J Clin Exp Neuropsychol. 2003;25(8):1154-68.
- Ferber S, Karnath HO. How to assess spatial neglect—line bisection or cancellation tasks?. J Clin Exp Neuropsychol. 2001;23(5):599-607.
- Molenberghs P, Sale MV. Testing for spatial neglect with line bisection and target cancellation: are both tasks really unrelated?. PLoS One. 2011;6(7):e23017.
- Guariglia P, Matano A, Piccardi L. Bisecting or not bisecting: this is the neglect question. Line bisection performance in the diagnosis of neglect in right brain-damaged patients. PLoS One. 2014;9(6):e99700.
- Huygelier H, Gillebert CR. Quantifying egocentric spatial neglect with cancellation tasks: A theoretical validation. J Neuropsychol. 2020;14(1):1-19.
- Lee BH, Kang SJ, Park JM, Son Y, Lee KH, Adair JC, et al. The Character-line Bisection Task: a new test for hemispatial neglect. Neuropsychologia. 2004;42(12):1715-24.
- Speedie LJ, Wertman E, Verfaellie M, Butter C, Silberman N, Liechtenstein M, et al. Reading direction and spatial neglect. Cortex. 2002;38(1):59-67.
- Chen P, Hreha K, Fortis P, Goedert KM, Barrett AM. Functional assessment of spatial neglect: a review of the Catherine Bergego scale and an introduction of the Kessler foundation neglect assessment process. Top Stroke Rehabil. 2012;19(5):423-35.
- Vuilleumier PO, Rafal RD. A systematic study of visual extinction. Between- and within-field deficits of attention in hemispatial neglect. Brain. 2000;123 ( Pt 6):1263-79.
- Riddoch MJ, Chechlacz M, Mevorach C, Mavritsaki E, Allen H, Humphreys GW. The neural mechanisms of visual selection: the view from neuropsychology. Ann N Y Acad Sci. 2010;1191:156-81.
- Bien N, Goebel R, Sack AT. Extinguishing extinction: hemispheric differences in the modulation of TMS-induced visual extinction by directing covert spatial attention. J Cogn Neurosci. 2012;24(4):809-18.
- Hilgetag CC, Théoret H, Pascual-Leone A. Enhanced visual spatial attention ipsilateral to rTMS-induced ‘virtual lesions’ of human parietal cortex. Nat Neurosci. 2001;4(9):953-7.
- Appelros P, Nydevik I, Karlsson GM, Thorwalls A, Seiger A. Recovery from unilateral neglect after right-hemisphere stroke. Disabil Rehabil. 2004;26(8):471-7.
- Ott J, Oh-Park M, Boukrina O. Association of delirium and spatial neglect in patients with right-hemisphere stroke. PM R. 2023;15(9):1075-1082.
- Hart E, Grattan E, Woodbury M, Herbert TL, Coker-Bolt P, Bonilha H. Pediatric unilateral spatial neglect: A systematic review. J Pediatr Rehabil Med. 2021;14(3):345-359.
- Robertson IH, Gray JM, Pentland B, Waite LJ. Microcomputer-based rehabilitation for unilateral left visual neglect: a randomized controlled trial. Arch Phys Med Rehabil. 1990;71(9):663-8.
- Luukkainen-Markkula R, Tarkka IM, Pitkänen K, Sivenius J, Hämäläinen H. Rehabilitation of hemispatial neglect: A randomized study using either arm activation or visual scanning training. Restor Neurol Neurosci. 2009;27(6):663-72.
- Zhang J, Wang X, Huang F, Wang W, Li Y, Zhang M, et al. Effect of Eye-Tracking Technology-Based Visual Scanning Training on Unilateral Spatial Neglect after Stroke. J Vis Exp. 2025.
- Lelaumier C, Hassaïni S, Hinault T, Petroff A, Platel H, Coello Y. Sound-based rehabilitation of unilateral spatial neglect: A systematic review of the literature. Appl Neuropsychol Adult. 2025.
- Middag-van Spanje M, Nijboer TCW, Schepers J, van Heugten C, Sack AT, Schuhmann T. Alpha transcranial alternating current stimulation as add-on to neglect training: a randomized trial. Brain Commun. 2024;6(5):fcae287.
- Ogourtsova T, Souza Silva W, Archambault PS, Lamontagne A. Virtual reality treatment and assessments for post-stroke unilateral spatial neglect: A systematic literature review. Neuropsychol Rehabil. 2017;27(3):409-454.
- Bazan R, Fonseca BHS, Miranda JMA, Nunes HRC, Bazan SGZ, Luvizutto GJ. Effect of Robot-Assisted Training on Unilateral Spatial Neglect After Stroke: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Neurorehabil Neural Repair. 2022;36(8):545-556.
- Luauté J, Halligan P, Rode G, Jacquin-Courtois S, Boisson D. Prism adaptation first among equals in alleviating left neglect: a review. Restor Neurol Neurosci. 2006;24(4-6):409-18.
- Jacquin-Courtois S, O’Shea J, Luauté J, Pisella L, Revol P, Mizuno K, et al. Rehabilitation of spatial neglect by prism adaptation: a peculiar expansion of sensorimotor after-effects to spatial cognition. Neurosci Biobehav Rev. 2013;37(4):594-609.
- Ten Brink AF, Visser-Meily JMA, Schut MJ, Kouwenhoven M, Eijsackers ALH, Nijboer TCW. Prism Adaptation in Rehabilitation? No Additional Effects of Prism Adaptation on Neglect Recovery in the Subacute Phase Poststroke: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2017;31(12):1017-1028.
- Székely O, Ten Brink AF, Mitchell AG, Bultitude JH, McIntosh RD. No short-term treatment effect of prism adaptation for spatial neglect: An inclusive meta-analysis. Neuropsychologia. 2023;189:108566.
- Chen P, Hreha K, Gonzalez-Snyder C, Rich TJ, Gillen RW, Parrott D, et al. Impacts of Prism Adaptation Treatment on Spatial Neglect and Rehabilitation Outcome: Dosage Matters. Neurorehabil Neural Repair. 2022;36(8):500-513.
- Gillen RW, Harmon EY, Weil B, Fusco-Gessick B, Novak PP, Barrett AM. Prism Adaptation Treatment of Spatial Neglect: Feasibility During Inpatient Rehabilitation and Identification of Patients Most Likely to Benefit. Front Neurol. 2022;13:803312.
- Chen P, Hreha K, MacPhee C, Salter A, Eskes GA. Does prism adaptation treatment reduce spatial neglect and improve function?. Front Rehabil Sci. 2025;6:1539887.
- Barrett AM, Goedert KM, Basso JC. Prism adaptation for spatial neglect after stroke: translational practice gaps. Nat Rev Neurol. 2012;8(10):567-77.
- Priftis K, Passarini L, Pilosio C, Meneghello F, Pitteri M. Visual Scanning Training, Limb Activation Treatment, and Prism Adaptation for Rehabilitating Left Neglect: Who is the Winner?. Front Hum Neurosci. 2013;7:360.
- Vaina LM. Functional segregation of color and motion processing in the human visual cortex: clinical evidence. Cereb Cortex. 1994;4(5):555-72.
- Bartolomeo P, Bachoud-Lévi AC, Thiebaut de Schotten M. The anatomy of cerebral achromatopsia: a reappraisal and comparison of two case reports. Cortex. 2014;56:138-44.
- Bartels A, Zeki S. The architecture of the colour centre in the human visual brain: new results and a review. Eur J Neurosci. 2000;12(1):172-93.
- Heywood CA, Gaffan D, Cowey A. Cerebral achromatopsia in monkeys. Eur J Neurosci. 1995;7(5):1064-73.
- Ishii K, Kita Y, Nagura H, Bandoh M, Yamanouchi H. [A case report of cerebral achromatopsia with bilateral occipital lesion]. Rinsho Shinkeigaku. 1992;32(3):293-8.
- Bartolomeo P, Liu J, Spagna A. Colors in the mind’s eye. Cortex. 2024;170:26-31.
- Browne JL, Krabbendam L, Blom JD. Akinetopsia: a systematic review on visual motion blindness. Front Neurol. 2024;15:1510807.
- Safran AB, Glaser JS. Statokinetic dissociation in lesions of the anterior visual pathways. A reappraisal of the Riddoch phenomenon. Arch Ophthalmol. 1980;98(2):291-5.
- Finkelstein JI, Johnson LN. Relative scotoma and statokinetic dissociation (Riddoch’s phenomenon) from occipital lobe dysfunction. Trans Pa Acad Ophthalmol Otolaryngol. 1989;41:789-92.
- Hayashi R, Yamaguchi S, Narimatsu T, Miyata H, Katsumata Y, Mimura M. Statokinetic Dissociation (Riddoch Phenomenon) in a Patient with Homonymous Hemianopsia as the First Sign of Posterior Cortical Atrophy. Case Rep Neurol. 2017;9(3):256-260.
- Maruta K, Shiomi K. [Posterior cortical atrophy presenting with agraphia for kanji and statokinetic dissociation (Riddoch phenomenon): a case report]. Rinsho Shinkeigaku. 2025;65(6):416-423.
- Maia da Silva MN, James-Galton M, Green C, Plant GT. Homonymous hemianopia in posterior cortical atrophy: right-left asymmetry, progression over time and relationship to the classical neuropsychological deficits. Front Neurol. 2026;17:1759440.
- Schaadt AK, Brandt SA, Kraft A, Kerkhoff G. Holmes and Horrax (1919) revisited: impaired binocular fusion as a cause of “flat vision” after right parietal brain damage - a case study. Neuropsychologia. 2015;69:31-8.
- Schaadt AK, Schmidt L, Kuhn C, Summ M, Adams M, Garbacenkaite R, et al. Perceptual relearning of binocular fusion after hypoxic brain damage: four controlled single-case treatment studies. Neuropsychology. 2014;28(3):382-7.
- Viader F. [Perception in space. Visual aspects of space perception]. Rev Neurol (Paris). 1995;151(8-9):466-73.
- Hublet C, Demeurisse G. Pure topographical disorientation due to a deep-seated lesion with cortical remote effects. Cortex. 1992;28(1):123-8.
- Blom JD, Nanuashvili N, Waters F. Time Distortions: A Systematic Review of Cases Characteristic of Alice in Wonderland Syndrome. Front Psychiatry. 2021;12:668633.
- Jia Y, Miao Y. Evidence for the Perception of Time Distortion During Episodes of Alice in Wonderland Syndrome. J Nerv Ment Dis. 2018;206(6):473-475.
- Saito G, Takagi G. Multisensory perceptual distortion including auditory distortions in Alice in Wonderland syndrome: a case report. Neurocase. 2023;29(2):46-49.
- Ansari AZ, Smith SL, Anderson AS, Siddiqi AA, Hafeez S. Alice in Wonderland Syndrome in a Child Following Epstein-Barr Virus Infection: A Case Report. Cureus. 2025;17(6):e86532.
- Piessens P, Indesteege F, Lemkens P. Alice in Wonderland syndrome and upper airway obstruction in infectious mononucleosis. B-ENT. 2011;7(1):51-4.
- Merino DA, Gérard AO, Cherikh F, Lavrut T, Thümmler S, Askenazy F, et al. Alice in wonderland syndrome: Down the rabbit hole of VigiBase®. Psychiatry Res. 2026;356:116920.
- Naarden T, Ter Meulen BC, van der Weele SI, Blom JD. Alice in Wonderland Syndrome as a Presenting Manifestation of Creutzfeldt-Jakob Disease. Front Neurol. 2019;10:473.
- Vis PJ, Goudriaan AE, Ter Meulen BC, Blom JD. On Perception and Consciousness in HPPD: A Systematic Review. Front Neurosci. 2021;15:675768.
- O’Toole P, Modestino EJ. Alice in Wonderland Syndrome: A real life version of Lewis Carroll’s novel. Brain Dev. 2017;39(6):470-474.
- Mantingh MR. [The Alice in Wonderland syndrome]. Ned Tijdschr Geneeskd. 2014;158:A7225.
- Toma K, Taguchi K, Ikeda A, Nishinaka K, Udaka F, Kameyama M. [The medial temporal area and parietal lobe are involved in epileptic polyopia and palinopsia: A case report]. Rinsho Shinkeigaku. 2012;52(9):651-5.
- Abert B, Ilsen PF. Palinopsia. Optometry. 2010;81(8):394-404.
- Mars JA, Rojas LC, Gurnani B. Charles Bonnet syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet. 1996;347(9004):794-7.
- Jurišić D, Sesar I, Ćavar I, Sesar A, Živković M, Ćurković M. Hallucinatory experiences in visually impaired individuals: Charles Bonnet syndrome - implications for research and clinical practice. Psychiatr Danub. 2018;30(2):122-128.
- Collerton D, Barnes J, Diederich NJ, Dudley R, Ffytche D, Friston K, et al. Understanding visual hallucinations: A new synthesis. Neurosci Biobehav Rev. 2023;150:105208.
- Weil RS, Lees AJ. Visual hallucinations. Pract Neurol. 2021.
- Arciniegas DB. Psychosis. Continuum (Minneap Minn). 2015;21(3 Behavioral Neurology and Neuropsychiatry):715-36.
- Altieri E, Battaglini L. Beyond Hyperexcitability: A Review of Neural Mechanisms in Charles Bonnet Syndrome. NeuroSci. 2026;7(2).
- Fernandez A, Lichtshein G, Vieweg WV. The Charles Bonnet syndrome: a review. J Nerv Ment Dis. 1997;185(3):195-200.
- Fénelon G. [Visual hallucinations: the Charles Bonnet syndrome]. Psychol Neuropsychiatr Vieil. 2003;1(2):121-7.
- Christoph SEG, Boden KT, Seitz B, Szurman P, Schulz A. Understanding the Charles Bonnet syndrome: An updated review. Brain Res Bull. 2026;234:111683.
- Satgunam P, Sumalini R, Chittapu G, Pamarthi G. Screening for Charles Bonnet syndrome: Should the definition be reconsidered?. Indian J Ophthalmol. 2019;67(7):1127-1132.
- Dhooge PPA, Teunisse RJ, Liefers B, Lambertus S, Bax NM, Hoyng CB, et al. Charles Bonnet syndrome in patients with Stargardt disease: prevalence and risk factors. Br J Ophthalmol. 2023;107(2):248-253.
- Russell G, Burns A. Charles Bonnet syndrome and cognitive impairment: a systematic review. Int Psychogeriatr. 2014;26(9):1431-1443.
- Dave S, Jones L, Lee M, Ditzel-Finn L, Castle C, Heinze N, et al. The experiences of visually impaired military veterans with Charles Bonnet syndrome. Ther Adv Ophthalmol. 2024;16:25158414241294022.
- Borsellino PJ, Schauer S, Rivas A, Aharonian K, Vida TA. Filling in the Blind Spot: Integrating Charles Bonnet Syndrome Screening in Ophthalmology. Clin Ophthalmol. 2025;19:3619-3657.
- Długoń U. [Charles Bonnet syndrome]. Psychiatr Pol. 2000;34(2):307-16.
- Yun JS, Prieto G. Expanding the Spectrum of Charles Bonnet Syndrome: Severe Psychiatric Manifestations Associated With Total Vision Loss. Cureus. 2025;17(5):e84849.
- McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-72.
- Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord. 2007;22(12):1689-707; quiz 1837.
- Gomperts SN. Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia. Continuum (Minneap Minn). 2016;22(2 Dementia):435-63.
- Pezzoli S, Sánchez-Valle R, Solanes A, Kempton MJ, Bandmann O, Shin JI, et al. Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson’s disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysis. Neurosci Biobehav Rev. 2021;128:367-382.
- Vignando M, Ffytche D, Mazibuko N, Palma G, Montagnese M, Dave S, et al. Visual mismatch negativity in Parkinson’s psychosis and potential for testing treatment mechanisms. Brain Commun. 2024;6(5):fcae291.
- Sekiya H, Matsubara T, DeTure MA, Dickson DW. Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies. Mol Neurodegener. 2025;20(1):117.
- Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?. BMC Med. 2018;16(1):34.
- Onofrj M, Carrozzino D, D’Amico A, Di Giacomo R, Delli Pizzi S, Thomas A, et al. Psychosis in parkinsonism: an unorthodox approach. Neuropsychiatr Dis Treat. 2017;13:1313-1330.
- Devanand DP, Jeste DV, Stroup TS, Goldberg TE. Overview of late-onset psychoses. Int Psychogeriatr. 2024;36(1):28-42.
- Aarsland D. Epidemiology and Pathophysiology of Dementia-Related Psychosis. J Clin Psychiatry. 2020;81(5).
- Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7(1):47.
- Drouin E, Péréon Y. Peduncular hallucinosis according to Jean Lhermitte. Rev Neurol (Paris). 2019;175(6):377-379.
- Howland RH. Peduncular hallucinosis. Clin Schizophr Relat Psychoses. 2011;5(2):106-7; author reply 107.
- Fénelon G. From Dreams to Hallucinations: Jean Lhermitte’s Contribution to the Study of Peduncular Hallucinosis and the Dissociation of States. J Neuropsychiatry Clin Neurosci. 2022;34(1):16-29.
- Roser F, Ritz R, Koerbel A, Loewenheim H, Tatagiba MS. Peduncular hallucinosis: insights from a neurosurgical point of view. Neurosurgery. 2005;57(5):E1068; discussion E1068.
- Shahab M, Ahmed R, Kaur N, Masoud H. Peduncular hallucinosis after a thalamic stroke. BMJ Case Rep. 2021;14(5).
- Papantoniou M, Panagou G, Gryllia M. Peduncular hallucinosis associated with pontine hemorrhage in an adult patient. Psychiatriki. 2024;35(1):78-82.
- Couse M, Wojtanowicz T, Comeau S, Bota R. Peduncular hallucinosis associated with a pontine cavernoma. Ment Illn. 2018;10(1):7586.
- Choi W, Lee SJ, Ko SH, Shin YI, Min JH. Peduncular Hallucinosis 7 Months After Pontine Hemorrhage With Hypertrophic Olivary Degeneration: A Case Report. Brain Neurorehabil. 2022;15(3):e31.
- Andrews JP, Taylor J, Saunders D, Qayyum Z. Peduncular psychosis. BMJ Case Rep. 2016;2016.
- Boes AD, Prasad S, Liu H, Liu Q, Pascual-Leone A, Caviness VS Jr, et al. Network localization of neurological symptoms from focal brain lesions. Brain. 2015;138(Pt 10):3061-75.
- Cascino GD, Adams RD. Brainstem auditory hallucinosis. Neurology. 1986;36(8):1042-7.
- Veillette JJ, Van Epps P. Ertapenem-Induced Hallucinations and Delirium in an Elderly Patient. Consult Pharm. 2016;31(4):207-14.
- Doyle MA, Ling S, Lui LMW, Fragnelli P, Teopiz KM, Ho R, et al. Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment. Expert Opin Drug Saf. 2022;21(6):733-743.
- Halpern JH, Lerner AG, Passie T. A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD. Curr Top Behav Neurosci. 2018;36:333-360.
- Lerner AG, Gelkopf M, Skladman I, Oyffe I, Finkel B, Sigal M, et al. Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach. Isr J Psychiatry Relat Sci. 2002;39(2):92-9.
- Lev-Ran S, Feingold D, Rudinski D, Katz S, Arturo LG. Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation. Am J Addict. 2015;24(3):197-199.
- Gaillard MC, Borruat FX. Persisting visual hallucinations and illusions in previously drug-addicted patients. Klin Monbl Augenheilkd. 2003;220(3):176-8.
- McCarthy-Jones S, Smailes D, Corvin A, Gill M, Morris DW, Dinan TG, et al. Occurrence and co-occurrence of hallucinations by modality in schizophrenia-spectrum disorders. Psychiatry Res. 2017;252:154-160.
- Schutte MJL, Linszen MMJ, Marschall TM, Ffytche DH, Koops S, van Dellen E, et al. Hallucinations and other psychotic experiences across diagnoses: A comparison of phenomenological features. Psychiatry Res. 2020;292:113314.
- Cachia A, Cury C, Brunelin J, Plaze M, Delmaire C, Oppenheim C, et al. Deviations in early hippocampus development contribute to visual hallucinations in schizophrenia. Transl Psychiatry. 2020;10(1):102.
- Gersztenkorn D, Lee AG. Palinopsia revamped: a systematic review of the literature. Surv Ophthalmol. 2015;60(1):1-35.
- Yun SH, Lavin PJ, Schatz MP, Lesser RL. Topiramate-induced palinopsia: a case series and review of the literature. J Neuroophthalmol. 2015;35(2):148-51.
- Klein A, Schankin CJ. Visual Snow Syndrome as a Network Disorder: A Systematic Review. Front Neurol. 2021;12:724072.
- Records RE. Monocular diplopia. Surv Ophthalmol. 1980;24(5):303-6.
- Margolin E. Approach to patient with diplopia. J Neurol Sci. 2020;417:117055.
- Lee MS, Volpe NJ. Double Vision. Curr Treat Options Neurol. 2001;3(4):383-388.
- Cornblath WT, Butter CM, Barnes LL, Hasselbach MM. Spatial characteristics of cerebral polyopia: a case study. Vision Res. 1998;38(24):3965-78.
- Sampatakakis SN, Lymperopoulos L, Mavridis T, Karagiorgis G, Papadopoulos C, Deligianni CI, et al. Visual snow: A systematic review and a case series. Cephalalgia. 2022;42(13):1409-1419.
- White OB, Clough M, McKendrick AM, Fielding J. Visual Snow: Visual Misperception. J Neuroophthalmol. 2018;38(4):514-521.
- Stern JI, Robertson CE. Visual Snow: Updates and Narrative Review. Curr Pain Headache Rep. 2024;28(2):55-63.
- Eren O, Schankin CJ. Insights into pathophysiology and treatment of visual snow syndrome: A systematic review. Prog Brain Res. 2020;255:311-326.
- Aeschlimann SA, Klein A, Schankin CJ. Visual snow syndrome: recent advances in understanding the pathophysiology and potential treatment approaches. Curr Opin Neurol. 2024;37(3):283-288.
- Grande M, Lattanzio L, Buard I, McKendrick AM, Chan YM, Pelak VS. A Study Protocol for an Open-Label Feasibility Treatment Trial of Visual Snow Syndrome With Transcranial Magnetic Stimulation. Front Neurol. 2021;12:724081.
- Werner RN, Gustafson JA. Case Report: Visual Snow Syndrome after Repetitive Mild Traumatic Brain Injury. Optom Vis Sci. 2022;99(4):413-416.
- Wagle AM, Lim WY, Yap TP, Neelam K, Au Eong KG. Utility values associated with vitreous floaters. Am J Ophthalmol. 2011;152(1):60-65.e1.
- Milston R, Madigan MC, Sebag J. Vitreous floaters: Etiology, diagnostics, and management. Surv Ophthalmol. 2016;61(2):211-27.
- Duke RCT, Fischer NA, Crosson JN, Albert MA Jr, Feist RM, Mason JO 3rd. Long-Term Outcomes on Quality of Life Following Sutureless Vitrectomy for Symptomatic Vitreous Floaters. J Vitreoretin Dis. 2025.
- Ankamah E, Green-Gomez M, Roche W, Ng E, Welge-Lüßen U, Kaercher T, et al. Dietary Intervention With a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated With Vitreous Degeneration. Transl Vis Sci Technol. 2021;10(12):19.
- Margo CE, Harman LE. Posterior vitreous detachment. How to approach sudden-onset floaters and flashing lights. Postgrad Med. 2005;117(3):37-42.
- Tsantilas P, Kühnl A, Kallmayer M, Knappich C, Schmid S, Kuetchou A, et al. Stroke risk in the early period after carotid related symptoms: a systematic review. J Cardiovasc Surg (Torino). 2015;56(6):845-52.
- Strömberg S, Nordanstig A, Bentzel T, Österberg K, Bergström GM. Risk of early recurrent stroke in symptomatic carotid stenosis. Eur J Vasc Endovasc Surg. 2015;49(2):137-44.
- Johansson E, Cuadrado-Godia E, Hayden D, Bjellerup J, Ois A, Roquer J, et al. Recurrent stroke in symptomatic carotid stenosis awaiting revascularization: A pooled analysis. Neurology. 2016;86(6):498-504.
- Biousse V, Nahab F, Newman NJ. Management of Acute Retinal Ischemia: Follow the Guidelines!. Ophthalmology. 2018;125(10):1597-1607.
- Hamedani AG, De Lott LB, Willis AW. Nationwide trends in emergency department utilisation for acute retinal ischaemia in the USA, 2011-2018. Br J Ophthalmol. 2023;107(10):1490-1495.
- Carnota-Méndez P, Remolí-Sargues L, Copete S, Fernández-Vega-Gonzálezd Á, Montero-Hernández J, Zarranz-Ventura J, et al. Clinical Guidelines for the Diagnosis and Management of Retinal Artery Occlusions by the Spanish Society of Retina and Vitreous. Ophthalmologica. 2026;249(3):288-312.
- Kappelle LJ, Donders RC, Algra A. Transient monocular blindness. Clin Exp Hypertens. 2006;28(3-4):259-63.
- Lord RS. Transient monocular blindness. Aust N Z J Ophthalmol. 1990;18(3):299-305.
- Bidot S, Biotti D. [Transient monocular blindness: Vascular causes and differential diagnoses]. J Fr Ophtalmol. 2018;41(5):453-461.
- Feroze KB, Gurnani B, O’Rourke MC. Transient loss of vision. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Kaur K, Najem K, Margolin E. Amaurosis fugax. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Calleja S, Vega F, Zeidán N, Lahoz CH. [Light-induced amaurosis fugax]. Neurologia. 2006;21(3):159-61.
- Shah RP, Menzoian JO. Sleep-induced amaurosis fugax. J Vasc Surg. 2011;54(5):1492-4.
- Abe A, Nishiyama Y, Kitahara I, Komatsu D, Katayama Y. Painless transient monocular loss of vision resulting from angle-closure glaucoma. Headache. 2007;47(7):1098-9.
- Pashaei-Marandi A, Kini A, Al Othman B, Lee AG, Falardeau J. The sign of the cross. Surv Ophthalmol. 2021;66(1):145-148.
- Amatya B, Mukherjee D. Cerebrovascular imaging of carotid embolization: Amaurosis fugax and transient ischemic attack in motion. J Vasc Surg Cases Innov Tech. 2025;11(5):101915.
- Kaufman EJ, Mahabadi N, Munakomi S, Patel BC. Hollenhorst plaque. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Bakri SJ, Luqman A, Pathik B, Chandrasekaran K. Is carotid ultrasound necessary in the clinical evaluation of the asymptomatic Hollenhorst plaque? (An American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013;111:17-23.
- Kim SK, Volpe NJ, Stoltz RA. Contemporaneous retinal and optic nerve infarcts, choroidal non-perfusion, and Hollenhorst plaque: are these all embolic events?. J Neuroophthalmol. 2006;26(2):113-6.
- Chawluk JB, Kushner MJ, Bank WJ, Silver FL, Jamieson DG, Bosley TM, et al. Atherosclerotic carotid artery disease in patients with retinal ischemic syndromes. Neurology. 1988;38(6):858-63.
- Diel NJ, Gerner ST, Doeppner TR, Juenemann M, Maxhuni T, Frühwald T, et al. Comparison of vascular risk profile and clinical outcomes among patients with central (branch) retinal artery occlusion versus amaurosis fugax. Neurol Res Pract. 2024;6(1):27.
- Hazin R, Daoud YJ, Khan F. Ocular ischemic syndrome: recent trends in medical management. Curr Opin Ophthalmol. 2009;20(6):430-3.
- Vilares-Morgado R, Nunes HMM, Dos Reis RS, Barbosa-Breda J. Management of ocular arterial ischemic diseases: a review. Graefes Arch Clin Exp Ophthalmol. 2023;261(1):1-22.
- Streifler JY, Eliasziw M, Benavente OR, Harbison JW, Hachinski VC, Barnett HJ, et al. The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol. 1995;52(3):246-9.
- Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJ, Meldrum H. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med. 2001;345(15):1084-90.
- Columbo JA, Martinez-Camblor P, Suckow BD, Krafcik BM, Hicks CW, Huber TS, et al. Rethinking the impact of amaurosis with contemporary outcomes of carotid endarterectomy among patients with transient monocular blindness. J Vasc Surg. 2026;83(5):1369-1378.e1.
- Volkers EJ, Donders RC, Koudstaal PJ, van Gijn J, Algra A, Jaap Kappelle L. Transient monocular blindness and the risk of vascular complications according to subtype: a prospective cohort study. J Neurol. 2016;263(9):1771-7.
- Tanaka K, Uehara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, et al. Features of patients with transient monocular blindness: a multicenter retrospective study in Japan. J Stroke Cerebrovasc Dis. 2014;23(3):e151-5.
- Raser JM, Cucchiara BL. Modifications of the ABCD2 score do not improve the risk stratification of transient ischemic attack patients. J Stroke Cerebrovasc Dis. 2012;21(6):467-70.
- Deris D, Mastroianni S, Kan J, Veroniki AA, Sharma M, Joundi RA, et al. Performance of Stratification Scores on the Risk of Stroke After a Transient Ischemic Attack: A Systematic Review and Network Meta-Analysis. J Clin Med. 2025;14(17).
- Cumbler E, Glasheen JJ. Risk stratification tools for transient ischemic attack: which patients require hospital admission?. J Hosp Med. 2009;4(4):247-51.
- Bonati LH, Kakkos S, Berkefeld J, de Borst GJ, Bulbulia R, Halliday A, et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J. 2021;6(2):I-XLVII.
- AbuRahma AF, Avgerinos ED, Chang RW, Darling RC 3rd, Duncan AA, Forbes TL, et al. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg. 2022;75(1S):4S-22S.
- Musialek P, Bonati LH, Bulbulia R, Halliday A, Bock B, Capoccia L, et al. Stroke risk management in carotid atherosclerotic disease: a clinical consensus statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases. Cardiovasc Res. 2025;121(1):13-43.
- Abbott AL, Paraskevas KI, Kakkos SK, Golledge J, Eckstein HH, Diaz-Sandoval LJ, et al. Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis. Stroke. 2015;46(11):3288-301.
- Henning RJ, Hoh BL. The diagnosis and treatment of asymptomatic and symptomatic patients with carotid artery stenosis. Curr Probl Cardiol. 2025;50(6):102992.
- Savardekar AR, Narayan V, Patra DP, Spetzler RF, Sun H. Timing of Carotid Endarterectomy for Symptomatic Carotid Stenosis: A Snapshot of Current Trends and Systematic Review of Literature on Changing Paradigm towards Early Surgery. Neurosurgery. 2019;85(2):E214-E225.
- Sardar P, Chatterjee S, Aronow HD, Kundu A, Ramchand P, Mukherjee D, et al. Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention: A Meta-Analysis of Clinical Trials. J Am Coll Cardiol. 2017;69(18):2266-2275.
- Chu G, Cheng L, Zhang K. Carotid Artery Stenting Versus Carotid Endarterectomy for Carotid Artery Stenosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Catheter Cardiovasc Interv. 2025;106(5):2913-2934.
- Vincent S, Eberg M, Eisenberg MJ, Filion KB. Meta-Analysis of Randomized Controlled Trials Comparing the Long-Term Outcomes of Carotid Artery Stenting Versus Endarterectomy. Circ Cardiovasc Qual Outcomes. 2015;8(6 Suppl 3):S99-108.
- Rodrigues JR, Coelho A, Mansilha A. Medical treatment versus endarterectomy for symptomatic carotid stenosis: systematic review and meta-analysis. Int Angiol. 2025;44(1):41-50.
- Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol. 1984;16(4):489-94.
- Liu IH, Wang AG, Yen MY. Idiopathic intracranial hypertension: clinical features in Chinese patients. Jpn J Ophthalmol. 2011;55(2):138-42.
- Hsu HT, Cheng HC, Hou TW, Tzeng YS, Fuh JL, Chen SP, et al. Idiopathic intracranial hypertension in Asians: a retrospective dual-center study. J Headache Pain. 2024;25(1):144.
- Urquiola Cortés N, Fernández Salgado V, Luco Franzoy C, Trigo Daroni C, Romero NA, Klagges Troncoso J. [Idiopathic Intracranial Hypertension: Clinical-Epidemiological Profile and Factors Associated with Visual Outcome]. Rev Med Chil. 2024;152(11):1120-1129.
- Sabet SJ, Gasquet NC, Henderson AD, Carey AR. Clinical Characteristics of Idiopathic Intracranial Hypertension in Older Adults. J Neuroophthalmol. 2024;44(4):502-506.
- Hayat SC, Yilmaz YC, Davulcu K, Ozal SA. Rising consultations for suspected papilledema: clinical and neuro-ophthalmologic insights. Int Ophthalmol. 2025;45(1):229.
- Sun X, Ji X, Zheng Y, Guo B. Primary chronic angle-closure glaucoma in Chinese—a clinical exploration of its pathogenesis and natural course. Yan Ke Xue Bao. 1994;10(3):176-85.
- Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S, et al. Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket Glaucoma Study. Ophthalmology. 2000;107(5):998-1003.
- Leung CK, Chan WM, Ko CY, Chui SI, Woo J, Tsang MK, et al. Visualization of anterior chamber angle dynamics using optical coherence tomography. Ophthalmology. 2005;112(6):980-4.
- Leibovitch I, Kurtz S, Almog Y. Adie’s tonic pupil-induced angle-closure glaucoma. Ophthalmologica. 2002;216(1):71-2.
- Pinto Ferreira N, Medeiros Pinto J, Pinto F, Abegão Pinto L. Angle closure as a cause for intermittent headache in a child. BMJ Case Rep. 2017;2017.
- Krohn J, Bjune C. Uveal effusion and angle-closure glaucoma in primary pulmonary hypertension. Am J Ophthalmol. 2003;135(5):705-6.
- Tsai RK, Chen JY, Wang HZ. Gaze-evoked amaurosis caused by intraconal cavernous hemangioma: a case report. Kaohsiung J Med Sci. 1997;13(5):324-7.
- Sibony P, Shindo M. Orbital osteoma with gaze-evoked amaurosis. Arch Ophthalmol. 2004;122(5):788.
- Patel MM, Lefebvre DR, Lee NG, Brachtel E, Rizzo J, Freitag SK. Gaze-evoked amaurosis from orbital breast carcinoma metastasis. Ophthalmic Plast Reconstr Surg. 2013;29(4):e98-e101.
- Garg A, DeAngelis D, Hojilla CV, Micieli JA. Gaze-evoked amaurosis from idiopathic orbital inflammation. Orbit. 2022;41(5):620-623.
- Salvi F, Bernardi B, Mascalchi M, Bisulli F, Zonari P, Foschini MP, et al. Gaze-evoked amaurosis heralding orbital angiomyoma. Case report. Ital J Neurol Sci. 1997;18(1):31-4.
- Orcutt JC, Tucker WM, Mills RP, Smith CH. Gaze-evoked amaurosis. Ophthalmology. 1987;94(3):213-8.
- Otto CS, Coppit GL, Mazzoli RA, Eusterman VD, Nixon KL, Ainbinder DJ, et al. Gaze-evoked amaurosis: a report of five cases. Ophthalmology. 2003;110(2):322-6.
- Hampton GR, Krohel GB. Gaze-evoked blindness. Ann Ophthalmol. 1983;15(1):73-6.
- Berglöff J, Mattes D, Brix-Grünwald G, Gröll R, Weger M. [Gaze-evoked amaurosis fugax]. Ophthalmologe. 2006;103(12):1044-6.
- Manor RS, Yassur Y, Hoyt WF. Reading-evoked visual dimming. Am J Ophthalmol. 1996;121(2):212-4.
- Magnin E, Mouton S, Abouaf L, Dumas-Stoeckel S, Hermier M, Tilikete C, et al. [Idiopathic vasospastic angiopathy of the internal carotid arteries: A rarely recognized cause of ischemic stroke in young individuals]. Rev Neurol (Paris). 2011;167(8-9):626-31.
- Paul NL, Simoni M, Rothwell PM. Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurol. 2013;12(1):65-71.
- Benjamin R, Ighodaro ET. Vertebrobasilar stroke. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Koçer A. Cognitive problems related to vertebrobasilar circulation. Turk J Med Sci. 2015;45(5):993-7.
- Sarkar J, Wolfe SQ, Ching BH, Kellicut DC. Bow hunter’s syndrome causing vertebrobasilar insufficiency in a young man with neck muscle hypertrophy. Ann Vasc Surg. 2014;28(4):1032.e1-1032.e10.
- Rastogi V, Rawls A, Moore O, Victorica B, Khan S, Saravanapavan P, et al. Rare Etiology of Bow Hunter’s Syndrome and Systematic Review of Literature. J Vasc Interv Neurol. 2015;8(3):7-16.
- Zeineddine HA, Galan Castro G, Dono A, Wroe WW, D’Amato SA, Trimble D, et al. Dynamic vertebral artery recanalization as a cause for recurrent posterior circulation thromboembolic stroke: illustrative case. J Neurosurg Case Lessons. 2025;9(18).
- Arntzen K, Alstadhaug KB. Room tilt illusion and subclavian steal - a case report. BMC Neurol. 2020;20(1):369.
- Pellenc Q, Renard R, Gaudemer A, Amarenco P, Lavallée P. Bypass grafting to the third segment of the vertebral artery for symptomatic extensive vertebrobasilar atherosclerotic disease. J Vasc Surg Cases Innov Tech. 2023;9(3):101260.
- Zhou G, Xu Y. Transient Ischemic Attack Progressing to Top-of-the-Basilar Syndrome: A Case Report. Am J Case Rep. 2026;27:e953007.
- Arena JE, Rabinstein AA. Transient global amnesia. Mayo Clin Proc. 2015;90(2):264-72.
- Lui F, Spurling BC. Transient global amnesia. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Hunter G. Transient global amnesia. Neurol Clin. 2011;29(4):1045-54.
- Marazzi C, Scoditti U, Ticinesi A, Nouvenne A, Pigna F, Guida L, et al. Transient global amnesia. Acta Biomed. 2014;85(3):229-35.
- Alessandro L, Calandri IL, Suarez MF, Heredia ML, Chaves H, Allegri RF, et al. Transient global amnesia: clinical features and prognostic factors suggesting recurrence. Arq Neuropsiquiatr. 2019;77(1):3-9.
- He S, Ye Z, Yang Q, Lin J, Chen X, Chen Z, et al. Transient Global Amnesia: Risk Factors, Imaging Features, and Prognosis. Neuropsychiatr Dis Treat. 2021;17:1611-1619.
- Gindes I, Kimiagar I, Peretz S, Kenan G. Clinical features and prognosis of transient global amnesia in Israel: 6 years’ single-center experience. Acta Neurol Belg. 2025;125(2):417-423.
- Piffer S, Nannoni S, Maulucci F, Beaud V, Rouaud O, Förster A, et al. Transient global amnesia with unexpected clinical and radiological findings: A case series and systematic review. J Neurol Sci. 2022;441:120349.
- Garg RK, Kumar N, Malhotra HS. Posterior reversible encephalopathy syndrome in eclampsia. Neurol India. 2018;66(5):1316-1323.
- Jeelani H, Sharma A, Halawa AM. Posterior Reversible Encephalopathy Syndrome in Organ Transplantation. Exp Clin Transplant. 2022;20(7):642-648.
- Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264(8):1608-1616.
- Gewirtz AN, Gao V, Parauda SC, Robbins MS. Posterior Reversible Encephalopathy Syndrome. Curr Pain Headache Rep. 2021;25(3):19.
- Ando Y, Ono Y, Sano A, Fujita N, Ono S. Posterior Reversible Encephalopathy Syndrome: A Review of the Literature. Intern Med. 2022;61(2):135-141.
- Zelaya JE, Al-Khoury L. Posterior reversible encephalopathy syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Singhal AB. Reversible cerebral vasoconstriction syndrome: A review of pathogenesis, clinical presentation, and treatment. Int J Stroke. 2023;18(10):1151-1160.
- Maher C, Guo B, Yek J. A Five-Step Approach to Acute Vision Loss: A Practical Narrative Review for Clinicians. Clin Ophthalmol. 2026;20:590753.
- Sené T, Clavel G, Villeneuve D, Philibert M, Mauget-Faÿsse M, Lamirel C, et al. [Delays in the management of ocular complications of giant cell arteritis: A retrospective monocentric study of 33 patients]. Rev Med Interne. 2020;41(10):661-666.
- Helliwell T, Muller S, Hider SL, Prior JA, Richardson JC, Mallen CD. Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study. BMJ Open. 2018;8(2):e019320.
- Smith SCM, Al-Hashimi MR, Jones CD, Mukhtyar CB. Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis. Clin Med (Lond). 2023;23(3):206-212.
- Ness T, Nölle B. Giant Cell Arteritis. Klin Monbl Augenheilkd. 2024;241(5):644-652.
- Patil P, Karia N, Jain S, Dasgupta B. Giant cell arteritis: a review. Eye Brain. 2013;5:23-33.
- Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, et al. The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess. 2016;20(90):1-238.
- Noumegni SR, Hoffmann C, Cornec D, Gestin S, Bressollette L, Jousse-Joulin S. Temporal Artery Ultrasound to Diagnose Giant Cell Arteritis: A Practical Guide. Ultrasound Med Biol. 2021;47(2):201-213.
- Hamann S, Ing EB, Lee AG, Van Stavern GP. Can Ultrasound Replace Temporal Artery Biopsy for Diagnosing Giant Cell Arteritis?. J Neuroophthalmol. 2024;44(2):273-279.
- Dejaco C, Ponte C, Monti S, Rozza D, Scirè CA, Terslev L, et al. The provisional OMERACT ultrasonography score for giant cell arteritis. Ann Rheum Dis. 2023;82(4):556-564.
- Bergner R, Löffler C, Schulz P, Klank D, Friedrich J. New versus old: comparison of the 2022 ACR/EULAR versus the 1990 ACR classification criteria for giant cell arteritis in a real-world cohort. Rheumatol Int. 2025;45(11):248.
- Duron L, Chazal T, Sene T, Savatovsky J, Lecler A. Fast-track pathway for giant cell arteritis: Improved visual outcomes and reduced healthcare costs. PLoS One. 2025;20(12):e0338397.
- Beirão TMBDM, Rua C, Silva C, Patela M, Vieira R, Abelha-Aleixo J, et al. Fast-Track Clinics and Visual Outcomes in Giant Cell Arteritis: A Systematic Review and Meta-Analysis. J Clin Rheumatol. 2026;32(3):96-100.
- Song J, Jiang H, Wang X, Gong K. Evolution of the Diagnostic Paradigm for Giant Cell Arteritis: From Histopathology to Multimodal Imaging Integration. J Rheumatol. 2026;53(8):842-848.
- Panginikkod S, Rayi A, Rocha Cabrero F, Rukmangadachar LA. Uhthoff phenomenon. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Davis SL, Jay O, Wilson TE. Thermoregulatory dysfunction in multiple sclerosis. Handb Clin Neurol. 2018;157:701-714.
- Sunness JS, Murphy O, Calabresi PA. Photostress-Induced Uhthoff Phenomenon. J Neuroophthalmol. 2025;45(1):e38-e39.
- Liang H, Xus C, Xu J. Uhthoff’s phenomenon as the initial symptom in neuromyelitis optica spectrum disorders: a case report. Hong Kong Med J. 2023;29(3):259-261.
- Pilato F, Capone F, Ferrante M, Marcosano M, Di Lazzaro V. Uhthoff Phenomenon in Guillain Barré Syndrome. Neurol India. 2023;71(1):149-150.
- Rae-Grant AD. Unusual symptoms and syndromes in multiple sclerosis. Continuum (Minneap Minn). 2013;19(4 Multiple Sclerosis):992-1006.
- Reynolds LF, Short CA, Westwood DA, Cheung SS. Head pre-cooling improves symptoms of heat-sensitive multiple sclerosis patients. Can J Neurol Sci. 2011;38(1):106-11.
- Critch AL, Snow NJ, Alcock LR, Chaves AR, Buragadda S, Ploughman M. Multiple sclerosis-related heat sensitivity linked to absence of DMT prescription and subjective hand impairment but not autonomic or corticospinal dysfunction. Mult Scler Relat Disord. 2023;70:104514.
- Sibony PA, Krauss HR, Kennerdell JS, Maroon JC, Slamovits TL. Optic nerve sheath meningiomas. Clinical manifestations. Ophthalmology. 1984;91(11):1313-26.
- Ahmed H, Khazaeni L. Optic disc drusen. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Potter BJ, Pinto DS. Subclavian steal syndrome. Circulation. 2014;129(22):2320-3.
- Zavaruev AV. [Subclavian steal syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(1):72-77.
- Lum CF, Ilsen PF, Kawasaki B. Subclavian steal syndrome. Optometry. 2004;75(3):147-60.
- Han J, Xiang H, Ridley WE, Ridley LJ. Bunny waveform: Early feature of subclavian steal syndrome. J Med Imaging Radiat Oncol. 2018;62 Suppl 1:22.
- Bey T, Qdaisat A. Hyperviscosity Syndrome: An Oncologic Emergency. Emerg Med Clin North Am. 2025;43(3):445-452.
- Higdon ML, Atkinson CJ, Lawrence KV. Oncologic Emergencies: Recognition and Initial Management. Am Fam Physician. 2018;97(11):741-748.
- Stone MJ. Waldenström’s macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia. Clin Lymphoma Myeloma. 2009;9(1):97-9.
- Aubineau A, Hrarat L, Giocanti-Aurégan A. [Hyperviscosity syndrome]. J Fr Ophtalmol. 2019;42(7):e301-e303.
- Menke MN, Feke GT, McMeel JW, Branagan A, Hunter Z, Treon SP. Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia. Arch Ophthalmol. 2006;124(11):1601-6.
- Dammacco R, Lisch W, Kivelä TT, Terpos E, Kastritis E, Sisto D, et al. The Spectrum of Ocular Manifestations in Patients with Waldenström’s Macroglobulinemia. Ocul Immunol Inflamm. 2022;30(7-8):1659-1668.
- Merz T, Marchesoni I, Caminiti G, Romanelli F. Efficacy of plasmapheresis as treatment for bilateral hyperviscosity syndrome related retinopathy in multiple myeloma. Eur J Ophthalmol. 2022;32(4):NP48-NP51.
- Kalayoglu-Besisik S. The use of emergency apheresis in the management of plasma cell disorders. Transfus Apher Sci. 2018;57(1):35-39.
- Brière JB. Essential thrombocythemia. Orphanet J Rare Dis. 2007;2:3.
- Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Semin Thromb Hemost. 2006;32(3):174-207.
- Koudstaal PJ, Koudstaal A. Neurologic and visual symptoms in essential thrombocythemia: efficacy of low-dose aspirin. Semin Thromb Hemost. 1997;23(4):365-70.
- AlRyalat SA, Nawaiseh M, Aladwan B, Roto A, Alessa Z, Al-Omar A. Ocular Manifestations of Sickle Cell Disease: Signs, Symptoms and Complications. Ophthalmic Epidemiol. 2020;27(4):259-264.
- Fadugbagbe AO, Gurgel RQ, Mendonça CQ, Cipolotti R, dos Santos AM, Cuevas LE. Ocular manifestations of sickle cell disease. Ann Trop Paediatr. 2010;30(1):19-26.
- Utz VM, Tang J. Ocular manifestations of the antiphospholipid syndrome. Br J Ophthalmol. 2011;95(4):454-9.
- Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OGP, Silva GS, et al. Neurologic manifestations of antiphospholipid syndrome. Lupus. 2018;27(9):1404-1414.
- Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J. Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neurol. 2022;21(6):537-550.
- Beatty S. Non-organic visual loss. Postgrad Med J. 1999;75(882):201-7.
- Manion GN, Stokkermans TJ. Nonorganic vision loss. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Ney JJ, Volpe NJ, Liu GT, Balcer LJ, Moster ML, Galetta SL. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology. 2009;116(9):1808-1813.e1.
- Incesu AI. Tests for malingering in ophthalmology. Int J Ophthalmol. 2013;6(5):708-17.
- Mursch-Edlmayr AS, Mojon D, Bolz M. [Testing and approach when non-organic visual loss is suspected]. Ophthalmologe. 2018;115(1):77-87.
- Gundogan FC, Sobaci G, Bayer A. Pattern visual evoked potentials in the assessment of visual acuity in malingering. Ophthalmology. 2007;114(12):2332-7.
- Pineles SL, Volpe NJ. Computerized kinetic perimetry detects tubular visual fields in patients with functional visual loss. Am J Ophthalmol. 2004;137(5):933-5.
- Bain KE, Beatty S, Lloyd C. Non-organic visual loss in children. Eye (Lond). 2000;14 Pt 5:770-2.
- Glisson CC. Approach to Diplopia. Continuum (Minneap Minn). 2019;25(5):1362-1375.
- Mackay DD. Approach to Diplopia. Continuum (Minneap Minn). 2025;31(2):463-478.
- Jain S. Diplopia: Diagnosis and management. Clin Med (Lond). 2022;22(2):104-106.
- Margolin E, Lam CTY. Approach to a Patient with Diplopia in the Emergency Department. J Emerg Med. 2018;54(6):799-806.
- Kremmyda O, Frenzel C, Hüfner K, Goldschagg N, Brem C, Linn J, et al. Acute binocular diplopia: peripheral or central?. J Neurol. 2020;267(Suppl 1):136-142.
- Tandt D, Le Lez ML, Level C, Stach É, Cottier JP, Pisella PJ, et al. [Management of binocular diplopia in the department of ophthalmic emergencies at the Regional University Hospital of Tours]. J Fr Ophtalmol. 2023;46(5):449-460.
- Brune AJ, Gold DR. Acute Visual Disorders-What Should the Neurologist Know?. Semin Neurol. 2019;39(1):53-60.
- Brazis PW, Lee AG. Binocular vertical diplopia. Mayo Clin Proc. 1998;73(1):55-66.
- Acierno MD. Vertical diplopia. Semin Neurol. 2000;20(1):21-30.
- Miller AM. Torsional Diplopia. Am Orthopt J. 2015;65:21-5.
- Luo G, Pundlik S, Tomasi M, Houston K. Using an Automated Hirschberg Test App to Evaluate Ocular Alignment. J Vis Exp. 2020.
- Cheng W, Lynn MH, Pundlik S, Almeida C, Luo G, Houston K. A smartphone ocular alignment measurement app in school screening for strabismus. BMC Ophthalmol. 2021;21(1):150.
- Elrod RD, Weinberg DA. Ocular myasthenia gravis. Ophthalmol Clin North Am. 2004;17(3):275-309; v.
- Gwathmey KG, Burns TM. Myasthenia Gravis. Semin Neurol. 2015;35(4):327-39.
- Sergeeva MS, Danilov SS, Sherbakova NI. [Ocular myasthenia gravis]. Vestn Oftalmol. 2024;140(4):86-91.
- Cornblath WT. Treatment of Ocular Myasthenia Gravis. Asia Pac J Ophthalmol (Phila). 2018;7(4):257-259.
- Gindelskhi Sagiv R, Levy N, Huna-Baron R, Leiba H, Paz T, Rappoport D. Diplopia in the Younger Adult (≤65 Years Old) Compared With Older Adult (>65 Years Old) Population-Presentation, Progression, and Outcome. J Neuroophthalmol. 2024;44(3):394-399.
- Kawai M, Goseki T, Ishikawa H, Hoshina M, Shoji N. Causes, background, and characteristics of binocular diplopia in the elderly. Jpn J Ophthalmol. 2018;62(6):659-666.
- Merino P, Fuentes D, Gómez de Liaño P, Ordóñez MA. Binocular diplopia in a tertiary hospital: Aetiology, diagnosis and treatment. Arch Soc Esp Oftalmol. 2017;92(12):565-570.
- Park KA, Oh SY, Min JH, Kim BJ, Kim Y. Cause of acquired onset of diplopia due to isolated third, fourth, and sixth cranial nerve palsies in patients aged 20 to 50 years in Korea: A high resolution magnetic resonance imaging study. J Neurol Sci. 2019;407:116546.
- Raucci U, Parisi P, Vanacore N, La Penna F, Ferro V, Calistri L, et al. Acute diplopia in the pediatric Emergency Department. A cohort multicenter Italian study. Eur J Paediatr Neurol. 2017;21(5):722-729.
- Teksam O, Gultekingil A, Konuskan B, Haliloglu G, Oguz KK, Yalnizoglu D. Acute Abducens Nerve Paralysis in the Pediatric Emergency Department: Analysis of 14 Patients. Pediatr Emerg Care. 2016;32(5):307-11.
- Ben Simon GJ, Katz G, Zloto O, Leiba H, Hadas B, Huna-Baron R. Age differences in clinical manifestation and prognosis of thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2301-8.
- Jang JH, Park JW, Park KA, Kim YD, Woo KI. Early response to intravenous methylprednisolone therapy for restrictive myopathy in patients with thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2023;261(8):2375-2382.
- Grob S, Yonkers M, Tao J. Orbital Fracture Repair. Semin Plast Surg. 2017;31(1):31-39.
- Tooley AA, Levine B, Godfrey KJ, Lisman RD, Tran AQ, Sherman JE. Inferior Oblique Entrapment After Orbital Fracture With Transection and Repair. Craniomaxillofac Trauma Reconstr. 2020;13(3):211-214.
- Chen VM, Dagi LR. Ocular misalignment in Graves disease may mimic that of superior oblique palsy. J Neuroophthalmol. 2008;28(4):302-4.
- Wu YT, Cafiero-Chin M, Marques C. Wall-eyed bilateral internuclear ophthalmoplegia: review of pathogenesis, diagnosis, prognosis and management. Clin Exp Optom. 2015;98(1):25-30.
- Borgman CJ, Krug C. Case Report: Asymptomatic Skew Deviation Secondary to Chronic Ischemic Infarction of the Cerebellum. Optom Vis Sci. 2022;99(10):786-790.
- Manchandia AM, Demer JL. Sensitivity of the three-step test in diagnosis of superior oblique palsy. J AAPOS. 2014;18(6):567-71.
- Goseki T, Suh SY, Robbins L, Pineles SL, Velez FG, Demer JL. Prevalence of Sagging Eye Syndrome in Adults with Binocular Diplopia. Am J Ophthalmol. 2020;209:55-61.
- Oohira A. Objective excyclotorsion in age-related distance esotropia. Strabismus. 2022;30(2):72-77.
- Cioplean D, Nitescu Raluca L. Age related strabismus. Rom J Ophthalmol. 2016;60(2):54-58.
- Gunton KB, Armstrong B. Diplopia in adult patients following cataract extraction and refractive surgery. Curr Opin Ophthalmol. 2010;21(5):341-4.
- Rossel-Zemkouo MJ, Bergholz R, Salchow DJ. Strabismus patterns after cataract surgery in adults. Strabismus. 2021;29(1):19-25.
- Shippman S, Cohen KR, Heiser L. Macular Diplopia. Am Orthopt J. 2015;65:26-30.
- Mosleh R, Peragallo JH. Nonneurologic causes of binocular diplopia for the neurologist. Curr Opin Neurol. 2023;36(1):26-35.
- Zheng J, Wan Y. Internal carotid artery aneurysm with incomplete isolated oculomotor nerve palsy: a case report. J Med Case Rep. 2023;17(1):77.
- Hayreh SS. Ophthalmic features of giant cell arteritis. Baillieres Clin Rheumatol. 1991;5(3):431-59.
- Habas E, Farfar K, Errayes N, Rayani A, Elzouki AN. Wernicke Encephalopathy: An Updated Narrative Review. Saudi J Med Med Sci. 2023;11(3):193-200.
- Teener JW. Miller Fisher’s syndrome. Semin Neurol. 2012;32(5):512-6.
- Lee SU, Kim HJ, Choi JY, Choi KD, Kim JS. Expanding Clinical Spectrum of Anti-GQ1b Antibody Syndrome: A Review. JAMA Neurol. 2024;81(7):762-770.
- Nair AG, Ambika S, Noronha VO, Gandhi RA. The diagnostic yield of neuroimaging in sixth nerve palsy—Sankara Nethralaya Abducens Palsy Study (SNAPS): Report 1. Indian J Ophthalmol. 2014;62(10):1008-12.
- Chi SL, Bhatti MT. The diagnostic dilemma of neuro-imaging in acute isolated sixth nerve palsy. Curr Opin Ophthalmol. 2009;20(6):423-9.
- Chou KL, Galetta SL, Liu GT, Volpe NJ, Bennett JL, Asbury AK, et al. Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessment. J Neurol Sci. 2004;219(1-2):35-9.
- Naidorf Rosenblatt H, Levy N, Paz T, Leiba H, Belyansky E, Rappoport D. [CASE SERIES OF EARLY NEUROIMAGING IN PATIENTS WITH VASCULAR RISK FACTORS AND ISOLATED SIX CRANIAL NERVE PALSY, DEMONSTRATING THE DILEMMA OF EARLY IMAGING]. Harefuah. 2022;161(10):617-622.
- Pineles SL, Velez FG. Isolated Ocular Motor Nerve Palsies. J Binocul Vis Ocul Motil. 2018;68(3):70-77.
- Billerot E, Nguyen TH, Sedira N, Espinoza S, Vende B, Heron E, et al. Ocular motor nerve palsy in patients with diabetes: High-resolution MR imaging of nerve enhancement. J Fr Ophtalmol. 2023;46(7):726-736.
- Iliescu DA, Timaru CM, Alexe N, Gosav E, De Simone A, Batras M, et al. Management of diplopia. Rom J Ophthalmol. 2017;61(3):166-170.
- Hyndman J. Spasm of the Near Reflex: Literature Review and Proposed Management Strategy. J Binocul Vis Ocul Motil. 2018;68(3):78-86.
- Gupta S, Gan J, Jain S. Efficacy of Botulinum Toxin in the Treatment of Convergence Spasm. Strabismus. 2018;26(3):122-125.
- Mastroianni G, Neri S, Ascoli M, Gasparini S, Cianci V, Aguglia U, et al. Functional convergence spasm: an unexpected finding in a patient with focal epilepsy. Eur Rev Med Pharmacol Sci. 2021;25(22):6995-6998.
- O’Colmain U, Gilmour C, MacEwen CJ. Acute-onset diplopia. Acta Ophthalmol. 2014;92(4):382-6.
- Santodomingo-Rubido J, Carracedo G, Suzaki A, Villa-Collar C, Vincent SJ, Wolffsohn JS. Keratoconus: An updated review. Cont Lens Anterior Eye. 2022;45(3):101559.
- Song M, Chen T, Moktar A, Chan E, Chong EW, Daniell M, et al. Diagnosis and Management of Keratoconus-A Narrative Review of Clinicians’ Perspectives. Children (Basel). 2022;9(12).
- Price LD, Larkin DFP. Diagnosis and management of keratoconus in the paediatric age group: a review of current evidence. Eye (Lond). 2023;37(18):3718-3724.
- Bourges JL. [Corneal dystrophies]. J Fr Ophtalmol. 2017;40(7):606-621.
- Lee WS, Lam CK, Manche EE. Phototherapeutic keratectomy for epithelial basement membrane dystrophy. Clin Ophthalmol. 2017;11:15-22.
- Delbarre M, Froussart-Maille F. [Signs, symptoms, and clinical forms of cataract in adults]. J Fr Ophtalmol. 2020;43(7):653-659.
- Neuhann I, Neuhann L, Neuhann T. [Age-related Cataract]. Klin Monbl Augenheilkd. 2022;239(4):615-633.
- Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476-85.
- Dhiman R, Kaur L, Sharma N, Pandey ML. Diverse presentations of ectopia lentis and lens coloboma in Marfan’s syndrome. Oman J Ophthalmol. 2023;16(2):310-313.
- Koh S. Mechanisms of Visual Disturbance in Dry Eye. Cornea. 2016;35 Suppl 1:S83-S88.
- Wei Z, Su Y, Su G, Baudouin C, Labbé A, Liang Q. Effect of artificial tears on dynamic optical quality in patients with dry eye disease. BMC Ophthalmol. 2022;22(1):64.
- Xie PY, Wang D, Yang LN, Zhou WJ. [The evaluation of visual quality in keratoconus eyes corrected by rigid gas-permeable contact lens]. Zhonghua Yan Ke Za Zhi. 2005;41(12):1086-91.
- Bouffard MA, Cestari DM. Diplopia after Cataract Extraction. Semin Ophthalmol. 2018;33(1):11-16.
- Hayashi K, Hayashi H, Nakao F, Hayashi F. Correlation between posterior capsule opacification and visual function before and after Neodymium: YAG laser posterior capsulotomy. Am J Ophthalmol. 2003;136(4):720-6.
- Yotsukura E, Torii H, Saiki M, Negishi K, Tsubota K. Effect of neodymium:YAG laser capsulotomy on visual function in patients with posterior capsule opacification and good visual acuity. J Cataract Refract Surg. 2016;42(3):399-404.
- Uzel MM, Ozates S, Koc M, Taslipinar Uzel AG, Yılmazbaş P. Decentration and Tilt of Intraocular Lens after Posterior Capsulotomy. Semin Ophthalmol. 2018;33(6):766-771.
- Chang PY, Lian CY, Wang JK, Su PY, Wang JY, Chang SW. Surgical approach affects intraocular lens decentration. J Formos Med Assoc. 2017;116(3):177-184.
- Lin H, Zhang J, Zhang Y, Jin A, Zhang Y, Jin L, et al. Capsular Tension Ring Implantation for Intraocular Lens Decentration and Tilt in Highly Myopic Eyes: A Randomized Clinical Trial. JAMA Ophthalmol. 2024;142(8):708-715.
- Tchah H, Nam K, Yoo A. Predictive factors for photic phenomena after refractive, rotationally asymmetric, multifocal intraocular lens implantation. Int J Ophthalmol. 2017;10(2):241-245.
- Giers BC, Khoramnia R, Varadi D, Wallek H, Son HS, Attia MS, et al. Functional results and photic phenomena with new extended-depth-of-focus intraocular Lens. BMC Ophthalmol. 2019;19(1):197.
- Huang Y, Zhan B, Han T, Zhou X. Effective optical zone following small incision lenticule extraction: a review. Graefes Arch Clin Exp Ophthalmol. 2024;262(6):1657-1665.
- Hammond SD Jr, Puri AK, Ambati BK. Quality of vision and patient satisfaction after LASIK. Curr Opin Ophthalmol. 2004;15(4):328-32.
- Wallerstein A, Kam JWK, Gauvin M, Adiguzel E, Bashour M, Kalevar A, et al. Refractive, visual, and subjective quality of vision outcomes for very high myopia LASIK from - 10.00 to - 13.50 diopters. BMC Ophthalmol. 2020;20(1):234.
- Yu M, Chen M, Wang B, Zou L, Zhu X, Dai J. Comparison of Visual Quality After SMILE and LASEK for Mild to Moderate Myopia. J Refract Surg. 2015;31(12):795-800.
- Liao T, Li L, Wei D, Mao H, Huang Y, Lu P, et al. Evaluation of changes in objective visual quality based on tear film stability after SMILE surgery. Front Med (Lausanne). 2025;12:1538359.
- Oshika T. [Quantitative assessment of quality of vision]. Nippon Ganka Gakkai Zasshi. 2004;108(12):770-807; discussion 808.
- Kohnen T, Klaproth OK. [Aspheric intraocular lenses]. Ophthalmologe. 2008;105(3):234-40.
- Fujikado T, Kuroda T, Maeda N, Kim A, Tano Y, Oshika T, et al. Wavefront analysis of an eye with monocular triplopia and nuclear cataract. Am J Ophthalmol. 2004;137(2):361-3.
- Kim A, Bessho K, Okawa Y, Maeda N, Tano Y, Hirohara Y, et al. Wavefront analysis of eyes with cataracts in patients with monocular triplopia. Ophthalmic Physiol Opt. 2006;26(1):65-70.
- Kalikivayi L, Ajitha Vilasendran J, Chettupuzha Lonappan A, Cherian Jacob S, Kalikivayi V. A novel method in correcting aberropia using pin hole soft contact lenses: A case report. Cont Lens Anterior Eye. 2019;42(3):334-338.
- Isherwood S, Jewsbury H, Nitkunan A, Ali N. An unusual case of cerebral polyopia. Can J Ophthalmol. 2017;52(3):e102-e104.
- Lahiri D. Palinopsia. Cortex. 2020;133:399.
- Smith PE, Shah P, Sharpe J, Todd A, Goringe AP. Palinopsia. Lancet. 2003;361(9363):1098.
- de Luis Eguileor B, Etxebarria Ecenarro J, Santamaria Carro A, Feijoo Lera R. Irregular Corneas: Improve Visual Function With Scleral Contact Lenses. Eye Contact Lens. 2018;44(3):159-163.
- Romero-Jiménez M, Flores-Rodríguez P. Utility of a semi-scleral contact lens design in the management of the irregular cornea. Cont Lens Anterior Eye. 2013;36(3):146-50.
- Sharma N, Sah R, Priyadarshini K, Titiyal JS. Contact lenses for the treatment of ocular surface diseases. Indian J Ophthalmol. 2023;71(4):1135-1141.
- Carrasquillo KG, Riccobono K, Liao J, Shi Y, Asghari B, Brocks D, et al. Pediatric Scleral Lenses: 21-Year Retrospective Review. Clin Optom (Auckl). 2024;16:327-339.
- Luo WL, Tong JP, Shen Y. Rigid gas-permeable contact lens for visual rehabilitation in aphakia following trauma. Clin Exp Optom. 2012;95(5):499-505.
- Shajari M, Mackert MJ, Langer J, Kreutzer T, Wolf A, Kohnen T, et al. Safety and efficacy of a small-aperture capsular bag-fixated intraocular lens in eyes with severe corneal irregularities. J Cataract Refract Surg. 2020;46(2):188-192.
- Avanzini G, Villani F. Ocular movements. Curr Opin Neurol. 1994;7(1):74-80.
- Nem S, Yoo H, Omole AE. Neuroanatomy, facial colliculus. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Khazaal O, Marquez DL, Naqvi IA. Foville syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Pastor AM, Calvo PM, de la Cruz RR, Baker R, Straka H. Discharge properties of morphologically identified vestibular neurons recorded during horizontal eye movements in the goldfish. J Neurophysiol. 2019;121(5):1865-1878.
- Choi SY, Choi JH, Kim HS, Lee JY, Lee SU, Lee SH, et al. Horizontal gaze-evoked nystagmus in pontine gaze palsy: patterns and anatomical correlates. Front Neurol. 2025;16:1624192.
- Ruehl RM, Ophey L, Ertl M, Zu Eulenburg P. The cingulate oculomotor cortex. Cortex. 2021;138:341-355.
- Pierrot-Deseilligny C, Rivaud S, Gaymard B, Müri R, Vermersch AI. Cortical control of saccades. Ann Neurol. 1995;37(5):557-67.
- Pierrot-Deseilligny C, Gaymard B, Müri R, Rivaud S. Cerebral ocular motor signs. J Neurol. 1997;244(2):65-70.
- Pierrot-Deseilligny Ch, Ploner CJ, Muri RM, Gaymard B, Rivaud-Pechoux S. Effects of cortical lesions on saccadic: eye movements in humans. Ann N Y Acad Sci. 2002;956:216-29.
- Pierrot-Deseilligny C, Müri RM, Ploner CJ, Gaymard B, Rivaud-Péchoux S. Cortical control of ocular saccades in humans: a model for motricity. Prog Brain Res. 2003;142:3-17.
- Pierrot-Deseilligny C, Milea D, Müri RM. Eye movement control by the cerebral cortex. Curr Opin Neurol. 2004;17(1):17-25.
- Rafal RD. Oculomotor functions of the parietal lobe: Effects of chronic lesions in humans. Cortex. 2006;42(5):730-9.
- Sharpe JA. Cortical control of eye movements. Curr Opin Neurol. 1998;11(1):31-8.
- Sharpe JA. Neurophysiology and neuroanatomy of smooth pursuit: lesion studies. Brain Cogn. 2008;68(3):241-54.
- Krauzlis RJ. The control of voluntary eye movements: new perspectives. Neuroscientist. 2005;11(2):124-37.
- Schröder R, Keidel K, Trautner P, Radbruch A, Ettinger U. Neural mechanisms of background and velocity effects in smooth pursuit eye movements. Hum Brain Mapp. 2023;44(3):1002-1018.
- Zhang W, Liu X, Zuo L, Guo Q, Chen Q, Wang Y. Ipsiversive ictal eye deviation in inferioposterior temporal lobe epilepsy-Two SEEG cases report. BMC Neurol. 2017;17(1):38.
- Tijssen CC, van Gisbergen JA, Schulte BP. Conjugate eye deviation: side, site, and size of the hemispheric lesion. Neurology. 1991;41(6):846-50.
- Simon JE, Morgan SC, Pexman JH, Hill MD, Buchan AM. CT assessment of conjugate eye deviation in acute stroke. Neurology. 2003;60(1):135-7.
- Steiner I, Melamed E. Conjugate eye deviation after acute hemispheric stroke: delayed recovery after previous contralateral frontal lobe damage. Ann Neurol. 1984;16(4):509-11.
- Kattah JC, Badihian S, Pula JH, Tarnutzer AA, Newman-Toker DE, Zee DS. Ocular lateral deviation with brief removal of visual fixation differentiates central from peripheral vestibular syndrome. J Neurol. 2020;267(12):3763-3772.
- Kattah JC, Pula J, Newman-Toker DE. Ocular lateropulsion as a central oculomotor sign in acute vestibular syndrome is not posturally dependent. Ann N Y Acad Sci. 2011;1233:249-55.
- Ilniczky S, Kamondi A, Várallyay G, Gaal B, Palásti A, Gulyás S, et al. One-and-a-half syndrome—two cases. Ideggyogy Sz. 2007;60(11-12):489-93.
- Ingle V, Panda S, Penuboina T, Kashyap M. Eight-and-a-half syndrome: a rare presentation. BMJ Case Rep. 2021;14(9).
- Kataoka S, Hori A, Shirakawa T, Hirose G. Paramedian pontine infarction. Neurological/topographical correlation. Stroke. 1997;28(4):809-15.
- Sim JPY, Sim JJL, Saleem S, Cordato D. Complete Horizontal Gaze Paresis Due to Medial Pontine Haemorrhage. Neuroophthalmology. 2023;47(1):7-10.
- Akhavan Sigari A, Etemadifar M, Salari M. Complete horizontal gaze palsy due to bilateral paramedian pontine reticular formation involvement as a presentation of multiple sclerosis: a case report. BMC Neurol. 2019;19(1):254.
- Pinero-Pinto E, Pérez-Cabezas V, Tous-Rivera C, Sánchez-González JM, Ruiz-Molinero C, Jiménez-Rejano JJ, et al. Mutation in ROBO3 Gene in Patients with Horizontal Gaze Palsy with Progressive Scoliosis Syndrome: A Systematic Review. Int J Environ Res Public Health. 2020;17(12).
- Dhiman R, Gandepalli L, Rathod A, Badkhane S, Phuljhele S, Saxena R. Horizontal gaze palsy with progressive scoliosis. J AAPOS. 2024;28(1):103822.
- Xavier C, Vieira M, Duarte AF, Xavier A, Silva ED. Horizontal Gaze Palsy and Progressive Scoliosis in Dizygotic Twins. J Binocul Vis Ocul Motil. 2022;72(2):105-110.
- Yi S, Qin Z, Zhou X, Chen J, Yi S, Chen Q, et al. Early onset horizontal gaze palsy and progressive scoliosis due to a noncanonical splicing-site variant and a missense variant in the ROBO3 gene. Mol Genet Genomic Med. 2023;11(9):e2215.
- Wente S, Schröder S, Buckard J, Büttel HM, von Deimling F, Diener W, et al. Nosological delineation of congenital ocular motor apraxia type Cogan: an observational study. Orphanet J Rare Dis. 2016;11(1):104.
- Schröder S, Li Y, Yigit G, Altmüller J, Bader I, Bevot A, et al. Heterozygous truncating variants in SUFU cause congenital ocular motor apraxia. Genet Med. 2021;23(2):341-351.
- Schröder S, Yigit G, Li Y, Altmüller J, Büttel HM, Fiedler B, et al. The genetic spectrum of congenital ocular motor apraxia type Cogan: an observational study, continued. Orphanet J Rare Dis. 2023;18(1):101.
- Saitoh S. [Ocular motor apraxia, Cogan congenital type]. Ryoikibetsu Shokogun Shirizu. 2001.
- Baumann O, Ziemus B, Luerding R, Schuierer G, Bogdahn U, Greenlee MW. Differences in cortical activation during smooth pursuit and saccadic eye movements following cerebellar lesions. Exp Brain Res. 2007;181(2):237-47.
- Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar Syndrome. Cerebellum. 2016;15(3):369-91.
- Prakash E, Kuht HJ, Harieaswar S, Thomas MG. Dorsal midbrain (Parinaud) syndrome. Pract Neurol. 2021;21(6):550-551.
- Ortiz JF, Eissa-Garces A, Ruxmohan S, Cuenca V, Kaur M, Fabara SP, et al. Understanding Parinaud’s Syndrome. Brain Sci. 2021;11(11).
- Feroze KB, Patel BC. Parinaud syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Yousif JE, Liao E, Trobe JD. Dorsal Midbrain Syndrome: Clinical and Imaging Features in 75 Cases. J Neuroophthalmol. 2021;41(4):e644-e654.
- Büttner-Ennever JA, Büttner U, Cohen B, Baumgartner G. Vertical glaze paralysis and the rostral interstitial nucleus of the medial longitudinal fasciculus. Brain. 1982;105(Pt 1):125-49.
- Wang SF, Spencer RF. Spatial organization of premotor neurons related to vertical upward and downward saccadic eye movements in the rostral interstitial nucleus of the medial longitudinal fasciculus (riMLF) in the cat. J Comp Neurol. 1996;366(1):163-80.
- Tsukada A, Yanaka K, Ishikawa E. Midbrain hemorrhage presenting with isolated downward gaze palsy: A case report. Surg Neurol Int. 2023;14:132.
- Chen B, May PJ. Premotor circuits controlling eyelid movements in conjunction with vertical saccades in the cat: I. The rostral interstitial nucleus of the medial longitudinal fasciculus. J Comp Neurol. 2002;450(2):183-202.
- Madhusudanan M. ABC of Gaze and Ocular Oscillations. Ann Indian Acad Neurol. 2022;25(Suppl 2):S113-S119.
- Willard A, Lueck CJ. Ocular motor disorders. Curr Opin Neurol. 2014;27(1):75-82.
- Yokose M, Furuya K, Suzuki M, Ozawa T, Kim Y, Miura K, et al. Vertical Gaze Palsy Caused by Selective Unilateral Rostral Midbrain Infarction. Neuroophthalmology. 2018;42(5):309-311.
- Park JH, Kim HJ, Kim JS. An alternative mechanism of crossed vertical gaze palsy in unilateral mesodiencephalic infarction. Med Hypotheses. 2021;146:110372.
- Rivaud-Péchoux S, Vidailhet M, Gallouedec G, Litvan I, Gaymard B, Pierrot-Deseilligny C. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2000;54(5):1029-32.
- Shams PN, Bremner FD, Smith SE, Plant GT, Matthews TD. Unilateral light-near dissociation in lesions of the rostral midbrain. Arch Ophthalmol. 2010;128(11):1486-9.
- Aladdin Y, Shirah B, Khan K. Vertical One-and-a-Half Syndrome with Pseudoabducens Palsy and Midbrain Horizontal Gaze Paresis. J Binocul Vis Ocul Motil. 2022;72(3):156-160.
- Pokharel BR, Thapa LJ, Paudel R, Rana PV. Vertical gaze palsy with skew deviation. Kathmandu Univ Med J (KUMJ). 2013;11(44):342-3.
- Hoehn ME, Calderwood J, O’Donnell T, Armstrong GT, Gajjar A. Children with dorsal midbrain syndrome as a result of pineal tumors. J AAPOS. 2017;21(1):34-38.
- Lukewich MK, Alshafai L, Micieli JA. Spontaneous Resolution of Dorsal Midbrain Syndrome Caused by a Pineal Cyst. World Neurosurg. 2020;136:289-292.
- Malloy KA, Draper EM, Maglione AK. Case Report: Transient Dorsal Midbrain Syndrome as the Initial Presentation of Multiple Sclerosis. Optom Vis Sci. 2019;96(8):617-619.
- Scheitler KM, Mustafa R, Wijdicks EFM. Lid and Convergence Retraction Nystagmus in Thalamic-Midbrain Hematoma. Neurocrit Care. 2021;34(2):691-692.
- Triarhou LC, Manto M. Nothnagel Syndrome. Cerebellum. 2023;22(4):487-505.
- Chen W, Feny C, Chu S, Zhao G, Sun X, Li Z, et al. Convergence-Retraction Nystagmus and Ophthalmoplegia as the Presenting Sign of Leigh Syndrome in a Young Boy. J Neuroophthalmol. 2023;43(2):e58-e59.
- Sarao MS, Blair K. Adie syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Lee EJ, Membrey L, Vickers S. Light-near dissociation of pupil reactions as a presenting feature of von Hippel-Lindau disease. Eye (Lond). 2005;19(7):812-3.
- Kawasaki AK. Diagnostic approach to pupillary abnormalities. Continuum (Minneap Minn). 2014;20(4 Neuro-ophthalmology):1008-22.
- Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017;32(6):853-864.
- Marchand F, Blaise AS, Defebvre L, Cailliau E, Bombois S, Devos D, et al. Clinical prognostic factors in progressive supranuclear palsy: Implications for clinical trials. J Parkinsons Dis. 2024;14(8):1652-1658.
- Hu MT, Coma AQ, Rowe JB, Zerenner T, Church A, Fumi R, et al. Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes. Brain. 2025;148(9):3239-3251.
- Pourfar M, Vonsattel JP. Progressive supranuclear palsy. Sci Aging Knowledge Environ. 2004;2004(30):dn1.
- Kassavetis P, Kaski D, Anderson T, Hallett M. Eye Movement Disorders in Movement Disorders. Mov Disord Clin Pract. 2022;9(3):284-295.
- Salsano E, Umeh C, Rufa A, Pareyson D, Zee DS. Vertical supranuclear gaze palsy in Niemann-Pick type C disease. Neurol Sci. 2012;33(6):1225-32.
- Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5:16.
- Vanier MT. Niemann-Pick diseases. Handb Clin Neurol. 2013;113:1717-21.
- Hopf S, Hennermann JB, Schuster AK, Pfeiffer N, Pitz S. Vertical saccadic palsy and foveal retinal thinning in Niemann-Pick disease type C. PLoS One. 2021;16(6):e0252825.
- Di Lazzaro V, Marano M, Florio L, De Santis S. Niemann-Pick type C: focus on the adolescent/adult onset form. Int J Neurosci. 2016;126(11):963-71.
- Mohamed AA, Gan W, Babici D, Hagan V, Wald R, Swerdloff M. Supranuclear Palsy as an Initial Presentation of the Adult-Onset Niemann-Pick Type C. Neurol Int. 2024;16(3):561-566.
- Bajwa H, Azhar W. Niemann-Pick disease. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Warner J, Lessell S. Neuro-ophthalmology of multiple sclerosis. Clin Neurosci. 1994;2(3-4):180-8.
- Liu GT, Volpe NJ, Galetta SL. Eye movement disorders. Curr Opin Ophthalmol. 1995;6(6):27-33.
- Keane JR. Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients. Arch Neurol. 2005;62(5):714-7.
- Tintore M, Rovira A, Arrambide G, Mitjana R, Río J, Auger C, et al. Brainstem lesions in clinically isolated syndromes. Neurology. 2010;75(21):1933-8.
- Kipfer S, Crook DW. Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis. Mult Scler. 2014;20(6):754-5.
- Calabrese M, Gajofatto A, Gobbin F, Turri G, Richelli S, Matinella A, et al. Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. Mult Scler. 2015;21(5):580-9.
- Rismanchi N, Crawford JR. Bilateral internuclear ophthalmoplegia associated with pediatric brain tumor progression: a case series and review of the literature. J Neurooncol. 2013;115(3):487-91.
- Sirisreetreerux N, Ponglikitmongkol K. Internuclear ophthalmoplegia as a presentation of procedural stroke: a case report. J Med Case Rep. 2024;18(1):79.
- Carla GA, Ana-Catalina RM, Jibran MN. How does a small area cause big syndromes? A case report of a patient with one-and-a-half syndrome and MRI review of the anatomical pathways involved in causing different pontine neuro-ophthalmological syndromes. Am J Ophthalmol Case Rep. 2021;24:101225.
- Borgman CJ, Jackson AM. Sixteen-and-a-half syndrome: a variant in the spectrum of Fisher’s one-and-a-half syndrome. Clin Exp Optom. 2019;102(1):94-96.
- Gonçalves DB, Barreira RP, Torres TZM, Correa BM, Rossette VM, Marques TDC, et al. Vertical one-and-a-half syndrome in a patient with pecheron artery ischemia: A case report. Radiol Case Rep. 2021;16(12):3908-3910.
- Bennetto L, Lueck CJ. Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO): what does it mean to be wall-eyed?. Pract Neurol. 2022;22(1):4-5.
- Johnston JL, Sharpe JA. Wall-Eyed Internuclear Ophthalmoplegia: History and Hypothesis. Can J Neurol Sci. 2024.
- Zhang LY, Zhu M, Wang Y, Wang GD, Wang Y, Wu YC, et al. Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome secondary to dorsal pontine infarction. BMJ Neurol Open. 2024;6(2):e000746.
- Uzawa A, Takeda Y, Kuwabara S. Wall-Eyed Bilateral Internuclear Ophthalmoplegia by Ischemic Stroke: Case Report and Literature Review. Neurologist. 2020;25(3):82-84.
- Vázquez-Justes D, Martín-Cucó A, Gallego-Sánchez Y, Vicente-Pascual M. WEBINO syndrome (wall-eyed bilateral internuclear ophthalmoplegia) secondary to ischemic stroke, about a case. Arch Soc Esp Oftalmol (Engl Ed). 2020;95(4):205-208.
- Wako S, Toi S, Mizuno T, Nishimura A, Ishizuka K, Kitagawa K. [A case of cardioembloic stroke with wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome]. Rinsho Shinkeigaku. 2022;62(7):541-545.
- Jo YS, Hong JY, Kim SY, Na SJ. Wall-Eyed Bilateral Internuclear Ophthalmoplegia (WEBINO) in a Patient With a Unilateral Midbrain Infarction. Neurologist. 2021;26(4):153-155.
- Khanna S, Liao K, Kaminski HJ, Tomsak RL, Joshi A, Leigh RJ. Ocular myasthenia revisited: insights from pseudo-internuclear ophthalmoplegia. J Neurol. 2007;254(11):1569-74.
- Ito K, Mizutani J, Murofushi T, Mizuno M. Bilateral pseudo-internuclear ophthalmoplegia in myasthenia gravis. ORL J Otorhinolaryngol Relat Spec. 1997;59(2):122-6.
- McClard CK, Lyons LJ, Yalamanchili S. Bilateral pseudo-internuclear ophthalmoplegia in a patient with myasthenia gravis. Am J Ophthalmol Case Rep. 2018;12:76-78.
- Munasinghe KVP, Herath WADJJ, Silva FHDS. A Case Report on Pseudo-Internuclear Ophthalmoplegia: A Rare Manifestation of Myasthenia Gravis. Cureus. 2023;15(10):e46788.
- Argyriou AA, Karanasios P, Potsios C, Makridou A, Doukas V, Koukopoulou I, et al. Myasthenia gravis initially presenting with pseudo-internuclear ophthalmoplegia. Neurol Sci. 2009;30(5):387-8.
- Weng Y, Min Y, Sheng Z, Li J, Huang D. Myasthenia Gravis With Reversible Pyramidal Tract Damage and Pseudo Internuclear Ophthalmoplegia. A Case Report and Literature Review. Front Neurol. 2019;10:957.
- Bogdan I, Crisanda V. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis]. Oftalmologia. 2011;55(3):70-3.
- Newman-Toker DE, Kerber KA, Hsieh YH, Pula JH, Omron R, Saber Tehrani AS, et al. HINTS outperforms ABCD2 to screen for stroke in acute continuous vertigo and dizziness. Acad Emerg Med. 2013;20(10):986-96.
- Matos S, Martins AI, Jorge A, Macário MDC, Pereira D, Strupp M, et al. Posterior semicircular canal cupulolithiasis during acute pontomedullary demyelination. Pract Neurol. 2024;24(1):51-55.
- Eggenberger E, Golnik K, Lee A, Santos R, Suntay A, Satana B, et al. Prognosis of ischemic internuclear ophthalmoplegia. Ophthalmology. 2002;109(9):1676-8.
- Brandt T, Dieterich M. Pathological eye-head coordination in roll: tonic ocular tilt reaction in mesencephalic and medullary lesions. Brain. 1987;110 ( Pt 3):649-66.
- Zurevinsky J. Skew Deviation. J Binocul Vis Ocul Motil. 2022;72(1):47-55.
- Sugawara T, Wada Y, Ito T, Sakai H. Bilateral Asymmetry in Ocular Counter-Rolling Reflex Is Associated With Individual Motion Sickness Susceptibility. Front Neurol. 2021;12:759764.
- Winnick A, Sadeghpour S, Sova M, Otero-Millan J, Kheradmand A. No handedness effect on spatial orientation or ocular counter-roll during lateral head tilts. Physiol Rep. 2019;7(13):e14160.
- Zalewski CK, Ackley RS, McCaslin DL, Clark MD, Hanks WD, Brewer CC. Examination of Utricular Response Using oVEMP and Unilateral Centrifugation Rotation Testing. Ear Hear. 2018;39(5):910-921.
- Beck B, Saramandi A, Ferrè ER, Haggard P. Which way is down? Visual and tactile verticality perception in expert dancers and non-experts. Neuropsychologia. 2020;146:107546.
- Choi KD, Kim JS, Choi JH. Contraversive Ocular Tilt Reaction in Pontomedullary Infarction. Neurologist. 2015;20(3):43.
- Wu YX, Ling X, Zhao TT, Feng YF, Wang ZX, Kim JS, et al. Contraversive Ocular Tilt Reaction, Body Lateropulsion and Gaze-Evoked Nystagmus After Inferior Cerebellar Peduncle and Dentate Nucleus Stroke. J Neuroophthalmol. 2023;43(4):e322-e324.
- Dresner SM, Kung NH, Palko JR, McJunkin JL, Goebel JA, Van Stavern GP. Skew Deviation and Partial Ocular Tilt Reaction Due to Intratympanic Gentamicin Injection, with Review of the Literature. Neuroophthalmology. 2017;41(5):268-270.
- Wang T, Qu SH, Yuan H, Ye LS, Cui L. [Analysis of features of ocular tilt reaction for patients with vestibular neuritis]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32(14):1091-1094.
- Kanku MS, Sele S, Held U, Jaggi GP, Landau K, Traber GL. Cyclotorsion Measurement on Scanning Laser Ophthalmoscopy Imaging Compared With Fundus Photography in Patients With Fourth Nerve Palsy and Healthy Controls: CySLO-IV Study. J Neuroophthalmol. 2021;41(4):e612-e618.
- Dysli M, Kanku M, Traber GL. Inter-Rater Reliability of Cyclotorsion Measurements Using Fundus Photography. Klin Monbl Augenheilkd. 2018;235(4):420-423.
- Seo J, Kim K, Kim J, Park K, Chung H. Measurement of ocular torsion using digital fundus image. Conf Proc IEEE Eng Med Biol Soc. 2004;2004:1711-3.
- Wong AM. Understanding skew deviation and a new clinical test to differentiate it from trochlear nerve palsy. J AAPOS. 2010;14(1):61-7.
- Wong AM, Colpa L, Chandrakumar M. Ability of an upright-supine test to differentiate skew deviation from other vertical strabismus causes. Arch Ophthalmol. 2011;129(12):1570-5.
- Lemos J, Subei A, Sousa M, Nunes C, Cunha L, Glisson C, et al. Differentiating Acute and Subacute Vertical Strabismus Using Different Head Positions During the Upright-Supine Test. JAMA Ophthalmol. 2018;136(4):322-328.
- Betts GA, Curthoys IS, Todd MJ. The effect of roll-tilt on ocular skew deviation. Acta Otolaryngol Suppl. 1995;520 Pt 2:304-6.
- Gufoni M. Uphill/downhill nystagmus. Acta Otorhinolaryngol Ital. 2017;37(6):513-518.
- Komiyama A, Kobayashi M, Nakamura H, Araki Y. Ocular Tilt Reaction in Compensated Vestibular Schwannoma. J Neuroophthalmol. 2019;39(2):244-246.
- Fan CF, Huang YP, Li X, Chen Y, Li Z, Qiao SD. [Posterior inferior cerebellar artery infarction with episodic postural diplopia as the initial symptom: A case report]. Beijing Da Xue Xue Bao Yi Xue Ban. 2023;55(4):762-765.
- Yadegari S. Skew deviation and ocular tilt reaction as presenting feature of CACNA1A mutation. J AAPOS. 2023;27(3):166-169.
- Arnoldi K. The Non-surgical Management of Ophthalmoplegia. J Binocul Vis Ocul Motil. 2018;68(1):24-27.
- Brune AJ 3rd, Eggenberger ER. Disorders of Vergence Eye Movements. Curr Treat Options Neurol. 2018;20(10):42.
- Coughlin DG, Litvan I. Progressive supranuclear palsy: Advances in diagnosis and management. Parkinsonism Relat Disord. 2020;73:105-116.
- Devani K, Kapoor N, Ganti L. Convergence insufficiency as a predictor of poor prognosis after acute mild traumatic brain injury. Int J Emerg Med. 2024;17(1):166.
- Fortenbaugh FC, Gustafson JA, Fonda JR, Fortier CB, Milberg WP, McGlinchey RE. Blast mild traumatic brain injury is associated with increased myopia and chronic convergence insufficiency. Vision Res. 2021;186:1-12.
- Chaudhuri Z, Demer JL. Sagging eye syndrome: connective tissue involution as a cause of horizontal and vertical strabismus in older patients. JAMA Ophthalmol. 2013;131(5):619-25.
- Claxton MR, Bang GM, Martinez-Thompson J, Hodge DO, Mohney BG. Prevalence and clinical characteristics of age-related distance esotropia. Strabismus. 2022;30(3):115-120.
- Trbovich AM, Sherry NK, Henley J, Emami K, Kontos AP. The utility of the Convergence Insufficiency Symptom Survey (CISS) post-concussion. Brain Inj. 2019;33(12):1545-1551.
- Lavrich JB. Convergence insufficiency and its current treatment. Curr Opin Ophthalmol. 2010;21(5):356-60.
- Scheiman M, Rouse M, Kulp MT, Cotter S, Hertle R, Mitchell GL. Treatment of convergence insufficiency in childhood: a current perspective. Optom Vis Sci. 2009;86(5):420-8.
- Roy S, Bharadwaj SR, Patil-Chhablani P, Satgunam PN. Spasm of near reflex: a comprehensive management protocol and treatment outcomes. J AAPOS. 2021;25(3):162.e1-162.e6.
- Manna P, Karmakar S, Bhardwaj GK, Mondal A. Accommodative spasm and its different treatment approaches: A systematic review. Eur J Ophthalmol. 2023;33(3):1273-1286.
- Oohira A. [Long-Term Follow-up of Age-related Strabismus Patients 50 Years-old and Over]. Nippon Ganka Gakkai Zasshi. 2015;119(9):619-24.
- Repka MX, Downing E. Characteristics and surgical results in patients with age-related divergence insufficiency esotropia. J AAPOS. 2014;18(4):370-3.
- Godts D, Mathysen DG. Distance esotropia in the elderly. Br J Ophthalmol. 2013;97(11):1415-9.
- Oatts JT, Salchow DJ. Age-related distance esotropia—fusional amplitudes and clinical course. Strabismus. 2014;22(2):52-7.
- Pineles SL. Divergence Insufficiency Esotropia: Surgical Treatment. Am Orthopt J. 2015;65:35-9.
- Li YP, Zhang W. [Advances in research of divergence insufficiency]. Zhonghua Yan Ke Za Zhi. 2017;53(7):552-556.
- Ruatta C, Schiavi C. Acute acquired concomitant esotropia associated with myopia: is the condition related to any binocular function failure?. Graefes Arch Clin Exp Ophthalmol. 2020;258(11):2509-2515.
- Topcu Yilmaz P, Ural Fatihoglu Ö, Sener EC. Acquired Comitant Esotropia in Children and Young Adults: Clinical Characteristics, Surgical Outcomes, and Association With Presumed Intensive Near Work With Digital Displays. J Pediatr Ophthalmol Strabismus. 2020;57(4):251-256.
- Bort-Martí AR, Rowe FJ, Ruiz Sifre L, Ng SM, Bort-Martí S, Ruiz Garcia V. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst Rev. 2023;3(3):CD006499.
- Crampton A, Teel E, Chevignard M, Gagnon I. Vestibular-ocular reflex dysfunction following mild traumatic brain injury: A narrative review. Neurochirurgie. 2021;67(3):231-237.
- Wright WG, Tierney RT, McDevitt J. Visual-vestibular processing deficits in mild traumatic brain injury. J Vestib Res. 2017;27(1):27-37.
- Mucha A, Collins MW, Elbin RJ, Furman JM, Troutman-Enseki C, DeWolf RM, et al. A Brief Vestibular/Ocular Motor Screening (VOMS) assessment to evaluate concussions: preliminary findings. Am J Sports Med. 2014;42(10):2479-86.
- Strominger M. Neuroanatomy and Imaging Assessment in Traumatic Brain Injury. J Binocul Vis Ocul Motil. 2020;70(4):119-121.
- Alvarez TL, Scheiman M, Gohel S, Hajebrahimi F, Noble M, Sangoi A, et al. Effectiveness of treatment for concussion-related convergence insufficiency: The CONCUSS study protocol for a randomized clinical trial. PLoS One. 2024;19(11):e0314027.
- Alvarez TL, Scheiman M, Hajebrahimi F, Noble M, Gohel S, Baro R, et al. CONCUSS randomised clinical trial of vergence/accommodative therapy for concussion-related symptomatic convergence insufficiency. Br J Sports Med. 2026;60(5):340-354.
- Hajebrahimi F, Sangoi A, Scheiman M, Santos E, Gohel S, Alvarez TL. From convergence insufficiency to functional reorganization: A longitudinal randomized controlled trial of treatment-induced connectivity plasticity. CNS Neurosci Ther. 2024;30(8):e70007.
- Alvarez TL, Scheiman M, Santos EM, Yaramothu C, d’Antonio-Bertagnolli JV. Convergence Insufficiency Neuro-mechanism in Adult Population Study Randomized Clinical Trial: Clinical Outcome Results. Optom Vis Sci. 2020;97(12):1061-1069.
- Alvarez TL, Scheiman M, Santos EM, Morales C, Yaramothu C, D’Antonio-Bertagnolli JV, et al. The Convergence Insufficiency Neuro-mechanism in Adult Population Study (CINAPS) Randomized Clinical Trial: Design, Methods, and Clinical Data. Ophthalmic Epidemiol. 2020;27(1):52-72.
- Barton JJS, Ranalli PJ. Vision Therapy: Ocular Motor Training in Mild Traumatic Brain Injury. Ann Neurol. 2020;88(3):453-461.
- Rucker JC, Phillips PH. Efferent Vision Therapy. J Neuroophthalmol. 2018;38(2):230-236.
- Convergence Insufficiency Treatment Trial (CITT) Study Group. The convergence insufficiency treatment trial: design, methods, and baseline data. Ophthalmic Epidemiol. 2008;15(1):24-36.
- Scheiman M, Kulp MT, Cotter SA, Lawrenson JG, Wang L, Li T. Interventions for convergence insufficiency: a network meta-analysis. Cochrane Database Syst Rev. 2020;12(12):CD006768.
- Morrison AM, Kulp MT, Cotter SA, Scheiman MM, Jenewein EC, Roberts TL, et al. One-year follow-up of clinical convergence measures in children enrolled in the Convergence Insufficiency Treatment Trial-Attention and Reading Trial. Ophthalmic Physiol Opt. 2024;44(7):1346-1353.
- Li S, Tang A, Yang B, Wang J, Liu L. Virtual reality-based vision therapy versus OBVAT in the treatment of convergence insufficiency, accommodative dysfunction: a pilot randomized controlled trial. BMC Ophthalmol. 2022;22(1):182.
- Fischer D, Edlow BL. Coma Prognostication After Acute Brain Injury: A Review. JAMA Neurol. 2024.
- Malik K, Hess DC. Evaluating the comatose patient. Rapid neurologic assessment is key to appropriate management. Postgrad Med. 2002;111(2):38-40, 43-6, 49-50 passim.
- Kuroiwa Y, Toda H. [Clinical aspects of abnormal eye movements]. Rinsho Shinkeigaku. 2003;43(11):765-8.
- Lussier BL, Olson DM, Aiyagari V. Automated Pupillometry in Neurocritical Care: Research and Practice. Curr Neurol Neurosci Rep. 2019;19(10):71.
- Phillips SS, Mueller CM, Nogueira RG, Khalifa YM. A Systematic Review Assessing the Current State of Automated Pupillometry in the NeuroICU. Neurocrit Care. 2019;31(1):142-161.
- Sandroni C, D’Arrigo S. Neurologic Prognostication: Neurologic Examination and Current Guidelines. Semin Neurol. 2017;37(1):40-47.
- Chang TP, Gold DR, Otero-Millan J, Huang BR, Zee DS. Pendular Oscillation and Ocular Bobbing After Pontine Hemorrhage. Cerebellum. 2021;20(5):734-743.
- Munakomi S, Thapa L. Seesaw-Pattern Ocular Bobbing in a Patient With Pontine Bleed. JAMA Neurol. 2019;76(3):362-363.
- Goldschmidt TJ, Wall M. Slow-upward ocular bobbing. J Clin Neuroophthalmol. 1987;7(4):241-3.
- Masucci EF, Fabara JA, Saini N, Kurtzke JF. Periodic alternating ping-pong gaze. Ann Ophthalmol. 1981;13(10):1123-7.
- Johkura K, Komiyama A, Tobita M, Hasegawa O. Saccadic ping-pong gaze. J Neuroophthalmol. 1998;18(1):43-6.
- Sieben A, Crevits L, Santens P. Saccadic ping pong gaze in coma. Neurologist. 2007;13(3):161-3.
- Sotiriou K, Artemiadis AK, Papanastasiou I. Ping-pong gaze in a patient with bilateral hemispheric ischemic stroke: case report and video. J Stroke Cerebrovasc Dis. 2015;24(3):e67-8.
- Wang X, Yang F, Chen B, Jiang W. Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit. Acta Neurol Scand. 2022;146(6):752-760.
- Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3-23.
- Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, et al. Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus—approach to clinical application. Epilepsy Behav. 2015;49:158-63.
- Leitinger M, Gaspard N, Hirsch LJ, Beniczky S, Kaplan PW, Husari K, et al. Diagnosing nonconvulsive status epilepticus: Defining electroencephalographic and clinical response to diagnostic intravenous antiseizure medication trials. Epilepsia. 2023;64(9):2351-2360.
- Trinka E, Leitinger M. Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus. Continuum (Minneap Minn). 2022;28(2):559-602.
- Godau J, Bharad K, Rösche J, Nagy G, Kästner S, Weber K, et al. Automated Pupillometry for Assessment of Treatment Success in Nonconvulsive Status Epilepticus. Neurocrit Care. 2022;36(1):148-156.
- Robba C, Crippa IA, Taccone FS. Septic Encephalopathy. Curr Neurol Neurosci Rep. 2018;18(12):82.
- Sharma S, Kochar GS, Sankhyan N, Gulati S. Approach to the child with coma. Indian J Pediatr. 2010;77(11):1279-87.
- Kirschen MP, Lewis A, Greer DM. The 2023 American Academy of Neurology, American Academy of Pediatrics, Child Neurology Society, and Society of Critical Care Medicine Pediatric and Adult Brain Death/Death by Neurologic Criteria Determination Consensus Guidelines: What the Critical Care Team Needs to Know. Crit Care Med. 2024;52(3):376-386.
- Harrar DB, Kukreti V, Dean NP, Berger JT 3rd, Carpenter JL. Clinical Determination of Brain Death in Children Supported by Extracorporeal Membrane Oxygenation. Neurocrit Care. 2019;31(2):304-311.
- Sandroni C, D’Arrigo S, Nolan JP. Prognostication after cardiac arrest. Crit Care. 2018;22(1):150.
- Horn J, Cronberg T, Taccone FS. Prognostication after cardiac arrest. Curr Opin Crit Care. 2014;20(3):280-6.
- Ben-Hamouda N, Taccone FS, Rossetti AO, Oddo M. Contemporary approach to neurologic prognostication of coma after cardiac arrest. Chest. 2014;146(5):1375-1386.
- Boto GR, Gómez PA, De la Cruz J, Lobato RD. [Prognostic factors in severe head injury]. Neurocirugia (Astur). 2004;15(3):233-47.
- Alkhachroum A, Aklepi G, Sarafraz A, Robayo LE, Manolovitz BM, Blandino CF, et al. Covert Tracking to Visual Stimuli in Comatose Patients With Traumatic Brain Injury. Neurology. 2023;101(11):489-494.
- Young MJ, Edlow BL, Bodien YG. Covert consciousness. NeuroRehabilitation. 2024;54(1):23-42.
- Giede-Jeppe A, Sprügel MI, Huttner HB, Borutta M, Kuramatsu JB, Hoelter P, et al. Automated Pupillometry Identifies Absence of Intracranial Pressure Elevation in Intracerebral Hemorrhage Patients. Neurocrit Care. 2021;35(1):210-220.
- Banco P, Taccone FS, Sourd D, Privitera C, Bosson JL, Teixeira TL, et al. Prediction of neurocritical care intensity through automated infrared pupillometry and transcranial doppler in blunt traumatic brain injury: the NOPE study. Eur J Trauma Emerg Surg. 2024;50(4):1209-1217.
- Su Y, Zhang Y, Chen W, Tian F, Fan L, Liu G, et al. Minimum Criteria for Brain Death Determination: Consensus Promotion and Chinese Practice. Neurocrit Care. 2022;37(2):479-486.
- Kim HJ, Kim HJ, Choi JY, Yang HK, Hwang JM, Kim JS. Etiological distribution of isolated oculomotor nerve palsy: analysis of 633 patients and literature review. Eur J Neurol. 2024;31(6):e16261.
- Chen H, Wang X, Yao S, Raza HK, Jing J, Cui G, et al. The aetiologies of unilateral oculomotor nerve palsy: a clinical analysis on 121 patients. Somatosens Mot Res. 2019;36(2):102-108.
- Zhang X, Wei S. Etiology, localization of the lesion, and prognosis for patients firstly diagnosed in ophthalmology department with oculomotor nerve palsy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020;45(12):1425-1430.
- Santillan A, Zink WE, Knopman J, Riina HA, Gobin YP. Early endovascular management of oculomotor nerve palsy associated with posterior communicating artery aneurysms. Interv Neuroradiol. 2010;16(1):17-21.
- Meienberg O, Müri R. Nuclear and infranuclear disorders. Baillieres Clin Neurol. 1992;1(2):417-34.
- Randhawa S, Donohue MM, Hamilton SR. Concomitant presentation of three rare mesencephalic syndromes: case report. Clin Neurol Neurosurg. 2010;112(8):697-700.
- Sato K, Takamori M. [Midbrain infarction presenting with unilateral blepharoptosis, trochlear nerve paresis and MLF syndrome]. Rinsho Shinkeigaku. 1998;38(7):689-92.
- Hall WA, Munakomi S. Uncal herniation. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Zhang CH, DeSouza RM, Kho JS, Vundavalli S, Critchley G. Kernohan-Woltman notch phenomenon: a review article. Br J Neurosurg. 2017;31(2):159-166.
- Schiavi C. Paralytic strabismus. Curr Opin Ophthalmol. 2000;11(5):318-23.
- Bagheri A, Borhani M, Salehirad S, Yazdani S, Tavakoli M. Blepharoptosis Associated With Third Cranial Nerve Palsy. Ophthalmic Plast Reconstr Surg. 2015;31(5):357-60.
- Islami RH, Agustini L, Suhartono G. Diplopia as a sign of third nerve palsy due to intracranial aneurysm: a case report. Pan Afr Med J. 2024;48:104.
- Furia A, Liguori R, Donadio V. Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature. Cephalalgia. 2023;43(1):3331024221133386.
- Mrabet S, Nasri A, Kessentini N, Ben Djebara M, Gargouri-Berrechid A, Kacem I, et al. Recurrent painful ophthalmoplegic neuropathy revealing oculomotor nerve schwannoma. Tunis Med. 2021;99(8):919-923.
- Bhatti MT, Eisenschenk S, Roper SN, Guy JR. Superior divisional third cranial nerve paresis: clinical and anatomical observations of 2 unique cases. Arch Neurol. 2006;63(5):771-6.
- Vosoughi AR, Micieli JA. Superior Division Third Nerve Palsy as the Presenting Sign of Metastatic Breast Cancer. Case Rep Ophthalmol. 2022;13(3):907-911.
- Pecen PE, Ramey NA, Richard MJ, Bhatti MT. Metastatic pancreatic carcinoma to the orbital apex presenting as a superior divisional third cranial nerve palsy. Clin Ophthalmol. 2012;6:1941-3.
- Flindris K, Papafotiou E, Mylona E, Chatzipetrou C, Kaliardas A, Koumpoulis I, et al. Superior Division Oculomotor Nerve Palsy and Diabetes Mellitus: A Case Report. Cureus. 2025;17(4):e82612.
- Saeki N, Yotsukura J, Adachi E, Yamaura A. Isolated superior division oculomotor palsy in a child with spontaneous recovery. J Clin Neurosci. 2000;7(1):62-4.
- Kim HM, Yang HK, Hwang JM. Quantitative analysis of pupillometry in isolated third nerve palsy. PLoS One. 2018;13(11):e0208259.
- Tan YJ, Ramesh R, Tan YH, Tan SML, Setiawan S. COVID-19 and isolated oculomotor nerve palsy: Clinical features and outcomes. Clin Neurol Neurosurg. 2023;225:107601.
- Kaido T, Tanaka Y, Kanemoto Y, Katsuragi Y, Okura H. Traumatic oculomotor nerve palsy. J Clin Neurosci. 2006;13(8):852-5.
- Nagendran ST, Lee V, Perry M. Traumatic orbital third nerve palsy. Br J Oral Maxillofac Surg. 2019;57(6):578-581.
- Muhammad S, Niemelä M. Management of oculomotor nerve schwannoma: Systematic review of literature and illustrative case. Surg Neurol Int. 2019;10:40.
- Cho YH, Sung KS, Song YJ, Kim DC, Choi S, Kim KU. Oculomotor nerve schwannoma: a case report. Brain Tumor Res Treat. 2014;2(1):43-7.
- Douglas VP, Flores C, Douglas KA, Strominger MB, Kasper E, Torun N. Oculomotor nerve schwannoma: case series and literature review. Surv Ophthalmol. 2022;67(4):1160-1174.
- Yokoyama T, Yamamiya M, Takakuwa M, Taniguchi C, Koizumi E, Jinkawa A, et al. Recurrent painful ophthalmoplegic neuropathy. J Paediatr Child Health. 2021;57(8):1303-1304.
- Falsaperla R, Presti S, Lo Bianco M, Catanzaro S, Marino S, Ruggieri M. Diagnostic controversies in recurrent painful ophthalmoplegic neuropathy: single case report with a systematic review. Ital J Pediatr. 2022;48(1):82.
- Akimoto J, Fukami S, Hashimoto R, Haraoka J. Neuromuscular hamartoma is a possible primary pathology of oculomotor ophthalmoplegic migraine. Cephalalgia. 2012;32(2):171-4.
- Ng YS, Lyons CJ. Oculomotor nerve palsy in childhood. Can J Ophthalmol. 2005;40(5):645-53.
- Schumacher-Feero LA, Yoo KW, Solari FM, Biglan AW. Third cranial nerve palsy in children. Am J Ophthalmol. 1999;128(2):216-21.
- Liu HJ, Lin Y, Feng YG. Predictors of Oculomotor Nerve Palsy with Posterior Communicating Aneurysm Clipping in a Surgically Treated Series of 585 Patients: A Single-Center Study. World Neurosurg. 2022;167:e117-e121.
- Engelhardt J, Berge J, Cuny E, Penchet G. Oculomotor nerve palsy induced by internal carotid artery aneurysm: prognostic factors for recovery. Acta Neurochir (Wien). 2015;157(7):1103-11.
- Hung A, Yang W, Jackson C, Caplan J, Gonzalez F, Huang J, et al. Chronic Oculomotor Nerve Palsy Presentation From Posterior Communicating Artery Aneurysm: A Case Series. Oper Neurosurg. 2026;30(5):703-710.
- Singh A, Bahuguna C, Nagpal R, Kumar B. Surgical management of third nerve palsy. Oman J Ophthalmol. 2016;9(2):80-6.
- Elabbasy M, Naxer S, Horn M, Schittkowski MP. The use of lyophilized bovine pericardium (Tutopatch®) in the management of third nerve palsy following prior conventional strabismus surgery - a case series. Strabismus. 2022;30(4):171-182.
- Garg A, Micieli JA. Importance of the “Rule of the Pupil” in the Modern Neuroimaging Era. J Neuroophthalmol. 2021;41(3):293-297.
- Soria E, Camell H, Dang H. Pupil-sparing oculomotor palsy caused by fusiform arteriosclerotic aneurysm of the basilar artery—a case report. Angiology. 1989;40(10):921-7.
- Mijin T, Tsutsumi K, Fujimoto T, Takahata H, Kawahara I, Ono T, et al. [Rupture of an internal carotid-posterior communicating artery aneurysm formerly presented with transient pupil-sparing oculomotor nerve palsy in an extremely elderly patient]. No Shinkei Geka. 2013;41(6):507-14.
- Wood SD. Normal pupil findings can give a false sense of security in a presumed cranial nerve III palsy patient: A unique case report. Optometry. 2010;81(10):505-9.
- Zimmer DV. Oculomotor nerve palsy from posterior communicating artery aneurysm. J La State Med Soc. 1991;143(8):22-5.
- Fogliarini C, Denis D. [Diagnostic approach for acquired and isolated third cranial nerve palsy: 18 case reports]. J Fr Ophtalmol. 2002;25(5):480-7.
- Jung EH, Kim SJ, Lee JY, Cho BJ. The Incidence and Etiologies of Third Cranial Nerve Palsy in Koreans: A 10-year Nationwide Cohort Study. Ophthalmic Epidemiol. 2020;27(6):460-467.
- Badary A, Helal A, Azab MA, Almealawy YF, Alibraheemi MQ, Jawed N, et al. Analyzing the relationship between cerebral aneurysms and Non-oculomotor cranial nerve palsies: a systematic review. Neurosurg Rev. 2024;47(1):358.
- Menke J, Larsen J, Kallenberg K. Diagnosing cerebral aneurysms by computed tomographic angiography: meta-analysis. Ann Neurol. 2011;69(4):646-54.
- Numminen J, Tarkiainen A, Niemelä M, Porras M, Hernesniemi J, Kangasniemi M. Detection of unruptured cerebral artery aneurysms by MRA at 3.0 tesla: comparison with multislice helical computed tomographic angiography. Acta Radiol. 2011;52(6):670-4.
- Schubert T, Husain HS, Thurner P, Madjidyar J, Barnaure I, Piccirelli M, et al. Ultra-High-Resolution Time-of-Flight MR-Angiography for the Noninvasive Assessment of Intracranial Aneurysms, Alternative to Preinterventional DSA?. Clin Neuroradiol. 2023;33(4):1115-1122.
- Matsusue E, Ogawa T. [Clinical applications of 3.0 T magnetic resonance system in the neuroradiological field]. Brain Nerve. 2007;59(5):479-85.
- Kwak Y, Son W, Kim YS, Park J, Kang DH. Discrepancy between MRA and DSA in identifying the shape of small intracranial aneurysms. J Neurosurg. 2021;134(6):1887-1893.
- Nakagawa D, Nagahama Y, Policeni BA, Raghavan ML, Dillard SI, Schumacher AL, et al. Accuracy of detecting enlargement of aneurysms using different MRI modalities and measurement protocols. J Neurosurg. 2019;130(2):559-565.
- Din M, Agarwal S, Grzeda M, Wood DA, Modat M, Booth TC. Detection of cerebral aneurysms using artificial intelligence: a systematic review and meta-analysis. J Neurointerv Surg. 2023;15(3):262-271.
- Tollard E, Perot G, Clavier E, Gerardin E. Imaging of giant cerebral aneurysms. Neurochirurgie. 2015;61(6):378-84.
- Skodvin TØ, Kloster R, Sorteberg W, Isaksen JG. Survey of European neurosurgeons’ management of unruptured intracranial aneurysms: inconsistent practice and organization. Acta Neurochir (Wien). 2021;163(1):113-121.
- Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93-112.
- Jeong HW, Seo JH, Kim ST, Jung CK, Suh SI. Clinical practice guideline for the management of intracranial aneurysms. Neurointervention. 2014;9(2):63-71.
- Malhotra A, Wu X, Gandhi D, Sanelli P, Matouk CC. Management of Small, Unruptured Intracranial Aneurysms. World Neurosurg. 2020;135:379-380.
- Wang Z, Kang X, Wang Q. Clipping versus coiling for the treatment of oculomotor nerve palsy induced by posterior communicating artery aneurysms: A comparison of effectiveness. Brain Behav. 2021;11(8):e2263.
- Li Y, Zhao M, Li X, Liu T, Zheng L, Hu D, et al. Risk factors for recovery from oculomotor nerve palsy after aneurysm surgery: a meta-analysis. PeerJ. 2024;12:e18207.
- Stiebel-Kalish H, Rappaport HZ. Outcome of oculomotor nerve palsy from posterior communicating artery aneurysms: comparison of clipping and coiling. Neurosurgery. 2007;60(1):E208; author reply E208.
- da Costa MDS, Lima JVF, Zanini MA, Hatamoto Filho PT, Naufal RFF, Reys L, et al. Risks for Oculomotor Nerve Palsy and Time to Recovery After Surgical Clipping of Posterior Communicating Artery Aneurysms: A Multicenter Retrospective Cohort Study. Neurosurgery. 2023;92(6):1192-1198.
- Gold DR, Shin RK, Bhatt NP, Eggenberger ER. Aberrant regeneration of the third nerve (oculomotor synkinesis). Pract Neurol. 2012;12(6):390-1.
- Chua HC, Tan CB, Tjia H. Aberrant regeneration of the third nerve. Singapore Med J. 2000;41(9):458-9.
- Lepore FE, Glaser JS. Misdirection revisited. A critical appraisal of acquired oculomotor nerve synkinesis. Arch Ophthalmol. 1980;98(12):2206-9.
- Sibony PA, Lessell S. Transient oculomotor synkinesis in temporal arteritis. Arch Neurol. 1984;41(1):87-8.
- Rao ACA, Shah SA, Sim BWC, Yun STH, Jain NS, Kalani Y, et al. Neuroradiological Endovascular Intervention for Diplopia in a Case of Aneurysmal Aberrant Regeneration of the Third Nerve. Cureus. 2017;9(6):e1340.
- Cox TA, Wurster JB, Godfrey WA. Primary aberrant oculomotor regeneration due to intracranial aneurysm. Arch Neurol. 1979;36(9):570-1.
- Sebag J, Sadun AA. Aberrant regeneration of the third nerve following orbital trauma. Synkinesis of the iris sphincter. Arch Neurol. 1983;40(12):762-4.
- Buckley EG, Ellis FD, Postel E, Saunders T. Posttraumatic abducens to oculomotor nerve misdirection. J AAPOS. 2005;9(1):12-6.
- Schatz NJ, Savino PJ, Corbett JJ. Primary aberrant aculomotor regeneration. A sign of intracavernous meningioma. Arch Neurol. 1977;34(1):29-32.
- Malloy KA, Draper EM, Maglione AK. Pupil-sparing third cranial nerve palsy with aberrant regeneration secondary to cavernous sinus arachnoid cyst. eNeurologicalSci. 2019;14:28-30.
- Lalwani S, Kekunnaya R, Sheth J. Oculomotor synkinesis: an uncommon sequela of paediatric cavernous sinus thrombosis. BMJ Case Rep. 2021;14(5).
- Mudgil AV, Repka MX. Ophthalmologic outcome after third cranial nerve palsy or paresis in childhood. J AAPOS. 1999;3(1):2-8.
- Oke I, Lorenz B, Basiakos S, Gokyigit B, Laurent E, Tsai CB, et al. Aberrant regeneration in an international registry of patients with 3rd-nerve palsy. Eur J Ophthalmol. 2023;33(6):2154-2161.
- Boghen D, Chartrand JP, Laflamme P, Kirkham T, Hardy J, Aube M. Primary aberrant third nerve regeneration. Ann Neurol. 1979;6(5):415-8.
- Alaraj AM. Rare Case of Post-Traumatic Abducens-Oculomotor Nerve Synkinesis Exhibiting Unusual Ocular Motility. Am J Case Rep. 2024;25:e944565.
- Jordan DR, Miller DG, Anderson RL. Acquired oculomotor-abducens synkinesis. Can J Ophthalmol. 1990;25(3):148-51.
- Krzizok T, Gräf M. [Post-traumatic anomalous innervation of the lateral rectus muscle by trigeminal fibers]. Klin Monbl Augenheilkd. 1994;205(1):33-6.
- Soares J, Brigham de Figueiredo M, Prior AR, Malveiro D. Jaw Winking Synkinesis. J Pediatr. 2019;210:234.
- Ziga N, Biscevic A, Pjano MA, Pidro A. Marcus Gunn Jaw-Winking Syndrome: a Case Report. Med Arch. 2019;73(4):282-284.
- Saldanha C, Daigavane S. Marcus Gunn Jaw-Winking Phenomenon and Monocular Elevation Deficiency in Association With Congenital Ptosis. Cureus. 2023;15(1):e33817.
- Alshamrani AA, Alghulaydhawi FA, Al Shamrani M. Marcus Gunn Jaw-Winking Syndrome Associated with Morning Glory Disc Anomaly. Middle East Afr J Ophthalmol. 2019;26(1):37-39.
- Chhajed M, Gunasekaran PK, Saini L. Marcus Gunn Jaw-Winking syndrome following endotracheal intubations. Pediatr Neonatol. 2024;65(2):192-193.
- Dżaman K, Zborowska-Piskadło K, Pietniczka-Załęska M, Kantor I. Marcus Gunn (jaw-winking) phenomenon in pediatric otorhinolaryngology practice. Int J Pediatr Otorhinolaryngol. 2019;117:153-156.
- Chua B, Johnson K, Donaldson C, Martin F. Management of Duane retraction syndrome. J Pediatr Ophthalmol Strabismus. 2005;42(1):13-7; quiz 45-6.
- Roggenkämper P, Laskawi R, Damenz W, Schröder M, Nüssgens Z. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Doc Ophthalmol. 1994;86(4):395-402.
- Shukla A, Zhang M, Lu GN. Safety and Efficacy of Upper Eyelid Orbicularis Oculi Botulinum Toxin in Patients with Synkinesis. Facial Plast Surg Aesthet Med. 2024;26(6):713-719.
- Fouad HM, Kamal AM, Awadein A, Del Monte MA. Contralateral Surgery for the Treatment of Third Nerve Palsy with Aberrant Regeneration. Am J Ophthalmol. 2021;222:166-173.
- Thanh Nguyen PT, Tibrewal S, Ganesh S. Contralateral eye surgery with adjustable suture for management of third nerve palsy with aberrant regeneration. Indian J Ophthalmol. 2017;65(10):1058-1061.
- Chaurasia S, Sharma P, Kishore P, Rasal A. Surgical strategy for third nerve palsy with aberrant regeneration: Harnessing the aberrant power. Indian J Ophthalmol. 2021;69(4):910-917.
- Peragallo JH, Bruce BB, Hutchinson AK, Lenhart PD, Biousse V, Newman NJ, et al. Predictors of Good Motor and Sensory Outcomes Following Strabismus Surgery for Patients with Third Nerve Palsies. Neuroophthalmology. 2015;39(1):12-16.
- Sener EC, Taylan Sekeroglu H, Ural O, Oztürk BT, Sanaç AS. Strabismus surgery in congenital fibrosis of the extraocular muscles: a paradigm. Ophthalmic Genet. 2014;35(4):208-25.
- Yamadera K, Kimura A, Okita Y, Mochizuki Y, Gomi F. Comparison of head tilt test between sagging eye syndrome and acquired unilateral trochlear nerve palsy. Graefes Arch Clin Exp Ophthalmol. 2024;262(5):1641-1646.
- Klainguti G. [Decompensated strabismus surso-adductorius]. Klin Monbl Augenheilkd. 2004;221(5):298-303.
- Mansour AM, Reinecke RD. Central trochlear palsy. Surv Ophthalmol. 1986;30(5):279-97.
- Brazis PW. Palsies of the trochlear nerve: diagnosis and localization—recent concepts. Mayo Clin Proc. 1993;68(5):501-9.
- Tago M, Hisata Y, Hirata R, Sakaguchi M, Katsuki NE, Yamashita SI. Traumatic bilateral fourth nerve palsy: Double vision induced by downward gaze after head injury. J Gen Fam Med. 2020;21(4):155-156.
- Lengwiler F, Heckmann J, Sturm V. [Ocular Motor Nerve Palsies Caused by Paragliding Accidents]. Klin Monbl Augenheilkd. 2020;237(4):497-501.
- Başak AT, Çakici N. An endoscope-assisted craniometric cadaveric study for the brain stem and the cisternal segment of the trochlear nerve. Ideggyogy Sz. 2022;75(7-08):241-246.
- Nche E, Ben-Avi R, Shemesh A, Kruger JM. Decompensated Superior Oblique Palsy Secondary to Bilateral Nutritional Optic Neuropathy Following Bariatric Surgery. Case Rep Ophthalmol. 2021;12(3):1008-1013.
- Lee S, Kim SH, Yang HK, Hwang JM, Kim JH, Kim JS, et al. Imaging demonstration of trochlear nerve agenesis in superior oblique palsy emerging during the later life. Clin Neurol Neurosurg. 2015;139:269-71.
- Gusek-Schneider GC, Kästle N, Reil F, Schürhoff S, Engelhorn T. [Isolated Unilateral Strabismus Sursoadductorius (Congenital Trochlear Palsy) with and without Hypotrophia of the Superior Oblique Muscle-Orthoptic Differences in Adulthood]. Klin Monbl Augenheilkd. 2018;235(10):1122-1128.
- Dosunmu EO, Hatt SR, Leske DA, Hodge DO, Holmes JM. Incidence and Etiology of Presumed Fourth Cranial Nerve Palsy: A Population-based Study. Am J Ophthalmol. 2018;185:110-114.
- Lekskul A, Wuthisiri W, Tangtammaruk P. The etiologies of isolated fourth cranial nerve palsy: a 10-year review of 158 cases. Int Ophthalmol. 2021;41(10):3437-3442.
- Mollan SP, Edwards JH, Price A, Abbott J, Burdon MA. Aetiology and outcomes of adult superior oblique palsies: a modern series. Eye (Lond). 2009;23(3):640-4.
- Cackett P, Fleck B, Mulhivill A. Bilateral fourth-nerve palsy occurring after shaking injury in infancy. J AAPOS. 2004;8(3):280-1.
- Ozoner B, Gungor A, Ture H, Ture U. Surgical Treatment of Trochlear Nerve Schwannomas: Case Series and Systematic Review. World Neurosurg. 2022;162:e288-e300.
- Torun N, Laviv Y, Jazi KK, Mahadevan A, Bhadelia RA, Matthew A, et al. Schwannoma of the trochlear nerve-an illustrated case series and a systematic review of management. Neurosurg Rev. 2018;41(3):699-711.
- Bison HS, Janetos TM, Russell EJ, Volpe NJ. Cranial Nerve Palsies in the Setting of Arachnoid Cysts: A Case Series and Literature Review. J Neuroophthalmol. 2024;44(2):242-246.
- Alrobaian MA, Henderson AD. Neuro-Ophthalmic Manifestations of Acute Leukemia. J Neuroophthalmol. 2021;41(4):e584-e590.
- Mielke C, Alexander MS, Anand N. Isolated bilateral trochlear nerve palsy as the first clinical sign of a metastatic [correction of metastasic] bronchial carcinoma. Am J Ophthalmol. 2001;132(4):593-4.
- Manici M, Görgülü RO, Darçın K, Gürkan Y. Cranial nerve palsies following neuraxial blocks. Agri. 2024;36(4):209-217.
- Diora JR, Plager DA. Sudden-onset trochlear nerve palsy: clinical characteristics and treatment implications. J AAPOS. 2019;23(6):321.e1-321.e5.
- Schumacher I, Kaeser PF, Voide N, Grabe H, Abegg M. Secondary Brown’s syndrome following fourth nerve palsy - case series and review of literature. Strabismus. 2026;34(2):133-138.
- Hunn RL, Firth AY. The effect of testing distance on the bielschowsky head tilt test. Binocul Vis Strabismus Q. 2009;24(1):33-8.
- Lee TH, Ji YS, Park SW, Yoon KC, Heo H. Intermittent exotropia with a positive Bielschowsky head-tilt test. Br J Ophthalmol. 2017;101(3):251-255.
- Elghonemy AM, Attia FS, Brodsky MC. Mechanisms for Positive Bielschowsky Head Tilt Testing in Horizontal Strabismus. J Binocul Vis Ocul Motil. 2024;74(2):69-74.
- Irsch K, Guyton DL, Ying HS. How Lingering Fusional Adaptation Influences the Bielschowsky Head Tilt Test in Superior Oblique Paresis. Klin Monbl Augenheilkd. 2022;239(10):1213-1220.
- Jägle H, Rudolph G, Hildebrand GD. Safety Aspects of DIMS Technology Glasses, Fixation as a Marker for Amblyopia, Bielschowsky Head Tilt Test in Superior Oblique Paresis and Successful Late Topical Treatment of Orbital Infantile Hemangioma. Klin Monbl Augenheilkd. 2022;239(10):1194-1196.
- Lemos J, Eggenberger E. Clinical utility and assessment of cyclodeviation. Curr Opin Ophthalmol. 2013;24(6):558-65.
- Burgos-Blasco B, Hernandez-Garcia E, Llorente-La-Orden C, Gomez-de-Liaño R. Inferior oblique recession associated to partial temporal inferior rectus recession in unilateral congenital superior oblique palsy. Eur J Ophthalmol. 2022;32(1):580-586.
- Aoba K, Matsuo T, Hamasaki I, Hasebe K. Clinical factors underlying a single surgery or repetitive surgeries to treat superior oblique muscle palsy. Springerplus. 2015;4:166.
- Murray C, Marsh I, Newsham D. Outcomes of the Harada-Ito Procedure. J Binocul Vis Ocul Motil. 2021;71(3):97-103.
- Roberts C, Dawson E, Lee J. Modified Harada-Ito procedure in bilateral superior oblique paresis. Strabismus. 2002;10(3):211-4.
- Bradfield YS, Struck MC, Kushner BJ, Neely DE, Plager DA, Gangnon RE. Outcomes of Harada-Ito surgery for acquired torsional diplopia. J AAPOS. 2012;16(5):453-7.
- Ayyıldız Ö, Mutlu FM, Küçükevcilioğlu M, Gökçe G, Altınsoy Hİ. Clinical Features and Surgical Results in Harada-Ito Surgery Patients. Turk J Ophthalmol. 2018;48(5):267-273.
- Ohtsuki H, Hasebe S, Hanabusa K, Fujimoto Y, Furuse T. Intraoperative adjustable suture surgery for bilateral superior oblique palsy. Ophthalmology. 1994;101(1):188-93.
- Jabroun MN, Marsh J, Guyton DL. Torsional incomitance after asymmetrically adjusted Harada-Ito procedures for the simultaneous correction of vertical and torsional deviations in bilateral trochlear nerve palsy. J AAPOS. 2021;25(6):338.e1-338.e6.
- Nejad M, Thacker N, Velez FG, Rosenbaum AL, Pineles SL. Surgical results of patients with unilateral superior oblique palsy presenting with large hypertropias. J Pediatr Ophthalmol Strabismus. 2013;50(1):44-52.
- Hanson RA, Ghosh S, Gonzalez-Gomez I, Levy ML, Gilles FH. Abducens length and vulnerability?. Neurology. 2004;62(1):33-6.
- Barges-Coll J, Fernandez-Miranda JC, Prevedello DM, Gardner P, Morera V, Madhok R, et al. Avoiding injury to the abducens nerve during expanded endonasal endoscopic surgery: anatomic and clinical case studies. Neurosurgery. 2010;67(1):144-54; discussion 154.
- Cain RB, Patel NP, Hoxworth JM, Lal D. Abducens palsy after lumbar drain placement: a rare complication in endoscopic skull base surgery. Laryngoscope. 2013;123(11):2633-8.
- Whelan RL, McDowell M, Chou C, Medsinge A, Lee J, Gardner PA, et al. Can Ophthalmologic Examination Predict Abducens Nerve Recovery After Endoscopic Skull Base Surgery?. Laryngoscope. 2021;131(3):513-517.
- Ravindran K, Lorensini B, Gaillard F, Kalus S. Bilateral traumatic abducens nerve avulsion: A case series and literature review. J Clin Neurosci. 2017;44:30-33.
- Ayberk G, Ozveren MF, Yildirim T, Ercan K, Cay EK, Koçak A. Review of a series with abducens nerve palsy. Turk Neurosurg. 2008;18(4):366-73.
- Mehndiratta MM, Garg S, Gurnani M. Cerebral venous thrombosis—clinical presentations. J Pak Med Assoc. 2006;56(11):513-6.
- Wani AM, Hussain WM, Fatani MI, Qadmani A, Maimani GA, Turkistani A, et al. Lower cranial nerve palsy, aseptic meningitis and hydrocephalus: unusual presentation of primary antiphospholipid syndrome. BMJ Case Rep. 2009;2009.
- Vogrig A, Muñiz-Castrillo S, Joubert B, Picard G, Rogemond V, Skowron F, et al. Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors. Neurology. 2021;96(6):e866-e875.
- Furtado SV, Mohan D, Hegde AS. Ophthalmic segment aneurysmal subarachnoid hemorrhage presenting with contralateral abducens nerve palsy: a false localizing sign. Optometry. 2010;81(9):450-3.
- Nichani P, Micieli JA. Retinal Manifestations of Idiopathic Intracranial Hypertension. Ophthalmol Retina. 2021;5(5):429-437.
- Fisher PG, Breiter SN, Carson BS, Wharam MD, Williams JA, Weingart JD, et al. A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer. 2000;89(7):1569-76.
- Agashe P, Aguiar M, Doshi A. Horizontal gaze palsy with ipsilateral esotropia with substituted convergence in a child with medulloblastoma. Strabismus. 2025;33(4):288-294.
- Sturm V, Schöffler C. Long-term follow-up of children with benign abducens nerve palsy. Eye (Lond). 2010;24(1):74-8.
- Kingma SDK, Ceulemans B. Recurrent Isolated Sixth Nerve Palsy in Childhood-Review on a Rare Phenomenon. Neuropediatrics. 2022;53(3):151-158.
- Jensen JV, von Holstein S, Saunte JP, Kessel L, Hofsli M. [Benign recurrent 6th nerve palsy]. Ugeskr Laeger. 2025;187(7).
- Barry BJ, Whitman MC, Hunter DG, Engle EC. Duane syndrome. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Muni I, Kaur K, Kumar B. Duane retraction syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Prasad P, Saxena A, Saxena R. Duane syndrome: An overview on the current management. Taiwan J Ophthalmol. 2023;13(4):489-499.
- Khorrami-Nejad M, Akbari MR, Masoomian B, Mahmood HA, Daneshvar K, Majdi A. Astigmatism in Duane Retraction Syndrome. BMC Ophthalmol. 2025;25(1):15.
- Gokahru S, Gupta E, Das S. Inverse Duane’s retraction syndrome: rare presentation of orbital myocysticercosis. Strabismus. 2025;33(4):283-287.
- Abu Melha A, Abbas AI, Alghamdi WS, Alghamdi SM, Alkhathami A. Duane Retraction Syndrome: A Report of Two Cases and Review of Literature. Cureus. 2024;16(11):e74460.
- Gaur N, Sharma P. Management of Duane retraction syndrome: A simplified approach. Indian J Ophthalmol. 2019;67(1):16-22.
- Akbari MR, Manouchehri V, Mirmohammadsadeghi A. Surgical treatment of Duane retraction syndrome. J Curr Ophthalmol. 2017;29(4):248-257.
- Velez FG, Oltra E, Isenberg SJ, Pineles SL. Assessment of torsion after superior rectus transposition with or without medial rectus recession for Duane syndrome and abducens nerve palsy. J AAPOS. 2014;18(5):457-60.
- Wong AM, Tweed D, Sharpe JA. Vertical misalignment in unilateral sixth nerve palsy. Ophthalmology. 2002;109(7):1315-25.
- Metz HS, Mazow M. Botulinum toxin treatment of acute sixth and third nerve palsy. Graefes Arch Clin Exp Ophthalmol. 1988;226(2):141-4.
- Metz HS, Dickey CF. Treatment of unilateral acute sixth-nerve palsy with botulinum toxin. Am J Ophthalmol. 1991;112(4):381-4.
- Wagner RS, Frohman LP. Long-term results: botulinum for sixth nerve palsy. J Pediatr Ophthalmol Strabismus. 1989;26(3):106-8.
- Chuenkongkaew W, Dulayajinda D, Deetae R. Botulinum toxin treatment of the sixth nerve palsy: an experience of 5-year duration in Thailand. J Med Assoc Thai. 2001;84(2):171-6.
- Kao LY, Chao AN. Subtenon injection of botulinum toxin for treatment of traumatic sixth nerve palsy. J Pediatr Ophthalmol Strabismus. 2003;40(1):27-30.
- Holmes JM, Beck RW, Kip KE, Droste PJ, Leske DA. Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis. J AAPOS. 2000;4(3):145-9.
- Sanjari MS, Falavarjani KG, Kashkouli MB, Aghai GH, Nojomi M, Rostami H. Botulinum toxin injection with and without electromyographic assistance for treatment of abducens nerve palsy: a pilot study. J AAPOS. 2008;12(3):259-62.
- Merticariu CI, Merticariu M, Dragomir MS. Botulinum Toxin Injection in Acute Sixth Nerve Palsy in a 1-Year-Old Child: Case Report, Management Strategy, and Review of Literature. Rom J Ophthalmol. 2025;69(1):22-27.
- Khalili MR, Hosseini S, Shirvani M, Sadati MS. Optic Neuropathy following Botulinum Toxin Injection into the Medial Rectus Muscle for Diplopia. J Ophthalmic Vis Res. 2022;17(2):296-302.
- Flanders M, Qahtani F, Gans M, Beneish R. Vertical rectus muscle transposition and botulinum toxin for complete sixth nerve palsy. Can J Ophthalmol. 2001;36(1):18-25.
- Leiba H, Wirth GM, Amstutz C, Landau K. Long-term results of vertical rectus muscle transposition and botulinum toxin for sixth nerve palsy. J AAPOS. 2010;14(6):498-501.
- Bagheri A, Veisi A, Tavakoli M. Hummelsheim procedure combined with medial rectus recession in complete sixth nerve palsy and esotropic Duane Retraction Syndrome. Eur J Ophthalmol. 2022;32(1):592-601.
- Ellis JA, Goldstein H, Connolly ES Jr, Meyers PM. Carotid-cavernous fistulas. Neurosurg Focus. 2012;32(5):E9.
- Schneider-Lise B, Vignal-Clermont C, Gastaud P. [Carotid-cavernous fistulas: Clinical features, management and differential diagnosis]. Rev Neurol (Paris). 2010;166(12):1010-6.
- Pe Yan MR, Sobrio MCS, Ranche FKT. Clinical Profile and Management Outcomes among Patients with Carotid-Cavernous Fistula. Acta Med Philipp. 2024;58(8):76-91.
- Li ZH, Wu Z, Zhang JT, Zhang LW. Surgical Management and Outcomes of Cavernous Sinus Hemangiomas: A Single-Institution Series of 47 Patients. World Neurosurg. 2019;122:e1181-e1194.
- Sharma R, Ponder C, Kamran M, Chacko J, Kapoor N, Mylavarapu K, et al. Bilateral Carotid-Cavernous Fistula: A Diagnostic and Therapeutic Challenge. J Investig Med High Impact Case Rep. 2022;10:23247096221094181.
- Sharkey B, Kosco E, Waack A, Lucarelli V, Gabel BC. Carotid Cavernous Fistula and Its Association With Spine Surgery: A Case Report. Cureus. 2024;16(12):e75160.
- Iampreechakul P, Tirakotai W, Tanpun A, Wattanasen Y, Lertbusayanukul P, Siriwimonmas S. Spontaneous resolution of direct carotid-cavernous fistulas: case series and literature review. Interv Neuroradiol. 2019;25(1):71-89.
- Korkmazer B, Kocak B, Tureci E, Islak C, Kocer N, Kizilkilic O. Endovascular treatment of carotid cavernous sinus fistula: A systematic review. World J Radiol. 2013;5(4):143-55.
- Mohankumar A, Gurnani B. Orbital apex syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Chang CC, Chang YC, Su KY, Lee YC, Chang FL, Li MH, et al. Acute Orbital Apex Syndrome Caused by Idiopathic Sclerosing Orbital Inflammation. Diagnostics (Basel). 2022;12(12).
- Massey D, Saab M. Orbital Apex Syndrome Secondary to SMARCB1-Deficient Invasive Sinonasal Carcinoma. Cureus. 2022;14(11):e31017.
- Borchard NA, Nayak JV. Orbital Apex Syndrome. N Engl J Med. 2018;378(17):e23.
- Astner ST, Nieder C, Stock K, Gaa J, Grosu AL. Carcinomatous meningitis appearing as acoustic neuromas: two cases. Strahlenther Onkol. 2007;183(5):279-83.
- Vellin JF, Achim V, Sinardet D, Gabrillargues J, Mom T, Gilain L. Rapidly developing leptomeningeal carcinomatosis following anterior skull base surgery: a case report. Auris Nasus Larynx. 2007;34(4):565-7.
- Hoppe J, Kalckreuth T, Metelmann M, Rumpf JJ, Klagges S, Dietzsch S, et al. [Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease]. Nervenarzt. 2022;93(8):812-818.
- Bhattacharyya A, Sarma P, Sharma DJ, Das KK, Kaur H, Prajapat M, et al. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian J Pharmacol. 2021;53(4):317-327.
- Naruka S, Rana N, Singh N, Kishore A, Nagpal K. COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series. Ear Nose Throat J. 2024;103(1_suppl):134S-144S.
- Dave TV, Gopinathan Nair A, Hegde R, Vithalani N, Desai S, Adulkar N, et al. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study. Ophthalmic Plast Reconstr Surg. 2021;37(5):488-495.
- Sreshta K, Dave TV, Varma DR, Nair AG, Bothra N, Naik MN, et al. Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis. Indian J Ophthalmol. 2021;69(7):1915-1927.
- Keshri A, Mathialagan A, Aishwarya A, Ravisankar, Bhuskute G, Kanaujia V, et al. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Eur Arch Otorhinolaryngol. 2023;280(2):819-827.
- Lam SC, Yuen HKL. Management of bilateral rhino-orbital cerebral mucormycosis. Hong Kong Med J. 2019;25(5):408-409.
- Al Reesi M, Al Muqbali T, Al Ajmi A, Menon V. Successful Management of Rhino-Orbital-Cerebral Mucormycosis in a Child with Acute-on-Chronic Kidney Disease and Malnutrition: Case report and literature review. Sultan Qaboos Univ Med J. 2023;23(2):259-263.
- Monzillo PH, Saab VM, Protti GG, Costa AR, Sanvito WL. [Tolosa-Hunt syndrome: analysis of six cases]. Arq Neuropsiquiatr. 2005;63(3A):648-51.
- Kim HJ, Lee SU, Lee ES, Choi JY, Kim JS. Recurrence and long-term outcomes of Tolosa-Hunt syndrome. J Neurol. 2024;271(2):935-943.
- İlgen Uslu F, Özkan M. Painful ophthalmoplegia: a case report and literature review. Agri. 2015;27(4):219-23.
- Oomura M, Uchida Y, Sakurai K, Toyoda T, Okita K, Matsukawa N. Miller Fisher Syndrome Mimicking Tolosa-Hunt Syndrome. Intern Med. 2018;57(18):2735-2738.
- Ammari W, Kammoun A, Zaghdoudi A, Berriche O, Younes S, Messaoud R. A Case of Painful Diplopia after COVID-19 Vaccination: Could It Be Tolosa-Hunt Syndrome?. Korean J Fam Med. 2023;44(4):240-243.
- Pantazopoulos D, Gouveri E, Papazoglou D, Papanas N. Ocular Motor Mononeuropathies in Diabetes Mellitus: A Brief Review. Exp Clin Endocrinol Diabetes. 2025;133(2):73-77.
- Erdal Y, Gunes T, Emre U. Isolated abducens nerve palsy: Comparison of microvascular and other causes. North Clin Istanb. 2022;9(4):353-357.
- Park SJ, Yang HK, Byun SJ, Park KH, Hwang JM. Risk of ischemic stroke after third, fourth, and sixth cranial nerve palsies in type 2 diabetes. J Diabetes. 2019;11(5):379-385.
- Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M, et al. Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options. Int J Mol Sci. 2023;24(4).
- Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44(11):1973-88.
- Jensen TS, Karlsson P, Gylfadottir SS, Andersen ST, Bennett DL, Tankisi H, et al. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain. 2021;144(6):1632-1645.
- Jacobson DM, McCanna TD, Layde PM. Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol. 1994;112(7):961-6.
- Kobashi R, Ohtsuki H, Hasebe S. Clinical studies of ocular motility disturbances: Part 2. Risk factors for ischemic ocular motor nerve palsy [corrected]. Jpn J Ophthalmol. 1997;41(2):115-9.
- Jung JS, Kim DH. Risk factors and prognosis of isolated ischemic third, fourth, or sixth cranial nerve palsies in the Korean population. J Neuroophthalmol. 2015;35(1):37-40.
- Komine N, Ohnari K, Murakami M, Kawata K, Suzuka K, Nakamata T. Ischemic ocular motor nerve palsy in three patients with end-stage renal disease. J UOEH. 2006;28(1):57-64.
- al Saleh M, Bosley TM. Microvascular cranial nerve palsies in an Arabic population. J Neuroophthalmol. 1999;19(4):252-6.
- Thömke F, Urban PP, Marx JJ, Mika-Grüttner A, Hopf HC. Seventh nerve palsies may be the only clinical sign of small pontine infarctions in diabetic and hypertensive patients. J Neurol. 2002;249(11):1556-62.
- Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 2006;29(2):340-4.
- Gaster B, Hirsch IB. The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Med. 1998;158(2):134-40.
- Ratner RE. Glycemic control in the prevention of diabetic complications. Clin Cornerstone. 2001;4(2):24-37.
- Biousse V, Newman N. Retinal and optic nerve ischemia. Continuum (Minneap Minn). 2014;20(4 Neuro-ophthalmology):838-56.
- Rodríguez-Gutiérrez R, Montori VM. Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence. Circ Cardiovasc Qual Outcomes. 2016;9(5):504-12.
- Gutowski NJ, Chilton JK. The congenital cranial dysinnervation disorders. Arch Dis Child. 2015;100(7):678-81.
- Singh A, Pandey PK, Agrawal A, Mittal SK, Rana KM, Bahuguna C. Congenital cranial dysinnervation disorders. Int Ophthalmol. 2017;37(6):1369-1381.
- Bosley TM, Abu-Amero KK, Oystreck DT. Congenital cranial dysinnervation disorders: a concept in evolution. Curr Opin Ophthalmol. 2013;24(5):398-406.
- Oystreck DT, Engle EC, Bosley TM. Recent progress in understanding congenital cranial dysinnervation disorders. J Neuroophthalmol. 2011;31(1):69-77.
- Oystreck DT. Ophthalmoplegia and Congenital Cranial Dysinnervation Disorders. J Binocul Vis Ocul Motil. 2018;68(1):31-33.
- Fels R. Congenital Cranial Dysinnervation Disorders: A Literature Review. Am Orthopt J. 2017;67(1):89-92.
- Nentwich MM, Nentwich MF, Maertz J, Brandlhuber U, Rudolph G. [Congenital cranial dysinnervation disorders (CCDD)]. Klin Monbl Augenheilkd. 2015;232(3):275-80.
- Xia W, Wei Y, Wu L, Zhao C. Congenital Fibrosis of the Extraocular Muscles: An Overview from Genetics to Management. Children (Basel). 2022;9(11).
- Price JM, Boparai RS, Wasserman BN. Congenital fibrosis of the extraocular muscles: review of recent literature. Curr Opin Ophthalmol. 2019;30(5):314-318.
- Vivian AJ. Congenital fibrosis of the extra-ocular muscles (CFEOM) and the cranial dysinnervation disorders. Eye (Lond). 2020;34(2):251-255.
- Wu J, Huang L, Zhou Y, Xie Y, Mo T, Li N. Clinical and genetic characteristics of Chinese patients with congenital fibrosis of the extraocular muscles. Orphanet J Rare Dis. 2024;19(1):300.
- Tiab L, d’Allèves Manzi V, Borruat FX, Munier F, Schorderet D. Mutation analysis of KIF21A in congenital fibrosis of the extraocular muscles (CFEOM) patients. Ophthalmic Genet. 2004;25(4):241-6.
- Hanisch F, Bau V, Zierz S. [Congenital fibrosis of extraocular muscles (CFEOM) and other phenotypes of congenital cranial dysinnervation syndromes (CCDD)]. Nervenarzt. 2005;76(4):395-402.
- Jurgens JA, Barry BJ, Chan WM, MacKinnon S, Whitman MC, Matos Ruiz PM, et al. Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders. medRxiv. 2024.
- Mravicic I, Lukacevic S, Biscevic A, Pjano MA, Ziga N, Tusek M. A Treatment Approach in Congenital Fibrosis of Extraocular Muscles. Med Arch. 2023;77(2):137-141.
- Monawwer SA, Ali S, Naeem R, Ali SH, Rabbani A, Khan M, et al. Moebius Syndrome: An Updated Review of Literature. Child Neurol Open. 2023;10:2329048X231205405.
- Zaidi SMH, Syed IN, Tahir U, Noor T, Choudhry MS. Moebius Syndrome: What We Know So Far. Cureus. 2023;15(2):e35187.
- Yaqoob A, Dar W, Raina A, Chandra A, Khawaja Z, Bukhari I, et al. Moebius Syndrome. Ann Indian Acad Neurol. 2021;24(6):929.
- Odedra A, Blumenow W, Dainty J, Dasgupta S, Dominguez-Gonzalez S, Gonzalez-Martin J, et al. Multidisciplinary Care for Moebius Syndrome and Related Disorders: Building a Management Protocol. J Clin Med. 2024;13(11).
- Ke Y, Meng J, Zhou M, Wu P, Zhang F, Hei X, et al. The Recurrence of Ptosis after Correction Surgery Is Associated with Refractive Error. Medicina (Kaunas). 2023;59(3).
- Zhang JY, Zhu XW, Ding X, Lin M, Li J. Prevalence of amblyopia in congenital blepharoptosis: a systematic review and Meta-analysis. Int J Ophthalmol. 2019;12(7):1187-1193.
- Marenco M, Macchi I, Macchi I, Galassi E, Massaro-Giordano M, Lambiase A. Clinical presentation and management of congenital ptosis. Clin Ophthalmol. 2017;11:453-463.
- Jubbal KT, Kania K, Braun TL, Katowitz WR, Marx DP. Pediatric Blepharoptosis. Semin Plast Surg. 2017;31(1):58-64.
- Landau Prat D, Ramakrishnan M, Zhao C, Revere K, Katowitz WR, Katowitz JA. Silicone sling frontalis suspension for congenital ptosis: Outcome of 174 consecutive cases. Clin Exp Ophthalmol. 2022;50(6):608-614.
- Salinas GR, Centelles IA, Rondón IR, Sánchez Tde J, Salas SV, Oduardo MD. Improved visual acuity after frontalis sling surgery for simple congenital ptosis. MEDICC Rev. 2011;13(1):23-8.
- Galindo-Ferreiro A, Zornoff DCM, Correntes JE, Akaishi PM, Schellini SA. Current management of upper lid ptosis: a web-based international survey of oculoplastic surgeons. Arq Bras Oftalmol. 2022;86(6).
- O’donnell B, Codère F, Dortzbach R, Lucarelli M, Kersten R, Rosser P. Clinical controversy: congenital unilateral and jaw-winking ptosis. Orbit. 2006;25(1):11-7.
- Fraine L. Nonsurgical management of diplopia. Am Orthopt J. 2012;62:13-8.
- Gelles JD, Weng A, Vought V, Vought R, Zhang I, Frohman LP, et al. Management of Binocular Diplopia With Prism Incorporated Ocular Impression-Based Scleral Lenses With and Without Wavefront-Guided Optics. Eye Contact Lens. 2026;52(6):245-251.
- Pichler U, Rohleder M, Ehrt O. [Prism adaptation test before strabismus surgery : Results of a survey and literature review]. Ophthalmologe. 2018;115(2):123-130.
- Kutschke PJ, Keech RV. Surgical outcome after prism adaptation for esotropia with a distance-near disparity. J AAPOS. 2001;5(3):189-92.
- Akbari MR, Mehrabi Bahar MR, Mirmohammadsadeghi A, Bayat R, Masoumi A. Short prism adaptation test in patients with acquired nonaccommodative esotropia; clinical findings and surgical outcome. J AAPOS. 2018;22(5):352-355.
- Zhang P, Zhang Y, Gao L, Yang J. Comparison of the therapeutic effects of surgery following prism adaptation test versus surgery alone in acute acquired comitant esotropia. BMC Ophthalmol. 2020;20(1):303.
- Nishikawa N, Kawaguchi Y, Fushitsu R. Prism adaptation response and surgical outcomes of acquired nonaccommodative comitant esotropia. Strabismus. 2023;31(1):9-16.
- Kiyak Yilmaz A, Kose S, Guven Yilmaz S, Uretmen O. The impact of prism adaptation test on surgical outcomes in patients with primary exotropia. Clin Exp Optom. 2015;98(3):224-7.
- Dadeya S, Kamlesh, Naniwal S. Usefulness of the preoperative prism adaptation test in patients with intermittent exotropia. J Pediatr Ophthalmol Strabismus. 2003;40(2):85-9.
- Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst Rev. 2017;3(3):CD006499.
- Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst Rev. 2012.
- Ai L, Chen X, Guo R, Li J, Wang J, Feng Y, et al. Botulinum toxin treatment for bielschowsky acquired commitant esotropia in adults. BMC Ophthalmol. 2022;22(1):395.
- Kang MS, Park J, Yang HK, Hwang JM. Long-term efficacy of botulinum toxin for treatment of acquired non-accommodative comitant esotropia. Sci Rep. 2025;15(1):5789.
- Shi M, Zhou Y, Qin A, Cheng J, Ren H. Treatment of acute acquired concomitant esotropia. BMC Ophthalmol. 2021;21(1):9.
- Wong ES, Lam CPS, Lau FHS, Lau WWY, Yam JCS. Botulinum toxin as an initial therapy for management of sixth nerve palsies caused by nasopharyngeal carcinomas. Eye (Lond). 2018;32(4):768-774.
- Nadeem S. Long-term outcomes of adjustable strabismus surgery at a Pakistani university hospital. Int Ophthalmol. 2023;43(3):825-836.
- Ferdi A, Kelly R, Logan P, Dooley I. Outcomes of adjustable strabismus surgery in an Irish University Hospital. Int Ophthalmol. 2017;37(5):1215-1219.
- Gawęcki M. Adjustable Versus Nonadjustable Sutures in Strabismus Surgery-Who Benefits the Most?. J Clin Med. 2020;9(2).
- Liu D, Kumar A, Shieh D, Bhargava S, Zobal-Ratner J, Simon JW. One-Month Postoperative Horizontal Strabismus Surgery Outcomes Using Adjustable and Nonadjustable Sutures. J Binocul Vis Ocul Motil. 2020;70(3):94-97.
- Leffler CT, Vaziri K, Cavuoto KM, McKeown CA, Schwartz SG, Kishor KS, et al. Strabismus Surgery Reoperation Rates With Adjustable and Conventional Sutures. Am J Ophthalmol. 2015;160(2):385-390.e4.
- Abdelmonem AA, Awadein A, Genidy MMM, Abdelhalim AS, Abdelaziz STA. Early and delayed suture adjustments after adjustable suture strabismus surgery: a randomized controlled trial. Med Hypothesis Discov Innov Ophthalmol. 2022;11(4):144-150.
- Modabber M, Dan AF, Coussa RG, Flanders M. Retrobulbar anaesthesia for adjustable strabismus surgery in adults: a prospective observational study. Can J Ophthalmol. 2018;53(6):621-626.
- Phanphruk W, Alkharashi M, Bilge A, Hunter DG. Sedated suture adjustment in children undergoing adjustable suture strabismus surgery. J AAPOS. 2017;21(3):196-200.
- Nassar MM, Dickinson AJ, Neoh C, Powell C, Buck D, Galal E, et al. Parameters predicting outcomes of strabismus surgery in the management of Graves’ ophthalmopathy. J AAPOS. 2009;13(3):236-40.
- Nelson DG, Peragallo JH. Strabismus surgery outcomes for internuclear ophthalmoplegia with exotropia. Strabismus. 2022;30(2):65-71.
- Stähr K, Eckstein A, Buschmeier M, Hussain T, Daser A, Oeverhaus M, et al. Risk Factors for New Onset Diplopia After Graduated Orbital Decompression. Ophthalmic Plast Reconstr Surg. 2021;37(6):564-570.
- Loba P, Kozakiewicz M, Nowakowska O, Omulecki W, Broniarczyk-Loba A. Management of persistent diplopia after surgical repair of orbital fractures. J AAPOS. 2012;16(6):548-53.
- Loba P, Kozakiewicz M, Broniarczyk-Loba A. Surgical management of upgaze diplopia in patients after posttraumatic orbital floor reconstruction. J Craniomaxillofac Surg. 2015;43(6):976-80.
- Navarrete-Sanchis J, Ortega-Evangelio L, Tomás-Torrent JM. Persistent Diplopia in Primary Position after Pars Plana Vitrectomy with Encircling Band in Rhegmatogenous Retinal Detachment. Ophthalmol Retina. 2018;2(3):197-200.
- Baxter SL, Nguyen BJ, Kinori M, Kikkawa DO, Robbins SL, Granet DB. Identification and Correction of Restrictive Strabismus After Pterygium Excision Surgery. Am J Ophthalmol. 2019;202:6-14.
- Subramanian PS, Birdsong RH. Surgical management of traumatic strabismus after combat-related injury. Mil Med. 2008;173(7):693-6.
- Huang YT, Lin SC, Huang LY, Rujikajorn K, Chen PJ, Chen JJ, et al. Incidence, Risk Factors and Management of Postoperative Complications in Horizontal Strabismus Surgery. Semin Ophthalmol. 2024;39(2):143-149.
- Yu B, Li YH, Li YL, Wei MY, Li GY. Enhanced diplopia detection and binocular single vision assessment through virtual reality: A comprehensive study. Sci Rep. 2025;15(1):8355.
- Arblaster G, Buckley D, Barnes S, Davis H. Strabismus Surgery for Psychosocial Reasons-A Literature Review. Br Ir Orthopt J. 2024;20(1):107-132.
- Tarnutzer AA, Straumann D. Nystagmus. Curr Opin Neurol. 2018;31(1):74-80.
- Strupp ML, Straumann D, Helmchen C. Nystagmus: Diagnosis, Topographic Anatomical Localization and Therapy. Klin Monbl Augenheilkd. 2021;238(11):1186-1195.
- Helmchen C, Heide W, Strupp ML, Straumann D. [Update on central oculomotor disorders and nystagmus]. Laryngorhinootologie. 2024;103(6):413-421.
- Agrawal Y, Van de Berg R, Wuyts F, Walther L, Magnusson M, Oh E, et al. Presbyvestibulopathy: Diagnostic criteria Consensus document of the classification committee of the Bárány Society. J Vestib Res. 2019;29(4):161-170.
- Abadi RV, Akman OE, Arblaster GE, Clement RA. Analysing nystagmus waveforms: a computational framework. Sci Rep. 2021;11(1):9761.
- Liu YZ, Shi XF. [Hierarchical clustering analysis of congenital nystagmus waveforms]. Zhonghua Yan Ke Za Zhi. 2022;58(3):194-199.
- Dell’Osso LF, Van Der Steen J, Steinman RM, Collewijn H. Foveation dynamics in congenital nystagmus IV: vergence. Doc Ophthalmol. 2020;140(3):221-232.
- Felius J, Muhanna ZA. Visual deprivation and foveation characteristics both underlie visual acuity deficits in idiopathic infantile nystagmus. Invest Ophthalmol Vis Sci. 2013;54(5):3520-5.
- Maybodi M. Infantile-onset nystagmus. Curr Opin Ophthalmol. 2003;14(5):276-85.
- Khanna S, Dell’Osso LF. The diagnosis and treatment of infantile nystagmus syndrome (INS). ScientificWorldJournal. 2006;6:1385-97.
- Theodorou M, Clement R, Taylor D, Moore A. The development of infantile nystagmus. Br J Ophthalmol. 2015;99(5):691-5.
- Bögli SY, Straumann D, Schuknecht B, Bertolini G, Tarnutzer AA. Cerebellar Rebound Nystagmus Explained as Gaze-Evoked Nystagmus Relative to an Eccentric Set Point: Implications for the Clinical Examination. Cerebellum. 2021;20(5):751-759.
- West PD, Sheppard ZA, King EV. Comparison of techniques for identification of peripheral vestibular nystagmus. J Laryngol Otol. 2012;126(12):1209-15.
- Fife TD. Positional dizziness. Continuum (Minneap Minn). 2012;18(5 Neuro-otology):1060-85.
- Gerling A, Leu SY, Morton AJ, Echegoyen J, Nalbandian A, Lingua RW. Reliability and application variability of a commercially available infrared videonystagmography unit. J Pediatr Ophthalmol Strabismus. 2015;52(2):114-8.
- Rosengren W, Nyström M, Hammar B, Rahne M, Sjödahl L, Stridh M. Modeling and quality assessment of nystagmus eye movements recorded using an eye-tracker. Behav Res Methods. 2020;52(4):1729-1743.
- Rosengren W, Nyström M, Hammar B, Stridh M. A robust method for calibration of eye tracking data recorded during nystagmus. Behav Res Methods. 2020;52(1):36-50.
- Dunn MJ, Harris CM, Ennis FA, Margrain TH, Woodhouse JM, McIlreavy L, et al. An automated segmentation approach to calibrating infantile nystagmus waveforms. Behav Res Methods. 2019;51(5):2074-2084.
- Lalanne C, Rateaux M, Oudre L, Robert MP, Moreau T. Extraction of Nystagmus Patterns from Eye-Tracker Data with Convolutional Sparse Coding. Annu Int Conf IEEE Eng Med Biol Soc. 2020;2020:928-931.
- Wang Z, Dell’Osso LF, Jacobs JB, Burnstine RA, Tomsak RL. Effects of tenotomy on patients with infantile nystagmus syndrome: foveation improvement over a broadened visual field. J AAPOS. 2006;10(6):552-60.
- Wang ZI, Dell’Osso LF. Factors influencing pursuit ability in infantile nystagmus syndrome: Target timing and foveation capability. Vision Res. 2009;49(2):182-9.
- Kim JM, Lee SH, Kim HJ, Kim JS. Less talked variants of benign paroxysmal positional vertigo. J Neurol Sci. 2022;442:120440.
- Shaikh AG, Zee DS, Crawford JD, Jinnah HA. Cervical dystonia: a neural integrator disorder. Brain. 2016;139(Pt 10):2590-2599.
- Halmagyi GM, Leigh RJ. Upbeat about downbeat nystagmus. Neurology. 2004;63(4):606-7.
- Skolka M, Pinto MV, Powell TE, Eggers S, Dahl H, Toledano M. Transient downbeat nystagmus. Pract Neurol. 2023;23(1):93-94.
- Stulin ID, Tardov MV, Kunel’skaya NL, Chugunova MA, Bajbakova EV, Boldin AV, et al. [Vertical nystagmus]. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(8):119-124.
- Feil K, Rattay TW, Adeyemi AK, Goldschagg N, Strupp ML. [What’s behind cerebellar dizziness? - News on diagnosis and therapy]. Laryngorhinootologie. 2024;103(5):337-343.
- Cham KM, Abel LA, Busija L, Kowal L, Bachar Zipori A, Downie LE. Surgical interventions for infantile nystagmus syndrome. Cochrane Database Syst Rev. 2021;2(2):CD013390.
- Serra A, Chen AL, Leigh RJ. Disorders of vergence eye movements. Curr Opin Neurol. 2011;24(1):32-7.
- Bertsch M, Floyd M, Kehoe T, Pfeifer W, Drack AV. The clinical evaluation of infantile nystagmus: What to do first and why. Ophthalmic Genet. 2017;38(1):22-33.
- Joseph S, Naithani R, Alvarez S, Glaser T, Freedman S, El-Dairi M. Modernizing the evaluation of infantile nystagmus: the role of handheld optical coherence tomography. J AAPOS. 2024;28(3):103924.
- Rim JH, Lee ST, Gee HY, Lee BJ, Choi JR, Park HW, et al. Accuracy of Next-Generation Sequencing for Molecular Diagnosis in Patients With Infantile Nystagmus Syndrome. JAMA Ophthalmol. 2017;135(12):1376-1385.
- Holmström G, Bondeson ML, Eriksson U, Åkerblom H, Larsson E. ‘Congenital’ nystagmus may hide various ophthalmic diagnoses. Acta Ophthalmol. 2014;92(5):412-6.
- Hertle RW, Maldanado VK, Maybodi M, Yang D. Clinical and ocular motor analysis of the infantile nystagmus syndrome in the first 6 months of life. Br J Ophthalmol. 2002;86(6):670-5.
- O’Gorman L, Norman CS, Michaels L, Newall T, Crosby AH, Mattocks C, et al. A small gene sequencing panel realises a high diagnostic rate in patients with congenital nystagmus following basic phenotyping. Sci Rep. 2019;9(1):13229.
- Cavuoto KM, Binenbaum G, Chang MY, Heidary G, Morrison DG, Trivedi RH, et al. Genetic testing for infantile nystagmus syndrome with or without associated findings. J AAPOS. 2023;27(5):259-264.
- Choi JH, Kim SJ, Thomas MG, Jung JH, Oh EH, Shin JH, et al. Diagnostic yield of targeted next-generation sequencing in infantile nystagmus syndrome. Ophthalmic Genet. 2021;42(5):561-569.
- Wang Y, Sun W, Xiao X, Li S, Jia X, Wang P, et al. Clinical and Genetic Analysis of 63 Families Demonstrating Early and Advanced Characteristic Fundus as the Signature of CRB1 Mutations. Am J Ophthalmol. 2021;223:160-168.
- Daich Varela M, Jeste M, de Guimaraes TAC, Mahroo OA, Arno G, Webster AR, et al. Clinical, Ophthalmic, and Genetic Characterization of RPGRIP1-Associated Leber Congenital Amaurosis/Early-Onset Severe Retinal Dystrophy. Am J Ophthalmol. 2024;266:255-263.
- Hedergott A, Volk AE, Herkenrath P, Thiele H, Fricke J, Altmüller J, et al. Clinical and genetic findings in a family with NMNAT1-associated Leber congenital amaurosis: case report and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2239-46.
- Katta M, de Guimaraes TAC, Fujinami-Yokokawa Y, Fujinami K, Georgiou M, Mahroo OA, et al. Congenital Stationary Night Blindness: Structure, Function and Genotype-Phenotype Correlations in a Cohort of 122 Patients. Ophthalmol Retina. 2024;8(9):932-941.
- Wang FB. Nystagmus associated with macular dysplasia. Strabismus. 2020;28(1):17-19.
- Michieletto P, Baldo F, Madonia M, Zupin L, Pensiero S, Bonati MT. Retinal Changes in Early-Onset cblC Methylmalonic Acidemia Identified Through Expanded Newborn Screening: Highlights from a Case Study and Literature Review. Genes (Basel). 2025;16(6).
- Kavalaraki A, Paraskevopoulos K, Kavalaraki M, Karakosta C, Liaskou M. Foveal Hypoplasia in a Child With Tyrosinase-Positive Albinism. Cureus. 2023;15(9):e44558.
- Liu S, Kuht HJ, Moon EH, Maconachie GDE, Thomas MG. Current and emerging treatments for albinism. Surv Ophthalmol. 2021;66(2):362-377.
- Schonhaut B L, Britzmann L J, Zanolli S M, Pavlov N J, Hasbun Z T, Repetto L G. [Nystagmus secondary to albinism with ocular involvement in a female: A diagnostic challenge]. Rev Chil Pediatr. 2020;91(4):573-578.
- Thomas MG, Gottlob I. Optical coherence tomography studies provides new insights into diagnosis and prognosis of infantile nystagmus: a review. Strabismus. 2012;20(4):175-80.
- Bouraoui R, Bouladi M, Nefaa F, Limaiem R, El Matri L. [Role of SD-OCT in the diagnosis and prognosis of macular hypoplasia in nystagmus patients]. J Fr Ophtalmol. 2016;39(3):272-6.
- Tusa RJ. Nystagmus: diagnostic and therapeutic strategies. Semin Ophthalmol. 1999;14(2):65-73.
- Dunn MJ, Wiggins D, Woodhouse JM, Margrain TH, Harris CM, Erichsen JT. The Effect of Gaze Angle on Visual Acuity in Infantile Nystagmus. Invest Ophthalmol Vis Sci. 2017;58(1):642-650.
- Kumar A, Shetty S, Vijayalakshmi P, Hertle RW. Improvement in visual acuity following surgery for correction of head posture in infantile nystagmus syndrome. J Pediatr Ophthalmol Strabismus. 2011;48(6):341-6.
- Wang P, Lou L, Song L. Design and efficacy of surgery for horizontal idiopathic nystagmus with abnormal head posture and strabismus. J Huazhong Univ Sci Technolog Med Sci. 2011;31(5):678.
- Chen JJ, Tian LL, Zhang LH, Wang JL, Kang XL. [Comprehensive analysis of the effect of null zone shifting surgery treatment on patients with infantile nystagmus syndrome]. Zhonghua Yan Ke Za Zhi. 2019;55(1):13-19.
- Kang NY, Isenberg SJ. Kestenbaum procedure with posterior fixation suture for anomalous head posture in infantile nystagmus. Graefes Arch Clin Exp Ophthalmol. 2009;247(7):981-7.
- Lueder GT, Galli M. Oblique muscle surgery for treatment of nystagmus with head tilt. J AAPOS. 2012;16(4):322-6.
- Law JJ, Zheng Y, Donahue SP. Recession-Resection of the Vertical Rectus Muscles for Chin-up Vertical Abnormal Head Position Associated With Infantile Nystagmus Syndrome. J Pediatr Ophthalmol Strabismus. 2022;59(6):410-415.
- Grace SF, Lam BL, Feuer WJ, Osigian CJ, Cavuoto KM, Capo H. Nonsedated handheld electroretinogram as a screening test of retinal dysfunction in pediatric patients with nystagmus. J AAPOS. 2017;21(5):384-388.
- Gong X, Boydstun IP, Lawhon WT, Hanna NN, Wall PB, Flickinger A, et al. Clinical Spectrum and Molecular Characteristics of Inherited Ocular Diseases in a Cohort of Pediatric Patients With Infantile Nystagmus Syndrome. Invest Ophthalmol Vis Sci. 2025;66(4):39.
- Thomas MG, Maconachie G, Hisaund M, Gottlob I. FRMD7-related infantile nystagmus. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Thomas S, Proudlock FA, Sarvananthan N, Roberts EO, Awan M, McLean R, et al. Phenotypical characteristics of idiopathic infantile nystagmus with and without mutations in FRMD7. Brain. 2008;131(Pt 5):1259-67.
- Arshad MW, Shabbir MI, Asif S, Shahzad M, Leydier L, Rai SK. FRMD7 Gene Alterations in a Pakistani Family Associated with Congenital Idiopathic Nystagmus. Genes (Basel). 2023;14(2).
- Su Y, Zhang J, Gao J, Ding G, Jiang H, Liu Y, et al. Truncated FRMD7 proteins in congenital Nystagmus: novel frameshift mutations and proteasomal pathway implications. BMC Med Genomics. 2024;17(1):36.
- Betts-Henderson J, Bartesaghi S, Crosier M, Lindsay S, Chen HL, Salomoni P, et al. The nystagmus-associated FRMD7 gene regulates neuronal outgrowth and development. Hum Mol Genet. 2010;19(2):342-51.
- Pu J, Dai S, Gao T, Hu J, Fang Y, Zheng R, et al. Nystagmus-related FRMD7 gene influences the maturation and complexities of neuronal processes in human neurons. Brain Behav. 2019;9(12):e01473.
- Jiang L, Li Y, Yang K, Wang Y, Wang J, Cui X, et al. FRMD7 Mutations Disrupt the Interaction with GABRA2 and May Result in Infantile Nystagmus Syndrome. Invest Ophthalmol Vis Sci. 2020;61(5):41.
- Scaramuzzi M, Murray J, Nucci P, Shaikh AG, Ghasia FF. Fixational eye movements abnormalities and rate of visual acuity and stereoacuity improvement with part time patching. Sci Rep. 2021;11(1):1217.
- Kiblinger GD, Wallace BS, Hines M, Siatkowski RM. Spasmus nutans-like nystagmus is often associated with underlying ocular, intracranial, or systemic abnormalities. J Neuroophthalmol. 2007;27(2):118-22.
- Newman SA, Hedges TR, Wall M, Sedwick LA. Spasmus nutans—or is it?. Surv Ophthalmol. 1990;34(6):453-6.
- Richards M, Wong A, Foeller P, Bradley D, Tychsen L. Duration of binocular decorrelation predicts the severity of latent (fusion maldevelopment) nystagmus in strabismic macaque monkeys. Invest Ophthalmol Vis Sci. 2008;49(5):1872-8.
- Dell’Osso LF, Orge FH, Jacobs JB, Wang ZI. Fusion maldevelopment (latent/manifest latent) nystagmus syndrome: effects of four-muscle tenotomy and reattachment. J Pediatr Ophthalmol Strabismus. 2014;51(3):180-8.
- Gwiazda J, Thorn F. Development of refraction and strabismus. Curr Opin Ophthalmol. 1999;10(5):293-9.
- Shallo-Hoffmann J, Faldon M, Hague S, Riordan-Eva P, Fells P, Gresty M. Motion detection deficits in infantile esotropia without nystagmus. Invest Ophthalmol Vis Sci. 1997;38(1):219-26.
- Nelson LB, Wagner RS, Simon JW, Harley RD. Congenital esotropia. Surv Ophthalmol. 1987;31(6):363-83.
- Ehrt O. Infantile and acquired nystagmus in childhood. Eur J Paediatr Neurol. 2012;16(6):567-72.
- Gottlob I, Wizov SS, Reinecke RD. Spasmus nutans. A long-term follow-up. Invest Ophthalmol Vis Sci. 1995;36(13):2768-71.
- Parikh RN, Simon JW, Zobal-Ratner JL, Barry GP. Long-Term Follow-up of Spasmus Nutans. J Binocul Vis Ocul Motil. 2018;68(4):137-139.
- Hennein L, Heidary G, Gaier ED, Gise R. Long-term visual outcomes in spasmus nutans. BMC Ophthalmol. 2024;24(1):253.
- Doummar D, Roussat B, Beauvais P, Billette de Villemeur T, Richardet JM. [Spasmus nutans: apropos of 16 cases]. Arch Pediatr. 1998;5(3):264-8.
- Mosca S, Martins J, Temudo T. Transient benign paroxysmal movement disorders in infancy. Rev Neurol. 2022;74(4):135-140.
- Oladiwura D, Shweikh Y, Roberts C, Theodorou M. Nystagmus in Down Syndrome - a Retrospective Notes Review. Br Ir Orthopt J. 2022;18(1):48-56.
- Reinhold A, Roulez F, Palmowski-Wolfe A. Importance of Early Electrophysiology in Spasmus Nutans. Klin Monbl Augenheilkd. 2022;239(4):597-598.
- Appen RE. Spasmus nutans: what to do?. J Pediatr Ophthalmol Strabismus. 1995;32(5):277.
- Aung T, Yap SK, Yap EY, Fam HB. Spasmus nutans. Ann Acad Med Singap. 1996;25(4):596-8.
- Ren CH, Fang F. [Spasmus nutans]. Zhonghua Er Ke Za Zhi. 2013;51(8):635-7.
- Bellini T, Ferretti M, Santaniello S, Pezzotta F, Piccotti E, Striano P. Teaching Video NeuroImage: Spasmus Nutans, an Infantile Nystagmus. Neurology. 2022;99(17):769-770.
- Knight CT, Rana HN, Standley T. A Unique Case of Sporadic Optic Pathway Glioma in an Infant With Acute Nystagmus. Cureus. 2021;13(8):e17568.
- Robert-Boire V, Rosca L, Samson Y, Ospina LH, Perreault S. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma. Pediatr Neurol. 2017;75:55-60.
- Teenan DW, Rajah B, Dutton GN. Nystagmus blockage syndrome associated with accommodative spasm. J Pediatr Ophthalmol Strabismus. 2001;38(3):181-2.
- von Noorden GK, Munoz M, Raab EL. Recurrent esotropia. J Pediatr Ophthalmol Strabismus. 1988;25(6):275-80; discussion 279-80.
- Havertape SA, Whitfill CR, Cruz OA. Early-onset accommodative esotropia. J Pediatr Ophthalmol Strabismus. 1999;36(2):69-73.
- Strupp M, Hüfner K, Sandmann R, Zwergal A, Dieterich M, Jahn K, et al. Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellum. Dtsch Arztebl Int. 2011;108(12):197-204.
- Rucker JC. Nystagmus and Saccadic Intrusions. Continuum (Minneap Minn). 2019;25(5):1376-1400.
- Gasca-González OO, Pérez-Cruz JC, Baldoncini M, Macías-Duvignau MA, Delgado-Reyes L. Neuroanatomical basis of Wallenberg syndrome. Cir Cir. 2020;88(3):376-382.
- Otero-Millan J, Colpak AI, Kheradmand A, Zee DS. Rebound nystagmus, a window into the oculomotor integrator. Prog Brain Res. 2019;249:197-209.
- Pierrot-Deseilligny C, Milea D. Vertical nystagmus: clinical facts and hypotheses. Brain. 2005;128(Pt 6):1237-46.
- Goodwin D, Halvorson AR. Chiari I malformation presenting as downbeat nystagmus: clinical presentation, diagnosis, and management. Optometry. 2012;83(2):80-6.
- Massuyama BK, Vale TC, Rezende Filho FM, Barsottini OGP, Pedroso JL. Downbeat nystagmus and progressive ataxia in adults: consider Chiari malformation type 1. Arq Neuropsiquiatr. 2023;81(10):937-938.
- Pellerin D, Danzi MC, Renaud M, Houlden H, Synofzik M, Zuchner S, et al. Spinocerebellar ataxia 27B: A novel, frequent and potentially treatable ataxia. Clin Transl Med. 2024;14(1):e1504.
- Pellerin D, Heindl F, Wilke C, Danzi MC, Traschütz A, Ashton C, et al. GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort. EBioMedicine. 2024;102:105076.
- Clément G, Puisieux S, Pellerin D, Brais B, Bonnet C, Renaud M. Spinocerebellar ataxia 27B (SCA27B), a frequent late-onset cerebellar ataxia. Rev Neurol (Paris). 2024;180(5):410-416.
- Kalla R, Glasauer S, Büttner U, Brandt T, Strupp M. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain. 2007;130(Pt 9):2441-51.
- Kalla R, Spiegel R, Claassen J, Bardins S, Hahn A, Schneider E, et al. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus. J Neuroophthalmol. 2011;31(4):320-5.
- Domínguez-Durán E, Mármol-Szombathy I, Baños-Roldán Ú, Sánchez-Gómez S. Clinical use of 4-aminopyridine in patients with downbeat nystagmus. Acta Otorrinolaringol Esp (Engl Ed). 2020;71(1):40-44.
- Janssen JC, Larner AJ, Morris H, Bronstein AM, Farmer SF. Upbeat nystagmus: clinicoanatomical correlation. J Neurol Neurosurg Psychiatry. 1998;65(3):380-1.
- Tilikete C, Milea D, Pierrot-Deseilligny C. Upbeat nystagmus from a demyelinating lesion in the caudal pons. J Neuroophthalmol. 2008;28(3):202-6.
- Choi SY, Jang JY, Oh EH, Choi JH, Park JY, Lee SH, et al. Persistent geotropic positional nystagmus in unilateral cerebellar lesions. Neurology. 2018;91(11):e1053-e1057.
- Crotty GF, Chwalisz BK. Ocular motor manifestations of movement disorders. Curr Opin Ophthalmol. 2019;30(6):443-448.
- Weber KP, Straumann D. Neuro-ophthalmology update. J Neurol. 2014;261(7):1251-6.
- Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics. 2007;4(2):267-73.
- Algahtani H, Shirah B, Algahtani R, Al-Qahtani MH, Abdulkareem AA, Naseer MI. A novel mutation in CACNA1A gene in a Saudi female with episodic ataxia type 2 with no response to acetazolamide or 4-aminopyridine. Intractable Rare Dis Res. 2019;8(1):67-71.
- González-Mingot C, López-Ortega R, Brieva-Ruiz L. The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2. Neurol Sci. 2022;43(8):5099-5101.
- Kalla R, Strupp M. Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders. Curr Neuropharmacol. 2019;17(1):7-13.
- Lemos J, Manto M. Pharmacotherapy of cerebellar and vestibular disorders. Curr Opin Neurol. 2022;35(1):118-125.
- Onodera O. Spinocerebellar ataxia with ocular motor apraxia and DNA repair. Neuropathology. 2006;26(4):361-7.
- Dawson DM. Recessive ataxia with ocular motor apraxia. Arch Neurol. 2001;58(2):173-4.
- Kim JS, Kim JS, Youn J, Seo DW, Jeong Y, Kang JH, et al. Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features. Mov Disord. 2013;28(9):1271-7.
- Lemos J, Novo A, Duque C, Cunha I, Ribeiro J, Castelhano J, et al. Static and Dynamic Ocular Motor Abnormalities as Potential Biomarkers in Spinocerebellar Ataxia Type 3. Cerebellum. 2021;20(3):402-409.
- Lee SU, Kim JS, Yoo D, Kim A, Kim HJ, Choi JY, et al. Ocular Motor Findings Aid in Differentiation of Spinocerebellar Ataxia Type 17 from Huntington’s Disease. Cerebellum. 2023;22(1):1-13.
- Murty S. Antiepileptic Overdose. Indian J Crit Care Med. 2019;23(Suppl 4):S290-S295.
- Craig S. Phenytoin poisoning. Neurocrit Care. 2005;3(2):161-70.
- Khadela A, Dave B, Premal Y, Patel N, Sadhwani D. The Phenytoin Ataxia Enigma Unveiled “A Case Report”. J Pharm Pract. 2025;38(1):180-186.
- Chandrappa SS, Ranka R, Dhar M, Karna G. Phenytoin toxicity caused by a drug-to-drug interaction between phenytoin and antitubercular therapy. BMJ Case Rep. 2025;18(1).
- Hadjikoutis S, Morgan JE, Wild JM, Smith PE. Ocular complications of neurological therapy. Eur J Neurol. 2005;12(7):499-507.
- Shah VP, Oliveira J E Silva L, Farah W, Seisa MO, Balla AK, Christensen A, et al. Diagnostic accuracy of the physical examination in emergency department patients with acute vertigo or dizziness: A systematic review and meta-analysis for GRACE-3. Acad Emerg Med. 2023;30(5):552-578.
- Zwergal A, Dieterich M. Vertigo and dizziness in the emergency room. Curr Opin Neurol. 2020;33(1):117-125.
- Maranhão ET, Maranhão-Filho P. Vestibulo-ocular reflex and the head impulse test. Arq Neuropsiquiatr. 2012;70(12):942-4.
- Welgampola MS, Taylor RL, Halmagyi GM. Video Head Impulse Testing. Adv Otorhinolaryngol. 2019;82:56-66.
- Machner B, Erber K, Choi JH, Sprenger A, Helmchen C, Trillenberg P. A Simple Gain-Based Evaluation of the Video Head Impulse Test Reliably Detects Normal Vestibulo-Ocular Reflex Indicative of Stroke in Patients With Acute Vestibular Syndrome. Front Neurol. 2021;12:741859.
- Eggers SDZ. Approach to the Examination and Classification of Nystagmus. J Neurol Phys Ther. 2019;43 Suppl 2:S20-S26.
- Büttner U, Helmchen C, Brandt T. Diagnostic criteria for central versus peripheral positioning nystagmus and vertigo: a review. Acta Otolaryngol. 1999;119(1):1-5.
- Imai T, Takeda N, Ikezono T, Shigeno K, Asai M, Watanabe Y, et al. Classification, diagnostic criteria and management of benign paroxysmal positional vertigo. Auris Nasus Larynx. 2017;44(1):1-6.
- Del Risco A, Cherches A, Smith SL, Riska KM. Guideline Adherence to Benign Paroxysmal Positional Vertigo Treatment and Management in Primary Care. Otolaryngol Head Neck Surg. 2023;169(4):865-874.
- Koshi EJ, Sutton AE. Benign paroxysmal positional vertigo. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Sharif S, Khoujah D, Greer A, Naples JG, Upadhye S, Edlow JA. Vestibular suppressants for benign paroxysmal positional vertigo: A systematic review and meta-analysis of randomized controlled trials. Acad Emerg Med. 2023;30(5):541-551.
- Macdonald NK, Kaski D, Saman Y, Al-Shaikh Sulaiman A, Anwer A, Bamiou DE. Central Positional Nystagmus: A Systematic Literature Review. Front Neurol. 2017;8:141.
- Choi JY, Kim JH, Kim HJ, Glasauer S, Kim JS. Central paroxysmal positional nystagmus: Characteristics and possible mechanisms. Neurology. 2015;84(22):2238-46.
- Shallo-Hoffmann J, Riordan-Eva P. Recognizing periodic alternating nystagmus. Strabismus. 2001;9(4):203-15.
- DiBartolomeo JR, Yee RD. Periodic alternating nystagmus. Otolaryngol Head Neck Surg. 1988;99(6):552-7.
- Lee MS, Lessell S. Lithium-induced periodic alternating nystagmus. Neurology. 2003;60(2):344.
- Comer RM, Dawson EL, Lee JP. Baclofen for patients with congenital periodic alternating nystagmus. Strabismus. 2006;14(4):205-9.
- Solomon D, Shepard N, Mishra A. Congenital periodic alternating nystagmus: response to baclofen. Ann N Y Acad Sci. 2002;956:611-5.
- Straube A. Pharmacology of vertigo/nystagmus/oscillopsia. Curr Opin Neurol. 2005;18(1):11-4.
- Yun SY, Lee JH, Kim HJ, Choi JY, Kim JS. Effects of Baclofen on Central Paroxysmal Positional Downbeat Nystagmus. Cerebellum. 2024;23(5):1892-1898.
- Saluja G, Samdani A, Bhatia P. See-saw nystagmus in giant craniopharyngioma. BMJ Case Rep. 2020;13(6).
- Jain H, Nair J, Krishnaswamy V. See-Saw Nystagmus in a Case of Sellar/Suprasellar Mass. J Neuroophthalmol. 2024;44(3):e481-e482.
- Williams IM, Dickinson P, Ramsay RJ, Thomas L. See-saw nystagmus. Aust J Ophthalmol. 1982;10(1):19-25.
- Gottlob I. Nystagmus. Curr Opin Ophthalmol. 2000;11(5):330-5.
- Chiew YR. See-saw nystagmus associated with retinitis pigmentosa. QJM. 2023;116(7):572-573.
- Ward BK, van de Berg R, van Rompaey V, Bisdorff A, Hullar TE, Welgampola MS, et al. Superior semicircular canal dehiscence syndrome: Diagnostic criteria consensus document of the committee for the classification of vestibular disorders of the Bárány Society. J Vestib Res. 2021;31(3):131-141.
- Steenerson KK, Crane BT, Minor LB. Superior Semicircular Canal Dehiscence Syndrome. Semin Neurol. 2020;40(1):151-159.
- Bi WL, Brewster R, Poe D, Vernick D, Lee DJ, Eduardo Corrales C, et al. Superior semicircular canal dehiscence syndrome. J Neurosurg. 2017;127(6):1268-1276.
- Matz O, Sutton AE, Shermetaro C. Tullio phenomenon. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Dumas G, Curthoys IS, Castellucci A, Dumas L, Perrin P, Schmerber S. A bone-conducted Tullio phenomenon-A bridge to understand skull vibration induced nystagmus in superior canal dehiscence. Front Neurol. 2023;14:1183040.
- Sarna B, Abouzari M, Merna C, Jamshidi S, Saber T, Djalilian HR. Perilymphatic Fistula: A Review of Classification, Etiology, Diagnosis, and Treatment. Front Neurol. 2020;11:1046.
- Deveze A, Matsuda H, Elziere M, Ikezono T. Diagnosis and Treatment of Perilymphatic Fistula. Adv Otorhinolaryngol. 2018;81:133-145.
- Maitland CG. Perilymphatic fistula. Curr Neurol Neurosci Rep. 2001;1(5):486-91.
- Rogers TS, Noel MA, Garcia B. Dizziness: Evaluation and Management. Am Fam Physician. 2023;107(5):514-523.
- Kang S, Shaikh AG. Acquired pendular nystagmus. J Neurol Sci. 2017;375:8-17.
- Stahl JS, Leigh RJ. Nystagmus. Curr Neurol Neurosci Rep. 2001;1(5):471-7.
- Averbuch-Heller L. Acquired Nystagmus. Curr Treat Options Neurol. 1999;1(1):68-73.
- Thurtell MJ, Joshi AC, Leone AC, Tomsak RL, Kosmorsky GS, Stahl JS, et al. Crossover trial of gabapentin and memantine as treatment for acquired nystagmus. Ann Neurol. 2010;67(5):676-80.
- Starck M, Albrecht H, Pöllmann W, Dieterich M, Straube A. Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. J Neurol. 2010;257(3):322-7.
- Thurtell MJ. Treatment of Nystagmus. Semin Neurol. 2015;35(5):522-6.
- Vosoughi AR, Barbosa NB, Micieli J, Margolin E. Unilateral Pendular Nystagmus in Multiple Sclerosis: A Case Series. J Neuroophthalmol. 2024;44(3):414-418.
- Tilikete C, Desestret V. Hypertrophic Olivary Degeneration and Palatal or Oculopalatal Tremor. Front Neurol. 2017;8:302.
- Wang H, Wang Y, Wang R, Li Y, Wang P, Li J, et al. Hypertrophic olivary degeneration: A comprehensive review focusing on etiology. Brain Res. 2019;1718:53-63.
- Onen MR, Moore K, Cikla U, Ucer M, Schmidt B, Field AS, et al. Hypertrophic Olivary Degeneration: Neurosurgical Perspective and Literature Review. World Neurosurg. 2018;112:e763-e771.
- Gu CN, Carr CM, Kaufmann TJ, Kotsenas AL, Hunt CH, Wood CP. MRI Findings in Nonlesional Hypertrophic Olivary Degeneration. J Neuroimaging. 2015;25(5):813-7.
- Mohammadzadeh N, Tung GA, Friedman JH. Hypertrophic Olivary Degeneration Following Clivus Meningioma Surgery. R I Med J (2013). 2024;107(2):24-25.
- McDonald MF, Rao G, Mandel JJ. Hypertrophic Olivary Degeneration Postoperatively Following Pilocytic Astrocytoma Resection. World Neurosurg. 2022;165:18-19.
- Hong S, Leigh RJ, Zee DS, Optican LM. Inferior olive hypertrophy and cerebellar learning are both needed to explain ocular oscillations in oculopalatal tremor. Prog Brain Res. 2008;171:219-26.
- Borruat FX. Oculopalatal tremor: current concepts and new observations. Curr Opin Neurol. 2013;26(1):67-73.
- Fiani B, Runnels J, Sarhadi K, Sarno E, Kondilis A. Oncologic causes of oculopalatal tremors: neurophysiology and treatment. Acta Neurol Belg. 2021;121(5):1111-1116.
- Kamath A, Huang WC, Madill SA. How should I approach and manage adult-onset oscillopsia?. Eye (Lond). 2024;38(12):2246-2252.
- Rowe F. Symptoms of stroke-related visual impairment. Strabismus. 2013;21(2):150-4.
- Szmulewicz DJ, Galli R, Tarnutzer AA. Patient-Related Outcome Measures for Oculomotor Symptoms in the Cerebellar Ataxias: Insights from Non-Cerebellar Disorders. Cerebellum. 2024;23(4):1435-1448.
- Bandini F, Castello E, Mazzella L, Mancardi GL, Solaro C. Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis?. J Neurol Neurosurg Psychiatry. 2001;71(1):107-10.
- Nerrant E, Abouaf L, Pollet-Villard F, Vie AL, Vukusic S, Berthiller J, et al. Gabapentin and Memantine for Treatment of Acquired Pendular Nystagmus: Effects on Visual Outcomes. J Neuroophthalmol. 2020;40(2):198-206.
- McLean R, Proudlock F, Thomas S, Degg C, Gottlob I. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin. Ann Neurol. 2007;61(2):130-8.
- Starck M, Albrecht H, Pöllmann W, Straube A, Dieterich M. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol. 1997;244(1):9-16.
- Thurtell MJ, Leigh RJ. Treatment of nystagmus. Curr Treat Options Neurol. 2012;14(1):60-72.
- Kremmyda O, Feil K, Bardins S, Strupp M. Acetyl-DL-leucine in combination with memantine improves acquired pendular nystagmus caused by multiple sclerosis: a case report. J Neurol. 2023;270(8):4107-4109.
- Murphy OC, Calabresi PA, Gold DR. Teaching Video NeuroImage: Dramatic Response to Topiramate in Acquired Pendular Nystagmus From Multiple Sclerosis. Neurology. 2023;100(1):47-48.
- Mehta AR, Kennard C. The pharmacological treatment of acquired nystagmus. Pract Neurol. 2012;12(3):147-53.
- Rucker JC. Current Treatment of Nystagmus. Curr Treat Options Neurol. 2005;7(1):69-77.
- Strupp M, Kremmyda O, Brandt T. Pharmacotherapy of vestibular disorders and nystagmus. Semin Neurol. 2013;33(3):286-96.
- Strupp M, Brandt T. Pharmacological advances in the treatment of neuro-otological and eye movement disorders. Curr Opin Neurol. 2006;19(1):33-40.
- Shaikh AG, Ramat S, Optican LM, Miura K, Leigh RJ, Zee DS. Saccadic burst cell membrane dysfunction is responsible for saccadic oscillations. J Neuroophthalmol. 2008;28(4):329-36.
- Anagnostou E, Karavasilis E, Potiri I, Constantinides V, Efstathopoulos E, Kapaki E, et al. A Cortical Substrate for Square-Wave Jerks in Progressive Supranuclear Palsy. J Clin Neurol. 2020;16(1):37-45.
- Zhou H, Wang X, Ma D, Jiang Y, Li F, Sun Y, et al. The differential diagnostic value of a battery of oculomotor evaluation in Parkinson’s Disease and Multiple System Atrophy. Brain Behav. 2021;11(7):e02184.
- Nakamagoe K, Yamada S, Kawakami R, Koganezawa T, Tamaoka A. Abnormal Saccadic Intrusions with Alzheimer’s Disease in Darkness. Curr Alzheimer Res. 2019;16(4):293-301.
- Shakespeare TJ, Kaski D, Yong KX, Paterson RW, Slattery CF, Ryan NS, et al. Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy. Brain. 2015;138(Pt 7):1976-91.
- Rekik A, Mrabet S, Nasri A, Abida Y, Gharbi A, Gargouri A, et al. Eye movement study in essential tremor patients and its clinical correlates. J Neural Transm (Vienna). 2023;130(4):537-548.
- Fridley J, Adams G, Sun P, York M, Atassi F, Lai E, et al. Effect of subthalamic nucleus or globus pallidus interna stimulation on oculomotor function in patients with Parkinson’s disease. Stereotact Funct Neurosurg. 2013;91(2):113-21.
- Grossman SN, Rucker JC. Opsoclonus and ocular flutter: evaluation and management. Curr Opin Ophthalmol. 2023;34(6):465-469.
- Verhaeghe S, Diallo R, Nyffeler T, Rivaud-Péchoux S, Gaymard B. Unidirectional ocular flutter. J Neurol Neurosurg Psychiatry. 2007;78(7):764-6.
- Oh EH, Choi JH, Park SJ, Kim HS, Choi SY, Choi KD. Triggered saccadic oscillations: case series and review of the literature. J Neurol. 2024;271(8):5622-5628.
- Rizzo JR, Hudson TE, Sequeira AJ, Dai W, Chaudhry Y, Martone J, et al. Eye position-dependent opsoclonus in mild traumatic brain injury. Prog Brain Res. 2019;249:65-78.
- Rossor T, Yeh EA, Khakoo Y, Angelini P, Hemingway C, Irani SR, et al. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective. Neurol Neuroimmunol Neuroinflamm. 2022;9(3).
- Bhatia P, Heim J, Cornejo P, Kane L, Santiago J, Kruer MC. Opsoclonus-myoclonus-ataxia syndrome in children. J Neurol. 2022;269(2):750-757.
- Pike M. Opsoclonus-myoclonus syndrome. Handb Clin Neurol. 2013;112:1209-11.
- Hsu M, Tejani I, Shah N, Olaosebikan R, Kumar A, Naik S. Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients. Children (Basel). 2024;11(3).
- Sahu JK, Prasad K. The opsoclonus–myoclonus syndrome. Pract Neurol. 2011;11(3):160-6.
- Du H, Cai W. Opsoclonus-myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity. Pediatr Blood Cancer. 2022;69(11):e29949.
- Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol. 2000;22(4):315-20.
- Gupta A, Kundal R, Pandey M. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management. J Coll Physicians Surg Pak. 2022;32(8):1086-1088.
- Nelson JL, Blume GM, Bansal SK, Kaufman JR, Woods FR, Zhang X, et al. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome. J Neuroophthalmol. 2022;42(2):251-255.
- Oh SY, Kim JS, Dieterich M. Update on opsoclonus-myoclonus syndrome in adults. J Neurol. 2019;266(6):1541-1548.
- Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, et al. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012;69(12):1598-607.
- Margolin E, Kaur K, Jeeva-Patel T. Opsoclonus. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Matsumoto H, Ugawa Y. [Paraneoplastic opsoclonus-myoclonus syndrome—a review]. Brain Nerve. 2010;62(4):365-9.
- Samah Y, Sahar B, Mebrouk Y. Opsoclonus-Myoclonus With Anti-YO Antibodies Revealing Breast Cancer: A Case Report. Cureus. 2024;16(5):e60452.
- Fedoseeva IF, Goncharenko AV, Poponnikova TV, Glebova IV, Pinevich OS, Goncharenko VA. [Paraneoplastic opsoclonus-myoclonus syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(12):165-170.
- Joubert B, Rostásy K, Honnorat J. Immune-mediated ataxias. Handb Clin Neurol. 2018;155:313-332.
- Arai H, Utsu Y, Horio J, Furukawa S, Kikkawa Y. Paraneoplastic Opsoclonus-myoclonus Syndrome with Anti-Hu and Anti-SOX-1 Antibodies after Immune-checkpoint Inhibitor Treatment Combined with Chemotherapy in a Patient with Small-cell Lung Cancer. Intern Med. 2022;61(1):71-74.
- Zhang M, Gilbert A, Hunter DG. Superior oblique myokymia. Surv Ophthalmol. 2018;63(4):507-517.
- Tandon A, Oliveira C. Superior oblique myokymia, a review. Curr Opin Ophthalmol. 2019;30(6):472-475.
- Kattah JC, FitzGibbon EJ. Superior oblique myokymia. Curr Neurol Neurosci Rep. 2003;3(5):395-400.
- Sathyan S, Antony RC. Superior Oblique Myokymia: Some Novel Observations. Middle East Afr J Ophthalmol. 2017;24(3):162-164.
- Donaldson L, van Adel B, Rodriguez AR. Superior Oblique Myokymia Presumed Due to Large Posterior Fossa Arteriovenous Malformation. Can J Neurol Sci. 2020;47(6):824-825.
- Zhang M, Gilbert AL, Hunter DG. Superior oblique myokymia treated with levobunolol. J AAPOS. 2018;22(1):67-69.e2.
- Borgman CJ. Topical timolol in the treatment of monocular oscillopsia secondary to superior oblique myokymia: a review. J Optom. 2014;7(2):68-74.
- Ma J, Labbé S, Micieli JA. Successful Treatment of Superior Oblique Myokymia With Cannabidiol Oil. J Neuroophthalmol. 2021;41(2):e192-e193.
- Law MX, Hoyt CS, Horton JC. Recurrent Superior Oblique Myokymia Treated by Distal Tendon Extirpation. J Neuroophthalmol. 2019;39(3):345-347.
- Noro S, Seo Y, Honjo K, Okuma M, Asayama B, Amano Y, et al. Lateral Supracerebellar Infratentorial Approach for Superior Oblique Myokymia: A Case Series. Oper Neurosurg. 2022;22(3):101-105.
- Mitchell WG, Wooten AA, O’Neil SH, Rodriguez JG, Cruz RE, Wittern R. Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS). J Child Neurol. 2015;30(8):976-82.
- Galstyan A, Wilbur C, Selby K, Hukin J. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?. Pediatr Neurol. 2017;72:65-69.
- Pranzatelli MR, Tate ED, McGee NR, MacArthur CA. Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome. Pediatr Neurol. 2018;85:71-75.
- Pranzatelli MR, Tate ED. Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome. Brain Dev. 2016;38(5):439-48.
- He F, Kessi M, Zhang C, Peng J, Yin F, Yang L. The utilization of the multimodal immunotherapy for the opsoclonus-myoclonus syndrome can reduce relapses and permanent neurological sequelae. Ital J Pediatr. 2025;51(1):33.
- Mohammad SS, Dale RC. Principles and approaches to the treatment of immune-mediated movement disorders. Eur J Paediatr Neurol. 2018;22(2):292-300.
- Gurnani B, Kaur K, Chaudhary S, Gandhi AS, Balakrishnan H, Mishra C, et al. Nystagmus in Clinical Practice: From Diagnosis to Treatment-A Comprehensive Review. Clin Ophthalmol. 2025;19:1617-1657.
- Li X, Huurneman B, Goossens J. Symptomatic treatment of infantile nystagmus: a systematic review. Front Neurosci. 2025;19:1612504.
- Serra A, Dell’Osso LF, Jacobs JB, Burnstine RA. Combined gaze-angle and vergence variation in infantile nystagmus: two therapies that improve the high-visual-acuity field and methods to measure it. Invest Ophthalmol Vis Sci. 2006;47(6):2451-60.
- Lavin PJ, Traccis S, Dell’Osso LF, Abel LA, Ellenberger C Jr. Downbeat nystagmus with a pseudocycloid waveform: improvement with base-out prisms. Ann Neurol. 1983;13(6):621-4.
- Kraft SP, Irving EL. A case of different null zones for distance and near fixation. Am Orthopt J. 2004;54:102-11.
- Biousse V, Tusa RJ, Russell B, Azran MS, Das V, Schubert MS, et al. The use of contact lenses to treat visually symptomatic congenital nystagmus. J Neurol Neurosurg Psychiatry. 2004;75(2):314-6.
- Theodorou M, Quartilho A, Xing W, Bunce C, Rubin G, Adams G, et al. Soft Contact Lenses to Optimize Vision in Adults with Idiopathic Infantile Nystagmus: A Pilot Parallel Randomized Controlled Trial. Strabismus. 2018;26(1):11-21.
- Bagheri A, Abbasi H, Tavakoli M, Sheibanizadeh A, Kheiri B, Yazdani S. Effect of Rigid Gas Permeable Contact Lenses on Nystagmus and Visual Function in Hyperopic Patients with Infantile Nystagmus Syndrome. Strabismus. 2017;25(1):17-22.
- Jin Y, Wang H, Li D, Zhen N, Yang D, Wang P. The application of rigid gas permeable contact lenses after surgery for infantile nystagmus syndrome. Sci Rep. 2024;14(1):29748.
- Salchow DJ. [Nystagmus in Children - a Survey]. Klin Monbl Augenheilkd. 2023;240(4):617-635.
- Tegetmeyer H. [Treatment options for nystagmus]. Klin Monbl Augenheilkd. 2015;232(2):174-80.
- Tomsak RL, Remler BF, Averbuch-Heller L, Chandran M, Leigh RJ. Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin. Am J Ophthalmol. 1995;119(4):489-96.
- Lennerstrand G, Nordbø OA, Tian S, Eriksson-Derouet B, Ali T. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 1998;76(1):27-7.
- Menon GJ, Thaller VT. Therapeutic external ophthalmoplegia with bilateral retrobulbar botulinum toxin- an effective treatment for acquired nystagmus with oscillopsia. Eye (Lond). 2002;16(6):804-6.
- Devogelaere T, Gobin C, Casaer P, Spileers W. Repeated bilateral retrobulbar injection of botulinum toxin in a blind patient with retinitis pigmentosa and incapacitating nystagmus. Binocul Vis Strabismus Q. 2006;21(4):235-8.
- Chen YR, Fredrick D, Steinberg GK, Liao YJ. Treatment of Nystagmus in Brainstem Cavernous Malformation with Botulinum Toxin. Cureus. 2016;8(4):e553.
- Kuziel J, Pope H, Kothapalli AJ, Larson SA, Drack A, Dumitrescu AV. The long-term outcomes of the Anderson-Kestenbaum procedure. Front Ophthalmol (Lausanne). 2023;3:1247385.
- Gräf M, Hausmann A, Lorenz B. High-dose Anderson operation for nystagmus-related anomalous head turn. Graefes Arch Clin Exp Ophthalmol. 2019;257(9):2033-2041.
- Gräf M, Hausmann A, Kowanz D, Lorenz B. [Highly dosed Anderson and Kestenbaum operations for anomalous head posture due to nystagmus]. Ophthalmologe. 2020;117(12):1210-1217.
- Chang YH, Chang JH, Han SH, Lee JB. Outcome study of two standard and graduated augmented modified Kestenbaum surgery protocols for abnormal head postures in infantile nystagmus. Binocul Vis Strabismus Q. 2007;22(4):235-41.
- Ugurbas SC, Baker JD. Secondary or new compensatory head posture after Anderson-Kestenbaum surgery. Eur J Ophthalmol. 2012;22(2):131-5.
- Hertle RW, Yang D, Adams K, Caterino R. Surgery for the treatment of vertical head posturing associated with infantile nystagmus syndrome: results in 24 patients. Clin Exp Ophthalmol. 2011;39(1):37-46.
- Escuder AG, Ranka MP, Lee K, Nam JN, Steele MA. The Role of Superior Oblique Posterior Tenectomy Along With Inferior Rectus Recessions for the Treatment of Chin-up Head Positioning in Patients With Nystagmus. J Pediatr Ophthalmol Strabismus. 2018;55(4):234-239.
- Wang Z, Dell’Osso LF, Zhang Z, Leigh RJ, Jacobs JB. Tenotomy does not affect saccadic velocities: support for the “small-signal” gain hypothesis. Vision Res. 2006;46(14):2259-67.
- Hertle RW, Dell’Osso LF, FitzGibbon EJ, Yang D, Mellow SD. Horizontal rectus muscle tenotomy in children with infantile nystagmus syndrome: a pilot study. J AAPOS. 2004;8(6):539-48.
- Greven MA, Nelson LB. Four-muscle tenotomy surgery for nystagmus. Curr Opin Ophthalmol. 2014;25(5):400-5.
- Akbari MR, Akbari-Kamrani M, Mohseni A, Jafari AK, Fard MA, Ameri A. Effect of Four Horizontal Rectus Muscle Tenotomy and Replacement (TAR) Alone and in Combination with Recessions for Strabismus, on Visual Function and Eye Movements in Patients with Infantile Nystagmus Syndrome (INS) Without Abnormal Head Posture (AHP). Binocul Vis Strabolog Q Simms Romano. 2013;28(4):211-21.
- Hertle RW, Curtis M, Boydstun I, Juric A, Evliyaoglu F, Ricker I. Clinical and Electrophysiological Outcomes After Eye Muscle Surgery in 81 Adults With Infantile Nystagmus Syndrome. J Pediatr Ophthalmol Strabismus. 2021;58(2):93-104.
- ElKamshoushy A, Shawky D, ElMassry A, ElBaha S, Abdel Wahab MM, Sprunger D. Improved visual acuity and recognition time in nystagmus patients following four-muscle recession or Kestenbaum-Anderson procedures. J AAPOS. 2012;16(1):36-40.
- Hertle RW, Yang D, Tai Z, Carey K, Mitchell E. A systematic approach to eye muscle surgery for infantile nystagmus syndrome: results in 100 patients. Binocul Vis Strabismus Q. 2010;25(2):72-93.
- Hertle RW, Felius J, Yang D, Kaufman M. Eye muscle surgery for infantile nystagmus syndrome in the first two years of life. Clin Ophthalmol. 2009;3:615-24.
- Newman-Toker DE, Nassery N, Schaffer AC, Yu-Moe CW, Clemens GD, Wang Z, et al. Burden of serious harms from diagnostic error in the USA. BMJ Qual Saf. 2024;33(2):109-120.
- Venkat A, Cappelen-Smith C, Askar S, Thomas PR, Bhaskar S, Tam A, et al. Factors Associated with Stroke Misdiagnosis in the Emergency Department: A Retrospective Case-Control Study. Neuroepidemiology. 2018;51(3-4):123-127.
- Edlow JA, Gurley KL, Newman-Toker DE. A New Diagnostic Approach to the Adult Patient with Acute Dizziness. J Emerg Med. 2018;54(4):469-483.
- Gurley KL, Edlow JA. Acute Dizziness. Semin Neurol. 2019;39(1):27-40.
- Bronstein AM, Golding JF, Gresty MA. Vertigo and dizziness from environmental motion: visual vertigo, motion sickness, and drivers’ disorientation. Semin Neurol. 2013;33(3):219-30.
- Kim JS, Newman-Toker DE, Kerber KA, Jahn K, Bertholon P, Waterston J, et al. Vascular vertigo and dizziness: Diagnostic criteria. J Vestib Res. 2022;32(3):205-222.
- Choi JY, Lee SH, Kim JS. Central vertigo. Curr Opin Neurol. 2018;31(1):81-89.
- von Brevern M, Bertholon P, Brandt T, Fife T, Imai T, Nuti D, et al. Benign paroxysmal positional vertigo: Diagnostic criteria. J Vestib Res. 2015;25(3-4):105-17.
- Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, et al. Diagnostic criteria for Menière’s disease. J Vestib Res. 2015;25(1):1-7.
- Beh SC. Vestibular Migraine. Curr Neurol Neurosci Rep. 2022;22(10):601-609.
- Strupp M, Dlugaiczyk J, Ertl-Wagner BB, Rujescu D, Westhofen M, Dieterich M. Vestibular Disorders. Dtsch Arztebl Int. 2020;117(17):300-310.
- Della-Morte D, Rundek T. Dizziness and vertigo. Front Neurol Neurosci. 2012;30:22-5.
- Seemungal BM, Agrawal Y, Bisdorff A, Bronstein A, Cullen KE, Goadsby PJ, et al. The Bárány Society position on ‘Cervical Dizziness’. J Vestib Res. 2022;32(6):487-499.
- Rosengren SM, Colebatch JG, Young AS, Govender S, Welgampola MS. Vestibular evoked myogenic potentials in practice: Methods, pitfalls and clinical applications. Clin Neurophysiol Pract. 2019;4:47-68.
- Yardley L, Barker F, Muller I, Turner D, Kirby S, Mullee M, et al. Clinical and cost effectiveness of booklet based vestibular rehabilitation for chronic dizziness in primary care: single blind, parallel group, pragmatic, randomised controlled trial. BMJ. 2012;344:e2237.
- Agarwal K, Bronstein AM, Faldon ME, Mandalà M, Murray K, Silove Y. Visual dependence and BPPV. J Neurol. 2012;259(6):1117-24.
- Nair MA, Mulavara AP, Bloomberg JJ, Sangi-Haghpeykar H, Cohen HS. Visual dependence and spatial orientation in benign paroxysmal positional vertigo. J Vestib Res. 2018;27(5-6):279-286.
- Lee SC. Relationship of visual dependence to age, balance, attention, and vertigo. J Phys Ther Sci. 2017;29(8):1318-1322.
- Chang TP, Hong YC, Schubert MC. Visual vertigo and motion sickness is different between persistent postural-perceptual dizziness and vestibular migraine. Am J Otolaryngol. 2024;45(4):104321.
- Webster KE, Kamo T, Smith L, Harrington-Benton NA, Judd O, Kaski D, et al. Non-pharmacological interventions for persistent postural-perceptual dizziness (PPPD). Cochrane Database Syst Rev. 2023;3(3):CD015333.
- Staab JP. Persistent Postural-Perceptual Dizziness. Semin Neurol. 2020;40(1):130-137.
- Saber Tehrani AS, Kattah JC, Mantokoudis G, Pula JH, Nair D, Blitz A, et al. Small strokes causing severe vertigo: frequency of false-negative MRIs and nonlacunar mechanisms. Neurology. 2014;83(2):169-73.
- Nakatsuka M, Molloy EE. The HINTS examination and STANDING algorithm in acute vestibular syndrome: A systematic review and meta-analysis involving frontline point-of-care emergency physicians. PLoS One. 2022;17(5):e0266252.
- Ohle R, Montpellier RA, Marchadier V, Wharton A, McIsaac S, Anderson M, et al. Can Emergency Physicians Accurately Rule Out a Central Cause of Vertigo Using the HINTS Examination? A Systematic Review and Meta-analysis. Acad Emerg Med. 2020;27(9):887-896.
- Tarnutzer AA, Gold D, Wang Z, Robinson KA, Kattah JC, Mantokoudis G, et al. Impact of Clinician Training Background and Stroke Location on Bedside Diagnostic Test Accuracy in the Acute Vestibular Syndrome - A Meta-Analysis. Ann Neurol. 2023;94(2):295-308.
- Machner B, Erber K, Choi JH, Trillenberg P, Sprenger A, Helmchen C. Usability of the head impulse test in routine clinical practice in the emergency department to differentiate vestibular neuritis from stroke. Eur J Neurol. 2021;28(5):1737-1744.
- Colagiorgio P, Colnaghi S, Versino M, Ramat S. A New Tool for Investigating the Functional Testing of the VOR. Front Neurol. 2013;4:165.
- Aubele M, Grill E, Eggert T, Schneider E, Strobl R, Jahn K, et al. Symptoms in unilateral vestibular hypofunction are associated with number of catch-up saccades and retinal error: results from the population-based KORA FF4 study. Front Neurol. 2023;14:1292312.
- Jaganathan N, Mohamed MH, Md Pauzi AL, Mahayidin H, Hanapai AF, Wan Sulaiman WA, et al. Video head impulse test in stroke: a review of published studies. Front Neurol. 2024;15:1339039.
- Thomas JO, Sharobeam A, Venkat A, Blair C, Ozalp N, Calic Z, et al. Video head impulse testing to differentiate vestibular neuritis from posterior circulation stroke in the emergency department: a prospective observational study. BMJ Neurol Open. 2022;4(1):e000284.
- Jasinska-Nowacka A, Niemczyk K. Application of a Video Head Impulse Test in the Diagnosis of Vestibular Neuritis. Life (Basel). 2024;14(6).
- Guler A, Karbek Akarca F, Eraslan C, Tarhan C, Bilgen C, Kirazli T, et al. Clinical and video head impulse test in the diagnosis of posterior circulation stroke presenting as acute vestibular syndrome in the emergency department. J Vestib Res. 2017;27(4):233-242.
- Siepmann T, Gruener C, Simon E, Sedghi A, Kitzler HH, Pallesen LP, et al. Video-Oculography-Assisted Head Impulse Test and Caloric Testing for Detecting Stroke in Acute Vertigo Patients via Modified HINTS Plus. J Clin Med. 2021;10(19).
- von Werdt M, Korda A, Zamaro E, Wagner F, Kompis M, Caversaccio MD, et al. The acute vestibular syndrome: prevalence of new hearing loss and its diagnostic value. Eur Arch Otorhinolaryngol. 2024;281(4):1781-1787.
- Martinez C, Wang Z, Zalazar G, Carmona S, Kattah J, Tarnutzer AA. Systematic Review and Meta-Analysis of the Diagnostic Accuracy of a Graded Gait and Truncal Instability Rating in Acutely Dizzy and Ataxic Patients. Cerebellum. 2024;23(6):2244-2256.
- Vanni S, Pecci R, Casati C, Moroni F, Risso M, Ottaviani M, et al. STANDING, a four-step bedside algorithm for differential diagnosis of acute vertigo in the Emergency Department. Acta Otorhinolaryngol Ital. 2014;34(6):419-26.
- Vanni S, Pecci R, Edlow JA, Nazerian P, Santimone R, Pepe G, et al. Differential Diagnosis of Vertigo in the Emergency Department: A Prospective Validation Study of the STANDING Algorithm. Front Neurol. 2017;8:590.
- Gerlier C, Hoarau M, Fels A, Vitaux H, Mousset C, Farhat W, et al. Differentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study. Acad Emerg Med. 2021;28(12):1368-1378.
- Gerlier C, Fels A, Vitaux H, Mousset C, Perugini A, Chatellier G, et al. Effectiveness and reliability of the four-step STANDING algorithm performed by interns and senior emergency physicians for predicting central causes of vertigo. Acad Emerg Med. 2023;30(5):487-500.
- Huang R, Bi GR. [Bilateral vestibulopathy]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017;31(24):1937-1939.
- Rutka J. Aminoglycoside Vestibulotoxicity. Adv Otorhinolaryngol. 2019;82:101-110.
- Proudlock FA, Gottlob I, Constantinescu CS. Oscillopsia without nystagmus caused by head titubation in a patient with multiple sclerosis. J Neuroophthalmol. 2002;22(2):88-91.
- Tilikete C, Vighetto A. Oscillopsia: causes and management. Curr Opin Neurol. 2011;24(1):38-43.
- Tilikete C, Pisella L, Pélisson D, Vighetto A. [Oscillopsia: pathophysiological mechanisms and treatment]. Rev Neurol (Paris). 2007;163(4):421-39.
- Ahmad H, Roberts RE, Patel M, Lobo R, Seemungal B, Arshad Q, et al. Downregulation of early visual cortex excitability mediates oscillopsia suppression. Neurology. 2017;89(11):1179-1185.
- King WM, Shanidze N. Anticipatory eye movements stabilize gaze during self-generated head movements. Ann N Y Acad Sci. 2011;1233:219-25.
- Anson ER, Kiemel T, Carey JP, Jeka JJ. Eye Movements Are Correctly Timed During Walking Despite Bilateral Vestibular Hypofunction. J Assoc Res Otolaryngol. 2017;18(4):591-600.
- Van Nechel C, Duquesne U, Toupet M, Hautefort C. Efficient gaze stabilization during video Active Gaze Shift Test (vAGST) in bilateral vestibulopathy. Front Neurol. 2024;15:1509762.
- Elsherif M, Eldeeb M. Video head impulse test in bilateral vestibulopathy. Braz J Otorhinolaryngol. 2022;88(2):181-186.
- van Stiphout L, Pleshkov M, Lucieer F, Dobbels B, Mavrodiev V, Guinand N, et al. Patterns of Vestibular Impairment in Bilateral Vestibulopathy and Its Relation to Etiology. Front Neurol. 2022;13:856472.
- Murofushi T, Monobe H, Ushio M. Isolated bilateral posterior semicircular canal hypofunction: comparison with bilateral vestibulopathy. Acta Otolaryngol. 2023;143(8):687-691.
- Greco A, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, Turchetta R, et al. Idiopathic bilateral vestibulopathy: an autoimmune disease?. Autoimmun Rev. 2014;13(10):1042-7.
- Cortese A, Curro’ R, Vegezzi E, Yau WY, Houlden H, Reilly MM. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects. Pract Neurol. 2022;22(1):14-18.
- Castiglione A, Möller C. Usher Syndrome. Audiol Res. 2022;12(1):42-65.
- Smyth D, Mossman S, Weatherall M, Jolliffe E, Joshi P, Taylor J, et al. Gentamicin vestibulotoxicity with modern systemic dosing regimens: a prospective study using video-oculography. Acta Otolaryngol. 2019;139(9):759-768.
- Black FO, Pesznecker S, Stallings V. Permanent gentamicin vestibulotoxicity. Otol Neurotol. 2004;25(4):559-69.
- Lau TB, Saniasiaya J, Govindaraju R. Topical gentamicin-induced acute vestibulopathy: A case report. Malays Fam Physician. 2023;18:23.
- Ahmed RM, Hannigan IP, MacDougall HG, Chan RC, Halmagyi GM. Gentamicin ototoxicity: a 23-year selected case series of 103 patients. Med J Aust. 2012;196(11):701-4.
- Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007;13(1):119-26.
- Hertz J, Djurhuus BD. [Bilateral vestibulopathy after intravenous gentamicin therapy]. Ugeskr Laeger. 2019;181(5).
- Kim HJ, Lee JO, Kim JS. Protective Effects of Deferoxamine on Vestibulotoxicity in Gentamicin-Induced Bilateral Vestibulopathy Rat Model. Front Neurol. 2021;12:650752.
- Chen G, Zhang J, Qiao Q, Zhou L, Li Y, Yang J, et al. Advances in dynamic visual acuity test research. Front Neurol. 2022;13:1047876.
- Wu TY, Wang YX, Li XM. Applications of dynamic visual acuity test in clinical ophthalmology. Int J Ophthalmol. 2021;14(11):1771-1778.
- Gimmon Y, Schubert MC. Vestibular Testing-Rotary Chair and Dynamic Visual Acuity Tests. Adv Otorhinolaryngol. 2019;82:39-46.
- Zhao D, Jiang Z, Li C. [Dynamic visual acuity screening test results analysis of 25 patients with peripheral vertigo]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024;38(2):146-149.
- Rodríguez-Montesdeoca I, Miguel ÁR, Falcón-González JC, Borkoski-Barreiro S, Benítez-Robaina S, Guerra-Jimenez G, et al. Dynamic Visual Acuity Results in Otolith Electrical Stimulation in Bilateral Vestibular Dysfunction. J Clin Med. 2022;11(19).
- Atilla MH, Kesici GG. Dynamic visual acuity test findings of migraine patients: Observational case-control study. Am J Otolaryngol. 2022;43(5):103559.
- Sutton AE, Franklin E. Vestibular rehabilitation. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Hassannia F, Misale P, Sulway S, Olmos GV, Dabiri S, Ranalli P, et al. Effectiveness of vestibular rehabilitation therapy in patients with idiopathic Cerebellar Ataxia with Bilateral Vestibulopathy (iCABV). J Vestib Res. 2022;32(5):479-485.
- Eder J, Kellerer S, Amberger T, Keywan A, Dlugaiczyk J, Wuehr M, et al. Combining vestibular rehabilitation with noisy galvanic vestibular stimulation for treatment of bilateral vestibulopathy. J Neurol. 2022;269(11):5731-5737.
- Ellis AW, Schöne CG, Vibert D, Caversaccio MD, Mast FW. Cognitive Rehabilitation in Bilateral Vestibular Patients: A Computational Perspective. Front Neurol. 2018;9:286.
- Schoo DP, Ward BK, Chow MR, Ayiotis AI, Fernández Brillet C, Boutros PJ, et al. Vestibular Implant Surgery. Laryngoscope. 2024;134(4):1842-1846.
- van Stiphout L, Lucieer F, Guinand N, Pérez Fornos A, van de Berg M, Van Rompaey V, et al. Bilateral vestibulopathy patients’ perspectives on vestibular implant treatment: a qualitative study. J Neurol. 2022;269(10):5249-5257.
- Cha YH. Chronic Dizziness. Continuum (Minneap Minn). 2021;27(2):420-446.
- Liu B, Leng Y, Zhou R, Liu J, Wang H. [Clinical analysis of idiopathic bilateral vestibulopathy]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;34(10):906-910.
- Kheradmand A, Colpak AI, Zee DS. Eye movements in vestibular disorders. Handb Clin Neurol. 2016;137:103-17.
- Junior EM, Magri F, Silva ABRL, Diógenes GP, Aguiar MFC, Bessa L, et al. Ocular contrapulsion followed by ipsipulsion in Wallenberg syndrome: The first case report in literature. Radiol Case Rep. 2022;17(11):4148-4151.
- Khan SR, Lueck CJ. Hemi-seesaw nystagmus in lateral medullary syndrome. Neurology. 2013;80(13):1261-2.
- Kattah JC, Saber Tehrani AS, Roeber S, Gujrati M, Bach SE, Newman Toker DE, et al. Transient Vestibulopathy in Wallenberg’s Syndrome: Pathologic Analysis. Front Neurol. 2017;8:191.
- Perloff MD, Patel NS, Kase CS, Oza AU, Voetsch B, Romero JR. Cerebellar stroke presenting with isolated dizziness: Brain MRI in 136 patients. Am J Emerg Med. 2017;35(11):1724-1729.
- Doijiri R, Uno H, Miyashita K, Ihara M, Nagatsuka K. How Commonly Is Stroke Found in Patients with Isolated Vertigo or Dizziness Attack?. J Stroke Cerebrovasc Dis. 2016;25(10):2549-52.
- Kim HA, Yi HA, Lee H. Recent Advances in Cerebellar Ischemic Stroke Syndromes Causing Vertigo and Hearing Loss. Cerebellum. 2016;15(6):781-788.
- Lee H. Isolated vascular vertigo. J Stroke. 2014;16(3):124-30.
- Choi KD, Kim JS. Vascular vertigo: updates. J Neurol. 2019;266(8):1835-1843.
- Welgampola MS, Young AS, Pogson JM, Bradshaw AP, Halmagyi GM. Dizziness demystified. Pract Neurol. 2019;19(6):492-501.
- Choi JY, Kim HJ, Kim JS. Recent advances in head impulse test findings in central vestibular disorders. Neurology. 2018;90(13):602-612.
- Imane M, Asmae M, Toufik R, Rachid S. [Papillary oedema revealing Arnold Chiari malformation type 1: about a case]. Pan Afr Med J. 2016;24:293.
- Masson C, Colombani JM. [Chiari type 1 malformation and magnetic resonance imaging]. Presse Med. 2005;34(21):1662-7.
- Goldschagg N, Feil K, Ihl F, Krafczyk S, Kunz M, Tonn JC, et al. Decompression in Chiari Malformation: Clinical, Ocular Motor, Cerebellar, and Vestibular Outcome. Front Neurol. 2017;8:292.
- Ridder T, Anderson RC, Hankinson TC. Ventral Decompression in Chiari Malformation, Basilar Invagination, and Related Disorders. Neurosurg Clin N Am. 2015;26(4):571-8.
- Mitoma H, Manto M, Hadjivassiliou M. Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms. J Mov Disord. 2021;14(1):10-28.
- Mitoma H, Manto M, Hampe CS. Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges. Curr Neuropharmacol. 2019;17(1):33-58.
- Mitoma H, Manto M. Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms. J Neurol. 2024;271(10):7046-7053.
- Manto M, Mitoma H. Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial. Brain Sci. 2023;13(12).
- Hadjivassiliou M, Manto M, Mitoma H. Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges. Brain Sci. 2022;12(9).
- Shargian-Alon L, Raanani P, Rozovski U, Siegal T, Yust-Katz S, Yeshurun M. Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease. Acta Haematol. 2019;141(1):19-22.
- Loehrer PA, Zieger L, Simon OJ. Update on Paraneoplastic Cerebellar Degeneration. Brain Sci. 2021;11(11).
- Aly R, Emmady PD. Paraneoplastic cerebellar degeneration. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Norrito RL, Puleo MG, Pintus C, Basso MG, Rizzo G, Di Chiara T, et al. Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review. Brain Sci. 2024;14(2).
- Yasuda T, Shimizu J, Miyagawa T, Tsutsumi Y, Iwatsubo T, Tsuji S. Paraneoplastic Cerebellar Degeneration Leading to an Early Diagnosis of Peritoneal Serous Papillary Carcinoma. Intern Med. 2024;63(19):2679-2682.
- Bustos-Merlo A, Ortiz-Parra A, Rosales-Castillo A, Espinosa-Sanchez JM, Navarrete-Navarrete N. Autoimmune inner ear disease associated with antiphospholipid antibodies. Clin Exp Rheumatol. 2024;42(11):2268-2271.
- Kim S, Kim JS, Lee SH, Kim JM, Na S, Choi JH, et al. Intellectual Disability in Episodic Ataxia Type 2: Beyond Paroxysmal Vertigo and Ataxia. J Clin Neurol. 2024;20(6):563-570.
- Ahuja AS, Rozen TD, Atwal PS. A sleep modulated Channelopathy: a novel CACNA1A pathogenic variant identified in episodic Ataxia type 2 and a potential link to sleep alleviated migraine. BMC Neurol. 2019;19(1):246.
- Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 2011;77(3):269-75.
- Baloh RW. Episodic vertigo: central nervous system causes. Curr Opin Neurol. 2002;15(1):17-21.
- Yu-Wai-Man P, Gorman G, Bateman DE, Leigh RJ, Chinnery PF. Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6. J Neurol. 2009;256(1):78-82.
- von Brevern M, Lempert T. Vestibular migraine. Handb Clin Neurol. 2016;137:301-16.
- Grønlund C, Devantier L, Karlberg M, Djurhuus BD. [Superior semicircular canal dehiscence syndrome]. Ugeskr Laeger. 2021;183(4).
- Staab JP. Persistent Postural-Perceptual Dizziness: Review and Update on Key Mechanisms of the Most Common Functional Neuro-otologic Disorder. Neurol Clin. 2023;41(4):647-664.
- Matz O, Shermetaro C. Persistent postural-perceptual dizziness. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Webster KE, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, et al. Pharmacological interventions for persistent postural-perceptual dizziness (PPPD). Cochrane Database Syst Rev. 2023;3(3):CD015188.
- Al-Haidar M, Benatar M, Kaminski HJ. Ocular Myasthenia. Neurol Clin. 2018;36(2):241-251.
- Tannemaat MR, Huijbers MG, Verschuuren JJGM. Myasthenia gravis-Pathophysiology, diagnosis, and treatment. Handb Clin Neurol. 2024;200:283-305.
- Goto T, Kimura A, Masuda A, Mochizuki Y, Gomi F. Clinical features of double seronegative ocular myasthenia gravis. Graefes Arch Clin Exp Ophthalmol. 2024;262(8):2617-2623.
- Zhao S, Zhou Y, Sun W, Li Z, Wang C. Clinical features, diagnosis, and management of pembrolizumab-induced myasthenia gravis. Clin Exp Immunol. 2023;211(2):85-92.
- Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, et al. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016;263(8):1473-94.
- Kim DH, Roh HC, Oh SY. Ophthalmologic clinical features of ocular myasthenia gravis. Medicine (Baltimore). 2023;102(2):e31972.
- Lin CW, Chen TC, Jou JR, Woung LC. Update on ocular myasthenia gravis in Taiwan. Taiwan J Ophthalmol. 2018;8(2):67-73.
- Sanadze AG, Sidnev DV, Tumurov DA, Afanasieva OI. [Ocular myasthenia gravis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(9):116-120.
- Fonseca NL Jr, Lucci LM, Rehder JR. [Ice pack test in the diagnosis of myasthenia gravis]. Arq Bras Oftalmol. 2010;73(2):161-4.
- Natarajan B, Saifudheen K, Gafoor VA, Jose J. Accuracy of the ice test in the diagnosis of myasthenic ptosis. Neurol India. 2016;64(6):1169-1172.
- Ramirez-Antunez ÁG, García-Ramos G, Estañol-Vidal B, Juárez-Flores A. [Validation of the ice pack test in ophthalmoparesis due to myasthenia gravis]. Rev Neurol. 2013;57(9):385-95.
- Chatzistefanou KI, Kouris T, Iliakis E, Piaditis G, Tagaris G, Katsikeris N, et al. The ice pack test in the differential diagnosis of myasthenic diplopia. Ophthalmology. 2009;116(11):2236-43.
- Kee HJ, Yang HK, Hwang JM, Park KS. Evaluation and validation of sustained upgaze combined with the ice-pack test for ocular myasthenia gravis in Asians. Neuromuscul Disord. 2019;29(4):296-301.
- Van Stavern GP, Bhatt A, Haviland J, Black EH. A prospective study assessing the utility of Cogan’s lid twitch sign in patients with isolated unilateral or bilateral ptosis. J Neurol Sci. 2007;256(1-2):84-5.
- Manjunathan S, Gunasekaran PK, Laxmi V, Kumar A, Saini L. Cogan’s Lid Twitch Sign in a Child with Congenital Myasthenia. Neuropediatrics. 2024;55(2):148.
- Apinyawasisuk S, Zhou X, Tian JJ, Garcia GA, Karanjia R, Sadun AA. Validity of Forced Eyelid Closure Test: A Novel Clinical Screening Test for Ocular Myasthenia Gravis. J Neuroophthalmol. 2017;37(3):253-257.
- Valko Y, Wirth MA, Fierz FC, Schesny MK, Rosengren S, Schmückle-Meier T, et al. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia. Neurology. 2024;102(10):e209395.
- Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology. 2016;87(4):419-25.
- Murai H. [The Japanese Clinical Guidelines 2022 for Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: An Overview]. Brain Nerve. 2024;76(1):7-12.
- O’Connell K, Ramdas S, Palace J. Management of Juvenile Myasthenia Gravis. Front Neurol. 2020;11:743.
- Jayawant S, Parr J, Vincent A. Autoimmune myasthenia gravis. Handb Clin Neurol. 2013;113:1465-8.
- Heckmann JM, Europa TA, Soni AJ, Nel M. The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review. Front Neurol. 2022;13:834212.
- Vanikieti K, Lowwongngam K, Padungkiatsagul T, Visudtibhan A, Poonyathalang A. Juvenile Ocular Myasthenia Gravis: Presentation and Outcome of a Large Cohort. Pediatr Neurol. 2018;87:36-41.
- Fisher K, Shah V. Pediatric Ocular Myasthenia Gravis. Curr Treat Options Neurol. 2019;21(10):46.
- Arruti N, Munot P, Bowman R. Demographics and ocular findings in children with myasthenia. Eye (Lond). 2023;37(4):700-704.
- Gabbard R, Yi R, Pratt J, Chang K, Keck K. Juvenile ocular myasthenia gravis: a report of two cases. Digit J Ophthalmol. 2024;30(1):15-18.
- Kraithat P, Hansapinyo L, Patikulsila P. Treatment Outcomes and Predictive Factors in Pediatric Ocular Myasthenia Gravis. J Med Assoc Thai. 2015;98(9):883-8.
- Hesami O, Ramezani M, Ghasemi A, Fatehi F, Okhovat AA, Ziaadini B, et al. COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum. Orphanet J Rare Dis. 2024;19(1):113.
- Gül Mert G, Özcan N, Hergüner Ö, Altunbaşak Ş, Incecik F, Bişgin A, et al. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients. Acta Neurol Belg. 2021;121(2):529-534.
- Muñoz-García MI, Guerrero-Molina MP, de Fuenmayor-Fernández de la Hoz CP, Bermejo-Guerrero L, Arteche-López A, Hernández-Laín A, et al. Delayed Diagnosis of Congenital Myasthenic Syndromes Erroneously Interpreted as Mitochondrial Myopathies. J Clin Med. 2023;12(9).
- Tan Y, Curragh DS, Selva D. The use of frontalis sling in the management of variable ptosis secondary to congenital myasthenic syndrome. Orbit. 2022;41(3):386-388.
- Chung IY, Sheth SJ, Wells KK, Campbell TG. The Usefulness of Anti-acetylcholine Receptor Binding Antibody Testing in Diagnosing Ocular Myasthenia Gravis. J Neuroophthalmol. 2021;41(4):e627-e630.
- Lee JJ, Koh KM, Kim US. The anti-acetylcholine receptor antibody test in suspected ocular myasthenia gravis. J Ophthalmol. 2014;2014:689792.
- Wiendl H, Abicht A, Chan A, Della Marina A, Hagenacker T, Hekmat K, et al. Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord. 2023;16:17562864231213240.
- Hoffmann S, Waters P, Jacobson L, Schuelke M, Stenzel W, Ruck T, et al. Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis. Neuromuscul Disord. 2023;33(2):139-144.
- Gastaldi M, Scaranzin S, Businaro P, Mobilia E, Benedetti L, Pesce G, et al. Improving laboratory diagnostics in myasthenia gravis. Expert Rev Mol Diagn. 2021;21(6):579-590.
- Vakrakou AG, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S, et al. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease. Front Immunol. 2023;14:1212757.
- Zhang Z, Guan Y, Han J, Li M, Shi M, Deng H. Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China. Front Neurol. 2020;11:516211.
- Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023-36.
- Klein CJ, Beecher G, Lamb C, Naddaf E, Milone M, Liewluck T, et al. LRP4-IgG service line testing in seronegative myasthenia gravis and controls. J Neuroimmunol. 2022;368:577895.
- Hong Y, Zisimopoulou P, Trakas N, Karagiorgou K, Stergiou C, Skeie GO, et al. Multiple antibody detection in ‘seronegative’ myasthenia gravis patients. Eur J Neurol. 2017;24(6):844-850.
- Misra UK, Kalita J, Srivastava A. A study of diagnostic yield, technical ease and patient discomfort of low rate repetitive nerve stimulation test in patients with myasthenia gravis. Electromyogr Clin Neurophysiol. 2006;46(6):337-41.
- Pike-Lee T, Higginbotham D, Li Y. Direct comparison of median and ulnar repetitive nerve stimulation in generalized myasthenia gravis. Muscle Nerve. 2021;64(4):490-493.
- Sanders DB, Kouyoumdjian JA, Stålberg EV. Single fiber electromyography and measuring jitter with concentric needle electrodes. Muscle Nerve. 2022;66(2):118-130.
- Juel VC. Single fiber electromyography. Handb Clin Neurol. 2019;160:303-310.
- Tanhehco JL. Single-fiber electromyography. Phys Med Rehabil Clin N Am. 2003;14(2):207-29.
- Sanders DB. Clinical impact of single-fiber electromyography. Muscle Nerve Suppl. 2002;11:S15-20.
- Valls-Canals J, Povedano M, Montero J, Pradas J. Stimulated single-fiber EMG of the frontalis and orbicularis oculi muscles in ocular myasthenia gravis. Muscle Nerve. 2003;28(4):501-3.
- Mercelis R, Merckaert V. Diagnostic utility of stimulated single-fiber electromyography of the orbicularis oculi muscle in patients with suspected ocular myasthenia. Muscle Nerve. 2011;43(2):168-70.
- Baslo MB, Yildiz N, Ertaş M. Surface stimulation single-fiber electromyography in myasthenia gravis. J Clin Neurophysiol. 2002;19(1):73-6.
- Papathanasiou ES, Zamba-Papanicolaou E. Differential orbicularis oculi involvement in neuromuscular junction dysfunction. J Clin Neurophysiol. 2008;25(5):293-8.
- Giannoccaro MP, Di Stasi V, Zanesini C, Donadio V, Avoni P, Liguori R. Sensitivity and specificity of single-fibre EMG in the diagnosis of ocular myasthenia varies accordingly to clinical presentation. J Neurol. 2020;267(3):739-745.
- Natarajan V, Verma S. Orbicularis Oculi Stimulated Jitter Analysis in Children With Autoimmune Myasthenia Gravis. Muscle Nerve. 2025;71(4):593-599.
- Bhatia S, Quinlan H, McCracken C, Price EW, Guglani L, Verma S. Serial Stimulated Jitter Analysis In Juvenile Myasthenia Gravis. Muscle Nerve. 2018;58(5):729-732.
- Pitt MC. Use of stimulated electromyography in the analysis of the neuromuscular junction in children. Muscle Nerve. 2017;56(5):841-847.
- Tidswell T, Pitt MC. A new analytical method to diagnose congenital myasthenia with stimulated single-fiber electromyography. Muscle Nerve. 2007;35(1):107-10.
- Khoo A, Hay Mar H, Borghi MV, Catania S. Electrophysiologic evaluation of myasthenia gravis and its mimics: real-world experience with single-fiber electromyography. Hosp Pract (1995). 2022;50(5):373-378.
- Tuan PA, Vien MV, Dong HV, Sibell D, Giang BV. The Value of CT and MRI for Determining Thymoma in Patients With Myasthenia Gravis. Cancer Control. 2019;26(1):1073274819865281.
- de Kraker M, Kluin J, Renken N, Maat AP, Bogers AJ. CT and myasthenia gravis: correlation between mediastinal imaging and histopathological findings. Interact Cardiovasc Thorac Surg. 2005;4(3):267-71.
- Li YF, Li YH, Cui LY. [Thymus CT scan and thymoma associated antibodies in myasthenia gravis with thymoma]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006;28(4):517-9.
- Wang S, Wang K, Chen X, Chen D, Lin S. Autoimmune thyroid disease and myasthenia gravis: a study bidirectional Mendelian randomization. Front Endocrinol (Lausanne). 2024;15:1310083.
- Benatar M, Mcdermott MP, Sanders DB, Wolfe GI, Barohn RJ, Nowak RJ, et al. Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial. Muscle Nerve. 2016;53(3):363-9.
- Benatar M, Kaminski H. Medical and surgical treatment for ocular myasthenia. Cochrane Database Syst Rev. 2012;12(12):CD005081.
- Kerty E, Elsais A, Argov Z, Evoli A, Gilhus NE. EFNS/ENS Guidelines for the treatment of ocular myasthenia. Eur J Neurol. 2014;21(5):687-93.
- Kupersmith MJ, Ying G. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. Br J Ophthalmol. 2005;89(10):1330-4.
- Melson AT, McClelland CM, Lee MS. Ocular myasthenia gravis: updates on an elusive target. Curr Opin Neurol. 2020;33(1):55-61.
- Hehir MK 2nd, Li Y. Diagnosis and Management of Myasthenia Gravis. Continuum (Minneap Minn). 2022;28(6):1615-1642.
- Antonio-Santos AA, Eggenberger ER. Medical treatment options for ocular myasthenia gravis. Curr Opin Ophthalmol. 2008;19(6):468-78.
- Pelak VS, Galetta SL. Ocular Myasthenia Gravis. Curr Treat Options Neurol. 2001;3(4):367-376.
- Piehl F, Eriksson-Dufva A, Budzianowska A, Feresiadou A, Hansson W, Hietala MA, et al. Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial. JAMA Neurol. 2022;79(11):1105-1112.
- Menon D, Bril V. Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals. Drugs. 2022;82(8):865-887.
- Binks SNM, Morse IM, Ashraghi M, Vincent A, Waters P, Leite MI. Myasthenia gravis in 2025: five new things and four hopes for the future. J Neurol. 2025;272(3):226.
- Narayanaswami P, Sanders DB, Thomas L, Thibault D, Blevins J, Desai R, et al. Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study. Lancet Neurol. 2024;23(3):267-276.
- Dodd KC, Ahmed R, Ambrose P, Holt JK, Jacob S, Leite MI, et al. Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis. Neuromuscul Disord. 2024;38:51-57.
- Hart IK, Sathasivam S, Sharshar T. Immunosuppressive agents for myasthenia gravis. Cochrane Database Syst Rev. 2007;2007(4):CD005224.
- Sanders DB, Evoli A. Immunosuppressive therapies in myasthenia gravis. Autoimmunity. 2010;43(5-6):428-35.
- Silvestri NJ, Wolfe GI. Myasthenia gravis. Semin Neurol. 2012;32(3):215-26.
- Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, et al. Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016;375(6):511-22.
- Rath J, Moser B, Zimprich F. Thymectomy in myasthenia gravis. Curr Opin Neurol. 2023;36(5):416-423.
- Aydin Y, Ulas AB, Mutlu V, Colak A, Eroglu A. Thymectomy in Myasthenia Gravis. Eurasian J Med. 2017;49(1):48-52.
- de Perrot M, McRae K. Evidence for thymectomy in myasthenia gravis: Getting stronger?. J Thorac Cardiovasc Surg. 2017;154(1):314-316.
- Guéguen A, Hijazi B, Zuber K, Deschamps R, Lamirel C, Vignal-Clermont C, et al. Generalization of ocular myasthenia gravis 10 years after onset. J Neurol. 2022;269(12):6597-6604.
- Li F, Hotter B, Swierzy M, Ismail M, Meisel A, Rückert JC. Generalization after ocular onset in myasthenia gravis: a case series in Germany. J Neurol. 2018;265(12):2773-2782.
- Witthayaweerasak J, Rattanalert N, Aui-Aree N. Prognostic factors for conversion to generalization in ocular myasthenia gravis. Medicine (Baltimore). 2021;100(19):e25899.
- Guo RJ, Gao T, Ruan Z, Zhou HY, Gao F, Xu Q, et al. Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study. Neurol Ther. 2022;11(1):73-86.
- Díaz-Maroto I, García-García J, Sánchez-Ayaso PA, Alcahut-Rodríguez C, González-Villar E, Pardal-Fernández JM, et al. Ocular myasthenia gravis and risk factors for developing a secondary generalisation: Description of a Spanish series. Neurologia (Engl Ed). 2020.
- Bi Z, Cao Y, Gui M, Lin J, Zhang Q, Li Y, et al. Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis. Neurol Sci. 2023;44(4):1383-1391.
- Wilson L, Davis H. The Role of Thymoma and Thymic Hyperplasia as Prognostic Risk Factors for Secondary Generalisation in Adults with Ocular Myasthenia Gravis: A Systematic Narrative Review. Br Ir Orthopt J. 2023;19(1):108-119.
- Wang J, Zhou H, Chen H, Feng H, Chang T, Sun C, et al. Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort study. QJM. 2024;117(2):109-118.
- Gilhus NE, Andersen H, Andersen LK, Boldingh M, Laakso S, Leopoldsdottir MO, et al. Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment. Eur J Neurol. 2024;31(5):e16229.
- Chaudhuri A, Behan PO. Myasthenic crisis. QJM. 2009;102(2):97-107.
- Bershad EM, Feen ES, Suarez JI. Myasthenia gravis crisis. South Med J. 2008;101(1):63-9.
- Stetefeld HR, Schroeter M. [Myasthenic Crisis]. Fortschr Neurol Psychiatr. 2018;86(5):301-307.
- Rabinstein AA. Acute Neuromuscular Respiratory Failure. Continuum (Minneap Minn). 2015;21(5 Neurocritical Care):1324-45.
- Saldanha Marques J, Santos P. Unexpected Myasthenic Crisis in Anesthesia for Magnetic Resonance Imaging - Diagnosis and Management. Cureus. 2023;15(2):e34959.
- Bansal R, Goyal MK, Modi M. Management of myasthenia gravis during pregnancy. Indian J Pharmacol. 2018;50(6):302-308.
- Lorenzo CJ, Fitzpatrick H, Campdesuner V, George J, Lattanzio N. Pembrolizumab-Induced Ocular Myasthenic Crisis. Cureus. 2020;12(7):e9192.
- Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020;94(22):959-969.
- Lipka AF, Verschuuren JJGM. Lambert-Eaton myasthenic syndrome. Handb Clin Neurol. 2024;200:307-325.
- Kesner VG, Oh SJ, Dimachkie MM, Barohn RJ. Lambert-Eaton Myasthenic Syndrome. Neurol Clin. 2018;36(2):379-394.
- El-Wahsh S, Reddel S. Lambert Eaton Myasthenic Syndrome. Int Rev Neurobiol. 2025;182:227-251.
- Ivanovski T, Miralles F. Lambert-Eaton Myasthenic syndrome: early diagnosis is key. Degener Neurol Neuromuscul Dis. 2019;9:27-37.
- Pascuzzi RM, Bodkin CL. Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment. Neuropsychiatr Dis Treat. 2022;18:3001-3022.
- Leavitt JA. Myasthenia gravis with a paraneoplastic marker. J Neuroophthalmol. 2000;20(2):102-5.
- Eymard B. [Myasthenia, from the internist’s point of view]. Rev Med Interne. 2014;35(7):421-9.
- Chauplannaz G, Vial C. [Electrodiagnostic assessment of neuromuscular junction disorders]. Rev Med Liege. 2004;59 Suppl 1:184-9.
- Maddison P, Newsom-Davis J. Treatment for Lambert-Eaton myasthenic syndrome. Cochrane Database Syst Rev. 2005.
- Kitanosono H, Yoshimura S, Shiraishi H, Motomura M. [Diagnosis and Treatment of Lambert-Eaton Myasthenic Syndrome]. Brain Nerve. 2024;76(1):33-40.
- Matsuo H. [Lambert-Eaton Myasthenic Syndrome]. Brain Nerve. 2024;76(5):630-634.
- Motte J, Sgodzai M, Schneider-Gold C, Steckel N, Mika T, Hegelmaier T, et al. Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells. Neuron. 2024;112(11):1757-1763.e2.
- An Y, Lv B, Zheng T, Gong Y, Hou J, Tian H, et al. Analysis of clinical challenges and prognostic risk factors for 195 cases of iatrogenic botulism in China. Clin Toxicol (Phila). 2025;63(5):337-342.
- Penas SC, Faria OM, Serrão R, Capão-Filipe JA, Mota-Miranda A, Falcão-Reis F. Ophthalmic manifestations in 18 patients with botulism diagnosed in Porto, Portugal between 1998 and 2003. J Neuroophthalmol. 2005;25(4):262-7.
- Rao AK, Lin NH, Jackson KA, Mody RK, Griffin PM. Clinical Characteristics and Ancillary Test Results Among Patients With Botulism-United States, 2002-2015. Clin Infect Dis. 2017;66(suppl_1):S4-S10.
- Sheikh S, Alvi U, Soliven B, Rezania K. Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update. J Clin Med. 2021;10(7).
- Jones SC, Sorbello A, Boucher RM. Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review. Drug Saf. 2011;34(10):839-47.
- Lotan I, Hellmann MA, Wilf-Yarkoni A, Steiner I. Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review. J Neurol. 2021;268(12):4573-4586.
- Schneider-Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev. 2005;2005(2):CD002828.
- Sanguandikul L, Apinyawasisuk S, Jariyakosol S, Hirunwiwatkul P, Chongpison Y. Complications of Preseptal Versus Pretarsal Botulinum Toxin Injection in Benign Essential Blepharospasm: A Randomized Controlled Trial. Am J Ophthalmol. 2021;232:9-16.
- Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review]. Arq Bras Oftalmol. 2006;69(1):23-6.
- Borba A, Matayoshi S, Rodrigues M. Avoiding Complications on the Upper Face Treatment With Botulinum Toxin: A Practical Guide. Aesthetic Plast Surg. 2022;46(1):385-394.
- Lai HT, Chen AD, Lee SS, Lin YH, Lai CS. Myotomy In Situ for Essential Blepharospasm Refractory to Botulinum Toxin. Ann Plast Surg. 2020;84(1S Suppl 1):S74-S79.
- Gore A. Broad Spectrum Treatment for Ocular Insult Induced by Organophosphate Chemical Warfare Agents. Toxicol Sci. 2020;177(1):1-10.
- Kinney M, Johnson AD, Reddix M, McCann MB. Temporal Effects of 2% Pilocarpine Ophthalmic Solution on Human Pupil Size and Accommodation. Mil Med. 2020;185(Suppl 1):435-442.
- Collins S, Roberts H, Hewer I. Anesthesia and Perioperative Considerations for Patients With Myasthenia Gravis. AANA J. 2020;88(6):485-491.
- Radkowski P, Oniszczuk H, Opolska J, Podlińska I, Pawluczuk M, Onichimowski D. A Review of Muscle Relaxants in Anesthesia in Patients with Neuromuscular Disorders Including Guillain-Barré Syndrome, Myasthenia Gravis, Duchenne Muscular Dystrophy, Charcot-Marie-Tooth Disease, and Inflammatory Myopathies. Med Sci Monit. 2024;30:e945675.
- Dillon FX. Anesthesia issues in the perioperative management of myasthenia gravis. Semin Neurol. 2004;24(1):83-94.
- Scheriau G, Weng R, Lassnigg A, Maleczek M, Zimprich F, Matilla J, et al. Perioperative Management of Patients With Myasthenia Gravis Undergoing Robotic-Assisted Thymectomy-A Retrospective Analysis and Clinical Evaluation. J Cardiothorac Vasc Anesth. 2022;36(10):3806-3813.
- Sungur Z, Sentürk M. Anaesthesia for thymectomy in adult and juvenile myasthenic patients. Curr Opin Anaesthesiol. 2016;29(1):14-9.
- Dalakas MC. Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy. Neurotherapeutics. 2021;18(4):2397-2418.
- Karimi N, Ghahvehchian H, Keyhani A, Manavishad A, Compton CJ, Clark JD, et al. Type and Frequency of Misdiagnosis and Time Lag to Diagnosis in Patients with Chronic Progressive External Ophthalmoplegia. J Ophthalmic Vis Res. 2024;19(3):334-339.
- Sokol JT, Hoyek S, Fulton AB, Patel NA. KEARNS-SAYRE SYNDROME MASQUERADING AS MYASTHENIA GRAVIS. Retin Cases Brief Rep. 2024;18(3):396-399.
- Takeda Y, Suzuki H, Hosono K, Hikoya A, Komori M, Inagaki R, et al. Exophthalmos associated with chronic progressive external ophthalmoplegia. Jpn J Ophthalmol. 2022;66(3):314-319.
- Tauber J, Polla DJ, Park S. Exophthalmos in Kearns-Sayre syndrome. J AAPOS. 2019;23(5):295-297.
- El-Hattab AW, Craigen WJ, Scaglia F. Mitochondrial DNA maintenance defects. Biochim Biophys Acta Mol Basis Dis. 2017;1863(6):1539-1555.
- Van Goethem G, Martin JJ, Van Broeckhoven C. Progressive external ophthalmoplegia and multiple mitochondrial DNA deletions. Acta Neurol Belg. 2002;102(1):39-42.
- Tang S, Wang J, Lee NC, Milone M, Halberg MC, Schmitt ES, et al. Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum. J Med Genet. 2011;48(10):669-81.
- Shemesh A, Margolin E. Kearns-Sayre syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Furuto-Kato S. [Kearns-Sayre syndrome]. Nihon Rinsho. 2006;Suppl 3:598-600.
- Nguyen MTB, Micieli J, Margolin E. Teaching NeuroImages: Kearns-Sayre syndrome. Neurology. 2019;92(5):e519-e520.
- Grigalionienė K, Burnytė B, Balkelienė D, Ambrozaitytė L, Utkus A. Kearns-Sayre syndrome case. Novel 5,9 kb mtDNA deletion. Mol Genet Genomic Med. 2023;11(1):e2059.
- Karaa A, Goldstein A. The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes. Pediatr Diabetes. 2015;16(1):1-9.
- Tsang SH, Aycinena ARP, Sharma T. Mitochondrial Disorder: Maternally Inherited Diabetes and Deafness. Adv Exp Med Biol. 2018;1085:163-165.
- Hoogstraten CA, Hoenderop JG, de Baaij JHF. Mitochondrial Dysfunction in Kidney Tubulopathies. Annu Rev Physiol. 2024;86:379-403.
- Birtel J, von Landenberg C, Gliem M, Gliem C, Reimann J, Kunz WS, et al. Mitochondrial Retinopathy. Ophthalmol Retina. 2022;6(1):65-79.
- Van Bergen NJ, Chakrabarti R, O’Neill EC, Crowston JG, Trounce IA. Mitochondrial disorders and the eye. Eye Brain. 2011;3:29-47.
- Han J, Lee YM, Kim SM, Han SY, Lee JB, Han SH. Ophthalmological manifestations in patients with Leigh syndrome. Br J Ophthalmol. 2015;99(4):528-35.
- Wang H, Ruan G, Yang S, Li H, Sun Z, Tian B, et al. Ocular manifestations of mitochondrial neurogastrointestinal encephalomyopathy: A case report and literature review. Am J Med Genet A. 2023;191(12):2819-2824.
- Lock JH, Irani NK, Newman NJ. Neuro-ophthalmic manifestations of mitochondrial disorders and their management. Taiwan J Ophthalmol. 2021;11(1):39-52.
- Milone M, Wong LJ. Diagnosis of mitochondrial myopathies. Mol Genet Metab. 2013;110(1-2):35-41.
- El-Hattab AW, Scaglia F. Mitochondrial cytopathies. Cell Calcium. 2016;60(3):199-206.
- Lin Y, Wang J, Ren H, Ma X, Wang W, Zhao Y, et al. Mitochondrial myopathy without extraocular muscle involvement: a unique clinicopathologic profile. J Neurol. 2024;271(2):864-876.
- Daut PM, Steinemann TL, Westfall CT. Chronic exposure keratopathy complicating surgical correction of ptosis in patients with chronic progressive external ophthalmoplegia. Am J Ophthalmol. 2000;130(4):519-21.
- Schmitz K, Lins H, Behrens-Baumann W. Bilateral spontaneous corneal perforation associated with complete external ophthalmoplegia in mitochondrial myopathy (kearns-sayre syndrome). Cornea. 2003;22(3):267-70.
- Cesneková T, Jurecka T, Skorkovská K, Tesarová M, Hanisková H, Wenchich L, et al. [Corneal ulceration complicating surgical correction of ptosis in patient with Kearns-Sayre syndrome—a case report]. Cesk Slov Oftalmol. 2011;67(4):133-5.
- Wong VA, Beckingsale PS, Oley CA, Sullivan TJ. Management of myogenic ptosis. Ophthalmology. 2002;109(5):1023-31.
- Doherty M, Winterton R, Griffiths PG. Eyelid surgery in ocular myopathies. Orbit. 2013;32(1):12-5.
- Becerra EM, Blanco G, Muiños Y, Bianciotto C. [Surgical treatment of acquired myogenic eyelid ptosis]. Arch Soc Esp Oftalmol. 2005;80(6):359-64.
- Lucci LM, Fonseca Junior NL, Sugano DM, Silvério J. [Tarsal switch levator for mitochondrial myogenic ptosis]. Arq Bras Oftalmol. 2009;72(2):159-63.
- Tinley C, Dawson E, Lee J. The management of strabismus in patients with chronic progressive external ophthalmoplegia. Strabismus. 2010;18(2):41-7.
- Moshirfar M, Webster CR, Seitz TS, Ronquillo YC, Hoopes PC. Ocular Features and Clinical Approach to Cataract and Corneal Refractive Surgery in Patients with Myotonic Dystrophy. Clin Ophthalmol. 2022;16:2837-2842.
- García-Cruz I, Muñoz-Negrete FJ, Benito-Pascual B, Arriola-Villalobos P, Pérez-Bañón MD, Alió JL, et al. Ocular findings in a Spanish cohort of myotonic dystrophy type 1. Graefes Arch Clin Exp Ophthalmol. 2023;261(4):1109-1114.
- Thornton CA. Myotonic dystrophy. Neurol Clin. 2014;32(3):705-19, viii.
- Brais B. Oculopharyngeal muscular dystrophy. Handb Clin Neurol. 2011;101:181-92.
- Yamashita S. Recent Progress in Oculopharyngeal Muscular Dystrophy. J Clin Med. 2021;10(7).
- Rahm L, Hale MA, Raaijmakers RHL, Marrero Quiñones A, Patki T, Johnson NE, et al. Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives. Nat Rev Neurol. 2025;21(11):623-641.
- Liao Q, Zhang Y, He J, Huang K. Global Prevalence of Myotonic Dystrophy: An Updated Systematic Review and Meta-Analysis. Neuroepidemiology. 2022;56(3):163-173.
- Louprasong AC, Light DJ, Diller RS. Spider dystrophy as an ocular manifestation of myotonic dystrophy. Optometry. 2010;81(4):188-93.
- Kirkegaard-Biosca E, Berges-Marti M, Azarfane B, Cilveti E, Distefano L, García-Arumí J. Fundus flavimaculatus-like in myotonic dystrophy: a case report. BMC Ophthalmol. 2021;21(1):240.
- Papageorgiou E, Bock SW, Schiefer U. [Myotonic dystrophy Curschmann-Steinert]. Klin Monbl Augenheilkd. 2007;224(1):70-5.
- Saint-Gerons M, Rubio MA, Aznar G, Matheu A. Ophthalmological Manifestations of Hereditary Myopathies. J Binocul Vis Ocul Motil. 2022;72(1):4-17.
- Varga D, Pál E. [Multiorgan manifestations in myotonic dystrophy type 1]. Orv Hetil. 2019;160(37):1447-1454.
- Mahadevan MS, Yadava RS, Mandal M. Cardiac Pathology in Myotonic Dystrophy Type 1. Int J Mol Sci. 2021;22(21).
- Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, Azriel S, Eulalio Bárcena J, Cabezudo García P, et al. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert’s disease. Neurologia (Engl Ed). 2020;35(3):185-206.
- Schoser B, Montagnese F, Bassez G, Fossati B, Gamez J, Heatwole C, et al. Consensus-based care recommendations for adults with myotonic dystrophy type 2. Neurol Clin Pract. 2019;9(4):343-353.
- Trollet C, Boulinguiez A, Roth F, Stojkovic T, Butler-Browne G, Evangelista T, et al. Oculopharyngeal muscular dystrophy. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Brais B, Rouleau GA, Bouchard JP, Fardeau M, Tomé FM. Oculopharyngeal muscular dystrophy. Semin Neurol. 1999;19(1):59-66.
- Smith IC, Chakraborty S, Bourque PR, Sampaio ML, Melkus G, Lochmüller H, et al. Emerging and established biomarkers of oculopharyngeal muscular dystrophy. Neuromuscul Disord. 2023;33(11):824-834.
- Kalin-Hajdu E, Attas-Fox L, Huang X, Hardy I, Codère F. Comparison of Two Polypropylene Frontalis Suspension Techniques in 92 Patients With Oculopharyngeal Muscular Dystrophy. Ophthalmic Plast Reconstr Surg. 2017;33(1):57-60.
- Lin TY, Chen AD, Chang CH, Liang WC, Minami N, Nishino I, et al. Severe Ocular Complications After Blepharoptosis Correction in the Oculopharyngeal Muscular Dystrophy Patient: Literature Review and Case Presentation. Ann Plast Surg. 2020;84(1S Suppl 1):S84-S88.
- Jordan DR, Klapper SR, Farmer J. Oculopharyngeal Muscular Dystrophy Ptosis, Mueller’s Muscle Involvement, and a Review of Management Over 34 Years. Ophthalmic Plast Reconstr Surg. 2022;38(6):535-542.
- Avior G, Noy R, Blumen SC, Guily JLS, Braverman I. Transillumination Assisted Cricopharyngeal Myotomy. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):2486-2492.
- Alungulese AL, García Soldevilla MA, Gordo Mañas R, Vidal Díaz MB. Oculopharyngeal muscular dystrophy coexisting with myasthenia gravis. Pract Neurol. 2022.
- Singanamalla B, Kesavan S, Aggarwal D, Chatterjee D, Urtizberea A, Suthar R. Marked Facial Weakness, Ptosis, and Hanging Jaw: A Case with RYR1 -Related Congenital Centronuclear Myopathy. J Pediatr Genet. 2023;12(4):318-324.
- Dilaver N, Mazaheri N, Maroofian R, Zeighami J, Seifi T, Zamani M, et al. Novel Homozygous Missense Mutation in RYR1 Leads to Severe Congenital Ptosis, Ophthalmoplegia, and Scoliosis in the Absence of Myopathy. Mol Syndromol. 2017;9(1):25-29.
- Lester EB, Larsen MJ, Laulund LW, Illum N, Dunkhase-Heinl U, Schrøder HD, et al. Ryanodine receptor 1 related myasthenia like myopathy responsive to pyridostigmine. Eur J Med Genet. 2023;66(3):104706.
- Johari M, Topf A, Folland C, Duff J, Dofash L, Marti P, et al. Loss-of-function variants in JPH1 cause congenital myopathy with prominent facial involvement. medRxiv. 2024.
- Phowthongkum P, Sun A. Novel truncating variant in DNA2-related congenital onset myopathy and ptosis suggests genotype-phenotype correlation. Neuromuscul Disord. 2017;27(7):616-618.
- Kim CS, Park JM, Park D, Kim DH, Park JS. Opioid use may be associated with postoperative complications in myotonic dystrophy type 1 with high-grade muscular impairment. Sci Rep. 2021;11(1):8.
- Mørk EL, Kristensen ML, Stokholm JB, Söderström CM, Madsen MV, Gätke MR. Resistance towards nondepolarising muscle relaxants: prolonged onset time: A systematic review. Eur J Anaesthesiol. 2019;36(7):477-485.
- Veyckemans F, Scholtes JL. Myotonic dystrophies type 1 and 2: anesthetic care. Paediatr Anaesth. 2013;23(9):794-803.
- van den Bersselaar LR, Heytens L, Silva HCA, Reimann J, Tasca G, Díaz-Cambronero Ó, et al. European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders. Eur J Neurol. 2022;29(12):3486-3507.
- Sinclair JL, Reed PW. Risk factors for perioperative adverse events in children with myotonic dystrophy. Paediatr Anaesth. 2009;19(8):740-7.
- Bensoussan L, De Saint Jean M, Lozato P, Auzerie O, Ohana L, Baudouin C. [Severe bilateral capsulorhexis contraction after cataract surgery in myotonic dystrophy: a case report]. J Fr Ophtalmol. 2004;27(5):479-83.
- Zalewska R, Mariak Z, Markowska E, Czaban S. [Problems of perioperative period in patients with Steinert’s myotonic dystrophy operated due to cataract]. Klin Oczna. 2005;107(1-3):113-4.
- McNab AA. Orbital Myositis: A Comprehensive Review and Reclassification. Ophthalmic Plast Reconstr Surg. 2020;36(2):109-117.
- Fraser CL, Skalicky SE, Gurbaxani A, McCluskey P. Ocular myositis. Curr Allergy Asthma Rep. 2013;13(3):315-21.
- Costa RM, Dumitrascu OM, Gordon LK. Orbital myositis: diagnosis and management. Curr Allergy Asthma Rep. 2009;9(4):316-23.
- Pidro A, Dizdarević A, Jovanović N, Čerim A, Sačak E, Miokovic AP. Diagnostics and treatment of orbital myositis. Rom J Ophthalmol. 2022;66(2):173-177.
- Yang HS, Zhang T, Ye HJ. [Role of imaging classification in the diagnosis and management of orbital inflammatory pseudotumor]. Zhonghua Yan Ke Za Zhi. 2023;59(1):8-12.
- Yan J, Wu P. Idiopathic orbital myositis. J Craniofac Surg. 2014;25(3):884-7.
- Zeppieri M, Patel R, Patel BC. Dacryoadenitis. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Amrutkar CV, Lui F, Burton EV. Tolosa-Hunt syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Zheng Y, Zhang YX, Ding MP. Treatment of idiopathic orbital myositis with frequent relapses: First case with tacrolimus and review of literature. J Neuroimmunol. 2020;346:577316.
- Lu JE, Ross C, Ivanov A, Hall N, Lorch A, Miller J, et al. Epidemiology of Orbital Inflammatory Disease: An AAO IRIS Registry Study. Ocul Immunol Inflamm. 2024;32(9):2081-2084.
- Lieb WE. [Idiopathic orbital inflammation]. Ophthalmologe. 2021;118(8):777-786.
- Mouriaux F, Coffin-Pichonnet S, Robert PY, Abad S, Martin-Silva N. [Orbital inflammation]. J Fr Ophtalmol. 2014;37(10):818-24.
- Vicino A, Hottinger AF, Latifyan S, Boughdad S, Becce F, Prior JO, et al. Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series. J Neurol. 2024;271(4):1947-1958.
- Seki M, Uruha A, Ohnuki Y, Kamada S, Noda T, Onda A, et al. Inflammatory myopathy associated with PD-1 inhibitors. J Autoimmun. 2019;100:105-113.
- Seki M, Kitano S, Suzuki S. Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies. Cancer Immunol Immunother. 2022;71(4):769-775.
- Sugiyama Y, Esa Y, Watanabe A, Kobayashi J, Suzuki S, Takahashi D. [Immune checkpoint inhibitor-induced anti-striational antibodies in myasthenia gravis and myositis: a case report]. Rinsho Shinkeigaku. 2021;61(9):630-634.
- Wang C, Zeng H, Fang W, Song L. Clinical characteristics, treatment and outcome of nivolumab-induced myasthenia gravis. Invest New Drugs. 2023;41(2):333-339.
- Wladis EJ, Kambam ML. Ophthalmic complications of immune checkpoint inhibitors. Orbit. 2022;41(1):28-33.
- Jebaraj AP, Etheridge TJ, Winegar BA, Marx DP. Ipilimumab-related orbitopathy: a case report. Orbit. 2024;43(1):100-104.
- Pushkarevskaya A, Neuberger U, Dimitrakopoulou-Strauss A, Enk A, Hassel JC. Severe Ocular Myositis After Ipilimumab Treatment for Melanoma: A Report of 2 Cases. J Immunother. 2017;40(7):282-285.
- Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velázquez-Villoria Á, Galofré JC. Graves’ Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management. J Ophthalmol. 2015;2015:249125.
- Irawati Y, Juhrie DM, Paramita C, Siswoyo D, Suharko H, Pramono LA. Sight-Threatening Condition in Severe Thyroid Eye Disease: How We Should Manage. Acta Med Indones. 2022;54(1):124-130.
- Smith TJ. Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves’ Orbitopathy. Eur J Endocrinol. 2021;185(6):L13-L14.
- Nowak M, Marek B, Kos-Kudła B, Siemińska L, Londzin-Olesik M, Głogowska-Szeląg J, et al. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves’ Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves’ Orbitopathy (EUGOGO)]. Endokrynol Pol. 2022;73(4):756-777.
- Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, et al. Teprotumumab for the Treatment of Active Thyroid Eye Disease. N Engl J Med. 2020;382(4):341-352.
- Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, et al. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study. Ophthalmology. 2022;129(4):438-449.
- Douglas RS, Couch S, Wester ST, Fowler BT, Liu CY, Subramanian PS, et al. Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity. J Clin Endocrinol Metab. 2023;109(1):25-35.
- Nie T, Lamb YN. Teprotumumab: A Review in Thyroid Eye Disease. Drugs. 2022;82(17):1663-1670.
- Nowak M, Nowak W, Marek B, Kos-Kudła B, Siemińska L, Londzin-Olesik M, et al. The position of monoclonal antibodies and small molecules in the treatment of thyroid orbitopathy. Endokrynol Pol. 2024;75(6):604-616.
- Fu L, Gurnani B, Malik J. Brown syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Gim Y, Jung JH. Extraocular muscle enlargement of indeterminate cause in pediatric patients: case series and literature review. J AAPOS. 2023;27(4):205.e1-205.e6.
- Zuo X, Ma L, Zhuo X, Li Y. Acquired monocular elevation deficit in a case of Parry-Romberg syndrome. Strabismus. 2019;27(4):215-217.
- Lanzillotta M, Culver E, Sharma A, Zen Y, Zhang W, Stone JH, et al. Fibrotic phenotype of IgG4-related disease. Lancet Rheumatol. 2024;6(7):e469-e480.
- Maritati F, Peyronel F, Vaglio A. IgG4-related disease: a clinical perspective. Rheumatology (Oxford). 2020;59(Suppl 3):iii123-iii131.
- Pitz S. [IgG4-related disease]. Ophthalmologe. 2021;118(8):787-793.
- Gross JR, McClelland CM, Lee MS. An approach to anisocoria. Curr Opin Ophthalmol. 2016;27(6):486-492.
- Bouffard MA. The Pupil. Continuum (Minneap Minn). 2019;25(5):1194-1214.
- Wilhelm H. The pupil. Curr Opin Neurol. 2008;21(1):36-42.
- Wilhelm H. Disorders of the pupil. Handb Clin Neurol. 2011;102:427-66.
- Lam BL, Thompson HS, Corbett JJ. The prevalence of simple anisocoria. Am J Ophthalmol. 1987;104(1):69-73.
- Lam BL, Thompson HS, Walls RC. Effect of light on the prevalence of simple anisocoria. Ophthalmology. 1996;103(5):790-3.
- George AS, Abraham AP, Nair S, Joseph M. The Prevalence of Physiological Anisocoria and its Clinical Significance - A Neurosurgical Perspective. Neurol India. 2019;67(6):1500-1503.
- Rickmann A, Waizel M, Kazerounian S, Szurman P, Wilhelm H, Boden KT. Digital Pupillometry in Normal Subjects. Neuroophthalmology. 2017;41(1):12-18.
- Fountas KN, Kapsalaki EZ, Machinis TG, Boev AN, Robinson JS, Troup EC. Clinical implications of quantitative infrared pupillometry in neurosurgical patients. Neurocrit Care. 2006;5(1):55-60.
- Kawasaki A, Kardon RH. Intrinsically photosensitive retinal ganglion cells. J Neuroophthalmol. 2007;27(3):195-204.
- Kawasaki A. Invited Commentary: Evaluation of Horner Syndrome in the MRI Era. J Neuroophthalmol. 2018;38(1):52-53.
- Cahill JA, Ross J. Eye on children: acute work-up for pediatric Horner’s syndrome. case presentation and review of the literature. J Emerg Med. 2015;48(1):58-62.
- Mojon DS, Stehberger B. [Diagnosis of horner syndrome by pupil dilation lag]. Klin Monbl Augenheilkd. 2005;222(3):211-3.
- Pellegrini F, Capello G, Napoleone R. Dilation lag in Horner syndrome can be measured with a diagnostic imaging system. Neurology. 2018;90(13):618.
- Yoo YJ, Yang HK, Hwang JM. Efficacy of digital pupillometry for diagnosis of Horner syndrome. PLoS One. 2017;12(6):e0178361.
- Crippa SV, Borruat FX, Kawasaki A. Pupillary dilation lag is intermittently present in patients with a stable oculosympathetic defect (Horner syndrome). Am J Ophthalmol. 2007;143(4):712-5.
- Bremner F. Apraclonidine Is Better Than Cocaine for Detection of Horner Syndrome. Front Neurol. 2019;10:55.
- Chen PL, Chen JT, Lu DW, Chen YC, Hsiao CH. Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients. J Ocul Pharmacol Ther. 2006;22(3):182-7.
- Antonio-Santos AA, Santo RN, Eggenberger ER. Pharmacological testing of anisocoria. Expert Opin Pharmacother. 2005;6(12):2007-13.
- Wermund T, Wilhelm H, Kelbsch C. [Pupil disorders]. Klin Monbl Augenheilkd. 2019;236(8):1033-1050.
- Cherayil NR, Tamhankar MA. Neuro-Ophthalmology for Internists. Med Clin North Am. 2021;105(3):511-529.
- Chadha V, Tey A, Kearns P. Benign episodic unilateral mydriasis. Eye (Lond). 2007;21(1):118-9.
- Skeik N, Jabr FI. Migraine with benign episodic unilateral mydriasis. Int J Gen Med. 2011;4:501-3.
- Bakkali El Bakkali I, Cisneros Arias P, Muñoz Salas A. Episodic benign unilateral mydriasis in migraine. Med Clin (Barc). 2022;159(12):e85-e86.
- Murphy SJX, Francis I, Nadarajan V. Prolonged Benign Episodic Unilateral Mydriasis in Hemiplegic Migraine. J Neuroophthalmol. 2024;44(1):e140.
- Correia Barbosa R, Vieira B, Lemos JA. Isolated Benign Unilateral Episodic Mydriasis in Relation to Anxiety: A Case Report. Neuroophthalmology. 2024;48(1):46-50.
- Donohoe CD. The role of the physical examination in the evaluation of headache. Med Clin North Am. 2013;97(2):197-216.
- Sadaka A, Schockman SL, Golnik KC. Evaluation of Horner Syndrome in the MRI Era. J Neuroophthalmol. 2017;37(3):268-272.
- Almog Y, Gepstein R, Kesler A. Diagnostic value of imaging in horner syndrome in adults. J Neuroophthalmol. 2010;30(1):7-11.
- Al-Moosa A, Eggenberger E. Neuroimaging yield in isolated Horner syndrome. Curr Opin Ophthalmol. 2011;22(6):468-71.
- Chen Y, Morgan ML, Barros Palau AE, Yalamanchili S, Lee AG. Evaluation and neuroimaging of the Horner syndrome. Can J Ophthalmol. 2015;50(2):107-11.
- Eppley SE, Qureshi A. Iris Heterochromia in Acquired Horner Syndrome Following Surgical Excision of Parapharyngeal Neuroblastoma. Child Neurol Open. 2023;10:2329048X231219205.
- Nannoni S, Maeder P, Vingerhoets F, Michel P. Horner syndrome in ipsilateral lenticulostriate stroke: a novel localization for a classic stroke syndrome. Clin Auton Res. 2018;28(6):583-587.
- Carsote M, Nistor CE, Popa FL, Stanciu M. Horner’s Syndrome and Lymphocele Following Thyroid Surgery. J Clin Med. 2023;12(2).
- Aleanakian R, Chung BY, Feldmann RE Jr, Benrath J. Effectiveness, Safety, and Predictive Potential in Ultrasound-Guided Stellate Ganglion Blockades for the Treatment of Sympathetically Maintained Pain. Pain Pract. 2020;20(6):626-638.
- Martin TJ. Horner Syndrome: A Clinical Review. ACS Chem Neurosci. 2018;9(2):177-186.
- Walton KA, Buono LM. Horner syndrome. Curr Opin Ophthalmol. 2003;14(6):357-63.
- Udry M, Kardon RH, Sadun F, Kawasaki A. The Tadpole Pupil: Case Series With Review of the Literature and New Considerations. Front Neurol. 2019;10:846.
- Trobe JD. The evaluation of horner syndrome. J Neuroophthalmol. 2010;30(1):1-2.
- Reede DL, Garcon E, Smoker WR, Kardon R. Horner’s syndrome: clinical and radiographic evaluation. Neuroimaging Clin N Am. 2008;18(2):369-85, xi.
- Fierz FC, Disse LR, Bockisch CJ, Weber KP. Apraclonidine-An eye opener. Front Ophthalmol (Lausanne). 2022;2:902821.
- Dewan MA, Harrison AR, Lee MS. False-negative apraclonidine testing in acute Horner syndrome. Can J Ophthalmol. 2009;44(1):109-10.
- Bohnsack BL, Parker JW. Positive apraclonidine test within two weeks of onset of Horner syndrome caused by carotid artery dissection. J Neuroophthalmol. 2008;28(3):235-6.
- Cooper-Knock J, Pepper I, Hodgson T, Sharrack B. Early diagnosis of Horner syndrome using topical apraclonidine. J Neuroophthalmol. 2011;31(3):214-6.
- Nguyen MTB, Farahvash A, Zhang A, Micieli JA. Apraclonidine for the pharmacologic confirmation of acute Horner syndrome. J Neurol Sci. 2020;419:117190.
- Martín-Moro JG, Botín DM, Muñoz-Negrete FJ. Possible effect of systemic sympathicolytic drugs on apraclonidine test. Can J Ophthalmol. 2009;44(4):463; author reply 463-4.
- Teixeira JC, Jackson PJ. Internal Carotid Artery Dissection Presenting as Partial Horner’s Syndrome and Vertigo. Mil Med. 2020;185(9-10):e1840-e1842.
- Keser Z, Chiang CC, Benson JC, Pezzini A, Lanzino G. Cervical Artery Dissections: Etiopathogenesis and Management. Vasc Health Risk Manag. 2022;18:685-700.
- Selim M, Caplan LR. Carotid Artery Dissection. Curr Treat Options Cardiovasc Med. 2004;6(3):249-253.
- Walburg ZG. Acute Painful Horner Syndrome as the First Presenting Sign of Carotid Artery Dissection. Fed Pract. 2023;40(5):160-166.
- Crahay FX, Lamalle A, Andris C, Rakic JM. [Painful Horner’s syndrome revealing carotid artery dissection : about four cases]. Rev Med Liege. 2018;73(7-8):428-432.
- Jeffery AR, Ellis FJ, Repka MX, Buncic JR. Pediatric Horner syndrome. J AAPOS. 1998;2(3):159-67.
- Hamed LM. Pediatric Horner syndrome and neuroblastoma threat. J AAPOS. 1998;2(3):129-30.
- Liu GT, Mahoney NR, Avery RA, Menacker SJ, Wilson MC, Hogarty MD, et al. Pediatric horner syndrome. Arch Ophthalmol. 2011;129(8):1108-9; author reply 1109.
- Barrea C, Vigouroux T, Karam J, Milet A, Vaessen S, Misson JP. Horner Syndrome in Children: A Clinical Condition with Serious Underlying Disease. Neuropediatrics. 2016;47(4):268-72.
- Ben Shabat A, Ash S, Luckman J, Toledano H, Goldenberg-Cohen N. Likelihood of Diagnosing Neuroblastoma in Isolated Horner Syndrome. J Neuroophthalmol. 2019;39(3):308-312.
- Khalatbari H, Ishak GE. Imaging of Horner syndrome in pediatrics: association with neuroblastoma. Pediatr Radiol. 2021;51(2):205-215.
- Kadom N, Rosman NP, Jubouri S, Trofimova A, Egloff AM, Zein WM. Neuroimaging experience in pediatric Horner syndrome. Pediatr Radiol. 2015;45(10):1535-43.
- Braungart S, Craigie RJ, Farrelly P, Losty PD. Paediatric Horner’s syndrome: is investigation for underlying malignancy always required?. Arch Dis Child. 2019;104(10):984-987.
- Asadigandomani H, Rajabi MT, Mohsenzadeh Kermani N, Nozarian Z, Ghaedamini M, Rafizadeh SM. Muller’s muscle fibrosis is a possible predictive factor in the outcome of Muller’s muscle-conjunctival resection. BMC Ophthalmol. 2025;25(1):284.
- Kardon RH, Corbett JJ, Thompson HS. Segmental denervation and reinnervation of the iris sphincter as shown by infrared videographic transillumination. Ophthalmology. 1998;105(2):313-21.
- Xu SY, Song MM, Li L, Li CX. Adie’s Pupil: A Diagnostic Challenge for the Physician. Med Sci Monit. 2022;28:e934657.
- Kanzaria HK, Farzan N, Coralic Z. Adie’s Tonic Pupil. West J Emerg Med. 2012;13(6):543.
- Beltraminelli T, Kawasaki A. Pupillary disorders. Handb Clin Neurol. 2026;216:131-155.
- Shanker V, Shukla A, Kumar S. Adie’s tonic pupil: a clinicoradiological insights. Eye (Lond). 2026.
- Markus C. THE TONIC PUPIL. Br J Ophthalmol. 1942;26(3):137-8.
- GRAVESON GS. The tonic pupil. J Neurol Neurosurg Psychiatry. 1949;12(3):219-30.
- Kuznetsova PI, Raskurazhev AA, Tanashyan MM. [Adie syndrome]. Vestn Oftalmol. 2019;135(4):83-85.
- Horkovičová K, Popov I, Valašková J. PUPILLOTONIA AND ADIE SYNDROME. Cesk Slov Oftalmol. 2020;76(5):232-235.
- Durán-Ferreras E, Idígoras-Hurtado A, Caballero-Granado J. [Adie’s pupil]. Med Clin (Barc). 2012;138(15):e29.
- Babiano Fernandez MA. [Adie’s pupil]. Aten Primaria. 2020;52(2):129-130.
- Rendón Fernández H, Arias Del Peso B. [Adiés tonic pupil and other associated signs]. Aten Primaria. 2021;53(5):101982.
- Nene AS, Pirdankar OH, Shah S, Badole P, Shah S. Adie’s Tonic Pupil: An Uncommon Ophthalmological Emergency. Neurol India. 2021;69(5):1487-1488.
- Guaraldi P, Mathias CJ. Progression of cardiovascular autonomic dysfunction in Holmes-Adie syndrome. J Neurol Neurosurg Psychiatry. 2011;82(9):1046-9.
- Martinelli P. Holmes-Adie syndrome. Lancet. 2000;356(9243):1760-1.
- Martinelli P, Montagna P, Gabellini AS. Holmes-Adie syndrome. J Neurol Neurosurg Psychiatry. 1980;43(12):1147.
- Mak W, Cheung RT. The Holmes-Adie plus syndrome. J Clin Neurosci. 2000;7(5):452.
- Weller M, Wilhelm H, Sommer N, Dichgans J, Wiethölter H. Tonic pupil, areflexia, and segmental anhidrosis: two additional cases of Ross syndrome and review of the literature. J Neurol. 1992;239(4):231-4.
- Ahmad R, Saurabh K. Two Cases of Tonic Pupil: Ross and Ross Syndrome Plus. Cureus. 2022;14(2):e22305.
- Yoo YJ, Hwang JM, Yang HK. Dilute pilocarpine test for diagnosis of Adie’s tonic pupil. Sci Rep. 2021;11(1):10089.
- Rivero Rodríguez D, Scherle Matamoros C, Pernas Sánchez Y. Adie pupil. Pilocarpine test. Med Clin (Barc). 2018;151(4):170.
- Li L, Lian L, Zhou R. Transdermal and Powdered Scopolamine-Induced Anisocoria: A Report of Two Cases. Case Rep Ophthalmol. 2025;16(1):341-345.
- Bladen JC, Moosajee M, Angunawela R, Roberts C. Transient internal ophthalmoplegia after inferior oblique myectomy. J AAPOS. 2009;13(6):596-7.
- Yin H, Yang S, Lu L. Adie’s tonic pupil in primary Sjögren syndrome. Clin Rheumatol. 2023;42(12):3419-3420.
- Vermersch P, Dufourd-Delalande S, Defoort-Dhellemmes S, Stojkovic T, Launay D, de Seze J. [Tonic pupils in Sjögren’s syndrome]. Rev Neurol (Paris). 2005;161(10):963-6.
- Bowie EM, Givre SJ. Tonic pupil and sarcoidosis. Am J Ophthalmol. 2003;135(3):417-9.
- Tetzschner R, Thineshkumar S, Molander L, Gade E. Tonic pupil in child after chicken pox. Ugeskr Laeger. 2023;185(48).
- Gopal M, Ambika S, Padmalakshmi K. Tonic Pupil Following COVID-19. J Neuroophthalmol. 2021;41(4):e764-e766.
- Quijano-Nieto BA, Córdoba-Ortega CM. Tonic pupil after COVID-19 infection. Arch Soc Esp Oftalmol (Engl Ed). 2021;96(7):353-355.
- Çakır GY, Paşaoğlu IB, Çakır İ, Solmaz B. Adie’s tonic pupil after COVID-19: a case report and literature review. Rom J Ophthalmol. 2024;68(2):89-91.
- Ordás CM, Villacieros-Álvarez J, Pastor-Vivas AI, Corrales-Benítez Á. Concurrent tonic pupil and trochlear nerve palsy in COVID-19. J Neurovirol. 2020;26(6):970-972.
- Gönültaş EN, Dereli Can G. Adie Pupil After BNT162b2 mRNA COVID-19 Vaccine. J Neuroophthalmol. 2024;44(1):e141-e142.
- Moura J, Carneiro P, Neves E, Santos E. Isolated Adie Pupil Associated With Anti-CASPR2 Antibodies. J Neuroophthalmol. 2023;43(4):e247-e248.
- Okamura K, Ibayashi H, Sato K, Fujikawa M, Bandai S, Shibasaki H, et al. A case of Graves’ disease presenting with internal ophthalmoplegia during methylmercaptoimidazole treatment. Endocr J. 2022;69(2):173-177.
- Vimisha MN, Virna MS, Karthik K, Sharanya R. Adie’s pupil and systemic manifestations: a rare unilateral presentation. GMS Ophthalmol Cases. 2024;14:Doc14.
- Kaufman AR, Gulati S, Pula JH, Janetos TM, Cherayil NR, Chiu E, et al. Pharmacologic Mydriasis Secondary to Topical Glycopyrronium Tosylate Cloths: Clinical Characterization From a Multicenter Analysis. J Neuroophthalmol. 2022;42(4):530-534.
- Seto S, Teo AA, Walsh RD. Pharmacologic mydriasis in an infant following parental use of topical glycopyrronium tosylate. J AAPOS. 2019;23(6):359-361.
- Razeghinejad R, Nowroozzadeh MH. Water-drinking Test and Pharmacologic Mydriasis as Provocative Tests in Primary Angle Closure Suspects. J Ophthalmic Vis Res. 2019;14(3):267-274.
- Friedman DS, Chang DS, Jiang Y, Huang S, Kim JA, Munoz B, et al. Acute Angle-Closure Attacks Are Uncommon in Primary Angle-Closure Suspects after Pharmacologic Mydriasis: The Zhongshan Angle-Closure Prevention Trial. Ophthalmol Glaucoma. 2022;5(6):581-586.
- Mohseni M, Gurnani B, Blair K. Blunt eye trauma. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Frisina R, Parrozzani R, Tozzi L, Pilotto E, Midena E. Pupil cerclage technique for treatment of traumatic mydriasis. Eur J Ophthalmol. 2020;30(3):480-486.
- Lumi X, Lumi A, Petrovic Pajic S. Iris cerclage pupilloplasty and IOL implantation for traumatic mydriasis and aphakia after the blunt trauma of the eye. Indian J Ophthalmol. 2021;69(5):1314-1317.
- Shen C, Liu L, Su N, Cui L, Zhao X, Li M, et al. Single‑pass four‑throw versus traditional knotting pupilloplasty for traumatic mydriasis combined with lens dislocation. BMC Ophthalmol. 2023;23(1):13.
- Li H, Cai J, Huang Y, Wu D, Zhang Y, Wu D. Coreoplasty and Artisan intraocular lens implantation for mydriasis and aphakic correction in post-traumatic vitrectomized eyes. Eye Sci. 2012;27(3):119-23.
- Mayer C, Khoramnia R. [Pupil reconstruction with an artificial iris]. Ophthalmologe. 2022;119(1):3-12.
- Chesnut RM, Temkin N, Dikmen S, Rondina C, Videtta W, Petroni G, et al. A Method of Managing Severe Traumatic Brain Injury in the Absence of Intracranial Pressure Monitoring: The Imaging and Clinical Examination Protocol. J Neurotrauma. 2018;35(1):54-63.
- Geraerts SD, Plötz FB, van Goor C, Duval EL, van Vught H. Unilateral fixed dilated pupil in a ventilated child with asthma. Eur J Emerg Med. 2000;7(3):247-8.
- Loewenfeld IE. The Argyll Robertson pupil 1869-1969. A critical survey of the literature. Surv Ophthalmol. 1969;14(3):199-299.
- Pearce JM. The Argyll Robertson pupil. J Neurol Neurosurg Psychiatry. 2004;75(9):1345.
- Dichter SL, Shubert G. Argyll Robertson pupil. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Diaz Olaizola C, Salvador Castellà N, Garcia Caballero M, Jerez Viñas N, Galvez Suarez A, Álvaro Rubio C. [Argyll-Robertson pupil]. Semergen. 2016;42(2):125-6.
- Berkowitz HL. Argyll-Robertson pupil and neurosyphilis. Psychosomatics. 2002;43(4):340-1; author reply 341.
- Cox FEG. Glasgow encounters with tropical diseases. Parasitology. 2017;144(12):1561-1566.
- Ramchandani MS, Cannon CA, Marra CM. Syphilis: A Modern Resurgence. Infect Dis Clin North Am. 2023;37(2):195-222.
- Hartung KJ, Tsang SH, Sharma T, Diaconita V. Syphilis. Adv Exp Med Biol. 2025;1467:245-247.
- Xie JS, Ocampo V, Kaplan AJ. Anterior uveitis for the comprehensive ophthalmologist. Can J Ophthalmol. 2025;60(2):69-78.
- Furtado JM, Simões M, Vasconcelos-Santos D, Oliver GF, Tyagi M, Nascimento H, et al. Ocular syphilis. Surv Ophthalmol. 2022;67(2):440-462.
- Tuddenham S, Ghanem KG. Management of Adult Syphilis: Key Questions to Inform the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022;74(Suppl_2):S127-S133.
- Bista Karki S, Coppell KJ, Mitchell LV, Ogbuehi KC. Dynamic Pupillometry in Type 2 Diabetes: Pupillary Autonomic Dysfunction and the Severity of Diabetic Retinopathy. Clin Ophthalmol. 2020;14:3923-3930.
- Ferrari GL, Marques JL, Gandhi RA, Heller SR, Schneider FK, Tesfaye S, et al. Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study. Biomed Eng Online. 2010;9:26.
- Cankurtaran V, Ozates S, Ozler S. Association of pupil responses with severity of erectile dysfunction in diabetes mellitus. Indian J Ophthalmol. 2019;67(8):1314-1319.
- Halperin A, Pajuelo M, Tornheim JA, Vu N, Carnero AM, Galdos-Cardenas G, et al. Pupillary Light Reflexes are Associated with Autonomic Dysfunction in Bolivian Diabetics But Not Chagas Disease Patients. Am J Trop Med Hyg. 2016;94(6):1290-8.
- Sekijima Y. Hereditary transthyretin amyloidosis. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Choi KJ, Son KY, Kang SW, Kim D, Choi JO, Kim HJ, et al. OCULAR MANIFESTATIONS OF ASP38ALA AND THR59LYS FAMILIAL TRANSTHYRETIN AMYLOIDOSIS. Retina. 2022;42(2):396-403.
- Rocha EA, Mehta N, Távora-Mehta MZP, Roncari CF, Cidrão AAL, Elias Neto J. Dysautonomia: A Forgotten Condition - Part 1. Arq Bras Cardiol. 2021;116(4):814-835.
- Coon EA, Singer W, Low PA. Pure Autonomic Failure. Mayo Clin Proc. 2019;94(10):2087-2098.
- González-Duarte A, Varma-Doyle A, Freeman R. Pure autonomic failure and the differential diagnosis of autonomic peripheral neuropathies. Curr Opin Neurol. 2021;34(5):675-682.
- Krismer F, Fanciulli A, Meissner WG, Coon EA, Wenning GK. Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment. Lancet Neurol. 2024;23(12):1252-1266.
- Stankovic I, Fanciulli A, Sidoroff V, Wenning GK. A Review on the Clinical Diagnosis of Multiple System Atrophy. Cerebellum. 2023;22(5):825-839.
- Stankovic I, Kuijpers M, Kaufmann H. An update on multiple system atrophy. Curr Opin Neurol. 2024;37(4):400-408.
- Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis. 2020;134:104700.
- Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567-1582.
- Arbique D, Cheek D, Welliver M, Vongpatanasin W. Management of neurogenic orthostatic hypotension. J Am Med Dir Assoc. 2014;15(4):234-9.
- Lamotte G, Sandroni P, Cutsforth-Gregory JK, Berini SE, Benarroch EE, Shouman K, et al. Clinical presentation and autonomic profile in Ross syndrome. J Neurol. 2021;268(10):3852-3860.
- Ramírez-Estudillo A, González-Saldivar G, Espinosa-Soto I, González-Cortez J, Salcido-Montenegro A. Riley-Day Syndrome in a Hispanic Infant of Non-Jewish Ashkenazi Descent. J Clin Diagn Res. 2017;11(7):ND01-ND02.
- Michaud L, Carrasquillo K. Piggyback cosmetic contact lens as an occlusion therapy in a patient with familial dysautonomia. Eye Contact Lens. 2010;36(6):367-70.
- Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res. 2006;82(5):885-98.
- Zoukhri D, Hodges RR, Dartt DA. Lacrimal gland innervation is not altered with the onset and progression of disease in a murine model of Sjögren’s syndrome. Clin Immunol Immunopathol. 1998;89(2):126-33.
- Patel J, Levin A, Patel BC. Epiphora. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Keegan DJ, Geerling G, Lee JP, Blake G, Collin JR, Plant GT. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Ophthalmol. 2002;86(1):43-6.
- Illigens BMW, Gibbons CH. Autonomic testing, methods and techniques. Handb Clin Neurol. 2019;160:419-433.
- Baker JR, Hira R, Uppal J, Raj SR. Clinical Assessment of the Autonomic Nervous System. Card Electrophysiol Clin. 2024;16(3):239-248.
- Ahmad SM, Della Rocca RC. Blepharoptosis: evaluation, techniques, and complications. Facial Plast Surg. 2007;23(3):203-15.
- Finsterer J. Ptosis: causes, presentation, and management. Aesthetic Plast Surg. 2003;27(3):193-204.
- Yadegari S. Approach to a patient with blepharoptosis. Neurol Sci. 2016;37(10):1589-96.
- Kakizaki H, Takahashi Y, Nakano T, Asamoto K, Ikeda H, Selva D, et al. Müller’s muscle: a component of the peribulbar smooth muscle network. Ophthalmology. 2010;117(11):2229-32.
- Landau-Prat D, Mayer C, Gomel N, Arazi M, Zloto O, Dori A, et al. Müller’s Muscle as a Sensory Proprioceptive Organ: Histological and Histochemical Analysis. Invest Ophthalmol Vis Sci. 2023;64(5):18.
- Hübner H. [Congenital ptosis]. Klin Monbl Augenheilkd. 2012;229(1):16-20.
- Surve A, Sharma MC, Pushker N, Bajaj MS, Meel R, Kashyap S. A study of changes in levator muscle in congenital ptosis. Int Ophthalmol. 2019;39(6):1231-1238.
- Nabie R, Manouchehri V, Aminmozaffari S, Sakha H, Heidari N. Levator muscle resection for simple congenital ptosis: its impact on preoperative levator function and dose-response ratio. Can J Ophthalmol. 2023;58(3):235-238.
- Suda T, Matsushita E, Minamide H. Oculomotor nerve palsy owing to cerebral aneurysm. QJM. 2022;115(6):395-396.
- Yokosako S, Kikkawa Y, Takeda R, Ikeda T, Kurita H. Oculomotor Nerve Palsy in a Patient with a Ruptured Middle Cerebral Artery Aneurysm. J Med Invest. 2017;64(1.2):165-167.
- Vaphiades MS, Roberson GH. Imaging of Oculomotor (Third) Cranial Nerve Palsy. Neurol Clin. 2017;35(1):101-113.
- Top Karti D, Karti O, Saruhan Durmaz G, Gokcay F, Celebisoy N. The evaluation of patient demographics, etiologies and apraclonidine test results in adult Horner’s syndrome. Int Ophthalmol. 2022;42(4):1233-1239.
- Kraker JA, Tajfirouz DA, Bhatti MT, Chen JJ. Tachyphylaxis With Sustained Apraclonidine Use in the Treatment of Ptosis Associated With Horner Syndrome. J Neuroophthalmol. 2023;43(4):e245-e246.
- Mittal MK, Barohn RJ, Pasnoor M, McVey A, Herbelin L, Whittaker T, et al. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response. J Clin Neuromuscul Dis. 2011;13(1):46-52.
- Hehir MK, Silvestri NJ. Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology. Neurol Clin. 2018;36(2):253-260.
- Fecto F. Myasthenia gravis: Mechanisms, clinical syndromes, and diagnosis. Dis Mon. 2025;71(8):101969.
- Sivakumar P, Tagare S, Kumar M. Diagnostic accuracy and clinical utility of bed side tests versus laboratory tests in the diagnosis of ocular myasthenia. Indian J Ophthalmol. 2022;70(4):1331-1337.
- Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, et al. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Lancet Neurol. 2023;22(5):383-394.
- Han C, Jia Z, Zhao G, Chen W, Hu Y, Liu H. Case Report: Kearns Sayre Syndrome Complicated With Postpartum Cardiac Failure. Front Med (Lausanne). 2022;9:906112.
- Teo L, Lagler CP, Mannor G, Glass LD, Freitag SK. Mullers Muscle Conjunctival Resection for Treatment of Contact Lens-Associated Ptosis. Ophthalmic Plast Reconstr Surg. 2016;32(4):257-60.
- Martin PA, Rogers PA. Involutional ptosis: recognition and management. Aust N Z J Ophthalmol. 1985;13(2):185-7.
- Saffari PS, Dallalzadeh LO, Kikkawa DO, Korn BS, Ramesh S, Shinder R, et al. The Utility of Preoperative Phenylephrine Testing in Müller Muscle Conjunctival Resection Surgery for Involutional Ptosis. Ophthalmic Plast Reconstr Surg. 2025;41(1):90-93.
- Baldwin HC, Bhagey J, Khooshabeh R. Open sky Müller muscle-conjunctival resection in phenylephrine test-negative blepharoptosis patients. Ophthalmic Plast Reconstr Surg. 2005;21(4):276-80.
- Kang S, Seo JW, Ahn CJ, Esmaeli B, Sa HS. Intraoperative lagophthalmos formula for levator resection in congenital ptosis. Br J Ophthalmol. 2019;103(6):802-804.
- Kumar SV, Goel S, Kumar V, Sati A, Mishra SK. Surgical outcomes of tarsofrontalis sling surgery using silicon rod versus supramaximal levator resection in unilateral congenital ptosis with poor levator function. Int Ophthalmol. 2023;43(3):957-964.
- Méjécase C, Nigam C, Moosajee M, Bladen JC. The Genetic and Clinical Features of FOXL2-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome. Genes (Basel). 2021;12(3).
- Bowyer JD, Sullivan TJ. Management of Marcus Gunn jaw winking synkinesis. Ophthalmic Plast Reconstr Surg. 2004;20(2):92-8.
- Mandal SK, Ganguly P, Lodh S. Surgical Outcomes of Unilateral Marcus Gunn Jaw Winking Ptosis Correction: A Novel Whitnall’s Ligament Approach. Korean J Ophthalmol. 2021;35(1):18-25.
- Al-Essa RS, Althaqib RN, Kikkawa DO, Alsuhaibani AH. Long-term surgical outcomes of levator resection in patients with Marcus-Gunn jaw-winking ptosis. Orbit. 2022;41(2):211-215.
- Kaur S, Sharda S, Aggarwal H, Dadeya S. Comprehensive review of amblyopia: Types and management. Indian J Ophthalmol. 2023;71(7):2677-2686.
- Ye JJ, Bouffard MA, Brooks E, Hung YP, Kimchi EY. Giant Cell Arteritis Presenting With Multiple Cranial Neuropathies - Case Report. Neurohospitalist. 2023;13(2):188-191.
- Guijt MC, Zamanipoor Najafabadi AH, Notting IC, Pereira AM, Verstegen MJT, Biermasz NR, et al. Towards a pituitary apoplexy classification based on clinical presentation and patient journey. Endocrine. 2022;76(1):132-141.
- Wong MB, Maamari RN, Couch SM. Contralateral eyelid elevation following unilateral upper eyelid retraction repair. Orbit. 2022;41(4):452-456.
- Zoumalan CI, Lisman RD. Evaluation and management of unilateral ptosis and avoiding contralateral ptosis. Aesthet Surg J. 2010;30(3):320-8.
- Davies MJ, Dolman PJ. Levator Muscle Enlargement in Thyroid Eye Disease-Related Upper Eyelid Retraction. Ophthalmic Plast Reconstr Surg. 2017;33(1):35-39.
- Shah SS, Patel BC. Enophthalmos. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Bartley GB, Gorman CA. Hepatic cirrhosis as a doubtful cause of eyelid retraction. Am J Ophthalmol. 1991;111(1):109-10.
- Slean GR, Silkiss RZ. Lenalidomide-Associated Thyroid-Related Eyelid Retraction. Ophthalmic Plast Reconstr Surg. 2018;34(2):e46-e48.
- Wiersinga WM, Eckstein AK, Žarković M. Thyroid eye disease (Graves’ orbitopathy): clinical presentation, epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2025;13(7):600-614.
- Şahlı E, Gündüz K. Thyroid-associated Ophthalmopathy. Turk J Ophthalmol. 2017;47(2):94-105.
- Ribeiro SF, Shekhovtsova M, Duarte AF, Velasco Cruz AA. Graves Lower Eyelid Retraction. Ophthalmic Plast Reconstr Surg. 2016;32(3):161-9.
- Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, et al. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol. 2021;185(4):G43-G67.
- Genere N, Stan MN. Current and Emerging Treatment Strategies for Graves’ Orbitopathy. Drugs. 2019;79(2):109-124.
- Damgacı L, Hayat B, Güreşçi S. Papillary Tumor of the Pineal Region with Parinaud Syndrome: A Case Report. Curr Med Imaging. 2020;16(8):1044-1047.
- Fetcko K, Dey M. Primary Central Nervous System Germ Cell Tumors: A Review and Update. Med Res Arch. 2018;6(3).
- Gnanapavan S, Sillery E, Acheson JF, Toosy AT. Parinaud’s syndrome - A rare presentation of clinically isolated syndrome. Mult Scler Relat Disord. 2014;3(3):398-401.
- Serino J, Martins J, Páris L, Duarte A, Ribeiro I. Parinaud’s syndrome due to an unilateral vascular ischemic lesion. Int Ophthalmol. 2015;35(2):275-9.
- Miyaishi M, Hemmi S, Hagiwara H, Murakami T, Sunada Y. [Collier’s sign in Miller Fisher syndrome]. Rinsho Shinkeigaku. 2006;46(10):712-4.
- Nejat F, Yazdani S, El Khashab M. Setting sun eye in normal healthy infants. Pediatr Neurosurg. 2008;44(3):190-2.
- Lee D, Lee GW, Yoon SH, Park JH, Kim SY. Congenital oculomotor nerve palsy with aberrant eyelid movements and pupillary spasms: a case report. BMC Ophthalmol. 2025;25(1):635.
- Nieto-Escamez F, Obrero-Gaitán E, Cortés-Pérez I. Visual Dysfunction in Parkinson’s Disease. Brain Sci. 2023;13(8).
- Grandas F, Esteban A. Eyelid motor abnormalities in progressive supranuclear palsy. J Neural Transm Suppl. 1994;42:33-41.
- Phokaewvarangkul O, Bhidayasiri R. How to spot ocular abnormalities in progressive supranuclear palsy? A practical review. Transl Neurodegener. 2019;8:20.
- Yoon WT, Chung EJ, Lee SH, Kim BJ, Lee WY. Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism. J Clin Neurol. 2005;1(2):159-65.
- Lee KC, Finley R, Miller B. Apraxia of lid opening: dose-dependent response to carbidopa-levodopa. Pharmacotherapy. 2004;24(3):401-3.
- Kataoka H, Sawada Y, Shimozato N, Inatomi S, Iguchi N, Yoshiji H, et al. Apraxia of eyelid opening might be critical for levodopa-carbidopa intestinal gel treatment. Clin Park Relat Disord. 2020;3:100073.
- Maamari RN, Custer PL, Neimkin MG, Couch SM. Medial canthoplasty for the management of exposure keratopathy. Eye (Lond). 2019;33(6):925-929.
- Yang J, Hu X, Li Q, Huang RL. Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy. J Craniofac Surg. 2023;34(5):e485-e488.
- Wabbels B, Förl M. [Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction]. Ophthalmologe. 2007;104(9):771-6.
- Young SM, Kim JH, Kim YD, Karnsiritanont V, Lang SS, Woo KI. Hyaluronic acid gel injection for dysthyroid upper eyelid retraction in Asian patients. Orbit. 2023;42(4):389-396.
- Desai A, Singh P, Rootman D, Naik MN. Management of Graves’ upper eyelid retraction (GUER): A review. Indian J Ophthalmol. 2025;73(2):164-172.
- Putterman AM. Surgical treatment of thyroid-related upper eyelid retraction. Graded Müller’s muscle excision and levator recession. Ophthalmology. 1981;88(6):507-12.
- Small RG. Upper eyelid retraction in Graves’ ophthalmopathy: a new surgical technique and a study of the abnormal levator muscle. Trans Am Ophthalmol Soc. 1988;86:725-93.
- Ueland HO, Uchermann A, Rødahl E. Levator recession with adjustable sutures for correction of upper eyelid retraction in thyroid eye disease. Acta Ophthalmol. 2014;92(8):793-7.
- Pushker N, Meel R, Bajaj MS. Levator-Muller’s recession using labial mucosa as a spacer in severe eyelid retraction. Can J Ophthalmol. 2019;54(6):678-681.
- Manna A, Mehta P, Ahluwalia H. Levator-Muller’s muscle recession with tarsorrhaphy: a technique for corneal protection in cases with cicatricial upper eyelid retraction. Orbit. 2013;32(3):190-3.
- Tao JP, Aakalu VK, Wladis EJ, Sobel RK, Freitag SK, Foster JA, et al. Bioengineered Acellular Dermal Matrix Spacer Grafts for Lower Eyelid Retraction Repair: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020;127(5):689-695.
- Scruggs JT, McGwin G Jr, Morgenstern KE. Use of Noncadaveric Human Acellular Dermal Tissue (BellaDerm) in Lower Eyelid Retraction Repair. Ophthalmic Plast Reconstr Surg. 2015;31(5):379-84.
- Dolar Bilge A. Lower eyelid retraction repair using autologous auricular scapha cartilage. Int Ophthalmol. 2024;44(1):313.
- Reich SG. Bell’s Palsy. Continuum (Minneap Minn). 2017;23(2, Selected Topics in Outpatient Neurology):447-466.
- Singh A, Deshmukh P. Bell’s Palsy: A Review. Cureus. 2022;14(10):e30186.
- Hohman MH, Warner MJ, Varacallo MA. Bell palsy. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Anderson CA, Sandberg E, Filley CM, Harris SL, Tyler KL. One and one-half syndrome with supranuclear facial weakness: magnetic resonance imaging localization. Arch Neurol. 1999;56(12):1509-11.
- Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, et al. Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg. 2013;149(3 Suppl):S1-27.
- Albers JR, Tamang S. Common questions about Bell palsy. Am Fam Physician. 2014;89(3):209-12.
- Kim SJ, Lee HY. Acute Peripheral Facial Palsy: Recent Guidelines and a Systematic Review of the Literature. J Korean Med Sci. 2020;35(30):e245.
- Gardner S, Garber L, Grossi J. Bell’s Palsy: Description, Diagnosis, and Current Management. Cureus. 2025;17(1):e77656.
- Tiemstra JD, Khatkhate N. Bell’s palsy: diagnosis and management. Am Fam Physician. 2007;76(7):997-1002.
- McCaul JA, Cascarini L, Godden D, Coombes D, Brennan PA, Kerawala CJ. Evidence based management of Bell’s palsy. Br J Oral Maxillofac Surg. 2014;52(5):387-91.
- Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK, Peleg AY. The benefits of steroids versus steroids plus antivirals for treatment of Bell’s palsy: a meta-analysis. BMJ. 2009;339:b3354.
- Fu X, Tang L, Wang C, Li M, Wu H, Li J, et al. A Network Meta-Analysis to Compare the Efficacy of Steroid and Antiviral Medications for Facial Paralysis from Bell´s Palsy. Pain Physician. 2018;21(6):559-569.
- Nakano H, Fujiwara T, Tsujimoto Y, Morishima N, Kasahara T, Ameya M, et al. Physical therapy for peripheral facial palsy: A systematic review and meta-analysis. Auris Nasus Larynx. 2024;51(1):154-160.
- Lin HW, Chen HC, Lin LF, Tam KW, Kuan YC. Laser therapy for Bell’s palsy: a systematic review and meta-analysis of randomized trials. Lasers Med Sci. 2024;39(1):282.
- Andresen NS, Sun DQ, Hansen MR. Facial nerve decompression. Curr Opin Otolaryngol Head Neck Surg. 2018;26(5):280-285.
- Fuzi J, Spencer S, Seckold E, Damiano S, Meller C. Bell’s palsy during pregnancy and the post-partum period: A contemporary management approach. Am J Otolaryngol. 2021;42(3):102914.
- Escalante DA, Malka RE, Wilson AG, Nygren ZS, Radcliffe KA, Ruhl DS, et al. Determining the Prognosis of Bell’s Palsy Based on Severity at Presentation and Electroneuronography. Otolaryngol Head Neck Surg. 2022;166(1):151-157.
- Bakshi SS, Ramesh S, Annam CS. Ramsay Hunt Syndrome. Am J Med. 2022;135(6):e125-e126.
- Khan YMT, Fatema N. Ramsay Hunt syndrome. Pan Afr Med J. 2019;34:201.
- Murphy B, Veras J, Kolli S, Formanowski B, Greenberg P, Kleinman L, et al. Seroprevalence of Lyme Disease in Children With Facial Nerve Palsy. J Child Neurol. 2024;39(9-10):310-316.
- Guez-Barber D, Swami SK, Harrison JB, McGuire JL. Differentiating Bell’s Palsy From Lyme-Related Facial Palsy. Pediatrics. 2022;149(6).
- Bruinsma RA, Smulders CA, Vermeeren YM, van Kooten B, Cats EA, van Hees B, et al. Acute facial nerve palsy in children in a Lyme disease-endemic area in the Netherlands. Eur J Clin Microbiol Infect Dis. 2021;40(11):2455-2458.
- Okumura R, Aoyama T, Oikawa J, Tamura T, Sai S. Facial palsy and subsequent posterior reversible encephalopathy syndrome due to Lyme disease. Pediatr Int. 2022;64(1):e15243.
- Miyamoto RC, Miyamoto RT. Pediatric neurotology. Semin Pediatr Neurol. 2003;10(4):298-303.
- Jančić J, Zeković J, Ćetković M, Nikolić B, Ivančević N, Vučević D, et al. Acute Peripheral Facial Nerve Palsy in Children and Adolescents: Clinical Aspects and Treatment Modalities. CNS Neurol Disord Drug Targets. 2023;22(9):1369-1377.
- Andina-Martínez D, Rodríguez-Palero S, Soto-Insuga V, Alonso-Cadenas JA, Bernardino-Cuesta B, Cartas-Carrión S, et al. Peripheral facial nerve palsy in children during the COVID-19 pandemic. Rev Neurol. 2022;74(11):361-366.
- Quesnel AM, Santos F. Evaluation and Management of Facial Nerve Schwannoma. Otolaryngol Clin North Am. 2018;51(6):1179-1192.
- Vrinceanu D, Dumitru M, Popa-Cherecheanu M, Marinescu AN, Patrascu OM, Bobirca F. Extracranial Facial Nerve Schwannoma-Histological Surprise or Therapeutic Planning?. Medicina (Kaunas). 2023;59(6).
- Damar M, Dinç AE, Şevik Eliçora S, Bişkin S, Erten G, Biz S. Facial Nerve Schwannoma of Parotid Gland: Difficulties in Diagnosis and Management. Case Rep Otolaryngol. 2016;2016:3939685.
- Ross L, Drazin D, Eboli P, Lekovic GP. Atypical tumors of the facial nerve: case series and review of the literature. Neurosurg Focus. 2013;34(3):E2.
- Patel A, Lofgren DH, Varacallo MA. Temporal fracture. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Habib SS, Al Rouq F, Meo I. Post-Traumatic Bilateral Facial Paralysis Associated with Temporal Bone Fracture. J Coll Physicians Surg Pak. 2015;25 Suppl 2:S132-3.
- Yadav S, Panda NK, Verma R, Bakshi J, Modi M. Surgery for post-traumatic facial paralysis: are we overdoing it?. Eur Arch Otorhinolaryngol. 2018;275(11):2695-2703.
- Srirangaramasamy J, Kathirvelu S. A Rare Case of Heerfordt’s Syndrome with Bilateral Facial Palsy. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 2):1027-1029.
- Kuang W, Luo X, Wang J, Zeng X. Research progress on Melkersson-Rosenthal syndrome. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021;50(2):148-154.
- Jung J, Park DC, Jung SY, Park MJ, Kim SH, Yeo SG. Bilateral facial palsy. Acta Otolaryngol. 2019;139(10):934-938.
- Suzuki C. [Fisher Syndrome]. Brain Nerve. 2024;76(5):508-514.
- Andreozzi V, D’arco B, Pagliano P, Toriello A, Barone P. Bilateral facial palsy after COVID-19 vaccination. Neurol Sci. 2022;43(7):4069-4079.
- House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93(2):146-7.
- Sanchez-Cuadrado I, Mato-Patino T, Morales-Puebla JM, Peñarrocha J, Diez-Sebastian J, Gavilán J, et al. Validation of the Spanish version of the Sunnybrook facial grading system. Eur Arch Otorhinolaryngol. 2023;280(2):543-548.
- Alagha MA, Ju X, Morley S, Ayoub AF. Mathematical Validation of the Modified Sunnybrook Facial Grading System Using Four-dimensional Imaging. J Plast Reconstr Surg. 2023;2(3):77-88.
- Banks CA, Bhama PK, Park J, Hadlock CR, Hadlock TA. Clinician-Graded Electronic Facial Paralysis Assessment: The eFACE. Plast Reconstr Surg. 2015;136(2):223e-230e.
- Custer PL. Ophthalmic management of the facial palsy patient. Semin Plast Surg. 2004;18(1):31-8.
- Sohrab M, Abugo U, Grant M, Merbs S. Management of the eye in facial paralysis. Facial Plast Surg. 2015;31(2):140-4.
- Nowak-Gospodarowicz I, Różycki R, Rękas M. Quality of Life in Patients with Unresolved Facial Nerve Palsy and Exposure Keratopathy Treated by Upper Eyelid Gold Weight Loading. Clin Ophthalmol. 2020;14:2211-2222.
- Píšová A, Chovanec M, Betka J, Ferrová K, Česká Burdová M, Odehnal M, et al. [The Tear Osmolarity of PATIENTS with Lagophthalmos]. Cesk Slov Oftalmol. 2016;72(5):172-176.
- Chiu SJ, Hickman SJ, Pepper IM, Tan JHY, Yianni J, Jefferis JM. Neuro-Ophthalmic Complications of Vestibular Schwannoma Resection: Current Perspectives. Eye Brain. 2021;13:241-253.
- Nosch DS, Käser E, Bracher T, Joos RE. Age-Related Changes in Corneal Sensitivity. Cornea. 2023;42(10):1257-1262.
- Yoshimura A, Araki-Sasaki K, Toyokawa N, Fujiwara R, Takahashi K, Gomi F. Synthetic rubber sheet to manage exposure keratopathy. Am J Ophthalmol Case Rep. 2021;23:101185.
- Mimouni M, Trinh T, Sorkin N, Cohen E, Santaella G, Rootman DS, et al. Sutureless dehydrated amniotic membrane for persistent epithelial defects. Eur J Ophthalmol. 2021.
- Golhait P, Gurnani B, Peseyie R. Persistent epithelial defect. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Özbek-Uzman S, Yalnız-Akkaya Z, Şingar Özdemir E, Burcu A. Treatment of persistent epithelial defects with single-dose autologous serum eye drops. Eur J Ophthalmol. 2022;32(4):2159-2165.
- Diaz-Valle D, Burgos-Blasco B, Rego-Lorca D, Puebla-Garcia V, Perez-Garcia P, Benitez-Del-Castillo JM, et al. Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea. Acta Ophthalmol. 2022;100(4):e912-e919.
- Grey F, Carley F, Biswas S, Tromans C. Scleral contact lens management of bilateral exposure and neurotrophic keratopathy. Cont Lens Anterior Eye. 2012;35(6):288-91.
- Gelles JD, Bekerman VP, Greenstein SA, Shafiq M, Hersh PS. Descemetocele Management With Therapeutic Scleral Lens Wear. Eye Contact Lens. 2021;47(5):314-316.
- Pflugfelder SC, Massaro-Giordano M, Perez VL, Hamrah P, Deng SX, Espandar L, et al. Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial. Ophthalmology. 2020;127(1):14-26.
- Dua HS, Said DG, Messmer EM, Rolando M, Benitez-Del-Castillo JM, Hossain PN, et al. Neurotrophic keratopathy. Prog Retin Eye Res. 2018;66:107-131.
- Mantelli F, Nardella C, Tiberi E, Sacchetti M, Bruscolini A, Lambiase A. Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management. Biomed Res Int. 2015;2015:805876.
- Yücel OE, Artürk N. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis. Ophthalmic Plast Reconstr Surg. 2012;28(4):256-60.
- Sharma N, Rana V, Tripathi AN, Kakati K. Hyaluronic Acid Dermal Filler for Inducing Mechanical Ptosis in Facial Nerve Palsy: A Novel Approach to Treat Exposure Keratopathy. Rom J Ophthalmol. 2025;69(1):28-35.
- Tzelikis PF, Diniz CM, Tanure MA, Trindade FC. [Tarsorrhaphy: applications in a Cornea Service]. Arq Bras Oftalmol. 2005;68(1):103-7.
- Maharjan SS, Pant AR, Joshi P, Shrestha P, Sharma R. Outcomes of Fungal Corneal Ulcer with Impending Perforation after Temporary Suture Tarsorrhaphy. Nepal J Ophthalmol. 2022;14(27):72-81.
- Ryu C, Chundury RV. Efficacy of the Buried Temporary Suture Tarsorrhaphy: A Novel Technique. Ophthalmic Plast Reconstr Surg. 2023;39(6):640-643.
- Bladen JC, Norris JH, Malhotra R. Cosmetic comparison of gold weight and platinum chain insertion in primary upper eyelid loading for lagophthalmos. Ophthalmic Plast Reconstr Surg. 2012;28(3):171-5.
- Malhotra R, Ziahosseini K, Poitelea C, Litwin A, Sagili S. Platinum segments: a new platinum chain for adjustable upper eyelid loading. Br J Ophthalmol. 2015;99(12):1680-5.
- Ben Artsi E, Ullrich K, Brusasco L, Malhotra R. Long-Term Outcomes of Upper Eyelid Loading with Platinum Segment Chains for Lagophthalmos: An Adjustable Approach. Am J Ophthalmol. 2020;214:188-195.
- Bladen JC, Norris JH, Malhotra R. Indications and outcomes for revision of gold weight implants in upper eyelid loading. Br J Ophthalmol. 2012;96(4):485-9.
- Wagh VK, Lim WS, Cascone NC, Morley AM. Post-septal upper eyelid loading for treatment of exposure keratopathy secondary to non-cicatricial lagophthalmos. Orbit. 2016;35(5):239-44.
- El Fahar MH, Zayed AE. A new sensory preservative plane for gold weight loading after paralytic lagophthalmos. J Plast Reconstr Aesthet Surg. 2023;84:365-367.
- Demirci H, Frueh BR. Palpebral spring in the management of lagophthalmos and exposure keratopathy secondary to facial nerve palsy. Ophthalmic Plast Reconstr Surg. 2009;25(4):270-5.
- Levine RE, Fay A. Re: “Palpebral spring in the management of lagophthalmos and exposure keratopathy secondary to facial nerve palsy”. Ophthalmic Plast Reconstr Surg. 2010;26(6):499-500.
- Verity DH, Collin JR. Eyelid reconstruction: the state of the art. Curr Opin Otolaryngol Head Neck Surg. 2004;12(4):344-8.
- Homer N, Fay A. Management of Long-Standing Flaccid Facial Palsy: Periocular Considerations. Otolaryngol Clin North Am. 2018;51(6):1107-1118.
- Boahene K. Reanimating the paralyzed face. F1000Prime Rep. 2013;5:49.
- Kim L, Byrne PJ. Controversies in Contemporary Facial Reanimation. Facial Plast Surg Clin North Am. 2016;24(3):275-97.
- Henstrom DK. Masseteric nerve use in facial reanimation. Curr Opin Otolaryngol Head Neck Surg. 2014;22(4):284-90.
- Caffaratti G, Giovannini SJM, Orfila D, Socolovsky M. Hemihypoglossal-Facial Nerve Transfer: Technical Description and Key Points: 2-Dimensional Operative Video. Oper Neurosurg. 2020;20(1):E53-E54.
- Liang H, Yang Z, Ma N, Wang W, Li Y. Comparison of Outcomes of Facial Reanimation Between the Use of Cross-facial Nerve Graft and the Masseteric Nerve as the Donor Nerve for Reinnervation of Gracilis Muscle Flap Transfer. J Craniofac Surg. 2024;35(1):172-176.
- Kim MJ, Kim HB, Jeong WS, Choi JW, Kim YK, Oh TS. Comparative Study of 2 Different Innervation Techniques in Facial Reanimation: Cross-face Nerve Graft-Innervated Versus Double-Innervated Free Gracilis Muscle Transfer. Ann Plast Surg. 2020;84(2):188-195.
- Kalra GS, Kalra S, Gupta S. Facial Reanimation Using Free Functional Muscle Transfer: Lessons Learnt From a Long Term Experience Comparing Innervation With Cross Facial Nerve Graft and Masseter Nerve. J Craniofac Surg. 2022;33(8):e791-e796.
- Weiss JBW, Spuerck F, Kollar B, Eisenhardt SU. Age-related outcome of facial reanimation surgery using cross face nerve graft and gracilis free functional muscle transfer-A retrospective cohort study. Microsurgery. 2022;42(6):557-567.
- Boahene K. Facial reanimation after acoustic neuroma resection: options and timing of intervention. Facial Plast Surg. 2015;31(2):103-9.
- Saad S, Labani S, Goemaere I, Cuyaubere R, Borderie M, Borderie V, et al. Corneal neurotization in the management of neurotrophic keratopathy: A review of the literature. J Fr Ophtalmol. 2023;46(1):83-96.
- Saini M, Jain A, Vanathi M, Kalia A, Saini K, Gupta P, et al. Current perspectives and concerns in corneal neurotization. Indian J Ophthalmol. 2024;72(10):1404-1411.
- Samoilă O, Samoilă L, Petrescu L. Corneal Neurotization, Recent Progress, and Future Perspectives. Biomedicines. 2025;13(4).
- Strianese A, Bolognesi F, Giannaccare G, de Ruvo V, Allevi F, Tarabbia F, et al. Long-term outcomes of sural nerve vertical cross-face graft for lacrimal gland neurotization in neurodeprivative dry eye. Graefes Arch Clin Exp Ophthalmol. 2025;263(4):1045-1049.
- Hwang CJ, Eftekhari K. Benign Essential Blepharospasm: What We Know and What We Don’t. Int Ophthalmol Clin. 2018;58(1):11-24.
- Zeppieri M, Patel BC. Benign essential blepharospasm. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, et al. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation. Am J Ophthalmol. 2014;157(3):591-7.e1-2.
- Zhao G, Wang J, Ma Q, Hao Y, Tian L, Jie Y. Comparison of upper eyelid pressure and ocular surface parameters in dry eye disease and benign essential Blepharospasm: A cross-sectional study. Cont Lens Anterior Eye. 2024;47(6):102298.
- Defazio G, Livrea P. Epidemiology of primary blepharospasm. Mov Disord. 2002;17(1):7-12.
- Sun Y, Tsai PJ, Chu CL, Huang WC, Bee YS. Epidemiology of benign essential blepharospasm: A nationwide population-based retrospective study in Taiwan. PLoS One. 2018;13(12):e0209558.
- Kilduff CL, Casswell EJ, Salam T, Hersh D, Ortiz-Perez S, Ezra D. Use of Alleviating Maneuvers for Periocular Facial Dystonias. JAMA Ophthalmol. 2016;134(11):1247-1252.
- Kulenkamp J, McClelland CM, Lee MS. Eye pain in the white and quiet eye. Curr Opin Ophthalmol. 2020;31(6):483-488.
- Schwingenschuh P, Katschnig P, Edwards MJ, Teo JT, Korlipara LV, Rothwell JC, et al. The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm. Neurology. 2011;76(7):610-4.
- Rocha Cabrero F, Kaur K. Apraxia of lid opening. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Cheng Q, Xiao H, Luo Y, Zhong L, Guo Y, Fan X, et al. Cortico-basal ganglia networks dysfunction associated with disease severity in patients with idiopathic blepharospasm. Front Neurosci. 2023;17:1159883.
- Jochim A, Li Y, Gora-Stahlberg G, Mantel T, Berndt M, Castrop F, et al. Altered functional connectivity in blepharospasm/orofacial dystonia. Brain Behav. 2018;8(1):e00894.
- Mantel T, Jochim A, Meindl T, Deppe J, Zimmer C, Li Y, et al. Thalamic structural connectivity profiles in blepharospam/Meige’s syndrome. Neuroimage Clin. 2022;34:103013.
- Glickman A, Nguyen P, Shelton E, Peterson DA, Berman BD. Basal ganglia and cerebellar circuits have distinct roles in blepharospasm. Parkinsonism Relat Disord. 2020;78:158-164.
- Grimm K, Prilop L, Schön G, Gelderblom M, Misselhorn J, Gerloff C, et al. Cerebellar Modulation of Sensorimotor Associative Plasticity Is Impaired in Cervical Dystonia. Mov Disord. 2023;38(11):2084-2093.
- Ma H, Qu J, Ye L, Shu Y, Qu Q. Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update. Front Neurol. 2021;12:630221.
- Zeppieri M, Ameer MA, Jahngir MU, Patel BC. Meige syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Gautam P, Bhatia MS, Kaur J, Rathi A. Meige’s syndrome. Ind Psychiatry J. 2016;25(2):232-233.
- Kizilkilic EK, Erener N, Meric M, Adatepe NU, Gunduz A. Risk of Spreading in Adult-onset Dystonia. Tremor Other Hyperkinet Mov (N Y). 2024;14:59.
- Evatt ML, Freeman A, Factor S. Adult-onset dystonia. Handb Clin Neurol. 2011;100:481-511.
- Velucci V, Di Lorenzo L, Erro R, Di Somma IM, Esposito M, Trinchillo A, et al. The relationship between occupation and specific forms of idiopathic adult-onset dystonia. Neurol Sci. 2025;46(10):5111-5121.
- Kinard K, Miller NR, Digre KB, Katz BJ, Crum AV, Warner JE. Blepharospasm in children and adolescents. Childs Nerv Syst. 2016;32(2):355-8.
- Sachdev P. Tardive blepharospasm. Mov Disord. 1998;13(6):947-51.
- Aia PG, Revuelta GJ, Cloud LJ, Factor SA. Tardive dyskinesia. Curr Treat Options Neurol. 2011;13(3):231-41.
- Byun YS, Kim SE, Paik JS, Yang SW. Increased pupillary constriction velocity in benign essential blepharospasm associated with photophobia. PLoS One. 2019;14(6):e0217924.
- Topcu H, Poslu Karademir F, Ulas MG, Kemer Atik B, Cetin Efe A, Serefoglu Cabuk K. Evaluation of Retinal and Choroidal Microvascularity in Patients with Benign Essential Blepharospasm. Curr Eye Res. 2025;50(4):431-436.
- Blackburn MK, Lamb RD, Digre KB, Smith AG, Warner JE, McClane RW, et al. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology. 2009;116(5):997-1001.
- Duarte GS, Rodrigues FB, Marques RE, Castelão M, Ferreira J, Sampaio C, et al. Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev. 2020;11(11):CD004900.
- Rayess YA, Awaida CJ, Jabbour SF, Ballan AS, Sleilati FH, Abou Zeid SM, et al. Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach. Rev Neurol (Paris). 2021;177(1-2):107-114.
- Karp BI, Alter K. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm. Semin Neurol. 2016;36(1):84-91.
- Tater P, Pandey S. Botulinum toxin in movement disorders. Neurol India. 2018;66(Supplement):S79-S89.
- Ayoub N. Botulinum Toxin Therapy: A Comprehensive Review on Clinical and Pharmacological Insights. J Clin Med. 2025;14(6).
- Mitsikostas DD, Dekundy A, Hanschmann A, Althaus M, Scheschonka A, Pagan F, et al. Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects. Curr Med Res Opin. 2021;37(10):1761-1768.
- Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M. Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry. 2002;72(4):459-62.
- Wohlfarth K, Kampe K, Bigalke H. Pharmacokinetic properties of different formulations of botulinum neurotoxin type A. Mov Disord. 2004;19 Suppl 8:S65-7.
- Jankovic J, Carruthers J, Naumann M, Ogilvie P, Boodhoo T, Attar M, et al. Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX(®)) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins (Basel). 2023;15(5).
- Namiguchi K, Mizoue S, Ohta K, Shiraishi A. Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm. Curr Eye Res. 2018;43(7):896-901.
- Yabumoto C, Osaki MH, Osaki T, Gameiro GR, Campos M, Osaki TH. Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections. Ophthalmic Plast Reconstr Surg. 2023;39(5):475-478.
- Lai CS, Wang YC, Ramachandran S, Chang YP, Huang SH, Hsieh MW. Selective Myectomy and Myotomy In Situ for the Management of Refractory Blepharospasm in Meige Syndrome. Ann Plast Surg. 2023;90(1 Suppl 1):S84-S88.
- Li MM, Cen ZM, Zhang H, Luo ZL. Surgical Myectomy and Myotomy for Refractory Blepharospasm in Meige Syndrome Patients: A Case Report. Clin Med Insights Case Rep. 2024;17:11795476241254266.
- Takahashi Y, Vaidya A, Lee PAL, Kono S, Kakizaki H. Disabling muscle of Riolan: A novel concept of orbicularis oculi myectomy for refractory benign essential blepharospasm. Eur J Ophthalmol. 2021;31(6):3411-3417.
- Doğan S, Yilmaz İE, Ari Ş. Effectiveness of Minimally Invasive Partial Orbicularis Myectomy for Treating Benign Essential Blepharospasm: A Study Using the Jankovic Scale and Blepharospasm Disability Index. Ophthalmic Plast Reconstr Surg. 2025;41(5):560-564.
- Sweeney AR, Dermarkarian CR, Williams KJ, Allen RC, Yen MT. Polytetrafluoroethylene frontalis suspension in blepharospasm with eyelid apraxia: an effective and well-tolerated adjunct to botulinum toxin therapy. Orbit. 2021;40(1):39-43.
- Lai CS, Ramachandran S, Lee CC, Lai YW, Chang YP, Huang SH. Evaluation of Blepharoptosis in Patients With Refractory Blepharospasm by VISA-Video Recordings, Idiosyncratic Expressions, Sensory Tricks, and Ancillary Procedures. Ann Plast Surg. 2023;90(5S Suppl 2):S172-S176.
- Sako W, Morigaki R, Mizobuchi Y, Tsuzuki T, Ima H, Ushio Y, et al. Bilateral pallidal deep brain stimulation in primary Meige syndrome. Parkinsonism Relat Disord. 2011;17(2):123-5.
- Kim HJ, Jeon B. Arching deep brain stimulation in dystonia types. J Neural Transm (Vienna). 2021;128(4):539-547.
- Aires A, Gomes T, Linhares P, Cunha F, Rosas MJ, Vaz R. The impact of deep brain stimulation on health related quality of life and disease-specific disability in Meige Syndrome (MS). Clin Neurol Neurosurg. 2018;171:53-57.
- Abbruzzese G, Berardelli A, Defazio G. Hemifacial spasm. Handb Clin Neurol. 2011;100:675-80.
- Batla A, Goyal C, Shukla G, Goyal V, Srivastava A, Behari M. Hemifacial spasm: clinical characteristics of 321 Indian patients. J Neurol. 2012;259(8):1561-5.
- Aktan D, Depierreux F. How to face the hemifacial spasm: challenges and misconceptions. Acta Neurol Belg. 2024;124(1):17-23.
- Lu AY, Yeung JT, Gerrard JL, Michaelides EM, Sekula RF Jr, Bulsara KR. Hemifacial spasm and neurovascular compression. ScientificWorldJournal. 2014;2014:349319.
- Lefaucheur JP. New insights into the pathophysiology of primary hemifacial spasm. Neurochirurgie. 2018;64(2):87-93.
- Sekiya T. Hemifacial spasm: a nodal, stretch-mediated paradigm beyond neurovascular compression. Br J Neurosurg. 2026.
- da Silva Martins WC, de Albuquerque LAF, de Carvalho GTC, Dourado JC, Dellaretti M, de Sousa AA. Tenth case of bilateral hemifacial spasm treated by microvascular decompression: Review of the pathophysiology. Surg Neurol Int. 2017;8:225.
- Potgieser AR, van Dijk JM, Elting JW, de Koning-Tijssen MA. [Facial tics and spasms]. Ned Tijdschr Geneeskd. 2014;158:A7615.
- Bacsi AM, Kiernan MC. Changes in axonal excitability and burst pattern behaviour in synkinesis. J Clin Neurosci. 2008;15(11):1288-90.
- Ozaki K, Higuchi Y, Nakano S, Horiguchi K, Yamakami I, Iwadate Y. Arachnoid cyst alone causes hemifacial spasm: illustrative case. J Neurosurg Case Lessons. 2022;3(15).
- Zhang X, Wang XH, Zhao H, Tang YD, Zhou P, Yuan Y, et al. Surgical Treatment of Secondary Hemifacial Spasm: Long-Term Follow-Up. World Neurosurg. 2019;125:e10-e15.
- Ardisana EF, Villalonga JF, Suárez MM, Campero A. Hemifacial spasm associated with trigeminal neuralgia secondary to trigeminal vascular compression. Neurocirugia (Engl Ed). 2025;36(1):69-73.
- Jia A, Dou NN, Zhong J. Microvascular decompression for pediatric-onset hemifacial spasm: case series and literature review. Childs Nerv Syst. 2022;38(7):1307-1312.
- Penchev P, Milanova-Ilieva D, Gaydarski L, Reghunathan K, Petrov PP, Stanchev P, et al. Microsurgical Resection vs Stereotactic Radiosurgery for Secondary Trigeminal Neuralgia Caused by Cerebellopontine Angle Tumors: A Systematic Review and Meta-Analysis with Meta-Regression. Neurosurg Rev. 2025;48(1):596.
- Duarte GS, Rodrigues FB, Castelão M, Marques RE, Ferreira J, Sampaio C, et al. Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev. 2020;11(11):CD004899.
- Tambasco N, Filidei M, Nigro P, Parnetti L, Simoni S. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies. Toxins (Basel). 2021;13(12).
- Jost WH, Laskawi R, Palmowski-Wolfe A, Spittau B, Urban PP. [Therapy of Hemifacial Spasm with Botulinum Toxin: an Update]. Fortschr Neurol Psychiatr. 2022;90(1-02):37-41.
- Maytharakcheep S, Bhidayasiri R. Botulinum toxin treatment for hemifacial spasm: harmonising neurological and aesthetic outcomes. J Neural Transm (Vienna). 2025;132(1):23-38.
- Wabbels B, Roggenkämper P. Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment. J Neural Transm (Vienna). 2012;119(8):963-80.
- Pandey S, Jain S. Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm. Neurol India. 2018;66(4):1036-1042.
- Wang C, Zhu X, Xia L, Xie P, Tian X, Shang J, et al. Botulinum toxin A improves psychological distress in patients with hemifacial spasm. Acta Neurol Belg. 2022;122(1):43-49.
- Holste K, Sahyouni R, Teton Z, Chan AY, Englot DJ, Rolston JD. Spasm Freedom Following Microvascular Decompression for Hemifacial Spasm: Systematic Review and Meta-Analysis. World Neurosurg. 2020;139:e383-e390.
- Suárez M, Ardisana E, Villalonga JF, Baldoncini M, Campero Á. [Microvascular decompression in hemifacial spasm: functional outcome]. Medicina (B Aires). 2024;84(6):1165-1172.
- Wang J, Chong Y, Jiang C, Dai Y, Liang W, Ding L. Microvascular decompression for hemifacial spasm involving the vertebral artery. Acta Neurochir (Wien). 2022;164(3):827-832.
- Lee S, Joo KM, Park K. Challenging Microvascular Decompression Surgery for Hemifacial Spasm. World Neurosurg. 2021;151:e94-e99.
- Deletis V, Ulkatan S. An improved methodology for intraoperative monitoring of the lateral spreading response during surgery for hemifacial spasm. Clin Neurophysiol. 2018;129(7):1457.
- Xu X, Su S, Cai L, Wang L, Fan H, Wu C, et al. Hemifacial Spasm Caused by Distal Neurovascular Compression Confirmed by Lateral Spread Response Monitoring. J Craniofac Surg. 2022;33(8):2555-2559.
- Kim M, Park SW, Lee HS, Park SK, Park K. Quantitative intraoperative lateral spread response amplitudes in hemifacial Spasm: Associations with vascular burden. Clin Neurophysiol. 2026;182:2111466.
- Xu L, Xu W, Wang J, Chong Y, Liang W, Jiang C. Persistent abnormal muscle response after microvascular decompression for hemifacial spasm. Sci Rep. 2020;10(1):18484.
- Lee JM, Park HR, Choi YD, Kim SM, Jeon B, Kim HJ, et al. Delayed facial palsy after microvascular decompression for hemifacial spasm: friend or foe?. J Neurosurg. 2018;129(2):299-307.
- Hua Z, Da TY, Hui WX, Tingting Y, Jin Z, Yan Y, et al. Delayed Facial Palsy After Microvascular Decompression for Hemifacial Spasm. J Craniofac Surg. 2016;27(3):781-3.
- Gunes IB. Association Between Eyelid Twitching and Digital Screen Time, Uncorrected Refractive Error, Intraocular Pressure, and Blood Electrolyte Imbalances. Cureus. 2024;16(9):e69249.
- Etemadifar M, Sabouri M, Zarepour M, Akhavan Sigari A, Salari M. Facial involvement in multiple sclerosis. Mult Scler Relat Disord. 2022;67:104110.
- Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, et al. Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. Mult Scler. 2014;20(7):843-7.
- Martí-Fàbregas J, Montero J, López-Villegas D, Quer M. Post-irradiation neuromyotonia in bilateral facial and trigeminal nerve distribution. Neurology. 1997;48(4):1107-9.
- Strupp M, Dieterich M, Brandt T, Feil K. Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia. Curr Treat Options Neurol. 2016;18(7):34.
- Kawasaki T, Fujitsu K, Ichikawa T, Miyahara K, Okada T, Tanino S, et al. Superior Oblique Myokymia: A Case Report of Surgical Treatment, Review of the Literature, and Consideration of Surgical Approach. World Neurosurg. 2019;131:197-199.
- Newman SA. Gaze-induced strabismus. Surv Ophthalmol. 1993;38(3):303-9.
- Kuroda M, Isozaki E, Matsubara S, Yoshida H, Hayashi H. [Case of ocular neuromyotonia with transient and gaze-induced diplopia]. Rinsho Shinkeigaku. 2007;47(6):344-7.
- Bower AS, Fisayo A, Baehring JM, Roy B. Clinical Reasoning: A 73-Year-Old Woman With Episodic Dysarthria and Horizontal Binocular Diplopia. Neurology. 2022;98(18):767-772.
- Suzuki Y, Kiyosawa M, Mochizuki M, Ishiwata K, Ishii K. The pre-supplementary and primary motor areas generate rhythm for voluntary eye opening and closing movements. Tohoku J Exp Med. 2010;222(2):97-104.
- McMonnies CW. The clinical and experimental significance of blinking behavior. J Optom. 2020;13(2):74-80.
- Kennelly KD. Clinical neurophysiology of cranial nerve disorders. Handb Clin Neurol. 2019;161:327-342.
- Coşkun Y, Fidanci H, Öztürk İ, Arlier Z. COVID-19 can cause blink reflex abnormalities. Ideggyogy Sz. 2022;75(5-06):199-205.
- Zadikoff C, Lang AE. Apraxia in movement disorders. Brain. 2005;128(Pt 7):1480-97.
- Huang XF, Hao XQ, Yin XX, Ren L, Wang D, Jin F, et al. Functional connectivity alterations in the frontoparietal network and sensorimotor network are associated with behavioral heterogeneity in blepharospasm. Front Neurol. 2023;14:1273935.
- Jiang W, Gan L, Sun Y, Dong M, Yu P. Apraxia of eyelid opening secondary to possible progressive supranuclear palsy: a case report. Int J Neurosci. 2021;131(7):708-710.
- Suzuki K, Nakamura T, Izawa N, Hashimoto K, Ouchi K, Aiba S, et al. [A 62-year-old woman presenting with progressive nonfluent aphasia, apraxia of eyelid opening, supranuclear gaze palsy, and asymmetric rigidity]. Brain Nerve. 2011;63(8):884-9.
- Pagonabarraga J, Horta-Barba A, Busteed L, Bejr-Kasem H, Illán-Gala I, Aracil-Bolaños I, et al. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy. Parkinsonism Relat Disord. 2021;85:63-68.
- Rana AQ, Kabir A, Dogu O, Patel A, Khondker S. Prevalence of blepharospasm and apraxia of eyelid opening in patients with parkinsonism, cervical dystonia and essential tremor. Eur Neurol. 2012;68(5):318-21.
- Kim MJ, Kim SJ, Kim BR, Lee J. Apraxia of eyelid opening after brain injury: a case report. Ann Rehabil Med. 2014;38(6):847-51.
- Krishnan S, Shetty K, Puthanveedu DK, Kesavapisharady K, Thulaseedharan JV, Sarma G, et al. Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease-Frequency, Risk Factors and Response to Treatment. Mov Disord Clin Pract. 2021;8(4):587-593.
- Tommasi G, Krack P, Fraix V, Pollak P. Effects of varying subthalamic nucleus stimulation on apraxia of lid opening in Parkinson’s disease. J Neurol. 2012;259(9):1944-50.
- Ting MA, Manta AI, Samia-Aly E, Lai M, de Carvalho ER, Buttery P, et al. Blepharospasm Secondary to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease: Clinical Characteristics and Management Outcomes. J Neuroophthalmol. 2024;44(4):517-522.
- Baizabal-Carvallo JF, Jankovic J. Movement disorders induced by deep brain stimulation. Parkinsonism Relat Disord. 2016;25:1-9.
- Bladen JC, Gill JS, Miszkiel K, Ezra DG. Stroke-induced resolution of primary blepharospasm: evidence for the lenticular nucleus as a control candidate. BMJ Case Rep. 2018;2018.
- Barbato G, Cirace F, Monteforte E, Costanzo A. Seasonal variation of spontaneous blink rate and beta EEG activity. Psychiatry Res. 2018;270:126-133.
- Hallett M. Clinical physiology of dopa dyskinesia. Ann Neurol. 2000;47(4 Suppl 1):S147-50; discussion S150-3.
- Nielsen JRW, Dietz M, Jefsen OH. Blink rates in patients with schizophrenia compared to healthy controls: A meta-analysis. Schizophr Res. 2025;279:87-93.
- Caplan R, Guthrie D. Blink rate in childhood schizophrenia spectrum disorder. Biol Psychiatry. 1994;35(4):228-34.
- Roberts JE, Symons FJ, Johnson AM, Hatton DD, Boccia ML. Blink rate in boys with fragile X syndrome: preliminary evidence for altered dopamine function. J Intellect Disabil Res. 2005;49(Pt 9):647-56.
- Baccega A, Garcia DM, Cruz AAV. Spontaneous Blinking Kinematics in Patients Who Have Undergone Autogeneous Fascia Frontalis Suspension. Curr Eye Res. 2017;42(9):1248-1253.
- Jie Y, Sella R, Feng J, Gomez ML, Afshari NA. Evaluation of incomplete blinking as a measurement of dry eye disease. Ocul Surf. 2019;17(3):440-446.
- Park J, Baek S. Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss. Acta Ophthalmol. 2019;97(5):e800-e806.
- Talens-Estarelles C, García-Marqués JV, Cerviño A, García-Lázaro S. Ocular surface predisposing factors for digital display-induced dry eye. Clin Exp Optom. 2023;106(4):373-379.
- Srivastav S, Basu S, Singh S. Tear film changes in symptomatic versus asymptomatic video display terminal users following computer challenge test. Ocul Surf. 2023;30:53-56.
- Kamøy B, Magno M, Nøland ST, Moe MC, Petrovski G, Vehof J, et al. Video display terminal use and dry eye: preventive measures and future perspectives. Acta Ophthalmol. 2022;100(7):723-739.
- Romeo MA, Coco G, Taloni A, Carnovale-Scalzo G, Scorcia V, Giannaccare G. Digital Applications for Videoterminal-Associated Dry Eye Disease. Vision (Basel). 2024;8(4).
- Arita R, Fukuoka S, Matsumoto R, Kaido M. Effects of blinking exercises on palpebral fissure height and tear film parameters. Ocul Surf. 2025;36:237-243.
- Kim AD, Muntz A, Lee J, Wang MTM, Craig JP. Therapeutic benefits of blinking exercises in dry eye disease. Cont Lens Anterior Eye. 2021;44(3):101329.
- Wolffsohn JS, Travé-Huarte S, Bahra I, Finch C, Anyaegbu U, Garcia-Porta N, et al. Optimisation of blinking exercises for dry eye disease. Cont Lens Anterior Eye. 2025;48(5):102453.
- Jung HY, Chung SJ, Hwang JM. Tic disorders in children with frequent eye blinking. J AAPOS. 2004;8(2):171-4.
- Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF. Tourette syndrome and tic disorders: a decade of progress. J Am Acad Child Adolesc Psychiatry. 2007;46(8):947-968.
- Han J, Jain S. Clinical Presentation and Prognosis of Common Movement Disorders. Prog Neurol Surg. 2018;33:25-40.
- Chen L, Chen X, Ke N, Pi L, Liu Q. Association between allergic conjunctivitis and provisional tic disorder in children. Int Ophthalmol. 2020;40(1):247-253.
- DAS S, Sreedharan RP, Remadevi PS, Saji CV. Psychogenic Blepharospasm: A Diagnostic Dilemma. Shanghai Arch Psychiatry. 2016;28(6):346-348.
- Bennett K, Diamond C, Hoeritzauer I, Gardiner P, McWhirter L, Carson A, et al. A practical review of functional neurological disorder (FND) for the general physician. Clin Med (Lond). 2021;21(1):28-36.
- Hayashi K, Asano R, Sato M, Nakaya Y, Suzuki A, Takaku N, et al. Efficacy of Trihexyphenidyl on Apraxia of Eyelid Opening in Parkinsonism: A Case Report. Cureus. 2024;16(3):e56232.
- Cardoso F. Botulinum toxin in parkinsonism: The when, how, and which for botulinum toxin injections. Toxicon. 2018;147:107-110.
- Dressler D, Karapantzou C, Rohrbach S, Schneider S, Laskawi R. Frontalis suspension surgery to treat patients with blepharospasm and eyelid opening apraxia: long-term results. J Neural Transm (Vienna). 2017;124(2):253-257.
- Karapantzou C, Dressler D, Rohrbach S, Laskawi R. Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results. Head Face Med. 2014;10:44.
- De Groot V, De Wilde F, Smet L, Tassignon MJ. Frontalis suspension combined with blepharoplasty as an effective treatment for blepharospasm associated with apraxia of eyelid opening. Ophthalmic Plast Reconstr Surg. 2000;16(1):34-8.
- Wang YC, Lai YW, Lee CC, Huang SH, Kuo YR, Lai CS. Extended frontalis orbicularis oculi muscle flap shortening for treating refractory apraxia of eyelid opening associated with blepharospasm. J Chin Med Assoc. 2023;86(10):935-939.
- Whitcup SM. The History of Botulinum Toxins in Medicine: A Thousand Year Journey. Handb Exp Pharmacol. 2021;263:3-10.
- Dressler D, Roggenkaemper P. A brief history of neurological botulinum toxin therapy in Germany. J Neural Transm (Vienna). 2017;124(10):1217-1221.
- Monheit GD, Pickett A. AbobotulinumtoxinA: A 25-Year History. Aesthet Surg J. 2017;37(suppl_1):S4-S11.
- Comella CL, Jankovic J, Hauser RA, Patel AT, Banach MD, Ehler E, et al. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology. 2024;102(4):e208091.
- Ellenbogen A, Xingyue H, Lingjing J, Banach M, Patel AT, Gross TM, et al. Efficacy and safety of DaxibotulinumtoxinA for injection in adults with cervical dystonia: Pooled global analysis of ASPEN-1 and ASPEN-1-CN randomized trials. Parkinsonism Relat Disord. 2025;140:108015.
- Sesardic D, Leung T, Gaines Das R. Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin. Biologicals. 2003;31(4):265-76.
- Sampaio C, Ferreira JJ, Simões F, Rosas MJ, Magalhães M, Correia AP, et al. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1. Mov Disord. 1997;12(6):1013-8.
- Han Y, Stevens AL, Dashtipour K, Hauser RA, Mari Z. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia. J Neurol. 2016;263(4):772-80.
- Rodrigues FB, Duarte GS, Marques RE, Castelão M, Ferreira J, Sampaio C, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2020;11(11):CD003633.
- Castelão M, Marques RE, Duarte GS, Rodrigues FB, Ferreira J, Sampaio C, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2017;12(12):CD003633.
- Hexsel D, Rutowitsch MS, de Castro LC, do Prado DZ, Lima MM. Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection. Dermatol Surg. 2009;35(6):933-9; discussion 940.
- Kalandakanond S, Coffield JA. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc. J Pharmacol Exp Ther. 2001;296(3):980-6.
- Gardner A, Tepp WH, Bradshaw M, Barbieri JT, Pellett S. Resolution of Two Steps in Botulinum Neurotoxin Serotype A1 Light Chain Localization to the Intracellular Plasma Membrane. Int J Mol Sci. 2021;22(20).
- Binenbaum G, Chang MY, Heidary G, Morrison DG, Trivedi RH, Galvin JA, et al. Botulinum Toxin Injection for the Treatment of Strabismus: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021;128(12):1766-1776.
- Gómez de Liaño R. The Use of Botulinum Toxin in Strabismus Treatment. J Binocul Vis Ocul Motil. 2019;69(2):51-60.
- Crouch ER. Use of botulinum toxin in strabismus. Curr Opin Ophthalmol. 2006;17(5):435-40.
- Mahan M, Engel JM. The resurgence of botulinum toxin injection for strabismus in children. Curr Opin Ophthalmol. 2017;28(5):460-464.
- Oke I, Elhusseiny AM, Shah AS, Hunter DG. Botulinum Toxin Injection of the Inferior Oblique Muscles for V-Pattern Strabismus and Primary Position Hypertropia. Am J Ophthalmol. 2022;235:32-37.
- Hofsli M, Torp-Pedersen TE, Sepstrup Lønkvist C, Saunte JP. Botulinum Toxin A Injection for Convergence Insufficiency. J Pediatr Ophthalmol Strabismus. 2023;60(2):108-113.
- Wagner RS. Strabismus Surgery Following Botulinum Injection for Infantile Esotropia. J Pediatr Ophthalmol Strabismus. 2024;61(4):228.
- Zong AM, Giannakakos VP, Delbourgo Patton C, Barmettler A. Botulinum Toxin Treatment in Thyroid Eye Disease: A Systematic Review and Meta-analysis. Ophthalmic Plast Reconstr Surg. 2025;41(3):250-257.
- Salour H, Bagheri B, Aletaha M, Babsharif B, Kleshadi M, Abrishami M, et al. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease. Orbit. 2010;29(2):114-8.
- Kandasamy S, Agrawal S, Pushker N, Meel R, Bajaj MS, Thirumurthy V, et al. Correlation of Levator-Muller’s Complex Thickness on Ultrasound Biomicroscopy to Botulinum Toxin A Injection in Thyroid-Related Upper Eyelid Retraction. J Ultrasound Med. 2023;42(2):399-408.
- Gusek-Schneider GC, Erbguth F. [Protective ptosis by botulinum A toxin injection in corneal affectations]. Klin Monbl Augenheilkd. 1998;213(1):15-22.
- Mathevon L, Declemy A, Laffont I, Perennou D. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review. Ann Phys Rehabil Med. 2019;62(4):241-251.
- Rahman E, Alhitmi HK, Mosahebi A. Immunogenicity to Botulinum Toxin Type A: A Systematic Review With Meta-Analysis Across Therapeutic Indications. Aesthet Surg J. 2022;42(1):106-120.
- Rahman E, Carruthers JDA. Immunogenicity of Botulinum Toxin A: Insights. Dermatol Surg. 2024;50(9S):S117-S126.
- Benecke R. Clinical relevance of botulinum toxin immunogenicity. BioDrugs. 2012;26(2):e1-9.
- Martin MU, Frevert J, Tay CM. Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity. Toxins (Basel). 2024;16(2).
- Kroumpouzos G, Silikovich F. Exploring Nonresponse to Botulinum Toxin in Aesthetics: Narrative Review of Key Trigger Factors and Effective Management Strategies. JMIR Dermatol. 2025;8:e69960.
- Wright E, Fetsko L. Botulinum Toxin Type A injections for pediatric spasticity: Keeping our patients informed and practices safe. J Pediatr Rehabil Med. 2021;14(2):199-211.
- Russo A, Iannone LF, Orologio I, Rivi V, Boccalini A, Lo Castro F, et al. Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review. Toxins (Basel). 2025;17(4).
- Edwards C, Borton R, Ross A, Molloy F. A Bespoke Electronic Health Journal for Monitoring Response to Botulinum Toxin in Treatment of Cervical Dystonia: Open-Label Observational Study of User Experience. JMIR Form Res. 2023;7:e45986.
- Robblee J, Patel JN. Approach to Eye Pain: Differential Diagnosis and Work Up for the Neurologist. Curr Neurol Neurosci Rep. 2025;25(1):48.
- Friedman DI. The Eye and Headache. Continuum (Minneap Minn). 2015;21(4 Headache):1109-17.
- Leston JM. [Functional anatomy of the trigeminal nerve]. Neurochirurgie. 2009;55(2):99-112.
- Crawford L, Midwinter M, Panizza B. Cadaveric Anatomical Study of Orbit-Preserving Ophthalmic Neurectomy via Endoscopic and Exoscopic Techniques. Head Neck. 2025;47(7):1878-1884.
- Pozo MA, Gallego R, Gallar J, Belmonte C. Blockade by calcium antagonists of chemical excitation and sensitization of polymodal nociceptors in the cat’s cornea. J Physiol. 1992;450:179-89.
- Fernández-Trillo J, Florez-Paz D, Íñigo-Portugués A, González-González O, Del Campo AG, González A, et al. Piezo2 Mediates Low-Threshold Mechanically Evoked Pain in the Cornea. J Neurosci. 2020;40(47):8976-8993.
- Luna C, Mizerska K, Quirce S, Belmonte C, Gallar J, Acosta MDC, et al. Sodium Channel Blockers Modulate Abnormal Activity of Regenerating Nociceptive Corneal Nerves After Surgical Lesion. Invest Ophthalmol Vis Sci. 2021;62(1):2.
- Kowtharapu BS, Stachs O. Corneal Cells: Fine-tuning Nerve Regeneration. Curr Eye Res. 2020;45(3):291-302.
- Brennan NA, Bruce AS. Esthesiometry as an indicator of corneal health. Optom Vis Sci. 1991;68(9):699-702.
- Villalba M, Sabates V, Ghalibafan S, Perez V, Swaminathan S, Sabater A. Detection of Subclinical Neurotrophic Keratopathy by Non-Contact Esthesiometry. Res Sq. 2023.
- Lv X, Wu Z, Li Y. Innervation of the cerebral dura mater. Neuroradiol J. 2014;27(3):293-8.
- Levy D, Moskowitz MA. Meningeal Mechanisms and the Migraine Connection. Annu Rev Neurosci. 2023;46:39-58.
- Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA. Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol. 2019;18(8):795-804.
- Iyengar S, Johnson KW, Ossipov MH, Aurora SK. CGRP and the Trigeminal System in Migraine. Headache. 2019;59(5):659-681.
- Veerapaneni KD, Kapoor N, Veerapaneni P, Lui F, Nalleballe K. Trigeminal neuropathy. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Hyung JW, Son BC. Generalized Extension of Referred Trigeminal Pain due to Greater Occipital Nerve Entrapment. Case Rep Neurol Med. 2023;2023:1099222.
- Son BC, Lee C. Ipsilateral Limb Extension of Referred Trigeminal Facial Pain due to Greater Occipital Nerve Entrapment: A Case Report. Case Rep Neurol Med. 2022;2022:9381881.
- Ko HC, Choi JG, Son BC. Hemifacial Trigeminal Pain Referred from Occipital Neuralgia Due to Compression of the Greater Occipital Nerve by the Occipital Artery. J Neurol Surg A Cent Eur Neurosurg. 2018;79(5):442-446.
- Lee J, Park W, Choi J, Lee G, Ma S, Lee S, et al. Effect of Repeated Greater Occipital Nerve Block in Patients with Ocular Neuropathic Pain: A Retrospective Observational Study. J Clin Med. 2023;12(23).
- Schwarz A, Luedtke K, Schöttker-Königer T. Only cervical vertebrae C0-C2, not C3 are relevant for subgrouping migraine patients according to manual palpation and pain provocation: secondary analysis of a cohort study. BMC Musculoskelet Disord. 2022;23(1):379.
- Moshirfar M, Benstead EE, Sorrentino PM, Tripathy K. Ocular neuropathic pain. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Liu C, Lin MT, Lee IXY, Wong JHF, Lu D, Lam TC, et al. Neuropathic Corneal Pain: Tear Proteomic and Neuromediator Profiles, Imaging Features, and Clinical Manifestations. Am J Ophthalmol. 2024;265:6-20.
- Mandić Z, Novak-Laus K, Lacmanović Loncar V, Petric Vicković I, Reiner ET, Iveković R, et al. [Ophthalmological causes of headache]. Acta Med Croatica. 2008;62(2):211-8.
- Khazaeni B, Zeppieri M, Khazaeni L. Acute angle-closure glaucoma. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Benson WE. Posterior scleritis. Surv Ophthalmol. 1988;32(5):297-316.
- Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza MT, Foster CS. Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases. Ophthalmology. 2012;119(7):1460-4.
- Guier CP, Kaur K, Stokkermans TJ. Optic neuritis. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Pareja JA, Sánchez del Río M. Primary trochlear headache and other trochlear painful disorders. Curr Pain Headache Rep. 2006;10(4):316-20.
- Tran TM, McClelland CM, Lee MS. Diagnosis and Management of Trochleodynia, Trochleitis, and Trochlear Headache. Front Neurol. 2019;10:361.
- Collado Sánchez L, Munuera I, Rodrigo Sanjuán MJ, Garcia-Martin E. Orbital trochleitis: Literature review. Arch Soc Esp Oftalmol (Engl Ed). 2024;99(10):436-449.
- Jaimes A, Gómez A, Pajares O, Rodríguez-Vico J. OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series. Headache. 2024;64(5):589-594.
- Ashina S, Mitsikostas DD, Lee MJ, Yamani N, Wang SJ, Messina R, et al. Tension-type headache. Nat Rev Dis Primers. 2021;7(1):24.
- Ashina S, Terwindt GM, Steiner TJ, Lee MJ, Porreca F, Tassorelli C, et al. Medication overuse headache. Nat Rev Dis Primers. 2023;9(1):5.
- Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 2019;92(3):134-144.
- Kelly M, Strelzik J, Langdon R, DiSabella M. Pediatric headache: overview. Curr Opin Pediatr. 2018;30(6):748-754.
- Abend NS, Younkin D. Medical causes of headache in children. Curr Pain Headache Rep. 2007;11(5):401-7.
- Frohman L, Wong AB, Matheos K, Leon-Alvarado LG, Danesh-Meyer HV. New developments in giant cell arteritis. Surv Ophthalmol. 2016;61(4):400-21.
- Guggenberger K, Bley T. Imaging in Large Vessel Vasculitides. Rofo. 2019;191(12):1083-1090.
- Ferrari MD, Goadsby PJ, Burstein R, Kurth T, Ayata C, Charles A, et al. Migraine. Nat Rev Dis Primers. 2022;8(1):2.
- Pescador Ruschel MA, De Jesus O. Migraine headache. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501-514.
- Aguilar-Shea AL, Membrilla Md JA, Diaz-de-Teran J. Migraine review for general practice. Aten Primaria. 2022;54(2):102208.
- Kowa H, Nakashima K. [Cortical spreading depression and molecular genetics in migraine]. Rinsho Shinkeigaku. 2012;52(11):1006-8.
- Dalla Volta G, Russo A, Silvestro M, Ornello R, Caponnetto V, Sacco S, et al. Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study. Cephalalgia. 2024;44(11):3331024241299453.
- Bidot S, Biotti D. Transient monocular blindness: Vascular causes and differential diagnoses. J Fr Ophtalmol. 2018;41(4):e129-e136.
- Chojdak-Łukasiewicz J, Dziadkowiak E. Visual Snow Syndrome in Patient with Migraine: Case Report and Literature Review. J Clin Med. 2024;13(5).
- Vongvaivanich K, Lertakyamanee P, Silberstein SD, Dodick DW. Late-life migraine accompaniments: A narrative review. Cephalalgia. 2015;35(10):894-911.
- Freedom T, Jay WM. Migraine with and without headache. Semin Ophthalmol. 2003;18(4):210-7.
- Yamani N, Chalmer MA, Olesen J. Migraine with brainstem aura: defining the core syndrome. Brain. 2019;142(12):3868-3875.
- Kaniecki R. Migraine with brainstem aura. Handb Clin Neurol. 2024;199:367-379.
- Kadian R, Shankar Kikkeri N, Kumar A. Basilar migraine. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Yang D, Zhang C, Omran SS, Cucchiara B, Rundek T, Wright CB, et al. Basilar artery curvature is associated with migraine with aura in the Northern Manhattan Study. J Neurol Sci. 2022;432:120073.
- Seok HY, Eun MY. Ophthalmoplegic Migraine: A Misnomer of Recurrent Painful Ophthalmoplegic Neuropathy. Neurol India. 2022;70(4):1759.
- Aleksic DZ, Drakulic SM, Ljubisavljevic S. Recurrent Painful Ophthalmoplegic Neuropathy: Migraine, Neuralgia, or Something Else?. J Oral Facial Pain Headache. 2020;34(4):374-378.
- Devos J, Nysten C, Buyse G, Cassiman C, Demaerel P. Neuro-image: recurrent painful ophthalmoplegic neuropathy. Acta Neurol Belg. 2021;121(5):1331-1333.
- Yan Y, Zhang B, Lou Z, Liu K, Lou M, Ding M, et al. A Case of Recurrent Painful Ophthalmoplegic Neuropathy. Front Neurol. 2020;11:440.
- Cameron C, Kelly S, Hsieh SC, Murphy M, Chen L, Kotb A, et al. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Headache. 2015;55 Suppl 4:221-35.
- Khoo CC, Liu CC, Lu M, Huang YC, Weng HY. Acute and preventive treatment of menstrual migraine: a meta-analysis. J Headache Pain. 2024;25(1):143.
- Chanchlani R, Agrawal A, Janjua D, Hafsa SN. The Efficacy of Different Triptans for the Treatment of Acute Headache in Pediatric Migraine: A Systematic Review. Indian Pediatr. 2023;60(8):663-671.
- DeJulio PA, Perese JK, Schuster NM, Oswald JC. Lasmiditan for the acute treatment of migraine. Pain Manag. 2021;11(5):437-449.
- Mecklenburg J, Raffaelli B, Neeb L, Sanchez Del Rio M, Reuter U. The potential of lasmiditan in migraine. Ther Adv Neurol Disord. 2020;13:1756286420967847.
- Knievel K, Buchanan AS, Lombard L, Baygani S, Raskin J, Krege JH, et al. Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans. Cephalalgia. 2020;40(1):19-27.
- Yu T, He L, Yang X, Zhou J, Luo G, Wang H, et al. Efficacy and Safety of Lasmiditan as a Novel Acute Treatment in Chinese Patients with Migraine: A Subpopulation Analysis of the Randomized Controlled Phase 3 CENTURION Trial. Neurol Ther. 2022;11(3):1269-1283.
- Lipton RB, Blumenfeld A, Jensen CM, Croop R, Thiry A, L’Italien G, et al. Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials. Cephalalgia. 2023;43(2):3331024221141686.
- Moreno-Ajona D, Villar-Martínez MD, Goadsby PJ. New Generation Gepants: Migraine Acute and Preventive Medications. J Clin Med. 2022;11(6).
- Yang CP, Liang CS, Chang CM, Yang CC, Shih PH, Yau YC, et al. Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021;4(10):e2128544.
- Puledda F, Younis S, Huessler EM, Haghdoost F, Lisicki M, Goadsby PJ, et al. Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature. Cephalalgia. 2023;43(3):3331024231151419.
- Laohapiboolrattana W, Jansem P, Anukoolwittaya P, Roongpiboonsopit D, Hiransuthikul A, Pongpitakmetha T, et al. Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis. J Headache Pain. 2024;25(1):194.
- Cortel-LeBlanc MA, Orr SL, Dunn M, James D, Cortel-LeBlanc A. Managing and Preventing Migraine in the Emergency Department: A Review. Ann Emerg Med. 2023;82(6):732-751.
- Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1337-45.
- Ailani J, Burch RC, Robbins MS. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021-1039.
- Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, et al. Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93(11):500-509.
- Tseng PT, Zeng BY, Chen JJ, Kuo CH, Zeng BS, Kuo JS, et al. High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis. Adv Nutr. 2024;15(2):100163.
- Sacco S, Amin FM, Ashina M, Bendtsen L, Deligianni CI, Gil-Gouveia R, et al. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update. J Headache Pain. 2022;23(1):67.
- Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, Mitsikostas DD. Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis. Cephalalgia. 2021;41(7):851-864.
- Sevivas H, Fresco P. Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review. Eur J Med Res. 2022;27(1):86.
- Sun W, Cheng H, Xia B, Liu X, Li Y, Wang X, et al. Comparative Efficacy and Safety of Five Anti-calcitonin Gene-related Peptide Agents for Migraine Prevention: A Network Meta-analysis. Clin J Pain. 2023;39(10):560-569.
- Kokoti L, Drellia K, Papadopoulos D, Mitsikostas DD. Placebo and nocebo phenomena in anti- CGRP monoclonal antibody trials for migraine prevention: a meta-analysis. J Neurol. 2020;267(4):1158-1170.
- Vernieri F, Iannone LF, Lo Castro F, Sebastianelli G, De Santis F, Corrado M, et al. Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study). Cephalalgia. 2025;45(4):3331024251335927.
- Voudris KV, Poulin MF, Kavinsky CJ. Updates on Patent Foramen Ovale (PFO) Closure. Curr Cardiol Rep. 2024;26(7):735-746.
- Alakbarzade V, Keteepe-Arachi T, Karsan N, Ray R, Pereira AC. Patent foramen ovale. Pract Neurol. 2020;20(3):225-233.
- Noseda R, Copenhagen D, Burstein R. Current understanding of photophobia, visual networks and headaches. Cephalalgia. 2019;39(13):1623-1634.
- Noseda R, Burstein R. Advances in understanding the mechanisms of migraine-type photophobia. Curr Opin Neurol. 2011;24(3):197-202.
- Nagata E, Takao M, Toriumi H, Suzuki M, Fujii N, Kohara S, et al. Hypersensitivity of Intrinsically Photosensitive Retinal Ganglion Cells in Migraine Induces Cortical Spreading Depression. Int J Mol Sci. 2024;25(14).
- Diel RJ, Mehra D, Kardon R, Buse DC, Moulton E, Galor A. Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway. Br J Ophthalmol. 2021;105(6):751-760.
- Md Isa NA, Krishnan AV, Zagami AS, Tummanapalli SS, Spira K, Papas EB, et al. A randomized crossover trial: The impact of ocular lubrication on migraine severity in persons with dry eye disease and migraine. Optom Vis Sci. 2025;102(4):183-188.
- Mallick J, Devi L, Malik PK, Mallick J. Update on Normal Tension Glaucoma. J Ophthalmic Vis Res. 2016;11(2):204-8.
- Anderson DR. Normal-tension glaucoma (Low-tension glaucoma). Indian J Ophthalmol. 2011;59 Suppl(Suppl1):S97-101.
- Eller M, Goadsby PJ. Trigeminal autonomic cephalalgias. Oral Dis. 2016;22(1):1-8.
- Goadsby PJ. Trigeminal autonomic cephalalgias. Continuum (Minneap Minn). 2012;18(4):883-95.
- Burish M. Cluster Headache and Other Trigeminal Autonomic Cephalalgias. Continuum (Minneap Minn). 2018;24(4, Headache):1137-1156.
- Burish M. Cluster Headache, SUNCT, and SUNA. Continuum (Minneap Minn). 2024;30(2):391-410.
- Schulte LH, Haji AA, May A. Phase dependent hypothalamic activation following trigeminal input in cluster headache. J Headache Pain. 2020;21(1):30.
- Wu JW, Chen ST, Wang YF, Lai KL, Chen TY, Chen SP, et al. Sphenopalatine ganglion volumetry in episodic cluster headache: from symptom laterality to cranial autonomic symptoms. J Headache Pain. 2023;24(1):2.
- May A, Schwedt TJ, Magis D, Pozo-Rosich P, Evers S, Wang SJ. Cluster headache. Nat Rev Dis Primers. 2018;4:18006.
- Ljubisavljevic S, Zidverc Trajkovic J. Cluster headache: pathophysiology, diagnosis and treatment. J Neurol. 2019;266(5):1059-1066.
- San-Juan D, Velez-Jimenez K, Hoffmann J, Martínez-Mayorga AP, Melo-Carrillo A, Rodríguez-Leyva I, et al. Cluster headache: an update on clinical features, epidemiology, pathophysiology, diagnosis, and treatment. Front Pain Res (Lausanne). 2024;5:1373528.
- Havelius U. A Horner-like syndrome and cluster headache. What comes first?. Acta Ophthalmol Scand. 2001;79(4):374-5.
- Ghosh A, Silva E, Burish MJ. Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis. Cephalalgia. 2021;41(13):1382-1395.
- Borrelli A, Valeriani M, Monte G, Ursitti F, Proietti Checchi M, Tarantino S, et al. Cluster Headache: Diagnosis, Management, and Treatment in Pediatric Headache. J Clin Med. 2024;13(5).
- Bahra A. Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment. Cephalalgia. 2023;43(11):3331024231214239.
- Osman C, Bahra A. Paroxysmal Hemicrania. Ann Indian Acad Neurol. 2018;21(Suppl 1):S16-S22.
- VanderPluym J. Indomethacin-responsive headaches. Curr Neurol Neurosci Rep. 2015;15(2):516.
- Goadsby PJ. Indomethacin-Responsive Headache Disorders. Continuum (Minneap Minn). 2024;30(2):488-497.
- Chan TLH, Hindiyeh N. Hemicrania continua: Indomethacin induced myoclonus. Clin Neurol Neurosurg. 2021;206:106703.
- Prakash S, Adroja B. Hemicrania Continua. Ann Indian Acad Neurol. 2018;21(Suppl 1):S23-S30.
- Kang MK, Cho SJ. SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update. Cephalalgia. 2024;44(2):3331024241232256.
- Levy A, Matharu MS. Short-Lasting Unilateral Neuralgiform Headache Attacks. Ann Indian Acad Neurol. 2018;21(Suppl 1):S31-S38.
- Al Khalili Y, Patel J, Veerapaneni KD. Short-lasting unilateral neuralgiform headache. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Smit RD, Mouchtouris N, Kang K, Reyes M, Sathe A, Collopy S, et al. Short-lasting unilateral neuralgiform headache attacks (SUNCT/SUNA): a narrative review of interventional therapies. J Neurol Neurosurg Psychiatry. 2023;94(1):49-56.
- Steel SJ, Robertson CE, Whealy MA. Current Understanding of the Pathophysiology and Approach to Tension-Type Headache. Curr Neurol Neurosci Rep. 2021;21(10):56.
- Onan D, Younis S, Wellsgatnik WD, Farham F, Andruškevičius S, Abashidze A, et al. Debate: differences and similarities between tension-type headache and migraine. J Headache Pain. 2023;24(1):92.
- Cumplido-Trasmonte C, Fernández-González P, Alguacil-Diego IM, Molina-Rueda F. Manual therapy in adults with tension-type headache: A systematic review. Neurologia (Engl Ed). 2021;36(7):537-547.
- Gosalia H, Moreno-Ajona D, Goadsby PJ. Medication-overuse headache: a narrative review. J Headache Pain. 2024;25(1):89.
- Murray D, Dilli E. Primary Stabbing Headache. Curr Neurol Neurosci Rep. 2019;19(7):47.
- Pareja JA, Sjaastad O. Primary stabbing headache. Handb Clin Neurol. 2010;97:453-7.
- Chua AL, Nahas S. Ice Pick Headache. Curr Pain Headache Rep. 2016;20(5):30.
- Bahra A. Other primary headaches-thunderclap-, cough-, exertional-, and sexual headache. J Neurol. 2020;267(5):1554-1566.
- Maynard P, Pace A. Primary Headache Associated with Sexual Activity: A Review of the Literature. Curr Pain Headache Rep. 2024;28(7):627-632.
- May A, Evers S, Goadsby PJ, Leone M, Manzoni GC, Pascual J, et al. European Academy of Neurology guidelines on the treatment of cluster headache. Eur J Neurol. 2023;30(10):2955-2979.
- Diener HC, May A. Drug Treatment of Cluster Headache. Drugs. 2022;82(1):33-42.
- Brandt RB, Doesborg PGG, Haan J, Ferrari MD, Fronczek R. Pharmacotherapy for Cluster Headache. CNS Drugs. 2020;34(2):171-184.
- Donnet A, Valade D, Fontaine D. [Cluster headache treatment]. Presse Med. 2015;44(11):1188-92.
- Peng KP, Burish MJ. Management of cluster headache: Treatments and their mechanisms. Cephalalgia. 2023;43(8):3331024231196808.
- Yang FC, Tsai CL, Lin GY, Yang CP, Chen WT. Acute and preventive medical treatment of cluster headache in Taiwan: A narrative review. J Chin Med Assoc. 2024;87(10):912-919.
- Krymchantowski A, Jevoux C, Piovesan ÉJ, Valença MM, Kowacs F, Kowacs PA, et al. Cluster headache and galcanezumab: the first real-world Brazilian study and an expert consensus on its use among other treatments. J Headache Pain. 2024;25(1):211.
- Kashiwagi K, Katsuki M, Kawamura S, Tachikawa S, Ono A, Koh A. Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases. Neurol Int. 2023;15(1):318-324.
- Fontaine D, Santucci S, Lanteri-Minet M. Managing cluster headache with sphenopalatine ganglion stimulation: a review. J Pain Res. 2018;11:375-381.
- Kollenburg L, Arnts H, Heitkamp M, Geerts S, Robinson C, Dominguez M, et al. Occipital nerve stimulation for cluster headache: lessons to learn from the ‘voltage tuners’. J Headache Pain. 2024;25(1):139.
- Bulsei J, Leplus A, Donnet A, Regis J, Lucas C, Buisset N, et al. Occipital Nerve Stimulation for Refractory Chronic Cluster Headache: A Cost-Effectiveness Study. Neuromodulation. 2021;24(6):1083-1092.
- Lansbergen CS, Fronczek R, Wilbrink LA, Cohen SP, de Vos CC, Huygen FJPM. 15. Cluster Headache. Pain Pract. 2025;25(5):e70050.
- Cittadini E, Matharu MS. Symptomatic trigeminal autonomic cephalalgias. Neurologist. 2009;15(6):305-12.
- Long RJ, Zhu YS, Wang AP. Cluster headache due to structural lesions: A systematic review of published cases. World J Clin Cases. 2021;9(14):3294-3307.
- Edvardsson B. Symptomatic cluster headache: a review of 63 cases. Springerplus. 2014;3:64.
- Edvardsson B. Cluster headache associated with acute maxillary sinusitis. Springerplus. 2013;2:509.
- Treatment Guideline Subcommittee of the Taiwan Headache Society. [Neuroimaging guidelines in nonacute headaches]. Acta Neurol Taiwan. 2010;19(2):137-44.
- Potter R, Probyn K, Bernstein C, Pincus T, Underwood M, Matharu M. Diagnostic and classification tools for chronic headache disorders: A systematic review. Cephalalgia. 2019;39(6):761-784.
- Friedman DI. Headaches Due to Low and High Intracranial Pressure. Continuum (Minneap Minn). 2018;24(4, Headache):1066-1091.
- Wall M. Update on Idiopathic Intracranial Hypertension. Neurol Clin. 2017;35(1):45-57.
- Togni C, Fierz F, Pohl H, Weber KP, Wegener S. [CME: Idiopathic Intracranial Hypertension]. Praxis (Bern 1994). 2022;111(5):250-258.
- Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492-5.
- Pandey A, Schreiber C, Garton ALA, Araveti N, Goldberg JL, Kocharian G, et al. Foundations of the Diagnosis and Management of Idiopathic Intracranial Hypertension and Pulsatile Tinnitus. World Neurosurg. 2024;184:361-371.
- Mollan SP, Wakerley BR, Alimajstorovic Z, Mitchell J, Ottridge R, Yiangou A, et al. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):118.
- De Simone R, Sansone M, Bonavita V. Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain?. Neurol Sci. 2020;41(Suppl 2):417-421.
- Değerliyurt A, Teber S, Karakaya G, Güven A, Şeker ED, Arhan EP, et al. Pseudotumor cerebri/idiopathic intracranial hypertension in children: an experience of a tertiary care hospital. Brain Dev. 2014;36(8):690-9.
- Dotan G, Hadar Cohen N, Qureshi HM, Shapira Rootman M, Nevo Y, Kershenovich A. External lumbar drainage in progressive pediatric idiopathic intracranial hypertension. J Neurosurg Pediatr. 2021;28(4):490-496.
- Tian T. Clinical Characteristics of Patients With Idiopathic Intracranial Hypertension in China. Cureus. 2024;16(7):e64990.
- Pal A, Sengupta P, Biswas D, Sen C, Mukherjee A, Pal S. Pattern of Idiopathic Intracranial Hypertension in Indian Population. Ann Indian Acad Neurol. 2019;22(1):47-51.
- Shaia JK, Rock JR, Singh RP, Talcott KE, Cohen DA. Drug-Induced Intracranial Hypertension: The Adverse Effects of Acne Medications and Topical Retinoids. J Neuroophthalmol. 2025;45(2):177-182.
- Gutkind NE, Tse DT, Johnson TE, Tse BC. Idiopathic Intracranial Hypertension in Female-to-Male Transgender Patients on Exogenous Testosterone Therapy. Ophthalmic Plast Reconstr Surg. 2023;39(5):449-453.
- Aaron S, Arthur A, Prabakhar AT, Mannam P, Shyamkumar NK, Mani S, et al. Spectrum of Visual Impairment in Cerebral Venous Thrombosis: Importance of Tailoring Therapies Based on Pathophysiology. Ann Indian Acad Neurol. 2017;20(3):294-301.
- Chen JJ, Bhatti MT. Papilledema. Int Ophthalmol Clin. 2019;59(3):3-22.
- Supuran CT. Acetazolamide for the treatment of idiopathic intracranial hypertension. Expert Rev Neurother. 2015;15(8):851-6.
- Nicolaou D, Nicolaou N, Douglas LM, Christou S. The Role of Exenatide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, in Idiopathic Intracranial Hypertension and Polycystic Ovary Syndrome: A Case Report. Cureus. 2025;17(10):e93846.
- Lagrèze WA, Gross N, Biermann J, Joachimsen L. [Indications and technique for transconjunctival optic nerve sheath fenestration : Video article]. Ophthalmologe. 2017;114(10):953-958.
- Lagrèze WA. [Indications and technique of optic nerve sheath fenestration]. Ophthalmologe. 2009;106(5):452-6.
- Patrick MM, Postma GK, Bielling RAH, Trokthi B, Carey AR, Maitland CG. Orthostatic Hemifacial Spasm in Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2024;44(4):523-526.
- Tubben RE, Jain S, Murphy PB. Epidural blood patch. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Jafari E, Karaminia M, Togha M. Early and Delayed Rebound Intracranial Hypertension following Epidural Blood Patch in a Case of Spontaneous Intracranial Hypotension. Case Rep Neurol Med. 2022;2022:5637276.
- Shiwlochan D, Ohanyan S, Rajput K. It Is Just a Blood Patch: Considerations for Patients with Preexisting Intracranial Hypertension. Case Rep Anesthesiol. 2020;2020:8365296.
- Sunohara Y, Nagashima Y, Nishimura Y, Choo J, Sago F, Somiya D, et al. Simultaneous Burr Hole Drainage and Epidural Blood Patch with Real-Time ICP Monitoring for Subdural Hematoma Associated with Spontaneous Intracranial Hypotension: Case Report and Technical Note. Asian J Neurosurg. 2025;20(4):848-853.
- Fargen KM, Coffman S, Torosian T, Brinjikji W, Nye BL, Hui F. “Idiopathic” intracranial hypertension: An update from neurointerventional research for clinicians. Cephalalgia. 2023;43(4):3331024231161323.
- Lim J, Monteiro A, Kuo CC, Jacoby WT, Cappuzzo JM, Becker AB, et al. Stenting for Venous Sinus Stenosis in Patients With Idiopathic Intracranial Hypertension: An Updated Systematic Review and Meta-Analysis of the Literature. Neurosurgery. 2024;94(4):648-656.
- Daggubati LC, Liu KC. Intracranial Venous Sinus Stenting: A Review of Idiopathic Intracranial Hypertension and Expanding Indications. Cureus. 2019;11(2):e4008.
- Ashina S, Robertson CE, Srikiatkhachorn A, Di Stefano G, Donnet A, Hodaie M, et al. Trigeminal neuralgia. Nat Rev Dis Primers. 2024;10(1):39.
- Bendtsen L, Zakrzewska JM, Heinskou TB, Hodaie M, Leal PRL, Nurmikko T, et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 2020;19(9):784-796.
- Cruccu G. Trigeminal Neuralgia. Continuum (Minneap Minn). 2017;23(2, Selected Topics in Outpatient Neurology):396-420.
- Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia - diagnosis and treatment. Cephalalgia. 2017;37(7):648-657.
- Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A, et al. European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019;26(6):831-849.
- Latorre G, González-García N, García-Ull J, González-Oria C, Porta-Etessam J, Molina FJ, et al. Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology’s Headache Study Group. Neurologia (Engl Ed). 2023;38 Suppl 1:S37-S52.
- Lambru G, Zakrzewska J, Matharu M. Trigeminal neuralgia: a practical guide. Pract Neurol. 2021;21(5):392-402.
- Allam AK, Sharma H, Larkin MB, Viswanathan A. Trigeminal Neuralgia: Diagnosis and Treatment. Neurol Clin. 2023;41(1):107-121.
- Khawaja SN, Scrivani SJ. Trigeminal Neuralgia. Dent Clin North Am. 2023;67(1):99-115.
- Yadav YR, Nishtha Y, Sonjjay P, Vijay P, Shailendra R, Yatin K. Trigeminal Neuralgia. Asian J Neurosurg. 2017;12(4):585-597.
- Villegas Díaz D, Guerrero Alvarado G, López Medina A, Gómez Clavel JF, García Muñoz A. Trigeminal neuralgia: therapeutic strategies to restore quality of life. J Oral Facial Pain Headache. 2024;38(3):32-37.
- Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments. Mol Pain. 2020;16:1744806920901890.
- Cheshire WP Jr. Cranial Neuralgias. Continuum (Minneap Minn). 2015;21(4 Headache):1072-85.
- Robblee J. Nervus Intermedius Neuralgia. Curr Pain Headache Rep. 2025;29(1):32.
- Nemzek WR. The trigeminal nerve. Top Magn Reson Imaging. 1996;8(3):132-54.
- Bond JD, Xu Z, Zhang H, Zhang M. Meckel’s Cave and Somatotopy of the Trigeminal Ganglion. World Neurosurg. 2021;148:178-187.
- Di Stefano G, Maarbjerg S, Truini A. Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options. J Headache Pain. 2019;20(1):20.
- Mousavi SH, Lindsey JW, Gupta RK, Wolinsky JS, Lincoln JA. Trigeminal neuralgia in multiple sclerosis: Association with demyelination and progression. Mult Scler Relat Disord. 2023;74:104727.
- Giuliani G, Zilli C, Caramia F, Di Piero V, Altieri M. SUNCT syndrome secondary to multiple sclerosis: Not only trigeminal neuralgia. Mult Scler. 2024;30(9):1227-1229.
- Badger D, Aygun N. Imaging of Perineural Spread in Head and Neck Cancer. Radiol Clin North Am. 2017;55(1):139-149.
- Liampas A, Parperis K, Erotocritou MF, Nteveros A, Papadopoulou M, Moschovos C, et al. Primary Sjögren syndrome-related peripheral neuropathy: A systematic review and meta-analysis. Eur J Neurol. 2023;30(1):255-265.
- Eika F, Berstad JER. [Numb chin syndrome]. Tidsskr Nor Laegeforen. 2022;142(3).
- Mertsch S, Alder J, Dua HS, Geerling G. [Pathogenesis and epidemiology of neurotrophic keratopathy]. Ophthalmologe. 2019;116(2):109-119.
- Okada Y, Reinach PS, Kitano A, Shirai K, Kao WW, Saika S. Neurotrophic keratopathy; its pathophysiology and treatment. Histol Histopathol. 2010;25(6):771-80.
- Liu CY, Arteaga AC, Fung SE, Cortina MS, Leyngold IM, Aakalu VK. Corneal neurotization for neurotrophic keratopathy: Review of surgical techniques and outcomes. Ocul Surf. 2021;20:163-172.
- Tereshko Y, Dal Bello S, Lettieri C, Belgrado E, Gigli GL, Merlino G, et al. Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review. Toxins (Basel). 2024;16(11).
- Hu X, Xia Y, Li J, Wang X, Liu H, Hu J, et al. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia: An Update on Systematic Review With Meta-analyses. Clin J Pain. 2024;40(6):383-392.
- Holste K, Chan AY, Rolston JD, Englot DJ. Pain Outcomes Following Microvascular Decompression for Drug-Resistant Trigeminal Neuralgia: A Systematic Review and Meta-Analysis. Neurosurgery. 2020;86(2):182-190.
- Soni P, Potter T, Soni PP, Estemalik E, Recinos PF, Kshettry VR. Outcomes of microvascular decompression for trigeminal neuralgia with purely venous compression: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2020;198:106230.
- Dou NN, Zhong J, Xia L, Li ST. Microvascular decompression for pediatric onset trigeminal neuralgia: patterns and variation. Childs Nerv Syst. 2022;38(4):767-772.
- Santiago RB, Ali A, Mandel M, Muhsen B, Adada B, Borghei-Razavi H, et al. Trigeminal Neuralgia-Step-by-Step DYNA-Computed Tomography-Assisted Balloon Compression Rhizotomy. World Neurosurg. 2023;171:84.
- Sato D, Hayashi M, Horiba A, Horisawa S, Kawamata T. Long-Term Results of Gamma Knife Radiosurgery for Trigeminal Neuralgia. World Neurosurg. 2023;171:e787-e791.
- Samanci Y, Mürdün E, Çil M, Düzkalir AH, Askeroglu MO, Peker S. Long-term outcomes of Gamma Knife radiosurgery in treating glossopharyngeal neuralgia. Headache. 2024;64(3):323-328.
- Minor M, Gurnani B, Payne E. Herpes zoster ophthalmicus. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Johnson JL, Amzat R, Martin N. Herpes Zoster Ophthalmicus. Prim Care. 2015;42(3):285-303.
- Shaikh S, Ta CN. Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician. 2002;66(9):1723-30.
- Patil A, Goldust M, Wollina U. Herpes zoster: A Review of Clinical Manifestations and Management. Viruses. 2022;14(2).
- Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.
- Li JY. Herpes zoster ophthalmicus: acute keratitis. Curr Opin Ophthalmol. 2018;29(4):328-333.
- Cohen EJ, Troxel AB, Liu M, Hochman JS, Baratz KH, Mian SI, et al. Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial. JAMA Ophthalmol. 2025;143(4):269-276.
- Vadoothker S, Jeng BH. Management of chronic complications associated with herpes zoster ophthalmicus. Curr Opin Ophthalmol. 2018;29(4):334-339.
- Mehkri Y, Valisno JA, Rivas LF, Hernandez J, Jain V, Elfasi A, et al. Management of Cavernous Sinus Thrombosis Following Herpes Zoster Ophthalmicus. Cureus. 2022;14(1):e21036.
- Saguil A, Kane S, Mercado M, Lauters R. Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. Am Fam Physician. 2017;96(10):656-663.
- Lim DZJ, Tey HL, Salada BMA, Oon JEL, Seah ED, Chandran NS, et al. Herpes Zoster and Post-Herpetic Neuralgia-Diagnosis, Treatment, and Vaccination Strategies. Pathogens. 2024;13(7).
- Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Díez-Domingo J, et al. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N Engl J Med. 2016;375(11):1019-32.
- Alexandra Echeverria Proano D, Zhu F, Sun X, Zoco J, Soni J, Parmar N, et al. Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial. Hum Vaccin Immunother. 2024;20(1):2351584.
- Erskine N, Tran H, Levin L, Ulbricht C, Fingeroth J, Kiefe C, et al. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS One. 2017;12(7):e0181565.
- Lu P, Cui L, Zhang X. Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis. J Neurovirol. 2023;29(4):449-459.
- Rosenthal P, Baran I, Jacobs DS. Corneal pain without stain: is it real?. Ocul Surf. 2009;7(1):28-40.
- Watson SL, Le DT. Corneal neuropathic pain: a review to inform clinical practice. Eye (Lond). 2024;38(12):2350-2358.
- Dieckmann G, Goyal S, Hamrah P. Neuropathic Corneal Pain: Approaches for Management. Ophthalmology. 2017;124(11S):S34-S47.
- McNally TW, Figueiredo FC. Corneal Neuropathic Pain: A Patient and Physician Perspective. Ophthalmol Ther. 2024;13(4):1041-1050.
- El Omda S, Tzoumas N, Calonge M, Figueiredo F. International Survey of Current Approaches to the Management of Neuropathic Corneal Pain by Experts. Ophthalmol Ther. 2025;14(12):3035-3046.
- Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15(3):276-283.
- Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334-365.
- Chin JY, Tong L, Liu C, Lee IXY, Wong JHF, Wong RKT, et al. Quality of Life and Symptomatology in Neuropathic Corneal Pain in Comparison With Dry Eye Syndrome. Cornea. 2024;44(7):825-831.
- Puja G, Sonkodi B, Bardoni R. Mechanisms of Peripheral and Central Pain Sensitization: Focus on Ocular Pain. Front Pharmacol. 2021;12:764396.
- Melik Parsadaniantz S, Rostène W, Baudouin C, Réaux-Le Goazigo A. [Understanding chronic ocular pain]. Biol Aujourdhui. 2018;212(1-2):1-11.
- Launay PS, Reboussin E, Liang H, Kessal K, Godefroy D, Rostene W, et al. Ocular inflammation induces trigeminal pain, peripheral and central neuroinflammatory mechanisms. Neurobiol Dis. 2016;88:16-28.
- Kikuchi K, Tagawa Y, Murata M, Ishida S. Effects of Mirogabalin on Hyperalgesia and Chronic Ocular Pain in Tear-Deficient Dry-Eye Rats. Invest Ophthalmol Vis Sci. 2023;64(5):27.
- Crane AM, Levitt RC, Felix ER, Sarantopoulos KD, McClellan AL, Galor A. Patients with more severe symptoms of neuropathic ocular pain report more frequent and severe chronic overlapping pain conditions and psychiatric disease. Br J Ophthalmol. 2017;101(2):227-231.
- Chang J, Hattenhauer A, Saccaro L, Mamatkazina F, Felix E, De Lott L, et al. Chronic Ocular Surface Pain: A Missing Member of the Chronic Overlapping Pain Conditions?. Drugs. 2026;86(8):1285-1306.
- Zidan AA, Dean J, Lin Z, Kheirkhah A, Dana R, You JY, et al. Symptoms of Small Fiber Neuropathy in Patients With Dry Eye Disease. Cornea. 2025.
- Bazancir-Apaydin Z, Apaydin H, Armagan B, Orhan K, Erten S. The Role of Central Sensitization in Autoimmune Connective Tissue Diseases: A Comparative Cross-Sectional Study. Int J Rheum Dis. 2025;28(1):e70069.
- Moein HR, Akhlaq A, Dieckmann G, Abbouda A, Pondelis N, Salem Z, et al. Visualization of microneuromas by using in vivo confocal microscopy: An objective biomarker for the diagnosis of neuropathic corneal pain?. Ocul Surf. 2020;18(4):651-656.
- Chinnery HR, Rajan R, Jiao H, Wu M, Zhang AC, De Silva MEH, et al. Identification of presumed corneal neuromas and microneuromas using laser-scanning in vivo confocal microscopy: a systematic review. Br J Ophthalmol. 2022;106(6):765-771.
- Ross AR, Al-Aqaba MA, Almaazmi A, Messina M, Nubile M, Mastropasqua L, et al. Clinical and in vivo confocal microscopic features of neuropathic corneal pain. Br J Ophthalmol. 2020;104(6):768-775.
- Qazi Y, Hurwitz S, Khan S, Jurkunas UV, Dana R, Hamrah P. Validity and Reliability of a Novel Ocular Pain Assessment Survey (OPAS) in Quantifying and Monitoring Corneal and Ocular Surface Pain. Ophthalmology. 2016;123(7):1458-68.
- Ng DM, Wang X, Liu C, Yu M, Lee IXY, Wong JHF, et al. Validation of the Ocular Pain Assessment Survey Instrument With Rasch Analysis. Transl Vis Sci Technol. 2025;14(2):20.
- Yamanishi R, Suzuki N, Uchino M, Kawashima M, Tsubota K, Negishi K. Reliability and validity of the Japanese version of the Ocular pain assessment survey (OPAS-J). Sci Rep. 2023;13(1):10197.
- Matar K, Yu Y, Augello P, Ying GS, Asbell PA, Sayegh RR. Defining Discordance Between Signs and Symptoms in Dry Eye Disease: Insights From the DRy Eye Assessment and Management (DREAM) Study. Am J Ophthalmol. 2026;286:41-49.
- Lu PT, Lee CY, Sun CC. Sex Differences and Discordance Between Symptoms and Signs of Dry Eye Disease. Am J Ophthalmol. 2024;260:14-20.
- Yavrum F, Ezerbolat Ozates M, Ozates S. An important contributing factor in dry eye disease: somatization. Int Ophthalmol. 2024;44(1):190.
- Segal BM, Pogatchnik B, Rhodus N, Sivils KM, McElvain G, Solid CA. Pain in primary Sjögren’s syndrome: the role of catastrophizing and negative illness perceptions. Scand J Rheumatol. 2014;43(3):234-41.
- Toda I. Dry Eye After LASIK. Invest Ophthalmol Vis Sci. 2018;59(14):DES109-DES115.
- Theophanous C, Jacobs DS, Hamrah P. Corneal Neuralgia after LASIK. Optom Vis Sci. 2015;92(9):e233-40.
- Levitt AE, Galor A, Weiss JS, Felix ER, Martin ER, Patin DJ, et al. Chronic dry eye symptoms after LASIK: parallels and lessons to be learned from other persistent post-operative pain disorders. Mol Pain. 2015;11:21.
- Vázquez A, Martínez-Plaza E, Fernández I, Sobas EM, González-García MJ, Enríquez-de-Salamanca A, et al. Phenotypic characterization of patients developing chronic dry eye and pain after refractive surgery: A cross-sectional study. Ocul Surf. 2022;26:63-74.
- Vázquez A, Blanco-Vázquez M, Martínez-Plaza E, Sobas EM, González-García MJ, López-Miguel A, et al. Corneal Sensory Changes and Nerve Plexus Abnormalities in Chronic Neuropathic Ocular Pain and Dry Eye Postrefractive Surgery. Am J Ophthalmol. 2025;276:170-185.
- Wilkinson JM, Cozine EW, Kahn AR. Refractive Eye Surgery: Helping Patients Make Informed Decisions About LASIK. Am Fam Physician. 2017;95(10):637-644.
- Aggarwal S, Colon C, Kheirkhah A, Hamrah P. Efficacy of autologous serum tears for treatment of neuropathic corneal pain. Ocul Surf. 2019;17(3):532-539.
- Anam A, Liu C, Tong L, Liu YC. Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain. J Ocul Pharmacol Ther. 2024;40(5):281-292.
- Yoon HJ, Kim J, Yang JM, Wei ET, Kim SJ, Yoon KC. Topical TRPM8 Agonist for Relieving Neuropathic Ocular Pain in Patients with Dry Eye: A Pilot Study. J Clin Med. 2021;10(2).
- Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88.
- Moisset X, Bouhassira D, Avez Couturier J, Alchaar H, Conradi S, Delmotte MH, et al. Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations. Rev Neurol (Paris). 2020;176(5):325-352.
- Ozmen MC, Dieckmann G, Cox SM, Rashad R, Paracha R, Sanayei N, et al. Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain. Ocul Surf. 2020;18(4):814-820.
- Patel S, Mittal R, Sarantopoulos KD, Galor A. Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications. Expert Opin Ther Targets. 2022;26(8):681-695.
- Zayan K, Felix ER, Galor A. Transcutaneous Electrical Nerve Stimulation for Facial Pain. Prog Neurol Surg. 2020;35:35-44.
- Olcucu O, de Leeuw A, Lamazales LL, Mallone F, Hamrah P. Efficacy of Extranasal Neurostimulation for Patients With Neuropathic Corneal Pain: A Pilot Study. Cornea. 2024;44(10):1266-1272.
- Jin T, Liu X, Li Y, Li PC, Wan MM, Li LJ, et al. Electroacupuncture Reduces Ocular Surface Neuralgia in Dry-Eyed Guinea Pigs by Inhibiting the Trigeminal Ganglion and Spinal Trigeminal Nucleus Caudalis P2X(3)R-PKC Signaling Pathway. Curr Eye Res. 2023;48(6):546-556.
- Shen HX, Zheng XJ, Jin T, Li PC, Gao WP, Wei QB, et al. [Effect of electroacupuncture on ocular surface sensory neuralgia and expression of P2X(3) receptor and PKC in cornea and trigeminal ganglion of dry eye guinea pigs]. Zhen Ci Yan Jiu. 2022;47(5):393-400.
- Hall WA, Gurnani B. Compressive optic neuropathy. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Bengoa-González Á, Lago-Llinás MD, Mencía-Gutiérrez E, Salvador E. Superior orbital fissure syndrome after deep lateral orbital wall decompression in Graves’ ophthalmopathy. Orbit. 2024;43(4):439-447.
- Reznikova LV, Kuchminskaya MB, Sherstneva LV, Aslamazova AE. [Tolosa-Hunt syndrome]. Vestn Oftalmol. 2025;141(6):114-118.
- Ata F, Yousaf Z, Arachchige SNM, Rose S, Alshurafa A, Muthanna B, et al. The demographics of Tolosa-Hunt syndrome in Qatar. eNeurologicalSci. 2021;24:100359.
- Dinaki K, Sarafidou A, Papadopoulos C, Triaridis S, Karkos P. Intracavernous Aneurysm Mimicking Tolosa-Hunt Syndrome. Maedica (Bucur). 2024;19(3):634-640.
- Khochtali S, Zayani M, Ksiaa I, Ben Meriem I, Zaouali S, Jelliti B, et al. [Idiopathic orbital inflammatory syndrome: Report of 24 cases]. J Fr Ophtalmol. 2018;41(4):333-342.
- Pakdel F, Haghighi A, Pirmarzdashti N. Disease modifying drugs in idiopathic sclerosing orbital inflammatory syndrome. Orbit. 2022;41(4):437-446.
- Parra-Rodas LM, Parra-Rodas E, Jiménez-Villegas MJ, Cartagena-Agudelo Y, Cabrera-Hemer D. [Orbital myositis, a cause of pediatric painful ophthalmoplegia]. Rev Chil Pediatr. 2020;91(6):930-935.
- Mejico LJ. IgG4-related ophthalmic disease. Saudi J Ophthalmol. 2015;29(1):53-6.
- Ulatowski H, Bequest A, Sharma A, Jha P. Granulomatosis With Polyangiitis Presenting As Orbital Apex Syndrome. Cureus. 2024;16(7):e64087.
- Noorani S, Tejani AS, Chen M, Truong-Le M. Eosinophilic Granulomatosis With Polyangiitis Presenting With Neuro-Ophthalmic Manifestations. J Neuroophthalmol. 2025;45(2):231-234.
- Gopal AD, Meeker A, Ramesh S. Bilateral orbital granulomatosis with polyangiitis complicated by central serous chorioretinopathy. Clin Exp Optom. 2022;105(2):233-236.
- Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med. 2015;36(4):669-83.
- Henderson AD, Tian J, Carey AR. Neuro-Ophthalmic Manifestations of Sarcoidosis. J Neuroophthalmol. 2021;41(4):e591-e597.
- Toumi E, Peyrade F, Nahon S, Marin L, Baillif S, Martel A. [Orbital mantle cell lymphoma succesfully treated by Bcl-2 inhibitor: Report of a case]. J Fr Ophtalmol. 2021;44(2):239-243.
- Sham JS, Cheung YK, Choy D, Chan FL, Leong L. Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma. Cancer. 1991;68(2):422-6.
- Batawi H, Micieli JA. Nasopharyngeal carcinoma presenting as a sixth nerve palsy and Horner’s syndrome. BMJ Case Rep. 2019;12(10).
- See A, Tan TY, Gan EC. Atypical culture-negative skull base osteomyelitis masquerading as advanced nasopharyngeal carcinoma. Am J Otolaryngol. 2016;37(3):236-9.
- Bielefeld V, Assad S, Guguen C, Goupil F, Le Meur G, Lebranchu P, et al. [Bilateral optic nerve infiltration by carcinomatous meningitis]. J Fr Ophtalmol. 2020;43(5):444-445.
- Smets L, Claerhout H, Van Laer C, Boeckx N. Malignant invasion of the cerebrospinal fluid in adult and paediatric patients with haematological and solid malignancies: a monocentric retrospective study. Acta Clin Belg. 2022;77(3):524-532.
- Oumerzouk J, Ahmimeche J, Hanafi Y, El Khiyat I, Nasri A, Bourazza A. [Rapidly worsening bilateral papilledema secondary to carcinomatous meningitis. Case report and review of the literature]. J Fr Ophtalmol. 2013;36(9):e183-5.
- Malik TG, Moin M. Clinical Presentation of Carotid-Cavernous Fistula and Outcomes of Endovascular Balloon Embolization. Turk J Ophthalmol. 2024;54(3):153-158.
- Mishra K, Kumar V, Vinay, Gandhi A, Srivastava T. Carotid cavernous fistula: Redefining the angioarchitecture. J Cerebrovasc Endovasc Neurosurg. 2022;24(4):356-365.
- Marin-Castañeda LA, Gorbachev J, Lopez-Zepeda PT, Choque-Ayala LC, Shubhangi F, De Nigris Vasconcellos F, et al. Pituitary Apoplexy and the Current Understanding of Its Management: A Meta-Analysis of 908 Patients. World Neurosurg. 2024;190:371-385.e1.
- Febres A, Jenks JD, Buckley CJ. Mucormycosis. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Werner MT, Powers LD, Fastenberg JH. Orbital preservation in the treatment of acute invasive fungal sinusitis. Am J Otolaryngol. 2024;45(6):104466.
- Lee IH, Yoon WS, Kim DH, Son SA. Endoscopic Endonasal Optic Nerve Decompression in a Patient With Invasive Fungal Sinusitis Invasion Into the Orbital Apex: Intraoperative Video and Literature Review. J Craniofac Surg. 2023;34(1):291-294.
- Anosike BI, Ganapathy V, Nakamura MM. Epidemiology and Management of Orbital Cellulitis in Children. J Pediatric Infect Dis Soc. 2022;11(5):214-220.
- Wong SJ, Levi J. Management of pediatric orbital cellulitis: A systematic review. Int J Pediatr Otorhinolaryngol. 2018;110:123-129.
- Wolffsohn JS, Lingham G, Downie LE, Huntjens B, Inomata T, Jivraj S, et al. TFOS Lifestyle: Impact of the digital environment on the ocular surface. Ocul Surf. 2023;28:213-252.
- García-Muñoz Á, Carbonell-Bonete S, Cacho-Martínez P. Symptomatology associated with accommodative and binocular vision anomalies. J Optom. 2014;7(4):178-92.
- Al-Mohtaseb Z, Schachter S, Shen Lee B, Garlich J, Trattler W. The Relationship Between Dry Eye Disease and Digital Screen Use. Clin Ophthalmol. 2021;15:3811-3820.
- Stapleton F, Velez FG, Lau C, Wolffsohn JS. Dry eye disease in the young: A narrative review. Ocul Surf. 2024;31:11-20.
- Sheppard AL, Wolffsohn JS. Digital eye strain: prevalence, measurement and amelioration. BMJ Open Ophthalmol. 2018;3(1):e000146.
- Heus P, Verbeek JH, Tikka C. Optical correction of refractive error for preventing and treating eye symptoms in computer users. Cochrane Database Syst Rev. 2018;4(4):CD009877.
- Lajmi H, Choura R, Ben Achour B, Doukh M, Amin Z, Hmaied W. Headache associated with refractive errors: Characteristics and risk factors. Rev Neurol (Paris). 2021;177(8):947-954.
- Chan VF, Fernandes Martins M, Juma Othman O, Yong AC, Mulewa D, Graham C, et al. Subjective Wellbeing, Work Performance and Lived Experience of Zanzibari Women Entrepreneurs with Uncorrected Functional Presbyopia: A Pre-Post Mixed-Methods Study. Ophthalmic Epidemiol. 2024;31(4):333-341.
- Katz JA, Karpecki PM, Dorca A, Chiva-Razavi S, Floyd H, Barnes E, et al. Presbyopia - A Review of Current Treatment Options and Emerging Therapies. Clin Ophthalmol. 2021;15:2167-2178.
- Burstein R, Noseda R, Fulton AB. Neurobiology of Photophobia. J Neuroophthalmol. 2019;39(1):94-102.
- Katz BJ, Digre KB. Diagnosis, pathophysiology, and treatment of photophobia. Surv Ophthalmol. 2016;61(4):466-77.
- Albilali A, Dilli E. Photophobia: When Light Hurts, a Review. Curr Neurol Neurosci Rep. 2018;18(9):62.
- Matynia A, Parikh S, Deot N, Wong A, Kim P, Nusinowitz S, et al. Light aversion and corneal mechanical sensitivity are altered by intrinscally photosensitive retinal ganglion cells in a mouse model of corneal surface damage. Exp Eye Res. 2015;137:57-62.
- Cui Q, Ren C, Sollars PJ, Pickard GE, So KF. The injury resistant ability of melanopsin-expressing intrinsically photosensitive retinal ganglion cells. Neuroscience. 2015;284:845-853.
- Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017;97(2):553-622.
- Theis J. Differential diagnosis and theories of pathophysiology of post-traumatic photophobia: A review. NeuroRehabilitation. 2022;50(3):309-319.
- Merezhinskaya N, Bai AC, Park D, Barker Ii FM, Gu W. Characterization of Mild Traumatic Brain Injury Cohort With Photophobia From the Defense and Veterans Eye Injury and Vision Registry. Mil Med. 2024;189(Suppl 3):736-742.
- Ten Brink AF, Proulx MJ, Bultitude JH. Validation of the Leiden Visual Sensitivity Scale and Visual Discomfort Scale in Chronic Pain Conditions. Perception. 2021;50(5):399-417.
- Chu MK, Im HJ, Chung CS, Oh K. Interictal pattern-induced visual discomfort and ictal photophobia in episodic migraineurs: an association of interictal and ictal photophobia. Headache. 2011;51(10):1461-7.
- Kahal F, Al Darra A, Torbey A. Computer vision syndrome: a comprehensive literature review. Future Sci OA. 2025;11(1):2476923.
- Kaur K, Gurnani B, Nayak S, Deori N, Kaur S, Jethani J, et al. Digital Eye Strain- A Comprehensive Review. Ophthalmol Ther. 2022;11(5):1655-1680.
- Auffret É, Gomart G, Bourcier T, Gaucher D, Speeg-Schatz C, Sauer A. [Digital eye strain. Symptoms, prevalence, pathophysiology, and management]. J Fr Ophtalmol. 2021;44(10):1605-1610.
- Scheiman M, Kulp MT, Cotter S, Mitchell GL, Gallaway M, Boas M, et al. Vision therapy/orthoptics for symptomatic convergence insufficiency in children: treatment kinetics. Optom Vis Sci. 2010;87(8):593-603.
- Chang MY, Morrison DG, Binenbaum G, Heidary G, Trivedi RH, Galvin JA, et al. Home- and Office-Based Vergence and Accommodative Therapies for Treatment of Convergence Insufficiency in Children and Young Adults: A Report by the American Academy of Ophthalmology. Ophthalmology. 2021;128(12):1756-1765.
- CITT-ART Investigator Group. Treatment of Symptomatic Convergence Insufficiency in Children Enrolled in the Convergence Insufficiency Treatment Trial-Attention & Reading Trial: A Randomized Clinical Trial. Optom Vis Sci. 2019;96(11):825-835.
- CITT-ART Investigator Group. Effect of Vergence/Accommodative Therapy on Reading in Children with Convergence Insufficiency: A Randomized Clinical Trial. Optom Vis Sci. 2019;96(11):836-849.
- CITT-ART Investigator Group. Effect of Vergence/Accommodative Therapy on Attention in Children with Convergence Insufficiency: A Randomized Clinical Trial. Optom Vis Sci. 2021;98(3):222-233.
- Abdi S, Kangari H, Rahmani S, Baghban AA, Rad ZK. Home vision therapy and prism prescription in presbyopic persons with convergence insufficiency: study protocol for a randomized controlled trial. BMC Ophthalmol. 2024;24(1):169.
- Gil-Casas A, Piñero DP, Molina-Martin A. Are near visual signs and symptoms in multiple sclerosis compatible with convergence insufficiency?. Clin Exp Optom. 2022;105(6):631-636.
- Storey EP, Master SR, Lockyer JE, Podolak OE, Grady MF, Master CL. Near Point of Convergence after Concussion in Children. Optom Vis Sci. 2017;94(1):96-100.
- Gallaway M, Scheiman M, Mitchell GL. Vision Therapy for Post-Concussion Vision Disorders. Optom Vis Sci. 2017;94(1):68-73.
- Abbas Farishta R, Farivar R. Montreal Brain Injury Vision Screening Test for General Practitioners. Front Hum Neurosci. 2022;16:858378.
- Enaholo ES, Gurnani B. Accommodative insufficiency. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Singh S, Keller PR, Busija L, McMillan P, Makrai E, Lawrenson JG, et al. Blue-light filtering spectacle lenses for visual performance, sleep, and macular health in adults. Cochrane Database Syst Rev. 2023;8(8):CD013244.
- Palavets T, Rosenfield M. Blue-blocking Filters and Digital Eyestrain. Optom Vis Sci. 2019;96(1):48-54.
- Rosenfield M, Li RT, Kirsch NT. A double-blind test of blue-blocking filters on symptoms of digital eye strain. Work. 2020;65(2):343-348.
- Redondo B, Vera J, Ortega-Sánchez A, Molina R, Jiménez R. Effects of a blue-blocking screen filter on accommodative accuracy and visual discomfort. Ophthalmic Physiol Opt. 2020;40(6):790-800.
- Clark J, Hasselfeld K, Bigsby K, Divine J. Colored Glasses to Mitigate Photophobia Symptoms Posttraumatic Brain Injury. J Athl Train. 2017;52(8):725-729.
- Bansal S, Green K. Application of colored filters in patients post-traumatic brain injury: A review. NeuroRehabilitation. 2022;50(3):321-330.
- Ritchie SJ, Della Sala S, McIntosh RD. Irlen colored overlays do not alleviate reading difficulties. Pediatrics. 2011;128(4):e932-8.
- Uccula A, Enna M, Mulatti C. Colors, colored overlays, and reading skills. Front Psychol. 2014;5:833.
- Eckstein A, Möller L, Führer D, Oeverhaus M. [Graves’ orbitopathy]. Dtsch Med Wochenschr. 2021;146(20):1344-1351.
- Bartalena L, Gallo D, Tanda ML, Kahaly GJ. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors. Ophthalmic Plast Reconstr Surg. 2023;39(6S):S2-S8.
- Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy. Front Endocrinol (Lausanne). 2020;11:615993.
- Shan SJ, Douglas RS. The pathophysiology of thyroid eye disease. J Neuroophthalmol. 2014;34(2):177-85.
- Smith TJ. Insulin-Like Growth Factor Pathway and the Thyroid. Front Endocrinol (Lausanne). 2021;12:653627.
- Allelein S, Schott M. [Update Graves’ disease 2019]. Dtsch Med Wochenschr. 2019;144(3):152-155.
- Menconi F, Profilo MA, Leo M, Sisti E, Altea MA, Rocchi R, et al. Spontaneous improvement of untreated mild Graves’ ophthalmopathy: Rundle’s curve revisited. Thyroid. 2014;24(1):60-6.
- Cruz AAV, Guimarães JA, Garcia DM. Rundle’s Curve: A Useful Construct That Does Not Fit All. Ophthalmic Plast Reconstr Surg. 2023;39(6S):S40-S45.
- Eshraghi B, Pourazizi M, Abbasi M, Mohammadbeigy I. Hypo vs. hyperthyroid eye disease: is there any difference?. BMC Ophthalmol. 2023;23(1):58.
- Eshraghi B, Pourazizi M, Abbasi M, Mohammadbeigy I. A comparison between bilateral and unilateral thyroid eye disease. Int Ophthalmol. 2023;43(8):2957-2962.
- Rana K, Garg D, Yong LSS, Leyden J, Patel S, Slattery J, et al. Asymmetric proptosis in thyroid eye disease. Int Ophthalmol. 2024;44(1):206.
- Kumari N, Arora N, Das S, Tiple S, Singh H, Patidar N, et al. Assessment of risk of obstructive sleep apnea with thyroid eye disease and its activity. Indian J Ophthalmol. 2023;71(12):3711-3714.
- Dolman PJ. Evaluating Graves’ orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012;26(3):229-48.
- Dolman PJ. Grading Severity and Activity in Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2018;34(4S Suppl 1):S34-S40.
- Boynes AC, Enright NJ, Hardy TG, Khong JJ. Interrater reliability of photographic assessment of thyroid eye disease using the VISA classification. Int Ophthalmol. 2024;44(1):98.
- Hötte GJ, Kolijn PM, de Bie M, de Keizer ROB, Medici M, van der Weerd K, et al. Thyroid stimulating immunoglobulin concentration is associated with disease activity and predicts response to treatment with intravenous methylprednisolone in patients with Graves’ orbitopathy. Front Endocrinol (Lausanne). 2024;15:1340415.
- Bayarmunkh O, Ganbold C, Das S, Davaatseren U, Minjuurdorj NE, Jav S. Association of clinical course with thyroid-stimulating immunoglobulin in Graves’ ophthalmopathy in Mongolians. PLoS One. 2022;17(11):e0277055.
- Nowak M, Marek B, Karpe J, Kos-Kudla B, Sieminska L, Kajdaniuk D, et al. Serum concentration of VEGF and PDGF-AA in patients with active thyroid orbitopathy before and after immunosuppressive therapy. Exp Clin Endocrinol Diabetes. 2014;122(10):582-6.
- Scofield-Kaplan SM, Dunbar K, Stein G, Kazim M. Improvement in Both Primary and Eccentric Ocular Alignment After Thyroid Eye Disease-Strabismus Surgery With Tenon’s Recession. Ophthalmic Plast Reconstr Surg. 2018;34(4S Suppl 1):S85-S89.
- Teope JK, Umezawa N, Takahashi Y. Lateral Rectus Muscle Resection for New-Onset Esotropia Following Medial Orbital Wall Decompression in Thyroid Eye Disease. Medicina (Kaunas). 2025;61(4).
- Choi SW, Lee JY, Lew H. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy. Korean J Ophthalmol. 2016;30(1):1-9.
- Garip Kuebler A, Halfter K, Reznicek L, Klingenstein A, Priglinger S, Rudolph G, et al. A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency. Graefes Arch Clin Exp Ophthalmol. 2021;259(11):3421-3426.
- Bhattacharjee K, Rehman O, Ichhpujani P, Venkatraman V. Central and peripheral contrast sensitivity in thyroid eye disease. Indian J Ophthalmol. 2024;72(10):1466-1470.
- Luo B, Liu R, Wang S, Hu W, Li Y, Tong B, et al. Utility of isolated-check visual evoked potential technique in dysthyroid optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2023;261(7):2031-2040.
- Wu JH, Luo LY, Zhou H, Wu Y, Zhang J, Cheng JW. Reduced choroidal peripapillary capillaries in thyroid-associated ophthalmopathy with early stage of dysthyroid optic neuropathy. Int J Ophthalmol. 2022;15(7):1135-1141.
- Liu P, Luo B, Feng Y, Chen L, Zhao YL, Wang QX, et al. Aberrant spontaneous brain activity in patients with thyroid-associated ophthalmopathy with and without optic neuropathy: a resting-state functional MRI study. Eur Radiol. 2023;33(11):7981-7991.
- Jeon C, Shin JH, Woo KI, Kim YD. Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy. Korean J Ophthalmol. 2012;26(2):73-9.
- Hu R, Tang S, Liu X, Liu Z, Cui Z, Chen J, et al. Predicting dysthyroid optic neuropathy in moderate-to-severe thyroid eye disease: a clinically applicable nomogram. Eur Thyroid J. 2025;14(6).
- Yu B, Gong C, Ji YF, Xia Y, Tu YH, Wu WC. Predictive parameters on CT scan for dysthyroid optic neuropathy. Int J Ophthalmol. 2020;13(8):1266-1271.
- Ma L, Wang M, Zhang Z, Jiang X, Hou Z, Li D. Three-dimensional soft tissue reconstruction and volume measurement used for the diagnosis of dysthyroid optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2024;262(6):1919-1924.
- Chung HW, Lee H, Baek S. Absent Bell’s phenomenon in patients with thyroid eye disease. BMC Ophthalmol. 2021;21(1):361.
- Grusha YO, Ismailova DS, Fettser EI. [Tarsorrhaphy in rehabilitation of patients with thyroid eye disease]. Vestn Oftalmol. 2021;137(5):47-51.
- Park K, Li J, Wen J, Li S, Lee J, Danesh K, et al. Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric Analysis. Cureus. 2024;16(7):e63843.
- Mimura M, Yang PT, Ko AC, Korn BS, Kikkawa DO. Analysis of Periorbital Soft Tissue in Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2020;36(1):30-33.
- Somer D, Ozkan SB, Ozdemir H, Atilla S, Söylev MF, Duman S. Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease. Jpn J Ophthalmol. 2002;46(3):341-5.
- Landray I, Carpenter J, Vahdani K, Miszkiel K, Ratnam LA, Rose GE. Reproducibility of the Unaided Subjective Assessment of Orbital Computed X-Ray Tomographic Features in Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2025;41(5):576-583.
- Lee MH, Chin YH, Ng CH, Nistala KRY, Ow ZGW, Sundar G, et al. Risk Factors of Thyroid Eye Disease. Endocr Pract. 2021;27(3):245-253.
- Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, et al. Selenium and the course of mild Graves’ orbitopathy. N Engl J Med. 2011;364(20):1920-31.
- Wang C, Qiao J, Liu S, Piao S, Zhou Y, Hu Y, et al. Selenium in the treatment of mild-to-moderate Graves’ orbitopathy: a 5-year prospective controlled cohort study. Endocrine. 2024;84(3):1072-1080.
- Samuel CG, Singh P, Abdullahi H, Ibrahim I. Unlocking the Therapeutic Potential: Selenium and Myo-Inositol Supplementation in Thyroid Disorders-Efficacy and Future Directions. Life (Basel). 2025;15(10).
- Muller I, Consonni D, Crivicich E, Di Marco F, Currò N, Salvi M. Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination. J Clin Endocrinol Metab. 2024;109(2):516-526.
- Lee THB, Sundar G. Quality of Life in Thyroid Eye Disease: A Systematic Review. Ophthalmic Plast Reconstr Surg. 2020;36(2):118-126.
- Sharma A, Stan MN, Rootman DB. Measuring Health-Related Quality of Life in Thyroid Eye Disease. J Clin Endocrinol Metab. 2022;107(Suppl_1):S27-S35.
- Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, et al. Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study. Ophthalmology. 2024;131(4):458-467.
- Salvi M, Campi I. Medical Treatment of Graves’ Orbitopathy. Horm Metab Res. 2015;47(10):779-88.
- Scarabosio A, Surico PL, Singh RB, Tereshenko V, Musa M, D’Esposito F, et al. Thyroid Eye Disease: Advancements in Orbital and Ocular Pathology Management. J Pers Med. 2024;14(7).
- Bartalena L, Krassas GE, Wiersinga W, Marcocci C, Salvi M, Daumerie C, et al. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves’ orbitopathy. J Clin Endocrinol Metab. 2012;97(12):4454-63.
- Sánchez-Ortiga R, Moreno-Pérez O, González Sánchez V, Arias Mendoza N, Mauri Dot M, Alfayate Guerra R, et al. Treatment of Graves’ ophthalmopathy with high-dose intravenous methylprednisolone: a comparison of two dosing regimens. Endocrinol Nutr. 2009;56(3):118-22.
- Li Z, Luo Y, Huang Q, Chen Z, Song D, Pan D, et al. A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy. J Clin Endocrinol Metab. 2023;109(1):36-45.
- Riedl M, Kolbe E, Kampmann E, Krämer I, Kahaly GJ. Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves’ orbitopathy. J Endocrinol Invest. 2015;38(2):177-82.
- Kahaly GJ, Riedl M, König J, Pitz S, Ponto K, Diana T, et al. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves’ orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. Lancet Diabetes Endocrinol. 2018;6(4):287-298.
- Fernando R, Caldera O, Smith TJ. Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy. Proc Natl Acad Sci U S A. 2021;118(52).
- Place RF, Krieger CC, Neumann S, Gershengorn MC. Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves’ ophthalmopathy: studies in orbital fibroblasts in vitro. Br J Pharmacol. 2017;174(4):328-340.
- Kahaly GJ, Subramanian PS, Conrad E, Holt RJ, Smith TJ. Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials. Thyroid. 2024;34(7):880-889.
- Huang W, Ou X, Lin S, Lin W, Chen G, Huang H, et al. Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: A Systematic Review and Meta-Analysis. Endocr Pract. 2025;31(5):640-649.
- Hiromatsu Y, Ishikawa E, Kozaki A, Takahashi Y, Tanabe M, Hayashi K, et al. A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients. Lancet Reg Health West Pac. 2025;55:101464.
- Goldberg H, Malik AI. Teprotumumab in thyroid eye disease. Saudi J Ophthalmol. 2024;38(1):29-33.
- Zhang H, Sun J, Li Y, Zhu L, Shan Z, Lu W, et al. IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients: The RESTORE-1 Randomized Clinical Trial. JAMA Ophthalmol. 2025;143(11):964-971.
- Lustig-Barzelay Y, Yagoda D, Zunz E, Hamed-Azzam S, Avisar I, Kehat-Ophir S, et al. Time to improvement following teprotumumab treatment of thyroid eye disease: real world experience. Graefes Arch Clin Exp Ophthalmol. 2025;263(8):2349-2358.
- Smith TJ, Cavida D, Hsu K, Kim S, Fu Q, Barbesino G, et al. Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials. Ophthalmology. 2024;131(7):815-826.
- Carter C, Marks M, Bundeff AW, Adewodu T, Alderman L. A case of rapidly declining glycemic control and diabetic ketoacidosis in a newly diagnosed diabetes patient after starting teprotumumab for thyroid eye disease. Endocrine. 2024;83(1):65-68.
- Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Perez-Pampin E, Romo Lopez A, Rodríguez Alvarez FM, et al. Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial. Am J Ophthalmol. 2018;195:181-190.
- Duarte AF, Xavier NF, Sales Sanz M, Cruz AAV. Efficiency and Safety of Tocilizumab for the Treatment of Thyroid Eye Disease: A Systematic Review. Ophthalmic Plast Reconstr Surg. 2024;40(4):367-373.
- Dorado Cortez O, Grivet D, Perrillat N, Gain P, Thuret G. Treatment of corticosteroid-resistant Graves’ orbitopathy with tocilizumab: a single-centre prospective study. Orbit. 2023;42(4):411-417.
- Stan MN, Garrity JA, Carranza Leon BG, Prabin T, Bradley EA, Bahn RS. Randomized controlled trial of rituximab in patients with Graves’ orbitopathy. J Clin Endocrinol Metab. 2015;100(2):432-41.
- Stan MN, Salvi M. MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves’ orbitopathy - lessons from randomized control trials. Eur J Endocrinol. 2017;176(2):R101-R109.
- Fatourechi V. Medical management of extrathyroidal manifestation of graves disease. Endocr Pract. 2014;20(12):1333-44.
- Dolman PJ, Rath S. Orbital radiotherapy for thyroid eye disease. Curr Opin Ophthalmol. 2012;23(5):427-32.
- Behbehani R, Sergott RC, Savino PJ. Orbital radiotherapy for thyroid-related orbitopathy. Curr Opin Ophthalmol. 2004;15(6):479-82.
- Vilar-González S, Lamas-Oliveira C, Fagúndez-Vargas MA, Núñez-Quintanilla AT, Pérez-Rozos A, Merayo-Lloves J, et al. [Thyroid orbitopathy, an overview with special attention to the role of radiotherapy]. Endocrinol Nutr. 2015;62(4):188-99.
- Sowerby LJ, Rajakumar C, Allen L, Rotenberg BW. Urgent endoscopic orbital decompression for vision deterioration in dysthyroid optic neuropathy. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136(3S):S49-S52.
- Yinghong Z, Jichao Z, Zhidi Z, Chiyu X, Haipeng Z, Yanrong R, et al. Combined endonasal and orbital approach for annulus of Zinn area decompression in dysthyroid optic neuropathy. Am J Otolaryngol. 2023;44(2):103692.
- Jefferis JM, Jones RK, Currie ZI, Tan JH, Salvi SM. Orbital decompression for thyroid eye disease: methods, outcomes, and complications. Eye (Lond). 2018;32(3):626-636.
- Boboridis KG, Uddin J, Mikropoulos DG, Bunce C, Mangouritsas G, Voudouragkaki IC, et al. Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search. Adv Ther. 2015;32(7):595-611.
- Jurek-Matusiak O, Brożek-Mądry E, Jastrzębska H, Krzeski A. Orbital decompression for thyroid eye disease: surgical treatment outcomes in endocrinological assessment. Endokrynol Pol. 2021;72(6):609-617.
- Parrilla C, Mele DA, Gelli S, Zelano L, Bussu F, Rigante M, et al. Multidisciplinary approach to orbital decompression. A review. Acta Otorhinolaryngol Ital. 2021;41(Suppl. 1):S90-S101.
- Lu JE, Pfeiffer ML, Burnstine MA. Graded transantral orbital decompression outcomes in stable thyroid eye disease: a series of 47 orbits. Orbit. 2021;40(3):215-221.
- Takahashi Y, Vaidya A. Secondary Effects of Orbital Decompression in Thyroid Eye Disease: A Review. Semin Ophthalmol. 2023;38(5):465-474.
- Chua MR, Tomlinson LA, Binenbaum G, Katowitz WR. Pediatric Thyroid Eye Disease: Clinical Characteristics and Orbital Decompression Outcomes. Ophthalmic Plast Reconstr Surg. 2018;34(4S Suppl 1):S52-S55.
- Nair AA, Ediriwickrema LS, Dolman PJ, Law G, Harrison AR, Mokhtarzadeh A, et al. Predictive Modeling of New-Onset Postoperative Diplopia Following Orbital Decompression for Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2022;38(6):551-557.
- Grusha YO, Kochetkov PA, Danilov SS, Duvanova ED, Sviridenko NY. [Complications of transnasal endoscopic orbital decompression in thyroid eye disease]. Vestn Oftalmol. 2023;139(3):63-68.
- Haugen OH, Mellgren AEC, Norli M, Ueland HO. Strabismus surgery in topical anaesthesia with intraoperative suture adjustment in Graves’ orbitopathy. Acta Ophthalmol. 2025;103(2):232-239.
- Capó H, Tibi C, Vila-Delgado MS, Huertas L. Influence of Age and Underlying Etiologies on Outcomes of Strabismus Surgery in the Elderly Population. Am J Ophthalmol. 2025;276:307-326.
- Zeppieri M, Patel BC. Nonspecific orbital inflammation. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Kim UR, Khazaei H, Stewart WB, Shah AD. Spectrum of orbital disease in South India: an aravind study of 6328 consecutive patients. Ophthalmic Plast Reconstr Surg. 2010;26(5):315-22.
- Pemberton JD, Fay A. Idiopathic sclerosing orbital inflammation: a review of demographics, clinical presentation, imaging, pathology, treatment, and outcome. Ophthalmic Plast Reconstr Surg. 2012;28(1):79-83.
- Son KY, Woo KI, Kim YD. Clinical Outcomes of IgG4-Related Ophthalmic Disease and Idiopathic Sclerosing Orbital Inflammation. Ophthalmic Plast Reconstr Surg. 2022;38(1):34-39.
- Butterfield SD, Silkiss RZ. Idiopathic sclerosing dacryoadenitis. J Ophthalmic Inflamm Infect. 2023;13(1):43.
- Spindle J, Tang SX, Davies B, Wladis EJ, Piozzi E, Pellegrini M, et al. Pediatric Idiopathic Orbital Inflammation: Clinical Features of 30 Cases. Ophthalmic Plast Reconstr Surg. 2016;32(4):270-4.
- Li Z, Chen Y, Liu H, Wu Q, Yang B, Zhang J, et al. Clinical features and recurrence patterns of pediatric idiopathic orbital inflammatory disease. BMC Ophthalmol. 2025;25(1):649.
- Tsukikawa M, Lally SE, Shields CL, Eagle RC Jr, Ellis FJ, Wasserman BN. Idiopathic Orbital Pseudotumor Preceding Systemic Inflammatory Disease in Children. J Pediatr Ophthalmol Strabismus. 2019;56(6):373-377.
- Kang MS, Yang HK, Kim N, Hwang JM. Clinical Features of Ocular Motility in Idiopathic Orbital Myositis. J Clin Med. 2020;9(4).
- Olsen TG, Heegaard S. Orbital lymphoma. Surv Ophthalmol. 2019;64(1):45-66.
- Wang KY, Kim BM, Yu CY, Welk GM, Churchill RA, White LJ, et al. Clinical characteristics and outcomes of primary orbital lymphoma. Eur J Ophthalmol. 2025;35(5):1776-1785.
- Stephen N, Manivannan P, Gochhait D, Sreerekha J, Ramasubramanian N, Srinivas BH, et al. The utility of fine needle aspiration cytology in orbital haematolymphoid neoplasms. Cytopathology. 2021;32(2):217-226.
- Flores Balverdi J, Baenas DF, Riscanevo NC, Sánchez AV, Figueroa Rosales R, Alvarellos A. IgG4-related orbital disease. Arch Soc Esp Oftalmol (Engl Ed). 2018;93(10):494-496.
- Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43(6):806-17.
- Chwalisz BK, Stone JH. Neuro-ophthalmic complications of IgG4-related disease. Curr Opin Ophthalmol. 2018;29(6):485-494.
- Baslund B, Wiencke AK, Rasmussen N, Faurschou M, Toft PB. Treatment of orbital inflammation with rituximab in Wegener’s granulomatosis. Clin Exp Rheumatol. 2012;30(1 Suppl 70):S7-10.
- Sorin B, Samson M, Durel CA, Diot E, Guichard I, Grados A, et al. Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitis. Rheumatology (Oxford). 2022;61(6):2619-2624.
- Sorin SM, Răzvan-Marian M, Daniela MM, Dan-Alexandru T. Therapy of ocular complications in ANCA+ associated vasculitis. Rom J Ophthalmol. 2021;65(1):10-14.
- Ahmed HS, Jayaram PR, Khar S. Tolosa-Hunt syndrome in children and adolescents: A systematic review. Headache. 2025;65(6):1027-1040.
- Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol. 2001;85(10):1220-4.
- Strianese D. Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2018;34(4S Suppl 1):S56-S59.
- Abou-Hanna JJ, Tiu Teo HM, Thangavel R, Elner VM, Demirci H. Long-term follow up of systemic rituximab therapy as first-line and salvage therapy for idiopathic orbital inflammation and review of the literature. Orbit. 2022;41(3):297-304.
- Michalova K, Lim L. Biologic agents in the management of inflammatory eye diseases. Curr Allergy Asthma Rep. 2008;8(4):339-47.
- Fionda B, Pagliara MM, Lancellotta V, Sammarco MG, Casà C, Savino G, et al. The Role of Radiotherapy in Orbital Pseudotumor: A Systematic Review of Literature. Ocul Immunol Inflamm. 2022;30(5):1162-1167.
- Kohli GS, Patel BC. Carotid cavernous fistula. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Jozef Č. Carotid-cavernous fistula from the perspective of an ophthalmologist A Review. Cesk Slov Oftalmol. 2020;1(Ahead of print):1-8.
- de Keizer R. Carotid-cavernous and orbital arteriovenous fistulas: ocular features, diagnostic and hemodynamic considerations in relation to visual impairment and morbidity. Orbit. 2003;22(2):121-42.
- Ghali MGZ. Sphenoid dural arteriovenous fistulas. Neurosurg Rev. 2021;44(1):77-96.
- Calafiore S, Perdicchi A, Scuderi G, Contestabile MT, Abdolrahimzadeh S, Recupero SM. Glaucoma Management in Carotid Cavernous Fistula. Case Rep Ophthalmol. 2016;7(2):296-302.
- Ide S, Kiyosue H. [Dural Arteriovenous Fistula]. No Shinkei Geka. 2021;49(2):362-367.
- Abaunza-Camacho JF, Vergara-Garcia D, Madrinan-Navia H, Riveros WM, Caballero A. Onyx Embolization of an Indirect Carotid-Cavernous Fistula with Cortical Venous Reflux: Technical Note. J Neurol Surg A Cent Eur Neurosurg. 2023;84(5):483-488.
- Chi CT, Nguyen D, Duc VT, Chau HH, Son VT. Direct traumatic carotid cavernous fistula: angiographic classification and treatment strategies. Study of 172 cases. Interv Neuroradiol. 2014;20(4):461-75.
- Ide S, Kiyosue H, Tokuyama K, Hori Y, Sagara Y, Kubo T. Direct Carotid Cavernous Fistulas. J Neuroendovasc Ther. 2020;14(12):583-592.
- Gronski HW, Creely JJ Jr. Carotid-cavernous fistula: a complication of maxillofacial trauma. South Med J. 1975;68(9):1096-102.
- Hasani H, Ghorbani M, Sheikhghomi S, Mahmoudi A. Traumatic Carotid-Cavernous Fistula in a Child with Nasal Penetrating Injury. J Binocul Vis Ocul Motil. 2025;75(3):81-84.
- Zhu L, Liu B, Zhong J. Post-traumatic right carotid-cavernous fistula resulting in symptoms in the contralateral eye: a case report and literature review. BMC Ophthalmol. 2018;18(1):183.
- Naragum V, Barest G, AbdalKader M, Cronk KM, Nguyen TN. Spontaneous Resolution of Post-Traumatic Direct Carotid-Cavernous Fistula. Interv Neurol. 2018;7(1-2):1-5.
- Agrawal M, Kumari L, Vichare N, Shyamsundar K, Avasthi A, Gupta S. Carotid-cavernous fistula masquerading as thyroid associated orbitopathy: a diagnostic challenge. Rom J Ophthalmol. 2022;66(2):168-172.
- Singhal A, Vichare N, Malik V. Carotid cavernous fistula masquerading as orbital cellulitis. Med J Armed Forces India. 2023;79(Suppl 1):S301-S303.
- Ying Sze C, Bakin S, Ismail R. Neuropsychiatric Presentation in Indirect Carotid-Cavernous Fistula: A Case Report. Cureus. 2023;15(4):e37523.
- Wu HC, Ro LS, Chen CJ, Chen ST, Lee TH, Chen YC, et al. Isolated ocular motor nerve palsy in dural carotid-cavernous sinus fistula. Eur J Neurol. 2006;13(11):1221-5.
- Madeira C, Alves G, Godinho G, Meira J, Leal V, Falcão M, et al. Bilateral Episcleral Corkscrew Vessels: Expedition into the Unknown - Case Report. Case Rep Ophthalmol. 2022;13(1):109-115.
- Venturini M, Cristel G, Marzoli SB, Simionato F, Agostini G, Barboni P, et al. Orbital color Doppler ultrasound as noninvasive tool in the diagnosis of anterior-draining carotid-cavernous fistula. Radiol Med. 2016;121(4):301-7.
- Lieb WE. Color Doppler ultrasonography of the eye and orbit. Curr Opin Ophthalmol. 1993;4(3):68-75.
- Cheng JW, Wei RL, Cai JP, Zhu H, Li Y. [Imaging diagnosis of carotid-cavernous fistula]. Zhonghua Yan Ke Za Zhi. 2007;43(1):36-9.
- Gemmete JJ, Chaudhary N, Pandey A, Ansari S. Treatment of carotid cavernous fistulas. Curr Treat Options Neurol. 2010;12(1):43-53.
- Barry RC, Wilkinson M, Ahmed RM, Lim CS, Parker GD, McCluskey PJ, et al. Interventional treatment of carotid cavernous fistula. J Clin Neurosci. 2011;18(8):1072-9.
- Sur S, Menaker SA, Alvarez C, Chen S, Shah SS, Peterson EC, et al. Multimodal Management of Carotid-Cavernous Fistulas. World Neurosurg. 2020;133:e796-e803.
- Izumi T. [Dural Arteriovenous Fistula:Endovascular Techniques and Devices]. No Shinkei Geka. 2023;51(2):289-293.
- Bing F, Albrieux M, Vinh Moreau-Gaudry V, Vasdev A. Cavernous sinus fistula treated through the transvenous approach: report of four cases. J Neuroradiol. 2009;36(5):265-9.
- Al Saiegh F, Velagapudi L, Jabbour P. Transvenous Onyx Embolization of a Type D Carotid-Cavernous-Fistula: Operative Video. World Neurosurg. 2021;156:11.
- Nishizawa T, Terada K, Matsuyama N. Transvenous detachable coil embolization of direct & high-flow carotid-cavernous fistula. Alternative of transarterial detachable balloon embolization. Interv Neuroradiol. 2000;6 Suppl 1(Suppl 1):117-24.
- Ma Y, Li Z, Zhang T, Chen H, Chen X, Zhao W. Efficiency of endovascular management with a combination of Onyx and coils for direct and indirect carotid cavernous fistula treatment: Experience of a single center. Clin Neurol Neurosurg. 2023;228:107700.
- Beer-Furlan A, Joshi KC, Brahimaj B, Lopes DK. Transvenous Onyx Embolization of Carotid-Cavernous Fistulas: Mid- and Long-Term Outcomes. J Neurol Surg B Skull Base. 2021;82(Suppl 3):e278-e284.
- Hou K, Li G, Luan T, Xu K, Yu J. Endovascular treatment of the cavernous sinus dural arteriovenous fistula: current status and considerations. Int J Med Sci. 2020;17(8):1121-1130.
- Alexandre AM, Sturiale CL, Bartolo A, Romi A, Scerrati A, Flacco ME, et al. Endovascular Treatment of Cavernous Sinus Dural Arteriovenous Fistulas. Institutional Series, Systematic Review and Meta-Analysis. Clin Neuroradiol. 2022;32(3):761-771.
- Park S, Lee K, Moon E, Park JC, Kwon B, Lee DH, et al. Endovascular Treatment With Targeted Embolization of Cavernous Sinus Dural Arteriovenous Fistulas: A Single-Center Study. Korean J Radiol. 2024;25(12):1083-1092.
- Perng PS, Chang Y, Sun YT, Wang HK, Jiang YS, Lee JS, et al. Endovascular treatment in bilateral cavernous sinus dural arteriovenous fistulas: a systematic review and meta-analysis. Sci Rep. 2023;13(1):7108.
- Rhim JK, Cho YD, Yoo DH, Kang HS, Cho WS, Kim JE, et al. Endovascular Treatment of Bilateral Cavernous Sinus Dural Arteriovenous Fistula: Therapeutic Strategy and Follow-Up Outcomes. Korean J Radiol. 2018;19(2):334-341.
- Fay LY, Luo CB, Chen LW, Wu JC, Wu CH, Chang FC, et al. Bilateral Cavernous Sinus Dural Arteriovenous Fistulae : The Strategies for Endovascular Treatment. Clin Neuroradiol. 2021;31(1):165-172.
- Pang PF, Jiang ZB, Zhou B, Li ZR, Huang MS, Zhu KS, et al. [Diagnosis and treatment of carotid-cavernous fistula: analysis of 28 patients]. Zhonghua Yi Xue Za Zhi. 2012;92(21):1458-62.
- Lee SH, Cho WS, Kang HS, Kim JE, Cho YD, Yoo DH, et al. Newly occurring cranial nerve palsy after endovascular treatment of cavernous sinus dural arteriovenous fistulas. J Neurointerv Surg. 2019;11(11):1168-1172.
- Tsirouki T, Dastiridou AI, Ibánez Flores N, Cerpa JC, Moschos MM, Brazitikos P, et al. Orbital cellulitis. Surv Ophthalmol. 2018;63(4):534-553.
- Danishyar A, Sergent SR. Orbital cellulitis. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Rashed F, Cannon A, Heaton PA, Paul SP. Diagnosis, management and treatment of orbital and periorbital cellulitis in children. Emerg Nurse. 2016;24(1):30-5; quiz 37.
- Galli L, Venturini E, Bassi A, Gattinara GC, Chiappini E, Defilippi C, et al. Common Community-acquired Bacterial Skin and Soft-tissue Infections in Children: an Intersociety Consensus on Impetigo, Abscess, and Cellulitis Treatment. Clin Ther. 2019;41(3):532-551.e17.
- Kwon E, Hathaway C, Sutton AE. Acute sinusitis. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Preda MA, Muşat O, Sarafoleanu CC, Popescu IS, Muşat A, Pîrvulescu R, et al. Oculo-orbital complications of odontogenic sinusitis. Rom J Ophthalmol. 2023;67(2):175-179.
- Alam MS, Backiavathy V, Noronha V, Mukherjee B. Orbital abscess: 20 years’ experience at a tertiary eye care center. Orbit. 2022;41(6):751-758.
- Luthra S, Kossler AL, Erickson BP, Homer NA. Orbital Subperiosteal Abscess Drainage: Transorbital vs. Endonasal Approach. J Clin Med. 2024;13(23).
- Mehta A, Rathod R, Arora K, Virk RS, Hage N, Basotia A, et al. Endoscope Assisted Combined Drainage of Sino-Orbital Abscess: Technique Revisited. Indian J Otolaryngol Head Neck Surg. 2022;74(2):172-177.
- Berdouk S, Pinto N. Fatal orbital cellulitis with intracranial complications: a case report. Int J Emerg Med. 2018;11(1):51.
- Koval T, Hunt S, Garrott H, Ford R. Fusobacterium necrophorum-induced orbital cellulitis with intracranial involvement: a case report and review of the literature. Orbit. 2022;41(4):517-521.
- Turbin RE, Wawrzusin PJ, Sakla NM, Traba CM, Wong KG, Mirani N, et al. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit. 2020;39(4):305-310.
- Halawa O, Gibbons A, Van Brummen A, Li E. Septic Cavernous Sinus Thrombosis: Clinical Characteristics, Management, and Outcomes. J Neuroophthalmol. 2025;45(1):50-54.
- Hanumappa SM, Karuppannasamy D. Clinical profile, prognostic factors, and outcomes of rhino-orbital-cerebral mucormycosis in the setting of COVID-19: A retrospective study. Saudi J Ophthalmol. 2023;37(2):100-106.
- Manade VV, Kotecha MR. A clinical study of rhino-orbital-cerebral mucormycosis during the COVID-19 pandemic in western Maharashtra. J Family Med Prim Care. 2024;13(9):3730-3734.
- Baeesa SS, Bokhari RF, Alghamdi KB, Alem HB, Al-Maghrabi JA, Madani TA. Invasive aspergillus sinusitis with orbitocranial extension. Asian J Neurosurg. 2017;12(2):172-179.
- Panda NK, Saravanan K, Chakrabarti A. Combination antifungal therapy for invasive aspergillosis: can it replace high-risk surgery at the skull base?. Am J Otolaryngol. 2008;29(1):24-30.
- Roland LT, Humphreys IM, Le CH, Babik JM, Bailey CE, Ediriwickrema LS, et al. Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence-Based Review with Recommendations. Int Forum Allergy Rhinol. 2023;13(9):1615-1714.
- Patel VA, LePhong CD, Osterbauer B, Gomez G, Don DM, Ference EH, et al. Pediatric Invasive Fungal Rhinosinusitis: A Comprehensive Analysis of Prognostic Factors for Survival. Laryngoscope. 2023;133(5):1239-1250.
- Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405-e421.
- Rudramurthy SM, Hoenigl M, Meis JF, Cornely OA, Muthu V, Gangneux JP, et al. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses. 2021;64(9):1028-1037.
- Wingen-Heimann SM, Cornely OA, Seidel D, Salmanton-García J. Costs for global guideline-based diagnosis of mucormycosis in patients with neutropenia, hematopoietic stem cell or solid organ transplantation - a perspective of the German healthcare system. Expert Rev Pharmacoecon Outcomes Res. 2024.
- Gebremariam T, Gu Y, Singh S, Kitt TM, Ibrahim AS. Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis. J Antimicrob Chemother. 2021;76(10):2636-2639.
- Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017;45(6):737-779.
- Shakrawal J, Sharma V, Goyal A, Kumar D, Meena S, Tiwari S, et al. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19. Int Ophthalmol. 2023;43(6):1919-1926.
- Sinha S, Kumar VB, Kumar A, Singh V, Anand A, Kusumesh R, et al. Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience. Cureus. 2022;14(8):e27817.
- Jeffrey J, Nelson F, Hohlbein J, Mehta A, Davies B. South Texas orbital fracture protocol for emergency department evaluation of orbital fractures. Am J Emerg Med. 2022;57:42-46.
- Winegar BA, Gutierrez JE. Imaging of Orbital Trauma and Emergent Non-traumatic Conditions. Neuroimaging Clin N Am. 2015;25(3):439-56.
- Ibanez L, Navallas M, de Caceres IA, Martinez-Chamorro E, Borruel S. CT Features of Posttraumatic Vision Loss. AJR Am J Roentgenol. 2021;217(2):469-479.
- Li X, Zarbin MA, Bhagat N. Pediatric open globe injury: A review of the literature. J Emerg Trauma Shock. 2015;8(4):216-23.
- El Chehab H, Renard JP, Dot C. [Post-traumatic endophthalmitis]. J Fr Ophtalmol. 2016;39(1):98-106.
- Bates A, Marx JT, Goett HJ. Point-of-care ocular ultrasound. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Kim HS, Jeong EC. Orbital Floor Fracture. Arch Craniofac Surg. 2016;17(3):111-118.
- Alinasab B, Borstedt KJ, Rudström R, Ryott M, Qureshi AR, Beckman MO, et al. New Algorithm for the Management of Orbital Blowout Fracture Based on Prospective Study. Craniomaxillofac Trauma Reconstr. 2018;11(4):285-295.
- Samukawa Y, Akiyama K, Takabayashi K, Hoshikawa H. A questionnaire survey for an orbital blowout fracture medical examination by Japanese otorhinolaryngologists. Auris Nasus Larynx. 2025;52(3):201-206.
- Takahashi Y, Vaidya A, Kono S, Miyazaki H, Yokoyama T, Kakizaki H. The relationship between orbital floor fracture patterns around the infraorbital groove and development of infraorbital nerve hypoesthesia: a computed tomographic study. Graefes Arch Clin Exp Ophthalmol. 2023;261(3):841-848.
- Devoti JF, Nicot R, Roland-Billecart T, Ferri J, Schlund M. Characterization of Infraorbital Nerve Sequelae After Orbital Floor or Zygomaticomaxillary Complex Fractures. J Craniofac Surg. 2022;33(1):52-56.
- Girodon M, Levasseur J, Wajszczak BL, Ernoult C, Zwetyenga N. [Traumatic superior orbital fissure syndrome: Update]. Rev Stomatol Chir Maxillofac Chir Orale. 2016;117(5):340-350.
- Amarath-Madav R, Adamkiewicz D, Bigler D, Yu JC, Lima MH. White-Eyed Orbital Blowout Fracture With Oculocardiac Reflex Secondary to Extraocular Entrapment in a Pediatric Patient. J Craniofac Surg. 2022;33(7):e767-e771.
- Jurdy L, Malhotra R. White-eyed medial wall blowout fracture mimicking head injury due to persistent oculocardiac reflex. J Craniofac Surg. 2011;22(5):1977-9.
- Coviello C, Williams KJ, Sivam SK. Pediatric orbital fractures. Curr Opin Otolaryngol Head Neck Surg. 2023;31(4):224-230.
- Zogheib S, Sukkarieh G, Mjaess G, Zeid SA. Displaced Orbital Fractures with Concurrent Orbital Compartment Syndrome: A Case-Based Systematic Review. Facial Plast Surg. 2022;38(3):274-278.
- Papadiochos I, Petsinis V, Sarivalasis SE, Strantzias P, Bourazani M, Goutzanis L, et al. Acute orbital compartment syndrome due to traumatic hemorrhage: 4-year case series and relevant literature review with emphasis on its management. Oral Maxillofac Surg. 2023;27(1):101-116.
- Desai NM, Shah SU. Lateral orbital canthotomy. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Rowh AD, Ufberg JW, Chan TC, Vilke GM, Harrigan RA. Lateral canthotomy and cantholysis: emergency management of orbital compartment syndrome. J Emerg Med. 2015;48(3):325-30.
- Kam S, Wrenn JO, Valenzuela DA. Reprint of: Retrobulbar hematoma and orbital compartment syndrome requiring lateral canthotomy and cantholysis in patient with penetrating facial trauma. Dis Mon. 2022;68(9):101369.
- Bailey LA, van Brummen AJ, Ghergherehchi LM, Chuang AZ, Richani K, Phillips ME. Visual Outcomes of Patients With Retrobulbar Hemorrhage Undergoing Lateral Canthotomy and Cantholysis. Ophthalmic Plast Reconstr Surg. 2019;35(6):586-589.
- Lakshmanan A, Bala S, Belfer KF. Intraorbital organic foreign body—a diagnostic challenge. Orbit. 2008;27(2):131-3.
- Hwang K, Park CY. Intraorbital Wooden Foreign Body in a Soldier. J Craniofac Surg. 2023;34(6):e592-e593.
- Jabang JN, Dampha L, Sanyang B, Roberts CA, Ceesay B. Management of a large intraorbital wooden foreign body: Case report. Surg Neurol Int. 2020;11:158.
- Holtmann C, Roth MB, Lanzman RS, Turowski B, Antoch G, Mackenzie CR, et al. [Diagnostics and treatment of organic intraorbital foreign bodies]. Ophthalmologie. 2023;120(7):734-739.
- Rastogi A, Gaonker T, Dhiman S, Rajurkar K. Orbital tumour or a retained foreign body? An uncommon case of missed diagnosis. Trop Doct. 2021;51(3):446-448.
- Ho VH, Wilson MW, Fleming JC, Haik BG. Retained intraorbital metallic foreign bodies. Ophthalmic Plast Reconstr Surg. 2004;20(3):232-6.
- Torche Velez E, Rojas Vilarroel P, Vera Figueroa F, Vigueras Alvarez S. Transorbital penetrating intracranial injury, with cavernous sinus involvement. Neurocirugia (Engl Ed). 2022;33(6):377-382.
- Park SJ, Chi M. Transorbital Penetrating Intracranial Injury by a Battery. J Craniofac Surg. 2018;29(1):e61-e64.
- Liu J, Zhao J, Wang Y, Wang Z, Li R, Chen Z, et al. Simultaneous Endoscopic Endonasal Decompression of the Optic Canal, Superior Orbital Fissure, and Proper Orbital Apex for Traumatic Orbital Apex Syndrome: Surgical Anatomy and Technical Note. Front Surg. 2021;8:811706.
- Vaitheeswaran K, Kaur P, Garg S. Minimal invasive transcaruncular optic canal decompression for traumatic optic neuropathy. Orbit. 2014;33(6):456-8.
- Kim K, Noh SR, Kang MS, Jin KH. Clinical Course and Prognostic Factors of Acquired Third, Fourth, and Sixth Cranial Nerve Palsy in Korean Patients. Korean J Ophthalmol. 2018;32(3):221-227.
- Cohen LM, Habib LA, Yoon MK. Post-traumatic enophthalmos secondary to orbital fat atrophy: a volumetric analysis. Orbit. 2020;39(5):319-324.
- Yalcin CE, Keskin O, Cihangir CC. Functional Recovery After Late Orbital Floor Reconstruction Using Autologous Grafts. J Craniofac Surg. 2026.
- Fan X, Zhou H, Lin M, Fu Y, Li J. Late reconstruction of the complex orbital fractures with computer-aided design and computer-aided manufacturing technique. J Craniofac Surg. 2007;18(3):665-73.
- Ponsford J, Velikonja D, Janzen S, Harnett A, McIntyre A, Wiseman-Hakes C, et al. INCOG 2.0 Guidelines for Cognitive Rehabilitation Following Traumatic Brain Injury, Part II: Attention and Information Processing Speed. J Head Trauma Rehabil. 2023;38(1):38-51.
- Wagner SK, Fu DJ, Faes L, Liu X, Huemer J, Khalid H, et al. Insights into Systemic Disease through Retinal Imaging-Based Oculomics. Transl Vis Sci Technol. 2020;9(2):6.
- Wang J, Wang YX, Zeng D, Zhu Z, Li D, Liu Y, et al. Artificial intelligence-enhanced retinal imaging as a biomarker for systemic diseases. Theranostics. 2025;15(8):3223-3233.
- Ghenciu LA, Dima M, Stoicescu ER, Iacob R, Boru C, Hațegan OA. Retinal Imaging-Based Oculomics: Artificial Intelligence as a Tool in the Diagnosis of Cardiovascular and Metabolic Diseases. Biomedicines. 2024;12(9).
- Zhao B, Bhatti MT, Fang C, Hodge DO, Holmes JM, Mohney BG, et al. Vascular Risk Factors in Isolated Microvascular Ischemic Third Nerve Palsy: A Population-Based Study. J Neuroophthalmol. 2023;43(2):248-253.
- Lajmi H, Hmaied W, Ben Jalel W, Chelly Z, Ben Yakhlef A, Ben Zineb F, et al. Oculomotor palsy in diabetics. J Fr Ophtalmol. 2018;41(1):45-49.
- Yunqing W, Shilei C, Yong L, Qing L, Xiaohong S, Jiawei W. Cavernous Sinus MRI Findings in Inflammatory and Ischemic Oculomotor Cranial Nerve Palsies. J Neuroophthalmol. 2024;44(2):236-241.
- Becker KN, Nichols J. 12. Review of diabetic papillitis. Dis Mon. 2021;67(5):101141.
- Ajmani U, Takkar B, Rani PK, Chhablani J, Sahoo NK. Optical coherence tomography characteristics and factors affecting visual acuity in diabetic papillopathy. Eur J Ophthalmol. 2024;34(5):1555-1561.
- Becker D, Larsen M, Lund-Andersen H, Hamann S. Diabetic papillopathy in patients with optic disc drusen: Description of two different phenotypes. Eur J Ophthalmol. 2023;33(4):NP129-NP132.
- Martin-Gutierrez MP, Petzold A, Saihan Z. NAION or not NAION? A literature review of pathogenesis and differential diagnosis of anterior ischaemic optic neuropathies. Eye (Lond). 2024;38(3):418-425.
- Suman S, Tiwari AK, Singh K. Computer-aided diagnostic system for hypertensive retinopathy: A review. Comput Methods Programs Biomed. 2023;240:107627.
- Suman S, Tiwari AK, Sachan S, Singh K, Meena S, Kumar S. Severity grading of hypertensive retinopathy using hybrid deep learning architecture. Comput Methods Programs Biomed. 2025;261:108585.
- Badawi SA, Fraz MM, Shehzad M, Mahmood I, Javed S, Mosalam E, et al. Detection and Grading of Hypertensive Retinopathy Using Vessels Tortuosity and Arteriovenous Ratio. J Digit Imaging. 2022;35(2):281-301.
- Chen X, Liu L, Liu M, Huang X, Meng Y, She H, et al. Hypertensive Retinopathy and the Risk of Stroke Among Hypertensive Adults in China. Invest Ophthalmol Vis Sci. 2021;62(9):28.
- Shen YS, Wang YS. Hypertensive choroidopathy with bilateral serous retinal detachment. Clin Exp Optom. 2023;106(4):443.
- Bourke K, Patel MR, Prisant LM, Marcus DM. Hypertensive choroidopathy. J Clin Hypertens (Greenwich). 2004;6(8):471-2.
- Hinduja A. Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome. Front Neurol. 2020;11:71.
- Suleymanoglu C, Cakmak MN, Uslusoy İH, Yazici C. Transient Cortical Blindness After Renal Angioplasty: Posterior Reversible Encephalopathy Syndrome After Renal Stenting. JACC Case Rep. 2025;30(41):105926.
- Bunt TJ. The clinical significance of the asymptomatic Hollenhorst plaque. J Vasc Surg. 1986;4(6):559-62.
- Vangipuram G, Yang L, Weigle MP, Blackorby BL, Blinder KJ, Dang S, et al. Workup following retinal artery occlusion-experience from an outpatient retina clinic and the delay in workup. Graefes Arch Clin Exp Ophthalmol. 2021;259(9):2625-2632.
- Abel AS, Suresh S, Hussein HM, Carpenter AF, Montezuma SR, Lee MS. Practice Patterns After Acute Embolic Retinal Artery Occlusion. Asia Pac J Ophthalmol (Phila). 2017;6(1):37-39.
- Klyscz P, Ihl T, Laumeier I, Steinicke M, Endres M, Michelson G, et al. Retinal microvascular signs and recurrent vascular events in patients with TIA or minor stroke. Stroke Vasc Neurol. 2023;8(5):379-386.
- Li G, Yu Y, Lin C, Zheng S, Tu H, Xu W. Association between major depressive disorder or depressive symptoms and the risk of vascular complications among patients with type 2 diabetes, and the mediating role of metabolic biomarkers: an analysis of the UK Biobank cohort. EClinicalMedicine. 2025;79:102982.
- Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2):135-149.
- Arevalo JF, Lowder CY, Muci-Mendoza R. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2002;13(6):404-10.
- Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 2007;46(12):1757-62.
- Wang X, Bao L. Simultaneous bilateral purtscher like retinopathy with systemic lupus erythematosus: a case. BMC Ophthalmol. 2024;24(1):418.
- Saidane R, Fendouli I, El Matri K, Hassairi A, Chebil A, El Matri L. Combined central retinal artery occlusion and anterior ischemic optic neuropathy as presenting signs of systemic lupus erythematosus. J Fr Ophtalmol. 2023;46(8):961-965.
- Sangani V, Pokal M, Balla M, Merugu GP, Adapa S, Naramala S, et al. A case of neuromyelitis optica spectrum disorder with coexisting systemic lupus erythematosus. J Community Hosp Intern Med Perspect. 2021;11(4):531-535.
- Lyutfi E, Kasabova E, Matev B, Shangova K, Kaprelyan A. Neuromyelitis Optica Spectrum Disorder With Unilateral Retrobulbar Neuritis: A Case Report. Cureus. 2024;16(12):e75410.
- Pueyo-Asensio C, Saint Gerons Trecu M, Rubio Pérez MA, Matheu Fabra A. Holmes-Adie syndrome as an early manifestation of systemic lupus erythematosus. Arch Soc Esp Oftalmol (Engl Ed). 2021;96(3):167-170.
- Jeyachandran D, Natarajan G, Balasubramaniyan T, Thanigachalam D. Rare Ocular Manifestations of Systemic Lupus Erythematosus—Two Case Reports. J Assoc Physicians India. 2014;62(11):52-4.
- Luboń W, Luboń M, Agaś-Lange A, Dorecka M. Systemic Lupus Erythematosus: Ophthalmological Safety Considerations of Emerging and Conventional Therapeutic Agents. Int J Mol Sci. 2025;26(23).
- Suvajac G, Stojanovich L, Milenkovich S. Ocular manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007;6(6):409-14.
- Uludag G, Onghanseng N, Tran ANT, Hassan M, Halim MS, Sepah YJ, et al. Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations. J Ophthalmic Inflamm Infect. 2021;11(1):11.
- Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol. 2023;75(10):1687-1702.
- Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;82(10):1258-1270.
- Joubert M, Desbois AC, Domont F, Ghembaza A, Lejoncour A, Mirouse A, et al. Behçet’s disease uveitis. Rev Med Interne. 2023;44(10):546-554.
- Guan Y, Li F, Li N, Yang P. Decoding Behcet’s Uveitis: an In-depth review of pathogenesis and therapeutic advances. J Neuroinflammation. 2024;21(1):133.
- Bonfioli AA, Orefice F. Behçet’s disease. Semin Ophthalmol. 2005;20(3):199-206.
- Bettiol A, Alibaz-Oner F, Direskeneli H, Hatemi G, Saadoun D, Seyahi E, et al. Vascular Behçet syndrome: from pathogenesis to treatment. Nat Rev Rheumatol. 2023;19(2):111-126.
- Belfeki N, Ghriss N, Fourati M, Leclercq D, Saadoun D. Neuro-Behçet’s disease: A review. Rev Med Interne. 2024;45(10):624-633.
- Borhani-Haghighi A, Kardeh B, Banerjee S, Yadollahikhales G, Safari A, Sahraian MA, et al. Neuro-Behcet’s disease: An update on diagnosis, differential diagnoses, and treatment. Mult Scler Relat Disord. 2020;39:101906.
- Tütüncü Toker R, Bodur M, Bican Demir A, Okan MS. Neuro-Behçet is a rare disease but should be considered in all kinds of neurological findings, even in childhood. Clin Exp Rheumatol. 2022;40(8):1588-1592.
- Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017;69(1):35-45.
- Popescu A, Hickernell J, Paulson A, Aouhab Z. Neurological and Psychiatric Clinical Manifestations of Sjögren Syndrome. Curr Neurol Neurosci Rep. 2024;24(8):293-301.
- Alunno A, Carubbi F, Bartoloni E, Cipriani P, Giacomelli R, Gerli R. The kaleidoscope of neurological manifestations in primary Sjögren’s syndrome. Clin Exp Rheumatol. 2019;37 Suppl 118(3):192-198.
- Seeliger T, Kramer E, Konen FF, Zehrfeld N, Beider S, Prenzler NK, et al. Sjögren’s syndrome with and without neurological involvement. J Neurol. 2023;270(6):2987-2996.
- Fu L, Jones S. Peripheral ulcerative keratitis. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Forestier MG, Calderón RM, Oliver A. An Overview of Rheumatoid Arthritis-Associated Dry Eye Disease, Scleritis, and Peripheral Ulcerative Keratitis. J Clin Med. 2026;15(9).
- Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024;83(1):30-47.
- Kozikowska M, Luboń W, Kucharz EJ, Mrukwa-Kominek E. Ocular manifestations in patients with systemic sclerosis. Reumatologia. 2020;58(6):401-406.
- Fukuda K, Mizobuchi T, Nakajima I, Kishimoto T, Miura Y, Taniguchi Y. Ocular Involvement in Relapsing Polychondritis. J Clin Med. 2021;10(21).
- Gallagher K, Al-Janabi A, Wang A. The ocular manifestations of relapsing polychondritis. Int Ophthalmol. 2023;43(8):2633-2641.
- Hernández P, Al Jalbout N, Matza M, Kohler MJ, Shokoohi H. Temporal Artery Ultrasound for the Diagnosis of Giant Cell Arteritis in the Emergency Department. Cureus. 2023;15(7):e42350.
- Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med. 2017;377(4):317-328.
- Pepper K. Giant cell arteritis. Postgrad Med. 2023;135(sup1):22-32.
- Ruggieri M, Polizzi A, Marceca GP, Catanzaro S, Praticò AD, Di Rocco C. Introduction to phacomatoses (neurocutaneous disorders) in childhood. Childs Nerv Syst. 2020;36(10):2229-2268.
- Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021;23(8):1506-1513.
- Kehrer-Sawatzki H, Cooper DN. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants. Hum Genet. 2022;141(2):177-191.
- Perrino MR, Das A, Scollon SR, Mitchell SG, Greer MC, Yohe ME, et al. Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies. Clin Cancer Res. 2024;30(21):4834-4843.
- Antoniolli LP, Milman LM, Bonamigo RR. Dermoscopy of the iris: identification of Lisch nodules and contribution to the diagnosis of Neurofibromatosis type 1. An Bras Dermatol. 2021;96(4):487-489.
- Bouirig K, Cherkaoui LO. [Lisch nodules: an ophthalmic marker of neurofibromatosis type 1]. Pan Afr Med J. 2022;42:108.
- Viola F, Villani E, Natacci F, Selicorni A, Melloni G, Vezzola D, et al. Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology. 2012;119(2):369-75.
- de Rivas MO, Gabás JM, Cabeza MÁT, Floría OE, Latorre RH, Moscarda EN, et al. Choroidal Hyperreflective Nodules Detected by Infrared Reflectance Images Are a Diagnostic Criterion for Neurofibromatosis Type 1 Patients Excluding Those with High Myopia. Diagnostics (Basel). 2023;13(7).
- Stemmer-Rachamimov AO, Kozanno L, Plotkin SR, Jordan JT, Rd Rizzo JF. Histologic correlates of “Choroidal abnormalities” in Neurofibromatosis type 1 (NF1). Acta Neuropathol. 2024;147(1):71.
- Aihara Y, Chiba K, Eguchi S, Amano K, Kawamata T. Pediatric Optic Pathway/Hypothalamic Glioma. Neurol Med Chir (Tokyo). 2018;58(1):1-9.
- Moreno L, Bautista F, Ashley S, Duncan C, Zacharoulis S. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence. Eur J Cancer. 2010;46(12):2253-9.
- Mohammad M, Alrawashdeh HM, Mehyar M, Amayiri N, Abu Laban D, Alnawaiseh I, et al. Visual Outcome for Children with Optic Pathway Gliomas Treated with Systemic Chemotherapy. Clin Ophthalmol. 2022;16:2933-2942.
- Fangusaro J, Onar-Thomas A, Young Poussaint T, Lensing S, Ligon AH, Lindeman N, et al. A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro Oncol. 2025;27(9):2415-2428.
- Delibay Akgün Y, Erdoğan M, Altınışık M, Mayalı H, İlker SS. Pulsatile Proptosis and Sphenoid Wing Dysplasia with no Evidence of Neurofibromatosis Type 1: A Case Report and Review of the Literature. Turk J Ophthalmol. 2024;54(5):304-308.
- Zapatero ZD, Kalmar CL, Kosyk MS, Carlson AR, Bartlett SP. Sphenoid Wing Dysplasia in the Absence of Neurofibromatosis: Diagnosis and Management of a Novel Phenotype. Plast Reconstr Surg Glob Open. 2021;9(3):e3483.
- Avery RA, Katowitz JA, Fisher MJ, Heidary G, Dombi E, Packer RJ, et al. Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care. Ophthalmology. 2017;124(1):123-132.
- Khatri N, Raza ML, Aijaz A, Ramesh R, Gianchand N, Khan FAA. Neurofibroma: Case Series with Clinical Features and Recommendations. Acta Neurol Taiwan. 2024;33(3):112-121.
- Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet Med. 2022;24(9):1967-1977.
- Evans DG. NF2-related schwannomatosis. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D, et al. EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol. 2020;22(1):31-45.
- Chin EK, Almeida DR, Boldt HC. Combined Hamartoma of the Retina and Retinal Pigment Epithelium Leading to the Diagnosis of Neurofibromatosis Type 2. JAMA Ophthalmol. 2015;133(9):e151289.
- Waisberg V, Rodrigues LO, Nehemy MB, Frasson M, de Miranda DM. Spectral-Domain Optical Coherence Tomography Findings in Neurofibromatosis Type 2. Invest Ophthalmol Vis Sci. 2016;57(9):OCT262-7.
- Emmanouil B, Wasik M, Charbel Issa P, Halliday D, Parry A, Sharma SM. Structural Abnormalities of the Central Retina in Neurofibromatosis Type 2. Ophthalmic Res. 2022;65(1):77-85.
- Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, et al. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021;123:50-66.
- Northrup H, Koenig MK, Pearson DA, Au KS. Tuberous sclerosis complex. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- von Ranke FM, Zanetti G, e Silva JL, Araujo Neto CA, Godoy MC, Souza CA, et al. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement. Lung. 2015;193(5):619-27.
- Pichi F, Massaro D, Serafino M, Carrai P, Giuliari GP, Shields CL, et al. RETINAL ASTROCYTIC HAMARTOMA: Optical Coherence Tomography Classification and Correlation With Tuberous Sclerosis Complex. Retina. 2016;36(6):1199-208.
- Louise M Binderup M, Smerdel M, Borgwadt L, Beck Nielsen SS, Madsen MG, Møller HU, et al. von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance. Eur J Med Genet. 2022;65(8):104538.
- Daniels AB, Tirosh A, Huntoon K, Mehta GU, Spiess PE, Friedman DL, et al. Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance. Cancer. 2023;129(19):2927-2940.
- Khan HA, Shahzad MA, Iqbal F, Awan MA, Khan QA, Saatci AO, et al. Ophthalmological Aspects of von-Hippel-Lindau Syndrome. Semin Ophthalmol. 2021;36(7):531-540.
- Bowen RC, Boldt HC, Mullins RF, Field MG, Affatigato LM, Hoffmann JM, et al. Intrafamilial Variability of Ocular Manifestations of von Hippel-Lindau Disease. Ophthalmol Retina. 2022;6(1):89-91.
- Di Nicola M, Williams BK Jr, Hua J, Bekerman VP, Mashayekhi A, Shields JA, et al. Photodynamic Therapy for Retinal Hemangioblastoma: Treatment Outcomes of 17 Consecutive Patients. Ophthalmol Retina. 2022;6(1):80-88.
- Jones AA, Schloemer NJ, Wirostko WJ. SUCCESSFUL TREATMENT OF VON HIPPEL-LINDAU DISEASE-ASSOCIATED RETINAL CAPILLARY HEMANGIOBLASTOMA WITH BELZUTIFAN IN A PEDIATRIC PATIENT. Retin Cases Brief Rep. 2024;18(5):656-659.
- Yeom S, Comi AM. Updates on Sturge-Weber Syndrome. Stroke. 2022;53(12):3769-3779.
- Ramirez EL, Jülich K. Sturge-Weber syndrome: an overview of history, genetics, clinical manifestations, and management. Semin Pediatr Neurol. 2024;51:101151.
- Sánchez-Espino LF, Ivars M, Antoñanzas J, Baselga E. Sturge-Weber Syndrome: A Review of Pathophysiology, Genetics, Clinical Features, and Current Management Approache. Appl Clin Genet. 2023;16:63-81.
- Poliner A, Fernandez Faith E, Blieden L, Kelly KM, Metry D. Port-wine Birthmarks: Update on Diagnosis, Risk Assessment for Sturge-Weber Syndrome, and Management. Pediatr Rev. 2022;43(9):507-516.
- Farr AK, Shalev B, Crawford TO, Lederman HM, Winkelstein JA, Repka MX. Ocular manifestations of ataxia-telangiectasia. Am J Ophthalmol. 2002;134(6):891-6.
- Torchia D. Types of phacomatosis pigmentovascularis associated with nevus cesius. Acta Dermatovenerol Alp Pannonica Adriat. 2026;35(2):113-120.
- Tam EK, Port A, Martin D, Fridman G, Ness S, Siegel NH. Ocular syphilis resurgence in an urban underserved community in the United States. Int J Ophthalmol. 2022;15(8):1357-1362.
- Eslami M, Noureddin G, Pakzad-Vaezi K, Warner S, Grennan T. Resurgence of ocular syphilis in British Columbia between 2013-2016: a retrospective chart review. Can J Ophthalmol. 2020;55(2):179-184.
- Tsan GL, Claiborne RT. Ocular syphilis. Clin Exp Optom. 2021;104(7):756-759.
- Dutta Majumder P, Chen EJ, Shah J, Ching Wen Ho D, Biswas J, See Yin L, et al. Ocular Syphilis: An Update. Ocul Immunol Inflamm. 2019;27(1):117-125.
- Mckibbin LR, Kadkhoda K, Kellen R, Embil JM. Ocular syphilis in an immunocompetent man. IDCases. 2020;21:e00840.
- Marra CM. Neurosyphilis. Brain. 2025;148(12):4222-4240.
- Sethi V, Marks M. Neurosyphilis in 2025. Curr Opin Neurol. 2025;38(4):397-405.
- Oliver GF, Stathis RM, Furtado JM, Arantes TE, McCluskey PJ, Matthews JM, et al. Current ophthalmology practice patterns for syphilitic uveitis. Br J Ophthalmol. 2019;103(11):1645-1649.
- Arns B, Vieceli T, Gomes E, Scherer MH, Nakashima L, Santos ML, et al. Risk factors for neurosyphilis in HIV patients: A retrospective cohort study. Braz J Infect Dis. 2025;29(3):104519.
- Lawrence D, Cresswell F, Whetham J, Fisher M. Syphilis treatment in the presence of HIV: the debate goes on. Curr Opin Infect Dis. 2015;28(1):44-52.
- Figueira L, Fonseca S, Ladeira I, Duarte R. Ocular tuberculosis: Position paper on diagnosis and treatment management. Rev Port Pneumol (2006). 2017;23(1):31-38.
- Kon OM, Beare N, Connell D, Damato E, Gorsuch T, Hagan G, et al. BTS clinical statement for the diagnosis and management of ocular tuberculosis. BMJ Open Respir Res. 2022;9(1).
- Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, et al. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis. Ophthalmology. 2021;128(2):277-287.
- Chawla R, Tripathy K, Meena S, Behera AK. Subretinal Hypopyon in Presumed Tubercular Uveitis: A Report of Two Cases. Middle East Afr J Ophthalmol. 2018;25(3-4):163-166.
- Rauer S, Kastenbauer S, Hofmann H, Fingerle V, Huppertz HI, Hunfeld KP, et al. Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis. Ger Med Sci. 2020;18:Doc03.
- Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8-16, e1-4.
- Ross Russell AL, Dryden MS, Pinto AA, Lovett JK. Lyme disease: diagnosis and management. Pract Neurol. 2018;18(6):455-464.
- Yap SM, Saeed M, Logan P, Healy DG. Bartonella neuroretinitis (cat-scratch disease). Pract Neurol. 2020;20(6):505-506.
- Akao S, Komori K, Rokutanda R. Self-remitting Bartonella neuroretinitis without a cat scratch. IDCases. 2023;31:e01690.
- Saxena R, Gajjar N, Karnath B, Zhou Y. Bartonella Neuroretinitis: There Is More to Cat Scratch Disease than Meets the Eye. Am J Case Rep. 2023;24:e938380.
- Orellana-Rios J, Verdaguer-Diaz JI, Opazo G, Leong BCS, Zett C, Smith RT, et al. Not cat-scratch disease: Bartonella henselae neuroretinitis associated with non-feline pet mammals. IDCases. 2020;22:e00978.
- Sauer A, Schaeffer M, Serrar Y, Kodjikian L. [Ocular toxoplasmosis]. J Fr Ophtalmol. 2024;47(10):104334.
- Kalogeropoulos D, Sakkas H, Mohammed B, Vartholomatos G, Malamos K, Sreekantam S, et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol. 2022;42(1):295-321.
- Goh EJH, Putera I, La Distia Nora R, Mahendradas P, Biswas J, Chee SP, et al. Ocular Toxoplasmosis. Ocul Immunol Inflamm. 2023;31(7):1342-1361.
- Pescador Ruschel MA, Tristram D, Thapa B. Cryptococcal meningitis. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Jjunju S, Nuwagira E, Meya DB, Muzoora C. Persistently elevated intracranial pressure in cryptococcal meningitis- 76 therapeutic lumbar punctures. Med Mycol Case Rep. 2023;40:50-53.
- Bennett JL. Optic Neuritis. Continuum (Minneap Minn). 2019;25(5):1236-1264.
- Eggenberger E. Optic Neuritis. Continuum (Minneap Minn). 2025;31(2):407-435.
- Mowatt L. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era. West Indian Med J. 2013;62(4):305-12.
- Yang M, Kamoi K, Zong Y, Zhang J, Zou Y, Ohno-Matsui K. Ocular Manifestations of Human Immunodeficiency Virus Infection in the Combination Antiretroviral Therapy Era. Pathogens. 2023;12(12).
- Agarwal A, Singh R, Sharma A, Gupta V, Dogra MR. Ocular Manifestations in Patients with Human Immunodeficiency Virus Infection in the Pre-HAART Versus the HAART Era in the North Indian Population. Ocul Immunol Inflamm. 2017;25(3):396-404.
- Ismail I, Venter M, Ismail S, Ally N. Ocular manifestations of HIV infection at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa. S Afr Med J. 2023;113(10):20-24.
- Sudharshan S, Menia NK, Selvamuthu P, Tyagi M, Kumarasamy N, Biswas J. Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy. Indian J Ophthalmol. 2020;68(9):1887-1893.
- Beltrame A, Kim K, Weiss LM. Human toxoplasmosis: current advances in the field. Curr Opin Infect Dis. 2025;38(5):392-402.
- Gordon LK, Danesh-Meyer H. Neuro-Ophthalmic Manifestations of HIV Infection. Ocul Immunol Inflamm. 2020;28(7):1085-1093.
- Demirkaya N, Wit F, Schlingemann R, Verbraak F. Neuroretinal Degeneration in HIV Patients Without Opportunistic Ocular Infections in the cART Era. AIDS Patient Care STDS. 2015;29(10):519-32.
- Zhang J, Kamoi K, Zong Y, Yang M, Zou Y, Miyagaki M, et al. Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment. Viruses. 2024;16(9).
- Wons J, Kempen J, Garweg JG. HIV-induced Retinitis. Ocul Immunol Inflamm. 2020;28(8):1259-1268.
- Gupta MP, Koenig LR, Doubrovina E, Hasan A, Dahi PB, O’Reilly RJ, et al. Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes. Ophthalmol Retina. 2021;5(9):838-849.
- Morjaria R, Sood V, Manavi K, Denniston AK, Palmer H. Lowering the limit: reducing the CD4 T-cell threshold for ophthalmic screening in patients with HIV in an ethnically diverse UK population. Clin Ophthalmol. 2014;8:2029-34.
- Newsom RS, Ong GL, Jackson TL, Coldrick I, Ripley LG, Fisher M, et al. Screening for CMV retinitis using chromatic discrimination thresholds and achromatic contrast sensitivity. Br J Ophthalmol. 2000;84(8):877-80.
- Aggarwal A, Mandadi S, Pathengay A, Pappuru RR, Sadda S, Naresh Shah P, et al. Acute Aggressive Posterior Progressive Necrotising Retinitis: Re-Evaluating Progressive Outer Retinal Necrosis. Semin Ophthalmol. 2025.
- Singh A, Kumar A, Shankar S, Vashisht R, Kaushik J, Dubbaka S. Triple trouble: syphilitic neuroretinitis preceding progressive outer retinal necrosis in a HIV-infected man. AIDS. 2022;36(8):1203-1204.
- Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2021;17(1):37-51.
- Sudhakar P, Bachman DM, Mark AS, Berger JR, Kedar S. Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review. J Neuroophthalmol. 2015;35(3):296-305.
- Hettipathirannahelage S, Wijetilleka S, Jewsbury H. Progressive multifocal leukoencephalopathy in a patient with occult hypogammaglobulinemia experiencing bilateral visual impairment. Eur J Ophthalmol. 2022;32(3):NP33-NP40.
- Varenne F, Siegfried-Vergnon A, Lhomme S, Treiner E, Pignolet B, Joly M, et al. JC Virus-Related Retinopathy. JAMA Ophthalmol. 2025;143(9):785-789.
- Vivekanandan G, Abubacker AP, Myneni R, Chawla HV, Iqbal A, Grewal A, et al. Risk of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patient Treated With Natalizumab: A Systematic Review. Cureus. 2021;13(4):e14764.
- Rindi LV, Zaçe D, Braccialarghe N, Massa B, Barchi V, Iannazzo R, et al. Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis. Drug Saf. 2024;47(4):333-354.
- Li J, Liao B, Yang Z, Zhang J, Fan Y, Xing S, et al. Combination of low-dose, long-term immunoglobulin and mirtazapine is effective in progressive multifocal leukoencephalopathy caused by JC virus infection. BMC Neurol. 2024;24(1):384.
- Urban B, Bakunowicz-Łazarczyk A, Michalczuk M. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment. Mediators Inflamm. 2014;2014:971417.
- Kim JH, Cho MH, Ban JH, Lee SH, Lee JS. Ocular Manifestations of Immune Reconstitution Inflammatory Syndrome in HIV after Highly Active Antiretroviral Therapy: Clinical Use of CD8+ T cell. Korean J Ophthalmol. 2025;39(1):71-79.
- Dionson MM. Immune recovery uveitis: an ocular manifestation in HIV/AIDS receiving treatment. Curr Opin Ophthalmol. 2024;35(6):507-512.
- Lequain H, Abramowicz S, Seiller J, Abukhashbah A, Burillon C, Vignot E, et al. Immune recovery uveitis in Whipple’s disease: an unusual ocular presentation. J Ophthalmic Inflamm Infect. 2024;14(1):10.
- Multani EK, Bajwa D, Multani PK, Nobakht E, Raj D, Paul RS. Eye disease in kidney transplantation: Clinical challenges in a unique patient population. Surv Ophthalmol. 2022;67(4):1252-1269.
- Oakes V, Bahl D, Antony S. Cytomegalovirus Retinitis Diagnosis and Treatment in a Kidney Transplant Recipient. Infect Disord Drug Targets. 2020;20(6):925-928.
- Soleimani M, Mahdavi Sharif P, Cheraqpour K, Koganti R, Masoumi A, Baharnoori SM, et al. Ocular graft-versus-host disease (oGVHD): From A to Z. Surv Ophthalmol. 2023;68(4):697-712.
- Martens A, Schauwvlieghe PP, Madoe A, Casteels I, Aspeslagh S. Ocular adverse events associated with immune checkpoint inhibitors, a scoping review. J Ophthalmic Inflamm Infect. 2023;13(1):5.
- Pinto SN, Liu CJ, Nelson MD Jr, Bluml S, Livingston D, Tamrazi B. Neuroimaging of complications arising after CD19 chimeric antigen receptor T-cell therapy: A review. J Neuroimaging. 2023;33(5):703-715.
- Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, et al. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev. 2015;14(6):503-9.
- Torres T, Brembilla NC, Langley RG, Warren RB, Thaçi D, Kolios AGA, et al. Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus. J Eur Acad Dermatol Venereol. 2025;39(1):52-69.
- Moodley A, Rae W, Bhigjee A. Visual loss in HIV-associated cryptococcal meningitis: A case series and review of the mechanisms involved. South Afr J HIV Med. 2015;16(1):305.
- Liu L, Zhang R, Tang Y, Lu H. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus. Biosci Trends. 2014;8(6):327-32.
- Soussain C, Malaise D, Cassoux N. Primary vitreoretinal lymphoma: a diagnostic and management challenge. Blood. 2021;138(17):1519-1534.
- Kalogeropoulos D, Vartholomatos G, Mitra A, Elaraoud I, Ch’ng SW, Zikou A, et al. Primary vitreoretinal lymphoma. Saudi J Ophthalmol. 2019;33(1):66-80.
- Sobolewska B, Chee SP, Zaguia F, Goldstein DA, Smith JR, Fend F, et al. Vitreoretinal Lymphoma. Cancers (Basel). 2021;13(16).
- Takuva S, Takalani A, Seocharan I, Yende-Zuma N, Reddy T, Engelbrecht I, et al. Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. PLoS Med. 2022;19(6):e1004024.
- Rayens E, Sy LS, Qian L, Wu J, Ackerson BK, Luo Y, et al. Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study. Ann Rheum Dis. 2025;84(6):960-969.
- Merle H, Donnio A, Jean-Charles A, Guyomarch J, Hage R, Najioullah F, et al. Ocular manifestations of emerging arboviruses: Dengue fever, Chikungunya, Zika virus, West Nile virus, and yellow fever. J Fr Ophtalmol. 2018;41(6):e235-e243.
- Zina SM, Hoarau G, Labetoulle M, Khairallah M, Rousseau A. Ocular Manifestations of Flavivirus Infections. Pathogens. 2023;12(12).
- Labib BA, Chigbu DI. Pathogenesis and Manifestations of Zika Virus-Associated Ocular Diseases. Trop Med Infect Dis. 2022;7(6).
- Wang C, Castillo A, Cortes-Bejarano F, Lopez E, de Souza EC, Wu L. An update on the ocular manifestations of dengue. Taiwan J Ophthalmol. 2024;14(4):540-547.
- Trivedi S, Chakravarty A. Neurological Complications of Dengue Fever. Curr Neurol Neurosci Rep. 2022;22(8):515-529.
- Dossett JP, Clavell CI, Ghorayeb G. Ocular manifestations of West Nile virus. Curr Opin Ophthalmol. 2024;35(6):521-525.
- Yu A, Ferenczi E, Moussa K, Eliott D, Matiello M. Clinical Spectrum of West Nile Virus Neuroinvasive Disease. Neurohospitalist. 2020;10(1):43-47.
- da Silva LCM, da Silva Platner F, da Silva Fonseca L, Rossato VF, de Andrade DCP, de Sousa Valente J, et al. Ocular Manifestations of Chikungunya Infection: A Systematic Review. Pathogens. 2022;11(4).
- Nguyen M, Doan T, Seitzman GD. Ocular manifestations of mpox. Curr Opin Ophthalmol. 2024;35(5):423-429.
- Chakravarty N, Hemani D, Paravastu R, Ahmad Z, Palani SN, Arumugaswami V, et al. Mpox Virus and its ocular surface manifestations. Ocul Surf. 2024;34:108-121.
- Dinkin M, Sathi S. Neuro-Ophthalmic Visual Impairment in the Setting of COVID-19. Semin Neurol. 2023;43(2):268-285.
- Tisdale AK, Chwalisz BK. Neuro-ophthalmic manifestations of coronavirus disease 19. Curr Opin Ophthalmol. 2020;31(6):489-494.
- Bista B, Yadav R, Gupta S, Das SS, Rajak A, Acharya R, et al. Ocular and Neuro-ophthalmic Manifestations Post COVID-19 Infection. J Nepal Health Res Counc. 2023;21(1):184-186.
- Hu K, Patel J, Swiston C, Patel BC. Ophthalmic manifestations of coronavirus (COVID-19). En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Stawowski AR, Konopińska J, Stawowski SS, Adamczuk J, Groth M, Moniuszko-Malinowska A, et al. The Review of Ophthalmic Symptoms in COVID-19. Clin Ophthalmol. 2024;18:1417-1432.
- Sitaula S, Shah C, Shah GS, Ojha R. Neuro-Ophthalmic Manifestation Associated With COVID-19 in a Tertiary Eye Center in Nepal. Case Rep Ophthalmol Med. 2025;2025:6694537.
- Shi J, Danesh-Meyer HV. A review of neuro-ophthalmic sequelae following COVID-19 infection and vaccination. Front Cell Infect Microbiol. 2024;14:1345683.
- Shemer A, Greenbaum A, Toledano A, Biron R, Dubinsky-Pertzov B, Or L. Optic Neuritis After SARS-CoV-2 Vaccination. J Neuroophthalmol. 2023;43(1):29-33.
- Pirani V, Pelliccioni P, Carpenè MJ, Nicolai M, Barbotti F, Franceschi A, et al. Optic neuritis following COVID-19 vaccination: Do autoimmune diseases play a role?. Eur J Ophthalmol. 2023;33(4):NP46-NP50.
- Elnahry AG, Asal ZB, Shaikh N, Dennett K, Abd Elmohsen MN, Elnahry GA, et al. Optic neuropathy after COVID-19 vaccination: a report of two cases. Int J Neurosci. 2023;133(8):901-907.
- Etemadifar M, Nouri H, Abtahi SH, Bathaei R, Mardi R, Salari M, et al. Optic neuritis following COVID-19 vaccination: Case series and review of the literature. J Fr Ophtalmol. 2024;47(8):104264.
- Zhang J, Joiner D, Zhang C. Hyperacute optic neuritis in a patient with COVID-19 infection and vaccination: a case report. BMC Ophthalmol. 2023;23(1):80.
- Hurissi EA, Abuallut II, Dibaji MQ, Jaly A, Alhazmi AH, Abuageelah BM, et al. Ocular Complications after COVID-19 Vaccination: A Systematic Review. Medicina (Kaunas). 2024;60(2).
- Jaffry M, Aftab OM, Mostafa FB, Faiz I, Jaffry K, Mandava K, et al. Optic Neuritis After COVID-19 Vaccination: An Analysis of the Vaccine Adverse Event Reporting System. J Neuroophthalmol. 2023;43(4):499-503.
- Li JX, Wang YH, Bair H, Hsu SB, Chen C, Wei JC, et al. Risk assessment of retinal vascular occlusion after COVID-19 vaccination. NPJ Vaccines. 2023;8(1):64.
- Dorney I, Shaia J, Kaelber DC, Talcott KE, Singh RP. Risk of New Retinal Vascular Occlusion After mRNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data. JAMA Ophthalmol. 2023;141(5):441-447.
- Napal B, García-Palacios JD, González-Mesones B, Napal JJ, Hernández JL. Retinal vein occlusion in the general population after COVID-19 vaccination and infection. Med Clin (Barc). 2023;161(6):231-237.
- Van Holle L. Observed Versus Expected Analysis-How Does It Fit in the Pharmacovigilance Toolkit?. Drug Saf. 2025;48(12):1325-1330.
- Nie X, Xu L, Bai Y, Liu Z, Liu Z, Farrington P, et al. Self-controlled case series design in vaccine safety: a systematic review. Expert Rev Vaccines. 2022;21(3):313-324.
- Amanzio M, Mitsikostas DD, Giovannelli F, Bartoli M, Cipriani GE, Brown WA. Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review. Lancet Reg Health Eur. 2022;12:100253.
- Bender FL, Rief W, Wilhelm M. Really just a little prick? A meta-analysis on adverse events in placebo control groups of seasonal influenza vaccination RCTs. Vaccine. 2023;41(2):294-303.
- Hazell L, Shakir SA. Under-reporting of adverse drug reactions : a systematic review. Drug Saf. 2006;29(5):385-96.
- Montané E, Santesmases J. Adverse drug reactions. Med Clin (Barc). 2020;154(5):178-184.
- Liu Q, Liang G, Song Y. Adverse events following 9-valent human papillomavirus vaccine (GARDASIL® 9) reported to the Vaccine Adverse Event Reporting System (VAERS), 2015-2024. Hum Vaccin Immunother. 2025;21(1):2530831.
- Zipkin DA, Umscheid CA, Keating NL, Allen E, Aung K, Beyth R, et al. Evidence-based risk communication: a systematic review. Ann Intern Med. 2014;161(4):270-80.
- Kundi M, Obermeier P, Helfert S, Oubari H, Fitzinger S, Yun JA, et al. The impact of the parent-physician relationship on parental vaccine safety perceptions. Curr Drug Saf. 2015;10(1):16-22.
- Prieto-Campo Á, García-Álvarez RM, López-Durán A, Roque F, Herdeiro MT, Figueiras A, et al. Understanding Primary Care Physician Vaccination Behaviour: A Systematic Review. Int J Environ Res Public Health. 2022;19(21).
- Moss HE. Neuro-ophthalmology and Pregnancy. Continuum (Minneap Minn). 2022;28(1):147-161.
- Gilbert AL, Prasad S, Mallery RM. Neuro-Ophthalmic Disorders in Pregnancy. Neurol Clin. 2019;37(1):85-102.
- Digre KB. Neuro-ophthalmology and pregnancy: what does a neuro-ophthalmologist need to know?. J Neuroophthalmol. 2011;31(4):381-7.
- Anton N, Bogdănici CM, Branișteanu DC, Armeanu T, Ilie OD, Doroftei B. A Narrative Review on Neuro-Ophthalmological Manifestations That May Occur during Pregnancy. Life (Basel). 2024;14(4).
- American College of Obstetricians and Gynecologists. Committee Opinion No. 723: guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017;130(4):e210-e216.
- Garg P, Aggarwal P. Ocular changes in pregnancy. Nepal J Ophthalmol. 2012;4(1):150-61.
- Agrawal N, Agarwal LT, Lavaju P, Chaudhary SK. Physiological Ocular Changes in Various Trimesters of Pregnancy. Nepal J Ophthalmol. 2018;10(19):16-22.
- Khong EWC, Chan HHL, Watson SL, Lim LL. Pregnancy and the eye. Curr Opin Ophthalmol. 2021;32(6):527-535.
- López-Prats MJ, Hidalgo-Mora JJ, Sanz-Marco E, Pellicer A, Perales A, Díaz-Llopis M. [Influence of pregnancy on refractive parameters after LASIK surgery]. Arch Soc Esp Oftalmol. 2012;87(6):173-8.
- Lee SC, Siebert E, Raja V, Mehrotra C, Richards J, Khan J, et al. Determinants of progression of diabetic retinopathy in pregnancy. Diabetes Res Clin Pract. 2024;214:111784.
- Widyaputri F, Lim LL. Diabetic retinopathy in pregnancy: A growing problem. Clin Exp Ophthalmol. 2023;51(3):192-194.
- Stern EM, Blace N. Ocular manifestations of preeclampsia. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Abu Samra K. The eye and visual system in the preeclampsia/eclampsia syndrome: What to expect?. Saudi J Ophthalmol. 2013;27(1):51-3.
- Roos NM, Wiegman MJ, Jansonius NM, Zeeman GG. Visual disturbances in (pre)eclampsia. Obstet Gynecol Surv. 2012;67(4):242-50.
- Păun VA, Ionescu ZR, Voinea L, Cîrstoiu M, Baroș A, Pricopie Ș, et al. Ocular posterior pole pathological modifications related to complicated pregnancy. A review. Rom J Ophthalmol. 2017;61(2):83-89.
- Chandran JR, Narayanan IB, Rajan J. Ocular Manifestations: Are They Significant in Hypertensive Disorders of Pregnancy?. J Obstet Gynaecol India. 2021;71(2):118-123.
- Benlghazi A, Bouhtouri Y, Belouad M, Brarou H, Messaoudi H, Benali S, et al. Bilateral serous retinal detachment in pre-eclampsia a rare but favorable complication: case report. Oxf Med Case Reports. 2023;2023(10):omad109.
- Kini AT, Tabba S, Mitchell T, Al Othman B, Lee AG. Simultaneous Bilateral Serous Retinal Detachments and Cortical Visual Loss in the PRES HELLP Syndrome. J Neuroophthalmol. 2021;41(1):e60-e63.
- Byth LA, Lust K, Jeffree RL, Paine M, Voldanova L, Craven AM. Management of idiopathic intracranial hypertension in pregnancy. Obstet Med. 2022;15(3):160-167.
- Scott C, Kaliaperumal C. Idiopathic intracranial hypertension and pregnancy: A comprehensive review of management. Clin Neurol Neurosurg. 2022;217:107240.
- Park DSJ, Park JSY, Sharma S, Sharma RA. Idiopathic Intracranial Hypertension in Pregnancy. J Obstet Gynaecol Can. 2021;43(11):1292-1295.
- Alves S, Sousa N, Cardoso LÍ, Alves J. Multidisciplinary management of idiopathic intracranial hypertension in pregnancy: case series and narrative review. Braz J Anesthesiol. 2022;72(6):790-794.
- Falardeau J, Lobb BM, Golden S, Maxfield SD, Tanne E. The use of acetazolamide during pregnancy in intracranial hypertension patients. J Neuroophthalmol. 2013;33(1):9-12.
- Tritos NA, Miller KK. Diagnosis and Management of Pituitary Adenomas: A Review. JAMA. 2023;329(16):1386-1398.
- Šulavíková Z, Krásnik V. GIANT PROLACTINOMA. A CASE REPORT. Cesk Slov Oftalmol. 2023;79(3):143-148.
- Iglesias P. Pituitary Apoplexy: An Updated Review. J Clin Med. 2024;13(9).
- Gheorghe AM, Trandafir AI, Stanciu M, Popa FL, Nistor C, Carsote M. Challenges of Pituitary Apoplexy in Pregnancy. J Clin Med. 2023;12(10).
- Miljic D, Pekic S, Popovic V. Empty sella. En: Endotext [Internet]. South Dartmouth: MDText.com; 2000.
- Vukusic S, Marignier R. Multiple sclerosis and pregnancy in the ‘treatment era’. Nat Rev Neurol. 2015;11(5):280-9.
- Graham EL. Neuroimmunological Disorders: The Gender Effect. Neurol Clin. 2023;41(2):315-330.
- Krysko KM, Dobson R, Alroughani R, Amato MP, Bove R, Ciplea AI, et al. Family planning considerations in people with multiple sclerosis. Lancet Neurol. 2023;22(4):350-366.
- Kaplan TB. Management of Demyelinating Disorders in Pregnancy. Neurol Clin. 2019;37(1):17-30.
- Wang Y, Wang J, Feng J. Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options. Autoimmun Rev. 2023;22(11):103449.
- Valderrama-Albino V, Loayza-Gamboa W, Campos-Dávila B, Quispe-Ramírez A, Arenas-Canchuja F, Valera-Cornejo D. Chorioretinal Findings in a Patient with New-Onset Systemic Lupus Erythematosus and Antiphospholipid Syndrome after Stillbirth Associated with Pre eclampsia. Ocul Immunol Inflamm. 2024;32(3):295-300.
- Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021;20(8):653-670.
- Razeghinejad MR. Glaucoma medications in pregnancy. Oman J Ophthalmol. 2018;11(3):195-199.
- Salvetat ML, Toro MD, Pellegrini F, Scollo P, Malaguarnera R, Musa M, et al. Advancing Glaucoma Treatment During Pregnancy and Breastfeeding: Contemporary Management Strategies and Prospective Therapeutic Developments. Biomedicines. 2024;12(12).
- Algahtani H, Bazaid A, Shirah B, Bouges RN. Cerebral venous sinus thrombosis in pregnancy and puerperium: A comprehensive review. Brain Circ. 2022;8(4):180-187.
- Dix C, Hunt BJ. The changing face of cerebral venous sinus thrombosis-emerging new causes and treatments. J Thromb Haemost. 2024;22(12):3346-3354.
- Song TJ, Lee KH, Li H, Kim JY, Chang K, Kim SH, et al. Reversible cerebral vasoconstriction syndrome: a comprehensive systematic review. Eur Rev Med Pharmacol Sci. 2021;25(9):3519-3529.
- Sharma M, Menon B, Manam G. Postpartum Reversible Cerebral Vasoconstriction Syndrome Presenting with Radiological Plethora. Indian J Radiol Imaging. 2021;31(3):764-767.
- More SA, Atal S, Mishra PS. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions. J Pharmacol Toxicol Methods. 2024;127:107514.
- Mustak H, Rogers G, Cook C. Ethambutol induced toxic optic neuropathy in HIV positive patients. Int J Ophthalmol. 2013;6(4):542-5.
- Kaur P, Singh S, Kaur K, Mahesh KV, Tigari B, Sehgal V, et al. The Genetics of Ethambutol-Induced Optic Neuropathy: A Narrative Review. Neuroophthalmology. 2022;46(5):304-313.
- Libershteyn Y. Ethambutol/Linezolid Toxic Optic Neuropathy. Optom Vis Sci. 2016;93(2):211-7.
- Chen D, Hedges TR. Amiodarone optic neuropathy—review. Semin Ophthalmol. 2003;18(4):169-73.
- Rasool N, Boudreault K, Lessell S, Prasad S, Cestari DM. Tacrolimus Optic Neuropathy. J Neuroophthalmol. 2018;38(2):160-166.
- Feizi N, Mohamadzadeh-Nabiei M, Vahedi H, Farabi Maleki S, Jafarizadeh A. Therapeutic role of erythropoietin in methanol induced optic neuropathy: a systematic review. Daru. 2024;33(1):2.
- Liu B, Zhu L, Zhong J, Zeng G, Deng T. The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis. Sex Med. 2018;6(3):185-192.
- Quist SW, Dorsthorst ST, Freriks RD, Postma MJ, Hoyng CB, van Asten F. Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens. Eur J Health Econ. 2025;26(3):413-425.
- Kang JS, Ahn SJ, Kim YJ. Effect of Cataracts on Hydroxychloroquine Retinopathy Screening. Diagnostics (Basel). 2025;15(21).
- Hanif AM, Armenti ST, Taylor SC, Shah RA, Igelman AD, Jayasundera KT, et al. Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study. JAMA Ophthalmol. 2019;137(11):1275-1282.
- Yuan Z, Vaughan S, Jeffcoat C, Hu P, Yuson R, Fife D, et al. Retrospective study of incidence/prevalence of pigmentary maculopathy and retinopathy in patients receiving pentosan polysulfate sodium. PLoS One. 2025;20(1):e0313497.
- Ohning C, Skopis G, Levinson J, Kasi S. Characteristics of Pentosan Polysulfate Sodium-Associated Maculopathy and Similarities With Other Maculopathies Commonly Managed in a Retina Practice. J Vitreoretin Dis. 2022;6(2):104-110.
- Tenney S, Oboh-Weilke A, Wagner D, Chen MY. Tamoxifen retinopathy: A comprehensive review. Surv Ophthalmol. 2024;69(1):42-50.
- Rentiya ZS, Wells M, Bae J, Chen KJ, Chao AN, Turgeon N, et al. Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations. Graefes Arch Clin Exp Ophthalmol. 2019;257(3):447-452.
- Arora S, Surakiatchanukul T, Arora T, Errera MH, Agrawal H, Lupidi M, et al. Retinal toxicities of systemic anticancer drugs. Surv Ophthalmol. 2022;67(1):97-148.
- Méndez-Martínez S, Calvo P, Ruiz-Moreno O, Pardiñas Barón N, Leciñena Bueno J, Gil Ruiz MDR, et al. OCULAR ADVERSE EVENTS ASSOCIATED WITH MEK INHIBITORS. Retina. 2019;39(8):1435-1450.
- Jeng-Miller KW, Miller MA, Heier JS. Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation. Oncologist. 2024;29(5):e616-e621.
- Hendershot A, Slabaugh M, Riaz KM, Moore KN, O’Malley DM, Matulonis U, et al. Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansine. Gynecol Oncol Rep. 2023;47:101155.
- Moore KN, Lorusso D, Oaknin A, Oza A, Colombo N, Van Gorp T, et al. Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha-expressing recurrent ovarian cancer: An integrated safety summary. Gynecol Oncol. 2024;191:249-258.
- Arkell TR, Brooks-Russell A, Downey LA, Shiferaw B, Brown T, Sherrick J, et al. Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review. Neurosci Biobehav Rev. 2022;141:104831.
- Roberti G, Oddone F, Agnifili L, Katsanos A, Michelessi M, Mastropasqua L, et al. Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management. Surv Ophthalmol. 2020;65(4):458-472.
- Rapoport Y, Benegas N, Kuchtey RW, Joos KM. Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: a case report and review of the literature. BMC Pediatr. 2014;14:96.
- Khan S, Ashraf A, Javaid H, Khizer MA. Topiramate-induced Acute Transient Myopia and Angle Narrowing. J Coll Physicians Surg Pak. 2021;31(6):728-731.
- Bettoli V, Borghi A, Mantovani L, Scorrano R, Minghetti S, Toni G, et al. Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline. Eur J Dermatol. 2011;21(6):1024-5.
- Fecarotta C, Sergott RC. Vigabatrin-associated visual field loss. Int Ophthalmol Clin. 2012;52(3):87-94, xii.
- Maguire MJ, Hemming K, Wild JM, Hutton JL, Marson AG. Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia. 2010;51(12):2423-31.
- Sevene E, Mariano A, Mehta U, Machai M, Dodoo A, Vilardell D, et al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf. 2008;31(10):867-76.
- Chan SHY, Layton D, Webley S, Salek S. Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting. Cancers (Basel). 2024;16(24).
- Hilkens NA, Casolla B, Leung TW, de Leeuw FE. Stroke. Lancet. 2024;403(10446):2820-2836.
- Shaikh MT, Younas U, Irshad I, Rathore FA. Rehabilitation of hemispatial neglect in stroke. J Pak Med Assoc. 2022;72(4):779-781.
- Shin JH, Kim M, Lee JY, Kim MY, Jeon YJ, Kim K. Feasibility of hemispatial neglect rehabilitation with virtual reality-based visual exploration therapy among patients with stroke: randomised controlled trial. Front Neurosci. 2023;17:1142663.
- Ruddy J, Asuncion RMD, Cardenas AC. Hemianopsia. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Romozzi M, Lucioli G, Marini S, Monforte M, Broccolini A. Anton syndrome. Neurol Sci. 2023;44(3):1119-1120.
- Pisella L, Vialatte A, Khan AZ, Rossetti Y. Bálint syndrome. Handb Clin Neurol. 2021;178:233-255.
- Rashid AS, Rashid D, Yang G, Link H, Gauffin H, Huang-Link Y. Homonymous visual field defect and retinal thinning after occipital stroke. Brain Behav. 2021;11(10):e2345.
- Fahrenthold BK, Cavanaugh MR, Tamhankar M, Lam BL, Feldon SE, Johnson BA, et al. Training in cortically-blind fields confers patient-specific benefit against retinal thinning after occipital stroke. medRxiv. 2023.
- Biousse V, Trobe JD. Transient monocular visual loss. Am J Ophthalmol. 2005;140(4):717-21.
- Shah J, Liu S, Yu W. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines. Stroke Vasc Neurol. 2022;7(5):406-414.
- Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I-LXII.
- Günkan A, Ferreira MY, Vilardo M, Scarcia L, Bocanegra-Becerra JE, Cardoso LJC, et al. Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials. Stroke. 2025;56(3):580-590.
- Warach SJ, Dula AN, Milling TJ Jr. Tenecteplase Thrombolysis for Acute Ischemic Stroke. Stroke. 2020;51(11):3440-3451.
- Rashedi S, Leyva H, Hamade N, Pfeferman MB, Ortega-Paz L, Sadeghipour P, et al. Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions. J Am Coll Cardiol. 2025;86(14):1065-1087.
- Jadhav AP, Desai SM, Jovin TG. Indications for Mechanical Thrombectomy for Acute Ischemic Stroke: Current Guidelines and Beyond. Neurology. 2021;97(20 Suppl 2):S126-S136.
- Bogenschutz KM, Fisher DS, Wright GW. Acute ischemic stroke: A guideline-based overview of evaluation and management. JAAPA. 2025;38(5):13-20.
- Wang X, Liu Y, Suo Y, Qin D, Ren M, Lei R, et al. Intravenous Recombinant Tissue-Type Plasminogen Activator Thrombolysis for Acute Central Retinal Artery Occlusion. J Craniofac Surg. 2021;32(1):313-316.
- Poli S, Grohmann C, Wenzel DA, Poli K, Tünnerhoff J, Nedelmann M, et al. Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial. Int J Stroke. 2024;19(7):823-829.
- Bhatia K, Ladd LM, Carr KH, Di Napoli M, Saver JL, McCullough LD, et al. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines. Curr Neurol Neurosci Rep. 2023;23(5):235-262.
- Rowe FJ, Hepworth LR, Howard C, Hanna KL, Cheyne CP, Currie J. High incidence and prevalence of visual problems after acute stroke: An epidemiology study with implications for service delivery. PLoS One. 2019;14(3):e0213035.
- Elfeky A, D’Août K, Lawson R, Hepworth LR, Thomas NDA, Clynch A, et al. Biomechanical adaptation to post-stroke visual field loss: a systematic review. Syst Rev. 2021;10(1):84.
- Bergsma DP, van der Wildt G. Visual training of cerebral blindness patients gradually enlarges the visual field. Br J Ophthalmol. 2010;94(1):88-96.
- Matteo BM, Viganò B, Cerri CG, Perin C. Visual field restorative rehabilitation after brain injury. J Vis. 2016;16(9):11.
- Raffin E, Salamanca-Giron RF, Hummel FC. Perspectives: Hemianopia-Toward Novel Treatment Options Based on Oscillatory Activity?. Neurorehabil Neural Repair. 2020;34(1):13-25.
- Cheng J, Paracha SS, Agrawal S, Wu Z, Sung CH. Recent Advances in Visual Dysfunction and Ocular Biomarkers in Neurological Disorders. Eye Brain. 2025;17:49-67.
- Buzzi M, Giannaccare G, Cennamo M, Bernabei F, Rothschild PR, Vagge A, et al. Ocular Surface Features in Patients with Parkinson Disease on and off Treatment: A Narrative Review. Life (Basel). 2022;12(12).
- Schindlbeck KA, Schönfeld S, Naumann W, Friedrich DJ, Maier A, Rewitzer C, et al. Characterization of diplopia in non-demented patients with Parkinson’s disease. Parkinsonism Relat Disord. 2017;45:1-6.
- Visser F, Vlaar AMM, Borm CDJM, Apostolov V, Lee YX, Notting IC, et al. Diplopia in Parkinson’s disease: visual illusion or oculomotor impairment?. J Neurol. 2019;266(10):2457-2464.
- Likitgorn T, Yan Y, Liao YJ. Freezing of saccades in dopa-responsive parkinsonian syndrome. Am J Ophthalmol Case Rep. 2021;23:101124.
- Bulens C, Meerwaldt JD, Van der Wildt GJ, Van Deursen JB. Effect of levodopa treatment on contrast sensitivity in Parkinson’s disease. Ann Neurol. 1987;22(3):365-9.
- Bernardinis M, Atashzar SF, Jog MS, Patel RV. Visual velocity perception dysfunction in Parkinson’s disease. Behav Brain Res. 2023;452:114490.
- Rascunà C, Russo A, Terravecchia C, Castellino N, Avitabile T, Bonfiglio V, et al. Retinal Thickness and Microvascular Pattern in Early Parkinson’s Disease. Front Neurol. 2020;11:533375.
- Lee JY, Martin-Bastida A, Murueta-Goyena A, Gabilondo I, Cuenca N, Piccini P, et al. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat Rev Neurol. 2022;18(4):203-220.
- Tran KKN, Wong VHY, Lim JKH, Shahandeh A, Hoang A, Finkelstein DI, et al. Characterization of retinal function and structure in the MPTP murine model of Parkinson’s disease. Sci Rep. 2022;12(1):7610.
- d’Angremont E, Begemann MJH, van Laar T, Sommer IEC. Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis. JAMA Neurol. 2023;80(8):813-823.
- Kukkle PL, Neupane R, Pantelyat A, Wills AM, Jabbari E, Dopper EGP, et al. Progressive Supranuclear Palsy-A Global Review. Mov Disord Clin Pract. 2026;13(3):611-622.
- Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, et al. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. Mov Disord. 2019;34(8):1144-1153.
- Lloyd-Smith Sequeira A, Rizzo JR, Rucker JC. Clinical Approach to Supranuclear Brainstem Saccadic Gaze Palsies. Front Neurol. 2017;8:429.
- Buch KA, Bouffard MA, Kardon RH, Wills AA, Privitera CM, Sharma M, et al. Clinical Correlation Between Vertical Gaze Palsy and Midbrain Volume in Progressive Supranuclear Palsy. J Neuroophthalmol. 2022;42(2):246-250.
- Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496-503.
- Rohrer J, Ryan B, Ahmed R. MAPT-related frontotemporal dementia. En: GeneReviews [Internet]. Seattle: University of Washington; 1993.
- Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, et al. The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Mov Disord. 2022;37(6):1131-1148.
- Winder JY, Roos RAC. Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice. PLoS One. 2018;13(3):e0193866.
- McBride SD, Ober J, Dylak J, Schneider W, Morton AJ. Oculomotor Abnormalities in a Sheep (Ovis aries) Model of Huntington’s Disease: Towards a Biomarker for Assessing Therapeutic Efficacy. J Huntingtons Dis. 2023;12(3):189-200.
- Donald A, Tan CY, Chakrapani A, Hughes DA, Sharma R, Cole D, et al. Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease. Orphanet J Rare Dis. 2020;15(1):349.
- Guo X, Liu X, Ye S, Liu X, Yang X, Fan D. Eye Movement Abnormalities in Amyotrophic Lateral Sclerosis. Brain Sci. 2022;12(4).
- Rekik A, Mrabet S, Kacem I, Nasri A, Ben Djebara M, Gargouri A, et al. Eye Movement Abnormalities in Amyotrophic Lateral Sclerosis in a Tunisian Cohort. Neuroophthalmology. 2022;46(4):227-235.
- Barczak A, Sitek EJ, Chudoba T. [Visual impairment in posterior cortical atrophy—visual variant of Alzheimer’s disease in the ophthalmic practice]. Klin Oczna. 2014;116(3):215-8.
- Putcha D, Brickhouse M, Touroutoglou A, Collins JA, Quimby M, Wong B, et al. Visual cognition in non-amnestic Alzheimer’s disease: Relations to tau, amyloid, and cortical atrophy. Neuroimage Clin. 2019;23:101889.
- Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. 2024;81(3):255-263.
- Heneka MT, Morgan D, Jessen F. Passive anti-amyloid β immunotherapy in Alzheimer’s disease-opportunities and challenges. Lancet. 2024;404(10468):2198-2208.
- Hardy J. Alzheimer’s Disease: Treatment Challenges for the Future. J Neurochem. 2025;169(8):e70176.
- Noah AM, Almghairbi D, Moppett IK. Optical coherence tomography in mild cognitive impairment - Systematic review and meta-analysis. Clin Neurol Neurosurg. 2020;196:106036.
- Wang X, Zhao Q, Tao R, Lu H, Xiao Z, Zheng L, et al. Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study. Front Aging Neurosci. 2020;12:572484.
- Lemmens S, Devulder A, Van Keer K, Bierkens J, De Boever P, Stalmans I. Systematic Review on Fractal Dimension of the Retinal Vasculature in Neurodegeneration and Stroke: Assessment of a Potential Biomarker. Front Neurosci. 2020;14:16.
- Koronyo Y, Rentsendorj A, Mirzaei N, Regis GC, Sheyn J, Shi H, et al. Retinal pathological features and proteome signatures of Alzheimer’s disease. Acta Neuropathol. 2023;145(4):409-438.
- Gaire BP, Koronyo Y, Fuchs DT, Shi H, Rentsendorj A, Danziger R, et al. Alzheimer’s disease pathophysiology in the Retina. Prog Retin Eye Res. 2024;101:101273.
- Biffi E, Turple Z, Chung J, Biffi A. Retinal biomarkers of Cerebral Small Vessel Disease: A systematic review. PLoS One. 2022;17(4):e0266974.
- Girach Z, Sarian A, Maldonado-García C, Ravikumar N, Sergouniotis PI, Rothwell PM, et al. Retinal imaging for the assessment of stroke risk: a systematic review. J Neurol. 2024;271(5):2285-2297.
- Costanzo E, Lengyel I, Parravano M, Biagini I, Veldsman M, Badhwar A, et al. Ocular Biomarkers for Alzheimer Disease Dementia: An Umbrella Review of Systematic Reviews and Meta-analyses. JAMA Ophthalmol. 2023;141(1):84-91.
- Yin GS, van der Heide F, Littlejohns TJ, Kuźma E, Hayat S, Brayne C, et al. Association Between Retinal Nerve Fiber Layer Thickness and Incident Dementia in the European Prospective Investigation into Cancer in Norfolk Cohort. J Alzheimers Dis. 2023;95(2):691-702.
- Cheung CY, Ran AR, Wang S, Chan VTT, Sham K, Hilal S, et al. A deep learning model for detection of Alzheimer’s disease based on retinal photographs: a retrospective, multicentre case-control study. Lancet Digit Health. 2022;4(11):e806-e815.
- Visitsattapongse S, Maneerat A, Trinavarat A, Rattanabannakit C, Morkphrom E, Senanarong V, et al. Feature-Based Classification of Mild Cognitive Impairment and Alzheimer’s Disease Based on Optical Coherence Tomographic Angiographic Image. Sensors (Basel). 2024;24(16).
- Sim MA, Tham YC, Nusinovici S, Quek TC, Yu M, Xue CC, et al. A deep-learning retinal aging biomarker for cognitive decline and incident dementia. Alzheimers Dement. 2025;21(3):e14601.
- Tran EM, Stefanick ML, Henderson VW, Rapp SR, Chen JC, Armstrong NM, et al. Association of Visual Impairment With Risk of Incident Dementia in a Women’s Health Initiative Population. JAMA Ophthalmol. 2020;138(6):624-633.
- Ferguson EL, Thoma M, Buto PT, Wang J, Glymour MM, Hoffmann TJ, et al. Visual Impairment, Eye Conditions, and Diagnoses of Neurodegeneration and Dementia. JAMA Netw Open. 2024;7(7):e2424539.
- Jiang F, Dong Q, Wu S, Liu X, Dayimu A, Liu Y, et al. A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis and Mendelian randomization study. BMC Med. 2024;22(1):518.
- Requena-Komuro MC, Jiang J, Dobson L, Benhamou E, Russell L, Bond RL, et al. Remote versus face-to-face neuropsychological testing for dementia research: a comparative study in people with Alzheimer’s disease, frontotemporal dementia and healthy older individuals. BMJ Open. 2022;12(11):e064576.
- Yeo BSY, Ong RYX, Ganasekar P, Tan BKJ, Seow DCC, Tsai ASH. Cataract Surgery and Cognitive Benefits in the Older Person: A Systematic Review and Meta-analysis. Ophthalmology. 2024;131(8):975-984.
- Miyata K, Yoshikawa T, Morikawa M, Mine M, Okamoto N, Kurumatani N, et al. Effect of cataract surgery on cognitive function in elderly: Results of Fujiwara-kyo Eye Study. PLoS One. 2018;13(2):e0192677.
- March de Ribot F, de Ribot AM, Walker X, Jamieson H, Cheung G. Dementia and cataract surgery in Australia and New Zealand. Australas J Ageing. 2023;42(3):450-454.
- Umeya R, Ono K, Yoshida Y. Changes in Caregiver Burden Following Cataract Surgery in Older Adults with Moderate-to-Severe Dementia: A Prospective Pilot Study. Geriatrics (Basel). 2026;11(4).
- Fraser CL, Mobbs R. Visual effects of concussion: A review. Clin Exp Ophthalmol. 2022;50(1):104-109.
- Tukur HN, Uwishema O, Sheikhah D, Akbay H, Chehab TE, Wellington J. The impact of traumatic brain injury on visual processing: a neuro-ophthalmological perspective. Postgrad Med J. 2025;101(1199):886-894.
- Merezhinskaya N, Mallia RK, Park D, Bryden DW, Mathur K, Barker FM 2nd. Visual Deficits and Dysfunctions Associated with Traumatic Brain Injury: A Systematic Review and Meta-analysis. Optom Vis Sci. 2019;96(8):542-555.
- Mavroudis I, Petridis F, Kazis D, Kamar AAM, Ciobica A, Gheban D, et al. Neuro-visual pathway after mild traumatic brain injury: a systematic scoping review of symptoms, objective testing, and rehabilitation. Acta Neurol Belg. 2026.
- Mona-Lisa M, Kaisa M, Taina N, Antti H, Ivan M, Susanna M, et al. Evaluation of Visual Disturbances After Mild Traumatic Brain Injury-A One-Year Follow-up Study. J Head Trauma Rehabil. 2025;40(3):E208-E215.
- Kaae C, Cadigan K, Lai K, Theis J. Vestibulo-ocular dysfunction in mTBI: Utility of the VOMS for evaluation and management - A review. NeuroRehabilitation. 2022;50(3):279-296.
- Alkathiry AA, Kontos AP, Furman JM, Whitney SL, Anson ER, Sparto PJ. Vestibulo-Ocular Reflex Function in Adolescents With Sport-Related Concussion: Preliminary Results. Sports Health. 2019;11(6):479-485.
- Corwin DJ, McDonald CC, Arbogast KB, Mohammed FN, Grady MF, Master CL. Visio-Vestibular Deficits in Healthy Child and Adolescent Athletes. Clin J Sport Med. 2022;32(4):376-384.
- Master CL, Bacal D, Grady MF, Hertle R, Shah AS, Strominger M, et al. Vision and Concussion: Symptoms, Signs, Evaluation, and Treatment. Pediatrics. 2022;150(2).
- Akhand O, Balcer LJ, Galetta SL. Assessment of vision in concussion. Curr Opin Neurol. 2019;32(1):68-74.
- Cortel-LeBlanc A, Cortel-LeBlanc M, Webster RJ, Chen K, Schytz HW, Jolliffe K, et al. Post-traumatic headache phenotypes and clinical characteristics. Cephalalgia. 2025;45(12):3331024251404912.
- Mavroudis I, Ciobica A, Luca AC, Balmus IM. Post-Traumatic Headache: A Review of Prevalence, Clinical Features, Risk Factors, and Treatment Strategies. J Clin Med. 2023;12(13).
- Ashina H, Dodick DW. Post-traumatic Headache: Pharmacologic Management and Targeting CGRP Signaling. Curr Neurol Neurosci Rep. 2022;22(2):105-111.
- Echemendia RJ, Burma JS, Bruce JM, Davis GA, Giza CC, Guskiewicz KM, et al. Acute evaluation of sport-related concussion and implications for the Sport Concussion Assessment Tool (SCAT6) for adults, adolescents and children: a systematic review. Br J Sports Med. 2023;57(11):722-735.
- Patricios JS, Schneider KJ, Dvorak J, Ahmed OH, Blauwet C, Cantu RC, et al. Consensus statement on concussion in sport: the 6th International Conference on Concussion in Sport-Amsterdam, October 2022. Br J Sports Med. 2023;57(11):695-711.
- Davis GA, Schneider KJ, Anderson V, Babl FE, Barlow KM, Blauwet CA, et al. Pediatric Sport-Related Concussion: Recommendations From the Amsterdam Consensus Statement 2023. Pediatrics. 2024;153(1).
- Laker SR. Sports-Related Concussion. Curr Pain Headache Rep. 2015;19(8):41.
- Howell DR, Mayer AR, Master CL, Leddy J, Zemek R, Meier TB, et al. Prognosis for Persistent Post Concussion Symptoms using a Multifaceted Objective Gait and Balance Assessment Approach. Gait Posture. 2020;79:53-59.
- McKee AC, Stein TD, Huber BR, Crary JF, Bieniek K, Dickson D, et al. Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts. Acta Neuropathol. 2023;145(4):371-394.
- Smaakjær P, Wachner LG, Rasmussen RS. Vision therapy improves binocular visual dysfunction in patients with mild traumatic brain injury. Neurol Res. 2022;44(5):439-445.
- Fox SM, Koons P, Dang SH. Vision Rehabilitation After Traumatic Brain Injury. Phys Med Rehabil Clin N Am. 2019;30(1):171-188.
- Rytter HM, Graff HJ, Henriksen HK, Aaen N, Hartvigsen J, Hoegh M, et al. Nonpharmacological Treatment of Persistent Postconcussion Symptoms in Adults: A Systematic Review and Meta-analysis and Guideline Recommendation. JAMA Netw Open. 2021;4(11):e2132221.
- Heinekamp A, Molnar N, Lennon A, Bailes A, Hugentobler J, Previtera M. Interventions to Improve the Occupational Performance of Youth With Persistent Postconcussion Symptoms: A Systematic Review. Am J Occup Ther. 2024;78(6).
- Wandling LJG, Wandling GR Jr, Faith Marshall M, Lee MS. Truth-telling and deception in the management of nonorganic vision loss. Can J Ophthalmol. 2016;51(5):390-392.
- Larner AJ. False localising signs. J Neurol Neurosurg Psychiatry. 2003;74(4):415-8.
- Broggi M, Zattra CM, Schiariti M, Acerbi F, Tringali G, Falco J, et al. Diagnosis of Ventriculoperitoneal Shunt Malfunction: A Practical Algorithm. World Neurosurg. 2020;137:e479-e486.
- Herbert K, Lam A, Mukherjee A, Drew A, Afshari FT. Parental diagnosis of shunt malfunction in children. Childs Nerv Syst. 2024;40(11):3597-3600.
- Riva-Cambrin J, Kestle JR, Holubkov R, Butler J, Kulkarni AV, Drake J, et al. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study. J Neurosurg Pediatr. 2016;17(4):382-90.
- Zervos T, Walters BC. Diagnosis of Ventricular Shunt Infection in Children: A Systematic Review. World Neurosurg. 2019;129:34-44.
- Goeser CD, McLeary MS, Young LW. Diagnostic imaging of ventriculoperitoneal shunt malfunctions and complications. Radiographics. 1998;18(3):635-51.
- Chen TA, Weinert MC, See AP, Kielian A, Lehman LL, Remenschneider AK, et al. Otitic hydrocephalus and papilloedema-re-evaluating a treatment paradigm. Eye (Lond). 2025;39(4):741-747.
- Mizrachi IB, Trobe JD, Gebarski SS, Garton HJ. Papilledema in the assessment of ventriculomegaly. J Neuroophthalmol. 2006;26(4):260-3.
- Nakajima M, Yamada S, Miyajima M, Ishii K, Kuriyama N, Kazui H, et al. Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo). 2021;61(2):63-97.
- Tipton PW, Elder BD, Cogswell PM, Graff-Radford N. Normal pressure hydrocephalus, or Hakim syndrome: review and update. Neurol Neurochir Pol. 2024;58(1):8-20.
- Hu T, Lee Y. Idiopathic normal-pressure hydrocephalus. CMAJ. 2019;191(1):E15.
- Bluett B, Acosta LM, Ash E, Bloem BR, Espay AJ, Farheen A, et al. Standardizing the large-volume “tap test” for evaluating idiopathic normal pressure hydrocephalus: a systematic review. J Neurosurg Sci. 2025;69(1):46-63.
- Rosenblum JS, Pomeraniec IJ, Heiss JD. Chiari Malformation (Update on Diagnosis and Treatment). Neurol Clin. 2022;40(2):297-307.
- Taylor FR, Larkins MV. Headache and Chiari I malformation: clinical presentation, diagnosis, and controversies in management. Curr Pain Headache Rep. 2002;6(4):331-7.
- Capra V, Iacomino M, Accogli A, Pavanello M, Zara F, Cama A, et al. Chiari malformation type I: what information from the genetics?. Childs Nerv Syst. 2019;35(10):1665-1671.
- Petracek LS, Rowe PC. Orthostatic Intolerance and Chiari I Malformation. Neurosurg Clin N Am. 2023;34(1):43-54.
- Talamonti G, Marcati E, Mastino L, Meccariello G, Picano M, D’Aliberti G. Surgical management of Chiari malformation type II. Childs Nerv Syst. 2020;36(8):1621-1634.
- Liebenberg WA, Georges H, Demetriades AK, Hardwidge C. Does posterior fossa decompression improve oculomotor and vestibulo-ocular manifestations in Chiari 1 malformation?. Acta Neurochir (Wien). 2005;147(12):1239-40; discussion 1240.
- Henderson FC Sr, Austin C, Benzel E, Bolognese P, Ellenbogen R, Francomano CA, et al. Neurological and spinal manifestations of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):195-211.
- Shirai S, Mizushima K, Fujiwara K, Koshimizu E, Matsushima M, Miyatake S, et al. Case series: Downbeat nystagmus in SCA27B. J Neurol Sci. 2023;454:120849.
- Waqar M, Ellenbogen JR, Mallucci C. Endoscopic third ventriculostomy for shunt malfunction in children: A review. J Clin Neurosci. 2018;51:6-11.
- Minta KJ, Kannan S, Kaliaperumal C. Outcomes of endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS) in the treatment of paediatric hydrocephalus: Systematic review and meta-analysis. Childs Nerv Syst. 2024;40(4):1045-1052.
- Yadav YR, Parihar V, Sinha M. Lumbar peritoneal shunt. Neurol India. 2010;58(2):179-84.
- de Moraes FM, Adissy ENB, Rocha E, Barros FCD, Freitas FGR, Miranda M, et al. Multimodal monitoring intracranial pressure by invasive and noninvasive means. Sci Rep. 2023;13(1):18404.
- Beniczky S, Tatum WO, Blumenfeld H, Stefan H, Mani J, Maillard L, et al. Seizure semiology: ILAE glossary of terms and their significance. Epileptic Disord. 2022;24(3):447-495.
- Wu S, Nordli DR. Motor seizure semiology. Handb Clin Neurol. 2023;196:295-304.
- Chan SC, Warnes P, Warsame M, Atan D. Prevalence of Vision and Eye Movement Abnormalities in Children Referred to the Children’s Epilepsy Surgery Service: A 5-Year Observational Study. J Pediatr Ophthalmol Strabismus. 2025;62(3):211-219.
- Kumar A, Ighodaro ET, Sharma S. Focal impaired awareness seizure. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Rosado Coelho C, Fernandez-Baca Vaca G, Lüders HO. Electrooculogram and submandibular montage to distinguish different eye, eyelid, and tongue movements in electroencephalographic studies. Clin Neurophysiol. 2018;129(11):2380-2391.
- Zawar I, Knight EP. Epilepsy With Eyelid Myoclonia (Jeavons Syndrome). Pediatr Neurol. 2021;121:75-80.
- Nilo A, Crespel A, Genton P, Macorig G, Gigli GL, Gélisse P. Prognostic factors in epilepsy with eyelid myoclonia (Jeavons syndrome). Rev Neurol (Paris). 2023;179(10):1081-1085.
- Marks WJ Jr, Laxer KD. Semiology of temporal lobe seizures: value in lateralizing the seizure focus. Epilepsia. 1998;39(7):721-6.
- Dupont S, Samson Y, Nguyen-Michel VH, Zavanone C, Navarro V, Baulac M, et al. Lateralizing value of semiology in medial temporal lobe epilepsy. Acta Neurol Scand. 2015;132(6):401-9.
- Chauvel P, Gonzalez-Martinez J, Bulacio J. Presurgical intracranial investigations in epilepsy surgery. Handb Clin Neurol. 2019;161:45-71.
- Pana RM, Nguyen DK. Anterior Cingulate Epilepsy: A Review. J Clin Neurophysiol. 2023;40(6):501-506.
- Bekdik P, Sener U, Asan IF, Ozcelik M, Zorlu Y. Epileptic nystagmus. Epileptic Disord. 2006;8(4):305-8.
- Aykac SC, Ekinci AS, Tabakoglu AY, Gulluoglu H, Aydogdu I, Bademkıran F, et al. What does epileptic nystagmus show us in cases presenting acute neurological symptoms?. Seizure. 2022;101:184-189.
- Acar A, Zampino A, Fotedar N. EEG based oculographic analysis of epileptic nystagmus. Epilepsy Res. 2024;200:107311.
- Poleon S, Szaflarski JP. Photosensitivity in generalized epilepsies. Epilepsy Behav. 2017;68:225-233.
- de Pémille CV, Rekik S, Amiel H, Meppiel E, Richard A, Masmoudi S, et al. Contribution of intermittent photic stimulation to routine EEG. Neurophysiol Clin. 2021;51(6):549-553.
- Harding GF, Takahashi T. Regulations: what next?. Epilepsia. 2004;45 Suppl 1:46-7.
- Heim MK, Gidal BE. Vigabatrin-associated retinal damage: potential biochemical mechanisms. Acta Neurol Scand. 2012;126(4):219-28.
- Constable S, Pirmohamed M. Drugs and the retina. Expert Opin Drug Saf. 2004;3(3):249-59.
- Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clin Rev Allergy Immunol. 2018;54(1):147-176.
- Inatomi Y, Nakajima M, Yonehara T. Nonconvulsive Status Epilepticus With Neuropsychological Symptoms: Two Case Reports. Cogn Behav Neurol. 2020;33(4):271-277.
- Stephani C, Paulus W, Focke NK. Focal visual status epilepticus. Epileptic Disord. 2019;21(1):102-107.
- Martínez-Lapiscina EH, Sanchez-Dalmau B, Fraga-Pumar E, Ortiz-Perez S, Tercero-Uribe AI, Torres-Torres R, et al. The visual pathway as a model to understand brain damage in multiple sclerosis. Mult Scler. 2014;20(13):1678-85.
- Dietrich M, Aktas O, Hartung HP, Albrecht P. Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects. Curr Opin Neurol. 2019;32(3):346-357.
- Kraker JA, Chen JJ. An update on optic neuritis. J Neurol. 2023;270(10):5113-5126.
- Shin T, Ahn M, Kim J, Jung K, Moon C, Kim MD. Visual Dysfunction in Multiple Sclerosis and its Animal Model, Experimental Autoimmune Encephalomyelitis: a Review. Mol Neurobiol. 2021;58(7):3484-3493.
- Gabilondo I, Martínez-Lapiscina EH, Martínez-Heras E, Fraga-Pumar E, Llufriu S, Ortiz S, et al. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol. 2014;75(1):98-107.
- Cordano C, Sin JH, Timmons G, Yiu HH, Stebbins K, Guglielmetti C, et al. Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy. Brain. 2022;145(11):3943-3952.
- Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017;16(10):797-812.
- Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ. Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler. 2014;20(10):1331-41.
- Narayanan D, Cheng H, Tang RA, Frishman LJ. Longitudinal Evaluation of Visual Function in Multiple Sclerosis. Optom Vis Sci. 2015;92(10):976-85.
- Al-Hawasi A, Lagali N, Fagerholm P, Huang-Link Y. Longitudinal Optical Coherence Tomography Measurement of Retinal Ganglion Cell and Nerve Fiber Layer to Assess Benign Course in Multiple Sclerosis. J Clin Med. 2023;12(6).
- Nij Bijvank J, Uitdehaag BMJ, Petzold A. Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics. J Neurol Neurosurg Psychiatry. 2022;93(2):216-219.
- Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012;11(11):963-72.
- Kaufhold F, Zimmermann H, Schneider E, Ruprecht K, Paul F, Oberwahrenbrock T, et al. Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One. 2013;8(8):e71145.
- Beisse F, Diem R. [Immunomodulation and neuroprotection in optic neuritis]. Ophthalmologe. 2016;113(5):398-401.
- Rodríguez-Acevedo B, Rovira A, Vidal-Jordana A, Moncho D, Pareto D, Sastre-Garriga J. [Optic neuritis: aetiopathogenesis, diagnosis, prognosis and management]. Rev Neurol. 2022;74(3):93-104.
- Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet. 2017;390(10111):2481-2489.
- Makhzoum H, El Majzoub R, Ismail A, Kassem M, Kotaich J, Chahine B. Interventions promoting remyelination in multiple sclerosis: a systematic review of clinical trials. Neurol Res. 2025;47(10):901-918.
- Selmaj K, Cree BAC, Barnett M, Thompson A, Hartung HP. Multiple sclerosis: time for early treatment with high-efficacy drugs. J Neurol. 2024;271(1):105-115.
- Button J, Al-Louzi O, Lang A, Bhargava P, Newsome SD, Frohman T, et al. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study. Neurology. 2017;88(6):525-532.
- Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, et al. Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials. Lancet Neurol. 2024;23(11):1119-1132.
- Schwake C, Ladopoulos T, Häußler V, Kleiter I, Ringelstein M, Aktas O, et al. Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks. J Neurol Neurosurg Psychiatry. 2025;96(7):639-646.
- Vidal-Jordana A, Rovira A, Calderon W, Arrambide G, Castilló J, Moncho D, et al. Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study. Neurology. 2024;102(1):e200805.
- Spiegel SJ, Moss HE. Neuro-Ophthalmic Emergencies. Neurol Clin. 2021;39(2):631-647.
- Dag Y, Aydın S, Kumantas E. The profile of patients attending to the general emergency department with ocular complaints within the last year: is it a true ocular emergency?. BMC Ophthalmol. 2024;24(1):330.
- Ghimire P, Karn R, Gajurel BP, Ojha R, Rajbhandari R, Shahi S, et al. Causes and Outcome of Neurogenic Vision Loss. J Nepal Health Res Counc. 2024;22(3):639-646.
- Dubosh NM, Edlow JA, Lefton M, Pope JV. Types of diagnostic errors in neurological emergencies in the emergency department. Diagnosis (Berl). 2015;2(1):21-28.
- Herasevich S, Soleimani J, Huang C, Pinevich Y, Dong Y, Pickering BW, et al. Diagnostic error among vulnerable populations presenting to the emergency department with cardiovascular and cerebrovascular or neurological symptoms: a systematic review. BMJ Qual Saf. 2023;32(11):676-688.
- Patil P, Williams M, Maw WW, Achilleos K, Elsideeg S, Dejaco C, et al. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol. 2015;33(2 Suppl 89):S-103-6.
- van Dantzig P, White D, Kurz J, Ming C, Kamalaksha S, Quincey V. Performance of a fast-track pathway for giant cell arteritis in Waikato, Aotearoa New Zealand. N Z Med J. 2024;137(1592):31-42.
- Sachdev A, Dubey S, George M, Crossman R, Mehta P. Role of Temporal artery biopsy in a sequential Giant Cell Arteritis fast-track pathway: a 5-year prospective study. Eye (Lond). 2023;37(8):1614-1618.
- Basilious A, Govas CN, Deans AM, Yoganathan P, Deans RM. Evaluating the Diagnostic Accuracy of a Novel Bayesian Decision-Making Algorithm for Vision Loss. Vision (Basel). 2022;6(2).
- Muste JC, Kim S, Dinicu A, Wang PR, Muir M, Sorrell M, et al. Emergency department evaluation of nurse triage questions about safe-at-home and abuse or neglect in traumatic ocular injuries. Can J Ophthalmol. 2024;59(5):e453-e460.
- Bloomstone JA, Houseman BT, Sande EV, Brantley A, Curran J, Maccioli GA, et al. Documentation of individualized preoperative risk assessment: a multi-center study. Perioper Med (Lond). 2020;9:28.
- Lemos J, Eggenberger E. Neuro-Ophthalmological Emergencies. Neurohospitalist. 2015;5(4):223-33.
- Douglas VP, Rachapudi SS, Davila-Siliezar P, Laylani NAR, Lee AG. Transient Monocular Visual Loss (Amaurosis Fugax): How Does Age Impact Diagnosis?. Ophthalmol Ther. 2024;13(6):1417-1425.
- Zarkali A, Cheng SF, Dados A, Simister R, Chandratheva A. Atrial Fibrillation: An Underestimated Cause of Ischemic Monocular Visual Loss?. J Stroke Cerebrovasc Dis. 2019;28(6):1495-1499.
- Kimyaghalam A, Lui F. Carotid artery stenosis. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Räty S, Silvennoinen K, Tatlisumak T. Prehospital pathways of occipital stroke patients with mainly visual symptoms. Acta Neurol Scand. 2018;137(1):51-58.
- Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014;13(1):83-99.
- Donaldson L, Margolin E. Vision loss in giant cell arteritis. Pract Neurol. 2022;22(2):138-140.
- Kokloni IN, Aligianni SI, Makri O, Daoussis D. Vision loss in giant cell arteritis: case-based review. Rheumatol Int. 2022;42(10):1855-1862.
- Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. JAMA. 2016;315(22):2442-58.
- Melville AR, Donaldson K, Dale J, Ciechomska A. Validation of the Southend giant cell arteritis probability score in a Scottish single-centre fast-track pathway. Rheumatol Adv Pract. 2022;6(1):rkab102.
- Bomkamp BT, Borgert AJ, Fitzsimmons AJ, Smith TJ, Shakhnovich I, Peschman JR. Temporal Artery Biopsy: When Is It Worth the Headache?. WMJ. 2023;122(1):38-43.
- Hoyer C, Kahlert C, Güney R, Schlichtenbrede F, Platten M, Szabo K. Central retinal artery occlusion as a neuro-ophthalmological emergency: the need to raise public awareness. Eur J Neurol. 2021;28(6):2111-2114.
- Madike R, Cugati S, Chen C. A review of the management of central retinal artery occlusion. Taiwan J Ophthalmol. 2022;12(3):273-281.
- Varma DD, Cugati S, Lee AW, Chen CS. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond). 2013;27(6):688-97.
- Youn TS, Lavin P, Patrylo M, Schindler J, Kirshner H, Greer DM, et al. Current treatment of central retinal artery occlusion: a national survey. J Neurol. 2018;265(2):330-335.
- Orwig DM, Wang J, Li Z, McGlynn JJ, HajAissa N, Davis A, et al. The effects of hyperbaric oxygen treatment for non-arteritic central retinal artery occlusion (HBOT-CRAO). Am J Emerg Med. 2025;98:1-5.
- Emmerton W, Banham ND, Gawthrope IC. Survey comparing the treatment of central retinal artery occlusion with hyperbaric oxygen in Australia and New Zealand with the recommended guidelines as outlined by the Undersea and Hyperbaric Medical Society. Diving Hyperb Med. 2024;54(2):97-104.
- Shaikh IS, Elsamna ST, Zarbin MA, Bhagat N. Assessing the risk of stroke development following retinal artery occlusion. J Stroke Cerebrovasc Dis. 2020;29(9):105002.
- Laczynski DJ, Gallop J, Lyden SP, Bena J, Yuan A, Smolock CJ, et al. Retinal artery occlusion does not portend an increased risk of stroke. J Vasc Surg. 2020;72(1):198-203.
- Riccardi A, Siniscalchi C, Lerza R. Embolic Central Retinal Artery Occlusion Detected with Point-of-care Ultrasonography in the Emergency Department. J Emerg Med. 2016;50(4):e183-5.
- Bruce BB. Nonmydriatic Ocular Fundus Photography in the Emergency Department: How It Can Benefit Neurologists. Semin Neurol. 2015;35(5):491-5.
- Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica. Nat Rev Dis Primers. 2020;6(1):85.
- Cortese R, Prados Carrasco F, Tur C, Bianchi A, Brownlee W, De Angelis F, et al. Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging. Neurology. 2023;100(3):e308-e323.
- Biousse V, Danesh-Meyer HV, Saindane AM, Lamirel C, Newman NJ. Imaging of the optic nerve: technological advances and future prospects. Lancet Neurol. 2022;21(12):1135-1150.
- Athappilly G, Pelak VS, Mandava N, Bennett JL. Ischemic optic neuropathy. Neurol Res. 2008;30(8):794-800.
- Sachdeva V, Garg R, Pathengay A, Chandrasekharan A, Kekunnaya R. Rapidly reversible visual loss in posterior reversible encephalopathy syndrome: An ophthalmologist’s enigma. Oman J Ophthalmol. 2015;8(3):211-2.
- Biagetti B, Marques P, Ntali G, Tsermoulas G, Karavitaki N, Sarria-Estrada S, et al. Management of endocrine disease: update on the management of pituitary apoplexy. Eur J Endocrinol. 2026;194(2):R49-R66.
- Dattilo M, Biousse V, Bruce BB, Newman NJ. Functional and simulated visual loss. Handb Clin Neurol. 2016;139:329-341.
- Biousse V, Bruce BB, Newman NJ. Ophthalmoscopy in the 21st century: The 2017 H. Houston Merritt Lecture. Neurology. 2018;90(4):167-175.
- Xu D, Uhr J, Patel SN, Pandit RR, Jenkins TL, Khan MA, et al. Sociodemographic Factors Influencing Rhegmatogenous Retinal Detachment Presentation and Outcome. Ophthalmol Retina. 2021;5(4):337-341.
- Cornblath WT. Diplopia due to ocular motor cranial neuropathies. Continuum (Minneap Minn). 2014;20(4 Neuro-ophthalmology):966-80.
- Holmes JM. Evaluation and Management of Divergence Insufficiency-Type Esotropia. J Binocul Vis Ocul Motil. 2022;72(4):230-233.
- Śmiłowska K, Wowra B, Sławek J. Double vision in Parkinson’s Disease: a systematic review. Neurol Neurochir Pol. 2020;54(6):502-507.
- Uthiyo P, Chantem Y. Diagnostic Value of Pupil Involvement and Yield of Vascular Imaging in Isolated Third Cranial Nerve Palsy: A 10-Year Retrospective Study. Clin Ophthalmol. 2026;20:620077.
- Tadros D, Tomoum MO, Shafik HM. Orbital Complications of Acute Invasive Fungal Rhinosinusitis: A New Challenge in the COVID-19 Convalescent Patients. Clin Ophthalmol. 2022;16:4011-4019.
- Senapathy G, Putta T, Sistla SK. Magnetic resonance imaging in COVID-19-associated acute invasive fungal rhinosinusitis - Diagnosis and beyond. J Clin Imaging Sci. 2023;13:23.
- Khanum I, Kanwar D, Habib K, Mubarak F. Skull base osteomyelitis (SBO): a dreaded clinical entity. J Pak Med Assoc. 2024;74(10):1767-1772.
- Sokołowski J, Lachowska M, Karchier E, Bartoszewicz R, Niemczyk K. Skull base osteomyelitis: factors implicating clinical outcome. Acta Neurol Belg. 2019;119(3):431-437.
- Fortin E, Cestari DM, Weinberg DH. Ocular myasthenia gravis: an update on diagnosis and treatment. Curr Opin Ophthalmol. 2018;29(6):477-484.
- García Estévez DA, Pardo Fernández J. Myasthenia gravis. Update on diagnosis and therapy. Med Clin (Barc). 2023;161(3):119-127.
- Misra UK, Kumar S, Singh VK, Dubey D, Kalita J. Noninvasive Ventilation in Myasthenia Gravis. Neurol India. 2020;68(3):648-651.
- Liu Z, Yao S, Zhou Q, Deng Z, Zou J, Feng H, et al. Predictors of extubation outcomes following myasthenic crisis. J Int Med Res. 2016;44(6):1524-1533.
- Noioso CM, Bevilacqua L, Acerra GM, Valle PD, Serio M, Pecoraro A, et al. The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis. Neurol Sci. 2024;45(12):5657-5669.
- Bellanti R, Rinaldi S. Guillain-Barré syndrome: a comprehensive review. Eur J Neurol. 2024;31(8):e16365.
- van Doorn PA, Van den Bergh PYK, Hadden RDM, Avau B, Vankrunkelsven P, Attarian S, et al. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome. Eur J Neurol. 2023;30(12):3646-3674.
- Ota Y, Capizzano AA, Moritani T, Naganawa S, Kurokawa R, Srinivasan A. Comprehensive review of Wernicke encephalopathy: pathophysiology, clinical symptoms and imaging findings. Jpn J Radiol. 2020;38(9):809-820.
- Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J. 2014;44(9):911-5.
- Elrayes M, Al Bachari S, Macdonagh R, Peel A, Khurshid S, Hamzah J, et al. Delayed onset post-traumatic wound botulism. Pract Neurol. 2024;24(4):320-325.
- Atallah O, Badary A, Sanker V, Awuah WA, Ergen A, Kandasamy R, et al. Isolated Sixth Cranial Nerve Palsy in Patients with Pituitary Apoplexy. J Neurol Surg A Cent Eur Neurosurg. 2025;86(4):408-414.
- Sotoodehnia M, Safaei A, Rasooli F, Bahreini M. Unilateral sixth nerve palsy. Am J Emerg Med. 2017;35(6):934.e1-934.e2.
- Kim JH, Choi HY, Jeon H. Clinical Characteristics for Predicting Recovery of Acquired Fourth Cranial Nerve Palsy. J Neuroophthalmol. 2022;42(2):234-238.
- Payne WN, Blair K, Barrett MJ. Anisocoria. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Steck RP, Kong M, McCray KL, Quan V, Davey PG. Physiologic anisocoria under various lighting conditions. Clin Ophthalmol. 2018;12:85-89.
- Simakurthy S, Stokkermans TJ, Tripathy K. Marcus Gunn pupil. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Salehi Omran S. Cervical Artery Dissection. Continuum (Minneap Minn). 2023;29(2):540-565.
- Debette S, Compter A, Labeyrie MA, Uyttenboogaart M, Metso TM, Majersik JJ, et al. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol. 2015;14(6):640-54.
- van der Zwet KVM, Brown AV, Bakker SLM. Internal Carotid Artery Dissection Presenting With Dysgeusia, Horner Syndrome, and Hypesthesia of the Fifth Cranial Nerve: A Case Report. J Emerg Med. 2020;58(1):e27-e29.
- Kesav P, Manesh Raj D, John S. Cerebrovascular Fibromuscular Dysplasia - A Practical Review. Vasc Health Risk Manag. 2023;19:543-556.
- Eldib AA, Patil P, Nischal KK, Mitchell ER, Hiasat JG, Pihlblad MS. Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic. J AAPOS. 2021;25(6):336.e1-336.e4.
- Disse LR, Bockisch CJ, Weber KP, Fierz FC. Differentiation of Horner Syndrome and Physiological Anisocoria by Automated Pupillometry. J Neuroophthalmol. 2024;45(3):327-332.
- Lambert SR, Yang LL, Stone C. Tonic pupil associated with congenital neuroblastoma, Hirschsprung disease, and central hypoventilation syndrome. Am J Ophthalmol. 2000;130(2):238-40.
- Claassen J, Park S. Spontaneous subarachnoid haemorrhage. Lancet. 2022;400(10355):846-862.
- Kopel D, Peeler C, Zhu S. Headache Emergencies. Neurol Clin. 2021;39(2):355-372.
- Alizadeh A, Moshiri M, Alizadeh J, Balali-Mood M. Black henbane and its toxicity - a descriptive review. Avicenna J Phytomed. 2014;4(5):297-311.
- Pejic R, Klaric B. Transient anisocoria in a patient treated with nebulized ipratropium bromide. Am J Ophthalmol Case Rep. 2017;7:11-13.
- Pennington KM, St Louis EK. “Don’t Believe Your Eyes” Ipratropium Induced Mydriasis: A Case Report and Review of the Literature. Gen Med (Los Angel). 2016;4(3).
- Gowda SN, Munakomi S. Brainstem stroke. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Munakomi S, Das JM. Weber syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Karabaş VL, Seyyar SA, Tokuc EO, Şahin Ö. A novel iridoplasty suture technique to repair iris defects and traumatic mydriasis. Indian J Ophthalmol. 2023;71(5):2254-2256.
- Ciapetti M, Circelli A, Zagli G, Migliaccio ML, Spina R, Alessi A, et al. Diagnosis of carotid arterial injury in major trauma using a modification of Memphis criteria. Scand J Trauma Resusc Emerg Med. 2010;18:61.
- Hazrati E, Shahali H. Retrobulbar hemorrhage with orbital compartment syndrome: A rare sight-threatening emergency during air medical evacuation. Med J Armed Forces India. 2024;80(1):110-114.
- Hsu CH, Kuo LT. Application of Pupillometry in Neurocritical Patients. J Pers Med. 2023;13(7).
- Ali AMS, Gul W, Sen J, Hewitt SJ, Olubajo F, McMahon C. Evaluating the utility of quantitative pupillometry in a neuro-critical care setting for the monitoring of intracranial pressure: A prospective cohort study. Clin Neurol Neurosurg. 2024;239:108215.
- Slot RER, Helbok R, van der Jagt M. Update on traumatic brain injury in the ICU. Curr Opin Anaesthesiol. 2025;38(2):93-99.
- Xie JS, Donaldson L, Margolin E. Papilledema: A review of etiology, pathophysiology, diagnosis, and management. Surv Ophthalmol. 2022;67(4):1135-1159.
- Boyter E. Idiopathic intracranial hypertension. JAAPA. 2019;32(5):30-35.
- Rohit W, Rajesh A, Mridula R, Jabeen SA. Idiopathic Intracranial Hypertension - Challenges and Pearls. Neurol India. 2021;69(Supplement):S434-S442.
- Cioana M, Ranalli PJ, Micieli JA. Transient Visual Obscurations as the Presenting Symptom of Papilledema from COVID-19-Related Cerebral Venous Sinus Thrombosis. Case Rep Ophthalmol. 2022;13(1):185-190.
- Kardon R. Optical coherence tomography in papilledema: what am I missing?. J Neuroophthalmol. 2014;34 Suppl:S10-7.
- Rebolleda G, Kawasaki A, de Juan V, Oblanca N, Muñoz-Negrete FJ. Optical Coherence Tomography to Differentiate Papilledema from Pseudopapilledema. Curr Neurol Neurosci Rep. 2017;17(10):74.
- Pardon LP, Cheng H, Tang RA, Saenz R, Frishman LJ, Patel NB. Custom Optical Coherence Tomography Parameters for Distinguishing Papilledema from Pseudopapilledema. Optom Vis Sci. 2019;96(8):599-608.
- Szanto D, Wang JK, Woods B, Garvin MK, Johnson BA, Kardon RH, et al. Deep Learning Differentiates Papilledema, NAION, and Healthy Eyes With Unsegmented 3D OCT Volumes. Am J Ophthalmol. 2025;277:249-259.
- Takkar A, Goyal MK, Bansal R, Lal V. Clinical and Neuro-ophthalmologic Predictors of Visual Outcome in Idiopathic Intracranial Hypertension. Neuroophthalmology. 2018;42(4):201-208.
- Manfield JH, Yu KK, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. Bariatric Surgery or Non-surgical Weight Loss for Idiopathic Intracranial Hypertension? A Systematic Review and Comparison of Meta-analyses. Obes Surg. 2017;27(2):513-521.
- Bouffard MA. Fulminant Idiopathic Intracranial Hypertension. Curr Neurol Neurosci Rep. 2020;20(4):8.
- Tsermoulas G, Thant KZ, Byrne ME, Whiting JL, White AM, Sinclair AJ, et al. The Birmingham Standardized Idiopathic Intracranial Hypertension Shunt Protocol: Technical Note. World Neurosurg. 2022;167:147-151.
- Patel J, Agwu C, Asif H, Das P. Cerebrospinal Fluid Diversion from the Cisterna Magna in Patients with Idiopathic Intracranial Hypertension and Slit Ventricles: Long-Term Effectiveness, Revision Rates, and Clinical Outcomes. World Neurosurg. 2024;186:e326-e334.
- Nicholson P, Brinjikji W, Radovanovic I, Hilditch CA, Tsang ACO, Krings T, et al. Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis. J Neurointerv Surg. 2019;11(4):380-385.
- Leishangthem L, SirDeshpande P, Dua D, Satti SR. Dural venous sinus stenting for idiopathic intracranial hypertension: An updated review. J Neuroradiol. 2019;46(2):148-154.
- Schuman TA, Senior BA. Long-term management and outcomes after repair of cerebrospinal fluid rhinorrhea related to idiopathic intracranial hypertension. Curr Opin Otolaryngol Head Neck Surg. 2018;26(1):46-51.
- Oh DJ, Kanu LN, Chen JL, Aref AA, Mieler WF, MacIntosh PW. Inpatient and Emergency Room Ophthalmology Consultations at a Tertiary Care Center. J Ophthalmol. 2019;2019:7807391.
- Yahalom S, Manias E. Nurses engaging with referral letters and discharge summaries: A qualitative study. J Clin Nurs. 2024;33(6):2309-2323.
- Yu Z, Zhang Y, Gu Y, Xu X, McArthur A. Pediatric clinical handover: a best practice implementation project. JBI Database System Rev Implement Rep. 2017;15(10):2585-2596.
- Munawar K, Khan MT, Hussain SW, Qadeer A, Shad ZS, Bano S, et al. Optic Nerve Sheath Diameter Correlation with Elevated Intracranial Pressure Determined via Ultrasound. Cureus. 2019;11(2):e4145.
- Berty Gutiérrez H, Carrera González E. Usefulness of optic nerve sheath diameter measurement in hypertensive patients during pregnancy and the puerperium. J Matern Fetal Neonatal Med. 2023;36(1):2187253.
- Robba C, Graziano F, Rebora P, Elli F, Giussani C, Oddo M, et al. Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU): an international, prospective observational cohort study. Lancet Neurol. 2021;20(7):548-558.
- Berman G, Pendley AM, Wright DW, Silverman R, Kelley C, Duran MR, et al. Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department. Surv Ophthalmol. 2025;70(1):153-161.
- Schwartz NU, Silverman A, Beres S, Moss HE, Kvam K, Galetta K. Inpatient Implementation of Portable Ocular Fundus Photography Among Neurology Residents. Neurohospitalist. 2025;15(3):275-280.
- Ting DSW, Pasquale LR, Peng L, Campbell JP, Lee AY, Raman R, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167-175.
- Wintergerst MWM, Jansen LG, Holz FG, Finger RP. Smartphone-Based Fundus Imaging-Where Are We Now?. Asia Pac J Ophthalmol (Phila). 2020;9(4):308-314.
- Brandão-de-Resende C, Alcântara LAR, Vasconcelos-Santos DV, Diniz-Filho A. Glaucoma and Telemedicine. J Glaucoma. 2023;32(5):327-332.
- Govindaraju VK, Chao JT, Duvall ER, Baker NS, Fahey KM, Lee R, et al. Incidence of Endogenous Fungal Endophthalmitis in Screening Dilated Exams in Patients with Elevated Beta-D-Glucan Levels versus Positive Fungal Blood Cultures. Clin Ophthalmol. 2022;16:2743-2750.
- Huth A, Roth M, Viestenz A. [Endogenous Candida endophthalmitis]. Ophthalmologie. 2024;121(4):272-281.
- Li A, Swinney C, Veeravagu A, Bhatti I, Ratliff J. Postoperative Visual Loss Following Lumbar Spine Surgery: A Review of Risk Factors by Diagnosis. World Neurosurg. 2015;84(6):2010-21.
- Raphael J, Moss HE, Roth S. Perioperative Visual Loss in Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019;33(5):1420-1429.
- Chen Y, He J, Wu Q, Pu S, Song C. Prevalence and risk factors of exposure keratopathy among critically ill patients: A systematic review and meta-analysis. Nurs Open. 2024;11(1):e2061.
- El Hachimi R, El Hadiri R, Benchekroun S, Boutimzine N, Amazouzi A, Cherkaoui LO, et al. [Incidence and risk factors of exposure keratopathy in intensive care units: About 91 patients]. J Fr Ophtalmol. 2022;45(10):1137-1143.
- Al-Tamimi S, Saleh MYN, Gharaibeh AM, Al-A’mar F, Al-Amer R. Characteristics and associated risk factors of exposure keratopathy among ventilated patients in intensive care units in Jordan. Acute Crit Care. 2025;40(2):330-8.
- Płaszewska-Żywko L, Sega A, Bukowa A, Wojnar-Gruszka K, Podstawa M, Kózka M. Risk Factors of Eye Complications in Patients Treated in the Intensive Care Unit. Int J Environ Res Public Health. 2021;18(21).
- Niemi A, Geddie BE, Rajasekaran S, Davis AT, VanDenBosch N, Steenland C, et al. Ocular Surface Disease in a PICU: Incidence and Outcomes With a Dynamic Eye Care Protocol. Pediatr Crit Care Med. 2020;21(4):357-362.
- Vilchez B, Manzanal I, Marcos M, Camacho V, González IM, Laín R, et al. Early detection of ocular lesions in critically ill children: Testing an ocular assessment scale. Nurs Crit Care. 2024;29(6):1663-1671.
- Ahmadinejad M, Karbasi E, Jahani Y, Ahmadipour M, Soltaninejad M, Karzari Z. Efficacy of Simple Eye Ointment, Polyethylene Cover, and Eyelid Taping in Prevention of Ocular Surface Disorders in Critically Ill Patients: A Randomized Clinical Trial. Crit Care Res Pract. 2020;2020:6267432.
- Rezaei K, Amini N, Rezaei R, Rafiei F, Harorani M. The Effects of Passive Blinking on Exposure Keratopathy among Patients in Intensive Care Units. Iran J Nurs Midwifery Res. 2022;27(2):144-148.
- Arevalo-Buitrago P, Romero Saldaña M, Rincón Recio ME, Dorante López FJ, Cabello Montoro FJ, Bermejo Collado MJ, et al. Impact of a structured educational intervention on the prevention of ocular surface disorders in critically ill patients: A non-randomized clinical trial. Intensive Crit Care Nurs. 2025;90:104107.
- Swiston CJ, Hu KS, Simpson A, Burton E, Brintz BJ, Lin A. Prevention of Exposure Keratopathy in the Intensive Care Unit: Evaluation of an EMR-Based Lubrication Order Protocol for Ventilated Patients. J Acad Ophthalmol (2017). 2022;14(2):e141-e146.
- Adebayo A, Tauber J, Tingley J, Eisen LA, Young Moon J, Rosenberg JB. Assessing an Exposure Keratopathy Prevention Strategy in Mechanically Ventilated Patients: A Retrospective Study. Eye Contact Lens. 2024;50(2):70-72.
- Basilious A, Feng M, Nicoletti L, Mather R. Prevention of exposure keratitis in Ontario intensive care units: a survey study. Can J Anaesth. 2023;70(3):461-463.
- Guérin C, Beuret P, Constantin JM, Bellani G, Garcia-Olivares P, Roca O, et al. A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study. Intensive Care Med. 2018;44(1):22-37.
- Leuzinger-Dias M, Lima-Fontes M, Oliveira-Ferreira C, Camisa E, Sousa C, Rocha-Sousa A, et al. Prone Positioning Covid-19 Patients: A Double-Edged Sword-A Case Report of a Devastating Ocular Complication. Ophthalmol Ther. 2021;10(3):691-697.
- Thompson DA, Mikó-Baráth E, Hardy SE, Jandó G, Shaw M, Hamilton R. ISCEV standard pattern reversal VEP development: paediatric reference limits from 649 healthy subjects. Doc Ophthalmol. 2023;147(3):147-164.
- Nemeș-Drăgan IA, Drăgan AM, Hapca MC, Oaida M. Retinal Nerve Fiber Layer Imaging with Two Different Spectral Domain Optical Coherence Tomographs: Normative Data for Romanian Children. Diagnostics (Basel). 2023;13(8).
- Amelia A, Fatimah-Halwani I, Shatriah I. Optic Nerve Head and Retinal Nerve Fiber Layer Analysis in Emmetropic Malay Children. Cureus. 2024;16(2):e53890.
- Erkan Turan K, Taylan Sekeroglu H, Karahan S, Sanac AS. Fixation preference test: reliability for the detection of amblyopia in patients with strabismus and interexaminer agreement. Int Ophthalmol. 2017;37(6):1305-1310.
- Taylan Şekeroğlu H, Bilgiç AA, Karakaya J. Is Fixation Preference a Potential Indicator of Macular Function in Children?. Turk J Ophthalmol. 2021;51(3):151-155.
- Wilson S, Ctori I, Shah R, Suttle C, Conway ML. Systematic review and meta-analysis on the agreement of non-cycloplegic and cycloplegic refraction in children. Ophthalmic Physiol Opt. 2022;42(6):1276-1288.
- Deshmukh AV, Gandhi UV, Mohamed A, Badakere A, Kekunnaya R. Interobserver Variability for Measurement of Grating Acuity in Preverbal and Nonverbal Children Using Lea Grating Paddles. J Pediatr Ophthalmol Strabismus. 2020;57(5):305-308.
- Opoku-Yamoah V, Christian LW, Irving EL, Jones D, McCulloch D, Rose K, et al. Validation of the Waterloo Differential Visual Acuity Test (WatDAT) and Comparison With Existing Pediatric Tests of Visual Acuity. Transl Vis Sci Technol. 2023;12(9):13.
- Zhu B, Yang M, Liu X, Yuan B, Yin Y, Cheng C, et al. Assessing pediatric visual acuity with a computerized optokinetic nystagmus analyzer. Clinics (Sao Paulo). 2025;80:100671.
- Murata N, Toda H, Ubukata H, Takagi M, Tanaka C, Machinaga A, et al. Development of Automated Visual Acuity Measurement Using a Calibration-Free Eye-Tracking System. Cureus. 2024;16(7):e64401.
- Nikolaidou A, Sandali A, Chatzidimitriou E, Pantelaki D, Gianni T, Lamprogiannis L. Virtual Reality With Eye Tracking for Pediatric Ophthalmology: A Systematic Review. J Pediatr Ophthalmol Strabismus. 2024;61(6):381-390.
- Simon JW, Siegfried JB, Mills MD, Calhoun JH, Gurland JE. A new visual evoked potential system for vision screening in infants and young children. J AAPOS. 2004;8(6):549-54.
- Winston M, Zhou A, Rand CM, Dunne EC, Warner JJ, Volpe LJ, et al. Pupillometry measures of autonomic nervous system regulation with advancing age in a healthy pediatric cohort. Clin Auton Res. 2020;30(1):43-51.
- Hsu J, Stec M, Ranaivo HR, Srdanovic N, Kurup SP. Concussion Alters Dynamic Pupillary Light Responses in Children. J Child Neurol. 2021;36(3):195-202.
- Sumner E, Hutton SB, Kuhn G, Hill EL. Oculomotor atypicalities in Developmental Coordination Disorder. Dev Sci. 2018;21(1).
- Postolache L, Monier A, Lhoir S. Neuro-Ophthalmological Manifestations in Children with Down Syndrome: Current Perspectives. Eye Brain. 2021;13:193-203.
- Pang Y, Frantz KA, Yin HK. Comparison of Cirrus spectral domain OCT with disc-macula distance to disc diameter ratio in diagnosing congenital optic nerve hypoplasia. Ophthalmic Physiol Opt. 2023;43(4):916-921.
- Mahmoud AO, Ayanniyi AA, Oyedepo OO. Pediatric ophthalmic indications for examination under anesthesia in Ilorin, Nigeria. Ann Afr Med. 2010;9(3):181-3.
- Siebelmann S, Bachmann B, Matthaei M, Horstmann J, Dietlein T, Lappas A, et al. [Microscope-integrated intraoperative optical coherence tomography in examination of pediatric patients under anesthesia]. Ophthalmologe. 2018;115(9):785-792.
- Davidson AJ, Disma N, de Graaff JC, Withington DE, Dorris L, Bell G, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial. Lancet. 2016;387(10015):239-50.
- McCann ME, de Graaff JC, Dorris L, Disma N, Withington D, Bell G, et al. Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial. Lancet. 2019;393(10172):664-677.
- Warner DO, Zaccariello MJ, Katusic SK, Schroeder DR, Hanson AC, Schulte PJ, et al. Neuropsychological and Behavioral Outcomes after Exposure of Young Children to Procedures Requiring General Anesthesia: The Mayo Anesthesia Safety in Kids (MASK) Study. Anesthesiology. 2018;129(1):89-105.
- Warner DO, Chelonis JJ, Paule MG, Frank RD, Lee M, Zaccariello MJ, et al. Performance on the Operant Test Battery in young children exposed to procedures requiring general anaesthesia: the MASK study. Br J Anaesth. 2019;122(4):470-479.
- Hansen TG. Anesthesia-related neurotoxicity and the developing animal brain is not a significant problem in children. Paediatr Anaesth. 2015;25(1):65-72.
- Andropoulos DB. Effect of Anesthesia on the Developing Brain: Infant and Fetus. Fetal Diagn Ther. 2018;43(1):1-11.
- Rufai SR. Handheld optical coherence tomography removes barriers to imaging the eyes of young children. Eye (Lond). 2022;36(5):907-908.
- Rufai SR, Bowman R, Bunce C, Panteli V, McLean RJ, Teli S, et al. Feasibility and Repeatability of Handheld Optical Coherence Tomography in Children With Craniosynostosis. Transl Vis Sci Technol. 2021;10(8):24.
- Sheck LHN, Esposti SD, Mahroo OA, Arno G, Pontikos N, Wright G, et al. Panel-based genetic testing for inherited retinal disease screening 176 genes. Mol Genet Genomic Med. 2021;9(12):e1663.
- O’Hara MA. Instrument-based pediatric vision screening. Curr Opin Ophthalmol. 2016;27(5):398-401.
- Silverstein E, McElhinny ER. Traditional and instrument-based vision screening in third-grade students. J AAPOS. 2020;24(4):232.e1-232.e6.
- Hutchinson AK, Melia M, Yang MB, VanderVeen DK, Wilson LB, Lambert SR. Clinical Models and Algorithms for the Prediction of Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology. Ophthalmology. 2016;123(4):804-16.
- Muhit M, Karim T, Islam J, Hardianto D, Muhiddin HS, Purwanta SA, et al. The epidemiology of childhood blindness and severe visual impairment in Indonesia. Br J Ophthalmol. 2018;102(11):1543-1549.
- Ahnoux-Zabsonre A, Meda R, Diallo JW, Djiguimde WP, Sanou J, Meda-Hien G, et al. [Causes of childhood blindness and visual impairment in Ouagadougou: About 398 cases]. J Fr Ophtalmol. 2020;43(9):907-912.
- Lambert SR. The timing of surgery for congenital cataracts: Minimizing the risk of glaucoma following cataract surgery while optimizing the visual outcome. J AAPOS. 2016;20(3):191-2.
- Khokhar SK, Pillay G, Dhull C, Agarwal E, Mahabir M, Aggarwal P. Pediatric cataract. Indian J Ophthalmol. 2017;65(12):1340-1349.
- Altınbay D, Taşkın İ. Evaluation of Behavioral Characteristics in Response to Visual Stimuli in Infants with Cerebral Visual Impairment. Turk J Ophthalmol. 2023;53(1):1-7.
- İdil ŞA, Altınbay D, Şahlı E, Kızıltunç PB, Timlioğlu-İper HS, Turan KE, et al. Ophthalmologic approach to babies with cerebral visual impairment. Turk J Pediatr. 2021;63(1):1-10.
- Lloyd A, Hadfield M. Average recovery time from delayed visual maturation. Int Ophthalmol. 2021;41(6):2241-2247.
- Huang CH, Yang CM, Yang CH, Hou YC, Chen TC. Leber’s Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations. Genes (Basel). 2021;12(8).
- Wang H, Wang X, Zou X, Xu S, Li H, Soens ZT, et al. Comprehensive Molecular Diagnosis of a Large Chinese Leber Congenital Amaurosis Cohort. Invest Ophthalmol Vis Sci. 2015;56(6):3642-55.
- Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390(10097):849-860.
- Ferraz Sallum JM, Godoy J, Kondo A, Kutner JM, Vasconcelos H, Maia A. The first gene therapy for RPE65 biallelic dystrophy with voretigene neparvovec-rzyl in Brazil. Ophthalmic Genet. 2022;43(4):550-554.
- Tsang SH, Sharma T. Rod Monochromatism (Achromatopsia). Adv Exp Med Biol. 2018;1085:119-123.
- Lejoyeux R, Alonso AS, Lafolie J, Michaud V, Lasseaux E, Vasseur V, et al. Foveal hypoplasia in parents of patients with albinism. Ophthalmic Genet. 2022;43(6):817-823.
- Kessel L, Kjølholm CDB, Jordana JT. Does Foveal Hypoplasia Affect Emmetropization in Patients with Albinism?. Children (Basel). 2023;10(12).
- Huizing M, Malicdan MCV, Wang JA, Pri-Chen H, Hess RA, Fischer R, et al. Hermansky-Pudlak syndrome: Mutation update. Hum Mutat. 2020;41(3):543-580.
- Karuntu JS, Almushattat H, Nguyen XT, Plomp AS, Wanders RJA, Hoyng CB, et al. Syndromic retinitis pigmentosa. Prog Retin Eye Res. 2025;107:101324.
- Bourke C, Panteli V, Marmoy OR, Thompson DA, Mankad K, Sudhakar S, et al. Optic neuropathy associated with vitamin A deficiency in children: a case series. J AAPOS. 2025;29(4):104277.
- Touzé R, Bremond-Gignac D, Robert MP. Ophthalmological management in craniosynostosis. Neurochirurgie. 2019;65(5):310-317.
- Lueck AH, Chokron S, Dutton GN. Commentary: Profiling Children With Cerebral Visual Impairment (CVI) Using Multiple Methods of Assessment to Aid in Differential Diagnosis. Semin Pediatr Neurol. 2023;47:101070.
- Cioni G, Fazzi B, Coluccini M, Bartalena L, Boldrini A, van Hof-van Duin J. Cerebral visual impairment in preterm infants with periventricular leukomalacia. Pediatr Neurol. 1997;17(4):331-8.
- Chock VY, Rao A, Van Meurs KP. Optimal neuromonitoring techniques in neonates with hypoxic ischemic encephalopathy. Front Pediatr. 2023;11:1138062.
- Chhablani PP, Kekunnaya R. Neuro-ophthalmic manifestations of prematurity. Indian J Ophthalmol. 2014;62(10):992-5.
- Creel DJ. Visually evoked potentials. Handb Clin Neurol. 2019;160:501-522.
- Mercuriali E, Ceccato C, Incagli F, Berto G, Suppiej A, Reffo ME. A new interdisciplinary perspective in the design of early evaluation and intervention programs for children with visual impairment. Front Pediatr. 2025;13:1596264.
- Olusanya BO, Wright SM, Smythe T, Khetani MA, Moreno-Angarita M, Gulati S, et al. Early childhood development strategy for the world’s children with disabilities. Front Public Health. 2024;12:1390107.
- Aylward SC, Reem RE. Pediatric Intracranial Hypertension. Pediatr Neurol. 2017;66:32-43.
- Mondragon J, Klovenski V. Pseudotumor cerebri. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel AK, Aktas O, Alexopoulos H, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021;20(9):762-772.
- Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019;15(2):89-102.
- Apperley L, Kumar R, Senniappan S. Idiopathic intracranial hypertension in children with obesity. Acta Paediatr. 2022;111(7):1420-1426.
- Colman BD, Boonstra F, Nguyen MN, Raviskanthan S, Sumithran P, White O, et al. Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments. J Neurol Neurosurg Psychiatry. 2024;95(4):375-383.
- Rogers JD, Jordan CO, Inger HE, Aylward SC. Secondary Intracranial Hypertension in Pediatric Lyme Meningitis. J Child Neurol. 2023;38(10-12):611-616.
- de Goederen R, Cuperus IE, Tasker RC, den Ottelander BK, Dremmen MHG, van Veelen MC, et al. Dural sinus volume in children with syndromic craniosynostosis and intracranial hypertension. J Neurosurg Pediatr. 2020;25(5):506-513.
- Still MEH, Chidarala S, Alvarado A, Neal D, Governale L, Ching J. Craniosynostosis Surgery for Increased Intracranial Pressure. J Craniofac Surg. 2022;33(5):1454-1457.
- Farfán-Albarracín JD, Ramírez-Sierra CL, Espitia Segura OM, Bedoya Morales AM, Pérez Cárdenas SH, Guzmán-Porras JJ, et al. Age-related variations in opening pressure in lumbar puncture: Implications for its interpretation in children. Brain Dev. 2025;47(3):104347.
- Kerscher SR, Zipfel J, Haas-Lude K, Bevot A, Schuhmann MU. Ultrasound-guided initial diagnosis and follow-up of pediatric idiopathic intracranial hypertension. Pediatr Radiol. 2024;54(6):1001-1011.
- Chang MY, Pineles SL. Optic disk drusen in children. Surv Ophthalmol. 2016;61(6):745-758.
- Jeon-Chapman J, Estrela T, Heidary G, Gise R. Prevalence, time course, and visual impact of peripapillary hyperreflective ovoid mass-like structures (PHOMS) in pediatric patients with optic nerve pathologies. J AAPOS. 2024;28(4):103966.
- Honorat R, Marchandot J, Tison C, Cances C, Chaix Y. [Treatment and prognosis of idiopathic intracranial hypertension in children. Retrospective study (1995-2009) and literature review]. Arch Pediatr. 2011;18(11):1139-47.
- Park KA, Yang HK, Han J, Kim SJ, Park SE, Lee HJ, et al. Characteristics of Optic Neuritis in South Korean Children and Adolescents: A Retrospective Multicenter Study. J Ophthalmol. 2022;2022:4281772.
- Pineles SL, Repka MX, Liu GT, Waldman AT, Borchert MS, Khanna S, et al. Assessment of Pediatric Optic Neuritis Visual Acuity Outcomes at 6 Months. JAMA Ophthalmol. 2020;138(12):1253-1261.
- Tenembaum SN. Acute disseminated encephalomyelitis. Handb Clin Neurol. 2013;112:1253-62.
- Bonhomme GR, Mitchell EB. Treatment of pediatric optic neuritis. Curr Treat Options Neurol. 2012;14(1):93-102.
- Lopez-Martin D, Martinez-Anton J. [Optic neuritis in childhood. A pediatric series, literature review and treatment approach]. Rev Neurol. 2016;63(3):103-8.
- Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018;89(2):127-137.
- Ringelstein M, Ayzenberg I, Lindenblatt G, Fischer K, Gahlen A, Novi G, et al. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders. Neurol Neuroimmunol Neuroinflamm. 2022;9(1).
- Kim W, Kim HJ. An update on biologic treatments for neuromyelitis optica spectrum disorder. Expert Rev Clin Immunol. 2023;19(1):111-121.
- Bigi S, Banwell B. Pediatric multiple sclerosis. J Child Neurol. 2012;27(11):1378-83.
- Hintzen RQ, Dale RC, Neuteboom RF, Mar S, Banwell B. Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis. Neurology. 2016;87(9 Suppl 2):S67-73.
- Lee H, Sheth V, Bibi M, Maconachie G, Patel A, McLean RJ, et al. Potential of handheld optical coherence tomography to determine cause of infantile nystagmus in children by using foveal morphology. Ophthalmology. 2013;120(12):2714-2724.
- Gräf M, Seliametova L, Hausmann A. [High-dose medialis recession in latent nystagmus]. Ophthalmologie. 2023;120(6):628-632.
- Rufai SR, Thomas MG, Purohit R, Bunce C, Lee H, Proudlock FA, et al. Can Structural Grading of Foveal Hypoplasia Predict Future Vision in Infantile Nystagmus?: A Longitudinal Study. Ophthalmology. 2020;127(4):492-500.
- Keeling E, Carter P, Musa AM, Shawkat F, Lee H, Self JE. Can a Portable Flash Visual Evoked Potential (VEP) Device Identify Chiasmal Decussation Anomalies in Albinism?. Diagnostics (Basel). 2025;15(11).
- Dawar B, Kuht HJ, Han J, Maconachie GDE, Thomas MG. Clinical utility gene card for FRMD7-related infantile nystagmus. Eur J Hum Genet. 2021;29(10):1584-1588.
- Salman A, Hutton SB, Newall T, Scott JA, Griffiths HL, Lee H, et al. Characterization of the Frmd7 Knock-Out Mice Generated by the EUCOMM/COMP Repository as a Model for Idiopathic Infantile Nystagmus (IIN). Genes (Basel). 2020;11(10).
- Brodsky MC, Keating GF. Chiasmal glioma in spasmus nutans: a cautionary note. J Neuroophthalmol. 2014;34(3):274-5.
- Brodsky MC, Torrado LA. Acquired monocular nystagmus in chiasmal glioma-a video-oculographic study. J AAPOS. 2019;23(3):185-187.
- Lama G, Esposito Salsano M, Grassia C, Calabrese E, Grassia MG, Bismuto R, et al. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up. Minerva Pediatr. 2007;59(1):13-21.
- Boricean ID, Bărar A. Understanding ocular torticollis in children. Oftalmologia. 2011;55(1):10-26.
- Hofsli M, Vinding T, Sandfeld L, Hesgaard HB. [Ocular torticollis is a diagnostic and surgical challenge]. Ugeskr Laeger. 2019;181(39).
- Yoon JA, Choi H, Shin YB, Jeon H. Development of a questionnaire to identify ocular torticollis. Eur J Pediatr. 2021;180(2):561-567.
- Teodorescu L. ANOMALOUS HEAD POSTURES IN STRABISMUS AND NYSTAGMUS DIAGNOSIS AND MANAGEMENT. Rom J Ophthalmol. 2015;59(3):137-40.
- Do TT. Congenital muscular torticollis: current concepts and review of treatment. Curr Opin Pediatr. 2006;18(1):26-9.
- Wicart P. [Congenital torticollis]. Arch Pediatr. 2012;19(3):335-9.
- Durnford L, Patel MSE, Khamar R, Khurram R. Bilateral sternocleidomastoid pseudotumors-a case report and literature review. Radiol Case Rep. 2021;16(4):964-967.
- Akbari MR, Khorrami-Nejad M, Kangari H, Akbarzadeh Baghban A, Ranjbar Pazouki M. Facial Asymmetry in Unilateral Congenital Superior Oblique Muscle Palsy. Optom Vis Sci. 2021;98(11):1248-1254.
- Enz TJ, Jaggi GP, Weber KP, Sturm V, Landau K. Inferior oblique muscle anteriorization in congenital superior oblique palsy. Klin Monbl Augenheilkd. 2014;231(4):386-9.
- Zetterström C, Lundvall A, Kugelberg M. Cataracts in children. J Cataract Refract Surg. 2005;31(4):824-40.
- Gu S, Hu Y, Zhao Y, Chen L, Sun W, Chang P, et al. A Retrospective Study on the Eye-Related Quality of Life, Functional Vision, and Their Determinants Among Children Following Congenital and Developmental Cataracts Surgery and Its Impact on Their Families Using the PedEyeQ. Front Public Health. 2022;10:788384.
- Sakki HEA, Dale NJ, Sargent J, Perez-Roche T, Bowman R. Is there consensus in defining childhood cerebral visual impairment? A systematic review of terminology and definitions. Br J Ophthalmol. 2018;102(4):424-432.
- Silveira S, Kelly N, Wright R. Australian children with cerebral visual impairment: using what we know now to improve future approaches. Strabismus. 2023;31(4):253-261.
- Chandna A, Ghahghaei S, Foster S, Kumar R. Higher Visual Function Deficits in Children With Cerebral Visual Impairment and Good Visual Acuity. Front Hum Neurosci. 2021;15:711873.
- Holwerda JC, Van Braeckel KNJA, Roze E, Hoving EW, Maathuis CGB, Brouwer OF, et al. Functional outcome at school age of neonatal post-hemorrhagic ventricular dilatation. Early Hum Dev. 2016;96:15-20.
- Tanis JC, van der Ree MH, Roze E, Huis in ‘t Veld AE, van den Berg PP, Van Braeckel KN, et al. Functional outcome of very preterm-born and small-for-gestational-age children at school age. Pediatr Res. 2012;72(6):641-8.
- Pierrat V, Marchand-Martin L, Marret S, Arnaud C, Benhammou V, Cambonie G, et al. Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study. BMJ. 2021;373:n741.
- Seely KR, Mangalesh S, Shen LL, McGeehan B, Ying GS, Sarin N, et al. Association Between Retinal Microanatomy in Preterm Infants and 9-Month Visual Acuity. JAMA Ophthalmol. 2022;140(7):699-706.
- Sadowska M, Sarecka-Hujar B, Kopyta I. Cerebral Palsy: Current Opinions on Definition, Epidemiology, Risk Factors, Classification and Treatment Options. Neuropsychiatr Dis Treat. 2020;16:1505-1518.
- Himmelmann K, Horber V, Sellier E, De la Cruz J, Papavasiliou A, Krägeloh-Mann I. Neuroimaging Patterns and Function in Cerebral Palsy-Application of an MRI Classification. Front Neurol. 2020;11:617740.
- Wilton GJ, Woodhouse R, Vinuela-Navarro V, England R, Woodhouse JM. Behavioural Features of Cerebral Visual Impairment Are Common in Children With Down Syndrome. Front Hum Neurosci. 2021;15:673342.
- Hokken MJ, Stein N, Pereira RR, Rours IGIJG, Frens MA, van der Steen J, et al. Eyes on CVI: Eye movements unveil distinct visual search patterns in Cerebral Visual Impairment compared to ADHD, dyslexia, and neurotypical children. Res Dev Disabil. 2024;151:104767.
- van der Zee YJ, Stiers PLJ, Evenhuis HM. Object Recognition and Dorsal Stream Vulnerabilities in Children With Early Brain Damage. Front Hum Neurosci. 2022;16:733055.
- Philip SS, Guzzetta A, Gole GA, Boyd RN. Clinimetric properties of visuo-perceptual and visuo-cognitive assessment tools used for children with cerebral visual impairment and cerebral palsy or developmental delay: a systematic review. Disabil Rehabil. 2022;44(23):6984-6996.
- Chang MY, Reid MW, Roman-Lantzy C, Contractor D, Granger K, O’Neil SH, et al. Validity and Reliability of the CVI Range for Clinical Research: Baseline and One-Year Results. Ophthalmol Sci. 2026;6(7):101233.
- Lueck AH, Dutton GN, Chokron S. Profiling Children With Cerebral Visual Impairment Using Multiple Methods of Assessment to Aid in Differential Diagnosis. Semin Pediatr Neurol. 2019;31:5-14.
- Blackstone S, Luo F, Barker RM, Sevcik RA, Romski M, Casella V, et al. Profiles of Children With Cortical Visual Impairment Who Use Augmentative and Alternative Communication: A Retrospective Examination. Am J Speech Lang Pathol. 2022;31(6):2707-2721.
- HeadSmart Be Brain Tumour Aware. A new clinical guideline from the Royal College of Paediatrics and Child Health with a national awareness campaign accelerates brain tumor diagnosis in UK children—“HeadSmart: Be Brain Tumour Aware”. Neuro Oncol. 2016;18(3):445-54.
- Shanmugavadivel D, Liu JF, Murphy L, Wilne S, Walker D. Accelerating diagnosis for childhood brain tumours: an analysis of the HeadSmart UK population data. Arch Dis Child. 2020;105(4):355-362.
- Fry CW, Perrow R, Paul SP. Brain tumours in children: importance of early identification. Br J Nurs. 2014;23(22):1202-7.
- Nuijts MA, Stegeman I, van Seeters T, Borst MD, Bennebroek CAM, Buis DR, et al. Ophthalmological Findings in Youths With a Newly Diagnosed Brain Tumor. JAMA Ophthalmol. 2022;140(10):982-993.
- Nuijts MA, Stegeman I, Porro GL, Duvekot JC, van Egmond-Ebbeling MB, van der Linden DCP, et al. Ophthalmological Evaluation in Children Presenting With a Primary Brain Tumor. J Neuroophthalmol. 2022;42(1):e99-e108.
- Alswaina N, Elkhamary SM, Shammari MA, Khan AO. Ophthalmic Features of Outpatient Children Diagnosed with Intracranial Space-Occupying Lesions by Ophthalmologists. Middle East Afr J Ophthalmol. 2015;22(3):327-30.
- Mole G, Edminson R, Higham A, Hopper C, Hildebrand D. The Management of Childhood Intracranial Tumours and the Role of the Ophthalmologist. Neuroophthalmology. 2019;43(6):375-381.
- Jariyakosol S, Peragallo JH. The Effects of Primary Brain Tumors on Vision and Quality of Life in Pediatric Patients. Semin Neurol. 2015;35(5):587-98.
- Kaur K, Patel BC. Retinoblastoma. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Patti G, Ibba A, Morana G, Napoli F, Fava D, di Iorgi N, et al. Central diabetes insipidus in children: Diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2020;34(5):101440.
- Walker DA, Aquilina K, Spoudeas H, Pilotto C, Gan HW, Meijer L. A new era for optic pathway glioma: A developmental brain tumor with life-long health consequences. Front Pediatr. 2023;11:1038937.
- Lohkamp LN, Parkin P, Puran A, Bartels UK, Bouffet E, Tabori U, et al. Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1. Front Surg. 2022;9:886697.
- Florent C, Beylerian M, Mairot K, Dambricourt L, André N, David T, et al. [Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children]. J Fr Ophtalmol. 2022;45(2):173-184.
- Gospe SM, Bhatti MT, El-Dairi MA. Emerging Applications of Optical Coherence Tomography in Pediatric Optic Neuropathies. Semin Pediatr Neurol. 2017;24(2):135-142.
- Hepokur M, Sarici AM. Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas. Graefes Arch Clin Exp Ophthalmol. 2018;256(9):1757-1765.
- de Blank PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A, et al. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. Neuro Oncol. 2022;24(11):1845-1856.
- Nysom K, Kilburn LB, Leary SES, Landi DB, de Vos-Kerkhof E, Perreault S, et al. Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial. Neuro Oncol. 2025;27(5):1341-1355.
- Tsang DS, Murphy ES, Merchant TE. Radiation Therapy for Optic Pathway and Hypothalamic Low-Grade Gliomas in Children. Int J Radiat Oncol Biol Phys. 2017;99(3):642-651.
- Steinbok P. Craniopharyngioma in Children: Long-term Outcomes. Neurol Med Chir (Tokyo). 2015;55(9):722-6.
- Magerman C, Boros E, Preziosi M, Lhoir S, Gilis N, De Witte O, et al. Childhood craniopharyngioma: a retrospective study of children followed in Hôpital Universitaire de Bruxelles. Front Endocrinol (Lausanne). 2024;15:1297132.
- Alkhaibary A, Alharbi A, Khairy S. Giant Craniopharyngioma. World Neurosurg. 2023;174:137-138.
- Vinchon M, Leblond P. Medulloblastoma: Clinical presentation. Neurochirurgie. 2021;67(1):23-27.
- Tamburrini G, Frassanito P, Chieffo D, Massimi L, Caldarelli M, Di Rocco C. Cerebellar mutism. Childs Nerv Syst. 2015;31(10):1841-51.
- Shen CJ, Kry SF, Buchsbaum JC, Milano MT, Inskip PD, Ulin K, et al. Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024;119(2):431-445.
- Whelan KF, Stratton K, Kawashima T, Waterbor JW, Castleberry RP, Stovall M, et al. Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2010;54(1):103-9.
- Carson A, Stone J, Hibberd C, Murray G, Duncan R, Coleman R, et al. Disability, distress and unemployment in neurology outpatients with symptoms ‘unexplained by organic disease’. J Neurol Neurosurg Psychiatry. 2011;82(7):810-3.
- Sharpe M, Stone J, Hibberd C, Warlow C, Duncan R, Coleman R, et al. Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome. Psychol Med. 2010;40(4):689-98.
- Watson M, Woodward J, Strom LA. The Financial Burden of Functional Neurological Disorders. Curr Neurol Neurosci Rep. 2023;23(10):637-643.
- Lehn A, Gelauff J, Hoeritzauer I, Ludwig L, McWhirter L, Williams S, et al. Functional neurological disorders: mechanisms and treatment. J Neurol. 2016;263(3):611-20.
- Mavroudis I, Kazis D, Kamal FZ, Gurzu IL, Ciobica A, Pădurariu M, et al. Understanding Functional Neurological Disorder: Recent Insights and Diagnostic Challenges. Int J Mol Sci. 2024;25(8).
- Finkelstein SA, Popkirov S. Functional Neurological Disorder: Diagnostic Pitfalls and Differential Diagnostic Considerations. Neurol Clin. 2023;41(4):665-679.
- Perez DL, Finkelstein S, Adams C, Saxena A. Toward a Precision Medicine Approach to the Outpatient Assessment and Treatment of Functional Neurological Disorder. Neurol Clin. 2023;41(4):681-693.
- Sverdlichenko I, Brossard-Barbosa N, Micieli JA, Margolin E. Characteristics of 110 Patients With Functional Visual Loss. Am J Ophthalmol. 2023;250:171-176.
- Lawlor M, Huynh B, Humphreys K, Ogunbowale L, Kopelman MD, Plant GT. Observational cohort study of 100 patients presenting with functional visual loss: clinical characteristics and comparison with other functional neurologic disorders. Can J Ophthalmol. 2024;59(6):e727-e736.
- Stone J, Smyth R, Carson A, Lewis S, Prescott R, Warlow C, et al. Systematic review of misdiagnosis of conversion symptoms and “hysteria”. BMJ. 2005;331(7523):989.
- Edwards MJ, Koens LH, Liepert J, Nonnekes J, Schwingenschuh P, van de Stouwe AMM, et al. Clinical neurophysiology of functional motor disorders: IFCN Handbook Chapter. Clin Neurophysiol Pract. 2024;9:69-77.
- Mojon DS, Flueckiger P. A new optotype chart for detection of nonorganic visual loss. Ophthalmology. 2002;109(4):810-5.
- Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology. 2012;79(3):282-4.
- Ding JM, Kanaan RA. Conversion disorder: A systematic review of current terminology. Gen Hosp Psychiatry. 2017;45:51-55.
- Loewenberger A, Cope SR, Poole N, Agrawal N. An investigation into the preferred terminology for functional seizures. Epilepsy Behav. 2020;111:107183.
- Loewenberger A, Davies K, Agrawal N, Poole N, Cope SR. What do patients prefer their functional seizures to be called, and what are their experiences of diagnosis? - A mixed methods investigation. Epilepsy Behav. 2021;117:107817.
- Hingray C, Popkirov S, Kozlowska K, Pretorius C, Sarudiansky M, El-Hage W, et al. Functional/dissociative seizures: Proposal for a new diagnostic label and definition by the ILAE task force. Epilepsia. 2025;66(11):4162-4182.
- Morsy SK, Aybek S, Carson A, Nicholson TR, Stone J, Kamal AM, et al. The relationship between types of life events and the onset of functional neurological (conversion) disorder in adults: a systematic review and meta-analysis. Psychol Med. 2022;52(3):401-418.
- Feinstein A. Conversion Disorder. Continuum (Minneap Minn). 2018;24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):861-872.
- McLoughlin C, Hoeritzauer I, Cabreira V, Aybek S, Adams C, Alty J, et al. Functional neurological disorder is a feminist issue. J Neurol Neurosurg Psychiatry. 2023;94(10):855-862.
- Galli S, Tatu L, Bogousslavsky J, Aybek S. Conversion, Factitious Disorder and Malingering: A Distinct Pattern or a Continuum?. Front Neurol Neurosci. 2018;42:72-80.
- Edwards MJ, Yogarajah M, Stone J. Why functional neurological disorder is not feigning or malingering. Nat Rev Neurol. 2023;19(4):246-256.
- Finkelstein SA, Diamond C, Carson A, Stone J. Incidence and prevalence of functional neurological disorder: a systematic review. J Neurol Neurosurg Psychiatry. 2025;96(4):383-395.
- Gelauff JM, Carson A, Ludwig L, Tijssen MAJ, Stone J. The prognosis of functional limb weakness: a 14-year case-control study. Brain. 2019;142(7):2137-2148.
- Santos-Bueso E, Sáenz-Francés F, García-Sáenz S, Martínez-de-la-Casa JM, García-Feijoo J. [Non-organic visual loss. A series of 5 cases]. An Pediatr (Barc). 2015;82(1):e122-5.
- McLoughlin C, McGhie-Fraser B, Carson A, Olde Hartman T, Stone J. How stigma unfolds for patients with Functional Neurological Disorder. J Psychosom Res. 2024;181:111667.
- Lyndon S. Precision dynamics of predictive coding in functional neurological disorder. Brain. 2026.
- Weber S, Heim S, Richiardi J, Van De Ville D, Serranová T, Jech R, et al. Multi-centre classification of functional neurological disorders based on resting-state functional connectivity. Neuroimage Clin. 2022;35:103090.
- Popkirov S, Jungilligens J, Michaelis R. [Understanding and explaining functional movement disorders]. Nervenarzt. 2024;95(6):499-506.
- Biousse V, Newman NJ. Diagnosis and clinical features of common optic neuropathies. Lancet Neurol. 2016;15(13):1355-1367.
- Vassilopoulos A, Mohammad S, Dure L, Kozlowska K, Fobian AD. Treatment Approaches for Functional Neurological Disorders in Children. Curr Treat Options Neurol. 2022;24(2):77-97.
- Kozlowska K, Chudleigh C, Savage B, Hawkes C, Scher S, Nunn KP. Evidence-Based Mind-Body Interventions for Children and Adolescents with Functional Neurological Disorder. Harv Rev Psychiatry. 2023;31(2):60-82.
- Ganslev CA, Storebø OJ, Callesen HE, Ruddy R, Søgaard U. Psychosocial interventions for conversion and dissociative disorders in adults. Cochrane Database Syst Rev. 2020;7(7):CD005331.
- Gedzelman ER, LaRoche SM. Long-term video EEG monitoring for diagnosis of psychogenic nonepileptic seizures. Neuropsychiatr Dis Treat. 2014;10:1979-86.
- Galli S, Béreau M, Magnin E, Moulin T, Aybek S. Functional movement disorders. Rev Neurol (Paris). 2020;176(4):244-251.
- Griffiths PG, Ali N. Medically unexplained visual loss in adult patients. Curr Opin Neurol. 2009;22(1):41-5.
- Laginaf M, Costello H, Price G. How do ophthalmologists manage functional visual symptoms? A UK survey of ophthalmologists’ experience. Graefes Arch Clin Exp Ophthalmol. 2022;260(4):1307-1313.
- Flueckiger P, Mojon DS. Detection of nonorganic visual loss with a new optotype chart in simulated malingerers. Klin Monbl Augenheilkd. 2003;220(3):89-92.
- Slavin ML. The prism dissociation test in detecting unilateral functional visual loss. J Clin Neuroophthalmol. 1990;10(2):127-30.
- Golnik KC, Lee AG, Eggenberger ER. The monocular vertical prism dissociation test. Am J Ophthalmol. 2004;137(1):135-7.
- Na H, Hwang JM, Yang HK, Han SB. Characterizing Visual Field Defects with Tangent Screen Perimetry in Organic Versus Non-Organic Pathologies. Diagnostics (Basel). 2026;16(6).
- Zinkernagel MS, Pellanda N, Kunz A, Mojon DS. Saccade testing to distinguish between non-organic and organic visual-field restriction. Br J Ophthalmol. 2009;93(9):1247-50.
- McBain VA, Robson AG, Hogg CR, Holder GE. Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials. Graefes Arch Clin Exp Ophthalmol. 2007;245(4):502-10.
- Raghunandan A, Buckingham RS. The utility of clinical electrophysiology in a case of nonorganic vision loss. Optometry. 2008;79(8):436-43.
- de Souza Soares T, Berezovsky A, Sacai PY, Fernandes AG, Rocha DM, Verna C, et al. Contribution of objectively measured grating acuity by sweep visually evoked potentials to the diagnosis of unexplained visual loss. Graefes Arch Clin Exp Ophthalmol. 2022;260(5):1687-1699.
- Renner AB, Kellner U, Tillack H, Kraus H, Foerster MH. Recording of both VEP and multifocal ERG for evaluation of unexplained visual loss electrophysiology in unexplained visual loss. Doc Ophthalmol. 2005;111(3):149-57.
- Holder GE, Gale RP, Acheson JF, Robson AG. Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol. 2009;22(1):3-10.
- Young B, Eggenberger E, Kaufman D. Current electrophysiology in ophthalmology: a review. Curr Opin Ophthalmol. 2012;23(6):497-505.
- Abazari A, Allam SS, Adamus G, Ghazi NG. Optical coherence tomography findings in autoimmune retinopathy. Am J Ophthalmol. 2012;153(4):750-6, 756.e1.
- Massengill MT, Park JC, McAnany JJ, Hyde RA. Occult retinopathy following treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret). Doc Ophthalmol. 2023;146(2):191-197.
- Cheng Y, Liu X, Lu J, Ren J, Fei P, Chen M, et al. Hyperacute Outer Retinal Dysfunction. JAMA Ophthalmol. 2025;143(3):222-229.
- Muñoz-Hernández AM, Santos-Bueso E, Sáenz-Francés F, Méndez-Hernández CD, García-Feijoó J, Gegúndez-Fernández JA, et al. Nonorganic visual loss and associated psychopathology in children. Eur J Ophthalmol. 2012;22(2):269-73.
- Sisera L, Patzelt S, Gerth-Kahlert C. [Non-Organic Visual Loss in Children and Teenagers]. Klin Monbl Augenheilkd. 2022;239(4):599-604.
- Kaski D, Bronstein AM. Functional eye movement disorders. Handb Clin Neurol. 2016;139:343-351.
- Kaski D, Pradhan V, Bronstein AM. Clinical features of functional (psychogenic) eye movement disorders. J Neurol Neurosurg Psychiatry. 2016;87(12):1389-1392.
- Kaski D, Bronstein AM, Edwards MJ, Stone J. Cranial functional (psychogenic) movement disorders. Lancet Neurol. 2015;14(12):1196-205.
- Stone J, Hoeritzauer I, Tesolin L, Carson A. Functional movement disorders of the face: A historical review and case series. J Neurol Sci. 2018;395:35-40.
- Mustafa MM, Akram H, Oliva-Domínguez M, Kaski D. Functional positional eye and eyelid movements. J Neurol. 2020;267(11):3425-3428.
- Schwingenschuh P, Espay AJ. Functional tremor. J Neurol Sci. 2022;435:120208.
- Rhatigan M, Byrne C, Logan P. Spasm of the near reflex: A case report. Am J Ophthalmol Case Rep. 2017;6:35-37.
- Neppert B, Rambold H. Familial voluntary nystagmus. Strabismus. 2006;14(2):115-9.
- Skacik P, Sivak S, Kurca E. Adult-onset ocular flutter-opsoclonus spectrum across diverse neurological disorders: a video-oculographic case series. BMC Neurol. 2026;26(1).
- Lemos J, Eggenberger E. Saccadic intrusions: review and update. Curr Opin Neurol. 2013;26(1):59-66.
- Coscarelli JM. Essential blepharospasm. Semin Ophthalmol. 2010;25(3):104-8.
- Kaltenmaier M, Vanselow K, Rollnik J, Maschke M. [Therapy of Benign Essential Blepharospasm with Botulinum Toxin]. Fortschr Neurol Psychiatr. 2019;87(7):355-360.
- Kerty E, Eidal K. Apraxia of eyelid opening: clinical features and therapy. Eur J Ophthalmol. 2006;16(2):204-8.
- Ho TC, Couch SM, Custer PL. Psychogenic Ptosis. Ophthalmic Plast Reconstr Surg. 2022;38(5):448-451.
- Bagheri A, Abbasnia E, Pakravan M, Roshani M, Tavakoli M. Psychogenic unilateral pseudoptosis. Ophthalmic Plast Reconstr Surg. 2015;31(3):e55-7.
- Barton JJ, Fouladvand M. Ocular aspects of myasthenia gravis. Semin Neurol. 2000;20(1):7-20.
- Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M, et al. Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurol. 2018;75(9):1132-1141.
- Perez DL, Edwards MJ, Nielsen G, Kozlowska K, Hallett M, LaFrance WC Jr. Decade of progress in motor functional neurological disorder: continuing the momentum. J Neurol Neurosurg Psychiatry. 2021.
- Barnett C, Davis R, Mitchell C, Tyson S. The vicious cycle of functional neurological disorders: a synthesis of healthcare professionals’ views on working with patients with functional neurological disorder. Disabil Rehabil. 2022;44(10):1802-1811.
- McWilliams A, Reilly C, McFarlane FA, Booker E, Heyman I. Nonepileptic seizures in the pediatric population: A qualitative study of patient and family experiences. Epilepsy Behav. 2016;59:128-36.
- Rockliffe-Fidler C, Willis M. Explaining dissociative seizures: a neuropsychological perspective. Pract Neurol. 2019;19(3):259-263.
- Cabreira V, Alty J, Antic S, Araújo R, Aybek S, Ball HA, et al. Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study. Eur J Neurol. 2025;32(1):e16318.
- Cabreira V, Frostholm L, McWhirter L, Stone J, Carson A. Clinical signs in functional cognitive disorders: A systematic review and diagnostic meta-analysis. J Psychosom Res. 2023;173:111447.
- Nielsen G, Stone J, Matthews A, Brown M, Sparkes C, Farmer R, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015;86(10):1113-9.
- Maggio JB, Ospina JP, Callahan J, Hunt AL, Stephen CD, Perez DL. Outpatient Physical Therapy for Functional Neurological Disorder: A Preliminary Feasibility and Naturalistic Outcome Study in a U.S. Cohort. J Neuropsychiatry Clin Neurosci. 2020;32(1):85-89.
- Maggio J, Kyle K, Stephen CD, Perez DL. Lessons Learned in Outpatient Physical Therapy for Motor Functional Neurological Disorder. J Neurol Phys Ther. 2023;47(1):52-59.
- Geary C. Physical therapy interventions in an inpatient rehabilitation setting for functional neurological disorder: A case series. NeuroRehabilitation. 2022;50(2):209-218.
- Hunter RM, Nielsen G, Le Novere M, Marston L, Lee TC, Stone J, et al. Cost Utility of Specialist Physiotherapy for Functional Motor Disorder (Physio4FMD): Economic Analysis of a Pragmatic Randomized Controlled Trial. Neurol Clin Pract. 2025;15(3):e200465.
- Nielsen G, Lee TC, Marston L, Carson A, Edwards MJ, Goldstein LH, et al. Which factors predict outcome from specialist physiotherapy for functional motor disorder? Prognostic modelling of the Physio4FMD intervention. J Psychosom Res. 2025;190:112056.
- Goldstein LH, Robinson EJ, Mellers JDC, Stone J, Carson A, Reuber M, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry. 2020;7(6):491-505.
- Macías-García D, Méndez-Del Barrio M, Canal-Rivero M, Muñoz-Delgado L, Adarmes-Gómez A, Jesús S, et al. Combined Physiotherapy and Cognitive Behavioral Therapy for Functional Movement Disorders: A Randomized Clinical Trial. JAMA Neurol. 2024;81(9):966-976.
- Petrochilos P, Elmalem MS, Patel D, Louissaint H, Hayward K, Ranu J, et al. Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD). J Neurol. 2020;267(9):2655-2666.
- Guy L, Caceres GA, Jackson T, Gorman S, Wilson J, Hsieh Y, et al. Routine outcomes and evaluation of an 8-week outpatient multidisciplinary rehabilitative therapy program for functional neurological disorder. J Neurol. 2024;271(4):1873-1884.
- Gasparini S, Beghi E, Ferlazzo E, Beghi M, Belcastro V, Biermann KP, et al. Management of psychogenic non-epileptic seizures: a multidisciplinary approach. Eur J Neurol. 2019;26(2):205-e15.
- Tolchin B, Baslet G, Suzuki J, Martino S, Blumenfeld H, Hirsch LJ, et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia. 2019;60(5):986-995.
- Gelauff J, Stone J. Prognosis of functional neurologic disorders. Handb Clin Neurol. 2016;139:523-541.
- van Nispen RM, Virgili G, Hoeben M, Langelaan M, Klevering J, Keunen JE, et al. Low vision rehabilitation for better quality of life in visually impaired adults. Cochrane Database Syst Rev. 2020;1(1):CD006543.
- Hernández-Moreno L, Senra H, Marques AP, Perdomo NM, Macedo AF. The Basic VRS-Effect Study: Clinical Trial Outcomes and Cost-Effectiveness of Low Vision Rehabilitation in Portugal. Ophthalmol Ther. 2023;12(1):307-323.
- Luu W, Kalloniatis M, Bartley E, Tu M, Dillon L, Zangerl B, et al. A holistic model of low vision care for improving vision-related quality of life. Clin Exp Optom. 2020;103(6):733-741.
- Gibson E, Koh CL, Eames S, Bennett S, Scott AM, Hoffmann TC. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2022;3(3):CD006430.
- Burgos-Blasco B, Perez-Garcia P, Fernandez-Vigo JI, Benito-Pascual B, Hernandez-Garcia E, Saenz-Frances F, et al. Binocular Visual Field and Vision-Related Quality of Life in Patients With Hemianopia. J Neuroophthalmol. 2022;42(1):e217-e224.
- Dogra N, Redmond BV, Lilley S, Johnson BA, Lam BL, Tamhankar M, et al. Vision-related quality of life after unilateral occipital stroke. Brain Behav. 2024;14(7):e3582.
- Thurtell MJ. Diagnostic approach to abnormal spontaneous eye movements. Continuum (Minneap Minn). 2014;20(4 Neuro-ophthalmology):993-1007.
- Schuett S. The rehabilitation of hemianopic dyslexia. Nat Rev Neurol. 2009;5(8):427-37.
- Freeman EE, Muñoz B, Rubin G, West SK. Visual field loss increases the risk of falls in older adults: the Salisbury eye evaluation. Invest Ophthalmol Vis Sci. 2007;48(10):4445-50.
- Clemson L, Stark S, Pighills AC, Fairhall NJ, Lamb SE, Ali J, et al. Environmental interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2023;3(3):CD013258.
- Pundlik S, Tomasi M, Luo G. Evaluation of a Portable Collision Warning Device for Patients With Peripheral Vision Loss in an Obstacle Course. Invest Ophthalmol Vis Sci. 2015;56(4):2571-9.
- Finger RP, McSweeney SC, Deverell L, O’Hare F, Bentley SA, Luu CD, et al. Developing an instrumental activities of daily living tool as part of the low vision assessment of daily activities protocol. Invest Ophthalmol Vis Sci. 2014;55(12):8458-66.
- Gobeille MR, Fujiwara K, Massof RW. Application of Rasch Analysis to Timed Instrumental Activities of Daily Living in Low Vision: A Validation Study. Optom Vis Sci. 2023;100(6):397-405.
- Sugawara T, Pak K, Miura G, Baba T. Visual activities of daily living survey for retinitis pigmentosa. Jpn J Ophthalmol. 2024;68(6):717-721.
- Virgili G, Acosta R, Bentley SA, Giacomelli G, Allcock C, Evans JR. Reading aids for adults with low vision. Cochrane Database Syst Rev. 2018;4(4):CD003303.
- Virgili G, Acosta R, Grover LL, Bentley SA, Giacomelli G. Reading aids for adults with low vision. Cochrane Database Syst Rev. 2013;10(10):CD003303.
- Hamade N, Hodge WG, Rakibuz-Zaman M, Malvankar-Mehta MS. The Effects of Low-Vision Rehabilitation on Reading Speed and Depression in Age Related Macular Degeneration: A Meta-Analysis. PLoS One. 2016;11(7):e0159254.
- Senjam SS, Primo SA. Challenges and Enablers for Smartphone Use by Persons With Vision Loss During the COVID-19 Pandemic: A Report of Two Case Studies. Front Public Health. 2022;10:912460.
- Hassan SE, Ross NC, Massof RW, Stelmack J. Changes in the Properties of the Preferred Retinal Locus with Eccentric Viewing Training. Optom Vis Sci. 2019;96(2):79-86.
- Rubin GS, Crossland MD, Dunbar HMP, Brown GM, Petriti B, Roche H, et al. Eccentric Viewing Training for Age-Related Macular Disease: Results of a Randomized Controlled Trial (the EFFECT Study). Ophthalmol Sci. 2024;4(2):100422.
- Jung JH, Peli E. Field Expansion for Acquired Monocular Vision Using a Multiplexing Prism. Optom Vis Sci. 2018;95(9):814-828.
- Hanna KL, Hepworth LR, Rowe FJ. The treatment methods for post-stroke visual impairment: A systematic review. Brain Behav. 2017;7(5):e00682.
- Frolov A, Feuerstein J, Subramanian PS. Homonymous Hemianopia and Vision Restoration Therapy. Neurol Clin. 2017;35(1):29-43.
- Leff A, Barton JJS. Rehabilitation of visual disorders. Handb Clin Neurol. 2021;178:361-386.
- Falahati M, Kurukuti NM, Vargas-Martin F, Peli E, Jung JH. Oblique multi-periscopic prism for field expansion of homonymous hemianopia. Biomed Opt Express. 2023;14(5):2352-2364.
- Bronstad PM, Peli E, Liu R, Doherty A, Fulton AB. High prevalence of strabismic visual field expansion in pediatric homonymous hemianopia. PLoS One. 2018;13(12):e0209213.
- Vilimovsky T, Chen P, Hoidekrova K, Slavicek O, Harsa P. Prism Adaptation Treatment Predicts Improved Rehabilitation Responses in Stroke Patients with Spatial Neglect. Healthcare (Basel). 2022;10(10).
- Fortis P, Ronchi R, Velardo V, Calzolari E, Banco E, Algeri L, et al. A home-based prism adaptation training for neglect patients. Cortex. 2020;122:61-80.
- Bourgeois A, Turri F, Schnider A, Ptak R. Virtual prism adaptation for spatial neglect: A double-blind study. Neuropsychol Rehabil. 2022;32(6):1033-1047.
- Kaiser AP, Villadsen KW, Samani A, Knoche H, Evald L. Virtual Reality and Eye-Tracking Assessment, and Treatment of Unilateral Spatial Neglect: Systematic Review and Future Prospects. Front Psychol. 2022;13:787382.
- Ayesha A, Riehle C, Leishangthem L. Diagnostic and Management Strategies of Visual Snow Syndrome: Current Perspectives. Eye Brain. 2025;17:1-11.
- Guadie YG, Demeke ZD, Aldersey H. Mobility assistive product abandonment and associated factors in Amhara regional state, Ethiopia: a multi centre study. Disabil Rehabil Assist Technol. 2026;21(5):2034-2044.
- Alberti CF, Goldstein RB, Peli E, Bowers AR. Driving with Hemianopia V: Do Individuals with Hemianopia Spontaneously Adapt Their Gaze Scanning to Differing Hazard Detection Demands?. Transl Vis Sci Technol. 2017;6(5):11.
- Barton JJS, Ranalli PJ. Vision therapy: Occlusion, prisms, filters, and vestibular exercises for mild traumatic brain injury. Surv Ophthalmol. 2021;66(2):346-353.
- Patel H, Polam S, Joseph R. Overview of Treatment Options for Mild Traumatic Brain Injury: A Literature Review. Cureus. 2024;16(4):e59021.
- Babicz MA, Woods SP, Cirino P, Presley C, Colton Z, Podell K. Vestibular/Ocular Motor Screening is Independently Associated With Concussion Symptom Severity in Youths. Clin J Sport Med. 2022;32(1):40-45.
- Tomczyk CP, Anderson M, Petit KM, Savage JL, Covassin T. Vestibular/Ocular Motor Screening Assessment Outcomes After Sport-Related Concussion in High School and Collegiate Athletes. J Athl Train. 2021;56(12):1285-1291.
- Rosenblum D, Donahue C, Higgins H, Brna M, Resch J. False-Positive Rates, Risk Factors, and Interpretations of the Vestibular/Ocular Motor Screening in Collegiate Athletes. J Athl Train. 2024;59(6):600-607.
- Nelles G, Pscherer A, de Greiff A, Forsting M, Gerhard H, Esser J, et al. Eye-movement training-induced plasticity in patients with post-stroke hemianopia. J Neurol. 2009;256(5):726-33.
- Alwashmi K, Meyer G, Rowe FJ. Audio-visual stimulation for visual compensatory functions in stroke survivors with visual field defect: a systematic review. Neurol Sci. 2022;43(4):2299-2321.
- Magosso E, Cuppini C, Bertini C. Audiovisual Rehabilitation in Hemianopia: A Model-Based Theoretical Investigation. Front Comput Neurosci. 2017;11:113.
- Scheiman M, Mitchell GL, Cotter SA, Kulp M, Chase C, Borsting E, et al. Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART): Design and Methods. Vis Dev Rehabil. 2015;1(3):214-228.
- Thiagarajan P, Ciuffreda KJ. Accommodative and pupillary dysfunctions in concussion/mild traumatic brain injury: A Review. NeuroRehabilitation. 2022;50(3):261-278.
- Thiagarajan P, Ciuffreda KJ. Effect of oculomotor rehabilitation on accommodative responsivity in mild traumatic brain injury. J Rehabil Res Dev. 2014;51(2):175-91.
- Houston KE, McDaniel CE, Greenspan L, Tirandazi P. Case Series: Periodic Accommodative Fluctuations after Concussion. Optom Vis Sci. 2021;98(12):1387-1393.
- Dutta P. Characteristics of binocular vision and oculomotor function among sports-concussed athletes. Indian J Ophthalmol. 2023;71(5):2076-2082.
- Trbovich AM, Zynda AJ, Togashi T, Burley C, Mucha A, Collins MW, et al. Randomized Controlled Trial of Brock String Vision Therapy for Receded Near Point of Convergence Following Concussion. J Neurotrauma. 2025;42(19-20):1708-1718.
- Theis J, Chen AM, Burgher AP, Greenspan LD, Morgenstern A, Salzano AD, et al. Ocular motor disorders in children and adults with mTBI: a scoping review protocol. BMJ Open. 2023;13(10):e073656.
- Cervera-Sánchez Z, Cacho-Martínez P, García-Muñoz Á. Efficacy of optometric phototherapy: a systematic review. J Optom. 2023;16(4):305-314.
- McBain HB, Au CK, Hancox J, MacKenzie KA, Ezra DG, Adams GG, et al. The impact of strabismus on quality of life in adults with and without diplopia: a systematic review. Surv Ophthalmol. 2014;59(2):185-91.
- Chang MY, Velez FG, Demer JL, Isenberg SJ, Coleman AL, Pineles SL. Quality of life in adults with strabismus. Am J Ophthalmol. 2015;159(3):539-44.e2.
- Buffenn AN. The impact of strabismus on psychosocial health and quality of life: a systematic review. Surv Ophthalmol. 2021;66(6):1051-1064.
- Holmes JM, Droste PJ, Beck RW. The natural history of acute traumatic sixth nerve palsy or paresis. J AAPOS. 1998;2(5):265-8.
- Hussaindeen JR, Mani R, Rakshit A, Ramasubramanian S, Vittal Praveen S. Natural history of idiopathic abducens nerve paresis in a young adult. J Optom. 2016;9(4):264-8.
- Merino P, Gutierrez C, de Liaño PG, Srur M. Long term outcomes of strabismus surgery for third nerve palsy. J Optom. 2019;12(3):186-191.
- Khalili MR, Roshanshad A, Vardanjani HM. Botulinum Toxin Injection for the Treatment of Third, Fourth, and Sixth Nerve Palsy: A Meta-Analysis. J Pediatr Ophthalmol Strabismus. 2024;61(3):160-171.
- Merino P, Cerdán Llach I, Gago Argüello A, Gómez de Liaño P, Yáñez-Merino J. Characteristics and type of strabismus associated to macular diplopia. Treatment outcomes. Arch Soc Esp Oftalmol (Engl Ed). 2024;99(7):275-280.
- Gómez de Liaño Sánchez P, Olavarri González G, Merino Sanz P, Escribano Villafruela JC. Age-related distance esotropia: Clinical features and therapeutic outcomes. Arch Soc Esp Oftalmol. 2016;91(12):561-566.
- Reichelt JA, de Decker Dannheim E, de Decker W. [Acquired esotropia at advanced age]. Klin Monbl Augenheilkd. 2006;223(7):610-4.
- Glasman P, Cheeseman R, Wong V, Young J, Durnian JM. Improvement in patients’ quality-of-life following strabismus surgery: evaluation of postoperative outcomes using the Adult Strabismus 20 (AS-20) score. Eye (Lond). 2013;27(11):1249-53.
- El Meshad N, Soliman H, Hunt S, Amarakoon S, Ahmad A, Ford R, et al. Psychological and functional outcomes of horizontal squint surgery in adults with no preoperative diplopia using Quality-of-Life AS-20 questionnaire. Br J Ophthalmol. 2024;109(1):152-156.
- Agarwal R, Sharma M, Saxena R, Sharma P. Surgical outcome of superior rectus transposition in esotropic Duane syndrome and abducens nerve palsy. J AAPOS. 2018;22(1):12-16.e1.
- Marchione G, Lambert SR. Inferior rectus transposition as a secondary surgery in patients with acquired abducens nerve palsy. J AAPOS. 2023;27(3):170-172.
- Hassan S, Haridas A, Sundaram V. Adjustable versus non-adjustable sutures for strabismus. Cochrane Database Syst Rev. 2018;3(3):CD004240.
- Franco E, Mancioppi S, Forini E, Franco M, Franco F. Phased strabismus surgery under topical anesthesia. Eur J Ophthalmol. 2024;34(1):89-94.
- Muste JC, Wang K, Hwang CJ, Perry JD, Traboulsi EI. Outcomes of the intraoperative relaxed muscle positioning technique in strabismus surgery for thyroid eye disease. J AAPOS. 2023;27(6):340.e1-340.e6.
- Pichard T, Paillard A, Santallier M, Criniere L, Pierre P, Pisella PJ, et al. [Surgical management of strabismus in dysthyroid orbitopathy: A retrospective single-center study of 32 cases]. J Fr Ophtalmol. 2018;41(8):687-695.
- Merino P, Gómez de Liaño P, Villalobo JM, Franco G, Gómez de Liaño R. Etiology and treatment of pediatric sixth nerve palsy. J AAPOS. 2010;14(6):502-5.
- Sandy CJ, Wilson S, Brian Page A, Frazer DG, McGinnity FG, Lee JP. Phacoemulsification and opaque intraocular lens implantation for the treatment of intractable diplopia. Ophthalmic Surg Lasers. 2000;31(5):429-31.
- Krieger FT, Lambert AC, Alves TC, Arruda Mde F. [Opaque intraocular lens in intractable diplopia: case report]. Arq Bras Oftalmol. 2006;69(4):597-600.
- MacKenzie K, Hancox J, McBain H, Ezra DG, Adams G, Newman S. Psychosocial interventions for improving quality of life outcomes in adults undergoing strabismus surgery. Cochrane Database Syst Rev. 2016;2016(5):CD010092.
- Hajek A, Brettschneider C, Eisele M, van den Bussche H, Wiese B, Mamone S, et al. Prevalence and determinants of driving habits in the oldest old: Results of the multicenter prospective AgeCoDe-AgeQualiDe study. Arch Gerontol Geriatr. 2019;82:245-250.
- Owsley C, McGwin G Jr. Vision impairment and driving. Surv Ophthalmol. 1999;43(6):535-50.
- Bowers A, Peli E, Elgin J, McGwin G Jr, Owsley C. On-road driving with moderate visual field loss. Optom Vis Sci. 2005;82(8):657-67.
- Racette L, Casson EJ. The impact of visual field loss on driving performance: evidence from on-road driving assessments. Optom Vis Sci. 2005;82(8):668-74.
- Bro T, Andersson J. Individuals with severe visual field loss from stroke and glaucoma could have on-road driving safety comparable to normally sighted drivers. Acta Ophthalmol. 2025;103(7):842-849.
- Kobal N, Hawlina M. Comparison of visual requirements and regulations for obtaining a driving license in different European countries and some open questions on their adequacy. Front Hum Neurosci. 2022;16:927712.
- Mérour A, Favrat B, Borruat FX, Pasche C. [Requirements on vision for driving: to see more clearly]. Rev Med Suisse. 2014;10(452):2252-4, 2256-7.
- Bro T. [Eyes for cars]. Lakartidningen. 2018;115.
- Almatar H, Alamri S, Alduhayan R, Alabdulkader B, Albdah B, Stalin A, et al. Visual Functions, Seatbelt Usage, Speed, and Alcohol Consumption Standards for Driving and Their Impact on Road Traffic Accidents. Clin Optom (Auckl). 2023;15:225-246.
- de Haan GA, Melis-Dankers BJ, Brouwer WH, Bredewoud RA, Tucha O, Heutink J. Car driving performance in hemianopia: an on-road driving study. Invest Ophthalmol Vis Sci. 2014;55(10):6482-9.
- Alfaqawi F, Young J, Kaye SB. Binocular visual field in adults with horizontal strabismus and driving requirements. Eye (Lond). 2023;37(11):2220-2225.
- Crabb DP, Fitzke FW, Hitchings RA, Viswanathan AC. A practical approach to measuring the visual field component of fitness to drive. Br J Ophthalmol. 2004;88(9):1191-6.
- Klejn A, Gong A, Skalicky SE. Comparing Online Circular Contrast Perimetry and the Esterman Visual Field Test in Glaucoma for Driving-relevant Vision. J Glaucoma. 2025;34(12):1024-1035.
- Blane A. Through the Looking Glass: A Review of the Literature Investigating the Impact of Glaucoma on Crash Risk, Driving Performance, and Driver Self-Regulation in Older Drivers. J Glaucoma. 2016;25(1):113-21.
- Swan G, Savage SW, Zhang L, Bowers AR. Driving With Hemianopia VII: Predicting Hazard Detection With Gaze and Head Scan Magnitude. Transl Vis Sci Technol. 2021;10(1):20.
- Andersson J, Bro T, Lajunen T. Self-Perception and the Relation to Actual Driving Abilities for Individuals With Visual Field Loss. Front Hum Neurosci. 2022;16:852794.
- Wood JM. Nighttime driving: visual, lighting and visibility challenges. Ophthalmic Physiol Opt. 2020;40(2):187-201.
- Wood JM, Black AA, Anstey KJ, Horswill MS. Hazard Perception in Older Drivers With Eye Disease. Transl Vis Sci Technol. 2021;10(1):31.
- Okonkwo OC, Crowe M, Wadley VG, Ball K. Visual attention and self-regulation of driving among older adults. Int Psychogeriatr. 2008;20(1):162-73.
- Agramunt S, Meuleners LB, Fraser ML, Morlet N, Chow KC, Ng JQ. Bilateral cataract, crash risk, driving performance, and self-regulation practices among older drivers. J Cataract Refract Surg. 2016;42(5):788-94.
- Omar R, Anan NS, Azri IA, Majumder C, Knight VF. Characteristics of eye injuries, medical cost and return-to-work status among industrial workers: a retrospective study. BMJ Open. 2022;12(1):e048965.
- Sekimitsu S, Shweikh Y, Zebardast N. Effect of visual impairment on depression and anxiety during the COVID-19 pandemic in the United States. Can J Ophthalmol. 2024;59(4):e331-e337.
- Yochim BP, Mueller AE, Kane KD, Kahook MY. Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma. J Glaucoma. 2012;21(4):250-4.
- Rokohl AC, Simon M, Wawer Matos Reimer PA, Knopp S, Hirt N, Dietlein TS, et al. Psychological comorbidity in glaucoma: prevalence and impact of anxiety and depression. Br J Ophthalmol. 2025;109(12):1351-1356.
- Donato UM, Nguyen OT, Alishahi Tabriz A, Hong YR, Turner K. Mental healthcare access among US adults with vision impairment and depression and/or anxiety symptoms. Disabil Health J. 2024;17(3):101619.
- van der Aa HP, van Rens GH, Comijs HC, Margrain TH, Gallindo-Garre F, Twisk JW, et al. Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial. BMJ. 2015;351:h6127.
- van der Aa HP, van Rens GH, Comijs HC, Bosmans JE, Margrain TH, van Nispen RM. Stepped-care to prevent depression and anxiety in visually impaired older adults—design of a randomised controlled trial. BMC Psychiatry. 2013;13:209.
- van der Aa HPA, van Rens GHMB, Bosmans JE, Comijs HC, van Nispen RMA. Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial. BMC Psychiatry. 2017;17(1):280.
- Kopp K. “People who acquire disability may grieve their loss forever”. Nurs Times. 2014;110(49):11.
- Jones L, Ditzel-Finn L, Potts J, Moosajee M. Exacerbation of visual hallucinations in Charles Bonnet syndrome due to the social implications of COVID-19. BMJ Open Ophthalmol. 2021;6(1):e000670.
- Zapata MA, Pearlstein JG. Disability self-worth relates to lower anxiety and depression in people with visual impairment. J Clin Psychol. 2022;78(7):1491-1499.
- Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302-11.
- Meitar D, Karnieli-Miller O. Twelve tips to manage a breaking bad news process: Using S-P-w-ICE-S - A revised version of the SPIKES protocol. Med Teach. 2022;44(10):1087-1091.
- Dean A, Willis S. The use of protocol in breaking bad news: evidence and ethos. Int J Palliat Nurs. 2016;22(6):265-71.
- Hilkert SM, Cebulla CM, Jain SG, Pfeil SA, Benes SC, Robbins SL. Breaking bad news: A communication competency for ophthalmology training programs. Surv Ophthalmol. 2016;61(6):791-798.
- Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N, et al. Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol. 2005;23(6):1278-88.
- Han PK, Klein WM, Arora NK. Varieties of uncertainty in health care: a conceptual taxonomy. Med Decis Making. 2011;31(6):828-38.
- Ruiz-Lozano RE, de la Rosa-Pacheco S, Hernández-Camarena JC, Garza-Garza LA, Davila-Cavazos O, Dominguez-Varela IA, et al. Burden and depression among informal caregivers of visually impaired patients in Mexico. Disabil Health J. 2022;15(3):101284.
- Ruiz-Lozano RE, Herrera-Rodriguez MI, Mendoza-Pallares JA, Reyes-Godinez N, Tamez-Tamez VE, Ramos-Dávila EM, et al. Validation of the Zarit Burden Interview in Informal Caregivers of Patients with Severe Visual Impairment and Blindness. Ophthalmol Ther. 2025;14(1):55-71.
- Rinaldi C, Leigheb F, Vanhaecht K, Donnarumma C, Panella M. Becoming a “second victim” in health care: Pathway of recovery after adverse event. Rev Calid Asist. 2016;31 Suppl 2:11-9.
- Awuah WA, Aderinto N, Ahluwalia A, Poornaselvan J, Tan JK, Bharadwaj HR, et al. Beyond the operating room: addressing the “second-victim” phenomenon in surgical practice. Eur J Med Res. 2024;29(1):486.
- Carugno J, Winkel AF. Surgical Catastrophe. Supporting the Gynecologic Surgeon after an Adverse Event. J Minim Invasive Gynecol. 2018;25(7):1117-1121.
- Le HD, Wolinska JM, Baertschiger RM, Himidan SA. Complication Is Inevitable, but Suffering is Optional-Psychological Aspects of Dealing with Complications in Surgery. Eur J Pediatr Surg. 2023;33(3):181-190.
- Elghazally SA, Alkarn AF, Elkhayat H, Ibrahim AK, Elkhayat MR. Burnout Impact of COVID-19 Pandemic on Health-Care Professionals at Assiut University Hospitals, 2020. Int J Environ Res Public Health. 2021;18(10).
- Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30.
- Panettieri RA, Schaafsma D, Amrani Y, Koziol-White C, Ostrom R, Tliba O. Non-genomic Effects of Glucocorticoids: An Updated View. Trends Pharmacol Sci. 2019;40(1):38-49.
- Benton KC, Lowry CA, Gasser PJ. Organic Cation Transporters and Nongenomic Glucocorticoid Action. Handb Exp Pharmacol. 2021;266:241-251.
- Czock D, Keller F, Rasche FM, Häussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61-98.
- Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021;11(3):866-893.
- Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, et al. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74(10):1799-807.
- Keller KK, Mukhtyar CB, Nielsen AW, Hemmig AK, Mackie SL, Sattui SE, et al. Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group. Ann Rheum Dis. 2024;83(11):1436-1442.
- Ponto KA, Pitz S, Mann WJ, Weber MM, Pfeiffer N, Kahaly GJ. [Management of Graves’ orbitopathy: evidence-based recommendations]. Dtsch Med Wochenschr. 2009;134(49):2521-4.
- Gurnell M, Heaney LG, Price D, Menzies-Gow A. Long-term corticosteroid use, adrenal insufficiency and the need for steroid-sparing treatment in adult severe asthma. J Intern Med. 2021;290(2):240-256.
- Theiler-Schwetz V, Prete A. Glucocorticoid withdrawal syndrome: what to expect and how to manage. Curr Opin Endocrinol Diabetes Obes. 2023;30(3):167-174.
- Cho JH, Suh S. Glucocorticoid-Induced Hyperglycemia: A Neglected Problem. Endocrinol Metab (Seoul). 2024;39(2):222-238.
- Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2023;75(12):2088-2102.
- Tanaka Y, Soen S, Hirata S, Okada Y, Fujiwara S, Tanaka I, et al. The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. J Bone Miner Metab. 2024;42(2):143-154.
- Konarski W, Poboży T, Śliwczyński A, Kotela I, Krakowiak J, Hordowicz M, et al. Avascular Necrosis of Femoral Head-Overview and Current State of the Art. Int J Environ Res Public Health. 2022;19(12).
- Youssef J, Novosad SA, Winthrop KL. Infection Risk and Safety of Corticosteroid Use. Rheum Dis Clin North Am. 2016;42(1):157-76, ix-x.
- Weyant RB, Kabbani D, Doucette K, Lau C, Cervera C. Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother. 2021;22(12):1579-1592.
- Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, et al. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2397-404.
- Dubovsky AN, Arvikar S, Stern TA, Axelrod L. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics. 2012;53(2):103-15.
- Kazi SE, Hoque S. Acute Psychosis Following Corticosteroid Administration. Cureus. 2021;13(9):e18093.
- Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, et al. Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder. N Engl J Med. 2019;381(22):2114-2124.
- Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017;16(12):976-986.
- Vu T, Meisel A, Mantegazza R, Annane D, Katsuno M, Aguzzi R, et al. Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis. NEJM Evid. 2022;1(5):EVIDoa2100066.
- Howard JF Jr, Vu T, Li G, Korobko D, Smilowski M, Liu L, et al. Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+). Neurotherapeutics. 2024;21(5):e00378.
- Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L, et al. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2023;82(6):742-753.
- Jansen MHA, Rondaan C, Legger GE, Minden K, Uziel Y, Toplak N, et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheum Dis. 2023;82(1):35-47.
- Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, et al. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn’s disease during 1 year of treatment with azathioprine or mesalazine. Ther Drug Monit. 2007;29(1):1-5.
- Anstey AV, Wakelin S, Reynolds NJ. Guidelines for prescribing azathioprine in dermatology. Br J Dermatol. 2004;151(6):1123-32.
- van den Bosch L, Luppi F, Ferrara G, Mura M. Immunomodulatory treatment of interstitial lung disease. Ther Adv Respir Dis. 2022;16:17534666221117002.
- Pathomrattanapiban C, Tisavipat N, Jitprapaikulsan J, Prayoonwiwat N, Rattanathamsakul N, Siritho S. The efficacy and safety of mycophenolate mofetil in Thai neuromyelitis optica spectrum disorder patients. Mult Scler Relat Disord. 2022;63:103882.
- Ouellette S, Shah R, Razi S, Ashforth G, Wassef C. Fatal low-dose methotrexate toxicity: A case report and literature review. Dermatol Ther. 2022;35(12):e15945.
- Romão VC, Lima A, Bernardes M, Canhão H, Fonseca JE. Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?. Immunol Res. 2014;60(2-3):289-310.
- Stockfelt M, Teng YKO, Vital EM. Opportunities and limitations of B cell depletion approaches in SLE. Nat Rev Rheumatol. 2025;21(2):111-126.
- Gao F, Chai B, Gu C, Wu R, Dong T, Yao Y, et al. Effectiveness of rituximab in neuromyelitis optica: a meta-analysis. BMC Neurol. 2019;19(1):36.
- Jodele S, Dandoy CE, Danziger-Isakov L, Myers KC, El-Bietar J, Nelson A, et al. Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination. Biol Blood Marrow Transplant. 2016;22(7):1337-1340.
- Živković S. Intravenous immunoglobulin in the treatment of neurologic disorders. Acta Neurol Scand. 2016;133(2):84-96.
- Láinez-Andrés JM, Gascón-Giménez F, Coret-Ferrer F, Casanova-Estruch B, Santonja JM. [Therapeutic plasma exchange: applications in neurology]. Rev Neurol. 2015;60(3):120-31.
- Memon AB, Lisak RP. Use of Therapeutic Plasma Exchange in Autoimmune Neuromuscular Disorders. Muscle Nerve. 2026;74(2):302-316.
- Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, et al. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019;19(6):e200-e212.
- Wostyn P, Killer HE. Normal-Tension Glaucoma: A Glymphopathy?. Eye Brain. 2023;15:37-44.
- Alsuhaibani AH, Carter KD, Nerad JA, Lee AG. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2011;118(2):412-4.
- Jefferis JM, Littlewood RA, Pepper IM, Hickman SJ, Salvi SM. Optic nerve sheath fenestration via a supero-medial eyelid skin crease approach for the treatment of idiopathic intracranial hypertension in a UK population. Eye (Lond). 2021;35(5):1418-1426.
- Vaidya NS, Mahmoud AM, Buzzacco D, Katz SE. Visual outcomes following optic nerve sheath fenestration via the medial transconjunctival approach. Orbit. 2016;35(5):271-7.
- Melson AT, Warmath JD, Moreau A, Farris BK. Superonasal Transconjunctival Optic Nerve Sheath Decompression: A Simplified Technique for Safe and Efficient Decompression. J Neuroophthalmol. 2021;41(1):e16-e21.
- Chandrasekaran S, McCluskey P, Minassian D, Assaad N. Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions. Clin Exp Ophthalmol. 2006;34(7):661-5.
- Prokop K, Opęchowska A, Sieśkiewicz A, Lisowski Ł, Mariak Z, Łysoń T. Effectiveness of optic nerve sheath fenestration in preserving vision in idiopathic intracranial hypertension: an updated meta-analysis and systematic review. Acta Neurochir (Wien). 2024;166(1):476.
- Xue X, Zhou C, Gao Y, Ji X, Zhang X. Optic nerve sheath fenestration for visual impairment in cerebral venous diseases. Front Neurol. 2023;14:1065315.
- [Sin autor personal]. Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update. Arch Ophthalmol. 2000;118(6):793-8.
- Trucchi L, Cohen M, Nahon-Esteve S, Lagier J, Leal C, Almairac F, et al. Optic nerve sheath fenestration: Current status in France and comparison of 6 different surgical approaches. J Fr Ophtalmol. 2023;46(2):137-147.
- Blessing NW, Tse DT. Optic nerve sheath fenestration: a revised lateral approach for nerve access. Orbit. 2019;38(2):137-143.
- Corecha Santos R, Gupta B, Santiago RB, Sabahi M, Kaye B, Dabecco R, et al. Endoscopic endonasal optic nerve sheath decompression (EONSD) for idiopathic intracranial hypertension: Technical details and meta-analysis. Clin Neurol Neurosurg. 2023;229:107750.
- Gilbert AL, Chwalisz B, Mallery R. Complications of Optic Nerve Sheath Fenestration as a Treatment for Idiopathic Intracranial Hypertension. Semin Ophthalmol. 2018;33(1):36-41.
- Fonseca PL, Rigamonti D, Miller NR, Subramanian PS. Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol. 2014;98(10):1360-3.
- Abecassis ZA, Nistal D, Basner L, Berrigan R, Sedwick J, Howell G, et al. Long-term visual outcomes after surgical management for intracranial idiopathic hypertension. Neurosurg Focus. 2026;60(1):E14.
- Spitze A, Lam P, Al-Zubidi N, Yalamanchili S, Lee AG. Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension. Indian J Ophthalmol. 2014;62(10):1015-21.
- Cho SS, Wakim AA, Teng CW, Sarris CE, Smith KA. Stereotactic-Guided Transcerebellar Cisternoperitoneal Shunt Placement for Idiopathic Intracranial Hypertension. Oper Neurosurg. 2022;23(3):268-275.
- Hoffman H, Ashok Kumar A, Wood JS, Mikhailova T, Yoo JH, Wakeman MB, et al. Outcomes After Endovascular Treatment of Direct Carotid Cavernous Fistulas: Systematic Review and Meta-Analysis. World Neurosurg. 2023;170:e242-e255.
- Holland LJ, Mitchell Ranzcr K, Harrison JD, Brauchli D, Wong Y, Sullivan TJ. Endovascular treatment of carotid-cavernous sinus fistulas: ophthalmic and visual outcomes. Orbit. 2019;38(4):290-299.
- Levy BR, Monteiro A, Raygor KP, Donnelly BM, Davies JM, Snyder KV, et al. Visual Morbidity in Patients With Ophthalmic Segment Aneurysms Treated With Flow Diverters: A Dual-Center Experience. Neurosurgery. 2024;94(3):538-544.
- Shahjouei S, Bavarsad Shahripour R, Dumitrascu OM. Thrombolysis for central retinal artery occlusion: An individual participant-level meta-analysis. Int J Stroke. 2024;19(1):29-39.
- Turpin J, White TG, Golub D, Mehta SH, Werner C, Donnelly BM, et al. Utilizing intravascular ultrasound for optimizing patient selection in venous sinus stenting: A pilot study. Interv Neuroradiol. 2025.
- Teleb MS, Cziep ME, Lazzaro MA, Gheith A, Asif K, Remler B, et al. Idiopathic Intracranial Hypertension. A Systematic Analysis of Transverse Sinus Stenting. Interv Neurol. 2013;2(3):132-143.
- Satti SR, Leishangthem L, Spiotta A, Chaudry MI. Dural venous sinus stenting for medically and surgically refractory idiopathic intracranial hypertension. Interv Neuroradiol. 2017;23(2):186-193.
- Abdelkhalek H, El Malky I, Elkordy A, Ahmed R, Abdelhameed E, Elaggan A, et al. Feasibility and Efficacy of Venous Sinus Stenting for Idiopathic Intracranial Hypertension in a Non-Western Country. World Neurosurg. 2025;201:124226.
- Touzé R, Bonnin S, Houdart E, Nicholson P, Bodaghi B, Shotar E, et al. Long-term Kinetic Papilledema Improvement After Venous Sinus Stenting in Idiopathic Intracranial Hypertension. Clin Neuroradiol. 2021;31(2):483-490.
- Higgins JNP, Kirollos SRW, Helmy A, Guilfoyle MR, Pickard JD, Axon PR, et al. Technical considerations and long-term results of endovascular venous stenting to control venous hypertension from meningiomas invading intracranial venous sinuses. J Neurosurg. 2024;140(3):826-838.
- Ma Y, Li Z, Zhao W. Endovascular Treatment of a Traumatic Carotid Cavernous Fistula Concomitant with Intracranial Pseudoaneurysm by Flow Diverter, 2-Dimensional Operative Video. World Neurosurg. 2023;173:95.
- Moriya S, Maeda S, Hayakawa M, Kuwahara K. Transvenous Embolization of Cavernous Sinus Dural Arteriovenous Fistula through the Angiographically Occlusive Superior Ophthalmic Vein. Asian J Neurosurg. 2021;16(3):610-613.
- Baltsavias G, Roth P, Valavanis A. Cranial dural arteriovenous shunts. Part 3. Classification based on the leptomeningeal venous drainage. Neurosurg Rev. 2015;38(2):273-81; discussion 281.
- Suzuki Y, Toma N. [Dural Arteriovenous Fistula:Indications and Outcomes]. No Shinkei Geka. 2023;51(2):278-288.
- Arrico L, Giannotti R, Ganino C, Lenzi T, Malagola R. Intracranial aneurysm and diplopia due to oculomotor nerve palsy: pre- and post-operative study. Clin Ter. 2014;165(4):e258-62.
- Wiśniewski K, Tomasik B, Bobeff EJ, Stefańczyk L, Hupało M, Jaskólski DJ. Predictors for ophthalmic segment aneurysms recanalization after coiling and flow diverter embolization in 6- and 12-month follow-up. J Clin Neurosci. 2019;68:151-157.
- Noble J, Weizblit N, Baerlocher MO, Eng KT. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol. 2008;92(5):588-93.
- Page PS, Khattar NK, White AC, Cambon AC, Brock GN, Rai SN, et al. Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Systematic Review and Meta-Analysis. Front Neurol. 2018;9:76.
- Girard SM, François C. Temporal Artery Biopsies: Understanding the Low Positivity Rate. Cureus. 2025;17(4):e81714.
- Jiang Z, Ji H, Dong J. Temporal artery biopsy for suspected giant cell arteritis: A mini review. Indian J Ophthalmol. 2023;71(10):3299-3304.
- Narváez J, Bernad B, Roig-Vilaseca D, García-Gómez C, Gómez-Vaquero C, Juanola X, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum. 2007;37(1):13-9.
- Papadakos SP, Papazoglou AS, Moysidis DV, Tsagkaris C, Papadakis DL, Koutsogianni A, et al. The Effect of Corticosteroids on Temporal Artery Biopsy Positivity in Giant Cell Arteritis: Timing is Everything. J Clin Rheumatol. 2023;29(4):173-176.
- Elahi E, Afshin EE, Zoltan S, Hu KY. Biopsy of the Parietal Branch of the Superficial Temporal Artery for the Diagnosis of Giant Cell Arteritis. J Neuroophthalmol. 2023;43(2):e41-e44.
- Grossman C, Ben-Zvi I, Barshack I, Bornstein G. Association between specimen length and diagnostic yield of temporal artery biopsy. Scand J Rheumatol. 2017;46(3):222-225.
- Muratore F, Boiardi L, Cavazza A, Tiengo G, Galli E, Aldigeri R, et al. Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis. Arthritis Care Res (Hoboken). 2021;73(3):402-408.
- Papadakis M, Kaptanis S, Kokkori-Steinbrecher A, Floros N, Schuster F, Hübner G. Temporal artery biopsy in the diagnosis of giant cell arteritis: Bigger is not always better. Am J Surg. 2018;215(4):647-650.
- Jean-Charles S, Shoji MK, Kikkawa DO, Bhatti MT. The mirrored arterial dilemma. Surv Ophthalmol. 2025;70(5):1029-1033.
- Stacy RC, Rizzo JF, Cestari DM. Subtleties in the histopathology of giant cell arteritis. Semin Ophthalmol. 2011;26(4-5):342-8.
- Bhatti MT, Goldstein MH. Facial nerve injury following superficial temporal artery biopsy. Dermatol Surg. 2001;27(1):15-7.
- Rison RA. Branch facial nerve trauma after superficial temporal artery biopsy: a case report. J Med Case Rep. 2011;5:34.
- Yoshida K, Sada RM, Yoshioka A, Akebo H, Miyake H, Hatta K. The diagnostic utility of intima-media thickness measurement compared with the halo sign in temporal artery ultrasonography: a single-centre retrospective study. Clin Exp Rheumatol. 2025;43(4):661-667.
- Schmidt WA. Imaging in vasculitis. Best Pract Res Clin Rheumatol. 2013;27(1):107-18.
- Schmidt WA, Nielsen BD. Imaging in large-vessel vasculitis. Best Pract Res Clin Rheumatol. 2020;34(6):101589.
- Lee YH, Choi SJ, Ji JD, Song GG. Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis : A meta-analysis. Z Rheumatol. 2016;75(9):924-931.
- van der Geest KSM, Treglia G, Glaudemans AWJM, Brouwer E, Sandovici M, Jamar F, et al. Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2021;48(12):3886-3902.
- Kim JL, Mendoza PR, Rashid A, Hayek B, Grossniklaus HE. Optic nerve lymphoma: report of two cases and review of the literature. Surv Ophthalmol. 2015;60(2):153-65.
- Shoji MK, Chen Y, Topilow NJ, Abou Khzam R, Dubovy SR, Johnson TE. Orbital Involvement in Multiple Myeloma. Ophthalmic Plast Reconstr Surg. 2023;39(4):347-356.
- Lai KKH, Li EYM, Chan RYC, Wong KCW, Yu JKS, Cheuk W, et al. Malignancies in Immunoglobulin G4-related ophthalmic disease. Eur J Ophthalmol. 2023;33(1):171-181.
- Pichler MR, Flanagan EP, Aksamit AJ, Leavitt JA, Salomão DR, Keegan BM. Conjunctival biopsy to diagnose neurosarcoidosis in patients with inflammatory nervous system disease of unknown etiology. Neurol Clin Pract. 2015;5(3):216-223.
- Ponto KA, Brockmann MA, Koutsimpelas D, Heider J, Ringel FA, Heindl LM, et al. [Excisional surgery of orbital tumors]. Ophthalmologe. 2021;118(10):995-1003.
- Tekumalla S, Xu D, Awh K, Philp N, Milman T, Garg S. DIAGNOSTIC YIELD OF IN VITRO VITREOUS BIOPSY FOR INTRAOCULAR LYMPHOMA AT VARIABLE VITREOUS CUTTER SPEEDS USING 25-GAUGE VITRECTOMY. Retina. 2023;43(6):1005-1009.
- Angus L, Deger T, Jager A, Martens JWM, de Weerd V, van Heuvel I, et al. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases. Clin Cancer Res. 2021;27(10):2798-2806.
- Simoens D, Shravah V, Jones WK, Kaja S. Clinical and pharmacovigilance safety evaluation of LUXTURNA(®) (voretigene neparvovec-rzyl). Cutan Ocul Toxicol. 2025;44(4):361-373.
- Masuda Y, Ishikawa H, Ishikawa H, Kezuka T, Miyazaki A, Matsumoto K, et al. Assessment of objective visual function following idebenone administration in patients with leber hereditary optic neuropathy. Jpn J Ophthalmol. 2024;68(5):548-555.
- Priglinger C, Klopstock T, Rudolph G, Priglinger SG. [Leber’s Hereditary Optic Neuropathy]. Klin Monbl Augenheilkd. 2019;236(11):1271-1282.
- Keshavan N, Minczuk M, Viscomi C, Rahman S. Gene therapy for mitochondrial disorders. J Inherit Metab Dis. 2024;47(1):145-175.
- Kwok E, Alam K, Lim J, Niyazmand H, Tang V, Trinh H, et al. Evaluating ocular health in retinal gene therapies. Clin Exp Optom. 2025;108(6):657-668.
- Esposito EP, Han IC, Johnson TV. Gene and cell-based therapies for retinal and optic nerve disease. Handb Clin Neurol. 2024;205:243-262.
- Crabtree E, Uribe K, Smith SM, Roberts D, Salmon JH, Bower JJ, et al. Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy. PLoS One. 2022;17(8):e0270972.
- Johnson TV, Baranov P, Di Polo A, Fortune B, Gokoffski KK, Goldberg JL, et al. The Retinal Ganglion Cell Repopulation, Stem Cell Transplantation, and Optic Nerve Regeneration Consortium. Ophthalmol Sci. 2023;3(4):100390.
- Soucy JR, Aguzzi EA, Cho J, Gilhooley MJ, Keuthan C, Luo Z, et al. Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium. Mol Neurodegener. 2023;18(1):64.
- Hu M, Veldman MB. Srebf2 mediates successful optic nerve axon regeneration via the mevalonate synthesis pathway. Mol Neurodegener. 2025;20(1):28.
- Tao Y, Chen T, Liu B, Wang LQ, Peng GH, Qin LM, et al. The transcorneal electrical stimulation as a novel therapeutic strategy against retinal and optic neuropathy: a review of experimental and clinical trials. Int J Ophthalmol. 2016;9(6):914-9.
- Ramirez KA, Drew-Bear LE, Vega-Garces M, Betancourt-Belandria H, Arevalo JF. An update on visual prosthesis. Int J Retina Vitreous. 2023;9(1):73.
- Wu KY, Mina M, Sahyoun JY, Kalevar A, Tran SD. Retinal Prostheses: Engineering and Clinical Perspectives for Vision Restoration. Sensors (Basel). 2023;23(13).
- Karadima V, Pezaris EA, Pezaris JS. Attitudes of potential recipients toward emerging visual prosthesis technologies. Sci Rep. 2023;13(1):10963.
- Busskamp V, Roska B, Sahel JA. Optogenetic Vision Restoration. Cold Spring Harb Perspect Med. 2024;14(8).
- Simon CJ, Sahel JA, Duebel J, Herlitze S, Dalkara D. Opsins for vision restoration. Biochem Biophys Res Commun. 2020;527(2):325-330.
- Spence C. The skin as a medium for sensory substitution. Multisens Res. 2014;27(5-6):293-312.
- Hinkle JW, Mahmoudzadeh R, Kuriyan AE. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer “cell therapy” clinics. Stem Cell Res Ther. 2021;12(1):538.
- Lyons S, Salgaonkar S, Flaherty GT. International stem cell tourism: a critical literature review and evidence-based recommendations. Int Health. 2022;14(2):132-141.
- Julian K, Yuhasz N, Hollingsworth E, Imitola J. The “Growing” Reality of the Neurological Complications of Global “Stem Cell Tourism”. Semin Neurol. 2018;38(2):176-181.
- Smith C, Crowley A, Munsie M, Behfar A, DeMartino ES, Staff NP, et al. Academic Physician Specialists’ Approaches to Counseling Patients Interested in Unproven Stem Cell and Regenerative Therapies-A Qualitative Analysis. Mayo Clin Proc. 2021;96(12):3086-3096.
- Acosta MT, Zaragoza Domingo S, Arango C, Bishop KI, Busner J, Dorffner G, et al. Methodological challenges in outcomes research for early-trials for implementation of new therapies in neuropediatric rare diseases. Orphanet J Rare Dis. 2025;20(1):521.
- Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 2008;65(6):727-32.
- Luo W, Deng X, Xu X, Song R, Luo M, Moss HE, et al. Development of a Prognostic Model for Predicting Multiple Sclerosis After Optic Neuritis: A Secondary Analysis of Data From the Optic Neuritis Treatment Trial. J Neuroophthalmol. 2022;42(1):88-96.
- Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev. 2012;4(4):CD001430.
- Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002;134(3):317-28.
- Horton JC. Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial. JAMA. 2014;311(16):1618-9.
- Cello KE, Keltner JL, Johnson CA, Wall M. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial. J Neuroophthalmol. 2016;36(1):6-12.
- Wall M, Kupersmith MJ, Thurtell MJ, Moss HE, Moss EA, Auinger P. The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12. Am J Ophthalmol. 2017;176:102-107.
- Wingerchuk DM, Zhang I, Kielhorn A, Royston M, Levy M, Fujihara K, et al. Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder. Neurol Ther. 2022;11(1):123-135.
- Davila-Siliezar P, Carter M, Milea D, Lee AG. Leber hereditary optic neuropathy: new and emerging therapies. Curr Opin Ophthalmol. 2022;33(6):574-578.
- Leong YY, Vasseneix C, Finkelstein MT, Milea D, Najjar RP. Artificial Intelligence Meets Neuro-Ophthalmology. Asia Pac J Ophthalmol (Phila). 2022;11(2):111-125.
- Lapka M, Straňák Z. The Current State of Artificial Intelligence in Neuro-Ophthalmology. A Review. Cesk Slov Oftalmol. 2024;80(4):179-186.
- Liu TYA, Wei J, Zhu H, Subramanian PS, Myung D, Yi PH, et al. Detection of Optic Disc Abnormalities in Color Fundus Photographs Using Deep Learning. J Neuroophthalmol. 2021;41(3):368-374.
- Liu TYA, Ting DSW, Yi PH, Wei J, Zhu H, Subramanian PS, et al. Deep Learning and Transfer Learning for Optic Disc Laterality Detection: Implications for Machine Learning in Neuro-Ophthalmology. J Neuroophthalmol. 2020;40(2):178-184.
- Asaoka R, Murata H. Prediction of visual field progression in glaucoma: existing methods and artificial intelligence. Jpn J Ophthalmol. 2023;67(5):546-559.
- Li F, Su Y, Lin F, Li Z, Song Y, Nie S, et al. A deep-learning system predicts glaucoma incidence and progression using retinal photographs. J Clin Invest. 2022;132(11).
- Clingo KA, Czerpak CA, Quigley HA, Nguyen TD. Deep learning method for semi-automated segmentation of optic nerve head tissues in optical coherence tomography images. Exp Eye Res. 2025;261:110678.
- Chen Z, Zhang H, Linton EF, Johnson BA, Choi YJ, Kupersmith MJ, et al. Hybrid deep learning and optimal graph search method for optical coherence tomography layer segmentation in diseases affecting the optic nerve. Biomed Opt Express. 2024;15(6):3681-3698.
- Bastani PB, Rieiro H, Badihian S, Otero-Millan J, Farrell N, Parker M, et al. Quantifying Induced Nystagmus Using a Smartphone Eye Tracking Application (EyePhone). J Am Heart Assoc. 2024;13(2):e030927.
- Engin CD, Selver MA, Köksaldı S, Kayabaşı M. GENERALIZABILITY OF DEEP LEARNING MODELS FOR REFERABLE DIABETIC RETINOPATHY DETECTION: A CROSS-POPULATION STUDY. Retina. 2026.
- Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Lancet Digit Health. 2020;2(10):e537-e548.
- Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.
- Elendu C, Amaechi DC, Elendu TC, Jingwa KA, Okoye OK, John Okah M, et al. Ethical implications of AI and robotics in healthcare: A review. Medicine (Baltimore). 2023;102(50):e36671.
- Muehlematter UJ, Daniore P, Vokinger KN. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. Lancet Digit Health. 2021;3(3):e195-e203.
- Betzler BK, Chen H, Cheng CY, Lee CS, Ning G, Song SJ, et al. Large language models and their impact in ophthalmology. Lancet Digit Health. 2023;5(12):e917-e924.
- Bedi S, Liu Y, Orr-Ewing L, Dash D, Koyejo S, Callahan A, et al. Testing and Evaluation of Health Care Applications of Large Language Models: A Systematic Review. JAMA. 2025;333(4):319-328.
- Luo MJ, Pang J, Bi S, Lai Y, Zhao J, Shang Y, et al. Development and Evaluation of a Retrieval-Augmented Large Language Model Framework for Ophthalmology. JAMA Ophthalmol. 2024;142(9):798-805.
- Baxter SL, Bass JS, Sitapati AM. Barriers to Implementing an Artificial Intelligence Model for Unplanned Readmissions. ACI open. 2020;4(2):e108-e113.
- Esmaeilzadeh P. Challenges and strategies for wide-scale artificial intelligence (AI) deployment in healthcare practices: A perspective for healthcare organizations. Artif Intell Med. 2024;151:102861.
- Sheth S, Ramirez-Sanchez L, Rincón-Lopez JV, Mejia-Vergara AJ. Neuro-Ophthalmology Referral Patterns: Learnings From Colombia. J Neuroophthalmol. 2025;45(4):515-520.
- Wechsler LR. Advantages and limitations of teleneurology. JAMA Neurol. 2015;72(3):349-54.
- Hatcher-Martin JM, Adams JL, Anderson ER, Bove R, Burrus TM, Chehrenama M, et al. Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update. Neurology. 2020;94(1):30-38.
- Arca KN, Bazarsky AB, Yuan DY, Villanueva R, Friedman DI, Charles A. Telemedicine is effective and safe for clinical management of patients with headache disorders: An American Headache Society position statement. Headache. 2026;66(3):738-743.
- Völkel N, Hubert GJ, Haberl RL. Telemedizin: „TEMPiS“-Netzwerk für Schlaganfallbehandlung in der Regelversorgung. Anasthesiol Intensivmed Notfallmed Schmerzther. 2017;52(2):127-136.
- Williams AM, Kalra G, Commiskey PW, Bowers EMR, Rudolph BR, Pitcher MD, et al. Ophthalmology Practice During the Coronavirus Disease 2019 Pandemic: The University of Pittsburgh Experience in Promoting Clinic Safety and Embracing Video Visits. Ophthalmol Ther. 2020;9(3):1-9.
- Ghazala FR, Hamilton R, Giardini ME, Ferguson A, Poyser OB, Livingstone IA. Live teleophthalmology avoids escalation of referrals to secondary care during COVID-19 lockdown. Clin Exp Optom. 2021;104(6):711-716.
- Al Owaifeer AM, Al-Swailem SA, Al Dehailan AM, Al Naim A, Al Molhim MF, Khandekar RB. Physician Satisfaction With Virtual Ophthalmology Clinics During the COVID-19 Pandemic: A Tertiary Eye Care Center Experience. Cureus. 2022;14(4):e23837.
- Nikolaidou A, Tsaousis KT. Teleophthalmology and Artificial Intelligence As Game Changers in Ophthalmic Care After the COVID-19 Pandemic. Cureus. 2021;13(7):e16392.
- Brill D, Papaliodis G. Uveitis Specialists Harnessing Disruptive Technology during the COVID-19 Pandemic and Beyond. Semin Ophthalmol. 2021;36(4):296-303.
- Armstrong GW, Liebman DL, Ashourizadeh H. Implementation of anterior segment ophthalmic telemedicine. Curr Opin Ophthalmol. 2024;35(4):343-350.
- Mulchandani D, Reiser BJ, Ho TC, Reid MW, Stewart C, Lee TC, et al. Evaluation of digital slit-lamp videos for paediatric anterior segment telemedicine consultations. J Telemed Telecare. 2023;29(6):467-473.
- Vujosevic S, Aldington SJ, Silva P, Hernández C, Scanlon P, Peto T, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8(4):337-347.
- Zimmer-Galler IE, Kimura AE, Gupta S. Diabetic retinopathy screening and the use of telemedicine. Curr Opin Ophthalmol. 2015;26(3):167-72.
- Thirunavukarasu AJ, Mullinger D, Rufus-Toye RM, Farrell S, Allen LE. Clinical validation of a novel web-application for remote assessment of distance visual acuity. Eye (Lond). 2022;36(10):2057-2061.
- Racano E, Malfatti G, Pertile R, Delle Site R, Romanelli F, Nicolini A. A novel smartphone App to support the clinical practice of pediatric ophthalmology and strabismus: the validation of visual acuity tests. Eur J Pediatr. 2023;182(9):4007-4013.
- Chen YX, Corbett J, Gale J, Meyerov J, Gong A, Cheng J, et al. Online Circular Contrast Perimetry: Validity and Repeatability of Home Performance. J Glaucoma. 2025;34(11):853-868.
- Sohail M, Hirji SH, Liebmann JM, Glass LD, Blumberg DM. Remote Contrast Sensitivity Testing Seems to Correlate With the Degree of Glaucomatous Macular Damage. J Glaucoma. 2023;32(6):533-539.
- Devraj K, Jones L, Higgins B, Thomas PBM, Moosajee M. User-Centred Design and Development of a Smartphone Application (OverSight) for Digital Phenotyping in Ophthalmology. Healthcare (Basel). 2024;12(24).
- Kruse CS, Krowski N, Rodriguez B, Tran L, Vela J, Brooks M. Telehealth and patient satisfaction: a systematic review and narrative analysis. BMJ Open. 2017;7(8):e016242.
- Rodriguez HP. Assessing the Impact of Telemedicine Implementation in Diverse Health Care Systems. Med Care. 2023;61(Suppl 1):S1-S3.
- Tierney AA, Mosqueda M, Cesena G, Frehn JL, Payán DD, Rodriguez HP. Telemedicine Implementation for Safety Net Populations: A Systematic Review. Telemed J E Health. 2024;30(3):622-641.
- Salvador FGF, Oliveira LFA, Machado CPF, Nzila PM, Silveira H, Valete CM. Telemedicine and human African trypanosomiasis in Angola: Local insights into challenges and opportunities for remote health delivery. IJID Reg. 2025;16:100696.
- Falvey JR, Sun N, Miller MJ, Pravdo A, Mullins CD. Demystifying the Digital Divide: Disparities in Telerehabilitation Readiness Among Older Adults in the United States. Arch Phys Med Rehabil. 2024;105(7):1255-1261.
- Cortelyou-Ward K, Atkins DN, Noblin A, Rotarius T, White P, Carey C. Navigating the Digital Divide: Barriers to Telehealth in Rural Areas. J Health Care Poor Underserved. 2020;31(4):1546-1556.
- Rodenbeck SJ, Mackay DD. Examining the ocular fundus in neurology. Curr Opin Neurol. 2019;32(1):105-110.
- Rose JS, Lalgudi S, Joshua RA, Paul J, Susanne MA, Phillips AC, et al. A validated audio-visual educational module on examination skills in ophthalmology for undergraduate medical students in the COVID-19 season - An observational longitudinal study. Indian J Ophthalmol. 2021;69(2):400-405.
- Bansal S, Bhambhwani V. Evaluation of a simulation-based ophthalmology education workshop for medical students: a pilot project. BMC Med Educ. 2025;25(1):153.
- Mahmoud A, Abid F, Ezdini M, Lahdhiri ML, Ouanes I, Messaoud R. The contribution of simulation in training for funduscopic examination. Tunis Med. 2021;99(12):1141-1147.
- Akaishi Y, Otaki J, Takahashi O, Breugelmans R, Kojima K, Seki M, et al. Validity of direct ophthalmoscopy skill evaluation with ocular fundus examination simulators. Can J Ophthalmol. 2014;49(4):377-81.
- Byrd JM, Longmire MR, Syme NP, Murray-Krezan C, Rose L. A pilot study on providing ophthalmic training to medical students while initiating a sustainable eye care effort for the underserved. JAMA Ophthalmol. 2014;132(3):304-9.
- Gosheva M, Klameth C, Norrenberg L, Clin L, Dietter J, Haq W, et al. Quality and learning curve of handheld versus stand-alone non-mydriatic cameras. Clin Ophthalmol. 2017;11:1601-1606.
- Popovic N, Vujosevic S, Radunović M, Radunović M, Popovic T. TREND database: Retinal images of healthy young subjects visualized by a portable digital non-mydriatic fundus camera. PLoS One. 2021;16(7):e0254918.
- Wintergerst MWM, Jansen LG, Holz FG, Finger RP. A Novel Device for Smartphone-Based Fundus Imaging and Documentation in Clinical Practice: Comparative Image Analysis Study. JMIR Mhealth Uhealth. 2020;8(7):e17480.
- Wintergerst MWM, Mishra DK, Hartmann L, Shah P, Konana VK, Sagar P, et al. Diabetic Retinopathy Screening Using Smartphone-Based Fundus Imaging in India. Ophthalmology. 2020;127(11):1529-1538.
- Bruce BB, Lamirel C, Biousse V, Ward A, Heilpern KL, Newman NJ, et al. Feasibility of nonmydriatic ocular fundus photography in the emergency department: Phase I of the FOTO-ED study. Acad Emerg Med. 2011;18(9):928-33.
- Browning SD, Costello JM, Dunn HP, Fraser CL. The Use Of Fundus Photography In The Emergency Room-A Review. Curr Neurol Neurosci Rep. 2025;25(1):30.
- Sachdeva V, Vasseneix C, Hage R, Bidot S, Clough LC, Wright DW, et al. Optic nerve head edema among patients presenting to the emergency department. Neurology. 2018;90(5):e373-e379.
- Dunn HP, Teo KZ, Smyth JW, Weerasinghe LS, Costello J, Pampapathi P, et al. Using non-mydriatic fundus photography to detect fundus pathology in Australian metropolitan emergency departments: A prospective prevalence and diagnostic accuracy study. Emerg Med Australas. 2021;33(2):302-309.
- Alm M, Hautala N, Bloigu R, Huhtakangas J. Comparison of optic disc evaluation methods in neurology emergency patients. Acta Neurol Scand. 2019;140(6):449-451.
- Lee WH, Lin MY, Bénard-Séguin E, Pendley AM, Newman NJ, Biousse V. The use of non-mydriatic ocular fundus imaging in the emergency department for detection of ocular syphilis presenting as presumed “papilledema”: a case series. Front Neurol. 2026;17:1881880.
- Ivan Y, Ramgopal S, Cardenas-Villa M, Winger DG, Wang L, Vitale MA, et al. Feasibility of the Digital Retinography System Camera in the Pediatric Emergency Department. Pediatr Emerg Care. 2018;34(7):488-491.
- Frohman LP. The human resource crisis in neuro-ophthalmology. J Neuroophthalmol. 2008;28(3):231-4.
- Schulze Schwering M, Kayange P, Wilhelm H. Neuro-ophthalmology in Malawi. J Neuroophthalmol. 2013;33(2):e11-2.
- Hedges TR 3rd, Torres MR. Neuro-ophthalmology in Cuba. Introduction. Semin Ophthalmol. 2010;25(4):109-11.
- Aldhahwani B. Neuro-ophthalmology in Saudi Arabia: Clinical practice, challenges, and future directions. Saudi J Ophthalmol. 2020;34(1):40-44.
- Solomon AM, Patel VR, Francis CE. Factors Affecting Ophthalmology Resident Choice to Pursue Neuro-Ophthalmology Fellowship Training. J Neuroophthalmol. 2022;42(1):56-61.
- Warner JEA, Krikova I. Physician Assistants in Neuro-Ophthalmology. Neuroophthalmology. 2025;49(2):123-126.
- Bsteh G, Macher S, Krajnc N, Marik W, Michl M, Müller N, et al. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension-a comprehensive assessment of clinical outcome. Eur J Neurol. 2024;31(10):e16401.
- Bsteh G, Macher S, Krajnc N, Marik W, Michl M, Müller N, et al. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension - a comprehensive assessment of patient satisfaction. J Headache Pain. 2024;25(1):127.
- Wiersinga WM. Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves’ orbitopathy. Pediatr Endocrinol Rev. 2010;7 Suppl 2:250-3.
- Lai KE, Ko MW. Can Tele-Neuro-Ophthalmology Be Useful Beyond the Pandemic?. Curr Neurol Neurosci Rep. 2023;23(2):15-23.
- Carter SB, Pistilli M, Livingston KG, Gold DR, Volpe NJ, Shindler KS, et al. The role of orbital ultrasonography in distinguishing papilledema from pseudopapilledema. Eye (Lond). 2014;28(12):1425-30.
- Cheung R, Yu B, Iordanous Y, Malvankar-Mehta MS. The Prevalence of Occupational Burnout Among Ophthalmologists: A Systematic Review and Meta-Analysis. Psychol Rep. 2021;124(5):2139-2154.
- Sutedja TA, Botha VE, Insull EA. Physician burnout in ophthalmology: a New Zealand survey. N Z Med J. 2026;139(1629):49-58.
- Lai KE, Antonio AA, Ko MW, Epling JP, Nguyen AX, Carey AR. Social Media in Neuro-Ophthalmology: Paradigms, Opportunities, and Strategies. J Neuroophthalmol. 2023;43(3):295-302.
- Martínez García L, Pardo-Hernández H, Sanabria AJ, Alonso-Coello P. Continuous surveillance of a pregnancy clinical guideline: an early experience. Syst Rev. 2017;6(1):143.
- Sánchez-Mendiola M, Morales-Castillo D, Torruco-García U, Varela-Ruiz M. Eight years’ experience with a Medical Education Journal Club in Mexico: a quasi-experimental one-group study. BMC Med Educ. 2015;15:222.
- Horntvedt MT, Nordsteien A, Fermann T, Severinsson E. Strategies for teaching evidence-based practice in nursing education: a thematic literature review. BMC Med Educ. 2018;18(1):172.
- Yakobashvili D, Zhu A, Aftab OM, Steidl T, Mahajan J, Khouri AS. Ophthalmology residency programs on social media. Int Ophthalmol. 2023;43(12):4815-4819.
- Al-Khersan H, Tanenbaum R, Kunkler AL, Patel NA, Sridhar J. Adoption and Use of Social Media Platforms by Ophthalmology Programs during the COVID-19 Pandemic. J Acad Ophthalmol (2017). 2022;14(1):e78-e80.
- Clarke C, Smith E, Khan M, Al-Mohtaseb Z. Social Media and Ophthalmology: Perspectives of Patients and Ophthalmologists. J Med Syst. 2018;42(12):258.
- Sarkis-Onofre R, Cenci MS, Demarco FF, Lynch CD, Fleming PS, Pereira-Cenci T, et al. Use of guidelines to improve the quality and transparency of reporting oral health research. J Dent. 2015;43(4):397-404.
- Barajas-Ochoa A, Cisneros-Barrios A, Ramirez-Trejo M, Ramos-Remus C. The Use of Reporting Guidelines in Rheumatology: A Cross-Sectional Study of Over 850 Manuscripts Published in 5 Major Rheumatology Journals. J Rheumatol. 2023;50(7):939-943.
- Chippaux JP. [The different models of scientific journals]. Med Trop Sante Int. 2023;3(4).
- Munn Z, Barker T, Stern C, Pollock D, Ross-White A, Klugar M, et al. Should I include studies from “predatory” journals in a systematic review? Interim guidance for systematic reviewers. JBI Evid Synth. 2021;19(8):1915-1923.
- Orlander JD, Barber TW, Fincke BG. The morbidity and mortality conference: the delicate nature of learning from error. Acad Med. 2002;77(10):1001-6.
- Cohen MB, Garvey EA, Kohn JL, Setzen SA, Grundfast KM, Platt MP. Beyond Morbidity and Mortality Conference: How Do We Learn From Special Cases?. Ann Otol Rhinol Laryngol. 2024;133(12):993-997.
- Freitag SK, Tanking T. A Nomenclature to Describe the Sequence of Visual Field Defects in Progressive Thyroid Eye Disease-Compressive Optic Neuropathy (An American Ophthalmological Society Thesis). Am J Ophthalmol. 2020;213:293-305.
- Choi CJ, Oropesa S, Callahan AB, Glass LR, Teo L, Cestari DM, et al. Patterns of visual field changes in thyroid eye disease. Orbit. 2017;36(4):201-207.
- Jacobson DM. The localizing value of a quadrantanopia. Arch Neurol. 1997;54(4):401-4.
- Thudium MO, Campos AR, Urbach H, Clusmann H. The basal temporal approach for mesial temporal surgery: sparing the Meyer loop with navigated diffusion tensor tractography. Neurosurgery. 2010;67(2 Suppl Operative):385-90.
- Vakharia VN, Vos SB, Winston GP, Gutman MJ, Wykes V, McEvoy AW, et al. Intraoperative overlay of optic radiation tractography during anteromesial temporal resection: a prospective validation study. J Neurosurg. 2022;136(2):543-552.
- Mandelstam SA. Challenges of the anatomy and diffusion tensor tractography of the Meyer loop. AJNR Am J Neuroradiol. 2012;33(7):1204-10.
- Yamaguchi I, Pooh KH, Azumi M, Takagi Y. Temporal crescent syndrome caused by a lateral ventricular glioependymal cyst: case report. J Neurosurg Pediatr. 2020;26(3):232-236.
- Walusinski O. Adolphe Gubler (1821-1879) or Parisian neurology outside La Salpêtrière in the age of Jean-Martin Charcot. Rev Neurol (Paris). 2019;175(4):207-216.
- Salerno A, Strambo D, Nannoni S, Dunet V, Michel P. Patterns of ischemic posterior circulation strokes: A clinical, anatomical, and radiological review. Int J Stroke. 2022;17(7):714-722.
- Sheikh Hassan M, Osman Sidow N, Adam BA, Adani AA. Superior alternating hemiplegia (Weber’s syndrome)- Case report. Ann Med Surg (Lond). 2022;77:103674.
- Cheng G, Yang Y, Wang Y, Tan H, Zhang S. Deep brain stimulation of the thalamic ventral intermediate nucleus for Benedikt’s syndrome mainly present as tremor: a long-term case observation. Acta Neurochir (Wien). 2018;160(7):1349-1353.
- Zanella GS, Brooks B, Lui F. Nothnagel Syndrome Without Extremity Symptoms: A Case Report. Cureus. 2024;16(11):e74346.
- Sheetal S, Byju P. Wernekink commissure syndrome. Neurol India. 2016;64(5):1055-7.
- Dong M, Wang L, Teng W, Tian L. Wernekink commissure syndrome secondary to a rare ‘V’-shaped pure midbrain infarction: a case report and review of the literature. Int J Neurosci. 2020;130(8):826-833.
- Hatgaonkar A, Hatgoankar K, Jobanputra M, Desale P. Clinico-Radiological Correlation of Weber’s Syndrome. Cureus. 2024;16(1):e51624.
- Margolin E, Emami S. Teaching Video NeuroImages: Convergence retraction nystagmus due to compressive lesion of the dorsal midbrain. Neurology. 2020;94(21):e2285-e2286.
- Horn AK. The reticular formation. Prog Brain Res. 2006;151:127-55.
- Cao S, Feng Y, Xu W, Xia M. Vertical one-and-a-half syndrome overlapping with pupillary abnormality. Acta Neurol Belg. 2023;123(3):1149-1151.
- Sakuru R, Elnahry AG, Lui F, Bollu PC. Millard-Gubler syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Omari B, Moustaide H, Alaoui Rachidi S, Belfkih R, Benkirane S, El Bahloul M. Foville’s syndrome caused by an epidermoid cyst of the brainstem discovered post-partum. J Fr Ophtalmol. 2022;45(6):e284-e287.
- Brogna C, Fiengo L, Türe U. Achille Louis Foville’s atlas of brain anatomy and the Defoville syndrome. Neurosurgery. 2012;70(5):1265-73; discussion 1273.
- Mégevand P, Pilly B, Delavelle J, Tajouri N, Safran AB, Landis T, et al. Sixth cranial nerve palsy and contralateral hemiparesis (Raymond’s syndrome) sparing the face. J Neurol. 2009;256(6):1017-8.
- Tosunoğlu B, Çokal BG, Güneş HN, Yoldaş TK. Millard-Gubler Syndrome due to Parenchymal Neuro-Behcet’s Syndrome Lesion: a Rare Case Report. Acta Neurol Taiwan. 2024;33(1):19-22.
- Murdoch S, Shah P, Jampana R. The Guillain-Mollaret triangle in action. Pract Neurol. 2016;16(3):243-6.
- Wilks A, McCullough A, Day GS. Oculopalatal Tremor Following Pontine Hemorrhage. Neurohospitalist. 2019;9(4):241-242.
- Siddik AB, Singh J, Gupta V. Medial medullary syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Sun B, Jin Y, Ye Z, Xu H, Luo W, Liu S. Vertebral artery dissection induced lateral medullary syndrome characterized with severe bradycardia: a case report and review of the literature. Ann Palliat Med. 2022;11(10):3330-3336.
- Roquer J, Lorenzo JL, Pou A. The anterior inferior cerebellar artery infarcts: a clinical-magnetic resonance imaging study. Acta Neurol Scand. 1998;97(4):225-30.
- Ogawa K, Suzuki Y, Takahashi K, Akimoto T, Kamei S, Soma M. Clinical Study of Seven Patients with Infarction in Territories of the Anterior Inferior Cerebellar Artery. J Stroke Cerebrovasc Dis. 2017;26(3):574-581.
- Cimmino AT, Vitali F, Iorio R. Teaching Video NeuroImage: Bilateral Eyelid Opening Apraxia in a Patient With Top of the Basilar Syndrome. Neurology. 2023;100(15):734-735.
- Baird TA, Muir KW, Bone I. Basilar artery occlusion. Neurocrit Care. 2004;1(3):319-29.
- Schnetzer L, McCoy M, Bergmann J, Kunz A, Leis S, Trinka E. Locked-in syndrome revisited. Ther Adv Neurol Disord. 2023;16:17562864231160873.
- Das JM, Anosike K, Asuncion RMD. Locked-in syndrome. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Kattah JC, Eggers SD, Bach SE, Dubey D, McKeon AB. Paraneoplastic Progressive Downbeat Nystagmus, Ataxia and Sensorineural Hearing Loss due to the ANTI-Kelch-11 Protein Antibody. J Neuroophthalmol. 2021;41(2):261-265.
- Hari Kumar KVS, Singh P. Seesaw Nystagmus. N Engl J Med. 2017;376(24):e51.
- Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol. 2017;69(12):2271-2282.
- Al-Ani A, Chen JJ, Costello F. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges. J Neurol. 2023;270(8):4132-4150.
- Klyscz P, Asseyer S, Alonso R, Bereuter C, Bialer O, Bick A, et al. Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network. Ann Clin Transl Neurol. 2024;11(9):2473-2484.
- Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982;45(1):13-8.
- Scott CJ, Kardon RH, Lee AG, Frisén L, Wall M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010;128(6):705-11.
- Betrains A, Moreel L, Blockmans D. The 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis and Takayasu arteritis: comment on the articles by Ponte et al and Grayson et al. Arthritis Rheumatol. 2023;75(6):1074.
- Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. 2021;96(3):114-122.
- Pasnoor M, Wolfe GI, Barohn RJ. Myasthenia gravis. Handb Clin Neurol. 2024;203:185-203.
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.
- Olesen J. The International Classification of Headache Disorders: History and future perspectives. Cephalalgia. 2024;44(1):3331024231214731.
- Paemeleire K, Vandenbussche N, Stark R. Migraine without aura. Handb Clin Neurol. 2023;198:151-167.
- Ravishankar K. Classification of Trigeminal Autonomic Cephalalgia: What has Changed in International Classification of Headache Disorders-3 Beta?. Ann Indian Acad Neurol. 2018;21(Suppl 1):S45-S50.
- Puledda F, Schankin C, Goadsby PJ. Visual snow syndrome: A clinical and phenotypical description of 1,100 cases. Neurology. 2020;94(6):e564-e574.
- Romozzi M, Trigila V, Tosto F, Cuffaro G, García-Azorín D, Iannone LF, et al. Prevalence and characteristics of visual snow syndrome in a cohort of young Italian adults. Eur J Neurol. 2024;31(12):e16472.
- Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020;72(1):7-19.
- International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338-47.
- Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391-404.
- Barrow DL, Spector RH, Braun IF, Landman JA, Tindall SC, Tindall GT. Classification and treatment of spontaneous carotid-cavernous sinus fistulas. J Neurosurg. 1985;62(2):248-56.
- Carelli V, Carbonelli M, de Coo IF, Kawasaki A, Klopstock T, Lagrèze WA, et al. International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy. J Neuroophthalmol. 2017;37(4):371-381.
- Perez DL, Aybek S, Popkirov S, Kozlowska K, Stephen CD, Anderson J, et al. A Review and Expert Opinion on the Neuropsychiatric Assessment of Motor Functional Neurological Disorders. J Neuropsychiatry Clin Neurosci. 2021;33(1):14-26.
- Clausen K, Davis S, Pourmand A. Approach to anisocoria in the emergency department. Am J Emerg Med. 2023;69:218.e1-218.e3.
- Lebas M, Seror J, Debroucker T. Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke. J Neuroophthalmol. 2010;30(1):12-7.
- Kauh CY, Bursztyn LL. Positive Apraclonidine Test in Horner Syndrome Caused by Thalamic Hemorrhage. J Neuroophthalmol. 2015;35(3):287-8.
- Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination. Am J Ophthalmol. 2006;142(3):469-74.
- Wijemanne S, Vijayakumar D, Jankovic J. Apraclonidine in the treatment of ptosis. J Neurol Sci. 2017;376:129-132.
- Jacobson DM, Berg R, Grinstead GF, Kruse JR. Duration of positive urine for cocaine metabolite after ophthalmic administration: implications for testing patients with suspected Horner syndrome using ophthalmic cocaine. Am J Ophthalmol. 2001;131(6):742-7.
- Moster ML, Galiani D, Garfinkle W. False negative hydroxyamphetamine test in horner syndrome caused by acute internal carotid artery dissection. J Neuroophthalmol. 2003;23(1):22-3.
- Bates AT, Chamberlain S, Champion M, Foley L, Hughes E, Jani B, et al. Pholedrine: a substitute for hydroxyamphetamine as a diagnostic eyedrop test in Horner’s syndrome. J Neurol Neurosurg Psychiatry. 1995;58(2):215-7.
- Han SW, Ryu JH, Baik JS, Kim JY, Hwang YS, Park JH. Early Dorsal Midbrain Syndrome Mimicking an Adie’s Tonic Pupil. J Clin Neurol. 2010;6(1):38-40.
- Garza Leon M, Herrera-Jimenez IP, González-Madrigal PM. Complete Vogt-Koyanagi-Harada disease and Holmes-Adie syndrome: case report. Ocul Immunol Inflamm. 2014;22(4):336-40.
- Szabo B, Popescu LA, Rusu A. [Tonic pupil, pupil Adie syndrome Adie Holmes: current reassessment of terminology — a clinical case]. Oftalmologia. 2012;56(3):46-51.
- La Corte E, Martinoni M. Pupillary Light-Near Dissociation. N Engl J Med. 2021;385(26):e94.
- Rubin MM, Sadoff RS, Cozzi GM. Unilateral mydriasis caused by transdermal scopolamine. Oral Surg Oral Med Oral Pathol. 1990;70(5):569-70.
- Vasselon P, Weiner L, Rossi-Pujo F, Socha M, Peton P, May I, et al. Unilateral mydriasis due to scopolamine patch. Int J Clin Pharm. 2011;33(5):737-9.
- Camkurt MA, Ay D, Akkucuk H, Ozcan H, Kunt MM. Pharmacologic unilateral mydriasis due to nebulized ipratropium bromide. Am J Emerg Med. 2011;29(5):576.e5-6.
- Bansal S, Yin K, Vishwanath M, Doran H, Laitt R, Ansons A. Isolated Pupil-Involving Third Nerve Palsy as the First Presentation of Sarcoidosis. Neuroophthalmology. 2014;38(5):278-280.
- Martel A. [Management of ptosis]. J Fr Ophtalmol. 2022;45(2):233-246.
- Pascuzzi RM. The edrophonium test. Semin Neurol. 2003;23(1):83-8.
- Pillai MR, Sinha S, Aggarwal P, Ravindran RD, Privitera CM. Quantification of RAPD by an automated pupillometer in asymmetric glaucoma and its correlation with manual pupillary assessment. Indian J Ophthalmol. 2019;67(2):227-232.
- Lovett ME, MacDonald JM, Mir M, Ghosh S, O’Brien NF, LaRovere KL. Noninvasive Neuromonitoring Modalities in Children Part I: Pupillometry, Near-Infrared Spectroscopy, and Transcranial Doppler Ultrasonography. Neurocrit Care. 2024;40(1):130-146.
- Wang Q, Yue WWS, Jiang Z, Xue T, Kang SH, Bergles DE, et al. Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. Curr Biol. 2017;27(12):1791-1800.e5.
- Lloyd MJ, Fraunfelder FW. Drug-induced optic neuropathies. Drugs Today (Barc). 2007;43(11):827-36.
- Sharma P, Sharma R. Toxic optic neuropathy. Indian J Ophthalmol. 2011;59(2):137-41.
- Singh P, Karkhur S, Verma V. Ethambutol-Induced Optic Neuropathy: A Retrospective Study of Incidences and Risk Factors. Cureus. 2025;17(2):e79160.
- Lee WH, You SK, Lee YH. Bilateral optic neuropathy following vincristine chemotherapy: A case report with description of multimodal imaging findings. Medicine (Baltimore). 2021;100(9):e24706.
- Goldblum D, Garweg JG. Amiodarone-induced cornea verticillata. Postgrad Med J. 1998;74(877):642.
- Wang M, Ma J, Zhong Y. [Ocular toxicity induced by tamoxifen: an overview]. Zhonghua Yan Ke Za Zhi. 2021;57(3):232-236.
- Vogel KR, Ainslie GR, Schmidt MA, Wisor JP, Gibson KM. mTOR Inhibition Mitigates Molecular and Biochemical Alterations of Vigabatrin-Induced Visual Field Toxicity in Mice. Pediatr Neurol. 2017;66:44-52.e1.
- Kim J, Kim KE, Kim JH, Ahn SJ. Practice Patterns of Screening for Hydroxychloroquine Retinopathy in South Korea. JAMA Netw Open. 2023;6(5):e2314816.
- Ali NS, Long BD, Manzoor NF, Sismanis A, Coelho DH. Doxycycline-Induced Intracranial Hypertension Presenting as Unilateral Pulsatile Tinnitus. Otol Neurotol Open. 2023;3(4):e043.
- Grzybowski A, Brona P. Nutritional optic neuropathy instead of tobacco-alcohol amblyopia. Can J Ophthalmol. 2017;52(5):533.
- Wijnia JW. A Clinician’s View of Wernicke-Korsakoff Syndrome. J Clin Med. 2022;11(22).
- Nishida H, Sahashi K. [Penicillamine-induced myasthenia gravis]. Ryoikibetsu Shokogun Shirizu. 2001.
- Pelechas E, Memi T, Markatseli TE, Voulgari PV, Drosos AA. Adalimumab-induced myasthenia gravis: case-based review. Rheumatol Int. 2020;40(11):1891-1894.
- Fraunfelder FW, Fraunfelder FT. Diplopia and fluoroquinolones. Ophthalmology. 2009;116(9):1814-7.
- Safa H, Johnson DH, Trinh VA, Rodgers TE, Lin H, Suarez-Almazor ME, et al. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature. J Immunother Cancer. 2019;7(1):319.
- Pathak R, Katel A, Massarelli E, Villaflor VM, Sun V, Salgia R. Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases. Oncologist. 2021;26(12):1052-1061.
- Auch LAM, Sieber C, Lehnick D, Hug BL. Adverse drug events of immune checkpoint inhibitors - a retrospective, descriptive real-world data analysis. BMC Cancer. 2025;25(1):1303.
- Gerischer L, Doksani P, Hoffmann S, Meisel A. New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making. BioDrugs. 2025;39(2):185-213.
- Arora S, Surakiatchanukul T, Arora T, Cagini C, Lupidi M, Chhablani J. Sildenafil in ophthalmology: An update. Surv Ophthalmol. 2022;67(2):463-487.
- Margo CE, French DD. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors. Am J Ophthalmol. 2007;143(3):538-9.
- Coppeto JR, Monteiro ML, Lessell S, Bear L, Martinez-Maldonado M. Downbeat nystagmus. Long-term therapy with moderate-dose lithium carbonate. Arch Neurol. 1983;40(12):754-5.
- Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, et al. Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2017;16(3):189-199.
- Moss HE, Gao W, Balcer LJ, Joslin CE. Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial. JAMA Ophthalmol. 2014;132(4):421-7.
- Kelman SE. The ischemic optic neuropathy decompression trial. Arch Ophthalmol. 1993;111(12):1616-8.
- Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med. 2000;343(13):898-904.
- Montalban X. The pros and cons of early treatment of relapsing forms of multiple sclerosis. J Neurol. 2004;251 Suppl 4:IV30-4.
- Stone JH, Spotswood H, Unizony SH, Aringer M, Blockmans D, Brouwer E, et al. New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension. Rheumatology (Oxford). 2022;61(7):2915-2922.
- Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, et al. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Neurol. 2021;20(7):526-536.
- Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, et al. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2024;23(10):1013-1024.
- Yu-Wai-Man P, Newman NJ, Carelli V, Moster ML, Biousse V, Sadun AA, et al. Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. Sci Transl Med. 2020;12(573).
- Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. N Engl J Med. 2017;376(2):115-124.
- Friedman ER, Juliano AF, Hagiwara M, Agarwal M, Bunch PM, Burns J, et al. ACR Appropriateness Criteria® Vision Loss. J Am Coll Radiol. 2025;22(11S):S738-S765.
- Kennedy TA, Corey AS, Policeni B, Agarwal V, Burns J, Harvey HB, et al. ACR Appropriateness Criteria(®) Orbits Vision and Visual Loss. J Am Coll Radiol. 2018;15(5S):S116-S131.
- Chen JJ, Bhatti MT. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Curr Opin Neurol. 2020;33(1):47-54.
- Zhao J, Chen X, Zhang J, Liu L, Wang J, Zhu L. Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features. Mult Scler Relat Disord. 2024;85:105518.
- Mealy MA, Whetstone A, Orman G, Izbudak I, Calabresi PA, Levy M. Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. J Neurol Sci. 2015;355(1-2):59-63.
- Zhou J, Yuan Q, Pu XY, Lu JL, Liu H, Chen HH, et al. Multiparametric MRI for Diagnosing Dysthyroid Optic Neuropathy: Added Value of Magnetization Transfer Imaging. Korean J Radiol. 2025;26(7):704-715.
- Sadik JC, Jianu DC, Sadik R, Purcell Y, Novaes N, Saragoussi E, et al. Imaging of Cerebral Venous Thrombosis. Life (Basel). 2022;12(8).
- Carvalho GB, Matas SL, Idagawa MH, Tibana LA, de Carvalho RS, Silva ML, et al. A new index for the assessment of transverse sinus stenosis for diagnosing idiopathic intracranial hypertension. J Neurointerv Surg. 2017;9(2):173-177.
- Schartz D, Finkelstein A, Bender M, Kessler A, Zhong J. Association of Extent of Transverse Sinus Stenosis With Cerebral Glymphatic Clearance in Patients With Idiopathic Intracranial Hypertension. Neurology. 2024;103(1):e209529.
- Wong GK, Boet R, Poon WS, Yu S, Lam JM. A review of isolated third nerve palsy without subarachnoid hemorrhage using computed tomographic angiography as the first line of investigation. Clin Neurol Neurosurg. 2004;107(1):27-31.
- Songsaeng D, Sakarunchai I, Mongkolnaowarat S, Harmontree S, Pornpunyawut P, Suwanbundit A, et al. Detection and Measurement of Intracranial Aneurysm Compared between Magnetic Resonance Intracranial Black Blood Vessel Imaging and Gold Standard Cerebral Digital Subtraction Angiography. J Neurosci Rural Pract. 2020;11(4):545-551.
- Liu X, Mao J, Sun N, Yu X, Chai L, Tian Y, et al. Deep Learning for Detection of Intracranial Aneurysms from Computed Tomography Angiography Images. J Digit Imaging. 2023;36(1):114-123.
- Pabbisetti D, Gudipati A, Kaul S, Nalla S. MR Imaging in Covid-19-Associated Invasive Fungal Sinusitis. Neurol India. 2024;72(5):1009-1015.
- Cassetta M, Barchetti F, Pranno N, Barchetti G, Fioravanti C, Stagnitti A, et al. High resolution 3-T MR imaging in the evaluation of the facial nerve course. G Chir. 2014;35(1-2):15-9.
- Dubey P, Shekhrajka N, Juliano AF, Agarwal M, Antonio AA, Auron M, et al. ACR Appropriateness Criteria® Horner Syndrome. J Am Coll Radiol. 2025;22(11S):S550-S577.
- Cuvinciuc V, Viallon M, Momjian-Mayor I, Sztajzel R, Pereira VM, Lovblad KO, et al. 3D fat-saturated T1 SPACE sequence for the diagnosis of cervical artery dissection. Neuroradiology. 2013;55(5):595-602.
- Kang DW, Kim DY, Kim J, Baik SH, Jung C, Singh N, et al. Emerging Concept of Intracranial Arterial Diseases: The Role of High Resolution Vessel Wall MRI. J Stroke. 2024;26(1):26-40.
- Bulut HT, Yildirim A, Ekmekci B, Eskut N, Gunbey HP. False-negative diffusion-weighted imaging in acute stroke and its frequency in anterior and posterior circulation ischemia. J Comput Assist Tomogr. 2014;38(5):627-33.
- Alkhiri A, Alturki F, Alansari NM, Almaghrabi AA, Alghamdi BA, Alamri AF, et al. Prognosis and distribution of ischemic stroke with negative diffusion-weighted imaging: a systematic review and meta-analysis. Front Neurol. 2024;15:1376439.
- Fujitani RM, Kafie F. Screening and preoperative imaging of candidates for carotid endarterectomy. Semin Vasc Surg. 1999;12(4):261-74.
- Musso CG. Eponyms in medicine. Arch Argent Pediatr. 2019;117(3):142.
- Woywodt A, Lefrak S, Matteson E. Tainted eponyms in medicine: the “Clara” cell joins the list. Eur Respir J. 2010;36(4):706-8.
- Wardrope A, Dworetzky BA, Barkley GL, Baslet G, Buchhalter J, Doss J, et al. How to do things with words: Two seminars on the naming of functional (psychogenic, non-epileptic, dissociative, conversion, …) seizures. Seizure. 2021;93:102-110.
- Brigo F, Tinazzi M, Trinka E. In Response: Terminology of psychogenic nonepileptic seizures—a Babel of different names?. Epilepsia. 2015;56(7):1179-80.
- Eggers SDZ, Bisdorff A, von Brevern M, Zee DS, Kim JS, Perez-Fernandez N, et al. Classification of vestibular signs and examination techniques: Nystagmus and nystagmus-like movements. J Vestib Res. 2019;29(2-3):57-87.
- Wall M. Perimetry and visual field defects. Handb Clin Neurol. 2021;178:51-77.
- Moussa G, Bassilious K, Mathews N. A novel excel sheet conversion tool from Snellen fraction to LogMAR including ‘counting fingers’, ‘hand movement’, ‘light perception’ and ‘no light perception’ and focused review of literature of low visual acuity reference values. Acta Ophthalmol. 2021;99(6):e963-e965.
- Chotiyarnwong P, McCloskey EV. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol. 2020;16(8):437-447.
- Whittier X, Saag KG. Glucocorticoid-induced Osteoporosis. Rheum Dis Clin North Am. 2016;42(1):177-89, x.
- Sinha A, Bagga A. Pulse steroid therapy. Indian J Pediatr. 2008;75(10):1057-66.
- Ford JA, Gewurz D, Gewurz-Singer O. Tocilizumab in giant cell arteritis: an update for the clinician. Curr Opin Rheumatol. 2023;35(3):135-140.
- Barreras P, Vasileiou ES, Filippatou AG, Fitzgerald KC, Levy M, Pardo CA, et al. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease. Neurology. 2022;99(22):e2504-e2516.
- Wang Y, Huan X, Jiao K, Jiang Q, Goh LY, Shi J, et al. Plasma exchange versus intravenous immunoglobulin in AChR subtype myasthenic crisis: A prospective cohort study. Clin Immunol. 2022;241:109058.
- Portelli M, Papageorgiou PN. An update on idiopathic intracranial hypertension. Acta Neurochir (Wien). 2017;159(3):491-499.
- Lee AG, Pless M, Falardeau J, Capozzoli T, Wall M, Kardon RH. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am J Ophthalmol. 2005;139(5):855-9.
- Kaur K, Gurnani B. Fresnel prisms. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2026.
- Jarrín E, Arranz Márquez E, Yebra González L, García Gil de Bernabé J. Botulinum toxin uses in strabismus: A review of the injections performed during one year in a general hospital. Arch Soc Esp Oftalmol. 2016;91(3):114-9.
- Sechi G, Serra A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6(5):442-55.
- Thewjitcharoen Y, Chongvoranond P, Nakasatien S, Krittiyawong S, Himathongkam T. Metformin-Associated Vitamin B12 Deficiency: An Underrecognized Complication. JCEM Case Rep. 2024;2(4):luae029.
- Lee HJ, Kim H, Lee JY. Diagnosis and management of three optic neuropathies: a national survey. Graefes Arch Clin Exp Ophthalmol. 2020;258(9):1975-1981.